data_1i6e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1i6e _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 CA--C 1.576 1.979 0 CA-C-O 118.135 -0.936 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.68 -28.82 30.51 Favored 'Trans proline' 0 CA--C 1.568 2.211 0 N-CA-C 118.364 2.409 . . . . 0.0 118.364 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.41 -50.32 70.29 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.52 72.08 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 163.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.48 -31.58 66.99 Favored Glycine 0 CA--C 1.55 2.27 0 N-CA-C 118.679 2.231 . . . . 0.0 118.679 165.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.67 -42.51 98.04 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 168.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.11 -40.7 98.38 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 167.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.92 -41.61 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -58.27 -24.8 60.62 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 168.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.19 -29.7 29.91 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 119.495 2.558 . . . . 0.0 119.495 163.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -59.52 -35.81 74.88 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 160.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.79 -33.64 30.73 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 173.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -46.69 -41.75 15.44 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 119.724 3.231 . . . . 0.0 119.724 -173.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.39 -35.95 72.81 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.2 m -91.82 -43.75 9.34 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 169.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -114.04 132.74 55.9 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.318 1.047 . . . . 0.0 111.196 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -117.62 122.68 44.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 170.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.2 mt -47.16 -51.79 17.31 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -92.14 76.78 5.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.083 0.944 . . . . 0.0 111.237 -157.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.89 -21.69 0.96 Allowed Glycine 0 CA--C 1.556 2.614 0 N-CA-C 120.523 2.969 . . . . 0.0 120.523 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -91.42 116.59 28.97 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 118.83 1.315 . . . . 0.0 112.043 -167.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -97.39 121.76 39.66 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.756 0.822 . . . . 0.0 109.972 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.11 -109.88 3.06 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.82 -0.55 . . . . 0.0 113.329 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.19 -47.78 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 117.186 0.493 . . . . 0.0 111.055 167.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.94 170.85 25.41 Favored Glycine 0 CA--C 1.559 2.833 0 N-CA-C 115.444 0.937 . . . . 0.0 115.444 163.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -69.14 169.03 19.05 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 C-N-CA 122.686 2.258 . . . . 0.0 115.111 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -70.07 123.65 22.1 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 120.536 -1.352 . . . . 0.0 112.326 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.4 mt -92.03 11.51 25.04 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 -173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.1 p30 -57.5 122.67 13.21 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 121.555 1.979 . . . . 0.0 113.267 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.85 43.66 94.64 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 118.683 2.233 . . . . 0.0 118.683 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.254 5.2 p -71.65 -23.06 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.1 t -73.82 107.42 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 124.311 1.044 . . . . 0.0 109.565 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.34 -3.82 79.83 Favored Glycine 0 CA--C 1.555 2.535 0 N-CA-C 119.039 2.376 . . . . 0.0 119.039 -162.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -84.83 143.13 29.27 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.802 2.301 . . . . 0.0 112.983 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.2 m -60.74 137.91 58.15 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.9 t -67.06 123.1 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.905 -0.497 . . . . 0.0 110.258 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.266 . . 62.95 50.0 3.34 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -163.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.63 -16.49 28.84 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 119.399 2.519 . . . . 0.0 119.399 -171.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.52 97.67 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 120.048 1.924 . . . . 0.0 109.599 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.21 109.05 5.01 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 123.19 0.596 . . . . 0.0 110.88 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.36 -57.07 0.67 Allowed Glycine 0 N--CA 1.49 2.275 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.018 -157.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -82.42 123.37 29.06 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 117.676 0.738 . . . . 0.0 110.417 167.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.13 124.85 29.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.478 -0.763 . . . . 0.0 110.735 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -94.55 173.53 7.57 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 121.879 0.847 . . . . 0.0 112.36 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.5 t -71.55 154.38 41.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.294 -1.504 . . . . 0.0 113.114 171.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -59.53 -49.66 91.08 Favored Pre-proline 0 CA--C 1.577 1.986 0 CA-C-O 115.959 -1.972 . . . . 0.0 115.239 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.29 -24.39 71.97 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 CA-C-N 124.805 2.752 . . . . 0.0 117.895 166.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.8 tpp -66.86 -49.34 66.01 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.646 1.566 . . . . 0.0 114.158 164.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -59.21 -43.07 92.3 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -12.42 61.47 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 118.862 2.912 . . . . 0.0 118.862 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -65.16 -55.62 17.6 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 120.835 1.652 . . . . 0.0 114.356 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.57 177.63 50.47 Favored Glycine 0 CA--C 1.548 2.104 0 N-CA-C 116.648 1.419 . . . . 0.0 116.648 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.06 -154.18 44.42 Favored Glycine 0 CA--C 1.548 2.147 0 N-CA-C 115.332 0.893 . . . . 0.0 115.332 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -130.7 154.36 48.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.149 0.976 . . . . 0.0 112.261 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -76.64 73.3 3.33 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 123.081 1.42 . . . . 0.0 113.254 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.5 p -70.11 159.6 83.78 Favored Pre-proline 0 CA--C 1.575 1.933 0 C-N-CA 124.516 1.127 . . . . 0.0 112.312 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -57.06 -34.7 98.19 Favored 'Trans proline' 0 CA--C 1.568 2.197 0 N-CA-C 117.794 2.19 . . . . 0.0 117.794 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.82 -45.56 74.35 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 164.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.64 -43.88 85.19 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 170.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.05 -47.37 86.14 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 165.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -55.69 -44.46 77.39 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 121.634 2.016 . . . . 0.0 116.324 169.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -61.41 -55.63 29.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 119.93 1.241 . . . . 0.0 114.111 170.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -60.97 -41.38 96.28 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.1 mt -73.13 -21.66 60.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -63.76 -52.03 62.23 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-N 120.942 1.701 . . . . 0.0 113.352 162.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -150.12 112.61 3.31 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-N 120.146 1.339 . . . . 0.0 109.299 168.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.96 -47.44 0.17 Allowed 'Trans proline' 0 CA--C 1.56 1.819 0 CA-C-N 122.672 1.99 . . . . 0.0 116.933 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.45 -26.53 65.55 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.92 -41.54 86.89 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 161.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.0 t -71.45 -58.86 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.416 1.007 . . . . 0.0 112.629 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.74 100.92 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -74.94 100.69 4.19 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 121.366 0.603 . . . . 0.0 111.685 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.52 18.47 12.94 Favored Glycine 0 CA--C 1.554 2.491 0 N-CA-C 118.58 2.192 . . . . 0.0 118.58 -165.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -71.77 137.46 47.69 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.141 1.971 . . . . 0.0 111.997 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -73.51 6.85 2.71 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 167.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.5 ttt -73.28 94.82 2.05 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 120.415 1.461 . . . . 0.0 111.451 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.62 70.75 5.01 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.754 1.264 . . . . 0.0 113.431 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -130.49 130.45 44.2 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.512 1.125 . . . . 0.0 107.988 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.06 -54.96 22.03 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.98 155.06 6.47 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.0 mt -103.97 98.14 12.84 Favored Pre-proline 0 CA--C 1.573 1.846 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.373 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.03 -33.32 15.78 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 122.572 2.181 . . . . 0.0 117.644 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.03 133.1 36.82 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.102 0.865 . . . . 0.0 112.361 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.1 tt -56.15 -44.58 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 171.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.9 -45.84 71.24 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.16 -47.72 80.49 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 169.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 75.0 mtm-85 -64.73 -50.96 64.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.35 93.11 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -56.9 -50.17 73.32 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 168.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.0 tp -54.89 -48.67 72.7 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.75 -41.77 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 119.859 1.209 . . . . 0.0 113.411 171.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.21 -43.12 74.18 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 164.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -62.44 -44.68 95.85 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 168.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.2 mt -64.08 -27.86 69.39 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 169.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.22 -44.3 76.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 120.261 1.391 . . . . 0.0 114.657 158.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -53.96 -54.37 31.62 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 117.44 1.736 . . . . 0.0 117.44 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -84.07 81.46 8.79 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 118.539 1.17 . . . . 0.0 111.649 160.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 C--O 1.253 1.249 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 155.149 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 CA--C 1.577 1.981 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.84 -28.5 24.79 Favored 'Trans proline' 0 CA--C 1.569 2.25 0 N-CA-C 118.523 2.47 . . . . 0.0 118.523 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.24 -46.83 79.01 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.29 -37.6 78.1 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 159.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.95 -35.5 76.23 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 119.14 2.416 . . . . 0.0 119.14 168.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.12 -42.93 91.74 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 163.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.44 -43.61 96.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.1 -45.01 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 166.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -56.88 -26.61 59.14 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.39 -34.1 6.24 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 161.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -59.2 -35.75 74.15 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 162.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.78 -20.23 43.08 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 171.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -73.86 67.6 1.23 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 123.802 1.763 . . . . 0.0 115.361 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.56 -57.18 0.1 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.365 1.466 . . . . 0.0 108.258 168.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.7 m -71.91 -44.26 63.97 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 166.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -112.42 138.29 49.38 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 119.925 1.238 . . . . 0.0 111.756 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -131.68 123.09 27.05 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.618 0.723 . . . . 0.0 109.774 -171.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.9 mt -72.48 -10.94 60.41 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.9 58.8 1.03 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 120.998 1.726 . . . . 0.0 112.052 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.02 15.6 36.73 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 121.129 3.212 . . . . 0.0 121.129 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -103.73 129.61 51.12 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 119.192 1.496 . . . . 0.0 110.897 -174.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.53 102.51 10.37 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.29 -105.57 3.04 Favored Glycine 0 N--CA 1.49 2.292 0 O-C-N 121.998 -0.439 . . . . 0.0 112.873 -174.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -73.4 -47.06 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.45 167.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.95 167.01 14.22 Favored Glycine 0 CA--C 1.56 2.899 0 CA-C-N 119.315 0.961 . . . . 0.0 114.711 164.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.7 173.03 13.25 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 CA-C-N 120.803 2.302 . . . . 0.0 115.799 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -70.18 122.39 19.38 Favored 'General case' 0 CA--C 1.57 1.713 0 O-C-N 120.561 -1.337 . . . . 0.0 112.43 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.76 7.72 38.22 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -65.07 127.49 31.84 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 120.86 1.664 . . . . 0.0 111.671 164.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.51 24.19 65.94 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 118.26 2.064 . . . . 0.0 118.26 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -79.34 -26.81 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 120.319 2.06 . . . . 0.0 116.259 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.9 t -77.89 105.16 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 120.208 1.367 . . . . 0.0 109.192 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.37 -7.93 64.2 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 118.72 2.248 . . . . 0.0 118.72 -160.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -81.32 142.76 32.77 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 120.987 2.393 . . . . 0.0 113.07 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.3 m -60.12 139.09 57.72 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -67.3 123.23 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.919 -0.488 . . . . 0.0 110.318 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 62.16 49.48 4.4 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -162.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.94 -15.63 30.54 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 119.268 2.467 . . . . 0.0 119.268 -170.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.1 t -83.76 96.67 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 119.965 1.882 . . . . 0.0 109.467 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.35 107.83 3.96 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-O 121.381 0.61 . . . . 0.0 111.006 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.68 -56.1 0.63 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.195 -157.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -83.07 127.12 33.29 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 117.791 0.796 . . . . 0.0 110.777 168.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -81.37 115.72 20.86 Favored 'General case' 0 CA--C 1.565 1.548 0 O-C-N 121.548 -0.72 . . . . 0.0 110.937 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -87.67 168.42 13.02 Favored 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 123.541 0.736 . . . . 0.0 112.529 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 p -73.33 152.58 40.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.106 -1.621 . . . . 0.0 113.056 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -57.57 -42.32 95.07 Favored Pre-proline 0 CA--C 1.574 1.895 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.31 -26.71 41.32 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 CA-C-N 125.017 2.828 . . . . 0.0 117.184 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.9 tpp -63.9 -46.32 85.4 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 120.451 1.478 . . . . 0.0 114.091 162.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.21 -46.63 82.74 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 166.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.81 -14.63 61.56 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 118.87 2.915 . . . . 0.0 118.87 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -62.55 -53.37 55.73 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 120.652 1.569 . . . . 0.0 114.84 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.61 -179.44 50.89 Favored Glycine 0 CA--C 1.547 2.045 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.61 -154.58 48.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -174.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -131.08 155.12 47.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.105 0.955 . . . . 0.0 112.356 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.32 75.15 3.11 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.968 1.366 . . . . 0.0 112.992 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.8 p -72.48 159.38 85.52 Favored Pre-proline 0 CA--C 1.576 1.949 0 C-N-CA 124.428 1.091 . . . . 0.0 112.191 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -57.31 -32.5 93.96 Favored 'Trans proline' 0 CA--C 1.572 2.391 0 N-CA-C 117.636 2.129 . . . . 0.0 117.636 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -64.82 -52.97 53.93 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 164.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.87 -43.73 86.17 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.5 mt -56.93 -50.76 71.61 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 167.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.7 pp0? -64.67 -32.73 74.53 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -61.34 -56.45 20.23 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 162.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -59.74 -41.5 91.06 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.2 mt -74.82 -14.56 60.7 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -67.54 -65.46 0.68 Allowed 'General case' 0 CA--C 1.57 1.714 0 CA-C-N 120.646 1.567 . . . . 0.0 111.308 156.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -133.06 101.58 13.66 Favored Pre-proline 0 CA--C 1.571 1.766 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.57 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.42 -51.11 0.14 Allowed 'Trans proline' 0 CA--C 1.562 1.917 0 CA-C-N 122.788 2.031 . . . . 0.0 115.693 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.58 -19.18 62.88 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.59 -43.21 56.66 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.692 1.587 . . . . 0.0 114.992 162.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.54 -57.14 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 119.423 1.011 . . . . 0.0 112.748 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.3 t -102.44 102.65 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -72.68 102.71 3.39 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-O 121.26 0.552 . . . . 0.0 111.44 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.58 26.45 9.2 Favored Glycine 0 CA--C 1.553 2.426 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -165.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -72.03 132.27 44.03 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.538 1.669 . . . . 0.0 111.254 160.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -76.03 11.04 1.58 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 166.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -73.52 99.03 2.92 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 120.848 -1.157 . . . . 0.0 111.278 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.4 72.9 6.05 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 122.564 1.174 . . . . 0.0 112.982 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -128.61 135.43 49.32 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 124.484 1.114 . . . . 0.0 108.662 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.46 -58.15 4.34 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.43 149.88 5.18 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-N 118.931 0.787 . . . . 0.0 114.944 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -102.01 99.15 11.52 Favored Pre-proline 0 CA--C 1.572 1.809 0 CA-C-O 117.774 -1.108 . . . . 0.0 109.441 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.43 -35.32 18.27 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 122.657 2.238 . . . . 0.0 117.624 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -72.37 127.42 32.51 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -58.33 -39.95 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 167.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -53.84 -46.59 71.24 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.048 1.869 . . . . 0.0 116.048 169.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.45 -44.43 89.19 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -63.75 -51.27 65.66 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.12 -43.75 91.98 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 170.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -54.33 -54.2 43.63 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.932 1.242 . . . . 0.0 114.017 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.1 tp -55.08 -47.65 74.6 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 170.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.251 61.7 mt -62.98 -41.29 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 117.396 -1.288 . . . . 0.0 113.116 173.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.7 -43.99 69.43 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 163.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -60.75 -47.6 85.59 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 167.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 52.6 mt -63.73 -31.29 72.41 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 171.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.86 -42.66 99.84 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 162.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.58 99.48 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 117.827 1.891 . . . . 0.0 117.827 163.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -83.11 72.5 10.12 Favored 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 118.356 1.078 . . . . 0.0 112.408 172.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.603 175.609 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 CA--C 1.576 1.958 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.04 -26.75 25.95 Favored 'Trans proline' 0 CA--C 1.568 2.219 0 N-CA-C 118.38 2.415 . . . . 0.0 118.38 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.82 85.59 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 167.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.85 -39.46 81.36 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 161.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.41 -36.49 77.06 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 119.083 2.393 . . . . 0.0 119.083 168.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -54.39 -47.6 72.51 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 162.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -59.62 -44.18 93.54 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.33 -42.72 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 119.527 1.058 . . . . 0.0 113.831 167.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -55.85 -26.98 49.44 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.93 -34.11 10.94 Favored Glycine 0 N--CA 1.5 2.928 0 N-CA-C 119.818 2.687 . . . . 0.0 119.818 166.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -58.32 -39.64 79.95 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 162.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -78.42 -32.88 48.87 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -45.32 -45.05 12.07 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 -174.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.46 -37.45 70.32 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 m -91.95 -43.31 9.53 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 171.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -112.43 128.04 56.2 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.372 0.987 . . . . 0.0 111.449 -169.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -113.37 130.35 56.31 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.992 0.901 . . . . 0.0 111.265 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.6 mt -74.46 -24.3 59.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.98 56.86 3.63 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 121.117 1.78 . . . . 0.0 113.095 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.39 16.21 34.58 Favored Glycine 0 CA--C 1.558 2.772 0 N-CA-C 120.624 3.009 . . . . 0.0 120.624 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -105.75 133.05 51.11 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.65 1.725 . . . . 0.0 112.395 -171.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.79 122.76 36.6 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.627 169.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.01 -107.37 2.56 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.85 -0.531 . . . . 0.0 112.089 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.51 -50.21 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-N 117.202 0.501 . . . . 0.0 110.987 165.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.04 170.75 21.01 Favored Glycine 0 CA--C 1.56 2.879 0 N-CA-C 115.046 0.778 . . . . 0.0 115.046 163.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.77 176.6 6.56 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 122.627 2.218 . . . . 0.0 116.085 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -71.77 120.18 16.99 Favored 'General case' 0 CA--C 1.566 1.58 0 O-C-N 120.217 -1.552 . . . . 0.0 112.406 173.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.97 -4.68 57.22 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -66.04 115.96 6.64 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-N 119.066 0.848 . . . . 0.0 110.51 160.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.44 39.61 10.8 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 -171.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 p -97.29 -31.84 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.29 109.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 120.871 1.669 . . . . 0.0 108.971 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.69 -14.57 64.63 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 118.778 2.271 . . . . 0.0 118.778 -162.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -75.3 143.11 43.12 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 121.103 2.452 . . . . 0.0 112.965 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.1 m -59.27 142.35 52.13 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.6 t -67.22 122.58 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.83 -0.544 . . . . 0.0 110.348 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 63.47 53.48 2.11 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -162.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.24 -11.28 29.91 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 119.38 2.512 . . . . 0.0 119.38 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.0 t -86.14 95.44 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 120.245 2.023 . . . . 0.0 109.032 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -69.35 118.22 11.97 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.943 0.897 . . . . 0.0 112.199 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.85 -52.56 0.81 Allowed Glycine 0 N--CA 1.492 2.396 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.788 -159.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -79.55 120.93 24.6 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 117.698 0.749 . . . . 0.0 110.918 171.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -76.36 118.29 18.91 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.635 -0.666 . . . . 0.0 110.541 170.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -88.24 169.95 11.43 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.608 0.763 . . . . 0.0 111.217 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.2 p -71.24 157.07 38.76 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 119.832 -1.793 . . . . 0.0 113.43 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -54.74 -50.0 88.29 Favored Pre-proline 0 CA--C 1.578 2.028 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.46 -24.96 48.76 Favored 'Trans proline' 0 CA--C 1.564 1.995 0 CA-C-N 124.349 2.589 . . . . 0.0 117.629 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.2 tpp -65.61 -48.57 71.82 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 120.633 1.56 . . . . 0.0 114.02 163.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -58.97 -44.37 91.52 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 168.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -11.04 60.39 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 118.959 2.948 . . . . 0.0 118.959 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -63.29 -54.2 40.84 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.862 1.664 . . . . 0.0 114.92 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.47 175.45 50.2 Favored Glycine 0 CA--C 1.547 2.062 0 N-CA-C 116.54 1.376 . . . . 0.0 116.54 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.04 -155.75 44.77 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 115.217 0.847 . . . . 0.0 115.217 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -131.85 156.2 46.48 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.891 0.853 . . . . 0.0 112.087 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -76.66 76.17 3.33 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 123.336 1.541 . . . . 0.0 112.831 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.0 p -76.46 160.75 76.76 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.966 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -57.21 -35.39 98.89 Favored 'Trans proline' 0 CA--C 1.571 2.337 0 N-CA-C 117.696 2.152 . . . . 0.0 117.696 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.29 -51.47 67.55 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 164.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.01 94.34 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.6 mt -56.42 -52.05 66.11 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 168.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.293 2.8 pp0? -63.06 -36.56 83.99 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -61.37 -54.46 43.37 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 165.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -57.55 -44.35 85.14 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.3 mt -72.65 -13.34 61.34 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 171.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -64.04 -53.84 43.55 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 120.997 1.726 . . . . 0.0 112.788 161.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.7 103.99 2.33 Favored Pre-proline 0 CA--C 1.577 1.994 0 CA-C-N 119.623 1.101 . . . . 0.0 108.59 173.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.02 -46.51 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 N-CA-C 117.429 2.05 . . . . 0.0 117.429 -168.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.65 -21.28 66.29 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.91 -48.99 56.39 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 161.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.68 -55.71 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 119.521 1.055 . . . . 0.0 113.255 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.23 104.53 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 171.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.15 96.53 2.24 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 121.371 0.605 . . . . 0.0 111.786 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.39 28.29 5.82 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 118.287 2.075 . . . . 0.0 118.287 -167.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -76.25 135.5 39.67 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.526 1.663 . . . . 0.0 111.463 162.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -72.3 7.97 1.53 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 167.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -73.44 99.01 2.87 Favored 'General case' 0 CA--C 1.564 1.512 0 O-C-N 120.63 -1.294 . . . . 0.0 111.395 170.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.41 74.87 4.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 122.737 1.255 . . . . 0.0 113.082 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -138.63 131.18 28.96 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.347 1.059 . . . . 0.0 108.182 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.68 -55.57 10.99 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.27 155.08 6.99 Favored Glycine 0 CA--C 1.545 1.95 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 99.3 mt -103.24 97.68 10.48 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 117.889 -1.053 . . . . 0.0 108.855 170.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.91 -32.95 27.75 Favored 'Trans proline' 0 CA--C 1.568 2.197 0 C-N-CA 122.648 2.232 . . . . 0.0 117.819 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -73.46 118.66 16.68 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 123.941 0.896 . . . . 0.0 113.252 174.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.97 -40.1 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 169.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -53.06 -47.73 68.23 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 170.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -61.41 -41.69 97.54 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 169.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 86.7 mtm-85 -60.12 -50.49 73.47 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.73 -45.58 81.86 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 167.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -54.55 -52.35 62.33 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -57.81 -45.7 85.73 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 170.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.258 62.6 mt -63.9 -41.6 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.161 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.46 -43.63 71.84 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 163.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -58.34 -49.94 75.43 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 166.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.1 mt -68.82 -26.64 65.28 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.29 -39.86 84.29 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 158.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.85 -47.52 82.09 Favored Glycine 0 CA--C 1.552 2.402 0 N-CA-C 117.357 1.703 . . . . 0.0 117.357 164.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -77.16 83.81 3.65 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 118.424 1.112 . . . . 0.0 112.344 173.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.188 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 CA--C 1.575 1.934 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.57 -28.25 31.88 Favored 'Trans proline' 0 CA--C 1.566 2.115 0 N-CA-C 118.42 2.431 . . . . 0.0 118.42 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.11 96.86 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 168.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.68 95.13 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 161.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.87 -38.06 72.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 119.146 2.418 . . . . 0.0 119.146 166.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -55.19 -48.8 73.29 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 164.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -59.75 -43.55 94.22 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.57 -38.15 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 167.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.77 -20.61 15.49 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 169.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.78 -38.51 4.41 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 119.636 2.615 . . . . 0.0 119.636 156.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.97 -31.91 73.1 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 166.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -87.91 -33.53 18.47 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -57.91 -32.09 67.4 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 120.505 3.521 . . . . 0.0 120.505 -166.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.02 82.36 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 171.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.2 m -87.41 -44.14 11.57 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -109.22 143.83 38.15 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.339 1.056 . . . . 0.0 112.872 -168.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -118.51 150.28 39.87 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.381 1.086 . . . . 0.0 112.139 -172.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -104.07 1.89 31.46 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -115.52 57.63 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.422 1.464 . . . . 0.0 111.548 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.69 4.87 21.26 Favored Glycine 0 CA--C 1.558 2.771 0 N-CA-C 120.492 2.957 . . . . 0.0 120.492 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -97.7 143.02 28.78 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 118.87 1.335 . . . . 0.0 112.766 -168.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.38 103.97 8.5 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.46 -105.7 3.05 Favored Glycine 0 N--CA 1.49 2.234 0 O-C-N 122.117 -0.365 . . . . 0.0 113.142 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.32 -49.75 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.848 166.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.65 163.49 16.39 Favored Glycine 0 CA--C 1.56 2.864 0 CA-C-N 118.911 0.778 . . . . 0.0 114.851 164.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.72 176.09 8.7 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 CA-C-N 120.845 2.323 . . . . 0.0 115.935 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -70.23 120.2 15.56 Favored 'General case' 0 CA--C 1.568 1.646 0 O-C-N 120.535 -1.353 . . . . 0.0 113.279 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -87.84 -4.01 58.89 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -62.95 111.7 2.27 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.349 1.431 . . . . 0.0 111.729 157.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.66 43.58 7.72 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 -173.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.09 -37.88 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 118.805 1.303 . . . . 0.0 114.491 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.39 107.8 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.898 1.226 . . . . 0.0 110.096 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.81 -19.96 52.26 Favored Glycine 0 CA--C 1.552 2.372 0 N-CA-C 118.503 2.161 . . . . 0.0 118.503 -163.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -73.01 143.63 47.49 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 120.929 2.364 . . . . 0.0 113.415 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.3 m -60.4 140.26 57.28 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.16 124.32 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 123.405 0.682 . . . . 0.0 110.824 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.39 48.72 5.79 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -164.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.05 -8.08 39.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 119.46 2.544 . . . . 0.0 119.46 -169.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.1 t -82.94 103.23 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 120.199 2.0 . . . . 0.0 109.12 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.27 90.33 0.91 Allowed 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.546 0.738 . . . . 0.0 112.081 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.27 -48.84 0.51 Allowed Glycine 0 N--CA 1.486 2.029 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.857 -160.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -81.22 132.16 35.33 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 118.098 0.949 . . . . 0.0 111.572 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -84.48 88.28 7.29 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.435 -0.79 . . . . 0.0 112.017 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -72.85 147.07 45.77 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.2 p -67.74 155.34 39.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -53.82 -49.23 90.45 Favored Pre-proline 0 CA--C 1.578 2.031 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.25 -23.6 38.73 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 CA-C-N 124.125 2.509 . . . . 0.0 117.521 170.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.1 tpp -65.4 -46.65 79.19 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 120.885 1.675 . . . . 0.0 114.147 161.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -57.84 -45.9 85.55 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 168.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.01 -11.96 61.01 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 170.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -60.4 -49.47 77.45 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.045 1.748 . . . . 0.0 114.638 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.88 164.72 36.08 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 163.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.46 -144.69 24.63 Favored Glycine 0 N--CA 1.486 2.015 0 CA-C-N 114.915 -0.642 . . . . 0.0 114.694 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -130.84 154.78 47.69 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.665 0.745 . . . . 0.0 111.493 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -76.12 76.81 2.95 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 123.149 1.452 . . . . 0.0 112.558 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -75.72 159.89 80.28 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.881 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.18 -33.75 91.33 Favored 'Trans proline' 0 CA--C 1.57 2.289 0 N-CA-C 117.66 2.139 . . . . 0.0 117.66 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.31 -50.66 59.27 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 166.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.65 -43.67 85.11 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -57.17 -50.73 71.93 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 165.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.304 1.6 pp0? -61.28 -37.24 82.47 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 175.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.43 -59.02 6.01 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 164.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -58.93 -42.83 90.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.5 mt -69.77 -17.39 63.42 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.5 m -62.71 -55.23 28.6 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.26 1.846 . . . . 0.0 112.869 164.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.23 103.32 2.42 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-N 119.496 1.044 . . . . 0.0 108.525 173.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.02 -46.63 0.37 Allowed 'Trans proline' 0 CA--C 1.558 1.686 0 N-CA-C 117.431 2.05 . . . . 0.0 117.431 -167.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.95 -25.85 68.55 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 169.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 -45.06 70.21 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 163.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.9 t -65.47 -55.3 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.558 1.072 . . . . 0.0 112.782 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.8 104.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -72.99 98.29 2.48 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-O 121.454 0.645 . . . . 0.0 111.316 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.83 23.84 7.61 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 118.657 2.223 . . . . 0.0 118.657 -168.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.4 t -75.41 134.52 40.89 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 119.615 1.708 . . . . 0.0 111.061 160.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -72.92 9.08 1.25 Allowed 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 117.409 2.374 . . . . 0.0 117.409 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -76.25 100.77 5.19 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 120.725 -1.234 . . . . 0.0 111.726 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.64 71.36 4.12 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 122.595 1.188 . . . . 0.0 113.611 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -138.63 128.03 24.49 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.85 -53.48 32.03 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.88 158.79 8.9 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 115.471 0.948 . . . . 0.0 115.471 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.7 mt -100.26 98.56 7.95 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 117.934 -1.031 . . . . 0.0 108.524 166.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.55 -36.39 11.46 Favored 'Trans proline' 0 CA--C 1.565 2.044 0 C-N-CA 122.658 2.239 . . . . 0.0 117.575 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.08 133.53 41.56 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 118.94 0.791 . . . . 0.0 112.527 175.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -57.77 -40.66 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 171.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.57 -43.25 84.37 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.78 -44.72 73.95 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 167.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -66.43 -55.27 16.52 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 173.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.66 98.07 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.64 -47.41 86.36 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.964 1.256 . . . . 0.0 114.11 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.39 -44.0 92.87 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 169.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.0 mt -60.55 -42.87 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 117.539 -1.22 . . . . 0.0 113.101 169.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.67 -44.05 72.97 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 164.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -58.92 -48.22 82.23 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 166.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.9 mt -69.39 -24.47 63.86 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.31 -41.21 92.99 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 156.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.3 -44.96 92.75 Favored Glycine 0 CA--C 1.554 2.5 0 N-CA-C 117.584 1.794 . . . . 0.0 117.584 163.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -79.17 82.36 5.34 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-N 118.623 1.212 . . . . 0.0 111.882 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.43 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.573 1.848 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.71 -23.51 30.93 Favored 'Trans proline' 0 CA--C 1.568 2.203 0 N-CA-C 118.227 2.357 . . . . 0.0 118.227 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.96 -47.36 83.51 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.08 81.56 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 162.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.83 -35.03 66.22 Favored Glycine 0 CA--C 1.552 2.383 0 N-CA-C 119.114 2.405 . . . . 0.0 119.114 164.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.53 -49.77 76.5 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 168.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -59.65 -41.59 90.89 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 169.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.52 -39.16 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 169.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -56.85 -23.03 41.21 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 167.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.05 -35.57 18.99 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 119.585 2.594 . . . . 0.0 119.585 162.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.8 -36.33 76.5 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 162.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -80.27 -32.54 38.22 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 171.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -49.85 -33.8 18.06 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.78 -26.34 23.29 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 118.145 2.646 . . . . 0.0 118.145 167.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.0 m -120.32 -38.77 2.86 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -108.48 147.28 31.9 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.322 1.049 . . . . 0.0 113.169 -169.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -119.74 148.93 42.82 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.937 0.875 . . . . 0.0 112.108 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -105.66 3.94 29.62 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.62 40.23 1.46 Allowed 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 121.095 1.771 . . . . 0.0 114.628 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.36 35.68 91.76 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 117.981 1.952 . . . . 0.0 117.981 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -131.06 142.38 50.29 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 117.905 0.853 . . . . 0.0 111.27 -166.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -91.82 140.66 29.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.032 -1.042 . . . . 0.0 111.505 174.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.91 -115.46 1.89 Allowed Glycine 0 N--CA 1.491 2.341 0 O-C-N 121.518 -0.739 . . . . 0.0 112.108 172.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.18 -47.54 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.817 164.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.39 173.63 27.59 Favored Glycine 0 CA--C 1.562 3.013 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 163.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.42 172.6 12.97 Favored 'Trans proline' 0 CA--C 1.564 1.996 0 C-N-CA 122.845 2.363 . . . . 0.0 115.583 173.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -68.51 125.83 27.73 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 120.425 -1.422 . . . . 0.0 113.754 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -91.57 -0.86 57.64 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -66.46 111.63 3.66 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-N 120.326 1.421 . . . . 0.0 111.234 162.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.99 41.42 7.58 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 116.687 1.435 . . . . 0.0 116.687 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -92.73 -34.31 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.02 106.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 120.428 1.467 . . . . 0.0 109.512 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.48 -12.12 66.51 Favored Glycine 0 CA--C 1.553 2.44 0 N-CA-C 118.731 2.252 . . . . 0.0 118.731 -161.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -78.31 148.45 33.82 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 121.228 2.514 . . . . 0.0 112.84 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.4 m -54.12 141.53 28.56 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.95 120.87 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.758 -0.589 . . . . 0.0 109.974 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.271 . . 66.42 54.66 0.89 Allowed 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -161.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.98 22.13 9.23 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 119.206 2.442 . . . . 0.0 119.206 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.3 t -102.99 109.22 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.323 1.561 . . . . 0.0 107.79 165.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -72.67 88.33 1.28 Allowed 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 123.453 0.701 . . . . 0.0 111.67 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.87 -47.07 0.54 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.075 -159.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -82.23 131.86 35.23 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 118.362 1.081 . . . . 0.0 111.829 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -78.68 105.58 10.07 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.517 0.727 . . . . 0.0 111.848 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -89.56 156.77 18.39 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -63.35 151.8 39.79 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 171.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -59.26 -48.42 96.23 Favored Pre-proline 0 CA--C 1.577 1.997 0 CA-C-O 116.124 -1.893 . . . . 0.0 115.473 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.42 -24.98 63.7 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 CA-C-N 124.477 2.635 . . . . 0.0 117.937 166.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.4 tpp -65.39 -48.61 72.29 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.796 1.634 . . . . 0.0 114.097 164.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -56.27 -47.83 77.8 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 166.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.64 -11.89 60.82 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 118.994 2.961 . . . . 0.0 118.994 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -63.6 -52.63 60.08 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.762 1.619 . . . . 0.0 114.316 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.08 175.26 49.81 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.69 -148.3 36.61 Favored Glycine 0 CA--C 1.547 2.039 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -134.26 155.03 50.91 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.644 0.735 . . . . 0.0 111.639 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -77.1 77.48 3.64 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.91 1.338 . . . . 0.0 112.838 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.0 p -73.84 159.82 83.38 Favored Pre-proline 0 CA--C 1.574 1.885 0 C-N-CA 124.455 1.102 . . . . 0.0 112.344 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -57.59 -34.39 98.02 Favored 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 122.399 2.066 . . . . 0.0 117.459 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.19 -39.84 74.99 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 116.382 1.994 . . . . 0.0 116.382 165.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.96 97.89 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.54 -43.21 93.57 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 166.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -54.27 -44.49 71.92 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -66.51 -55.6 14.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -59.71 -39.87 86.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 67.8 mt -76.37 -15.03 60.05 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 170.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.0 m -66.36 -53.29 37.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 121.323 1.874 . . . . 0.0 112.738 160.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -150.28 113.36 3.29 Favored Pre-proline 0 CA--C 1.575 1.922 0 CA-C-N 119.986 1.266 . . . . 0.0 109.197 168.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.49 -46.26 0.22 Allowed 'Trans proline' 0 CA--C 1.56 1.807 0 CA-C-N 122.597 1.963 . . . . 0.0 116.954 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.75 -28.83 68.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.77 -41.88 86.99 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 162.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.65 -57.76 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.482 1.037 . . . . 0.0 112.655 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -99.87 101.36 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.67 100.13 2.74 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.336 0.589 . . . . 0.0 111.066 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.84 19.39 12.02 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 118.928 2.331 . . . . 0.0 118.928 -167.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.3 t -73.08 136.83 44.98 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.289 2.044 . . . . 0.0 111.937 163.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -76.99 12.81 1.24 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.484 2.402 . . . . 0.0 117.484 169.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -74.12 95.96 2.65 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.665 -1.272 . . . . 0.0 110.972 169.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.92 74.3 4.47 Favored 'General case' 0 CA--C 1.567 1.627 0 CA-C-O 122.802 1.286 . . . . 0.0 113.24 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -142.05 127.36 18.72 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.57 -52.59 43.89 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.11 161.1 10.09 Favored Glycine 0 CA--C 1.545 1.917 0 CA-C-O 122.6 1.111 . . . . 0.0 115.171 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -100.74 99.17 9.57 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 117.851 -1.071 . . . . 0.0 108.646 168.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.79 -34.46 18.28 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 C-N-CA 122.608 2.206 . . . . 0.0 117.432 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.25 129.26 38.44 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.005 0.82 . . . . 0.0 112.85 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 tp -56.79 -45.21 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 169.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.39 -40.35 74.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -59.24 -46.8 87.52 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 120.176 1.353 . . . . 0.0 114.606 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -62.44 -53.75 50.25 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.24 -45.03 95.17 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -61.54 -45.64 93.32 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.9 tp -55.38 -45.0 76.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 166.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 61.3 mt -61.48 -42.62 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 117.46 -1.257 . . . . 0.0 113.219 171.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.3 -44.36 71.89 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 164.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -59.93 -47.85 84.11 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 167.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.04 -25.96 65.63 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -63.59 -42.75 98.24 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 159.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.99 -45.3 96.4 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 117.69 1.836 . . . . 0.0 117.69 165.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -78.33 77.71 4.81 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 118.292 1.046 . . . . 0.0 112.132 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.577 -0.702 . . . . 0.0 109.774 176.701 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 CA--C 1.575 1.935 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.66 -29.76 23.83 Favored 'Trans proline' 0 CA--C 1.568 2.221 0 N-CA-C 118.389 2.419 . . . . 0.0 118.389 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.34 -46.19 87.73 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 169.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.35 78.36 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 160.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.89 -34.79 72.72 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 168.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.36 -41.75 94.35 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 163.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -59.99 -44.75 94.31 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 167.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.46 -42.81 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 166.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -54.82 -28.05 46.6 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 169.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.62 -35.44 4.14 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 160.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -60.3 -35.8 76.42 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 163.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -80.12 -18.8 48.89 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -73.47 67.4 1.05 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 123.792 1.758 . . . . 0.0 115.0 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.34 -54.83 0.18 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 125.149 1.379 . . . . 0.0 109.059 167.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 m -83.52 -34.87 25.19 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 171.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -110.5 151.68 27.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 119.549 1.068 . . . . 0.0 112.716 -170.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.67 153.18 41.17 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.363 1.077 . . . . 0.0 110.983 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.9 -25.7 17.19 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.28 57.52 4.02 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 121.49 1.95 . . . . 0.0 113.685 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.65 7.69 12.12 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 121.732 3.453 . . . . 0.0 121.732 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -113.31 146.49 39.32 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.632 1.716 . . . . 0.0 112.925 -169.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.1 138.3 44.6 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.296 1.038 . . . . 0.0 111.102 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.72 -108.08 0.62 Allowed Glycine 0 N--CA 1.489 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 113.206 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.83 -51.35 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 CA-C-N 117.297 0.548 . . . . 0.0 111.088 169.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.13 169.82 17.01 Favored Glycine 0 CA--C 1.562 2.974 0 CA-C-N 118.577 0.626 . . . . 0.0 114.254 161.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.28 175.72 10.58 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 120.878 2.339 . . . . 0.0 115.398 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -68.9 124.68 24.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.647 -1.283 . . . . 0.0 112.615 173.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.85 -5.23 58.7 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.878 2.177 . . . . 0.0 116.878 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -63.65 117.31 6.65 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 119.423 1.011 . . . . 0.0 110.638 157.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.59 40.58 12.44 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 116.633 1.413 . . . . 0.0 116.633 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 p -95.68 -33.28 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.48 107.78 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-N 120.572 1.533 . . . . 0.0 109.57 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.07 -11.76 69.04 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 118.743 2.257 . . . . 0.0 118.743 -162.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -76.06 146.62 39.26 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 121.132 2.466 . . . . 0.0 112.704 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.9 m -53.89 140.94 29.09 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.66 113.37 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.669 -0.644 . . . . 0.0 109.298 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.27 . . 68.05 65.23 0.36 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -157.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.34 -25.52 4.95 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 119.187 2.435 . . . . 0.0 119.187 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.28 98.52 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 120.041 1.921 . . . . 0.0 109.504 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -69.25 107.89 3.43 Favored 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 123.284 0.634 . . . . 0.0 111.21 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.31 -52.79 0.75 Allowed Glycine 0 N--CA 1.49 2.239 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.767 -155.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -79.94 129.15 34.26 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 118.081 0.94 . . . . 0.0 111.749 172.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -76.53 98.76 4.74 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.523 0.729 . . . . 0.0 112.514 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -80.89 158.21 25.38 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.4 t -64.06 151.38 43.19 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 172.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -58.76 -48.03 97.59 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 115.963 -1.97 . . . . 0.0 115.8 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.21 -23.63 66.25 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 CA-C-N 124.724 2.723 . . . . 0.0 117.967 165.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.4 tpp -66.5 -49.14 67.56 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 120.794 1.634 . . . . 0.0 113.806 163.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -57.06 -45.89 82.89 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 168.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.71 -14.47 62.46 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 118.777 2.88 . . . . 0.0 118.777 172.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -65.48 -55.42 17.98 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 120.726 1.603 . . . . 0.0 113.777 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.59 178.32 51.2 Favored Glycine 0 CA--C 1.547 2.042 0 N-CA-C 116.853 1.501 . . . . 0.0 116.853 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.72 -145.4 32.63 Favored Glycine 0 CA--C 1.547 2.062 0 O-C-N 121.961 -0.729 . . . . 0.0 114.627 -174.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -134.74 155.75 50.02 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.891 0.853 . . . . 0.0 111.935 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -76.24 76.65 3.04 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 123.148 1.451 . . . . 0.0 112.791 171.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.4 p -72.78 161.5 79.0 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.565 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -57.11 -36.6 99.24 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 122.293 1.995 . . . . 0.0 116.909 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -61.06 -49.62 76.63 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 165.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.35 -43.51 83.52 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 172.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.09 -44.19 93.09 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 167.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -51.1 -47.71 61.85 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 121.047 1.749 . . . . 0.0 115.598 165.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -61.25 -60.98 2.9 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -61.31 -39.46 90.58 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.0 mt -75.65 -17.08 60.1 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 171.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.1 m -66.23 -51.27 59.23 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 120.838 1.654 . . . . 0.0 113.317 159.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -150.46 113.22 3.24 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 120.045 1.293 . . . . 0.0 109.646 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.92 -48.39 0.23 Allowed 'Trans proline' 0 CA--C 1.561 1.827 0 CA-C-N 122.656 1.984 . . . . 0.0 116.713 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.33 -27.4 64.34 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.69 -40.74 88.63 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 162.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.9 t -71.8 -57.85 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 119.323 0.965 . . . . 0.0 112.514 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.71 100.45 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 172.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -73.25 98.94 2.75 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 121.333 0.587 . . . . 0.0 111.633 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.02 22.82 8.07 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -165.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -74.17 136.65 42.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.733 1.767 . . . . 0.0 111.887 163.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -72.45 3.94 4.32 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.7 ttt -73.15 92.43 1.72 Allowed 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 120.334 1.425 . . . . 0.0 111.789 168.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.78 76.87 9.6 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 122.019 0.914 . . . . 0.0 112.624 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -128.02 129.14 46.22 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.459 0.704 . . . . 0.0 110.102 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.96 106.73 5.79 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 121.874 -0.516 . . . . 0.0 111.233 166.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.42 172.81 9.22 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 119.49 2.556 . . . . 0.0 119.49 -168.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.2 107.86 31.83 Favored Pre-proline 0 CA--C 1.572 1.817 0 CA-C-O 117.682 -1.152 . . . . 0.0 111.219 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.54 -35.84 9.71 Favored 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.691 2.261 . . . . 0.0 117.151 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.71 128.1 34.52 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 123.94 0.896 . . . . 0.0 112.975 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.8 tp -56.36 -45.27 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 170.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.16 -46.04 75.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.12 -45.29 83.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 170.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -64.36 -51.74 61.81 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 171.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.78 92.65 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 171.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -54.91 -53.55 54.12 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-N 119.813 1.188 . . . . 0.0 114.098 168.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.6 tp -57.42 -47.68 81.12 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 59.4 mt -63.59 -41.97 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.99 1.268 . . . . 0.0 113.083 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.02 68.54 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 163.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.88 -49.48 77.31 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 167.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.7 mt -66.4 -25.76 66.92 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.33 -44.03 97.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 158.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.03 -40.5 97.11 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 118.301 2.081 . . . . 0.0 118.301 167.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -83.2 84.19 7.58 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 118.655 1.228 . . . . 0.0 110.979 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 C--O 1.257 1.456 0 CA-C-O 118.299 -0.858 . . . . 0.0 109.537 176.597 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 CA--C 1.574 1.889 0 CA-C-O 118.417 -0.802 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.85 -29.93 34.24 Favored 'Trans proline' 0 CA--C 1.567 2.143 0 N-CA-C 118.549 2.48 . . . . 0.0 118.549 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.27 -42.66 99.15 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.51 93.71 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 161.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.86 -37.06 75.83 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 118.912 2.325 . . . . 0.0 118.912 168.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.85 -37.97 77.69 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 164.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -65.5 -45.09 84.96 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 168.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.0 -40.1 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 166.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -56.5 -18.99 13.29 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.5 -39.23 5.68 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 119.237 2.455 . . . . 0.0 119.237 156.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -65.11 -33.83 76.95 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 166.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -87.32 -35.65 18.3 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -58.38 -27.42 64.22 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 119.896 3.295 . . . . 0.0 119.896 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.87 -31.21 62.59 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 166.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 m -105.87 -39.1 6.13 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 171.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -111.64 137.48 49.45 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.257 1.023 . . . . 0.0 112.901 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.33 147.77 23.45 Favored 'General case' 0 CA--C 1.565 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 113.28 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.9 mt -97.89 17.25 18.61 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 162.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -130.44 60.96 1.61 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.49 -1.381 . . . . 0.0 111.388 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.82 -33.12 0.38 Allowed Glycine 0 CA--C 1.557 2.694 0 N-CA-C 120.483 2.953 . . . . 0.0 120.483 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -76.94 145.56 38.09 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.583 1.153 . . . . 0.0 113.618 -172.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -111.13 115.84 30.09 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -109.44 -113.42 3.58 Favored Glycine 0 N--CA 1.491 2.309 0 O-C-N 121.707 -0.621 . . . . 0.0 113.646 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.12 -48.75 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 122.396 -0.473 . . . . 0.0 111.208 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.67 167.02 17.17 Favored Glycine 0 CA--C 1.561 2.936 0 CA-C-N 118.782 0.719 . . . . 0.0 114.514 159.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -68.98 176.68 5.86 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 CA-C-N 120.889 2.345 . . . . 0.0 115.059 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -68.82 126.75 30.74 Favored 'General case' 0 CA--C 1.57 1.72 0 O-C-N 120.427 -1.42 . . . . 0.0 113.158 175.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.2 -2.57 55.08 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -65.74 108.67 2.18 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.307 1.412 . . . . 0.0 111.711 162.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.02 52.53 4.28 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.82 -37.36 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 171.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.9 t -71.99 109.4 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 120.644 1.566 . . . . 0.0 109.016 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.06 -29.52 12.29 Favored Glycine 0 CA--C 1.551 2.313 0 N-CA-C 117.664 1.825 . . . . 0.0 117.664 -161.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -66.18 144.27 56.75 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 120.933 2.367 . . . . 0.0 113.949 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.4 m -53.38 140.67 26.72 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.12 121.43 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.579 -0.701 . . . . 0.0 110.191 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.267 . . 64.78 44.81 3.56 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -163.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.24 36.68 4.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 117.71 1.844 . . . . 0.0 117.71 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.72 105.27 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.23 96.77 2.31 Favored 'General case' 0 CA--C 1.566 1.596 0 C-N-CA 123.488 0.715 . . . . 0.0 110.697 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 149.06 -52.74 0.53 Allowed Glycine 0 N--CA 1.489 2.173 0 CA-C-O 119.58 -0.567 . . . . 0.0 114.087 -158.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -86.42 134.76 33.67 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.026 0.913 . . . . 0.0 111.955 175.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -76.97 108.62 10.15 Favored 'General case' 0 CA--C 1.568 1.668 0 C-N-CA 123.745 0.818 . . . . 0.0 112.964 171.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -94.49 150.77 19.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.451 -0.781 . . . . 0.0 112.231 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.2 p -69.66 157.21 37.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.622 -1.299 . . . . 0.0 114.323 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -55.79 -48.12 97.28 Favored Pre-proline 0 CA--C 1.576 1.959 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.55 -26.34 34.03 Favored 'Trans proline' 0 CA--C 1.565 2.067 0 CA-C-N 124.969 2.81 . . . . 0.0 117.205 170.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -63.35 -47.74 80.85 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 120.428 1.467 . . . . 0.0 114.189 163.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -59.18 -46.22 88.98 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 168.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.27 -13.79 61.6 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 174.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -61.01 -53.51 56.38 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 120.735 1.607 . . . . 0.0 114.831 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.09 176.59 49.88 Favored Glycine 0 CA--C 1.547 2.043 0 N-CA-C 116.764 1.466 . . . . 0.0 116.764 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.92 -153.17 43.32 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.84 155.9 47.0 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.042 0.925 . . . . 0.0 111.732 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -76.02 75.81 2.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.039 1.4 . . . . 0.0 112.882 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.7 p -73.92 159.93 83.03 Favored Pre-proline 0 CA--C 1.576 1.973 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.098 171.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -57.69 -34.21 97.83 Favored 'Trans proline' 0 CA--C 1.57 2.291 0 N-CA-C 117.777 2.184 . . . . 0.0 117.777 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.67 -47.27 72.99 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 165.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.14 89.58 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 170.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.5 mt -59.49 -45.91 90.32 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 165.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -55.87 -43.91 77.6 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 121.556 1.98 . . . . 0.0 116.307 168.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.69 -57.35 13.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.888 1.222 . . . . 0.0 114.155 169.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -61.82 -40.42 95.2 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.36 -22.82 61.09 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 170.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.2 m -61.85 -52.31 64.66 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.377 1.899 . . . . 0.0 113.445 164.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -151.28 113.17 3.05 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-N 119.91 1.232 . . . . 0.0 108.892 167.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.01 -46.43 0.24 Allowed 'Trans proline' 0 CA--C 1.56 1.81 0 CA-C-N 122.724 2.009 . . . . 0.0 116.798 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.16 -29.12 68.73 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.31 -41.02 90.32 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 162.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.7 t -70.32 -57.94 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 119.45 1.023 . . . . 0.0 112.475 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.37 102.19 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -73.11 99.32 2.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.599 -0.688 . . . . 0.0 111.429 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.84 21.84 9.36 Favored Glycine 0 CA--C 1.553 2.464 0 N-CA-C 118.622 2.209 . . . . 0.0 118.622 -166.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.5 t -74.31 132.27 41.92 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.793 1.797 . . . . 0.0 111.042 159.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -77.03 16.79 0.51 Allowed 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.9 ttt -78.68 101.73 7.67 Favored 'General case' 0 CA--C 1.561 1.377 0 O-C-N 120.847 -1.158 . . . . 0.0 111.059 171.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.12 70.77 3.56 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 122.637 1.208 . . . . 0.0 113.854 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -136.56 128.63 29.58 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 124.517 1.127 . . . . 0.0 108.053 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.38 -53.9 20.81 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.8 158.48 8.53 Favored Glycine 0 CA--C 1.544 1.861 0 N-CA-C 115.928 1.131 . . . . 0.0 115.928 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.5 mt -104.56 96.1 9.71 Favored Pre-proline 0 CA--C 1.575 1.917 0 C-N-CA 124.072 0.949 . . . . 0.0 108.9 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.48 -34.3 20.56 Favored 'Trans proline' 0 CA--C 1.567 2.159 0 C-N-CA 122.652 2.234 . . . . 0.0 117.555 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.88 131.53 38.63 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.835 0.854 . . . . 0.0 111.972 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.9 tt -55.9 -45.11 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 170.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -52.83 -44.29 66.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.7 -44.36 93.71 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 -67.01 -53.91 26.73 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.62 -42.85 93.58 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.05 -48.68 80.71 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 119.816 1.189 . . . . 0.0 113.838 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.8 tp -59.34 -44.9 92.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.23 -42.79 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 119.807 1.185 . . . . 0.0 112.88 171.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.67 -43.95 69.27 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 163.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -60.32 -48.77 80.3 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 167.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.8 -25.26 66.37 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.09 -35.36 80.89 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 158.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.79 -46.56 73.79 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 161.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.64 68.72 9.95 Favored 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 118.451 1.125 . . . . 0.0 111.459 172.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.872 -166.227 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 CA--C 1.576 1.955 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.66 -27.82 26.49 Favored 'Trans proline' 0 CA--C 1.568 2.193 0 N-CA-C 118.361 2.408 . . . . 0.0 118.361 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 -48.17 80.24 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 169.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.22 82.06 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 162.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.16 -36.52 68.55 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 119.009 2.364 . . . . 0.0 119.009 167.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -54.86 -47.43 74.2 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 162.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -59.93 -44.1 94.55 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.5 t -58.82 -42.64 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -55.37 -25.97 38.45 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 170.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.04 -34.55 7.71 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 119.75 2.66 . . . . 0.0 119.75 164.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -58.13 -41.85 84.54 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 161.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -75.39 -33.94 61.03 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -47.03 -37.75 9.83 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 119.025 2.972 . . . . 0.0 119.025 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.49 -29.33 58.59 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 170.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.9 m -113.64 -37.13 4.68 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 174.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -112.52 141.43 46.27 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.686 1.194 . . . . 0.0 111.588 -171.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.48 154.73 25.42 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.794 1.283 . . . . 0.0 113.372 171.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.6 mt -94.91 15.35 18.88 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 170.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -119.66 57.21 0.92 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 120.826 1.648 . . . . 0.0 112.776 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.51 -45.83 1.29 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 119.685 2.634 . . . . 0.0 119.685 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -77.57 157.77 30.16 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.32 1.057 . . . . 0.0 113.405 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.96 140.47 34.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.112 -0.992 . . . . 0.0 111.292 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.12 -116.2 3.62 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.802 -0.562 . . . . 0.0 113.045 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -75.88 -49.6 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 122.384 -0.48 . . . . 0.0 110.802 166.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.78 171.41 30.23 Favored Glycine 0 CA--C 1.559 2.832 0 CA-C-N 118.715 0.689 . . . . 0.0 114.796 158.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.41 175.41 7.85 Favored 'Trans proline' 0 CA--C 1.564 2.018 0 CA-C-N 120.845 2.322 . . . . 0.0 115.227 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -65.04 129.55 40.12 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 120.47 -1.394 . . . . 0.0 113.178 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.7 mt -96.51 -0.46 48.88 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -66.11 112.15 3.75 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.468 1.485 . . . . 0.0 111.233 158.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.98 51.45 5.38 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 115.733 1.053 . . . . 0.0 115.733 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -100.64 -35.99 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 170.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 t -72.24 109.87 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 120.503 1.502 . . . . 0.0 109.158 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.32 -17.63 58.25 Favored Glycine 0 CA--C 1.552 2.369 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -161.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -73.57 142.81 46.63 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 121.35 2.575 . . . . 0.0 113.311 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.7 m -59.94 138.65 57.78 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.2 123.92 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.787 -0.571 . . . . 0.0 110.221 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.8 45.51 7.67 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -164.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.43 -4.44 43.55 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 119.636 2.615 . . . . 0.0 119.636 -170.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.9 t -84.75 103.16 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 120.255 2.027 . . . . 0.0 108.994 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.0 94.31 0.63 Allowed 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.8 -46.08 0.82 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 114.934 0.734 . . . . 0.0 114.934 -161.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -76.93 131.8 38.72 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 118.405 1.103 . . . . 0.0 112.274 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -81.39 84.23 6.72 Favored 'General case' 0 CA--C 1.568 1.671 0 O-C-N 121.528 -0.732 . . . . 0.0 111.978 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -71.42 146.15 48.87 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.6 p -67.72 156.8 36.11 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -55.61 -43.94 99.41 Favored Pre-proline 0 CA--C 1.574 1.901 0 CA-C-O 115.162 -2.351 . . . . 0.0 117.316 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.12 -27.63 29.27 Favored 'Trans proline' 0 CA--C 1.565 2.044 0 CA-C-N 124.866 2.774 . . . . 0.0 116.977 168.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.4 tpp -63.33 -47.75 80.89 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.427 1.467 . . . . 0.0 114.019 163.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -57.87 -46.11 85.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 167.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.95 -14.45 61.92 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 118.881 2.919 . . . . 0.0 118.881 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -61.67 -53.7 52.67 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.722 1.601 . . . . 0.0 114.512 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.04 176.16 47.96 Favored Glycine 0 CA--C 1.547 2.059 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.1 -149.83 38.17 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 114.893 0.717 . . . . 0.0 114.893 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -131.91 156.07 46.77 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.818 0.818 . . . . 0.0 111.847 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -75.94 74.25 2.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.237 1.494 . . . . 0.0 112.988 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.0 p -73.75 161.48 78.55 Favored Pre-proline 0 CA--C 1.575 1.937 0 C-N-CA 124.985 1.314 . . . . 0.0 112.371 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -56.87 -35.28 98.28 Favored 'Trans proline' 0 CA--C 1.569 2.247 0 N-CA-C 117.575 2.106 . . . . 0.0 117.575 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -64.82 -49.51 70.33 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 164.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.64 90.48 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 172.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.65 -45.17 95.11 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 165.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -55.88 -44.42 78.11 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.635 2.016 . . . . 0.0 116.238 168.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -61.15 -57.74 11.25 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 120.047 1.294 . . . . 0.0 113.944 169.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -60.27 -41.36 93.11 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.83 -18.9 60.38 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -63.44 -51.4 65.86 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.071 1.76 . . . . 0.0 113.409 161.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -151.95 112.0 2.9 Favored Pre-proline 0 CA--C 1.575 1.94 0 CA-C-N 120.096 1.316 . . . . 0.0 108.993 167.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.51 -47.02 0.19 Allowed 'Trans proline' 0 CA--C 1.559 1.736 0 CA-C-N 122.71 2.004 . . . . 0.0 116.924 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.25 -27.6 67.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.96 -42.84 84.51 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 162.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.11 -57.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 119.546 1.066 . . . . 0.0 112.709 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.26 101.46 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -73.29 94.77 2.05 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-O 121.462 0.649 . . . . 0.0 111.561 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.93 25.93 5.98 Favored Glycine 0 CA--C 1.554 2.499 0 N-CA-C 118.379 2.111 . . . . 0.0 118.379 -166.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -76.08 137.61 40.27 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 119.749 1.774 . . . . 0.0 111.355 160.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -74.32 7.62 2.72 Favored 'General case' 0 CA--C 1.579 2.067 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 167.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -74.6 97.55 3.19 Favored 'General case' 0 CA--C 1.565 1.533 0 O-C-N 120.677 -1.264 . . . . 0.0 111.53 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.22 71.83 5.76 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 122.61 1.195 . . . . 0.0 113.472 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -129.93 133.41 46.82 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.465 1.106 . . . . 0.0 108.479 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.27 -56.09 9.87 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.48 155.2 6.66 Favored Glycine 0 CA--C 1.545 1.933 0 N-CA-C 116.159 1.224 . . . . 0.0 116.159 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.5 mt -105.72 97.88 16.1 Favored Pre-proline 0 CA--C 1.575 1.918 0 C-N-CA 123.962 0.905 . . . . 0.0 109.323 172.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.17 -33.21 15.44 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 122.632 2.221 . . . . 0.0 117.717 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.62 131.37 39.92 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 175.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.8 tt -56.63 -43.88 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -52.71 -47.4 67.34 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -57.19 -47.13 82.01 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -65.01 -51.55 61.03 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.32 83.79 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -56.47 -50.74 70.87 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.5 tp -57.34 -46.4 83.32 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 169.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.8 mt -64.4 -39.82 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-N 119.933 1.242 . . . . 0.0 113.202 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.22 -45.11 75.92 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 163.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -57.37 -50.51 72.76 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.3 mt -67.71 -26.78 66.34 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -62.39 -40.78 97.6 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 158.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.75 88.86 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 163.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -84.28 78.33 9.81 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 123.684 0.794 . . . . 0.0 111.997 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 123.581 0.752 . . . . 0.0 109.508 175.001 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 CA--C 1.58 2.124 0 CA-C-O 117.927 -1.035 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.12 -26.4 18.12 Favored 'Trans proline' 0 CA--C 1.566 2.091 0 N-CA-C 118.501 2.462 . . . . 0.0 118.501 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.08 -47.78 83.15 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 168.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.92 73.01 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 160.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.98 -35.69 70.03 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 168.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.49 -41.85 95.09 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 164.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.4 -44.47 95.67 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 165.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -58.7 -41.06 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -54.85 -19.48 6.61 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.77 -37.59 4.03 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 119.853 2.701 . . . . 0.0 119.853 157.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -65.75 -39.68 91.34 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 164.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.17 -33.9 38.01 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.08 -33.78 67.62 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 119.904 3.298 . . . . 0.0 119.904 -171.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.95 -33.37 66.96 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 171.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.6 m -99.18 -40.88 7.75 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 170.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -109.18 141.62 41.16 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.168 0.987 . . . . 0.0 113.035 -169.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -105.78 153.1 22.36 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.9 0.857 . . . . 0.0 112.77 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.8 mt -106.23 7.62 31.56 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 172.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -115.54 57.61 0.74 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.629 1.559 . . . . 0.0 112.282 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.77 1.93 10.41 Favored Glycine 0 CA--C 1.557 2.712 0 N-CA-C 121.487 3.355 . . . . 0.0 121.487 173.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -124.98 153.2 43.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 119.471 1.636 . . . . 0.0 112.362 -168.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -83.7 143.96 29.7 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.949 -1.095 . . . . 0.0 113.275 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.13 -119.01 2.62 Favored Glycine 0 N--CA 1.491 2.324 0 O-C-N 121.605 -0.685 . . . . 0.0 112.232 170.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.69 -48.08 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 122.178 -0.601 . . . . 0.0 110.938 165.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.36 172.18 30.14 Favored Glycine 0 CA--C 1.561 2.931 0 CA-C-N 118.971 0.805 . . . . 0.0 114.753 157.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -70.51 174.28 10.4 Favored 'Trans proline' 0 CA--C 1.563 1.942 0 CA-C-N 120.853 2.327 . . . . 0.0 115.506 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -66.54 122.59 17.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.499 -1.375 . . . . 0.0 113.36 176.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.22 -5.94 59.3 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -64.81 112.19 3.14 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 120.825 1.648 . . . . 0.0 110.766 159.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.56 36.1 24.05 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 116.981 1.552 . . . . 0.0 116.981 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -80.17 -34.54 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 118.925 1.362 . . . . 0.0 114.252 162.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.8 t -69.45 108.87 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 119.573 1.079 . . . . 0.0 109.966 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.59 -27.38 19.91 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 117.933 1.933 . . . . 0.0 117.933 -164.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -71.27 147.47 48.12 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.482 2.141 . . . . 0.0 113.968 -174.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.3 m -53.26 141.86 22.66 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -68.28 119.83 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.653 . . . . 0.0 109.767 170.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 64.37 55.92 1.35 Allowed 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -159.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.57 -20.1 14.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 119.238 2.455 . . . . 0.0 119.238 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.3 t -83.58 94.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.849 1.825 . . . . 0.0 109.236 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -69.33 113.1 6.35 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 123.315 0.646 . . . . 0.0 111.432 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 131.17 -49.79 0.91 Allowed Glycine 0 N--CA 1.491 2.323 0 CA-C-O 119.731 -0.483 . . . . 0.0 114.069 -155.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -77.48 129.26 35.48 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 118.059 0.93 . . . . 0.0 111.888 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -81.13 89.94 6.02 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.699 -0.625 . . . . 0.0 111.238 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -71.64 154.26 41.52 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.0 p -65.23 153.5 40.84 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.69 -1.256 . . . . 0.0 114.071 171.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.96 -47.45 99.06 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.47 -24.23 56.96 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 CA-C-N 125.115 2.863 . . . . 0.0 117.691 168.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 52.2 tpp -65.57 -48.42 72.44 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 120.65 1.568 . . . . 0.0 113.962 163.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -57.1 -46.29 82.69 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 167.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.67 -13.81 61.44 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -63.95 -54.41 34.95 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 120.805 1.639 . . . . 0.0 114.34 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 175.9 49.85 Favored Glycine 0 CA--C 1.546 2.005 0 N-CA-C 116.698 1.439 . . . . 0.0 116.698 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.78 -150.49 39.67 Favored Glycine 0 CA--C 1.547 2.064 0 O-C-N 121.914 -0.756 . . . . 0.0 114.943 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -133.02 154.11 50.84 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.815 0.817 . . . . 0.0 111.5 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -76.54 77.45 3.23 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.323 1.535 . . . . 0.0 112.552 171.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.0 p -71.75 160.6 82.16 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.208 169.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -58.01 -35.0 99.06 Favored 'Trans proline' 0 CA--C 1.57 2.283 0 N-CA-C 117.118 1.93 . . . . 0.0 117.118 174.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.73 -50.26 74.2 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 164.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.26 87.0 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.18 -43.6 97.78 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -50.91 -47.54 60.81 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 121.046 1.748 . . . . 0.0 115.68 165.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.53 -61.39 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -61.76 -40.11 94.0 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 mt -74.05 -16.87 61.03 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 171.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.4 m -63.9 -54.67 31.12 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 121.241 1.837 . . . . 0.0 112.927 161.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -150.44 112.59 3.23 Favored Pre-proline 0 CA--C 1.576 1.944 0 CA-C-N 119.781 1.173 . . . . 0.0 108.889 168.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.02 -45.95 0.26 Allowed 'Trans proline' 0 CA--C 1.56 1.786 0 CA-C-N 122.622 1.972 . . . . 0.0 116.904 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.18 -25.4 66.13 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.863 2.171 . . . . 0.0 116.863 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.59 78.63 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 161.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.5 t -71.48 -58.62 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-N 119.558 1.072 . . . . 0.0 112.723 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.5 103.62 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 171.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.11 94.15 3.43 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.582 0.706 . . . . 0.0 111.764 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.37 27.39 5.3 Favored Glycine 0 CA--C 1.554 2.489 0 N-CA-C 118.036 1.975 . . . . 0.0 118.036 -165.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.6 t -73.89 132.34 42.4 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.444 1.622 . . . . 0.0 111.187 160.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -73.85 10.41 1.16 Allowed 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 166.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -71.94 97.43 1.85 Allowed 'General case' 0 CA--C 1.564 1.501 0 O-C-N 120.933 -1.104 . . . . 0.0 111.261 166.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 75.48 4.25 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.72 1.248 . . . . 0.0 112.969 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -141.3 128.87 21.41 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.84 -52.7 33.76 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.13 157.06 7.87 Favored Glycine 0 N--CA 1.484 1.879 0 CA-C-O 122.275 0.93 . . . . 0.0 115.231 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.63 96.88 8.08 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.121 -0.942 . . . . 0.0 108.521 168.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.88 -33.63 15.76 Favored 'Trans proline' 0 CA--C 1.568 2.183 0 C-N-CA 122.636 2.224 . . . . 0.0 117.431 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.7 133.33 42.07 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.817 0.847 . . . . 0.0 112.993 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.0 tp -58.27 -42.75 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.12 -53.01 61.37 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -50.98 -41.73 59.72 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -66.91 -54.62 20.29 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.6 -45.6 91.43 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -53.13 -52.83 57.46 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 168.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.1 tp -60.61 -45.8 92.64 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 172.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 62.9 mt -61.55 -41.43 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 120.194 1.361 . . . . 0.0 113.034 172.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.68 -43.94 72.9 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 163.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -60.55 -46.61 89.54 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.58 -24.0 63.62 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 172.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -61.1 -45.48 94.52 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 157.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.9 88.23 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 117.846 1.898 . . . . 0.0 117.846 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -75.56 97.31 3.7 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 118.338 1.069 . . . . 0.0 111.575 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.065 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 CA--C 1.578 2.033 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.56 -28.46 26.19 Favored 'Trans proline' 0 CA--C 1.569 2.26 0 N-CA-C 118.522 2.47 . . . . 0.0 118.522 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.73 -42.29 97.92 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 168.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.34 77.87 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 159.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.73 96.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 118.955 2.342 . . . . 0.0 118.955 171.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.73 -38.67 91.38 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.82 97.0 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 164.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.09 -40.42 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 167.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -54.97 -19.81 7.62 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 166.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.72 -36.98 4.96 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 119.718 2.647 . . . . 0.0 119.718 159.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.67 -37.49 86.66 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 164.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -80.28 -34.56 36.84 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -57.52 -32.74 67.35 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -170.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.78 -35.89 71.41 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.2 m -93.69 -42.86 8.93 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 169.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -108.27 142.86 37.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.074 0.95 . . . . 0.0 113.092 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -110.63 150.21 29.31 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.548 1.166 . . . . 0.0 113.013 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -113.7 33.42 5.19 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.239 -0.913 . . . . 0.0 113.263 170.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -137.15 60.68 1.64 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.032 -1.667 . . . . 0.0 111.061 169.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.49 -47.73 1.78 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 119.522 2.569 . . . . 0.0 119.522 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -75.68 151.51 37.7 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.659 1.183 . . . . 0.0 113.109 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -101.9 131.33 48.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.749 . . . . 0.0 110.451 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.64 -114.33 3.7 Favored Glycine 0 N--CA 1.491 2.361 0 O-C-N 121.676 -0.64 . . . . 0.0 113.415 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.08 -47.79 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 122.413 -0.463 . . . . 0.0 110.77 165.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.9 168.72 24.95 Favored Glycine 0 CA--C 1.56 2.894 0 CA-C-N 118.985 0.812 . . . . 0.0 114.966 159.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -70.03 166.36 28.2 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 CA-C-N 120.699 2.249 . . . . 0.0 114.902 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -62.46 123.14 17.51 Favored 'General case' 0 CA--C 1.57 1.735 0 O-C-N 120.776 -1.203 . . . . 0.0 113.226 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.65 6.22 35.78 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -63.23 117.22 6.26 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.971 1.26 . . . . 0.0 110.929 159.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.96 44.35 37.16 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 116.244 1.257 . . . . 0.0 116.244 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 p -87.9 -30.59 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 170.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.79 107.0 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 119.945 1.248 . . . . 0.0 109.653 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.55 -10.28 71.01 Favored Glycine 0 CA--C 1.553 2.438 0 N-CA-C 118.925 2.33 . . . . 0.0 118.925 -163.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -77.0 144.0 38.99 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 121.078 2.439 . . . . 0.0 113.012 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.5 m -52.21 141.03 19.82 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -70.01 112.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.64 -0.663 . . . . 0.0 109.218 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.281 . . 70.0 66.63 0.23 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -154.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.32 -23.22 6.74 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 119.174 2.429 . . . . 0.0 119.174 -172.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.9 t -83.22 98.83 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 119.953 1.877 . . . . 0.0 109.369 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -69.59 104.59 2.41 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.417 0.627 . . . . 0.0 110.988 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.55 -55.12 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 CA-C-O 119.647 -0.53 . . . . 0.0 113.534 -155.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -78.92 129.07 34.1 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 118.037 0.919 . . . . 0.0 111.62 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -78.34 93.5 4.69 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.616 0.767 . . . . 0.0 112.724 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -76.17 161.11 29.09 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.9 t -65.44 152.15 44.62 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.46 -49.46 92.26 Favored Pre-proline 0 CA--C 1.576 1.98 0 CA-C-O 115.991 -1.957 . . . . 0.0 115.513 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.25 -21.75 67.06 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 CA-C-N 124.769 2.739 . . . . 0.0 118.149 166.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.8 tpp -66.94 -51.39 55.77 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.436 1.471 . . . . 0.0 113.344 163.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -57.87 -45.48 86.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 169.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.49 0.55 16.8 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 173.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -63.81 -49.81 71.42 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.69 81.19 1.06 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.27 -160.33 32.5 Favored Glycine 0 N--CA 1.485 1.908 0 CA-C-O 122.361 0.978 . . . . 0.0 115.161 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -125.21 155.1 40.57 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.017 0.913 . . . . 0.0 111.301 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -76.62 74.32 3.32 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 123.122 1.439 . . . . 0.0 113.272 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.0 p -71.44 161.2 79.75 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.67 171.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -58.5 -26.73 79.55 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 N-CA-C 117.528 2.088 . . . . 0.0 117.528 171.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.88 -56.99 10.02 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 161.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.76 94.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.28 -50.43 73.63 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 169.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.68 -35.58 78.38 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.21 -50.96 58.9 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -59.73 -40.57 88.47 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 171.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 70.7 mt -74.77 -16.35 60.72 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 169.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -67.77 -56.77 7.97 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 120.991 1.723 . . . . 0.0 112.293 160.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -145.12 109.55 4.64 Favored Pre-proline 0 CA--C 1.574 1.904 0 CA-C-N 119.503 1.047 . . . . 0.0 108.918 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.63 -41.28 0.82 Allowed 'Trans proline' 0 CA--C 1.561 1.859 0 C-N-CA 122.162 1.908 . . . . 0.0 116.874 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -58.3 -38.73 77.64 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 170.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.26 -42.95 87.76 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 169.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.62 -51.66 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 119.096 0.862 . . . . 0.0 113.31 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.8 101.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -75.07 94.64 2.92 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.322 0.582 . . . . 0.0 111.585 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.66 25.3 6.03 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 118.264 2.066 . . . . 0.0 118.264 -165.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 t -71.68 136.37 47.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.56 1.68 . . . . 0.0 112.046 163.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -73.94 6.96 2.91 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -72.61 100.61 2.82 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 120.72 -1.237 . . . . 0.0 111.507 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.61 75.54 7.49 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.588 1.185 . . . . 0.0 112.815 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -137.98 132.34 32.15 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.207 1.003 . . . . 0.0 108.539 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.65 -55.83 7.84 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.79 153.01 6.24 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 122.222 0.901 . . . . 0.0 115.199 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.8 mt -97.71 104.31 20.65 Favored Pre-proline 0 CA--C 1.574 1.868 0 CA-C-O 117.772 -1.108 . . . . 0.0 109.135 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.44 -36.22 9.36 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.684 2.256 . . . . 0.0 117.769 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.66 134.0 37.17 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 119.227 0.921 . . . . 0.0 112.813 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -58.01 -41.63 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 170.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.98 -47.36 74.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 172.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -56.39 -42.88 78.63 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -64.61 -53.94 39.77 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.89 -43.3 90.94 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.373 2.361 . . . . 0.0 117.373 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -56.1 -52.17 65.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 169.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.03 -46.13 82.6 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 169.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.7 mt -60.35 -41.63 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 120.096 1.316 . . . . 0.0 113.333 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.69 75.14 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 165.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.39 -44.61 95.51 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 166.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.4 mt -67.21 -26.95 66.86 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 171.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -63.76 -41.36 98.0 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 159.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.61 -48.11 87.84 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 117.421 1.729 . . . . 0.0 117.421 163.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -78.4 84.91 4.53 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 118.015 0.907 . . . . 0.0 112.189 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 . . . . . 0 C--O 1.256 1.414 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.041 174.626 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t70 . . . . . 0 CA--C 1.577 1.988 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.01 -31.92 22.8 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 N-CA-C 117.947 2.249 . . . . 0.0 117.947 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.24 78.76 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 168.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.3 -39.24 74.94 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 159.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.51 -33.86 59.39 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 120.222 2.849 . . . . 0.0 120.222 174.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.25 -36.4 79.88 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 168.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -62.8 -45.37 92.96 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 165.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 t -56.87 -42.6 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 168.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.12 -25.15 44.82 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.27 -35.28 9.36 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 119.79 2.676 . . . . 0.0 119.79 165.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -58.63 -38.17 77.48 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 162.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -77.34 -34.72 55.14 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -46.17 -40.41 11.15 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 119.144 3.016 . . . . 0.0 119.144 -177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.17 -32.57 64.45 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.7 m -104.92 -38.06 6.76 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 172.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -116.39 142.99 46.13 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.457 1.103 . . . . 0.0 112.421 -167.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -115.84 147.98 40.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.802 0.81 . . . . 0.0 112.387 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.8 mt -102.21 15.11 30.11 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -128.88 65.29 1.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 119.221 -2.175 . . . . 0.0 111.353 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.3 -37.7 0.82 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 119.939 2.736 . . . . 0.0 119.939 170.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -73.9 149.58 41.4 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.532 1.133 . . . . 0.0 113.43 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.71 132.75 49.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.415 -0.803 . . . . 0.0 110.235 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.61 -111.92 3.65 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 121.891 -0.506 . . . . 0.0 113.02 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -78.33 -48.16 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 122.433 -0.451 . . . . 0.0 110.769 164.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.75 170.53 25.38 Favored Glycine 0 CA--C 1.559 2.843 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 161.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -71.53 175.1 9.95 Favored 'Trans proline' 0 CA--C 1.565 2.038 0 CA-C-N 120.617 2.208 . . . . 0.0 115.784 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -66.81 124.95 24.37 Favored 'General case' 0 CA--C 1.568 1.656 0 O-C-N 120.485 -1.384 . . . . 0.0 113.353 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.42 -0.78 57.33 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -66.26 108.21 2.23 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 120.095 1.316 . . . . 0.0 111.483 161.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.91 46.15 5.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -171.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.11 -36.14 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 t -74.58 109.02 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 120.544 1.52 . . . . 0.0 109.202 -172.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.16 -28.58 15.29 Favored Glycine 0 CA--C 1.551 2.295 0 N-CA-C 117.653 1.821 . . . . 0.0 117.653 -160.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -68.09 146.41 53.5 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 120.844 2.322 . . . . 0.0 113.816 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.4 m -53.14 140.59 25.45 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.09 120.78 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.757 -0.59 . . . . 0.0 109.946 171.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . 63.94 51.96 2.19 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -162.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.08 -27.8 9.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 118.693 2.237 . . . . 0.0 118.693 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.2 t -74.95 95.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.329 1.565 . . . . 0.0 109.678 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.96 106.92 8.94 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.468 0.707 . . . . 0.0 110.223 -176.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.2 -50.75 0.82 Allowed Glycine 0 N--CA 1.489 2.232 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.678 -152.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -76.97 130.6 37.71 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 118.224 1.012 . . . . 0.0 111.881 172.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -79.5 80.58 5.86 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -67.73 150.91 48.07 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.5 p -68.97 153.51 43.67 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -53.71 -48.39 93.47 Favored Pre-proline 0 CA--C 1.575 1.912 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.8 -23.56 47.97 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 CA-C-N 124.198 2.535 . . . . 0.0 117.708 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ttm -66.92 -47.11 72.74 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 121.282 1.856 . . . . 0.0 113.849 162.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -57.58 -45.49 85.16 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 168.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.08 -16.65 62.03 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -61.72 -54.53 41.31 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 120.808 1.64 . . . . 0.0 114.404 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 177.39 49.96 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.14 -149.5 39.29 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 114.931 0.733 . . . . 0.0 114.931 -175.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -132.39 154.01 50.22 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.04 0.924 . . . . 0.0 111.562 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -75.92 76.42 2.82 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 123.023 1.392 . . . . 0.0 112.913 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.1 p -73.13 159.32 85.41 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.166 171.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.11 -34.84 98.48 Favored 'Trans proline' 0 CA--C 1.571 2.369 0 N-CA-C 117.585 2.11 . . . . 0.0 117.585 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.6 -50.11 70.69 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 165.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.22 92.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 172.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.7 mt -57.34 -49.87 74.77 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.5 pp0? -64.26 -33.85 76.77 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.71 -55.25 28.51 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 163.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -59.54 -41.65 90.54 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 73.9 mt -73.52 -17.51 61.2 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 170.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.9 m -65.83 -63.32 1.11 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 120.919 1.691 . . . . 0.0 111.662 158.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -134.63 100.42 12.35 Favored Pre-proline 0 CA--C 1.571 1.774 0 CA-C-O 118.397 -0.811 . . . . 0.0 109.834 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.1 -46.58 0.23 Allowed 'Trans proline' 0 CA--C 1.563 1.929 0 CA-C-N 122.504 1.93 . . . . 0.0 115.708 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -61.49 -34.51 75.6 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 169.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.97 -43.26 65.44 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 170.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.24 -54.83 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 119.261 0.937 . . . . 0.0 112.795 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.11 100.59 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -74.94 98.6 3.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.684 -0.635 . . . . 0.0 111.362 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.59 25.24 7.39 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -165.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 t -69.33 135.11 49.93 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.409 1.604 . . . . 0.0 111.307 159.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -72.88 7.92 1.78 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 166.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -77.34 104.64 7.97 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 120.81 -1.181 . . . . 0.0 111.955 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.32 69.85 6.85 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 122.316 1.055 . . . . 0.0 113.492 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -125.81 135.69 52.28 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.222 1.009 . . . . 0.0 108.951 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.33 -57.68 4.01 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.95 150.49 5.49 Favored Glycine 0 N--CA 1.485 1.902 0 CA-C-N 119.069 0.85 . . . . 0.0 115.138 -175.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -101.99 97.13 7.71 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.135 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.26 -32.72 20.07 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 C-N-CA 122.652 2.235 . . . . 0.0 117.812 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -76.94 127.58 32.96 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 119.039 0.836 . . . . 0.0 112.505 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -58.8 -41.0 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 172.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.05 -46.47 71.94 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 170.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.89 -45.92 82.24 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -62.82 -52.53 62.81 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 171.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.08 86.29 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -57.29 -50.4 73.05 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 170.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.5 -48.25 74.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.255 57.7 mt -63.92 -40.92 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 119.765 1.166 . . . . 0.0 113.231 174.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.25 74.12 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 163.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -59.32 -47.82 83.94 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 166.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.3 -27.87 69.33 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.26 -34.42 77.97 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 162.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.91 -47.07 68.16 Favored Glycine 0 CA--C 1.553 2.446 0 N-CA-C 116.989 1.555 . . . . 0.0 116.989 160.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 70.12 9.55 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 118.419 1.11 . . . . 0.0 111.534 172.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.254 1.32 0 O-C-N 121.339 -0.851 . . . . 0.0 111.181 -164.34 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.576 1.961 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.68 -29.4 19.54 Favored 'Trans proline' 0 CA--C 1.567 2.146 0 N-CA-C 118.333 2.397 . . . . 0.0 118.333 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.52 80.72 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 168.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.58 72.97 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 162.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.81 -33.91 84.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 118.126 2.01 . . . . 0.0 118.126 168.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -38.75 86.69 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 115.888 1.811 . . . . 0.0 115.888 167.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.254 21.7 pttm -67.01 -43.52 82.64 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.872 1.669 . . . . 0.0 115.083 166.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.8 t -60.43 -34.58 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 114.384 1.254 . . . . 0.0 114.384 171.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -54.82 -20.23 8.18 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 168.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.99 -37.28 5.44 Favored Glycine 0 CA--C 1.559 2.808 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 157.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.65 -31.44 72.12 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 166.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 m -90.73 -33.95 15.56 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -32.27 62.53 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 120.416 3.487 . . . . 0.0 120.416 -171.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.78 -34.84 71.91 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 170.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.7 m -95.55 -43.23 8.05 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -110.14 126.39 54.01 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.244 1.018 . . . . 0.0 111.752 -168.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -94.81 147.24 23.56 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.807 0.813 . . . . 0.0 111.427 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.5 -28.76 28.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -81.29 61.74 4.92 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.33 1.877 . . . . 0.0 113.805 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.75 10.11 16.88 Favored Glycine 0 CA--C 1.556 2.605 0 N-CA-C 121.94 3.536 . . . . 0.0 121.94 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -128.35 156.77 42.57 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 119.278 1.539 . . . . 0.0 112.557 -170.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.42 148.23 30.64 Favored 'General case' 0 CA--C 1.572 1.826 0 O-C-N 120.885 -1.135 . . . . 0.0 112.559 166.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.21 -100.75 2.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 157.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -79.73 -51.88 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.617 160.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.32 156.0 19.91 Favored Glycine 0 CA--C 1.559 2.84 0 N-CA-C 115.068 0.787 . . . . 0.0 115.068 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.93 151.23 27.45 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 CA-C-N 120.985 2.393 . . . . 0.0 113.601 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -45.51 126.74 6.94 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -167.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.74 -6.58 59.36 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -64.22 117.71 7.55 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 119.609 1.095 . . . . 0.0 110.651 158.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.05 44.61 11.51 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.65 -31.04 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -80.84 100.31 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 120.588 1.54 . . . . 0.0 109.162 -172.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.47 -20.7 29.67 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 117.872 1.909 . . . . 0.0 117.872 -158.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -73.05 146.45 45.85 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 120.743 2.272 . . . . 0.0 113.337 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.8 m -54.27 141.01 31.21 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.3 116.44 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.681 -0.637 . . . . 0.0 109.484 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.286 . . 68.14 61.6 0.4 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -159.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.45 -26.03 6.38 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 119.221 2.449 . . . . 0.0 119.221 -170.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.77 94.59 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 120.078 1.939 . . . . 0.0 109.625 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.43 126.73 30.56 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 123.269 0.628 . . . . 0.0 112.167 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.67 -54.7 0.63 Allowed Glycine 0 N--CA 1.491 2.341 0 CA-C-O 119.925 -0.375 . . . . 0.0 113.567 -157.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -79.23 116.58 19.58 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 117.771 0.786 . . . . 0.0 110.844 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -78.78 98.87 6.45 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.814 0.816 . . . . 0.0 110.817 172.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -65.21 162.71 16.65 Favored 'General case' 0 CA--C 1.574 1.874 0 C-N-CA 123.865 0.866 . . . . 0.0 112.969 172.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 p -68.59 158.66 33.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.243 -1.536 . . . . 0.0 114.216 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -54.25 -49.99 87.24 Favored Pre-proline 0 CA--C 1.578 2.027 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.68 -25.16 46.98 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 CA-C-N 124.241 2.55 . . . . 0.0 117.521 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -65.57 -48.8 71.13 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 120.419 1.463 . . . . 0.0 114.056 163.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -58.84 -43.79 90.78 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 168.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 -15.06 61.88 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 118.909 2.929 . . . . 0.0 118.909 172.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -62.7 -55.42 26.97 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 120.958 1.708 . . . . 0.0 114.364 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.35 178.15 50.82 Favored Glycine 0 CA--C 1.548 2.128 0 N-CA-C 116.879 1.511 . . . . 0.0 116.879 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.46 -148.7 35.94 Favored Glycine 0 N--CA 1.488 2.156 0 O-C-N 121.95 -0.736 . . . . 0.0 114.796 -174.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -133.86 153.11 51.97 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.863 0.839 . . . . 0.0 111.925 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -76.35 78.73 3.1 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.73 1.253 . . . . 0.0 112.782 171.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -73.99 157.45 87.02 Favored Pre-proline 0 CA--C 1.575 1.908 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.438 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -58.96 -29.17 89.8 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 N-CA-C 117.495 2.075 . . . . 0.0 117.495 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.75 -56.53 13.06 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 162.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.99 -38.93 84.03 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.2 mt -56.4 -40.23 74.31 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 167.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -56.81 -41.73 78.27 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 170.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.89 -55.73 20.52 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.239 1.381 . . . . 0.0 113.357 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -59.57 -41.63 90.64 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -71.74 -24.21 61.74 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.1 m -62.68 -52.29 63.88 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.265 1.848 . . . . 0.0 113.364 164.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -150.41 114.5 3.3 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-N 119.82 1.191 . . . . 0.0 108.94 169.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.53 -44.15 0.25 Allowed 'Trans proline' 0 CA--C 1.563 1.927 0 CA-C-N 122.693 1.998 . . . . 0.0 116.22 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.19 -43.01 73.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 117.033 2.234 . . . . 0.0 117.033 169.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.26 92.78 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 170.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.12 -57.51 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 118.876 0.762 . . . . 0.0 112.43 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.72 102.96 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 172.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -74.92 90.28 2.41 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.762 0.791 . . . . 0.0 111.627 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.03 28.76 3.75 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 118.01 1.964 . . . . 0.0 118.01 -166.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 t -76.11 134.95 39.86 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.677 1.738 . . . . 0.0 111.42 163.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -76.75 21.58 0.2 Allowed 'General case' 0 CA--C 1.582 2.176 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 170.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.8 ttt -87.92 102.53 14.8 Favored 'General case' 0 CA--C 1.56 1.358 0 O-C-N 120.776 -1.202 . . . . 0.0 110.813 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.1 69.79 2.7 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -135.98 131.83 35.56 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.434 1.093 . . . . 0.0 108.613 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.07 -55.37 8.39 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.03 155.74 7.52 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 115.769 1.068 . . . . 0.0 115.769 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.8 mt -100.85 98.16 7.97 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 118.167 -0.921 . . . . 0.0 109.076 168.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.02 -34.76 16.28 Favored 'Trans proline' 0 CA--C 1.568 2.182 0 C-N-CA 122.674 2.249 . . . . 0.0 117.272 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.06 129.87 40.08 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.66 0.784 . . . . 0.0 112.982 175.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.1 tt -57.54 -43.08 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 166.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.54 -48.69 68.85 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -54.82 -45.88 74.5 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.7 mtm-85 -66.49 -54.13 27.41 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.27 -44.14 88.27 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -59.4 -52.73 64.37 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 113.728 1.011 . . . . 0.0 113.728 169.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.18 -46.49 85.69 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -61.12 -42.38 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 117.552 -1.213 . . . . 0.0 112.945 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.76 -44.32 73.52 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 164.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -58.42 -50.67 72.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 167.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.09 -24.51 65.95 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 174.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.85 -44.82 96.05 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 158.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.69 -41.8 93.63 Favored Glycine 0 CA--C 1.553 2.427 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 168.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.99 83.27 6.74 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 118.725 1.262 . . . . 0.0 111.0 172.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.414 -0.803 . . . . 0.0 109.753 175.872 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 CA--C 1.575 1.938 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.45 -27.8 27.5 Favored 'Trans proline' 0 CA--C 1.569 2.26 0 N-CA-C 118.458 2.445 . . . . 0.0 118.458 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.7 98.73 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 167.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.48 -32.79 74.37 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 159.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.75 -38.43 95.18 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 118.848 2.299 . . . . 0.0 118.848 171.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.01 -38.96 90.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 169.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -61.87 -42.02 98.56 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 164.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.67 -39.13 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 168.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -55.61 -25.29 37.84 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 169.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.9 -29.08 26.2 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 119.809 2.684 . . . . 0.0 119.809 165.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -58.51 -38.4 77.63 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 159.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -82.05 -32.2 30.54 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -45.39 -46.33 13.17 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 119.664 3.209 . . . . 0.0 119.664 -173.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.83 -38.5 70.13 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.8 m -89.84 -43.91 10.31 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -112.36 132.94 54.73 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 119.453 1.024 . . . . 0.0 112.179 -169.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -117.61 132.52 56.5 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.9 0.857 . . . . 0.0 111.105 -173.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.2 mt -80.04 -9.14 59.67 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 117.33 2.345 . . . . 0.0 117.33 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -102.76 58.62 0.78 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.175 1.807 . . . . 0.0 112.011 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.2 24.23 50.47 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 121.124 3.21 . . . . 0.0 121.124 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -106.57 121.99 45.41 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.007 1.404 . . . . 0.0 110.697 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -93.22 103.59 15.84 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.381 0.672 . . . . 0.0 109.454 173.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.0 -107.41 3.21 Favored Glycine 0 N--CA 1.489 2.224 0 O-C-N 122.096 -0.377 . . . . 0.0 112.689 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.19 -49.44 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 118.923 -0.561 . . . . 0.0 111.087 166.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.95 166.77 14.78 Favored Glycine 0 CA--C 1.561 2.93 0 CA-C-N 119.035 0.834 . . . . 0.0 114.924 164.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.78 169.24 20.68 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 120.813 2.307 . . . . 0.0 115.174 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -65.76 124.34 22.17 Favored 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.456 -1.402 . . . . 0.0 113.434 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.2 mt -90.41 6.47 43.14 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -67.41 125.97 27.79 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 121.149 1.795 . . . . 0.0 110.96 159.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.24 53.51 13.67 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 115.619 1.007 . . . . 0.0 115.619 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -107.0 -29.87 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 t -79.36 100.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 120.811 1.642 . . . . 0.0 109.0 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.82 -15.62 48.3 Favored Glycine 0 CA--C 1.552 2.398 0 N-CA-C 118.304 2.082 . . . . 0.0 118.304 -159.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -72.12 141.06 49.16 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 121.339 2.569 . . . . 0.0 113.201 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.8 m -58.18 136.99 57.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -67.12 123.85 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 123.267 0.627 . . . . 0.0 110.72 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 62.76 45.31 5.88 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -165.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.05 12.82 29.08 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 -170.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.5 t -92.74 115.18 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 120.072 1.936 . . . . 0.0 109.09 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.92 120.19 16.13 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.904 -0.497 . . . . 0.0 110.717 166.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.21 17.91 21.02 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 118.209 2.044 . . . . 0.0 118.209 -163.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -139.11 127.45 22.8 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 119.785 1.792 . . . . 0.0 109.118 165.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -80.61 93.39 6.1 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.376 -0.827 . . . . 0.0 112.765 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -76.73 152.14 35.79 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.9 p -70.08 156.7 38.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.766 -1.209 . . . . 0.0 114.061 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.26 -49.6 91.43 Favored Pre-proline 0 CA--C 1.576 1.98 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.01 -24.39 45.42 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 CA-C-N 124.095 2.498 . . . . 0.0 117.468 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.8 tpp -65.89 -46.44 78.34 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.784 1.629 . . . . 0.0 114.253 163.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -57.81 -45.64 85.84 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 166.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.38 -13.5 61.87 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 170.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -60.7 -48.67 80.75 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 120.87 1.668 . . . . 0.0 114.915 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.72 164.69 35.73 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 117.704 1.842 . . . . 0.0 117.704 163.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.8 -144.14 26.16 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 114.756 0.662 . . . . 0.0 114.756 -177.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -129.53 154.02 47.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.781 0.801 . . . . 0.0 111.528 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -75.82 76.65 2.75 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 123.05 1.405 . . . . 0.0 112.782 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.2 p -73.71 159.7 83.81 Favored Pre-proline 0 CA--C 1.574 1.892 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.114 173.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -56.01 -39.2 92.64 Favored 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 122.403 2.069 . . . . 0.0 117.159 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.01 -42.12 94.75 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 166.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.76 98.06 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 170.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -58.86 -49.11 78.97 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 166.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -55.21 -40.31 70.65 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 172.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.17 -57.54 11.13 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 167.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -60.36 -40.96 92.66 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.87 -27.83 66.16 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.8 m -67.99 -60.09 2.77 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 120.61 1.55 . . . . 0.0 113.37 161.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -127.63 97.13 31.17 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-N 120.864 1.666 . . . . 0.0 110.562 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.63 -51.88 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.886 0 CA-C-N 122.514 1.934 . . . . 0.0 115.625 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.5 -21.19 62.78 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 173.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.47 -43.46 55.97 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.867 1.667 . . . . 0.0 115.06 163.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.33 -54.7 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.474 1.034 . . . . 0.0 112.695 172.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.85 101.63 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -72.61 98.47 2.34 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 121.701 -0.624 . . . . 0.0 111.383 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.54 24.1 8.01 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 118.457 2.143 . . . . 0.0 118.457 -166.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -76.09 135.34 39.87 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.627 1.713 . . . . 0.0 111.025 159.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -74.89 8.92 2.15 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 117.32 2.341 . . . . 0.0 117.32 167.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -73.42 95.94 2.29 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 120.565 -1.334 . . . . 0.0 111.294 170.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.72 69.65 6.07 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-O 122.497 1.142 . . . . 0.0 113.382 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.28 133.28 55.5 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.349 1.059 . . . . 0.0 108.95 175.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.14 -56.2 14.28 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 115.886 1.809 . . . . 0.0 115.886 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.18 142.76 3.65 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 115.664 1.026 . . . . 0.0 115.664 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.2 mt -95.22 106.73 27.72 Favored Pre-proline 0 CA--C 1.574 1.879 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.084 168.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.97 -40.16 1.45 Allowed 'Trans proline' 0 CA--C 1.569 2.236 0 CA-C-N 123.239 2.192 . . . . 0.0 116.982 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.9 132.9 40.59 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.8 tt -51.36 -47.94 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 168.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -48.95 -50.63 34.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 173.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.18 -41.16 97.23 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -65.84 -52.93 46.34 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 170.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.76 -44.71 86.31 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -58.53 -51.73 68.65 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 169.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.43 -48.08 72.08 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 168.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 62.1 mt -62.33 -40.72 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.273 172.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.14 -44.68 71.6 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 121.778 2.081 . . . . 0.0 116.567 163.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -60.14 -47.97 83.7 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 166.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.5 mt -65.07 -30.43 71.38 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -61.1 -43.24 99.18 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 161.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.01 -42.48 99.74 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 117.809 1.884 . . . . 0.0 117.809 165.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -80.33 72.05 7.17 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-N 118.526 1.163 . . . . 0.0 112.478 171.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.242 -0.885 . . . . 0.0 109.466 176.293 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.7 t0 . . . . . 0 CA--C 1.575 1.94 0 CA-C-O 118.6 -0.714 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -67.8 -35.54 21.13 Favored 'Trans proline' 0 CA--C 1.563 1.972 0 N-CA-C 119.18 2.723 . . . . 0.0 119.18 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.86 75.74 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.01 82.65 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 164.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.46 -38.12 94.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.281 2.072 . . . . 0.0 118.281 167.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -58.16 -44.57 88.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 164.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -58.24 -47.08 84.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 167.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.75 -40.73 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 169.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -52.87 -24.99 10.25 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.06 -34.51 5.92 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 119.79 2.676 . . . . 0.0 119.79 161.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -58.98 -38.73 79.8 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 163.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -83.2 -31.45 27.07 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -48.17 -34.92 10.75 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.59 -28.63 47.54 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 117.932 2.568 . . . . 0.0 117.932 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.1 m -112.9 -43.97 3.35 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -102.18 152.1 21.43 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.127 0.965 . . . . 0.0 113.503 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -128.2 138.59 52.53 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.793 0.806 . . . . 0.0 111.13 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.5 mt -100.68 41.4 1.18 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.373 -0.829 . . . . 0.0 113.186 168.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -143.53 55.92 1.35 Allowed 'General case' 0 CA--C 1.571 1.768 0 O-C-N 120.79 -1.194 . . . . 0.0 110.802 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.6 -43.62 1.63 Allowed Glycine 0 N--CA 1.497 2.739 0 N-CA-C 119.465 2.546 . . . . 0.0 119.465 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -74.81 136.86 41.6 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -112.25 125.88 54.63 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.78 0.832 . . . . 0.0 109.385 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.4 -101.01 0.6 Allowed Glycine 0 N--CA 1.491 2.336 0 O-C-N 121.748 -0.595 . . . . 0.0 113.966 -172.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.11 -52.98 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 117.396 0.598 . . . . 0.0 110.901 170.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.71 164.5 13.92 Favored Glycine 0 CA--C 1.561 2.909 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.811 161.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.17 170.4 15.95 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 CA-C-N 120.961 2.38 . . . . 0.0 115.116 174.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -71.39 127.19 31.75 Favored 'General case' 0 CA--C 1.568 1.662 0 O-C-N 120.526 -1.359 . . . . 0.0 111.933 173.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -90.33 4.95 49.29 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -61.71 118.97 7.82 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 119.954 1.252 . . . . 0.0 111.511 168.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.65 19.71 65.37 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -175.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.92 -29.05 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-N 121.005 2.403 . . . . 0.0 116.68 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.0 t -78.98 103.42 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 120.068 1.303 . . . . 0.0 109.181 -171.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.96 -19.68 45.93 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 118.25 2.06 . . . . 0.0 118.25 -159.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -75.24 147.02 40.65 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.776 2.288 . . . . 0.0 113.866 -174.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.3 m -55.15 138.63 44.16 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.21 122.03 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.78 -0.575 . . . . 0.0 110.224 172.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.07 49.64 4.42 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -164.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.75 -18.59 24.83 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 119.185 2.434 . . . . 0.0 119.185 -169.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 65.0 t -84.97 100.6 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.686 1.743 . . . . 0.0 109.622 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.35 105.08 2.44 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.534 0.683 . . . . 0.0 110.999 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.65 -56.53 0.53 Allowed Glycine 0 N--CA 1.487 2.098 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.213 -157.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -82.55 129.58 34.95 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 117.894 0.847 . . . . 0.0 111.111 169.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.54 99.96 10.48 Favored 'General case' 0 CA--C 1.567 1.597 0 O-C-N 121.539 -0.726 . . . . 0.0 110.918 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -77.83 158.56 29.43 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.9 p -71.37 156.09 39.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.616 -1.302 . . . . 0.0 113.782 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.85 -48.67 92.89 Favored Pre-proline 0 CA--C 1.576 1.962 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.11 -26.12 43.09 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 CA-C-N 124.322 2.579 . . . . 0.0 117.66 171.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.9 ttm -65.86 -46.79 77.15 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 121.253 1.842 . . . . 0.0 113.97 162.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -56.89 -45.65 82.41 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 167.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.19 -17.14 61.39 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 118.81 2.892 . . . . 0.0 118.81 172.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -61.44 -54.58 41.63 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.853 1.66 . . . . 0.0 114.617 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.09 -179.27 50.38 Favored Glycine 0 CA--C 1.546 2.03 0 N-CA-C 116.709 1.443 . . . . 0.0 116.709 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.34 -151.52 43.63 Favored Glycine 0 N--CA 1.487 2.099 0 O-C-N 121.879 -0.777 . . . . 0.0 114.88 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -132.84 153.41 51.33 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.052 0.929 . . . . 0.0 111.722 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -76.87 74.32 3.48 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 122.832 1.301 . . . . 0.0 113.166 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.7 p -69.7 158.93 85.81 Favored Pre-proline 0 CA--C 1.576 1.969 0 C-N-CA 124.293 1.037 . . . . 0.0 112.382 171.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.55 -33.24 96.2 Favored 'Trans proline' 0 CA--C 1.57 2.292 0 N-CA-C 117.559 2.1 . . . . 0.0 117.559 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.51 -49.5 68.76 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 164.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.11 90.55 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 171.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.3 mt -59.77 -45.83 91.05 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 165.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -56.19 -43.07 78.08 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 121.636 2.016 . . . . 0.0 116.329 168.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -60.81 -56.42 21.43 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 120.068 1.304 . . . . 0.0 114.261 169.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -62.26 -39.98 94.69 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 74.2 mt -71.14 -25.0 62.37 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 169.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.1 m -62.45 -51.86 65.81 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 121.247 1.84 . . . . 0.0 113.504 164.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -150.54 112.63 3.21 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 120.05 1.295 . . . . 0.0 109.147 167.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.22 -46.9 0.21 Allowed 'Trans proline' 0 CA--C 1.559 1.76 0 CA-C-N 122.714 2.005 . . . . 0.0 116.985 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.02 -28.15 67.16 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.91 -40.88 91.9 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 161.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.3 t -71.44 -58.54 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.394 0.997 . . . . 0.0 112.511 175.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.35 101.28 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -74.43 102.54 4.48 Favored 'General case' 0 CA--C 1.566 1.589 0 O-C-N 121.566 -0.709 . . . . 0.0 111.578 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.56 22.16 10.64 Favored Glycine 0 CA--C 1.554 2.507 0 N-CA-C 118.446 2.138 . . . . 0.0 118.446 -164.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -74.79 134.14 41.84 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 119.64 1.72 . . . . 0.0 111.321 161.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -74.21 9.86 1.48 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -72.99 95.88 2.06 Favored 'General case' 0 CA--C 1.565 1.551 0 O-C-N 120.696 -1.253 . . . . 0.0 111.194 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.18 72.63 4.72 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 122.8 1.286 . . . . 0.0 113.383 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -136.32 128.86 30.48 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.94 -54.54 24.96 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.12 156.88 7.58 Favored Glycine 0 CA--C 1.544 1.852 0 N-CA-C 115.664 1.025 . . . . 0.0 115.664 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.1 mt -104.06 96.04 8.9 Favored Pre-proline 0 CA--C 1.574 1.868 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.176 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.08 -34.2 17.39 Favored 'Trans proline' 0 CA--C 1.568 2.193 0 C-N-CA 122.672 2.248 . . . . 0.0 117.198 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -73.04 129.56 38.35 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.76 0.824 . . . . 0.0 112.831 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 tt -57.73 -43.05 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -52.68 -45.27 66.73 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.38 -46.6 88.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 73.5 mtm-85 -64.4 -52.38 58.46 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -47.25 86.75 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -60.12 -46.45 89.59 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 119.732 1.151 . . . . 0.0 113.971 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.9 tp -60.04 -47.73 84.65 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.43 -43.36 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-N 119.918 1.236 . . . . 0.0 112.884 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.1 73.55 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 165.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -57.5 -47.68 81.27 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 165.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.29 -31.6 72.82 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.57 -40.42 91.61 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 159.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.51 -49.56 75.63 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -87.22 77.85 8.94 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 118.814 1.307 . . . . 0.0 112.445 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 . . . . . 0 N--CA 1.487 1.402 0 C-N-CA 123.679 0.792 . . . . 0.0 110.05 172.135 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 CA--C 1.578 2.049 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.25 -32.13 21.32 Favored 'Trans proline' 0 CA--C 1.567 2.13 0 N-CA-C 118.317 2.391 . . . . 0.0 118.317 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.65 -48.7 79.66 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 169.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.7 71.43 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 164.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.41 -33.04 65.09 Favored Glycine 0 CA--C 1.551 2.318 0 N-CA-C 119.145 2.418 . . . . 0.0 119.145 166.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -65.42 -40.85 93.85 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -61.7 -41.14 97.2 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 164.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.92 -37.45 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 169.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -54.95 -18.9 5.61 Favored 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 165.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.12 -38.28 6.17 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 119.81 2.684 . . . . 0.0 119.81 158.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.04 -31.47 72.71 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 164.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -87.58 -34.23 18.62 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -56.79 -34.37 67.58 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 119.981 3.326 . . . . 0.0 119.981 -169.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.22 -35.9 72.36 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.6 m -91.15 -42.87 10.21 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 168.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -110.32 135.14 51.51 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.207 0.912 . . . . 0.0 112.617 -169.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.25 146.15 27.24 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.684 0.754 . . . . 0.0 112.571 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.5 mt -95.19 6.09 49.99 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 166.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.15 -40.4 52.71 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.9 -38.43 1.9 Allowed Glycine 0 N--CA 1.496 2.65 0 CA-C-N 119.3 0.955 . . . . 0.0 115.335 -163.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -73.69 153.71 39.97 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-O 121.979 0.895 . . . . 0.0 112.623 168.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -91.21 145.56 24.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 111.668 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.36 -115.35 4.02 Favored Glycine 0 N--CA 1.492 2.392 0 O-C-N 121.571 -0.706 . . . . 0.0 112.843 175.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -78.52 -48.3 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 122.337 -0.508 . . . . 0.0 110.745 163.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.29 173.89 33.27 Favored Glycine 0 CA--C 1.56 2.896 0 N-CA-C 115.327 0.891 . . . . 0.0 115.327 160.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -69.62 173.18 11.22 Favored 'Trans proline' 0 CA--C 1.565 2.039 0 CA-C-N 120.578 2.189 . . . . 0.0 115.468 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -65.75 126.21 27.71 Favored 'General case' 0 CA--C 1.573 1.828 0 O-C-N 120.468 -1.395 . . . . 0.0 113.399 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.48 1.08 57.45 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -64.97 125.33 24.56 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 121.496 1.953 . . . . 0.0 111.112 158.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.05 47.13 32.51 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 116.787 1.475 . . . . 0.0 116.787 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -99.17 -28.45 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 t -81.05 105.14 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 120.631 1.559 . . . . 0.0 109.173 -171.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.35 -13.33 61.56 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.085 1.994 . . . . 0.0 118.085 -159.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -74.42 146.37 42.95 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.025 2.412 . . . . 0.0 112.745 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 64.9 m -54.62 141.56 31.34 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.64 114.71 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.639 -0.663 . . . . 0.0 109.386 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.276 . . 67.59 62.26 0.43 Allowed 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -158.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.83 -20.99 8.07 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 119.462 2.545 . . . . 0.0 119.462 -170.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.3 t -81.88 101.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 120.23 2.015 . . . . 0.0 109.877 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -70.27 102.04 2.04 Favored 'General case' 0 CA--C 1.566 1.58 0 C-N-CA 123.727 0.811 . . . . 0.0 110.784 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.91 -51.87 0.72 Allowed Glycine 0 N--CA 1.49 2.287 0 CA-C-O 119.783 -0.454 . . . . 0.0 113.782 -155.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -85.74 124.93 32.81 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 117.98 0.89 . . . . 0.0 110.479 168.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -80.62 118.18 21.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.422 -0.799 . . . . 0.0 110.07 167.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -89.81 172.51 8.85 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.829 0.823 . . . . 0.0 112.423 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.5 t -70.55 152.92 43.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.373 -1.455 . . . . 0.0 112.961 171.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.56 -45.55 99.85 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-O 115.274 -2.298 . . . . 0.0 116.525 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.63 -26.84 45.98 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 CA-C-N 124.807 2.753 . . . . 0.0 117.338 166.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.2 tpp -64.2 -47.85 78.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.604 1.547 . . . . 0.0 114.123 164.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -60.55 -43.47 97.18 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 168.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.41 -14.96 62.33 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 118.784 2.883 . . . . 0.0 118.784 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -65.18 -56.21 14.19 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.741 1.609 . . . . 0.0 114.247 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.08 -179.78 52.6 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 116.717 1.447 . . . . 0.0 116.717 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.99 -149.57 37.96 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 121.836 -0.802 . . . . 0.0 114.809 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -133.87 155.25 50.21 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.923 0.868 . . . . 0.0 112.061 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -76.8 78.17 3.41 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.938 1.352 . . . . 0.0 112.962 172.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.7 p -75.47 159.85 80.89 Favored Pre-proline 0 CA--C 1.577 1.983 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.514 173.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -59.09 -28.01 86.62 Favored 'Trans proline' 0 CA--C 1.572 2.388 0 N-CA-C 118.014 2.275 . . . . 0.0 118.014 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.13 -53.49 30.2 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 163.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.38 -43.25 88.39 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.62 -51.14 71.2 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -62.62 -33.07 74.27 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 175.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -63.89 -54.44 34.76 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 164.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -60.63 -42.59 97.2 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.55 -20.48 62.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 170.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -65.42 -63.17 1.16 Allowed 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.802 1.637 . . . . 0.0 111.756 158.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -134.66 102.24 11.51 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.921 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.52 -50.77 0.12 Allowed 'Trans proline' 0 CA--C 1.561 1.865 0 CA-C-N 122.731 2.011 . . . . 0.0 115.947 -175.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -69.87 -20.68 63.39 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 171.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.03 -42.4 69.56 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 121.363 1.892 . . . . 0.0 114.92 163.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.18 -56.88 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.492 0.717 . . . . 0.0 112.538 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.63 97.28 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 172.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -73.01 104.95 4.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.385 -0.822 . . . . 0.0 111.909 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.33 17.26 22.67 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 118.554 2.182 . . . . 0.0 118.554 -166.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 t -69.1 136.27 52.0 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.121 1.96 . . . . 0.0 111.841 163.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -73.78 8.61 1.85 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 168.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 ttt -74.35 99.61 3.55 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 120.784 -1.198 . . . . 0.0 111.302 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.16 70.99 6.89 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 122.604 1.192 . . . . 0.0 113.327 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -130.37 134.16 46.95 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.31 1.044 . . . . 0.0 108.69 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.88 -56.47 6.99 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.56 154.18 6.84 Favored Glycine 0 CA--C 1.544 1.89 0 CA-C-O 121.983 0.768 . . . . 0.0 114.668 -177.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.1 mt -98.86 98.15 5.88 Favored Pre-proline 0 CA--C 1.573 1.832 0 CA-C-O 117.851 -1.071 . . . . 0.0 108.87 167.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 -33.63 19.8 Favored 'Trans proline' 0 CA--C 1.568 2.214 0 C-N-CA 122.706 2.271 . . . . 0.0 117.383 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -71.41 126.06 28.64 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.974 0.91 . . . . 0.0 113.335 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -56.37 -43.6 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 168.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -54.08 -45.22 71.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.39 -45.56 88.09 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 169.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -62.68 -54.34 40.86 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 171.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.38 -45.59 87.99 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -59.34 -49.81 76.38 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 171.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.57 -44.9 89.9 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.6 mt -66.71 -34.49 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-N 119.804 1.184 . . . . 0.0 113.688 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.49 79.85 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 121.792 2.087 . . . . 0.0 115.905 159.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.67 -51.47 69.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 170.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.1 mt -66.29 -24.22 66.52 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.14 -45.64 87.6 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 160.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.68 91.41 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 117.882 1.913 . . . . 0.0 117.882 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -79.31 71.59 5.86 Favored 'General case' 0 CA--C 1.573 1.853 0 CA-C-N 118.372 1.086 . . . . 0.0 112.566 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.353 -177.887 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 CA--C 1.576 1.974 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.52 -25.78 29.37 Favored 'Trans proline' 0 CA--C 1.567 2.131 0 N-CA-C 118.424 2.432 . . . . 0.0 118.424 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.82 -49.22 71.48 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.37 77.59 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 162.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.9 -41.49 84.24 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 118.825 2.29 . . . . 0.0 118.825 166.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -56.09 -44.09 78.67 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 164.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.73 -47.03 87.29 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 168.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.0 t -58.6 -36.46 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -54.26 -19.43 5.28 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 168.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.93 -38.46 4.58 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 120.045 2.778 . . . . 0.0 120.045 158.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -66.07 -38.04 87.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 164.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -81.59 -33.44 31.57 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -55.8 -35.06 65.89 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 119.95 3.315 . . . . 0.0 119.95 -171.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.08 -35.27 71.15 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 117.041 2.238 . . . . 0.0 117.041 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 m -96.38 -43.05 7.83 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -103.69 127.77 51.11 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.281 1.032 . . . . 0.0 111.91 -172.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -102.95 135.76 44.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.646 0.736 . . . . 0.0 110.965 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.2 mt -79.14 -23.75 43.78 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.43 61.64 6.94 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 121.502 1.955 . . . . 0.0 112.79 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.91 -30.58 0.4 Allowed Glycine 0 CA--C 1.557 2.674 0 N-CA-C 120.908 3.123 . . . . 0.0 120.908 173.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -79.24 148.18 32.3 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 124.339 1.056 . . . . 0.0 113.534 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -113.84 106.08 14.04 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -171.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.32 -108.9 3.16 Favored Glycine 0 N--CA 1.491 2.338 0 O-C-N 121.824 -0.547 . . . . 0.0 113.625 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.0 t -70.32 -53.34 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 119.222 -0.418 . . . . 0.0 110.666 165.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.39 152.38 18.83 Favored Glycine 0 CA--C 1.56 2.879 0 CA-C-O 119.118 -0.824 . . . . 0.0 114.675 167.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.56 143.57 27.49 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 CA-C-N 121.255 2.528 . . . . 0.0 113.319 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -44.32 122.94 3.22 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -169.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.16 -7.86 59.63 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -65.39 113.53 4.16 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 119.139 0.882 . . . . 0.0 110.767 160.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.03 44.07 8.4 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.35 -33.54 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 174.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.69 106.32 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 120.418 1.463 . . . . 0.0 109.401 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.67 -10.99 66.69 Favored Glycine 0 CA--C 1.553 2.466 0 N-CA-C 118.733 2.253 . . . . 0.0 118.733 -162.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -73.47 145.36 45.75 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 121.23 2.515 . . . . 0.0 112.924 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.0 m -54.39 140.3 34.18 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.71 117.6 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.605 -0.685 . . . . 0.0 109.524 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.264 . . 64.36 57.84 1.15 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -157.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.53 -27.11 5.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 -169.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.8 t -70.47 115.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 119.614 1.707 . . . . 0.0 109.948 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.81 73.9 6.54 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.87 1.319 . . . . 0.0 111.852 176.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.99 39.49 0.02 OUTLIER Glycine 0 CA--C 1.551 2.312 0 CA-C-N 114.421 -1.263 . . . . 0.0 115.23 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -154.12 144.05 21.86 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 118.137 0.969 . . . . 0.0 110.12 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -74.83 90.51 2.38 Favored 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 111.593 170.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -82.82 146.24 29.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.419 -0.801 . . . . 0.0 112.574 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.9 t -68.15 153.64 43.32 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -60.7 -46.85 97.12 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 115.906 -1.997 . . . . 0.0 115.24 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.92 -24.25 67.73 Favored 'Trans proline' 0 CA--C 1.564 1.988 0 CA-C-N 124.902 2.786 . . . . 0.0 117.975 166.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.4 tpp -65.08 -49.44 70.03 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 121.131 1.787 . . . . 0.0 113.818 162.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -59.93 -46.67 88.62 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 171.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -12.66 60.57 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 118.979 2.955 . . . . 0.0 118.979 169.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -68.53 -58.08 4.83 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 120.366 1.439 . . . . 0.0 113.643 175.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.2 -178.59 52.52 Favored Glycine 0 CA--C 1.547 2.08 0 N-CA-C 116.574 1.39 . . . . 0.0 116.574 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.48 -149.39 38.55 Favored Glycine 0 N--CA 1.488 2.143 0 O-C-N 121.818 -0.813 . . . . 0.0 114.905 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -133.67 155.56 49.48 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.972 0.892 . . . . 0.0 111.987 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -76.56 77.99 3.25 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-O 123.111 1.434 . . . . 0.0 112.817 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.9 p -77.19 161.24 73.72 Favored Pre-proline 0 CA--C 1.575 1.938 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.317 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -56.29 -35.82 96.23 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 N-CA-C 117.709 2.157 . . . . 0.0 117.709 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.43 -51.75 64.4 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 166.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.37 94.91 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 172.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.5 mt -57.77 -51.96 67.42 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 167.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.3 2.6 pp0? -62.52 -33.71 75.45 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 176.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -62.88 -55.26 27.66 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 164.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -59.38 -41.33 89.09 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.79 -18.6 62.09 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.7 m -66.18 -64.35 0.88 Allowed 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 120.554 1.525 . . . . 0.0 111.46 159.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -134.72 101.92 11.57 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 118.191 -0.909 . . . . 0.0 109.66 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.66 -51.4 0.11 Allowed 'Trans proline' 0 CA--C 1.561 1.853 0 CA-C-N 122.89 2.068 . . . . 0.0 116.218 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.65 -20.95 64.48 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.12 -43.89 61.04 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.771 1.623 . . . . 0.0 114.995 162.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.4 -57.27 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-N 119.426 1.012 . . . . 0.0 112.723 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.76 99.63 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -74.24 94.49 2.49 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.645 0.736 . . . . 0.0 111.945 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.05 20.71 7.01 Favored Glycine 0 CA--C 1.551 2.286 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 -166.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.4 t -72.71 137.62 46.06 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 120.199 2.0 . . . . 0.0 111.549 160.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -73.46 5.52 3.69 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 117.608 2.447 . . . . 0.0 117.608 165.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -70.26 98.21 1.34 Allowed 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 120.334 1.425 . . . . 0.0 112.198 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.06 69.57 5.25 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 122.481 1.134 . . . . 0.0 113.847 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.36 135.9 50.2 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.32 1.048 . . . . 0.0 109.044 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.26 -58.26 3.96 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 176.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.13 154.21 6.9 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-O 122.207 0.893 . . . . 0.0 115.109 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.5 mt -98.63 101.83 12.96 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-O 117.747 -1.121 . . . . 0.0 108.893 168.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.36 -37.38 10.2 Favored 'Trans proline' 0 CA--C 1.565 2.039 0 C-N-CA 122.574 2.183 . . . . 0.0 117.59 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -78.22 135.34 37.58 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 119.414 1.006 . . . . 0.0 112.454 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -58.37 -39.84 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 168.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.09 -44.78 79.34 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -56.46 -45.6 80.79 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -64.42 -54.24 35.83 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.45 90.19 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 117.379 2.362 . . . . 0.0 117.379 173.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -60.29 -47.96 83.79 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.4 tp -58.65 -46.53 86.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 168.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.4 mt -59.29 -41.45 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.914 1.233 . . . . 0.0 113.16 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.16 -44.58 75.32 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 164.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -58.94 -47.29 85.59 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 166.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.05 -22.57 63.06 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.43 -42.87 98.7 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 156.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.22 96.56 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 117.672 1.829 . . . . 0.0 117.672 165.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -77.98 85.1 4.23 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 118.136 0.968 . . . . 0.0 111.581 170.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.419 -0.8 . . . . 0.0 109.22 173.733 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 CA--C 1.576 1.967 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.11 -34.06 23.45 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 C-N-CA 122.573 2.182 . . . . 0.0 117.666 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.41 -44.55 96.95 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.42 77.86 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 165.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.49 -27.23 58.14 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 119.866 2.707 . . . . 0.0 119.866 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -59.66 -39.56 84.84 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 166.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -65.26 -44.06 89.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 168.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.6 t -56.14 -44.71 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 166.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.75 -23.53 18.29 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 170.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.05 -37.79 16.91 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 119.556 2.582 . . . . 0.0 119.556 162.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -60.72 -33.64 73.19 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 164.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -82.94 -30.0 28.69 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 171.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -56.26 -19.63 14.95 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.36 -26.52 19.56 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 159.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.0 m -125.13 -43.61 1.94 Allowed 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -96.47 140.39 31.19 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -126.06 123.11 37.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.758 -0.589 . . . . 0.0 110.301 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.66 -25.56 63.96 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.82 55.57 2.78 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.366 1.894 . . . . 0.0 113.72 -172.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.84 12.95 7.45 Favored Glycine 0 CA--C 1.561 2.941 0 N-CA-C 120.192 2.837 . . . . 0.0 120.192 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.86 137.67 38.93 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 118.936 1.368 . . . . 0.0 112.281 -168.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -127.58 110.37 12.64 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.14 -97.78 0.75 Allowed Glycine 0 N--CA 1.493 2.452 0 O-C-N 121.875 -0.516 . . . . 0.0 113.943 -171.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.71 -49.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.913 166.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.64 160.67 13.35 Favored Glycine 0 CA--C 1.56 2.895 0 CA-C-N 119.195 0.907 . . . . 0.0 114.004 163.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -69.93 174.62 9.39 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 CA-C-N 120.92 2.36 . . . . 0.0 115.369 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -74.48 118.19 17.16 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 120.439 -1.413 . . . . 0.0 112.615 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.0 mt -83.36 -4.92 58.93 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -59.18 117.88 5.25 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 120.033 1.288 . . . . 0.0 111.06 155.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.1 39.99 30.89 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 116.9 1.52 . . . . 0.0 116.9 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.01 -36.93 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.19 1.495 . . . . 0.0 114.512 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.5 t -68.18 108.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 119.966 1.257 . . . . 0.0 110.004 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.35 -19.16 55.56 Favored Glycine 0 CA--C 1.554 2.471 0 N-CA-C 118.535 2.174 . . . . 0.0 118.535 -162.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -73.51 144.14 46.27 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 120.802 2.301 . . . . 0.0 113.086 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.8 m -59.07 144.07 46.58 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.66 117.51 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.616 -0.677 . . . . 0.0 110.351 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.267 . . 65.76 56.77 0.88 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -160.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.69 31.2 5.08 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 -169.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.73 110.73 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 162.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -72.17 97.31 1.93 Allowed 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 123.593 0.757 . . . . 0.0 112.019 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.2 -52.09 0.58 Allowed Glycine 0 N--CA 1.489 2.167 0 CA-C-O 119.304 -0.72 . . . . 0.0 114.507 -159.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -81.57 134.58 35.52 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-N 118.449 1.125 . . . . 0.0 111.955 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -82.87 105.06 13.57 Favored 'General case' 0 CA--C 1.566 1.574 0 O-C-N 121.587 -0.696 . . . . 0.0 111.267 172.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.62 168.89 14.91 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.6 0.714 . . . . 0.0 112.628 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.1 t -70.92 153.01 43.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.305 -1.497 . . . . 0.0 113.319 171.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.15 -49.58 92.26 Favored Pre-proline 0 CA--C 1.577 2.001 0 CA-C-O 116.035 -1.936 . . . . 0.0 115.368 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.95 -21.29 64.02 Favored 'Trans proline' 0 CA--C 1.567 2.169 0 CA-C-N 124.744 2.73 . . . . 0.0 118.001 166.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.5 tpp -67.85 -50.44 56.57 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 120.394 1.452 . . . . 0.0 113.897 162.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -56.68 -44.37 81.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 169.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.86 -8.59 55.28 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 118.967 2.951 . . . . 0.0 118.967 171.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -66.44 -55.03 17.63 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 120.775 1.625 . . . . 0.0 114.637 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.47 174.85 50.33 Favored Glycine 0 CA--C 1.548 2.103 0 N-CA-C 116.451 1.341 . . . . 0.0 116.451 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.4 -158.52 47.55 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 115.321 0.888 . . . . 0.0 115.321 -174.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -128.7 156.61 43.21 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.913 0.863 . . . . 0.0 112.247 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -76.31 76.08 3.09 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.338 1.542 . . . . 0.0 112.898 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.5 p -76.42 160.43 77.54 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.943 172.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -57.25 -35.0 98.83 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.387 2.058 . . . . 0.0 117.416 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.64 -51.53 69.02 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 164.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.54 -44.78 93.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 171.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -59.47 -48.73 80.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -62.53 -36.89 84.03 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -62.29 -55.65 26.14 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 165.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -60.6 -40.38 91.61 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.8 mt -74.74 -12.62 60.45 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 169.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 m -67.04 -55.32 14.85 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 121.247 1.839 . . . . 0.0 112.337 161.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -149.19 114.24 3.61 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 117.919 -1.039 . . . . 0.0 108.503 167.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.04 -45.85 0.43 Allowed 'Trans proline' 0 CA--C 1.562 1.881 0 CA-C-N 122.655 1.984 . . . . 0.0 116.599 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.22 -28.57 67.35 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.63 93.44 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 162.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.7 t -70.56 -57.35 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.501 1.046 . . . . 0.0 112.532 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.9 103.27 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-N 120.083 1.31 . . . . 0.0 107.564 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -72.84 106.54 4.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.744 . . . . 0.0 111.058 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.98 17.68 17.71 Favored Glycine 0 CA--C 1.554 2.497 0 N-CA-C 118.919 2.327 . . . . 0.0 118.919 -169.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.1 t -75.57 135.88 40.55 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.806 1.803 . . . . 0.0 112.764 169.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.279 64.5 pttt -82.24 12.77 4.01 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 168.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.2 mmm -59.77 83.32 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.777 0 C-N-CA 125.195 1.398 . . . . 0.0 112.548 153.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.94 78.95 7.7 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 122.931 1.348 . . . . 0.0 112.47 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -150.77 133.92 16.11 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.509 -171.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.53 -56.05 9.63 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.46 158.68 8.99 Favored Glycine 0 N--CA 1.484 1.863 0 CA-C-O 122.292 0.94 . . . . 0.0 114.934 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.2 mt -99.04 101.66 13.11 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.767 -1.111 . . . . 0.0 108.315 168.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.87 -35.67 9.02 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 C-N-CA 122.697 2.265 . . . . 0.0 117.805 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -78.74 135.41 37.12 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 119.257 0.935 . . . . 0.0 112.503 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.15 -40.61 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 169.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.19 -45.12 75.82 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 170.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -57.18 -47.2 81.81 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 120.791 1.632 . . . . 0.0 115.173 169.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -61.77 -54.14 46.39 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.9 -43.37 86.1 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 171.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -58.5 -50.38 73.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 170.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.92 -45.38 92.77 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.2 -46.21 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 120.039 1.291 . . . . 0.0 113.0 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.84 -44.96 74.41 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 166.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -56.61 -48.54 77.23 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 167.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.7 mt -71.02 -25.14 62.54 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -60.77 -42.88 98.36 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 159.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 -44.35 95.35 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 164.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -81.6 85.3 6.56 Favored 'General case' 0 CA--C 1.572 1.81 0 CA-C-N 118.372 1.086 . . . . 0.0 111.855 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 123.828 0.851 . . . . 0.0 109.689 -174.649 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 CA--C 1.578 2.02 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.48 -29.08 25.79 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 N-CA-C 118.243 2.363 . . . . 0.0 118.243 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.93 86.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 167.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.62 79.79 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 162.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.69 -35.94 69.63 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 118.784 2.274 . . . . 0.0 118.784 165.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.74 -46.53 87.2 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.86 -41.71 98.18 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 167.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.3 t -60.63 -37.25 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 169.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -55.66 -19.57 11.09 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 117.014 2.228 . . . . 0.0 117.014 167.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.1 -37.02 7.48 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 119.699 2.639 . . . . 0.0 119.699 160.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -64.55 -38.1 89.85 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 164.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.64 -34.84 34.66 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -55.66 -35.74 66.31 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 120.299 3.444 . . . . 0.0 120.299 -168.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.34 80.66 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.8 m -89.85 -40.32 12.51 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 169.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -115.31 121.67 43.57 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.472 1.109 . . . . 0.0 110.643 -169.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -105.02 131.12 52.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 111.07 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.2 mt -70.82 -26.11 63.16 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -83.35 54.47 2.82 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.194 1.816 . . . . 0.0 113.396 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.32 9.84 18.81 Favored Glycine 0 CA--C 1.559 2.838 0 N-CA-C 120.593 2.997 . . . . 0.0 120.593 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -101.85 134.09 45.58 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.442 1.621 . . . . 0.0 111.869 -170.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -102.54 104.57 14.99 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.48 -106.45 2.93 Favored Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.966 -0.459 . . . . 0.0 113.386 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.02 -44.33 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.256 166.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.69 166.17 12.51 Favored Glycine 0 CA--C 1.564 3.115 0 CA-C-N 119.505 1.048 . . . . 0.0 115.051 161.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.29 151.79 43.76 Favored 'Trans proline' 0 CA--C 1.562 1.908 0 C-N-CA 122.835 2.357 . . . . 0.0 114.745 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -48.19 121.16 4.07 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.0 -9.32 59.6 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -63.03 111.86 2.36 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 118.921 0.782 . . . . 0.0 110.986 161.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.69 45.42 8.55 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 -170.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 p -100.37 -31.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 170.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.5 t -73.09 106.45 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 120.477 1.49 . . . . 0.0 109.563 -175.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.69 -12.33 66.1 Favored Glycine 0 CA--C 1.553 2.425 0 N-CA-C 118.692 2.237 . . . . 0.0 118.692 -162.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -72.52 140.12 47.98 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 121.018 2.409 . . . . 0.0 113.125 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.3 m -59.89 136.97 58.17 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.7 125.92 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 123.391 0.676 . . . . 0.0 110.797 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.254 . . 60.98 42.42 12.78 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -164.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.87 -3.12 39.7 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 119.751 2.66 . . . . 0.0 119.751 -170.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.6 t -83.53 103.3 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 120.386 2.093 . . . . 0.0 109.541 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.6 104.27 3.27 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.331 0.586 . . . . 0.0 110.482 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.32 -56.43 0.55 Allowed Glycine 0 N--CA 1.489 2.205 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.269 -157.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -87.67 128.24 35.29 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 117.721 0.761 . . . . 0.0 111.278 171.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -81.81 105.12 12.69 Favored 'General case' 0 CA--C 1.566 1.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.599 171.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -78.7 159.13 28.13 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.7 p -76.71 147.13 37.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.032 -1.043 . . . . 0.0 113.067 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -53.79 -44.45 98.05 Favored Pre-proline 0 CA--C 1.576 1.979 0 N-CA-C 117.882 2.549 . . . . 0.0 117.882 -175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.95 -19.58 58.04 Favored 'Trans proline' 0 CA--C 1.569 2.238 0 CA-C-N 125.069 2.846 . . . . 0.0 117.977 170.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.7 tpp -69.24 -45.28 70.16 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.128 1.331 . . . . 0.0 114.187 162.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -55.6 -44.24 76.8 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 164.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.13 -17.27 64.31 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 118.672 2.841 . . . . 0.0 118.672 169.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -64.4 -52.57 57.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.528 1.513 . . . . 0.0 114.44 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.85 167.33 34.9 Favored Glycine 0 CA--C 1.548 2.139 0 N-CA-C 117.842 1.897 . . . . 0.0 117.842 167.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.07 -145.52 23.39 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -130.52 153.35 48.92 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.801 0.81 . . . . 0.0 111.536 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.42 76.04 3.17 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 123.217 1.484 . . . . 0.0 113.11 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.3 p -75.3 160.52 79.76 Favored Pre-proline 0 CA--C 1.577 1.981 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.547 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -58.74 -27.6 84.07 Favored 'Trans proline' 0 CA--C 1.572 2.381 0 N-CA-C 118.171 2.335 . . . . 0.0 118.171 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.58 -53.27 23.88 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 163.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.1 90.1 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 174.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.2 mt -56.84 -52.42 65.16 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 168.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.253 8.2 pt20 -64.26 -33.85 76.77 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 176.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -60.39 -55.76 29.64 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 119.636 1.107 . . . . 0.0 113.938 163.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -58.3 -41.02 83.55 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.98 -16.75 61.51 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 170.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.5 m -65.2 -54.83 23.57 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 121.1 1.773 . . . . 0.0 112.693 164.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -149.73 112.53 3.4 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.334 167.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.05 -45.19 0.48 Allowed 'Trans proline' 0 CA--C 1.559 1.749 0 CA-C-N 122.565 1.952 . . . . 0.0 116.889 -174.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.03 -29.16 68.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 173.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.17 88.0 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 163.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.1 t -68.94 -56.36 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 119.48 1.036 . . . . 0.0 112.584 173.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.56 101.04 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -69.62 102.67 1.91 Allowed 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 121.307 0.575 . . . . 0.0 111.642 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.15 10.25 32.36 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 119.352 2.501 . . . . 0.0 119.352 -170.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 t -66.47 134.73 53.06 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.48 2.64 . . . . 0.0 112.742 171.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -73.11 9.78 1.13 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -77.08 103.73 7.17 Favored 'General case' 0 CA--C 1.563 1.461 0 O-C-N 120.585 -1.322 . . . . 0.0 111.691 173.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.28 71.48 4.75 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 122.535 1.159 . . . . 0.0 113.624 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -137.44 129.51 29.14 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.303 1.041 . . . . 0.0 108.405 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.01 -54.46 15.08 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.08 157.96 8.3 Favored Glycine 0 CA--C 1.544 1.897 0 CA-C-O 122.525 1.07 . . . . 0.0 115.555 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.22 101.13 15.37 Favored Pre-proline 0 CA--C 1.575 1.912 0 CA-C-O 117.924 -1.036 . . . . 0.0 108.665 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.41 -37.17 7.95 Favored 'Trans proline' 0 CA--C 1.566 2.085 0 C-N-CA 122.689 2.259 . . . . 0.0 117.752 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -76.89 134.2 39.05 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 119.193 0.906 . . . . 0.0 112.888 174.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.8 tt -57.06 -41.25 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 168.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.86 -49.32 49.7 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.81 -45.11 90.69 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 171.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -62.77 -53.73 49.9 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 171.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.71 -46.32 84.54 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 172.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -56.95 -50.98 70.97 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 169.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.3 tp -56.65 -45.63 81.53 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 169.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.0 -42.18 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.237 171.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.93 -43.28 77.25 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 165.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -58.32 -48.01 81.89 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.6 -23.64 63.56 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.866 2.172 . . . . 0.0 116.866 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -61.63 -43.14 99.41 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 156.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.23 -47.2 90.1 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 117.576 1.79 . . . . 0.0 117.576 166.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -76.48 88.82 3.24 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 118.317 1.058 . . . . 0.0 112.119 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.48 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 CA--C 1.578 2.032 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.49 -28.45 26.54 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 N-CA-C 118.428 2.434 . . . . 0.0 118.428 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.36 -47.08 80.65 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 169.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.92 -38.77 79.73 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 161.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.47 -38.46 80.22 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 119.009 2.364 . . . . 0.0 119.009 166.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -55.63 -45.9 77.51 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 163.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.49 -47.75 84.31 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 t -57.83 -39.87 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 168.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -55.07 -20.82 10.58 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 169.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.52 -36.8 24.99 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 119.525 2.57 . . . . 0.0 119.525 160.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -57.87 -41.74 83.09 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 163.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -76.59 -34.18 58.41 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -52.6 -25.95 12.11 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 119.061 2.986 . . . . 0.0 119.061 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.18 -25.89 15.35 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 162.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.5 m -128.55 -34.32 2.02 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -108.0 142.12 38.62 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.547 1.139 . . . . 0.0 112.922 -169.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -103.1 157.16 17.19 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.244 1.021 . . . . 0.0 111.814 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.68 -27.52 13.63 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -84.74 60.3 6.06 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-N 121.542 1.974 . . . . 0.0 113.982 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.6 -40.01 0.39 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 120.166 2.827 . . . . 0.0 120.166 174.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -80.32 154.99 27.44 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 124.879 1.271 . . . . 0.0 112.96 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -96.77 152.21 18.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 111.952 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -122.68 -118.93 2.5 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 121.397 -0.815 . . . . 0.0 112.742 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.7 t -73.82 -48.23 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 122.337 -0.507 . . . . 0.0 111.104 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.11 171.06 26.62 Favored Glycine 0 CA--C 1.562 3.027 0 CA-C-N 118.836 0.744 . . . . 0.0 114.775 156.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.44 175.24 9.7 Favored 'Trans proline' 0 CA--C 1.567 2.137 0 CA-C-N 121.124 2.462 . . . . 0.0 114.799 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -65.08 122.52 17.25 Favored 'General case' 0 CA--C 1.568 1.668 0 O-C-N 120.402 -1.436 . . . . 0.0 113.094 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.32 -3.68 59.04 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 116.631 2.085 . . . . 0.0 116.631 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -63.95 121.11 13.3 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 119.401 1.001 . . . . 0.0 110.792 155.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.77 42.81 16.07 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 116.413 1.325 . . . . 0.0 116.413 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -100.45 -33.69 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.9 t -74.99 105.02 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 120.652 1.569 . . . . 0.0 109.4 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.22 -26.45 22.89 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 117.761 1.864 . . . . 0.0 117.761 -160.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -66.07 142.92 57.63 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 120.978 2.389 . . . . 0.0 113.736 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.0 m -53.68 139.71 31.48 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.39 120.34 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.647 -0.658 . . . . 0.0 109.738 173.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 63.54 49.01 3.21 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -162.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.93 -27.01 13.13 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 118.875 2.31 . . . . 0.0 118.875 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.5 t -73.53 98.43 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.266 1.533 . . . . 0.0 109.966 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.25 105.65 8.48 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.369 0.667 . . . . 0.0 110.168 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.9 -52.43 0.71 Allowed Glycine 0 N--CA 1.489 2.216 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.66 -154.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -79.65 130.23 35.17 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 118.036 0.918 . . . . 0.0 111.647 171.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -81.27 90.5 6.12 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 121.581 -0.699 . . . . 0.0 111.642 177.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.91 157.38 37.95 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 t -66.87 155.02 39.5 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 174.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -59.58 -49.12 93.7 Favored Pre-proline 0 CA--C 1.577 2.003 0 CA-C-O 116.094 -1.908 . . . . 0.0 115.488 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.36 -25.14 64.01 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 CA-C-N 124.71 2.718 . . . . 0.0 117.732 166.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.5 tpp -65.22 -48.38 73.57 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.533 1.515 . . . . 0.0 114.17 164.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -58.78 -45.81 88.97 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 167.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.79 -14.7 62.52 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 118.976 2.954 . . . . 0.0 118.976 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -62.52 -53.15 59.04 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.715 1.598 . . . . 0.0 114.708 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.98 175.72 48.67 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 116.728 1.451 . . . . 0.0 116.728 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.46 -151.76 40.34 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 115.121 0.808 . . . . 0.0 115.121 -176.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -132.34 154.76 49.42 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.001 0.905 . . . . 0.0 111.568 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -76.04 76.16 2.91 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 123.01 1.386 . . . . 0.0 112.877 172.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -72.58 160.17 83.5 Favored Pre-proline 0 CA--C 1.576 1.964 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.386 171.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.27 -32.39 95.82 Favored 'Trans proline' 0 CA--C 1.571 2.366 0 N-CA-C 117.504 2.079 . . . . 0.0 117.504 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -64.06 -52.71 58.05 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 163.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.77 80.55 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 172.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.9 mt -60.9 -45.22 95.5 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 166.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -55.81 -43.56 77.01 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 121.583 1.992 . . . . 0.0 116.207 167.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -61.72 -56.02 24.03 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 120.029 1.286 . . . . 0.0 114.333 169.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.54 -39.87 95.0 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.0 mt -72.2 -22.67 61.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 169.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.5 m -62.48 -52.53 63.13 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.347 1.885 . . . . 0.0 113.365 163.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -151.35 113.11 3.03 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-N 119.902 1.228 . . . . 0.0 109.088 167.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.94 -47.8 0.16 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 CA-C-N 122.752 2.019 . . . . 0.0 116.91 -174.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -67.27 -26.3 66.49 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.77 -42.47 86.06 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 161.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.53 -58.56 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.432 1.014 . . . . 0.0 112.617 175.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.51 99.89 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -74.91 98.85 3.66 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-O 121.477 0.656 . . . . 0.0 111.725 -177.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.08 18.33 10.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 -166.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -69.92 138.37 52.36 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.268 2.034 . . . . 0.0 112.003 163.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -73.95 8.76 1.84 Allowed 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.4 ttt -78.4 99.05 6.23 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.708 -1.245 . . . . 0.0 111.795 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.99 73.33 4.55 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 122.504 1.145 . . . . 0.0 113.702 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -135.99 130.15 33.16 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.229 1.012 . . . . 0.0 108.507 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.11 -54.39 18.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.24 159.93 9.27 Favored Glycine 0 CA--C 1.544 1.862 0 N-CA-C 115.909 1.124 . . . . 0.0 115.909 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.0 mt -102.39 98.96 11.66 Favored Pre-proline 0 CA--C 1.575 1.908 0 C-N-CA 123.903 0.881 . . . . 0.0 108.932 168.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.61 -34.05 15.89 Favored 'Trans proline' 0 CA--C 1.567 2.131 0 C-N-CA 122.592 2.195 . . . . 0.0 117.623 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -76.98 136.0 38.72 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 119.214 0.916 . . . . 0.0 113.064 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 tt -57.12 -43.18 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 167.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -54.57 -46.15 73.64 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.18 -45.97 83.23 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 75.7 mtm-85 -66.49 -52.48 45.57 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 172.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.56 -46.62 86.5 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -57.2 -49.33 76.33 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 169.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.6 tp -59.28 -46.45 88.5 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 170.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.72 -40.47 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-N 120.099 1.318 . . . . 0.0 112.976 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.77 -44.82 74.03 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 163.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -58.55 -47.78 83.09 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 167.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.1 mt -71.94 -23.01 61.39 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.29 -43.24 99.27 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 155.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.7 -41.91 98.84 Favored Glycine 0 CA--C 1.554 2.481 0 N-CA-C 118.056 1.982 . . . . 0.0 118.056 166.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -81.47 83.6 6.93 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 118.527 1.164 . . . . 0.0 111.351 170.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 . . . . . 0 N--CA 1.487 1.396 0 O-C-N 121.472 -0.768 . . . . 0.0 109.58 173.925 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 CA--C 1.572 1.824 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -57.15 -34.64 98.12 Favored 'Trans proline' 0 CA--C 1.566 2.108 0 N-CA-C 119.605 2.887 . . . . 0.0 119.605 172.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.83 76.75 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.31 -42.35 77.48 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 162.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.97 -36.71 91.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 169.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.88 -46.96 78.16 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 163.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -57.62 -46.81 83.64 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 168.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.22 -39.45 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -55.21 -18.46 6.03 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.24 -37.94 6.26 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 119.6 2.6 . . . . 0.0 119.6 158.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.25 -38.72 88.54 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 164.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -79.42 -37.1 37.9 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -56.28 -27.77 56.47 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 120.133 3.382 . . . . 0.0 120.133 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.24 -33.17 67.29 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.812 2.153 . . . . 0.0 116.812 168.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.6 m -103.69 -35.95 8.06 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -112.01 142.5 44.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -167.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -107.9 148.6 29.39 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.997 0.903 . . . . 0.0 113.288 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.97 10.29 39.8 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 171.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -123.72 62.29 1.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 120.388 1.449 . . . . 0.0 110.999 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.12 -15.72 0.71 Allowed Glycine 0 CA--C 1.558 2.768 0 N-CA-C 121.616 3.406 . . . . 0.0 121.616 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -90.02 161.47 15.84 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 119.215 1.508 . . . . 0.0 114.489 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -130.02 141.4 50.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.228 -1.545 . . . . 0.0 110.978 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.19 -98.8 0.18 Allowed Glycine 0 N--CA 1.489 2.186 0 O-C-N 121.732 -0.605 . . . . 0.0 112.964 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.96 -51.76 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 117.275 0.537 . . . . 0.0 111.406 167.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.03 175.97 17.64 Favored Glycine 0 CA--C 1.562 2.986 0 N-CA-C 115.067 0.787 . . . . 0.0 115.067 164.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.06 -179.06 3.97 Favored 'Trans proline' 0 CA--C 1.569 2.249 0 C-N-CA 122.723 2.282 . . . . 0.0 114.569 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -76.97 138.09 39.43 Favored 'General case' 0 CA--C 1.566 1.593 0 O-C-N 120.585 -1.322 . . . . 0.0 113.325 173.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.71 -2.57 34.97 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -65.15 113.44 3.97 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.865 1.666 . . . . 0.0 111.964 164.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.34 54.72 6.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 -168.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.2 -38.15 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 171.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -66.88 107.59 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 120.248 1.385 . . . . 0.0 110.118 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.26 -17.08 59.73 Favored Glycine 0 CA--C 1.551 2.342 0 N-CA-C 118.649 2.22 . . . . 0.0 118.649 -163.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -71.69 142.14 49.85 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.177 2.489 . . . . 0.0 113.107 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -59.19 136.56 57.99 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.82 126.66 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 123.465 0.706 . . . . 0.0 111.134 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 59.05 39.88 22.78 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -166.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.72 3.74 49.63 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 119.353 2.501 . . . . 0.0 119.353 -171.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.79 104.17 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.875 1.838 . . . . 0.0 108.375 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.75 86.24 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.458 0.647 . . . . 0.0 111.704 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.55 -46.93 0.37 Allowed Glycine 0 CA--C 1.545 1.965 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.123 -158.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -86.15 137.83 32.36 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 118.814 1.307 . . . . 0.0 112.184 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.1 85.77 3.59 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.189 0.995 . . . . 0.0 113.191 172.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -77.41 142.99 38.96 Favored 'General case' 0 CA--C 1.567 1.628 0 O-C-N 121.408 -0.808 . . . . 0.0 112.753 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.5 p -70.03 157.63 37.17 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -54.03 -49.27 90.73 Favored Pre-proline 0 CA--C 1.578 2.022 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.24 -28.0 40.56 Favored 'Trans proline' 0 CA--C 1.568 2.192 0 CA-C-N 124.328 2.582 . . . . 0.0 117.154 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -62.67 -47.21 84.68 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 120.379 1.445 . . . . 0.0 114.559 163.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -58.32 -47.05 84.95 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 167.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.59 -17.44 63.54 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 118.916 2.932 . . . . 0.0 118.916 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -58.38 -51.39 70.02 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.64 1.564 . . . . 0.0 114.528 175.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.84 170.65 35.8 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 117.732 1.853 . . . . 0.0 117.732 165.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.86 -143.11 26.23 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 122.088 -0.654 . . . . 0.0 114.629 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -129.89 154.12 47.62 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.669 0.747 . . . . 0.0 111.759 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -76.26 76.75 3.05 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.929 1.347 . . . . 0.0 112.977 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.3 p -74.11 160.05 82.53 Favored Pre-proline 0 CA--C 1.573 1.865 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.662 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.4 -29.04 87.12 Favored 'Trans proline' 0 CA--C 1.569 2.233 0 N-CA-C 117.461 2.062 . . . . 0.0 117.461 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -66.12 -54.7 22.27 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 163.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.97 88.89 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.6 -44.55 93.36 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 164.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -57.73 -42.7 84.37 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -63.43 -55.84 21.01 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.967 1.258 . . . . 0.0 114.226 169.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -60.79 -42.2 97.13 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 71.2 mt -73.87 -16.33 61.12 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.9 m -64.1 -54.62 31.02 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 121.296 1.862 . . . . 0.0 112.788 161.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.98 115.29 3.45 Favored Pre-proline 0 CA--C 1.575 1.922 0 CA-C-N 119.625 1.102 . . . . 0.0 108.805 167.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.32 -45.78 0.32 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 CA-C-N 122.586 1.959 . . . . 0.0 116.753 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -66.11 -33.24 75.32 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.57 95.84 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 165.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.91 -58.14 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-N 118.843 0.747 . . . . 0.0 112.095 171.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.94 98.2 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -73.21 101.32 3.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.877 . . . . 0.0 111.474 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.5 19.96 10.72 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 118.559 2.184 . . . . 0.0 118.559 -164.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -76.35 132.36 39.7 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 119.964 1.882 . . . . 0.0 110.682 156.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.282 64.2 pttt -82.54 26.83 0.54 Allowed 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 170.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.02 101.3 1.37 Allowed 'General case' 0 CA--C 1.567 1.62 0 O-C-N 120.501 -1.375 . . . . 0.0 109.919 159.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.06 73.42 4.62 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.882 1.325 . . . . 0.0 112.166 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -152.42 123.33 7.48 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.094 -166.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.96 -49.63 60.61 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.35 164.42 13.09 Favored Glycine 0 CA--C 1.543 1.824 0 CA-C-O 122.686 1.159 . . . . 0.0 115.557 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.8 mt -101.99 95.16 5.25 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 164.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.33 -34.1 16.77 Favored 'Trans proline' 0 CA--C 1.567 2.154 0 C-N-CA 122.648 2.232 . . . . 0.0 117.343 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -74.64 132.82 42.04 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-O 121.885 0.85 . . . . 0.0 112.913 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.06 -42.97 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.18 -48.27 68.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.05 -43.88 78.3 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -64.5 -52.58 57.14 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 170.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.87 82.85 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -60.1 -48.59 81.08 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 172.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.2 tp -61.2 -45.71 93.45 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 172.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.25 60.6 mt -61.96 -41.09 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 119.79 1.177 . . . . 0.0 112.783 171.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.7 -43.3 80.4 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 164.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -56.71 -48.1 78.47 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 164.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.86 -23.23 61.48 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -64.9 -42.92 94.36 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.326 -1.484 . . . . 0.0 114.684 155.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.53 -56.75 23.54 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.837 1.495 . . . . 0.0 116.837 167.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -82.69 82.38 8.07 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.544 1.172 . . . . 0.0 112.285 165.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 . . . . . 0 C--O 1.259 1.6 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.947 158.626 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtm . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.675 0.274 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.46 73.63 0.96 Allowed 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.037 0.923 . . . . 0.0 112.347 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -101.97 119.67 56.11 Favored Pre-proline 0 CA--C 1.576 1.979 0 C-N-CA 124.095 0.958 . . . . 0.0 111.24 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.68 -28.82 30.51 Favored 'Trans proline' 0 CA--C 1.568 2.211 0 N-CA-C 118.364 2.409 . . . . 0.0 118.364 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.41 -50.32 70.29 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.52 72.08 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 163.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.48 -31.58 66.99 Favored Glycine 0 CA--C 1.55 2.27 0 N-CA-C 118.679 2.231 . . . . 0.0 118.679 165.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.67 -42.51 98.04 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 168.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.11 -40.7 98.38 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 167.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.92 -41.61 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -58.27 -24.8 60.62 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 168.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.19 -29.7 29.91 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 119.495 2.558 . . . . 0.0 119.495 163.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -59.52 -35.81 74.88 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 160.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.79 -33.64 30.73 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 173.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -46.69 -41.75 15.44 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 119.724 3.231 . . . . 0.0 119.724 -173.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.39 -35.95 72.81 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.2 m -91.82 -43.75 9.34 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 169.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -114.04 132.74 55.9 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.318 1.047 . . . . 0.0 111.196 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -117.62 122.68 44.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 170.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.2 mt -47.16 -51.79 17.31 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -92.14 76.78 5.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.083 0.944 . . . . 0.0 111.237 -157.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.89 -21.69 0.96 Allowed Glycine 0 CA--C 1.556 2.614 0 N-CA-C 120.523 2.969 . . . . 0.0 120.523 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -91.42 116.59 28.97 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 118.83 1.315 . . . . 0.0 112.043 -167.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -97.39 121.76 39.66 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.756 0.822 . . . . 0.0 109.972 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.11 -109.88 3.06 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.82 -0.55 . . . . 0.0 113.329 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.19 -47.78 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 117.186 0.493 . . . . 0.0 111.055 167.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.94 170.85 25.41 Favored Glycine 0 CA--C 1.559 2.833 0 N-CA-C 115.444 0.937 . . . . 0.0 115.444 163.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -69.14 169.03 19.05 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 C-N-CA 122.686 2.258 . . . . 0.0 115.111 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -70.07 123.65 22.1 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 120.536 -1.352 . . . . 0.0 112.326 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.4 mt -92.03 11.51 25.04 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 -173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.1 p30 -57.5 122.67 13.21 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 121.555 1.979 . . . . 0.0 113.267 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.85 43.66 94.64 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 118.683 2.233 . . . . 0.0 118.683 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.254 5.2 p -71.65 -23.06 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.1 t -73.82 107.42 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 124.311 1.044 . . . . 0.0 109.565 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.34 -3.82 79.83 Favored Glycine 0 CA--C 1.555 2.535 0 N-CA-C 119.039 2.376 . . . . 0.0 119.039 -162.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -84.83 143.13 29.27 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.802 2.301 . . . . 0.0 112.983 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.2 m -60.74 137.91 58.15 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.9 t -67.06 123.1 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.905 -0.497 . . . . 0.0 110.258 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.266 . . 62.95 50.0 3.34 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -163.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.63 -16.49 28.84 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 119.399 2.519 . . . . 0.0 119.399 -171.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.52 97.67 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 120.048 1.924 . . . . 0.0 109.599 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.21 109.05 5.01 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 123.19 0.596 . . . . 0.0 110.88 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.36 -57.07 0.67 Allowed Glycine 0 N--CA 1.49 2.275 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.018 -157.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -82.42 123.37 29.06 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 117.676 0.738 . . . . 0.0 110.417 167.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.13 124.85 29.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.478 -0.763 . . . . 0.0 110.735 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -94.55 173.53 7.57 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 121.879 0.847 . . . . 0.0 112.36 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.5 t -71.55 154.38 41.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.294 -1.504 . . . . 0.0 113.114 171.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -59.53 -49.66 91.08 Favored Pre-proline 0 CA--C 1.577 1.986 0 CA-C-O 115.959 -1.972 . . . . 0.0 115.239 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.29 -24.39 71.97 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 CA-C-N 124.805 2.752 . . . . 0.0 117.895 166.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.8 tpp -66.86 -49.34 66.01 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.646 1.566 . . . . 0.0 114.158 164.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -59.21 -43.07 92.3 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -12.42 61.47 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 118.862 2.912 . . . . 0.0 118.862 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -65.16 -55.62 17.6 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 120.835 1.652 . . . . 0.0 114.356 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.57 177.63 50.47 Favored Glycine 0 CA--C 1.548 2.104 0 N-CA-C 116.648 1.419 . . . . 0.0 116.648 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.06 -154.18 44.42 Favored Glycine 0 CA--C 1.548 2.147 0 N-CA-C 115.332 0.893 . . . . 0.0 115.332 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -130.7 154.36 48.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.149 0.976 . . . . 0.0 112.261 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -76.64 73.3 3.33 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 123.081 1.42 . . . . 0.0 113.254 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.5 p -70.11 159.6 83.78 Favored Pre-proline 0 CA--C 1.575 1.933 0 C-N-CA 124.516 1.127 . . . . 0.0 112.312 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -57.06 -34.7 98.19 Favored 'Trans proline' 0 CA--C 1.568 2.197 0 N-CA-C 117.794 2.19 . . . . 0.0 117.794 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.82 -45.56 74.35 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 164.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.64 -43.88 85.19 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 170.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.05 -47.37 86.14 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 165.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -55.69 -44.46 77.39 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 121.634 2.016 . . . . 0.0 116.324 169.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -61.41 -55.63 29.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 119.93 1.241 . . . . 0.0 114.111 170.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -60.97 -41.38 96.28 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.1 mt -73.13 -21.66 60.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -63.76 -52.03 62.23 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-N 120.942 1.701 . . . . 0.0 113.352 162.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -150.12 112.61 3.31 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-N 120.146 1.339 . . . . 0.0 109.299 168.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.96 -47.44 0.17 Allowed 'Trans proline' 0 CA--C 1.56 1.819 0 CA-C-N 122.672 1.99 . . . . 0.0 116.933 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.45 -26.53 65.55 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.92 -41.54 86.89 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 161.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.0 t -71.45 -58.86 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.416 1.007 . . . . 0.0 112.629 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.74 100.92 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -74.94 100.69 4.19 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 121.366 0.603 . . . . 0.0 111.685 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.52 18.47 12.94 Favored Glycine 0 CA--C 1.554 2.491 0 N-CA-C 118.58 2.192 . . . . 0.0 118.58 -165.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -71.77 137.46 47.69 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.141 1.971 . . . . 0.0 111.997 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -73.51 6.85 2.71 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 167.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.412 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.5 ttt -73.28 94.82 2.05 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 120.415 1.461 . . . . 0.0 111.451 171.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.62 70.75 5.01 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.754 1.264 . . . . 0.0 113.431 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -130.49 130.45 44.2 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.512 1.125 . . . . 0.0 107.988 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.06 -54.96 22.03 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.98 155.06 6.47 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.0 mt -103.97 98.14 12.84 Favored Pre-proline 0 CA--C 1.573 1.846 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.373 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.03 -33.32 15.78 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 122.572 2.181 . . . . 0.0 117.644 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.03 133.1 36.82 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.102 0.865 . . . . 0.0 112.361 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.1 tt -56.15 -44.58 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 171.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.9 -45.84 71.24 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.16 -47.72 80.49 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 169.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 75.0 mtm-85 -64.73 -50.96 64.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.35 93.11 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -56.9 -50.17 73.32 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 168.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.0 tp -54.89 -48.67 72.7 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.75 -41.77 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 119.859 1.209 . . . . 0.0 113.411 171.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.21 -43.12 74.18 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 164.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -62.44 -44.68 95.85 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 168.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.2 mt -64.08 -27.86 69.39 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 169.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.22 -44.3 76.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 120.261 1.391 . . . . 0.0 114.657 158.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -53.96 -54.37 31.62 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 117.44 1.736 . . . . 0.0 117.44 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -84.07 81.46 8.79 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 118.539 1.17 . . . . 0.0 111.649 160.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 C--O 1.253 1.249 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 155.149 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.412 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.91 70.37 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.104 0.865 . . . . 0.0 113.06 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -102.64 118.55 58.26 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.009 0.924 . . . . 0.0 111.118 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.84 -28.5 24.79 Favored 'Trans proline' 0 CA--C 1.569 2.25 0 N-CA-C 118.523 2.47 . . . . 0.0 118.523 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.24 -46.83 79.01 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.29 -37.6 78.1 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 159.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.95 -35.5 76.23 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 119.14 2.416 . . . . 0.0 119.14 168.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.12 -42.93 91.74 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 163.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.44 -43.61 96.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.1 -45.01 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 166.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -56.88 -26.61 59.14 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.39 -34.1 6.24 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 161.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -59.2 -35.75 74.15 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 162.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.78 -20.23 43.08 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 171.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -73.86 67.6 1.23 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 123.802 1.763 . . . . 0.0 115.361 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.56 -57.18 0.1 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.365 1.466 . . . . 0.0 108.258 168.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.7 m -71.91 -44.26 63.97 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 166.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -112.42 138.29 49.38 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 119.925 1.238 . . . . 0.0 111.756 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -131.68 123.09 27.05 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.618 0.723 . . . . 0.0 109.774 -171.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.9 mt -72.48 -10.94 60.41 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.9 58.8 1.03 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 120.998 1.726 . . . . 0.0 112.052 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.02 15.6 36.73 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 121.129 3.212 . . . . 0.0 121.129 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -103.73 129.61 51.12 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 119.192 1.496 . . . . 0.0 110.897 -174.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.53 102.51 10.37 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.29 -105.57 3.04 Favored Glycine 0 N--CA 1.49 2.292 0 O-C-N 121.998 -0.439 . . . . 0.0 112.873 -174.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -73.4 -47.06 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.45 167.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.95 167.01 14.22 Favored Glycine 0 CA--C 1.56 2.899 0 CA-C-N 119.315 0.961 . . . . 0.0 114.711 164.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.7 173.03 13.25 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 CA-C-N 120.803 2.302 . . . . 0.0 115.799 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -70.18 122.39 19.38 Favored 'General case' 0 CA--C 1.57 1.713 0 O-C-N 120.561 -1.337 . . . . 0.0 112.43 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.76 7.72 38.22 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -65.07 127.49 31.84 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 120.86 1.664 . . . . 0.0 111.671 164.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.51 24.19 65.94 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 118.26 2.064 . . . . 0.0 118.26 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -79.34 -26.81 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 120.319 2.06 . . . . 0.0 116.259 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.9 t -77.89 105.16 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 120.208 1.367 . . . . 0.0 109.192 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.37 -7.93 64.2 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 118.72 2.248 . . . . 0.0 118.72 -160.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -81.32 142.76 32.77 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 120.987 2.393 . . . . 0.0 113.07 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.3 m -60.12 139.09 57.72 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -67.3 123.23 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.919 -0.488 . . . . 0.0 110.318 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 62.16 49.48 4.4 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -162.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.94 -15.63 30.54 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 119.268 2.467 . . . . 0.0 119.268 -170.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.1 t -83.76 96.67 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 119.965 1.882 . . . . 0.0 109.467 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.35 107.83 3.96 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-O 121.381 0.61 . . . . 0.0 111.006 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.68 -56.1 0.63 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.195 -157.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -83.07 127.12 33.29 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 117.791 0.796 . . . . 0.0 110.777 168.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -81.37 115.72 20.86 Favored 'General case' 0 CA--C 1.565 1.548 0 O-C-N 121.548 -0.72 . . . . 0.0 110.937 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -87.67 168.42 13.02 Favored 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 123.541 0.736 . . . . 0.0 112.529 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 p -73.33 152.58 40.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.106 -1.621 . . . . 0.0 113.056 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -57.57 -42.32 95.07 Favored Pre-proline 0 CA--C 1.574 1.895 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.31 -26.71 41.32 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 CA-C-N 125.017 2.828 . . . . 0.0 117.184 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.9 tpp -63.9 -46.32 85.4 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 120.451 1.478 . . . . 0.0 114.091 162.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.21 -46.63 82.74 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 166.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.81 -14.63 61.56 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 118.87 2.915 . . . . 0.0 118.87 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -62.55 -53.37 55.73 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 120.652 1.569 . . . . 0.0 114.84 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.61 -179.44 50.89 Favored Glycine 0 CA--C 1.547 2.045 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.61 -154.58 48.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -174.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -131.08 155.12 47.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.105 0.955 . . . . 0.0 112.356 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.32 75.15 3.11 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.968 1.366 . . . . 0.0 112.992 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.8 p -72.48 159.38 85.52 Favored Pre-proline 0 CA--C 1.576 1.949 0 C-N-CA 124.428 1.091 . . . . 0.0 112.191 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -57.31 -32.5 93.96 Favored 'Trans proline' 0 CA--C 1.572 2.391 0 N-CA-C 117.636 2.129 . . . . 0.0 117.636 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -64.82 -52.97 53.93 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 164.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.87 -43.73 86.17 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.5 mt -56.93 -50.76 71.61 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 167.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.7 pp0? -64.67 -32.73 74.53 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -61.34 -56.45 20.23 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 162.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -59.74 -41.5 91.06 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.2 mt -74.82 -14.56 60.7 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -67.54 -65.46 0.68 Allowed 'General case' 0 CA--C 1.57 1.714 0 CA-C-N 120.646 1.567 . . . . 0.0 111.308 156.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -133.06 101.58 13.66 Favored Pre-proline 0 CA--C 1.571 1.766 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.57 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.42 -51.11 0.14 Allowed 'Trans proline' 0 CA--C 1.562 1.917 0 CA-C-N 122.788 2.031 . . . . 0.0 115.693 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.58 -19.18 62.88 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.59 -43.21 56.66 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.692 1.587 . . . . 0.0 114.992 162.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.54 -57.14 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 119.423 1.011 . . . . 0.0 112.748 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.3 t -102.44 102.65 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -72.68 102.71 3.39 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-O 121.26 0.552 . . . . 0.0 111.44 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.58 26.45 9.2 Favored Glycine 0 CA--C 1.553 2.426 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -165.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -72.03 132.27 44.03 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.538 1.669 . . . . 0.0 111.254 160.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -76.03 11.04 1.58 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 166.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -73.52 99.03 2.92 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 120.848 -1.157 . . . . 0.0 111.278 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.4 72.9 6.05 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 122.564 1.174 . . . . 0.0 112.982 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -128.61 135.43 49.32 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 124.484 1.114 . . . . 0.0 108.662 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.46 -58.15 4.34 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.43 149.88 5.18 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-N 118.931 0.787 . . . . 0.0 114.944 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -102.01 99.15 11.52 Favored Pre-proline 0 CA--C 1.572 1.809 0 CA-C-O 117.774 -1.108 . . . . 0.0 109.441 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.43 -35.32 18.27 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 122.657 2.238 . . . . 0.0 117.624 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -72.37 127.42 32.51 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -58.33 -39.95 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 167.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -53.84 -46.59 71.24 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.048 1.869 . . . . 0.0 116.048 169.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.45 -44.43 89.19 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -63.75 -51.27 65.66 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.12 -43.75 91.98 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 170.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -54.33 -54.2 43.63 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.932 1.242 . . . . 0.0 114.017 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.1 tp -55.08 -47.65 74.6 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 170.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.251 61.7 mt -62.98 -41.29 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 117.396 -1.288 . . . . 0.0 113.116 173.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.7 -43.99 69.43 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 163.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -60.75 -47.6 85.59 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 167.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 52.6 mt -63.73 -31.29 72.41 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 171.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.86 -42.66 99.84 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 162.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.58 99.48 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 117.827 1.891 . . . . 0.0 117.827 163.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -83.11 72.5 10.12 Favored 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 118.356 1.078 . . . . 0.0 112.408 172.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.603 175.609 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.6 ttm . . . . . 0 CA--C 1.562 1.417 0 CA-C-O 121.142 0.496 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.279 . . 61.66 29.46 18.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 118.606 2.817 . . . . 0.0 118.606 -174.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -98.9 113.18 64.3 Favored Pre-proline 0 CA--C 1.576 1.958 0 O-C-N 120.883 -1.136 . . . . 0.0 110.355 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.04 -26.75 25.95 Favored 'Trans proline' 0 CA--C 1.568 2.219 0 N-CA-C 118.38 2.415 . . . . 0.0 118.38 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.82 85.59 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 167.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.85 -39.46 81.36 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 161.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.41 -36.49 77.06 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 119.083 2.393 . . . . 0.0 119.083 168.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -54.39 -47.6 72.51 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 162.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -59.62 -44.18 93.54 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.33 -42.72 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 119.527 1.058 . . . . 0.0 113.831 167.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -55.85 -26.98 49.44 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.93 -34.11 10.94 Favored Glycine 0 N--CA 1.5 2.928 0 N-CA-C 119.818 2.687 . . . . 0.0 119.818 166.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -58.32 -39.64 79.95 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 162.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -78.42 -32.88 48.87 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -45.32 -45.05 12.07 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 -174.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.46 -37.45 70.32 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 m -91.95 -43.31 9.53 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 171.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -112.43 128.04 56.2 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.372 0.987 . . . . 0.0 111.449 -169.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -113.37 130.35 56.31 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.992 0.901 . . . . 0.0 111.265 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.6 mt -74.46 -24.3 59.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.98 56.86 3.63 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 121.117 1.78 . . . . 0.0 113.095 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.39 16.21 34.58 Favored Glycine 0 CA--C 1.558 2.772 0 N-CA-C 120.624 3.009 . . . . 0.0 120.624 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -105.75 133.05 51.11 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.65 1.725 . . . . 0.0 112.395 -171.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.79 122.76 36.6 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.627 169.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.01 -107.37 2.56 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.85 -0.531 . . . . 0.0 112.089 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.51 -50.21 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-N 117.202 0.501 . . . . 0.0 110.987 165.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.04 170.75 21.01 Favored Glycine 0 CA--C 1.56 2.879 0 N-CA-C 115.046 0.778 . . . . 0.0 115.046 163.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.77 176.6 6.56 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 122.627 2.218 . . . . 0.0 116.085 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -71.77 120.18 16.99 Favored 'General case' 0 CA--C 1.566 1.58 0 O-C-N 120.217 -1.552 . . . . 0.0 112.406 173.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.97 -4.68 57.22 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -66.04 115.96 6.64 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-N 119.066 0.848 . . . . 0.0 110.51 160.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.44 39.61 10.8 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 -171.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 p -97.29 -31.84 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.29 109.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 120.871 1.669 . . . . 0.0 108.971 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.69 -14.57 64.63 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 118.778 2.271 . . . . 0.0 118.778 -162.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -75.3 143.11 43.12 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 121.103 2.452 . . . . 0.0 112.965 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.1 m -59.27 142.35 52.13 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.6 t -67.22 122.58 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.83 -0.544 . . . . 0.0 110.348 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 63.47 53.48 2.11 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -162.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.24 -11.28 29.91 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 119.38 2.512 . . . . 0.0 119.38 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.0 t -86.14 95.44 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 120.245 2.023 . . . . 0.0 109.032 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -69.35 118.22 11.97 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.943 0.897 . . . . 0.0 112.199 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.85 -52.56 0.81 Allowed Glycine 0 N--CA 1.492 2.396 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.788 -159.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -79.55 120.93 24.6 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 117.698 0.749 . . . . 0.0 110.918 171.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -76.36 118.29 18.91 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.635 -0.666 . . . . 0.0 110.541 170.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -88.24 169.95 11.43 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.608 0.763 . . . . 0.0 111.217 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.2 p -71.24 157.07 38.76 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 119.832 -1.793 . . . . 0.0 113.43 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -54.74 -50.0 88.29 Favored Pre-proline 0 CA--C 1.578 2.028 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.46 -24.96 48.76 Favored 'Trans proline' 0 CA--C 1.564 1.995 0 CA-C-N 124.349 2.589 . . . . 0.0 117.629 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.2 tpp -65.61 -48.57 71.82 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 120.633 1.56 . . . . 0.0 114.02 163.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -58.97 -44.37 91.52 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 168.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -11.04 60.39 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 118.959 2.948 . . . . 0.0 118.959 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -63.29 -54.2 40.84 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.862 1.664 . . . . 0.0 114.92 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.47 175.45 50.2 Favored Glycine 0 CA--C 1.547 2.062 0 N-CA-C 116.54 1.376 . . . . 0.0 116.54 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.04 -155.75 44.77 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 115.217 0.847 . . . . 0.0 115.217 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -131.85 156.2 46.48 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.891 0.853 . . . . 0.0 112.087 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -76.66 76.17 3.33 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 123.336 1.541 . . . . 0.0 112.831 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.0 p -76.46 160.75 76.76 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.966 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -57.21 -35.39 98.89 Favored 'Trans proline' 0 CA--C 1.571 2.337 0 N-CA-C 117.696 2.152 . . . . 0.0 117.696 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.29 -51.47 67.55 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 164.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.01 94.34 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.6 mt -56.42 -52.05 66.11 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 168.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.293 2.8 pp0? -63.06 -36.56 83.99 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -61.37 -54.46 43.37 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 165.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -57.55 -44.35 85.14 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.3 mt -72.65 -13.34 61.34 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 171.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -64.04 -53.84 43.55 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 120.997 1.726 . . . . 0.0 112.788 161.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.7 103.99 2.33 Favored Pre-proline 0 CA--C 1.577 1.994 0 CA-C-N 119.623 1.101 . . . . 0.0 108.59 173.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.02 -46.51 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 N-CA-C 117.429 2.05 . . . . 0.0 117.429 -168.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.65 -21.28 66.29 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.91 -48.99 56.39 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 161.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.68 -55.71 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 119.521 1.055 . . . . 0.0 113.255 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.23 104.53 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 171.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.15 96.53 2.24 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 121.371 0.605 . . . . 0.0 111.786 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.39 28.29 5.82 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 118.287 2.075 . . . . 0.0 118.287 -167.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -76.25 135.5 39.67 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.526 1.663 . . . . 0.0 111.463 162.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -72.3 7.97 1.53 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 167.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -73.44 99.01 2.87 Favored 'General case' 0 CA--C 1.564 1.512 0 O-C-N 120.63 -1.294 . . . . 0.0 111.395 170.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.41 74.87 4.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 122.737 1.255 . . . . 0.0 113.082 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -138.63 131.18 28.96 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.347 1.059 . . . . 0.0 108.182 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.68 -55.57 10.99 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.27 155.08 6.99 Favored Glycine 0 CA--C 1.545 1.95 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 99.3 mt -103.24 97.68 10.48 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 117.889 -1.053 . . . . 0.0 108.855 170.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.91 -32.95 27.75 Favored 'Trans proline' 0 CA--C 1.568 2.197 0 C-N-CA 122.648 2.232 . . . . 0.0 117.819 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -73.46 118.66 16.68 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 123.941 0.896 . . . . 0.0 113.252 174.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.97 -40.1 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 169.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -53.06 -47.73 68.23 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 170.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -61.41 -41.69 97.54 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 169.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 86.7 mtm-85 -60.12 -50.49 73.47 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.73 -45.58 81.86 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 167.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -54.55 -52.35 62.33 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -57.81 -45.7 85.73 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 170.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.258 62.6 mt -63.9 -41.6 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.161 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.46 -43.63 71.84 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 163.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -58.34 -49.94 75.43 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 166.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.1 mt -68.82 -26.64 65.28 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.29 -39.86 84.29 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 158.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.85 -47.52 82.09 Favored Glycine 0 CA--C 1.552 2.402 0 N-CA-C 117.357 1.703 . . . . 0.0 117.357 164.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -77.16 83.81 3.65 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 118.424 1.112 . . . . 0.0 112.344 173.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.188 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 mmt . . . . . 0 CA--C 1.567 1.623 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.73 70.65 1.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.055 -1.028 . . . . 0.0 112.36 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -105.72 111.36 64.69 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.703 -175.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.57 -28.25 31.88 Favored 'Trans proline' 0 CA--C 1.566 2.115 0 N-CA-C 118.42 2.431 . . . . 0.0 118.42 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.11 96.86 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 168.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.68 95.13 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 161.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.87 -38.06 72.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 119.146 2.418 . . . . 0.0 119.146 166.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -55.19 -48.8 73.29 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 164.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -59.75 -43.55 94.22 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.57 -38.15 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 167.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.77 -20.61 15.49 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 169.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.78 -38.51 4.41 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 119.636 2.615 . . . . 0.0 119.636 156.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.97 -31.91 73.1 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 166.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -87.91 -33.53 18.47 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -57.91 -32.09 67.4 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 120.505 3.521 . . . . 0.0 120.505 -166.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.02 82.36 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 171.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.2 m -87.41 -44.14 11.57 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -109.22 143.83 38.15 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.339 1.056 . . . . 0.0 112.872 -168.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -118.51 150.28 39.87 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.381 1.086 . . . . 0.0 112.139 -172.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -104.07 1.89 31.46 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -115.52 57.63 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.422 1.464 . . . . 0.0 111.548 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.69 4.87 21.26 Favored Glycine 0 CA--C 1.558 2.771 0 N-CA-C 120.492 2.957 . . . . 0.0 120.492 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -97.7 143.02 28.78 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 118.87 1.335 . . . . 0.0 112.766 -168.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.38 103.97 8.5 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.46 -105.7 3.05 Favored Glycine 0 N--CA 1.49 2.234 0 O-C-N 122.117 -0.365 . . . . 0.0 113.142 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.32 -49.75 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.848 166.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.65 163.49 16.39 Favored Glycine 0 CA--C 1.56 2.864 0 CA-C-N 118.911 0.778 . . . . 0.0 114.851 164.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.72 176.09 8.7 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 CA-C-N 120.845 2.323 . . . . 0.0 115.935 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -70.23 120.2 15.56 Favored 'General case' 0 CA--C 1.568 1.646 0 O-C-N 120.535 -1.353 . . . . 0.0 113.279 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -87.84 -4.01 58.89 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -62.95 111.7 2.27 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.349 1.431 . . . . 0.0 111.729 157.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.66 43.58 7.72 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 -173.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.09 -37.88 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 118.805 1.303 . . . . 0.0 114.491 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.39 107.8 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.898 1.226 . . . . 0.0 110.096 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.81 -19.96 52.26 Favored Glycine 0 CA--C 1.552 2.372 0 N-CA-C 118.503 2.161 . . . . 0.0 118.503 -163.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -73.01 143.63 47.49 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 120.929 2.364 . . . . 0.0 113.415 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.3 m -60.4 140.26 57.28 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.16 124.32 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 123.405 0.682 . . . . 0.0 110.824 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.39 48.72 5.79 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -164.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.05 -8.08 39.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 119.46 2.544 . . . . 0.0 119.46 -169.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.1 t -82.94 103.23 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 120.199 2.0 . . . . 0.0 109.12 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.27 90.33 0.91 Allowed 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.546 0.738 . . . . 0.0 112.081 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.27 -48.84 0.51 Allowed Glycine 0 N--CA 1.486 2.029 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.857 -160.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -81.22 132.16 35.33 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 118.098 0.949 . . . . 0.0 111.572 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -84.48 88.28 7.29 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.435 -0.79 . . . . 0.0 112.017 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -72.85 147.07 45.77 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.2 p -67.74 155.34 39.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -53.82 -49.23 90.45 Favored Pre-proline 0 CA--C 1.578 2.031 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.25 -23.6 38.73 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 CA-C-N 124.125 2.509 . . . . 0.0 117.521 170.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.1 tpp -65.4 -46.65 79.19 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 120.885 1.675 . . . . 0.0 114.147 161.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -57.84 -45.9 85.55 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 168.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.01 -11.96 61.01 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 170.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -60.4 -49.47 77.45 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.045 1.748 . . . . 0.0 114.638 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.88 164.72 36.08 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 163.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.46 -144.69 24.63 Favored Glycine 0 N--CA 1.486 2.015 0 CA-C-N 114.915 -0.642 . . . . 0.0 114.694 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -130.84 154.78 47.69 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.665 0.745 . . . . 0.0 111.493 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -76.12 76.81 2.95 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 123.149 1.452 . . . . 0.0 112.558 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -75.72 159.89 80.28 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.881 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.18 -33.75 91.33 Favored 'Trans proline' 0 CA--C 1.57 2.289 0 N-CA-C 117.66 2.139 . . . . 0.0 117.66 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.31 -50.66 59.27 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 166.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.65 -43.67 85.11 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -57.17 -50.73 71.93 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 165.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.304 1.6 pp0? -61.28 -37.24 82.47 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 175.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.43 -59.02 6.01 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 164.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -58.93 -42.83 90.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.5 mt -69.77 -17.39 63.42 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.5 m -62.71 -55.23 28.6 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.26 1.846 . . . . 0.0 112.869 164.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.23 103.32 2.42 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-N 119.496 1.044 . . . . 0.0 108.525 173.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.02 -46.63 0.37 Allowed 'Trans proline' 0 CA--C 1.558 1.686 0 N-CA-C 117.431 2.05 . . . . 0.0 117.431 -167.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.95 -25.85 68.55 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 169.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 -45.06 70.21 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 163.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.9 t -65.47 -55.3 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.558 1.072 . . . . 0.0 112.782 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.8 104.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -72.99 98.29 2.48 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-O 121.454 0.645 . . . . 0.0 111.316 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.83 23.84 7.61 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 118.657 2.223 . . . . 0.0 118.657 -168.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.4 t -75.41 134.52 40.89 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 119.615 1.708 . . . . 0.0 111.061 160.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -72.92 9.08 1.25 Allowed 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 117.409 2.374 . . . . 0.0 117.409 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -76.25 100.77 5.19 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 120.725 -1.234 . . . . 0.0 111.726 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.64 71.36 4.12 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 122.595 1.188 . . . . 0.0 113.611 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -138.63 128.03 24.49 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.85 -53.48 32.03 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.88 158.79 8.9 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 115.471 0.948 . . . . 0.0 115.471 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.7 mt -100.26 98.56 7.95 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 117.934 -1.031 . . . . 0.0 108.524 166.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.55 -36.39 11.46 Favored 'Trans proline' 0 CA--C 1.565 2.044 0 C-N-CA 122.658 2.239 . . . . 0.0 117.575 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.08 133.53 41.56 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 118.94 0.791 . . . . 0.0 112.527 175.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -57.77 -40.66 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 171.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.57 -43.25 84.37 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.78 -44.72 73.95 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 167.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -66.43 -55.27 16.52 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 173.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.66 98.07 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.64 -47.41 86.36 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.964 1.256 . . . . 0.0 114.11 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.39 -44.0 92.87 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 169.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.0 mt -60.55 -42.87 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 117.539 -1.22 . . . . 0.0 113.101 169.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.67 -44.05 72.97 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 164.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -58.92 -48.22 82.23 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 166.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.9 mt -69.39 -24.47 63.86 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.31 -41.21 92.99 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 156.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.3 -44.96 92.75 Favored Glycine 0 CA--C 1.554 2.5 0 N-CA-C 117.584 1.794 . . . . 0.0 117.584 163.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -79.17 82.36 5.34 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-N 118.623 1.212 . . . . 0.0 111.882 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.43 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mmt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.99 56.3 0.9 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -114.53 103.67 54.82 Favored Pre-proline 0 CA--C 1.573 1.848 0 O-C-N 120.865 -1.147 . . . . 0.0 109.807 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.71 -23.51 30.93 Favored 'Trans proline' 0 CA--C 1.568 2.203 0 N-CA-C 118.227 2.357 . . . . 0.0 118.227 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.96 -47.36 83.51 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.08 81.56 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 162.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.83 -35.03 66.22 Favored Glycine 0 CA--C 1.552 2.383 0 N-CA-C 119.114 2.405 . . . . 0.0 119.114 164.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.53 -49.77 76.5 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 168.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -59.65 -41.59 90.89 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 169.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.52 -39.16 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 169.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -56.85 -23.03 41.21 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 167.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.05 -35.57 18.99 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 119.585 2.594 . . . . 0.0 119.585 162.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.8 -36.33 76.5 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 162.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -80.27 -32.54 38.22 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 171.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -49.85 -33.8 18.06 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.78 -26.34 23.29 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 118.145 2.646 . . . . 0.0 118.145 167.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.0 m -120.32 -38.77 2.86 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -108.48 147.28 31.9 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.322 1.049 . . . . 0.0 113.169 -169.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -119.74 148.93 42.82 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.937 0.875 . . . . 0.0 112.108 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -105.66 3.94 29.62 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.62 40.23 1.46 Allowed 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 121.095 1.771 . . . . 0.0 114.628 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.36 35.68 91.76 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 117.981 1.952 . . . . 0.0 117.981 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -131.06 142.38 50.29 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 117.905 0.853 . . . . 0.0 111.27 -166.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -91.82 140.66 29.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.032 -1.042 . . . . 0.0 111.505 174.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.91 -115.46 1.89 Allowed Glycine 0 N--CA 1.491 2.341 0 O-C-N 121.518 -0.739 . . . . 0.0 112.108 172.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.18 -47.54 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.817 164.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.39 173.63 27.59 Favored Glycine 0 CA--C 1.562 3.013 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 163.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.42 172.6 12.97 Favored 'Trans proline' 0 CA--C 1.564 1.996 0 C-N-CA 122.845 2.363 . . . . 0.0 115.583 173.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -68.51 125.83 27.73 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 120.425 -1.422 . . . . 0.0 113.754 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -91.57 -0.86 57.64 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -66.46 111.63 3.66 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-N 120.326 1.421 . . . . 0.0 111.234 162.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.99 41.42 7.58 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 116.687 1.435 . . . . 0.0 116.687 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -92.73 -34.31 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.02 106.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 120.428 1.467 . . . . 0.0 109.512 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.48 -12.12 66.51 Favored Glycine 0 CA--C 1.553 2.44 0 N-CA-C 118.731 2.252 . . . . 0.0 118.731 -161.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -78.31 148.45 33.82 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 121.228 2.514 . . . . 0.0 112.84 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.4 m -54.12 141.53 28.56 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.95 120.87 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.758 -0.589 . . . . 0.0 109.974 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.271 . . 66.42 54.66 0.89 Allowed 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -161.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.98 22.13 9.23 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 119.206 2.442 . . . . 0.0 119.206 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.3 t -102.99 109.22 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.323 1.561 . . . . 0.0 107.79 165.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -72.67 88.33 1.28 Allowed 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 123.453 0.701 . . . . 0.0 111.67 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.87 -47.07 0.54 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.075 -159.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -82.23 131.86 35.23 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 118.362 1.081 . . . . 0.0 111.829 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -78.68 105.58 10.07 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.517 0.727 . . . . 0.0 111.848 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -89.56 156.77 18.39 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -63.35 151.8 39.79 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 171.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -59.26 -48.42 96.23 Favored Pre-proline 0 CA--C 1.577 1.997 0 CA-C-O 116.124 -1.893 . . . . 0.0 115.473 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.42 -24.98 63.7 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 CA-C-N 124.477 2.635 . . . . 0.0 117.937 166.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.4 tpp -65.39 -48.61 72.29 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.796 1.634 . . . . 0.0 114.097 164.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -56.27 -47.83 77.8 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 166.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.64 -11.89 60.82 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 118.994 2.961 . . . . 0.0 118.994 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -63.6 -52.63 60.08 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.762 1.619 . . . . 0.0 114.316 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.08 175.26 49.81 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.69 -148.3 36.61 Favored Glycine 0 CA--C 1.547 2.039 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -134.26 155.03 50.91 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.644 0.735 . . . . 0.0 111.639 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -77.1 77.48 3.64 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.91 1.338 . . . . 0.0 112.838 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.0 p -73.84 159.82 83.38 Favored Pre-proline 0 CA--C 1.574 1.885 0 C-N-CA 124.455 1.102 . . . . 0.0 112.344 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -57.59 -34.39 98.02 Favored 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 122.399 2.066 . . . . 0.0 117.459 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.19 -39.84 74.99 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 116.382 1.994 . . . . 0.0 116.382 165.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.96 97.89 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.54 -43.21 93.57 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 166.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -54.27 -44.49 71.92 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -66.51 -55.6 14.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -59.71 -39.87 86.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 67.8 mt -76.37 -15.03 60.05 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 170.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.0 m -66.36 -53.29 37.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 121.323 1.874 . . . . 0.0 112.738 160.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -150.28 113.36 3.29 Favored Pre-proline 0 CA--C 1.575 1.922 0 CA-C-N 119.986 1.266 . . . . 0.0 109.197 168.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.49 -46.26 0.22 Allowed 'Trans proline' 0 CA--C 1.56 1.807 0 CA-C-N 122.597 1.963 . . . . 0.0 116.954 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.75 -28.83 68.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.77 -41.88 86.99 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 162.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.65 -57.76 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.482 1.037 . . . . 0.0 112.655 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -99.87 101.36 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.67 100.13 2.74 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.336 0.589 . . . . 0.0 111.066 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.84 19.39 12.02 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 118.928 2.331 . . . . 0.0 118.928 -167.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.3 t -73.08 136.83 44.98 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.289 2.044 . . . . 0.0 111.937 163.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -76.99 12.81 1.24 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.484 2.402 . . . . 0.0 117.484 169.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -74.12 95.96 2.65 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.665 -1.272 . . . . 0.0 110.972 169.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.92 74.3 4.47 Favored 'General case' 0 CA--C 1.567 1.627 0 CA-C-O 122.802 1.286 . . . . 0.0 113.24 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -142.05 127.36 18.72 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.57 -52.59 43.89 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.11 161.1 10.09 Favored Glycine 0 CA--C 1.545 1.917 0 CA-C-O 122.6 1.111 . . . . 0.0 115.171 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -100.74 99.17 9.57 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 117.851 -1.071 . . . . 0.0 108.646 168.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.79 -34.46 18.28 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 C-N-CA 122.608 2.206 . . . . 0.0 117.432 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.25 129.26 38.44 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.005 0.82 . . . . 0.0 112.85 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 tp -56.79 -45.21 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 169.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.39 -40.35 74.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -59.24 -46.8 87.52 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 120.176 1.353 . . . . 0.0 114.606 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -62.44 -53.75 50.25 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.24 -45.03 95.17 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -61.54 -45.64 93.32 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.9 tp -55.38 -45.0 76.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 166.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 61.3 mt -61.48 -42.62 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 117.46 -1.257 . . . . 0.0 113.219 171.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.3 -44.36 71.89 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 164.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -59.93 -47.85 84.11 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 167.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.04 -25.96 65.63 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -63.59 -42.75 98.24 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 159.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.99 -45.3 96.4 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 117.69 1.836 . . . . 0.0 117.69 165.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -78.33 77.71 4.81 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 118.292 1.046 . . . . 0.0 112.132 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.577 -0.702 . . . . 0.0 109.774 176.701 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 mmt . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.83 70.32 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.373 0.988 . . . . 0.0 113.064 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -104.17 115.8 62.5 Favored Pre-proline 0 CA--C 1.575 1.935 0 C-N-CA 124.009 0.924 . . . . 0.0 110.565 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.66 -29.76 23.83 Favored 'Trans proline' 0 CA--C 1.568 2.221 0 N-CA-C 118.389 2.419 . . . . 0.0 118.389 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.34 -46.19 87.73 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 169.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.35 78.36 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 160.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.89 -34.79 72.72 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 168.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.36 -41.75 94.35 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 163.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -59.99 -44.75 94.31 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 167.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.46 -42.81 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 166.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -54.82 -28.05 46.6 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 169.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.62 -35.44 4.14 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 160.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -60.3 -35.8 76.42 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 163.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -80.12 -18.8 48.89 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -73.47 67.4 1.05 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 123.792 1.758 . . . . 0.0 115.0 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.34 -54.83 0.18 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 125.149 1.379 . . . . 0.0 109.059 167.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 m -83.52 -34.87 25.19 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 171.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -110.5 151.68 27.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 119.549 1.068 . . . . 0.0 112.716 -170.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.67 153.18 41.17 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.363 1.077 . . . . 0.0 110.983 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.9 -25.7 17.19 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.28 57.52 4.02 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 121.49 1.95 . . . . 0.0 113.685 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.65 7.69 12.12 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 121.732 3.453 . . . . 0.0 121.732 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -113.31 146.49 39.32 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.632 1.716 . . . . 0.0 112.925 -169.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.1 138.3 44.6 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.296 1.038 . . . . 0.0 111.102 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.72 -108.08 0.62 Allowed Glycine 0 N--CA 1.489 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 113.206 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.83 -51.35 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 CA-C-N 117.297 0.548 . . . . 0.0 111.088 169.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.13 169.82 17.01 Favored Glycine 0 CA--C 1.562 2.974 0 CA-C-N 118.577 0.626 . . . . 0.0 114.254 161.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.28 175.72 10.58 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 120.878 2.339 . . . . 0.0 115.398 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -68.9 124.68 24.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.647 -1.283 . . . . 0.0 112.615 173.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.85 -5.23 58.7 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.878 2.177 . . . . 0.0 116.878 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -63.65 117.31 6.65 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 119.423 1.011 . . . . 0.0 110.638 157.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.59 40.58 12.44 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 116.633 1.413 . . . . 0.0 116.633 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 p -95.68 -33.28 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.48 107.78 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-N 120.572 1.533 . . . . 0.0 109.57 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.07 -11.76 69.04 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 118.743 2.257 . . . . 0.0 118.743 -162.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -76.06 146.62 39.26 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 121.132 2.466 . . . . 0.0 112.704 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.9 m -53.89 140.94 29.09 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.66 113.37 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.669 -0.644 . . . . 0.0 109.298 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.27 . . 68.05 65.23 0.36 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -157.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.34 -25.52 4.95 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 119.187 2.435 . . . . 0.0 119.187 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.28 98.52 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 120.041 1.921 . . . . 0.0 109.504 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -69.25 107.89 3.43 Favored 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 123.284 0.634 . . . . 0.0 111.21 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.31 -52.79 0.75 Allowed Glycine 0 N--CA 1.49 2.239 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.767 -155.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -79.94 129.15 34.26 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 118.081 0.94 . . . . 0.0 111.749 172.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -76.53 98.76 4.74 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.523 0.729 . . . . 0.0 112.514 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -80.89 158.21 25.38 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.4 t -64.06 151.38 43.19 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 172.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -58.76 -48.03 97.59 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 115.963 -1.97 . . . . 0.0 115.8 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.21 -23.63 66.25 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 CA-C-N 124.724 2.723 . . . . 0.0 117.967 165.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.4 tpp -66.5 -49.14 67.56 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 120.794 1.634 . . . . 0.0 113.806 163.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -57.06 -45.89 82.89 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 168.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.71 -14.47 62.46 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 118.777 2.88 . . . . 0.0 118.777 172.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -65.48 -55.42 17.98 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 120.726 1.603 . . . . 0.0 113.777 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.59 178.32 51.2 Favored Glycine 0 CA--C 1.547 2.042 0 N-CA-C 116.853 1.501 . . . . 0.0 116.853 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.72 -145.4 32.63 Favored Glycine 0 CA--C 1.547 2.062 0 O-C-N 121.961 -0.729 . . . . 0.0 114.627 -174.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -134.74 155.75 50.02 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.891 0.853 . . . . 0.0 111.935 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -76.24 76.65 3.04 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 123.148 1.451 . . . . 0.0 112.791 171.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.4 p -72.78 161.5 79.0 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.565 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -57.11 -36.6 99.24 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 122.293 1.995 . . . . 0.0 116.909 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -61.06 -49.62 76.63 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 165.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.35 -43.51 83.52 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 172.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.09 -44.19 93.09 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 167.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -51.1 -47.71 61.85 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 121.047 1.749 . . . . 0.0 115.598 165.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -61.25 -60.98 2.9 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -61.31 -39.46 90.58 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.0 mt -75.65 -17.08 60.1 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 171.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.1 m -66.23 -51.27 59.23 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 120.838 1.654 . . . . 0.0 113.317 159.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -150.46 113.22 3.24 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 120.045 1.293 . . . . 0.0 109.646 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.92 -48.39 0.23 Allowed 'Trans proline' 0 CA--C 1.561 1.827 0 CA-C-N 122.656 1.984 . . . . 0.0 116.713 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.33 -27.4 64.34 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.69 -40.74 88.63 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 162.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.9 t -71.8 -57.85 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 119.323 0.965 . . . . 0.0 112.514 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.71 100.45 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 172.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -73.25 98.94 2.75 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 121.333 0.587 . . . . 0.0 111.633 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.02 22.82 8.07 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -165.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -74.17 136.65 42.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.733 1.767 . . . . 0.0 111.887 163.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -72.45 3.94 4.32 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.7 ttt -73.15 92.43 1.72 Allowed 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 120.334 1.425 . . . . 0.0 111.789 168.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.78 76.87 9.6 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 122.019 0.914 . . . . 0.0 112.624 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -128.02 129.14 46.22 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.459 0.704 . . . . 0.0 110.102 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.96 106.73 5.79 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 121.874 -0.516 . . . . 0.0 111.233 166.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.42 172.81 9.22 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 119.49 2.556 . . . . 0.0 119.49 -168.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.2 107.86 31.83 Favored Pre-proline 0 CA--C 1.572 1.817 0 CA-C-O 117.682 -1.152 . . . . 0.0 111.219 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.54 -35.84 9.71 Favored 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.691 2.261 . . . . 0.0 117.151 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.71 128.1 34.52 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 123.94 0.896 . . . . 0.0 112.975 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.8 tp -56.36 -45.27 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 170.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.16 -46.04 75.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.12 -45.29 83.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 170.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -64.36 -51.74 61.81 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 171.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.78 92.65 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 171.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -54.91 -53.55 54.12 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-N 119.813 1.188 . . . . 0.0 114.098 168.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.6 tp -57.42 -47.68 81.12 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 59.4 mt -63.59 -41.97 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.99 1.268 . . . . 0.0 113.083 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.02 68.54 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 163.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.88 -49.48 77.31 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 167.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.7 mt -66.4 -25.76 66.92 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.33 -44.03 97.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 158.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.03 -40.5 97.11 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 118.301 2.081 . . . . 0.0 118.301 167.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -83.2 84.19 7.58 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 118.655 1.228 . . . . 0.0 110.979 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 C--O 1.257 1.456 0 CA-C-O 118.299 -0.858 . . . . 0.0 109.537 176.597 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.44 68.39 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.688 0.756 . . . . 0.0 112.492 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.1 111.82 63.35 Favored Pre-proline 0 CA--C 1.574 1.889 0 O-C-N 121.36 -0.837 . . . . 0.0 110.73 -175.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.85 -29.93 34.24 Favored 'Trans proline' 0 CA--C 1.567 2.143 0 N-CA-C 118.549 2.48 . . . . 0.0 118.549 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.27 -42.66 99.15 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.51 93.71 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 161.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.86 -37.06 75.83 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 118.912 2.325 . . . . 0.0 118.912 168.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.85 -37.97 77.69 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 164.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -65.5 -45.09 84.96 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 168.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.0 -40.1 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 166.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -56.5 -18.99 13.29 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.5 -39.23 5.68 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 119.237 2.455 . . . . 0.0 119.237 156.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -65.11 -33.83 76.95 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 166.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -87.32 -35.65 18.3 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -58.38 -27.42 64.22 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 119.896 3.295 . . . . 0.0 119.896 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.87 -31.21 62.59 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 166.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 m -105.87 -39.1 6.13 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 171.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -111.64 137.48 49.45 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.257 1.023 . . . . 0.0 112.901 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.33 147.77 23.45 Favored 'General case' 0 CA--C 1.565 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 113.28 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.9 mt -97.89 17.25 18.61 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 162.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -130.44 60.96 1.61 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.49 -1.381 . . . . 0.0 111.388 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.82 -33.12 0.38 Allowed Glycine 0 CA--C 1.557 2.694 0 N-CA-C 120.483 2.953 . . . . 0.0 120.483 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -76.94 145.56 38.09 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.583 1.153 . . . . 0.0 113.618 -172.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -111.13 115.84 30.09 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -109.44 -113.42 3.58 Favored Glycine 0 N--CA 1.491 2.309 0 O-C-N 121.707 -0.621 . . . . 0.0 113.646 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.12 -48.75 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 122.396 -0.473 . . . . 0.0 111.208 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.67 167.02 17.17 Favored Glycine 0 CA--C 1.561 2.936 0 CA-C-N 118.782 0.719 . . . . 0.0 114.514 159.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -68.98 176.68 5.86 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 CA-C-N 120.889 2.345 . . . . 0.0 115.059 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -68.82 126.75 30.74 Favored 'General case' 0 CA--C 1.57 1.72 0 O-C-N 120.427 -1.42 . . . . 0.0 113.158 175.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.2 -2.57 55.08 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -65.74 108.67 2.18 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.307 1.412 . . . . 0.0 111.711 162.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.02 52.53 4.28 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.82 -37.36 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 171.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.9 t -71.99 109.4 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 120.644 1.566 . . . . 0.0 109.016 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.06 -29.52 12.29 Favored Glycine 0 CA--C 1.551 2.313 0 N-CA-C 117.664 1.825 . . . . 0.0 117.664 -161.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -66.18 144.27 56.75 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 120.933 2.367 . . . . 0.0 113.949 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.4 m -53.38 140.67 26.72 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.12 121.43 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.579 -0.701 . . . . 0.0 110.191 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.267 . . 64.78 44.81 3.56 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -163.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.24 36.68 4.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 117.71 1.844 . . . . 0.0 117.71 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.72 105.27 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.23 96.77 2.31 Favored 'General case' 0 CA--C 1.566 1.596 0 C-N-CA 123.488 0.715 . . . . 0.0 110.697 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 149.06 -52.74 0.53 Allowed Glycine 0 N--CA 1.489 2.173 0 CA-C-O 119.58 -0.567 . . . . 0.0 114.087 -158.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -86.42 134.76 33.67 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.026 0.913 . . . . 0.0 111.955 175.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -76.97 108.62 10.15 Favored 'General case' 0 CA--C 1.568 1.668 0 C-N-CA 123.745 0.818 . . . . 0.0 112.964 171.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -94.49 150.77 19.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.451 -0.781 . . . . 0.0 112.231 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.2 p -69.66 157.21 37.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.622 -1.299 . . . . 0.0 114.323 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -55.79 -48.12 97.28 Favored Pre-proline 0 CA--C 1.576 1.959 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.55 -26.34 34.03 Favored 'Trans proline' 0 CA--C 1.565 2.067 0 CA-C-N 124.969 2.81 . . . . 0.0 117.205 170.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -63.35 -47.74 80.85 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 120.428 1.467 . . . . 0.0 114.189 163.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -59.18 -46.22 88.98 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 168.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.27 -13.79 61.6 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 174.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -61.01 -53.51 56.38 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 120.735 1.607 . . . . 0.0 114.831 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.09 176.59 49.88 Favored Glycine 0 CA--C 1.547 2.043 0 N-CA-C 116.764 1.466 . . . . 0.0 116.764 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.92 -153.17 43.32 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.84 155.9 47.0 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.042 0.925 . . . . 0.0 111.732 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -76.02 75.81 2.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.039 1.4 . . . . 0.0 112.882 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.7 p -73.92 159.93 83.03 Favored Pre-proline 0 CA--C 1.576 1.973 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.098 171.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -57.69 -34.21 97.83 Favored 'Trans proline' 0 CA--C 1.57 2.291 0 N-CA-C 117.777 2.184 . . . . 0.0 117.777 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.67 -47.27 72.99 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 165.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.14 89.58 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 170.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.5 mt -59.49 -45.91 90.32 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 165.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -55.87 -43.91 77.6 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 121.556 1.98 . . . . 0.0 116.307 168.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.69 -57.35 13.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.888 1.222 . . . . 0.0 114.155 169.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -61.82 -40.42 95.2 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.36 -22.82 61.09 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 170.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.2 m -61.85 -52.31 64.66 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.377 1.899 . . . . 0.0 113.445 164.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -151.28 113.17 3.05 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-N 119.91 1.232 . . . . 0.0 108.892 167.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.01 -46.43 0.24 Allowed 'Trans proline' 0 CA--C 1.56 1.81 0 CA-C-N 122.724 2.009 . . . . 0.0 116.798 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.16 -29.12 68.73 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.31 -41.02 90.32 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 162.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.7 t -70.32 -57.94 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 119.45 1.023 . . . . 0.0 112.475 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.37 102.19 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -73.11 99.32 2.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.599 -0.688 . . . . 0.0 111.429 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.84 21.84 9.36 Favored Glycine 0 CA--C 1.553 2.464 0 N-CA-C 118.622 2.209 . . . . 0.0 118.622 -166.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.5 t -74.31 132.27 41.92 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.793 1.797 . . . . 0.0 111.042 159.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -77.03 16.79 0.51 Allowed 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.403 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 1.9 ttt -78.68 101.73 7.67 Favored 'General case' 0 CA--C 1.561 1.377 0 O-C-N 120.847 -1.158 . . . . 0.0 111.059 171.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.12 70.77 3.56 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 122.637 1.208 . . . . 0.0 113.854 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -136.56 128.63 29.58 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 124.517 1.127 . . . . 0.0 108.053 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.38 -53.9 20.81 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.8 158.48 8.53 Favored Glycine 0 CA--C 1.544 1.861 0 N-CA-C 115.928 1.131 . . . . 0.0 115.928 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.5 mt -104.56 96.1 9.71 Favored Pre-proline 0 CA--C 1.575 1.917 0 C-N-CA 124.072 0.949 . . . . 0.0 108.9 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.48 -34.3 20.56 Favored 'Trans proline' 0 CA--C 1.567 2.159 0 C-N-CA 122.652 2.234 . . . . 0.0 117.555 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.88 131.53 38.63 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.835 0.854 . . . . 0.0 111.972 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.9 tt -55.9 -45.11 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 170.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -52.83 -44.29 66.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.7 -44.36 93.71 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 -67.01 -53.91 26.73 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.62 -42.85 93.58 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.05 -48.68 80.71 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 119.816 1.189 . . . . 0.0 113.838 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.8 tp -59.34 -44.9 92.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.23 -42.79 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 119.807 1.185 . . . . 0.0 112.88 171.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.67 -43.95 69.27 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 163.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -60.32 -48.77 80.3 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 167.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.8 -25.26 66.37 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.09 -35.36 80.89 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 158.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.79 -46.56 73.79 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 161.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.64 68.72 9.95 Favored 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 118.451 1.125 . . . . 0.0 111.459 172.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.872 -166.227 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.403 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.009 0.433 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.261 . . 58.68 39.26 24.64 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -174.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -99.21 112.87 64.11 Favored Pre-proline 0 CA--C 1.576 1.955 0 O-C-N 121.012 -1.055 . . . . 0.0 110.675 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.66 -27.82 26.49 Favored 'Trans proline' 0 CA--C 1.568 2.193 0 N-CA-C 118.361 2.408 . . . . 0.0 118.361 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 -48.17 80.24 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 169.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.22 82.06 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 162.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.16 -36.52 68.55 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 119.009 2.364 . . . . 0.0 119.009 167.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -54.86 -47.43 74.2 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 162.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -59.93 -44.1 94.55 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.5 t -58.82 -42.64 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -55.37 -25.97 38.45 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 170.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.04 -34.55 7.71 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 119.75 2.66 . . . . 0.0 119.75 164.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -58.13 -41.85 84.54 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 161.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -75.39 -33.94 61.03 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -47.03 -37.75 9.83 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 119.025 2.972 . . . . 0.0 119.025 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.49 -29.33 58.59 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 170.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.9 m -113.64 -37.13 4.68 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 174.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -112.52 141.43 46.27 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.686 1.194 . . . . 0.0 111.588 -171.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.48 154.73 25.42 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.794 1.283 . . . . 0.0 113.372 171.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.6 mt -94.91 15.35 18.88 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 170.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -119.66 57.21 0.92 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 120.826 1.648 . . . . 0.0 112.776 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.51 -45.83 1.29 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 119.685 2.634 . . . . 0.0 119.685 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -77.57 157.77 30.16 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.32 1.057 . . . . 0.0 113.405 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.96 140.47 34.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.112 -0.992 . . . . 0.0 111.292 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.12 -116.2 3.62 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.802 -0.562 . . . . 0.0 113.045 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -75.88 -49.6 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 122.384 -0.48 . . . . 0.0 110.802 166.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.78 171.41 30.23 Favored Glycine 0 CA--C 1.559 2.832 0 CA-C-N 118.715 0.689 . . . . 0.0 114.796 158.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.41 175.41 7.85 Favored 'Trans proline' 0 CA--C 1.564 2.018 0 CA-C-N 120.845 2.322 . . . . 0.0 115.227 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -65.04 129.55 40.12 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 120.47 -1.394 . . . . 0.0 113.178 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.7 mt -96.51 -0.46 48.88 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -66.11 112.15 3.75 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.468 1.485 . . . . 0.0 111.233 158.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.98 51.45 5.38 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 115.733 1.053 . . . . 0.0 115.733 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -100.64 -35.99 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 170.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 t -72.24 109.87 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 120.503 1.502 . . . . 0.0 109.158 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.32 -17.63 58.25 Favored Glycine 0 CA--C 1.552 2.369 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -161.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -73.57 142.81 46.63 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 121.35 2.575 . . . . 0.0 113.311 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.7 m -59.94 138.65 57.78 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.2 123.92 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.787 -0.571 . . . . 0.0 110.221 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.8 45.51 7.67 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -164.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.43 -4.44 43.55 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 119.636 2.615 . . . . 0.0 119.636 -170.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.9 t -84.75 103.16 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 120.255 2.027 . . . . 0.0 108.994 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.0 94.31 0.63 Allowed 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.8 -46.08 0.82 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 114.934 0.734 . . . . 0.0 114.934 -161.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -76.93 131.8 38.72 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 118.405 1.103 . . . . 0.0 112.274 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -81.39 84.23 6.72 Favored 'General case' 0 CA--C 1.568 1.671 0 O-C-N 121.528 -0.732 . . . . 0.0 111.978 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -71.42 146.15 48.87 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.6 p -67.72 156.8 36.11 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -55.61 -43.94 99.41 Favored Pre-proline 0 CA--C 1.574 1.901 0 CA-C-O 115.162 -2.351 . . . . 0.0 117.316 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.12 -27.63 29.27 Favored 'Trans proline' 0 CA--C 1.565 2.044 0 CA-C-N 124.866 2.774 . . . . 0.0 116.977 168.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.4 tpp -63.33 -47.75 80.89 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.427 1.467 . . . . 0.0 114.019 163.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -57.87 -46.11 85.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 167.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.95 -14.45 61.92 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 118.881 2.919 . . . . 0.0 118.881 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -61.67 -53.7 52.67 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.722 1.601 . . . . 0.0 114.512 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.04 176.16 47.96 Favored Glycine 0 CA--C 1.547 2.059 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.1 -149.83 38.17 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 114.893 0.717 . . . . 0.0 114.893 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -131.91 156.07 46.77 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.818 0.818 . . . . 0.0 111.847 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -75.94 74.25 2.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.237 1.494 . . . . 0.0 112.988 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.0 p -73.75 161.48 78.55 Favored Pre-proline 0 CA--C 1.575 1.937 0 C-N-CA 124.985 1.314 . . . . 0.0 112.371 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -56.87 -35.28 98.28 Favored 'Trans proline' 0 CA--C 1.569 2.247 0 N-CA-C 117.575 2.106 . . . . 0.0 117.575 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -64.82 -49.51 70.33 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 164.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.64 90.48 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 172.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.65 -45.17 95.11 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 165.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -55.88 -44.42 78.11 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.635 2.016 . . . . 0.0 116.238 168.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -61.15 -57.74 11.25 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 120.047 1.294 . . . . 0.0 113.944 169.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -60.27 -41.36 93.11 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.83 -18.9 60.38 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -63.44 -51.4 65.86 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.071 1.76 . . . . 0.0 113.409 161.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -151.95 112.0 2.9 Favored Pre-proline 0 CA--C 1.575 1.94 0 CA-C-N 120.096 1.316 . . . . 0.0 108.993 167.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.51 -47.02 0.19 Allowed 'Trans proline' 0 CA--C 1.559 1.736 0 CA-C-N 122.71 2.004 . . . . 0.0 116.924 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.25 -27.6 67.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.96 -42.84 84.51 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 162.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.11 -57.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 119.546 1.066 . . . . 0.0 112.709 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.26 101.46 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -73.29 94.77 2.05 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-O 121.462 0.649 . . . . 0.0 111.561 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.93 25.93 5.98 Favored Glycine 0 CA--C 1.554 2.499 0 N-CA-C 118.379 2.111 . . . . 0.0 118.379 -166.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -76.08 137.61 40.27 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 119.749 1.774 . . . . 0.0 111.355 160.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -74.32 7.62 2.72 Favored 'General case' 0 CA--C 1.579 2.067 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 167.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -74.6 97.55 3.19 Favored 'General case' 0 CA--C 1.565 1.533 0 O-C-N 120.677 -1.264 . . . . 0.0 111.53 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.22 71.83 5.76 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 122.61 1.195 . . . . 0.0 113.472 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -129.93 133.41 46.82 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.465 1.106 . . . . 0.0 108.479 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.27 -56.09 9.87 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.48 155.2 6.66 Favored Glycine 0 CA--C 1.545 1.933 0 N-CA-C 116.159 1.224 . . . . 0.0 116.159 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.5 mt -105.72 97.88 16.1 Favored Pre-proline 0 CA--C 1.575 1.918 0 C-N-CA 123.962 0.905 . . . . 0.0 109.323 172.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.17 -33.21 15.44 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 122.632 2.221 . . . . 0.0 117.717 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.62 131.37 39.92 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 175.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.8 tt -56.63 -43.88 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -52.71 -47.4 67.34 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -57.19 -47.13 82.01 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -65.01 -51.55 61.03 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.32 83.79 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -56.47 -50.74 70.87 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.5 tp -57.34 -46.4 83.32 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 169.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.8 mt -64.4 -39.82 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-N 119.933 1.242 . . . . 0.0 113.202 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.22 -45.11 75.92 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 163.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -57.37 -50.51 72.76 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.3 mt -67.71 -26.78 66.34 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -62.39 -40.78 97.6 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 158.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.75 88.86 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 163.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -84.28 78.33 9.81 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 123.684 0.794 . . . . 0.0 111.997 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 123.581 0.752 . . . . 0.0 109.508 175.001 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptp . . . . . 0 CA--C 1.563 1.47 0 CA-C-O 121.675 0.75 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.29 . . 63.88 7.8 3.48 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 119.865 3.283 . . . . 0.0 119.865 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -83.25 117.44 68.61 Favored Pre-proline 0 CA--C 1.58 2.124 0 O-C-N 120.747 -1.221 . . . . 0.0 111.238 172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.12 -26.4 18.12 Favored 'Trans proline' 0 CA--C 1.566 2.091 0 N-CA-C 118.501 2.462 . . . . 0.0 118.501 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.08 -47.78 83.15 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 168.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.92 73.01 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 160.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.98 -35.69 70.03 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 168.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.49 -41.85 95.09 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 164.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.4 -44.47 95.67 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 165.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -58.7 -41.06 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -54.85 -19.48 6.61 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.77 -37.59 4.03 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 119.853 2.701 . . . . 0.0 119.853 157.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -65.75 -39.68 91.34 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 164.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.17 -33.9 38.01 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.08 -33.78 67.62 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 119.904 3.298 . . . . 0.0 119.904 -171.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.95 -33.37 66.96 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 171.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.6 m -99.18 -40.88 7.75 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 170.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -109.18 141.62 41.16 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.168 0.987 . . . . 0.0 113.035 -169.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -105.78 153.1 22.36 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.9 0.857 . . . . 0.0 112.77 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.8 mt -106.23 7.62 31.56 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 172.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -115.54 57.61 0.74 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.629 1.559 . . . . 0.0 112.282 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.77 1.93 10.41 Favored Glycine 0 CA--C 1.557 2.712 0 N-CA-C 121.487 3.355 . . . . 0.0 121.487 173.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -124.98 153.2 43.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 119.471 1.636 . . . . 0.0 112.362 -168.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -83.7 143.96 29.7 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.949 -1.095 . . . . 0.0 113.275 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.13 -119.01 2.62 Favored Glycine 0 N--CA 1.491 2.324 0 O-C-N 121.605 -0.685 . . . . 0.0 112.232 170.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.69 -48.08 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 122.178 -0.601 . . . . 0.0 110.938 165.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.36 172.18 30.14 Favored Glycine 0 CA--C 1.561 2.931 0 CA-C-N 118.971 0.805 . . . . 0.0 114.753 157.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -70.51 174.28 10.4 Favored 'Trans proline' 0 CA--C 1.563 1.942 0 CA-C-N 120.853 2.327 . . . . 0.0 115.506 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -66.54 122.59 17.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.499 -1.375 . . . . 0.0 113.36 176.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.22 -5.94 59.3 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -64.81 112.19 3.14 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 120.825 1.648 . . . . 0.0 110.766 159.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.56 36.1 24.05 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 116.981 1.552 . . . . 0.0 116.981 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -80.17 -34.54 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 118.925 1.362 . . . . 0.0 114.252 162.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.8 t -69.45 108.87 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 119.573 1.079 . . . . 0.0 109.966 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.59 -27.38 19.91 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 117.933 1.933 . . . . 0.0 117.933 -164.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -71.27 147.47 48.12 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.482 2.141 . . . . 0.0 113.968 -174.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.3 m -53.26 141.86 22.66 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -68.28 119.83 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.653 . . . . 0.0 109.767 170.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 64.37 55.92 1.35 Allowed 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -159.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.57 -20.1 14.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 119.238 2.455 . . . . 0.0 119.238 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.3 t -83.58 94.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.849 1.825 . . . . 0.0 109.236 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -69.33 113.1 6.35 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 123.315 0.646 . . . . 0.0 111.432 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 131.17 -49.79 0.91 Allowed Glycine 0 N--CA 1.491 2.323 0 CA-C-O 119.731 -0.483 . . . . 0.0 114.069 -155.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -77.48 129.26 35.48 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 118.059 0.93 . . . . 0.0 111.888 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -81.13 89.94 6.02 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.699 -0.625 . . . . 0.0 111.238 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -71.64 154.26 41.52 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.0 p -65.23 153.5 40.84 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.69 -1.256 . . . . 0.0 114.071 171.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.96 -47.45 99.06 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.47 -24.23 56.96 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 CA-C-N 125.115 2.863 . . . . 0.0 117.691 168.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 52.2 tpp -65.57 -48.42 72.44 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 120.65 1.568 . . . . 0.0 113.962 163.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -57.1 -46.29 82.69 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 167.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.67 -13.81 61.44 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -63.95 -54.41 34.95 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 120.805 1.639 . . . . 0.0 114.34 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 175.9 49.85 Favored Glycine 0 CA--C 1.546 2.005 0 N-CA-C 116.698 1.439 . . . . 0.0 116.698 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.78 -150.49 39.67 Favored Glycine 0 CA--C 1.547 2.064 0 O-C-N 121.914 -0.756 . . . . 0.0 114.943 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -133.02 154.11 50.84 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.815 0.817 . . . . 0.0 111.5 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -76.54 77.45 3.23 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.323 1.535 . . . . 0.0 112.552 171.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.0 p -71.75 160.6 82.16 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.208 169.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -58.01 -35.0 99.06 Favored 'Trans proline' 0 CA--C 1.57 2.283 0 N-CA-C 117.118 1.93 . . . . 0.0 117.118 174.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.73 -50.26 74.2 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 164.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.26 87.0 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.18 -43.6 97.78 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -50.91 -47.54 60.81 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 121.046 1.748 . . . . 0.0 115.68 165.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.53 -61.39 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -61.76 -40.11 94.0 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 mt -74.05 -16.87 61.03 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 171.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.4 m -63.9 -54.67 31.12 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 121.241 1.837 . . . . 0.0 112.927 161.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -150.44 112.59 3.23 Favored Pre-proline 0 CA--C 1.576 1.944 0 CA-C-N 119.781 1.173 . . . . 0.0 108.889 168.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.02 -45.95 0.26 Allowed 'Trans proline' 0 CA--C 1.56 1.786 0 CA-C-N 122.622 1.972 . . . . 0.0 116.904 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.18 -25.4 66.13 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.863 2.171 . . . . 0.0 116.863 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.59 78.63 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 161.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.5 t -71.48 -58.62 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-N 119.558 1.072 . . . . 0.0 112.723 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.5 103.62 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 171.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.11 94.15 3.43 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.582 0.706 . . . . 0.0 111.764 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.37 27.39 5.3 Favored Glycine 0 CA--C 1.554 2.489 0 N-CA-C 118.036 1.975 . . . . 0.0 118.036 -165.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.6 t -73.89 132.34 42.4 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.444 1.622 . . . . 0.0 111.187 160.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -73.85 10.41 1.16 Allowed 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 166.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -71.94 97.43 1.85 Allowed 'General case' 0 CA--C 1.564 1.501 0 O-C-N 120.933 -1.104 . . . . 0.0 111.261 166.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 75.48 4.25 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.72 1.248 . . . . 0.0 112.969 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -141.3 128.87 21.41 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.84 -52.7 33.76 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.13 157.06 7.87 Favored Glycine 0 N--CA 1.484 1.879 0 CA-C-O 122.275 0.93 . . . . 0.0 115.231 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.63 96.88 8.08 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.121 -0.942 . . . . 0.0 108.521 168.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.88 -33.63 15.76 Favored 'Trans proline' 0 CA--C 1.568 2.183 0 C-N-CA 122.636 2.224 . . . . 0.0 117.431 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.7 133.33 42.07 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.817 0.847 . . . . 0.0 112.993 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.0 tp -58.27 -42.75 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.12 -53.01 61.37 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -50.98 -41.73 59.72 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -66.91 -54.62 20.29 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.6 -45.6 91.43 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -53.13 -52.83 57.46 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 168.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.1 tp -60.61 -45.8 92.64 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 172.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 62.9 mt -61.55 -41.43 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 120.194 1.361 . . . . 0.0 113.034 172.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.68 -43.94 72.9 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 163.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -60.55 -46.61 89.54 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.58 -24.0 63.62 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 172.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -61.1 -45.48 94.52 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 157.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.9 88.23 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 117.846 1.898 . . . . 0.0 117.846 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -75.56 97.31 3.7 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 118.338 1.069 . . . . 0.0 111.575 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.065 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 tpp . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.42 73.0 0.82 Allowed 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 121.902 0.858 . . . . 0.0 112.684 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -106.48 119.48 51.63 Favored Pre-proline 0 CA--C 1.578 2.033 0 C-N-CA 123.98 0.912 . . . . 0.0 111.248 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.56 -28.46 26.19 Favored 'Trans proline' 0 CA--C 1.569 2.26 0 N-CA-C 118.522 2.47 . . . . 0.0 118.522 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.73 -42.29 97.92 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 168.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.34 77.87 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 159.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.73 96.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 118.955 2.342 . . . . 0.0 118.955 171.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.73 -38.67 91.38 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.82 97.0 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 164.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.09 -40.42 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 167.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -54.97 -19.81 7.62 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 166.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.72 -36.98 4.96 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 119.718 2.647 . . . . 0.0 119.718 159.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.67 -37.49 86.66 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 164.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -80.28 -34.56 36.84 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -57.52 -32.74 67.35 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -170.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.78 -35.89 71.41 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.2 m -93.69 -42.86 8.93 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 169.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -108.27 142.86 37.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.074 0.95 . . . . 0.0 113.092 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -110.63 150.21 29.31 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.548 1.166 . . . . 0.0 113.013 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -113.7 33.42 5.19 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.239 -0.913 . . . . 0.0 113.263 170.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -137.15 60.68 1.64 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.032 -1.667 . . . . 0.0 111.061 169.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.49 -47.73 1.78 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 119.522 2.569 . . . . 0.0 119.522 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -75.68 151.51 37.7 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.659 1.183 . . . . 0.0 113.109 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -101.9 131.33 48.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.749 . . . . 0.0 110.451 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.64 -114.33 3.7 Favored Glycine 0 N--CA 1.491 2.361 0 O-C-N 121.676 -0.64 . . . . 0.0 113.415 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.08 -47.79 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 122.413 -0.463 . . . . 0.0 110.77 165.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.9 168.72 24.95 Favored Glycine 0 CA--C 1.56 2.894 0 CA-C-N 118.985 0.812 . . . . 0.0 114.966 159.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -70.03 166.36 28.2 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 CA-C-N 120.699 2.249 . . . . 0.0 114.902 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -62.46 123.14 17.51 Favored 'General case' 0 CA--C 1.57 1.735 0 O-C-N 120.776 -1.203 . . . . 0.0 113.226 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.65 6.22 35.78 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -63.23 117.22 6.26 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.971 1.26 . . . . 0.0 110.929 159.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.96 44.35 37.16 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 116.244 1.257 . . . . 0.0 116.244 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 p -87.9 -30.59 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 170.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.79 107.0 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 119.945 1.248 . . . . 0.0 109.653 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.55 -10.28 71.01 Favored Glycine 0 CA--C 1.553 2.438 0 N-CA-C 118.925 2.33 . . . . 0.0 118.925 -163.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -77.0 144.0 38.99 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 121.078 2.439 . . . . 0.0 113.012 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.5 m -52.21 141.03 19.82 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -70.01 112.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.64 -0.663 . . . . 0.0 109.218 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.281 . . 70.0 66.63 0.23 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -154.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.32 -23.22 6.74 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 119.174 2.429 . . . . 0.0 119.174 -172.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.9 t -83.22 98.83 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 119.953 1.877 . . . . 0.0 109.369 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -69.59 104.59 2.41 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.417 0.627 . . . . 0.0 110.988 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.55 -55.12 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 CA-C-O 119.647 -0.53 . . . . 0.0 113.534 -155.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -78.92 129.07 34.1 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 118.037 0.919 . . . . 0.0 111.62 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -78.34 93.5 4.69 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.616 0.767 . . . . 0.0 112.724 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -76.17 161.11 29.09 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.9 t -65.44 152.15 44.62 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.46 -49.46 92.26 Favored Pre-proline 0 CA--C 1.576 1.98 0 CA-C-O 115.991 -1.957 . . . . 0.0 115.513 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.25 -21.75 67.06 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 CA-C-N 124.769 2.739 . . . . 0.0 118.149 166.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.8 tpp -66.94 -51.39 55.77 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.436 1.471 . . . . 0.0 113.344 163.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -57.87 -45.48 86.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 169.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.49 0.55 16.8 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 173.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -63.81 -49.81 71.42 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.69 81.19 1.06 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.27 -160.33 32.5 Favored Glycine 0 N--CA 1.485 1.908 0 CA-C-O 122.361 0.978 . . . . 0.0 115.161 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -125.21 155.1 40.57 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.017 0.913 . . . . 0.0 111.301 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -76.62 74.32 3.32 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 123.122 1.439 . . . . 0.0 113.272 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.0 p -71.44 161.2 79.75 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.67 171.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -58.5 -26.73 79.55 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 N-CA-C 117.528 2.088 . . . . 0.0 117.528 171.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.88 -56.99 10.02 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 161.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.76 94.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.28 -50.43 73.63 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 169.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.68 -35.58 78.38 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.21 -50.96 58.9 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -59.73 -40.57 88.47 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 171.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 70.7 mt -74.77 -16.35 60.72 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 169.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -67.77 -56.77 7.97 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 120.991 1.723 . . . . 0.0 112.293 160.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -145.12 109.55 4.64 Favored Pre-proline 0 CA--C 1.574 1.904 0 CA-C-N 119.503 1.047 . . . . 0.0 108.918 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.63 -41.28 0.82 Allowed 'Trans proline' 0 CA--C 1.561 1.859 0 C-N-CA 122.162 1.908 . . . . 0.0 116.874 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -58.3 -38.73 77.64 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 170.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.26 -42.95 87.76 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 169.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.62 -51.66 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 119.096 0.862 . . . . 0.0 113.31 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.8 101.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -75.07 94.64 2.92 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.322 0.582 . . . . 0.0 111.585 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.66 25.3 6.03 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 118.264 2.066 . . . . 0.0 118.264 -165.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 t -71.68 136.37 47.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.56 1.68 . . . . 0.0 112.046 163.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -73.94 6.96 2.91 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -72.61 100.61 2.82 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 120.72 -1.237 . . . . 0.0 111.507 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.61 75.54 7.49 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.588 1.185 . . . . 0.0 112.815 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -137.98 132.34 32.15 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.207 1.003 . . . . 0.0 108.539 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.65 -55.83 7.84 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.79 153.01 6.24 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 122.222 0.901 . . . . 0.0 115.199 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.8 mt -97.71 104.31 20.65 Favored Pre-proline 0 CA--C 1.574 1.868 0 CA-C-O 117.772 -1.108 . . . . 0.0 109.135 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.44 -36.22 9.36 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.684 2.256 . . . . 0.0 117.769 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.66 134.0 37.17 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 119.227 0.921 . . . . 0.0 112.813 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -58.01 -41.63 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 170.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.98 -47.36 74.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 172.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -56.39 -42.88 78.63 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -64.61 -53.94 39.77 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.89 -43.3 90.94 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.373 2.361 . . . . 0.0 117.373 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -56.1 -52.17 65.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 169.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.03 -46.13 82.6 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 169.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.7 mt -60.35 -41.63 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 120.096 1.316 . . . . 0.0 113.333 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.69 75.14 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 165.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.39 -44.61 95.51 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 166.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.4 mt -67.21 -26.95 66.86 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 171.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -63.76 -41.36 98.0 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 159.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.61 -48.11 87.84 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 117.421 1.729 . . . . 0.0 117.421 163.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -78.4 84.91 4.53 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 118.015 0.907 . . . . 0.0 112.189 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 . . . . . 0 C--O 1.256 1.414 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.041 174.626 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtp . . . . . 0 CA--C 1.561 1.37 0 CA-C-O 121.385 0.612 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.287 . . 63.47 34.35 12.86 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 118.322 2.712 . . . . 0.0 118.322 -177.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.27 111.45 62.45 Favored Pre-proline 0 CA--C 1.577 1.988 0 O-C-N 121.025 -1.047 . . . . 0.0 110.388 176.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.01 -31.92 22.8 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 N-CA-C 117.947 2.249 . . . . 0.0 117.947 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.24 78.76 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 168.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.3 -39.24 74.94 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 159.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.51 -33.86 59.39 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 120.222 2.849 . . . . 0.0 120.222 174.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.25 -36.4 79.88 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 168.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -62.8 -45.37 92.96 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 165.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 t -56.87 -42.6 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 168.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.12 -25.15 44.82 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.27 -35.28 9.36 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 119.79 2.676 . . . . 0.0 119.79 165.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -58.63 -38.17 77.48 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 162.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -77.34 -34.72 55.14 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -46.17 -40.41 11.15 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 119.144 3.016 . . . . 0.0 119.144 -177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.17 -32.57 64.45 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.7 m -104.92 -38.06 6.76 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 172.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -116.39 142.99 46.13 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.457 1.103 . . . . 0.0 112.421 -167.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -115.84 147.98 40.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.802 0.81 . . . . 0.0 112.387 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.8 mt -102.21 15.11 30.11 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -128.88 65.29 1.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 119.221 -2.175 . . . . 0.0 111.353 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.3 -37.7 0.82 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 119.939 2.736 . . . . 0.0 119.939 170.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -73.9 149.58 41.4 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.532 1.133 . . . . 0.0 113.43 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.71 132.75 49.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.415 -0.803 . . . . 0.0 110.235 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.61 -111.92 3.65 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 121.891 -0.506 . . . . 0.0 113.02 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -78.33 -48.16 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 122.433 -0.451 . . . . 0.0 110.769 164.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.75 170.53 25.38 Favored Glycine 0 CA--C 1.559 2.843 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 161.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -71.53 175.1 9.95 Favored 'Trans proline' 0 CA--C 1.565 2.038 0 CA-C-N 120.617 2.208 . . . . 0.0 115.784 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -66.81 124.95 24.37 Favored 'General case' 0 CA--C 1.568 1.656 0 O-C-N 120.485 -1.384 . . . . 0.0 113.353 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.42 -0.78 57.33 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -66.26 108.21 2.23 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 120.095 1.316 . . . . 0.0 111.483 161.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.91 46.15 5.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -171.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.11 -36.14 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 t -74.58 109.02 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 120.544 1.52 . . . . 0.0 109.202 -172.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.16 -28.58 15.29 Favored Glycine 0 CA--C 1.551 2.295 0 N-CA-C 117.653 1.821 . . . . 0.0 117.653 -160.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -68.09 146.41 53.5 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 120.844 2.322 . . . . 0.0 113.816 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.4 m -53.14 140.59 25.45 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.09 120.78 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.757 -0.59 . . . . 0.0 109.946 171.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . 63.94 51.96 2.19 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -162.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.08 -27.8 9.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 118.693 2.237 . . . . 0.0 118.693 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.2 t -74.95 95.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.329 1.565 . . . . 0.0 109.678 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.96 106.92 8.94 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.468 0.707 . . . . 0.0 110.223 -176.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.2 -50.75 0.82 Allowed Glycine 0 N--CA 1.489 2.232 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.678 -152.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -76.97 130.6 37.71 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 118.224 1.012 . . . . 0.0 111.881 172.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -79.5 80.58 5.86 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -67.73 150.91 48.07 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.5 p -68.97 153.51 43.67 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -53.71 -48.39 93.47 Favored Pre-proline 0 CA--C 1.575 1.912 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.8 -23.56 47.97 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 CA-C-N 124.198 2.535 . . . . 0.0 117.708 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ttm -66.92 -47.11 72.74 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 121.282 1.856 . . . . 0.0 113.849 162.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -57.58 -45.49 85.16 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 168.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.08 -16.65 62.03 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -61.72 -54.53 41.31 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 120.808 1.64 . . . . 0.0 114.404 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 177.39 49.96 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.14 -149.5 39.29 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 114.931 0.733 . . . . 0.0 114.931 -175.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -132.39 154.01 50.22 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.04 0.924 . . . . 0.0 111.562 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -75.92 76.42 2.82 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 123.023 1.392 . . . . 0.0 112.913 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.1 p -73.13 159.32 85.41 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.166 171.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.11 -34.84 98.48 Favored 'Trans proline' 0 CA--C 1.571 2.369 0 N-CA-C 117.585 2.11 . . . . 0.0 117.585 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.6 -50.11 70.69 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 165.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.22 92.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 172.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.7 mt -57.34 -49.87 74.77 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.5 pp0? -64.26 -33.85 76.77 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.71 -55.25 28.51 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 163.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -59.54 -41.65 90.54 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 73.9 mt -73.52 -17.51 61.2 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 170.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.9 m -65.83 -63.32 1.11 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 120.919 1.691 . . . . 0.0 111.662 158.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -134.63 100.42 12.35 Favored Pre-proline 0 CA--C 1.571 1.774 0 CA-C-O 118.397 -0.811 . . . . 0.0 109.834 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.1 -46.58 0.23 Allowed 'Trans proline' 0 CA--C 1.563 1.929 0 CA-C-N 122.504 1.93 . . . . 0.0 115.708 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -61.49 -34.51 75.6 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 169.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.97 -43.26 65.44 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 170.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.24 -54.83 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 119.261 0.937 . . . . 0.0 112.795 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.11 100.59 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -74.94 98.6 3.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.684 -0.635 . . . . 0.0 111.362 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.59 25.24 7.39 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -165.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 t -69.33 135.11 49.93 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.409 1.604 . . . . 0.0 111.307 159.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -72.88 7.92 1.78 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 166.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -77.34 104.64 7.97 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 120.81 -1.181 . . . . 0.0 111.955 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.32 69.85 6.85 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 122.316 1.055 . . . . 0.0 113.492 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -125.81 135.69 52.28 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.222 1.009 . . . . 0.0 108.951 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.33 -57.68 4.01 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.95 150.49 5.49 Favored Glycine 0 N--CA 1.485 1.902 0 CA-C-N 119.069 0.85 . . . . 0.0 115.138 -175.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -101.99 97.13 7.71 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.135 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.26 -32.72 20.07 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 C-N-CA 122.652 2.235 . . . . 0.0 117.812 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -76.94 127.58 32.96 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 119.039 0.836 . . . . 0.0 112.505 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -58.8 -41.0 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 172.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.05 -46.47 71.94 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 170.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.89 -45.92 82.24 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -62.82 -52.53 62.81 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 171.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.08 86.29 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -57.29 -50.4 73.05 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 170.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.5 -48.25 74.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.255 57.7 mt -63.92 -40.92 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 119.765 1.166 . . . . 0.0 113.231 174.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.25 74.12 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 163.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -59.32 -47.82 83.94 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 166.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.3 -27.87 69.33 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.26 -34.42 77.97 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 162.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.91 -47.07 68.16 Favored Glycine 0 CA--C 1.553 2.446 0 N-CA-C 116.989 1.555 . . . . 0.0 116.989 160.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 70.12 9.55 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 118.419 1.11 . . . . 0.0 111.534 172.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.254 1.32 0 O-C-N 121.339 -0.851 . . . . 0.0 111.181 -164.34 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 CA--C 1.56 1.346 0 CA-C-O 121.183 0.516 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.4 72.95 9.67 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -107.32 108.59 62.01 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.905 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.68 -29.4 19.54 Favored 'Trans proline' 0 CA--C 1.567 2.146 0 N-CA-C 118.333 2.397 . . . . 0.0 118.333 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.52 80.72 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 168.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.58 72.97 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 162.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.81 -33.91 84.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 118.126 2.01 . . . . 0.0 118.126 168.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -38.75 86.69 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 115.888 1.811 . . . . 0.0 115.888 167.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.254 21.7 pttm -67.01 -43.52 82.64 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.872 1.669 . . . . 0.0 115.083 166.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.8 t -60.43 -34.58 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 114.384 1.254 . . . . 0.0 114.384 171.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -54.82 -20.23 8.18 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 168.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.99 -37.28 5.44 Favored Glycine 0 CA--C 1.559 2.808 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 157.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.65 -31.44 72.12 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 166.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 m -90.73 -33.95 15.56 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -32.27 62.53 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 120.416 3.487 . . . . 0.0 120.416 -171.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.78 -34.84 71.91 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 170.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.7 m -95.55 -43.23 8.05 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -110.14 126.39 54.01 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.244 1.018 . . . . 0.0 111.752 -168.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -94.81 147.24 23.56 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.807 0.813 . . . . 0.0 111.427 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.5 -28.76 28.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -81.29 61.74 4.92 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.33 1.877 . . . . 0.0 113.805 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.75 10.11 16.88 Favored Glycine 0 CA--C 1.556 2.605 0 N-CA-C 121.94 3.536 . . . . 0.0 121.94 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -128.35 156.77 42.57 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 119.278 1.539 . . . . 0.0 112.557 -170.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.42 148.23 30.64 Favored 'General case' 0 CA--C 1.572 1.826 0 O-C-N 120.885 -1.135 . . . . 0.0 112.559 166.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.21 -100.75 2.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 157.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -79.73 -51.88 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.617 160.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.32 156.0 19.91 Favored Glycine 0 CA--C 1.559 2.84 0 N-CA-C 115.068 0.787 . . . . 0.0 115.068 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.93 151.23 27.45 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 CA-C-N 120.985 2.393 . . . . 0.0 113.601 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -45.51 126.74 6.94 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -167.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.74 -6.58 59.36 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -64.22 117.71 7.55 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 119.609 1.095 . . . . 0.0 110.651 158.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.05 44.61 11.51 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.65 -31.04 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -80.84 100.31 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 120.588 1.54 . . . . 0.0 109.162 -172.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.47 -20.7 29.67 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 117.872 1.909 . . . . 0.0 117.872 -158.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -73.05 146.45 45.85 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 120.743 2.272 . . . . 0.0 113.337 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.8 m -54.27 141.01 31.21 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.3 116.44 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.681 -0.637 . . . . 0.0 109.484 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.286 . . 68.14 61.6 0.4 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -159.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.45 -26.03 6.38 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 119.221 2.449 . . . . 0.0 119.221 -170.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.77 94.59 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 120.078 1.939 . . . . 0.0 109.625 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.43 126.73 30.56 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 123.269 0.628 . . . . 0.0 112.167 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.67 -54.7 0.63 Allowed Glycine 0 N--CA 1.491 2.341 0 CA-C-O 119.925 -0.375 . . . . 0.0 113.567 -157.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -79.23 116.58 19.58 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 117.771 0.786 . . . . 0.0 110.844 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -78.78 98.87 6.45 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.814 0.816 . . . . 0.0 110.817 172.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -65.21 162.71 16.65 Favored 'General case' 0 CA--C 1.574 1.874 0 C-N-CA 123.865 0.866 . . . . 0.0 112.969 172.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 p -68.59 158.66 33.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.243 -1.536 . . . . 0.0 114.216 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -54.25 -49.99 87.24 Favored Pre-proline 0 CA--C 1.578 2.027 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.68 -25.16 46.98 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 CA-C-N 124.241 2.55 . . . . 0.0 117.521 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -65.57 -48.8 71.13 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 120.419 1.463 . . . . 0.0 114.056 163.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -58.84 -43.79 90.78 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 168.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 -15.06 61.88 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 118.909 2.929 . . . . 0.0 118.909 172.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -62.7 -55.42 26.97 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 120.958 1.708 . . . . 0.0 114.364 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.35 178.15 50.82 Favored Glycine 0 CA--C 1.548 2.128 0 N-CA-C 116.879 1.511 . . . . 0.0 116.879 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.46 -148.7 35.94 Favored Glycine 0 N--CA 1.488 2.156 0 O-C-N 121.95 -0.736 . . . . 0.0 114.796 -174.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -133.86 153.11 51.97 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.863 0.839 . . . . 0.0 111.925 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -76.35 78.73 3.1 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.73 1.253 . . . . 0.0 112.782 171.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -73.99 157.45 87.02 Favored Pre-proline 0 CA--C 1.575 1.908 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.438 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -58.96 -29.17 89.8 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 N-CA-C 117.495 2.075 . . . . 0.0 117.495 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.75 -56.53 13.06 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 162.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.99 -38.93 84.03 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.2 mt -56.4 -40.23 74.31 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 167.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -56.81 -41.73 78.27 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 170.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.89 -55.73 20.52 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.239 1.381 . . . . 0.0 113.357 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -59.57 -41.63 90.64 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -71.74 -24.21 61.74 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.1 m -62.68 -52.29 63.88 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.265 1.848 . . . . 0.0 113.364 164.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -150.41 114.5 3.3 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-N 119.82 1.191 . . . . 0.0 108.94 169.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.53 -44.15 0.25 Allowed 'Trans proline' 0 CA--C 1.563 1.927 0 CA-C-N 122.693 1.998 . . . . 0.0 116.22 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.19 -43.01 73.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 117.033 2.234 . . . . 0.0 117.033 169.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.26 92.78 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 170.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.12 -57.51 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 118.876 0.762 . . . . 0.0 112.43 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.72 102.96 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 172.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -74.92 90.28 2.41 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.762 0.791 . . . . 0.0 111.627 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.03 28.76 3.75 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 118.01 1.964 . . . . 0.0 118.01 -166.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 t -76.11 134.95 39.86 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.677 1.738 . . . . 0.0 111.42 163.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -76.75 21.58 0.2 Allowed 'General case' 0 CA--C 1.582 2.176 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 170.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.409 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 1.8 ttt -87.92 102.53 14.8 Favored 'General case' 0 CA--C 1.56 1.358 0 O-C-N 120.776 -1.202 . . . . 0.0 110.813 173.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.1 69.79 2.7 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -135.98 131.83 35.56 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.434 1.093 . . . . 0.0 108.613 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.07 -55.37 8.39 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.03 155.74 7.52 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 115.769 1.068 . . . . 0.0 115.769 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.8 mt -100.85 98.16 7.97 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 118.167 -0.921 . . . . 0.0 109.076 168.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.02 -34.76 16.28 Favored 'Trans proline' 0 CA--C 1.568 2.182 0 C-N-CA 122.674 2.249 . . . . 0.0 117.272 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.06 129.87 40.08 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.66 0.784 . . . . 0.0 112.982 175.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.1 tt -57.54 -43.08 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 166.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.54 -48.69 68.85 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -54.82 -45.88 74.5 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.7 mtm-85 -66.49 -54.13 27.41 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.27 -44.14 88.27 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -59.4 -52.73 64.37 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 113.728 1.011 . . . . 0.0 113.728 169.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.18 -46.49 85.69 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -61.12 -42.38 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 117.552 -1.213 . . . . 0.0 112.945 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.76 -44.32 73.52 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 164.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -58.42 -50.67 72.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 167.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.09 -24.51 65.95 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 174.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.85 -44.82 96.05 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 158.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.69 -41.8 93.63 Favored Glycine 0 CA--C 1.553 2.427 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 168.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.99 83.27 6.74 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 118.725 1.262 . . . . 0.0 111.0 172.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.414 -0.803 . . . . 0.0 109.753 175.872 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.409 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.5 67.64 0.66 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.767 0.794 . . . . 0.0 112.523 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -106.29 115.4 61.02 Favored Pre-proline 0 CA--C 1.575 1.938 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.914 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.45 -27.8 27.5 Favored 'Trans proline' 0 CA--C 1.569 2.26 0 N-CA-C 118.458 2.445 . . . . 0.0 118.458 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.7 98.73 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 167.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.48 -32.79 74.37 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 159.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.75 -38.43 95.18 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 118.848 2.299 . . . . 0.0 118.848 171.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.01 -38.96 90.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 169.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -61.87 -42.02 98.56 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 164.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.67 -39.13 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 168.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -55.61 -25.29 37.84 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 169.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.9 -29.08 26.2 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 119.809 2.684 . . . . 0.0 119.809 165.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -58.51 -38.4 77.63 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 159.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -82.05 -32.2 30.54 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -45.39 -46.33 13.17 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 119.664 3.209 . . . . 0.0 119.664 -173.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.83 -38.5 70.13 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.8 m -89.84 -43.91 10.31 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -112.36 132.94 54.73 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 119.453 1.024 . . . . 0.0 112.179 -169.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -117.61 132.52 56.5 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.9 0.857 . . . . 0.0 111.105 -173.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.2 mt -80.04 -9.14 59.67 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 117.33 2.345 . . . . 0.0 117.33 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -102.76 58.62 0.78 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.175 1.807 . . . . 0.0 112.011 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.2 24.23 50.47 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 121.124 3.21 . . . . 0.0 121.124 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -106.57 121.99 45.41 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.007 1.404 . . . . 0.0 110.697 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -93.22 103.59 15.84 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.381 0.672 . . . . 0.0 109.454 173.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.0 -107.41 3.21 Favored Glycine 0 N--CA 1.489 2.224 0 O-C-N 122.096 -0.377 . . . . 0.0 112.689 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.19 -49.44 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 118.923 -0.561 . . . . 0.0 111.087 166.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.95 166.77 14.78 Favored Glycine 0 CA--C 1.561 2.93 0 CA-C-N 119.035 0.834 . . . . 0.0 114.924 164.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.78 169.24 20.68 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 120.813 2.307 . . . . 0.0 115.174 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -65.76 124.34 22.17 Favored 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.456 -1.402 . . . . 0.0 113.434 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.2 mt -90.41 6.47 43.14 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -67.41 125.97 27.79 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 121.149 1.795 . . . . 0.0 110.96 159.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.24 53.51 13.67 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 115.619 1.007 . . . . 0.0 115.619 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -107.0 -29.87 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 t -79.36 100.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 120.811 1.642 . . . . 0.0 109.0 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.82 -15.62 48.3 Favored Glycine 0 CA--C 1.552 2.398 0 N-CA-C 118.304 2.082 . . . . 0.0 118.304 -159.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -72.12 141.06 49.16 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 121.339 2.569 . . . . 0.0 113.201 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.8 m -58.18 136.99 57.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -67.12 123.85 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 123.267 0.627 . . . . 0.0 110.72 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 62.76 45.31 5.88 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -165.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.05 12.82 29.08 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 -170.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.5 t -92.74 115.18 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 120.072 1.936 . . . . 0.0 109.09 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.92 120.19 16.13 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.904 -0.497 . . . . 0.0 110.717 166.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.21 17.91 21.02 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 118.209 2.044 . . . . 0.0 118.209 -163.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -139.11 127.45 22.8 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 119.785 1.792 . . . . 0.0 109.118 165.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -80.61 93.39 6.1 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.376 -0.827 . . . . 0.0 112.765 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -76.73 152.14 35.79 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.9 p -70.08 156.7 38.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.766 -1.209 . . . . 0.0 114.061 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.26 -49.6 91.43 Favored Pre-proline 0 CA--C 1.576 1.98 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.01 -24.39 45.42 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 CA-C-N 124.095 2.498 . . . . 0.0 117.468 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.8 tpp -65.89 -46.44 78.34 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.784 1.629 . . . . 0.0 114.253 163.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -57.81 -45.64 85.84 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 166.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.38 -13.5 61.87 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 170.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -60.7 -48.67 80.75 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 120.87 1.668 . . . . 0.0 114.915 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.72 164.69 35.73 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 117.704 1.842 . . . . 0.0 117.704 163.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.8 -144.14 26.16 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 114.756 0.662 . . . . 0.0 114.756 -177.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -129.53 154.02 47.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.781 0.801 . . . . 0.0 111.528 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -75.82 76.65 2.75 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 123.05 1.405 . . . . 0.0 112.782 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.2 p -73.71 159.7 83.81 Favored Pre-proline 0 CA--C 1.574 1.892 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.114 173.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -56.01 -39.2 92.64 Favored 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 122.403 2.069 . . . . 0.0 117.159 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.01 -42.12 94.75 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 166.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.76 98.06 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 170.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -58.86 -49.11 78.97 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 166.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -55.21 -40.31 70.65 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 172.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.17 -57.54 11.13 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 167.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -60.36 -40.96 92.66 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.87 -27.83 66.16 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.8 m -67.99 -60.09 2.77 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 120.61 1.55 . . . . 0.0 113.37 161.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -127.63 97.13 31.17 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-N 120.864 1.666 . . . . 0.0 110.562 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.63 -51.88 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.886 0 CA-C-N 122.514 1.934 . . . . 0.0 115.625 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.5 -21.19 62.78 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 173.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.47 -43.46 55.97 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.867 1.667 . . . . 0.0 115.06 163.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.33 -54.7 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.474 1.034 . . . . 0.0 112.695 172.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.85 101.63 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -72.61 98.47 2.34 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 121.701 -0.624 . . . . 0.0 111.383 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.54 24.1 8.01 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 118.457 2.143 . . . . 0.0 118.457 -166.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -76.09 135.34 39.87 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.627 1.713 . . . . 0.0 111.025 159.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -74.89 8.92 2.15 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 117.32 2.341 . . . . 0.0 117.32 167.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -73.42 95.94 2.29 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 120.565 -1.334 . . . . 0.0 111.294 170.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.72 69.65 6.07 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-O 122.497 1.142 . . . . 0.0 113.382 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.28 133.28 55.5 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.349 1.059 . . . . 0.0 108.95 175.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.14 -56.2 14.28 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 115.886 1.809 . . . . 0.0 115.886 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.18 142.76 3.65 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 115.664 1.026 . . . . 0.0 115.664 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.2 mt -95.22 106.73 27.72 Favored Pre-proline 0 CA--C 1.574 1.879 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.084 168.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.97 -40.16 1.45 Allowed 'Trans proline' 0 CA--C 1.569 2.236 0 CA-C-N 123.239 2.192 . . . . 0.0 116.982 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.9 132.9 40.59 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.8 tt -51.36 -47.94 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 168.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -48.95 -50.63 34.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 173.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.18 -41.16 97.23 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -65.84 -52.93 46.34 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 170.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.76 -44.71 86.31 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -58.53 -51.73 68.65 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 169.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.43 -48.08 72.08 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 168.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 62.1 mt -62.33 -40.72 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.273 172.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.14 -44.68 71.6 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 121.778 2.081 . . . . 0.0 116.567 163.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -60.14 -47.97 83.7 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 166.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.5 mt -65.07 -30.43 71.38 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -61.1 -43.24 99.18 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 161.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.01 -42.48 99.74 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 117.809 1.884 . . . . 0.0 117.809 165.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -80.33 72.05 7.17 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-N 118.526 1.163 . . . . 0.0 112.478 171.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.242 -0.885 . . . . 0.0 109.466 176.293 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.57 1.732 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.68 45.43 21.64 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 119.107 3.002 . . . . 0.0 119.107 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -127.88 84.29 63.73 Favored Pre-proline 0 CA--C 1.575 1.94 0 O-C-N 120.934 -1.104 . . . . 0.0 110.91 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -67.8 -35.54 21.13 Favored 'Trans proline' 0 CA--C 1.563 1.972 0 N-CA-C 119.18 2.723 . . . . 0.0 119.18 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.86 75.74 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.01 82.65 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 164.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.46 -38.12 94.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.281 2.072 . . . . 0.0 118.281 167.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -58.16 -44.57 88.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 164.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -58.24 -47.08 84.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 167.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.75 -40.73 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 169.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -52.87 -24.99 10.25 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.06 -34.51 5.92 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 119.79 2.676 . . . . 0.0 119.79 161.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -58.98 -38.73 79.8 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 163.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -83.2 -31.45 27.07 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -48.17 -34.92 10.75 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.59 -28.63 47.54 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 117.932 2.568 . . . . 0.0 117.932 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.1 m -112.9 -43.97 3.35 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -102.18 152.1 21.43 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.127 0.965 . . . . 0.0 113.503 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -128.2 138.59 52.53 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.793 0.806 . . . . 0.0 111.13 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.5 mt -100.68 41.4 1.18 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.373 -0.829 . . . . 0.0 113.186 168.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -143.53 55.92 1.35 Allowed 'General case' 0 CA--C 1.571 1.768 0 O-C-N 120.79 -1.194 . . . . 0.0 110.802 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.6 -43.62 1.63 Allowed Glycine 0 N--CA 1.497 2.739 0 N-CA-C 119.465 2.546 . . . . 0.0 119.465 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -74.81 136.86 41.6 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -112.25 125.88 54.63 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.78 0.832 . . . . 0.0 109.385 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.4 -101.01 0.6 Allowed Glycine 0 N--CA 1.491 2.336 0 O-C-N 121.748 -0.595 . . . . 0.0 113.966 -172.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.11 -52.98 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 117.396 0.598 . . . . 0.0 110.901 170.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.71 164.5 13.92 Favored Glycine 0 CA--C 1.561 2.909 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.811 161.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.17 170.4 15.95 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 CA-C-N 120.961 2.38 . . . . 0.0 115.116 174.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -71.39 127.19 31.75 Favored 'General case' 0 CA--C 1.568 1.662 0 O-C-N 120.526 -1.359 . . . . 0.0 111.933 173.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -90.33 4.95 49.29 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -61.71 118.97 7.82 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 119.954 1.252 . . . . 0.0 111.511 168.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.65 19.71 65.37 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -175.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.92 -29.05 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-N 121.005 2.403 . . . . 0.0 116.68 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.0 t -78.98 103.42 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 120.068 1.303 . . . . 0.0 109.181 -171.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.96 -19.68 45.93 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 118.25 2.06 . . . . 0.0 118.25 -159.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -75.24 147.02 40.65 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.776 2.288 . . . . 0.0 113.866 -174.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.3 m -55.15 138.63 44.16 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.21 122.03 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.78 -0.575 . . . . 0.0 110.224 172.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.07 49.64 4.42 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -164.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.75 -18.59 24.83 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 119.185 2.434 . . . . 0.0 119.185 -169.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 65.0 t -84.97 100.6 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.686 1.743 . . . . 0.0 109.622 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.35 105.08 2.44 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.534 0.683 . . . . 0.0 110.999 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.65 -56.53 0.53 Allowed Glycine 0 N--CA 1.487 2.098 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.213 -157.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -82.55 129.58 34.95 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 117.894 0.847 . . . . 0.0 111.111 169.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.54 99.96 10.48 Favored 'General case' 0 CA--C 1.567 1.597 0 O-C-N 121.539 -0.726 . . . . 0.0 110.918 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -77.83 158.56 29.43 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.9 p -71.37 156.09 39.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.616 -1.302 . . . . 0.0 113.782 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.85 -48.67 92.89 Favored Pre-proline 0 CA--C 1.576 1.962 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.11 -26.12 43.09 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 CA-C-N 124.322 2.579 . . . . 0.0 117.66 171.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.9 ttm -65.86 -46.79 77.15 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 121.253 1.842 . . . . 0.0 113.97 162.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -56.89 -45.65 82.41 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 167.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.19 -17.14 61.39 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 118.81 2.892 . . . . 0.0 118.81 172.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -61.44 -54.58 41.63 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.853 1.66 . . . . 0.0 114.617 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.09 -179.27 50.38 Favored Glycine 0 CA--C 1.546 2.03 0 N-CA-C 116.709 1.443 . . . . 0.0 116.709 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.34 -151.52 43.63 Favored Glycine 0 N--CA 1.487 2.099 0 O-C-N 121.879 -0.777 . . . . 0.0 114.88 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -132.84 153.41 51.33 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.052 0.929 . . . . 0.0 111.722 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -76.87 74.32 3.48 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 122.832 1.301 . . . . 0.0 113.166 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.7 p -69.7 158.93 85.81 Favored Pre-proline 0 CA--C 1.576 1.969 0 C-N-CA 124.293 1.037 . . . . 0.0 112.382 171.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.55 -33.24 96.2 Favored 'Trans proline' 0 CA--C 1.57 2.292 0 N-CA-C 117.559 2.1 . . . . 0.0 117.559 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.51 -49.5 68.76 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 164.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.11 90.55 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 171.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.3 mt -59.77 -45.83 91.05 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 165.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -56.19 -43.07 78.08 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 121.636 2.016 . . . . 0.0 116.329 168.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -60.81 -56.42 21.43 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 120.068 1.304 . . . . 0.0 114.261 169.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -62.26 -39.98 94.69 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 74.2 mt -71.14 -25.0 62.37 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 169.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.1 m -62.45 -51.86 65.81 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 121.247 1.84 . . . . 0.0 113.504 164.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -150.54 112.63 3.21 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 120.05 1.295 . . . . 0.0 109.147 167.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.22 -46.9 0.21 Allowed 'Trans proline' 0 CA--C 1.559 1.76 0 CA-C-N 122.714 2.005 . . . . 0.0 116.985 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.02 -28.15 67.16 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.91 -40.88 91.9 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 161.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.3 t -71.44 -58.54 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.394 0.997 . . . . 0.0 112.511 175.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.35 101.28 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -74.43 102.54 4.48 Favored 'General case' 0 CA--C 1.566 1.589 0 O-C-N 121.566 -0.709 . . . . 0.0 111.578 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.56 22.16 10.64 Favored Glycine 0 CA--C 1.554 2.507 0 N-CA-C 118.446 2.138 . . . . 0.0 118.446 -164.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -74.79 134.14 41.84 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 119.64 1.72 . . . . 0.0 111.321 161.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -74.21 9.86 1.48 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -72.99 95.88 2.06 Favored 'General case' 0 CA--C 1.565 1.551 0 O-C-N 120.696 -1.253 . . . . 0.0 111.194 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.18 72.63 4.72 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 122.8 1.286 . . . . 0.0 113.383 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -136.32 128.86 30.48 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.94 -54.54 24.96 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.12 156.88 7.58 Favored Glycine 0 CA--C 1.544 1.852 0 N-CA-C 115.664 1.025 . . . . 0.0 115.664 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.1 mt -104.06 96.04 8.9 Favored Pre-proline 0 CA--C 1.574 1.868 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.176 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.08 -34.2 17.39 Favored 'Trans proline' 0 CA--C 1.568 2.193 0 C-N-CA 122.672 2.248 . . . . 0.0 117.198 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -73.04 129.56 38.35 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.76 0.824 . . . . 0.0 112.831 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 tt -57.73 -43.05 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -52.68 -45.27 66.73 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.38 -46.6 88.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 73.5 mtm-85 -64.4 -52.38 58.46 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -47.25 86.75 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -60.12 -46.45 89.59 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 119.732 1.151 . . . . 0.0 113.971 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.9 tp -60.04 -47.73 84.65 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.43 -43.36 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-N 119.918 1.236 . . . . 0.0 112.884 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.1 73.55 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 165.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -57.5 -47.68 81.27 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 165.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.29 -31.6 72.82 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.57 -40.42 91.61 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 159.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.51 -49.56 75.63 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -87.22 77.85 8.94 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 118.814 1.307 . . . . 0.0 112.445 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 . . . . . 0 N--CA 1.487 1.402 0 C-N-CA 123.679 0.792 . . . . 0.0 110.05 172.135 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ttt . . . . . 0 CA--C 1.565 1.528 0 CA-C-O 121.206 0.527 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.3 85.05 2.07 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 121.786 0.803 . . . . 0.0 111.428 -172.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -97.85 118.54 63.83 Favored Pre-proline 0 CA--C 1.578 2.049 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.685 -175.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.25 -32.13 21.32 Favored 'Trans proline' 0 CA--C 1.567 2.13 0 N-CA-C 118.317 2.391 . . . . 0.0 118.317 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.65 -48.7 79.66 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 169.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.7 71.43 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 164.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.41 -33.04 65.09 Favored Glycine 0 CA--C 1.551 2.318 0 N-CA-C 119.145 2.418 . . . . 0.0 119.145 166.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -65.42 -40.85 93.85 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -61.7 -41.14 97.2 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 164.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.92 -37.45 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 169.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -54.95 -18.9 5.61 Favored 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 165.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.12 -38.28 6.17 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 119.81 2.684 . . . . 0.0 119.81 158.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.04 -31.47 72.71 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 164.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -87.58 -34.23 18.62 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -56.79 -34.37 67.58 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 119.981 3.326 . . . . 0.0 119.981 -169.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.22 -35.9 72.36 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.6 m -91.15 -42.87 10.21 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 168.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -110.32 135.14 51.51 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.207 0.912 . . . . 0.0 112.617 -169.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.25 146.15 27.24 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.684 0.754 . . . . 0.0 112.571 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.5 mt -95.19 6.09 49.99 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 166.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.15 -40.4 52.71 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.9 -38.43 1.9 Allowed Glycine 0 N--CA 1.496 2.65 0 CA-C-N 119.3 0.955 . . . . 0.0 115.335 -163.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -73.69 153.71 39.97 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-O 121.979 0.895 . . . . 0.0 112.623 168.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -91.21 145.56 24.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 111.668 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.36 -115.35 4.02 Favored Glycine 0 N--CA 1.492 2.392 0 O-C-N 121.571 -0.706 . . . . 0.0 112.843 175.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -78.52 -48.3 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 122.337 -0.508 . . . . 0.0 110.745 163.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.29 173.89 33.27 Favored Glycine 0 CA--C 1.56 2.896 0 N-CA-C 115.327 0.891 . . . . 0.0 115.327 160.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -69.62 173.18 11.22 Favored 'Trans proline' 0 CA--C 1.565 2.039 0 CA-C-N 120.578 2.189 . . . . 0.0 115.468 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -65.75 126.21 27.71 Favored 'General case' 0 CA--C 1.573 1.828 0 O-C-N 120.468 -1.395 . . . . 0.0 113.399 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.48 1.08 57.45 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -64.97 125.33 24.56 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 121.496 1.953 . . . . 0.0 111.112 158.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.05 47.13 32.51 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 116.787 1.475 . . . . 0.0 116.787 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -99.17 -28.45 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 t -81.05 105.14 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 120.631 1.559 . . . . 0.0 109.173 -171.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.35 -13.33 61.56 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.085 1.994 . . . . 0.0 118.085 -159.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -74.42 146.37 42.95 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.025 2.412 . . . . 0.0 112.745 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 64.9 m -54.62 141.56 31.34 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.64 114.71 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.639 -0.663 . . . . 0.0 109.386 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.276 . . 67.59 62.26 0.43 Allowed 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -158.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.83 -20.99 8.07 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 119.462 2.545 . . . . 0.0 119.462 -170.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.3 t -81.88 101.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 120.23 2.015 . . . . 0.0 109.877 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -70.27 102.04 2.04 Favored 'General case' 0 CA--C 1.566 1.58 0 C-N-CA 123.727 0.811 . . . . 0.0 110.784 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.91 -51.87 0.72 Allowed Glycine 0 N--CA 1.49 2.287 0 CA-C-O 119.783 -0.454 . . . . 0.0 113.782 -155.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -85.74 124.93 32.81 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 117.98 0.89 . . . . 0.0 110.479 168.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -80.62 118.18 21.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.422 -0.799 . . . . 0.0 110.07 167.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -89.81 172.51 8.85 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.829 0.823 . . . . 0.0 112.423 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.5 t -70.55 152.92 43.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.373 -1.455 . . . . 0.0 112.961 171.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.56 -45.55 99.85 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-O 115.274 -2.298 . . . . 0.0 116.525 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.63 -26.84 45.98 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 CA-C-N 124.807 2.753 . . . . 0.0 117.338 166.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.2 tpp -64.2 -47.85 78.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.604 1.547 . . . . 0.0 114.123 164.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -60.55 -43.47 97.18 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 168.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.41 -14.96 62.33 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 118.784 2.883 . . . . 0.0 118.784 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -65.18 -56.21 14.19 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.741 1.609 . . . . 0.0 114.247 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.08 -179.78 52.6 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 116.717 1.447 . . . . 0.0 116.717 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.99 -149.57 37.96 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 121.836 -0.802 . . . . 0.0 114.809 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -133.87 155.25 50.21 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.923 0.868 . . . . 0.0 112.061 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -76.8 78.17 3.41 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.938 1.352 . . . . 0.0 112.962 172.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.7 p -75.47 159.85 80.89 Favored Pre-proline 0 CA--C 1.577 1.983 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.514 173.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -59.09 -28.01 86.62 Favored 'Trans proline' 0 CA--C 1.572 2.388 0 N-CA-C 118.014 2.275 . . . . 0.0 118.014 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.13 -53.49 30.2 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 163.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.38 -43.25 88.39 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.62 -51.14 71.2 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -62.62 -33.07 74.27 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 175.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -63.89 -54.44 34.76 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 164.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -60.63 -42.59 97.2 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.55 -20.48 62.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 170.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -65.42 -63.17 1.16 Allowed 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.802 1.637 . . . . 0.0 111.756 158.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -134.66 102.24 11.51 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.921 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.52 -50.77 0.12 Allowed 'Trans proline' 0 CA--C 1.561 1.865 0 CA-C-N 122.731 2.011 . . . . 0.0 115.947 -175.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -69.87 -20.68 63.39 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 171.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.03 -42.4 69.56 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 121.363 1.892 . . . . 0.0 114.92 163.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.18 -56.88 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.492 0.717 . . . . 0.0 112.538 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.63 97.28 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 172.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -73.01 104.95 4.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.385 -0.822 . . . . 0.0 111.909 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.33 17.26 22.67 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 118.554 2.182 . . . . 0.0 118.554 -166.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 t -69.1 136.27 52.0 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.121 1.96 . . . . 0.0 111.841 163.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -73.78 8.61 1.85 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 168.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.433 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.3 ttt -74.35 99.61 3.55 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 120.784 -1.198 . . . . 0.0 111.302 170.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.16 70.99 6.89 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 122.604 1.192 . . . . 0.0 113.327 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -130.37 134.16 46.95 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.31 1.044 . . . . 0.0 108.69 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.88 -56.47 6.99 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.56 154.18 6.84 Favored Glycine 0 CA--C 1.544 1.89 0 CA-C-O 121.983 0.768 . . . . 0.0 114.668 -177.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.1 mt -98.86 98.15 5.88 Favored Pre-proline 0 CA--C 1.573 1.832 0 CA-C-O 117.851 -1.071 . . . . 0.0 108.87 167.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 -33.63 19.8 Favored 'Trans proline' 0 CA--C 1.568 2.214 0 C-N-CA 122.706 2.271 . . . . 0.0 117.383 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -71.41 126.06 28.64 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.974 0.91 . . . . 0.0 113.335 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -56.37 -43.6 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 168.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -54.08 -45.22 71.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.39 -45.56 88.09 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 169.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -62.68 -54.34 40.86 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 171.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.38 -45.59 87.99 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -59.34 -49.81 76.38 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 171.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.57 -44.9 89.9 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.6 mt -66.71 -34.49 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-N 119.804 1.184 . . . . 0.0 113.688 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.49 79.85 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 121.792 2.087 . . . . 0.0 115.905 159.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.67 -51.47 69.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 170.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.1 mt -66.29 -24.22 66.52 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.14 -45.64 87.6 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 160.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.68 91.41 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 117.882 1.913 . . . . 0.0 117.882 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -79.31 71.59 5.86 Favored 'General case' 0 CA--C 1.573 1.853 0 CA-C-N 118.372 1.086 . . . . 0.0 112.566 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.353 -177.887 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.433 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.343 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.094 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.53 57.28 5.06 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -97.09 110.67 55.11 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.158 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.52 -25.78 29.37 Favored 'Trans proline' 0 CA--C 1.567 2.131 0 N-CA-C 118.424 2.432 . . . . 0.0 118.424 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.82 -49.22 71.48 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.37 77.59 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 162.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.9 -41.49 84.24 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 118.825 2.29 . . . . 0.0 118.825 166.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -56.09 -44.09 78.67 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 164.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.73 -47.03 87.29 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 168.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.0 t -58.6 -36.46 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -54.26 -19.43 5.28 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 168.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.93 -38.46 4.58 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 120.045 2.778 . . . . 0.0 120.045 158.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -66.07 -38.04 87.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 164.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -81.59 -33.44 31.57 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -55.8 -35.06 65.89 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 119.95 3.315 . . . . 0.0 119.95 -171.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.08 -35.27 71.15 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 117.041 2.238 . . . . 0.0 117.041 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 m -96.38 -43.05 7.83 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -103.69 127.77 51.11 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.281 1.032 . . . . 0.0 111.91 -172.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -102.95 135.76 44.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.646 0.736 . . . . 0.0 110.965 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.2 mt -79.14 -23.75 43.78 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.43 61.64 6.94 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 121.502 1.955 . . . . 0.0 112.79 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.91 -30.58 0.4 Allowed Glycine 0 CA--C 1.557 2.674 0 N-CA-C 120.908 3.123 . . . . 0.0 120.908 173.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -79.24 148.18 32.3 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 124.339 1.056 . . . . 0.0 113.534 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -113.84 106.08 14.04 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -171.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.32 -108.9 3.16 Favored Glycine 0 N--CA 1.491 2.338 0 O-C-N 121.824 -0.547 . . . . 0.0 113.625 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.0 t -70.32 -53.34 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 119.222 -0.418 . . . . 0.0 110.666 165.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.39 152.38 18.83 Favored Glycine 0 CA--C 1.56 2.879 0 CA-C-O 119.118 -0.824 . . . . 0.0 114.675 167.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.56 143.57 27.49 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 CA-C-N 121.255 2.528 . . . . 0.0 113.319 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -44.32 122.94 3.22 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -169.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.16 -7.86 59.63 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -65.39 113.53 4.16 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 119.139 0.882 . . . . 0.0 110.767 160.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.03 44.07 8.4 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.35 -33.54 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 174.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.69 106.32 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 120.418 1.463 . . . . 0.0 109.401 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.67 -10.99 66.69 Favored Glycine 0 CA--C 1.553 2.466 0 N-CA-C 118.733 2.253 . . . . 0.0 118.733 -162.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -73.47 145.36 45.75 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 121.23 2.515 . . . . 0.0 112.924 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.0 m -54.39 140.3 34.18 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.71 117.6 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.605 -0.685 . . . . 0.0 109.524 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.264 . . 64.36 57.84 1.15 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -157.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.53 -27.11 5.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 -169.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.8 t -70.47 115.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 119.614 1.707 . . . . 0.0 109.948 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.81 73.9 6.54 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.87 1.319 . . . . 0.0 111.852 176.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.99 39.49 0.02 OUTLIER Glycine 0 CA--C 1.551 2.312 0 CA-C-N 114.421 -1.263 . . . . 0.0 115.23 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -154.12 144.05 21.86 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 118.137 0.969 . . . . 0.0 110.12 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -74.83 90.51 2.38 Favored 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 111.593 170.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -82.82 146.24 29.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.419 -0.801 . . . . 0.0 112.574 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.9 t -68.15 153.64 43.32 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -60.7 -46.85 97.12 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 115.906 -1.997 . . . . 0.0 115.24 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.92 -24.25 67.73 Favored 'Trans proline' 0 CA--C 1.564 1.988 0 CA-C-N 124.902 2.786 . . . . 0.0 117.975 166.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.4 tpp -65.08 -49.44 70.03 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 121.131 1.787 . . . . 0.0 113.818 162.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -59.93 -46.67 88.62 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 171.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -12.66 60.57 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 118.979 2.955 . . . . 0.0 118.979 169.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -68.53 -58.08 4.83 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 120.366 1.439 . . . . 0.0 113.643 175.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.2 -178.59 52.52 Favored Glycine 0 CA--C 1.547 2.08 0 N-CA-C 116.574 1.39 . . . . 0.0 116.574 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.48 -149.39 38.55 Favored Glycine 0 N--CA 1.488 2.143 0 O-C-N 121.818 -0.813 . . . . 0.0 114.905 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -133.67 155.56 49.48 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.972 0.892 . . . . 0.0 111.987 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -76.56 77.99 3.25 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-O 123.111 1.434 . . . . 0.0 112.817 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.9 p -77.19 161.24 73.72 Favored Pre-proline 0 CA--C 1.575 1.938 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.317 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -56.29 -35.82 96.23 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 N-CA-C 117.709 2.157 . . . . 0.0 117.709 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.43 -51.75 64.4 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 166.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.37 94.91 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 172.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.5 mt -57.77 -51.96 67.42 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 167.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.3 2.6 pp0? -62.52 -33.71 75.45 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 176.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -62.88 -55.26 27.66 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 164.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -59.38 -41.33 89.09 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.79 -18.6 62.09 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.7 m -66.18 -64.35 0.88 Allowed 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 120.554 1.525 . . . . 0.0 111.46 159.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -134.72 101.92 11.57 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 118.191 -0.909 . . . . 0.0 109.66 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.66 -51.4 0.11 Allowed 'Trans proline' 0 CA--C 1.561 1.853 0 CA-C-N 122.89 2.068 . . . . 0.0 116.218 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.65 -20.95 64.48 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.12 -43.89 61.04 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.771 1.623 . . . . 0.0 114.995 162.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.4 -57.27 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-N 119.426 1.012 . . . . 0.0 112.723 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.76 99.63 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -74.24 94.49 2.49 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.645 0.736 . . . . 0.0 111.945 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.05 20.71 7.01 Favored Glycine 0 CA--C 1.551 2.286 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 -166.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.4 t -72.71 137.62 46.06 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 120.199 2.0 . . . . 0.0 111.549 160.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -73.46 5.52 3.69 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 117.608 2.447 . . . . 0.0 117.608 165.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.433 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.8 ttt -70.26 98.21 1.34 Allowed 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 120.334 1.425 . . . . 0.0 112.198 172.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.06 69.57 5.25 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 122.481 1.134 . . . . 0.0 113.847 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.36 135.9 50.2 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.32 1.048 . . . . 0.0 109.044 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.26 -58.26 3.96 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 176.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.13 154.21 6.9 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-O 122.207 0.893 . . . . 0.0 115.109 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.5 mt -98.63 101.83 12.96 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-O 117.747 -1.121 . . . . 0.0 108.893 168.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.36 -37.38 10.2 Favored 'Trans proline' 0 CA--C 1.565 2.039 0 C-N-CA 122.574 2.183 . . . . 0.0 117.59 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -78.22 135.34 37.58 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 119.414 1.006 . . . . 0.0 112.454 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -58.37 -39.84 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 168.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.09 -44.78 79.34 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -56.46 -45.6 80.79 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -64.42 -54.24 35.83 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.45 90.19 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 117.379 2.362 . . . . 0.0 117.379 173.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -60.29 -47.96 83.79 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.4 tp -58.65 -46.53 86.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 168.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.4 mt -59.29 -41.45 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.914 1.233 . . . . 0.0 113.16 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.16 -44.58 75.32 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 164.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -58.94 -47.29 85.59 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 166.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.05 -22.57 63.06 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.43 -42.87 98.7 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 156.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.22 96.56 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 117.672 1.829 . . . . 0.0 117.672 165.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -77.98 85.1 4.23 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 118.136 0.968 . . . . 0.0 111.581 170.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.419 -0.8 . . . . 0.0 109.22 173.733 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.433 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.571 1.779 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.92 77.4 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.283 -0.886 . . . . 0.0 111.785 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -100.41 115.85 64.99 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.329 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.11 -34.06 23.45 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 C-N-CA 122.573 2.182 . . . . 0.0 117.666 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.41 -44.55 96.95 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.42 77.86 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 165.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.49 -27.23 58.14 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 119.866 2.707 . . . . 0.0 119.866 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -59.66 -39.56 84.84 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 166.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -65.26 -44.06 89.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 168.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.6 t -56.14 -44.71 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 166.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.75 -23.53 18.29 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 170.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.05 -37.79 16.91 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 119.556 2.582 . . . . 0.0 119.556 162.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -60.72 -33.64 73.19 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 164.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -82.94 -30.0 28.69 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 171.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -56.26 -19.63 14.95 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.36 -26.52 19.56 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 159.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.0 m -125.13 -43.61 1.94 Allowed 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -96.47 140.39 31.19 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -126.06 123.11 37.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.758 -0.589 . . . . 0.0 110.301 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.66 -25.56 63.96 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.82 55.57 2.78 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.366 1.894 . . . . 0.0 113.72 -172.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.84 12.95 7.45 Favored Glycine 0 CA--C 1.561 2.941 0 N-CA-C 120.192 2.837 . . . . 0.0 120.192 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.86 137.67 38.93 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 118.936 1.368 . . . . 0.0 112.281 -168.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -127.58 110.37 12.64 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.14 -97.78 0.75 Allowed Glycine 0 N--CA 1.493 2.452 0 O-C-N 121.875 -0.516 . . . . 0.0 113.943 -171.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.71 -49.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.913 166.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.64 160.67 13.35 Favored Glycine 0 CA--C 1.56 2.895 0 CA-C-N 119.195 0.907 . . . . 0.0 114.004 163.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -69.93 174.62 9.39 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 CA-C-N 120.92 2.36 . . . . 0.0 115.369 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -74.48 118.19 17.16 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 120.439 -1.413 . . . . 0.0 112.615 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.0 mt -83.36 -4.92 58.93 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -59.18 117.88 5.25 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 120.033 1.288 . . . . 0.0 111.06 155.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.1 39.99 30.89 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 116.9 1.52 . . . . 0.0 116.9 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.01 -36.93 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.19 1.495 . . . . 0.0 114.512 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.5 t -68.18 108.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 119.966 1.257 . . . . 0.0 110.004 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.35 -19.16 55.56 Favored Glycine 0 CA--C 1.554 2.471 0 N-CA-C 118.535 2.174 . . . . 0.0 118.535 -162.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -73.51 144.14 46.27 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 120.802 2.301 . . . . 0.0 113.086 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.8 m -59.07 144.07 46.58 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.66 117.51 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.616 -0.677 . . . . 0.0 110.351 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.267 . . 65.76 56.77 0.88 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -160.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.69 31.2 5.08 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 -169.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.73 110.73 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 162.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -72.17 97.31 1.93 Allowed 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 123.593 0.757 . . . . 0.0 112.019 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.2 -52.09 0.58 Allowed Glycine 0 N--CA 1.489 2.167 0 CA-C-O 119.304 -0.72 . . . . 0.0 114.507 -159.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -81.57 134.58 35.52 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-N 118.449 1.125 . . . . 0.0 111.955 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -82.87 105.06 13.57 Favored 'General case' 0 CA--C 1.566 1.574 0 O-C-N 121.587 -0.696 . . . . 0.0 111.267 172.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.62 168.89 14.91 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.6 0.714 . . . . 0.0 112.628 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.1 t -70.92 153.01 43.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.305 -1.497 . . . . 0.0 113.319 171.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.15 -49.58 92.26 Favored Pre-proline 0 CA--C 1.577 2.001 0 CA-C-O 116.035 -1.936 . . . . 0.0 115.368 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.95 -21.29 64.02 Favored 'Trans proline' 0 CA--C 1.567 2.169 0 CA-C-N 124.744 2.73 . . . . 0.0 118.001 166.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.5 tpp -67.85 -50.44 56.57 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 120.394 1.452 . . . . 0.0 113.897 162.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -56.68 -44.37 81.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 169.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.86 -8.59 55.28 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 118.967 2.951 . . . . 0.0 118.967 171.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -66.44 -55.03 17.63 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 120.775 1.625 . . . . 0.0 114.637 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.47 174.85 50.33 Favored Glycine 0 CA--C 1.548 2.103 0 N-CA-C 116.451 1.341 . . . . 0.0 116.451 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.4 -158.52 47.55 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 115.321 0.888 . . . . 0.0 115.321 -174.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -128.7 156.61 43.21 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.913 0.863 . . . . 0.0 112.247 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -76.31 76.08 3.09 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.338 1.542 . . . . 0.0 112.898 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.5 p -76.42 160.43 77.54 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.943 172.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -57.25 -35.0 98.83 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.387 2.058 . . . . 0.0 117.416 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.64 -51.53 69.02 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 164.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.54 -44.78 93.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 171.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -59.47 -48.73 80.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -62.53 -36.89 84.03 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -62.29 -55.65 26.14 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 165.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -60.6 -40.38 91.61 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.8 mt -74.74 -12.62 60.45 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 169.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 m -67.04 -55.32 14.85 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 121.247 1.839 . . . . 0.0 112.337 161.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -149.19 114.24 3.61 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 117.919 -1.039 . . . . 0.0 108.503 167.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.04 -45.85 0.43 Allowed 'Trans proline' 0 CA--C 1.562 1.881 0 CA-C-N 122.655 1.984 . . . . 0.0 116.599 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.22 -28.57 67.35 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.63 93.44 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 162.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.7 t -70.56 -57.35 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.501 1.046 . . . . 0.0 112.532 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.9 103.27 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-N 120.083 1.31 . . . . 0.0 107.564 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -72.84 106.54 4.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.744 . . . . 0.0 111.058 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.98 17.68 17.71 Favored Glycine 0 CA--C 1.554 2.497 0 N-CA-C 118.919 2.327 . . . . 0.0 118.919 -169.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.455 ' HG1' ' CGD' ' A' ' 101' ' ' HEC . 11.1 t -75.57 135.88 40.55 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.806 1.803 . . . . 0.0 112.764 169.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.279 64.5 pttt -82.24 12.77 4.01 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 168.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.416 ' HG2' ' C4D' ' A' ' 101' ' ' HEC . 1.2 mmm -59.77 83.32 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.777 0 C-N-CA 125.195 1.398 . . . . 0.0 112.548 153.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.94 78.95 7.7 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 122.931 1.348 . . . . 0.0 112.47 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -150.77 133.92 16.11 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.509 -171.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.53 -56.05 9.63 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.46 158.68 8.99 Favored Glycine 0 N--CA 1.484 1.863 0 CA-C-O 122.292 0.94 . . . . 0.0 114.934 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.2 mt -99.04 101.66 13.11 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.767 -1.111 . . . . 0.0 108.315 168.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.87 -35.67 9.02 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 C-N-CA 122.697 2.265 . . . . 0.0 117.805 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -78.74 135.41 37.12 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 119.257 0.935 . . . . 0.0 112.503 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.15 -40.61 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 169.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.19 -45.12 75.82 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 170.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -57.18 -47.2 81.81 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 120.791 1.632 . . . . 0.0 115.173 169.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -61.77 -54.14 46.39 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.9 -43.37 86.1 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 171.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -58.5 -50.38 73.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 170.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.92 -45.38 92.77 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.2 -46.21 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 120.039 1.291 . . . . 0.0 113.0 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.84 -44.96 74.41 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 166.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -56.61 -48.54 77.23 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 167.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.7 mt -71.02 -25.14 62.54 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -60.77 -42.88 98.36 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 159.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 -44.35 95.35 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 164.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -81.6 85.3 6.56 Favored 'General case' 0 CA--C 1.572 1.81 0 CA-C-N 118.372 1.086 . . . . 0.0 111.855 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 123.828 0.851 . . . . 0.0 109.689 -174.649 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.455 ' CGD' ' HG1' ' A' ' 76' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 mtt . . . . . 0 CA--C 1.561 1.373 0 CA-C-O 121.15 0.5 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.273 . . 61.51 29.2 18.26 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 119.507 3.151 . . . . 0.0 119.507 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -97.5 113.15 62.98 Favored Pre-proline 0 CA--C 1.578 2.02 0 O-C-N 120.775 -1.203 . . . . 0.0 110.54 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.48 -29.08 25.79 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 N-CA-C 118.243 2.363 . . . . 0.0 118.243 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.93 86.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 167.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.62 79.79 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 162.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.69 -35.94 69.63 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 118.784 2.274 . . . . 0.0 118.784 165.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.74 -46.53 87.2 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.86 -41.71 98.18 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 167.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.3 t -60.63 -37.25 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 169.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -55.66 -19.57 11.09 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 117.014 2.228 . . . . 0.0 117.014 167.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.1 -37.02 7.48 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 119.699 2.639 . . . . 0.0 119.699 160.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -64.55 -38.1 89.85 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 164.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.64 -34.84 34.66 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -55.66 -35.74 66.31 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 120.299 3.444 . . . . 0.0 120.299 -168.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.34 80.66 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.8 m -89.85 -40.32 12.51 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 169.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -115.31 121.67 43.57 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.472 1.109 . . . . 0.0 110.643 -169.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -105.02 131.12 52.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 111.07 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.2 mt -70.82 -26.11 63.16 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -83.35 54.47 2.82 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.194 1.816 . . . . 0.0 113.396 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.32 9.84 18.81 Favored Glycine 0 CA--C 1.559 2.838 0 N-CA-C 120.593 2.997 . . . . 0.0 120.593 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -101.85 134.09 45.58 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.442 1.621 . . . . 0.0 111.869 -170.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -102.54 104.57 14.99 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.48 -106.45 2.93 Favored Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.966 -0.459 . . . . 0.0 113.386 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.02 -44.33 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.256 166.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.69 166.17 12.51 Favored Glycine 0 CA--C 1.564 3.115 0 CA-C-N 119.505 1.048 . . . . 0.0 115.051 161.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.29 151.79 43.76 Favored 'Trans proline' 0 CA--C 1.562 1.908 0 C-N-CA 122.835 2.357 . . . . 0.0 114.745 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -48.19 121.16 4.07 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.0 -9.32 59.6 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -63.03 111.86 2.36 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 118.921 0.782 . . . . 0.0 110.986 161.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.69 45.42 8.55 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 -170.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 p -100.37 -31.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 170.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.5 t -73.09 106.45 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 120.477 1.49 . . . . 0.0 109.563 -175.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.69 -12.33 66.1 Favored Glycine 0 CA--C 1.553 2.425 0 N-CA-C 118.692 2.237 . . . . 0.0 118.692 -162.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -72.52 140.12 47.98 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 121.018 2.409 . . . . 0.0 113.125 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.3 m -59.89 136.97 58.17 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.7 125.92 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 123.391 0.676 . . . . 0.0 110.797 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.254 . . 60.98 42.42 12.78 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -164.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.87 -3.12 39.7 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 119.751 2.66 . . . . 0.0 119.751 -170.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.6 t -83.53 103.3 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 120.386 2.093 . . . . 0.0 109.541 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.6 104.27 3.27 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.331 0.586 . . . . 0.0 110.482 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.32 -56.43 0.55 Allowed Glycine 0 N--CA 1.489 2.205 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.269 -157.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -87.67 128.24 35.29 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 117.721 0.761 . . . . 0.0 111.278 171.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -81.81 105.12 12.69 Favored 'General case' 0 CA--C 1.566 1.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.599 171.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -78.7 159.13 28.13 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.7 p -76.71 147.13 37.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.032 -1.043 . . . . 0.0 113.067 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -53.79 -44.45 98.05 Favored Pre-proline 0 CA--C 1.576 1.979 0 N-CA-C 117.882 2.549 . . . . 0.0 117.882 -175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.95 -19.58 58.04 Favored 'Trans proline' 0 CA--C 1.569 2.238 0 CA-C-N 125.069 2.846 . . . . 0.0 117.977 170.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.7 tpp -69.24 -45.28 70.16 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.128 1.331 . . . . 0.0 114.187 162.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -55.6 -44.24 76.8 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 164.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.13 -17.27 64.31 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 118.672 2.841 . . . . 0.0 118.672 169.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -64.4 -52.57 57.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.528 1.513 . . . . 0.0 114.44 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.85 167.33 34.9 Favored Glycine 0 CA--C 1.548 2.139 0 N-CA-C 117.842 1.897 . . . . 0.0 117.842 167.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.07 -145.52 23.39 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -130.52 153.35 48.92 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.801 0.81 . . . . 0.0 111.536 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.42 76.04 3.17 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 123.217 1.484 . . . . 0.0 113.11 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.3 p -75.3 160.52 79.76 Favored Pre-proline 0 CA--C 1.577 1.981 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.547 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -58.74 -27.6 84.07 Favored 'Trans proline' 0 CA--C 1.572 2.381 0 N-CA-C 118.171 2.335 . . . . 0.0 118.171 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.58 -53.27 23.88 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 163.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.1 90.1 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 174.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.2 mt -56.84 -52.42 65.16 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 168.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.253 8.2 pt20 -64.26 -33.85 76.77 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 176.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -60.39 -55.76 29.64 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 119.636 1.107 . . . . 0.0 113.938 163.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -58.3 -41.02 83.55 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.98 -16.75 61.51 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 170.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.5 m -65.2 -54.83 23.57 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 121.1 1.773 . . . . 0.0 112.693 164.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -149.73 112.53 3.4 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.334 167.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.05 -45.19 0.48 Allowed 'Trans proline' 0 CA--C 1.559 1.749 0 CA-C-N 122.565 1.952 . . . . 0.0 116.889 -174.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.03 -29.16 68.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 173.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.17 88.0 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 163.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.1 t -68.94 -56.36 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 119.48 1.036 . . . . 0.0 112.584 173.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.56 101.04 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -69.62 102.67 1.91 Allowed 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 121.307 0.575 . . . . 0.0 111.642 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.15 10.25 32.36 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 119.352 2.501 . . . . 0.0 119.352 -170.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 t -66.47 134.73 53.06 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.48 2.64 . . . . 0.0 112.742 171.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -73.11 9.78 1.13 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.444 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -77.08 103.73 7.17 Favored 'General case' 0 CA--C 1.563 1.461 0 O-C-N 120.585 -1.322 . . . . 0.0 111.691 173.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.28 71.48 4.75 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 122.535 1.159 . . . . 0.0 113.624 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -137.44 129.51 29.14 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.303 1.041 . . . . 0.0 108.405 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.01 -54.46 15.08 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.08 157.96 8.3 Favored Glycine 0 CA--C 1.544 1.897 0 CA-C-O 122.525 1.07 . . . . 0.0 115.555 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.22 101.13 15.37 Favored Pre-proline 0 CA--C 1.575 1.912 0 CA-C-O 117.924 -1.036 . . . . 0.0 108.665 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.41 -37.17 7.95 Favored 'Trans proline' 0 CA--C 1.566 2.085 0 C-N-CA 122.689 2.259 . . . . 0.0 117.752 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -76.89 134.2 39.05 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 119.193 0.906 . . . . 0.0 112.888 174.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.8 tt -57.06 -41.25 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 168.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.86 -49.32 49.7 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.81 -45.11 90.69 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 171.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -62.77 -53.73 49.9 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 171.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.71 -46.32 84.54 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 172.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -56.95 -50.98 70.97 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 169.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.3 tp -56.65 -45.63 81.53 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 169.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.0 -42.18 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.237 171.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.93 -43.28 77.25 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 165.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -58.32 -48.01 81.89 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.6 -23.64 63.56 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.866 2.172 . . . . 0.0 116.866 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -61.63 -43.14 99.41 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 156.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.23 -47.2 90.1 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 117.576 1.79 . . . . 0.0 117.576 166.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -76.48 88.82 3.24 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 118.317 1.058 . . . . 0.0 112.119 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.48 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.444 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tmm? . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.68 96.35 3.0 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -98.86 117.29 64.6 Favored Pre-proline 0 CA--C 1.578 2.032 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.005 -171.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.49 -28.45 26.54 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 N-CA-C 118.428 2.434 . . . . 0.0 118.428 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.36 -47.08 80.65 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 169.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.92 -38.77 79.73 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 161.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.47 -38.46 80.22 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 119.009 2.364 . . . . 0.0 119.009 166.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -55.63 -45.9 77.51 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 163.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.49 -47.75 84.31 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 t -57.83 -39.87 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 168.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -55.07 -20.82 10.58 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 169.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.52 -36.8 24.99 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 119.525 2.57 . . . . 0.0 119.525 160.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -57.87 -41.74 83.09 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 163.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -76.59 -34.18 58.41 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -52.6 -25.95 12.11 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 119.061 2.986 . . . . 0.0 119.061 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.18 -25.89 15.35 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 162.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.5 m -128.55 -34.32 2.02 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -108.0 142.12 38.62 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.547 1.139 . . . . 0.0 112.922 -169.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -103.1 157.16 17.19 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.244 1.021 . . . . 0.0 111.814 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.68 -27.52 13.63 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -84.74 60.3 6.06 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-N 121.542 1.974 . . . . 0.0 113.982 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.6 -40.01 0.39 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 120.166 2.827 . . . . 0.0 120.166 174.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -80.32 154.99 27.44 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 124.879 1.271 . . . . 0.0 112.96 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -96.77 152.21 18.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 111.952 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -122.68 -118.93 2.5 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 121.397 -0.815 . . . . 0.0 112.742 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.7 t -73.82 -48.23 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 122.337 -0.507 . . . . 0.0 111.104 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.11 171.06 26.62 Favored Glycine 0 CA--C 1.562 3.027 0 CA-C-N 118.836 0.744 . . . . 0.0 114.775 156.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.44 175.24 9.7 Favored 'Trans proline' 0 CA--C 1.567 2.137 0 CA-C-N 121.124 2.462 . . . . 0.0 114.799 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -65.08 122.52 17.25 Favored 'General case' 0 CA--C 1.568 1.668 0 O-C-N 120.402 -1.436 . . . . 0.0 113.094 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.32 -3.68 59.04 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 116.631 2.085 . . . . 0.0 116.631 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -63.95 121.11 13.3 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 119.401 1.001 . . . . 0.0 110.792 155.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.77 42.81 16.07 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 116.413 1.325 . . . . 0.0 116.413 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -100.45 -33.69 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.9 t -74.99 105.02 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 120.652 1.569 . . . . 0.0 109.4 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.22 -26.45 22.89 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 117.761 1.864 . . . . 0.0 117.761 -160.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -66.07 142.92 57.63 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 120.978 2.389 . . . . 0.0 113.736 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.0 m -53.68 139.71 31.48 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.39 120.34 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.647 -0.658 . . . . 0.0 109.738 173.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 63.54 49.01 3.21 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -162.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.93 -27.01 13.13 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 118.875 2.31 . . . . 0.0 118.875 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.5 t -73.53 98.43 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.266 1.533 . . . . 0.0 109.966 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.25 105.65 8.48 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.369 0.667 . . . . 0.0 110.168 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.9 -52.43 0.71 Allowed Glycine 0 N--CA 1.489 2.216 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.66 -154.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -79.65 130.23 35.17 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 118.036 0.918 . . . . 0.0 111.647 171.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -81.27 90.5 6.12 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 121.581 -0.699 . . . . 0.0 111.642 177.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.91 157.38 37.95 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 t -66.87 155.02 39.5 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 174.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -59.58 -49.12 93.7 Favored Pre-proline 0 CA--C 1.577 2.003 0 CA-C-O 116.094 -1.908 . . . . 0.0 115.488 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.36 -25.14 64.01 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 CA-C-N 124.71 2.718 . . . . 0.0 117.732 166.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.5 tpp -65.22 -48.38 73.57 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.533 1.515 . . . . 0.0 114.17 164.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -58.78 -45.81 88.97 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 167.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.79 -14.7 62.52 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 118.976 2.954 . . . . 0.0 118.976 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -62.52 -53.15 59.04 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.715 1.598 . . . . 0.0 114.708 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.98 175.72 48.67 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 116.728 1.451 . . . . 0.0 116.728 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.46 -151.76 40.34 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 115.121 0.808 . . . . 0.0 115.121 -176.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -132.34 154.76 49.42 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.001 0.905 . . . . 0.0 111.568 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -76.04 76.16 2.91 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 123.01 1.386 . . . . 0.0 112.877 172.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -72.58 160.17 83.5 Favored Pre-proline 0 CA--C 1.576 1.964 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.386 171.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.27 -32.39 95.82 Favored 'Trans proline' 0 CA--C 1.571 2.366 0 N-CA-C 117.504 2.079 . . . . 0.0 117.504 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -64.06 -52.71 58.05 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 163.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.77 80.55 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 172.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.9 mt -60.9 -45.22 95.5 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 166.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -55.81 -43.56 77.01 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 121.583 1.992 . . . . 0.0 116.207 167.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -61.72 -56.02 24.03 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 120.029 1.286 . . . . 0.0 114.333 169.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.54 -39.87 95.0 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.0 mt -72.2 -22.67 61.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 169.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.5 m -62.48 -52.53 63.13 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.347 1.885 . . . . 0.0 113.365 163.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -151.35 113.11 3.03 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-N 119.902 1.228 . . . . 0.0 109.088 167.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.94 -47.8 0.16 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 CA-C-N 122.752 2.019 . . . . 0.0 116.91 -174.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -67.27 -26.3 66.49 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.77 -42.47 86.06 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 161.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.53 -58.56 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.432 1.014 . . . . 0.0 112.617 175.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.51 99.89 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -74.91 98.85 3.66 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-O 121.477 0.656 . . . . 0.0 111.725 -177.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.08 18.33 10.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 -166.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -69.92 138.37 52.36 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.268 2.034 . . . . 0.0 112.003 163.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -73.95 8.76 1.84 Allowed 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.431 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.4 ttt -78.4 99.05 6.23 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.708 -1.245 . . . . 0.0 111.795 174.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.99 73.33 4.55 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 122.504 1.145 . . . . 0.0 113.702 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -135.99 130.15 33.16 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.229 1.012 . . . . 0.0 108.507 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.11 -54.39 18.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.24 159.93 9.27 Favored Glycine 0 CA--C 1.544 1.862 0 N-CA-C 115.909 1.124 . . . . 0.0 115.909 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.0 mt -102.39 98.96 11.66 Favored Pre-proline 0 CA--C 1.575 1.908 0 C-N-CA 123.903 0.881 . . . . 0.0 108.932 168.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.61 -34.05 15.89 Favored 'Trans proline' 0 CA--C 1.567 2.131 0 C-N-CA 122.592 2.195 . . . . 0.0 117.623 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -76.98 136.0 38.72 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 119.214 0.916 . . . . 0.0 113.064 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 tt -57.12 -43.18 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 167.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -54.57 -46.15 73.64 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.18 -45.97 83.23 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 75.7 mtm-85 -66.49 -52.48 45.57 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 172.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.56 -46.62 86.5 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -57.2 -49.33 76.33 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 169.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.6 tp -59.28 -46.45 88.5 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 170.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.72 -40.47 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-N 120.099 1.318 . . . . 0.0 112.976 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.77 -44.82 74.03 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 163.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -58.55 -47.78 83.09 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 167.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.1 mt -71.94 -23.01 61.39 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.29 -43.24 99.27 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 155.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.7 -41.91 98.84 Favored Glycine 0 CA--C 1.554 2.481 0 N-CA-C 118.056 1.982 . . . . 0.0 118.056 166.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -81.47 83.6 6.93 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 118.527 1.164 . . . . 0.0 111.351 170.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 . . . . . 0 N--CA 1.487 1.396 0 O-C-N 121.472 -0.768 . . . . 0.0 109.58 173.925 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.431 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 119.647 -0.215 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.06 83.33 7.99 Favored 'General case' 0 CA--C 1.564 1.489 0 O-C-N 121.096 -1.003 . . . . 0.0 113.091 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.57 100.05 10.33 Favored Pre-proline 0 CA--C 1.572 1.824 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.67 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -57.15 -34.64 98.12 Favored 'Trans proline' 0 CA--C 1.566 2.108 0 N-CA-C 119.605 2.887 . . . . 0.0 119.605 172.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.83 76.75 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.31 -42.35 77.48 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 162.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.97 -36.71 91.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 169.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.88 -46.96 78.16 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 163.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -57.62 -46.81 83.64 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 168.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.22 -39.45 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -55.21 -18.46 6.03 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.24 -37.94 6.26 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 119.6 2.6 . . . . 0.0 119.6 158.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.25 -38.72 88.54 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 164.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -79.42 -37.1 37.9 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -56.28 -27.77 56.47 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 120.133 3.382 . . . . 0.0 120.133 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.24 -33.17 67.29 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.812 2.153 . . . . 0.0 116.812 168.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.6 m -103.69 -35.95 8.06 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -112.01 142.5 44.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -167.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -107.9 148.6 29.39 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.997 0.903 . . . . 0.0 113.288 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.97 10.29 39.8 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 171.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -123.72 62.29 1.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 120.388 1.449 . . . . 0.0 110.999 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.12 -15.72 0.71 Allowed Glycine 0 CA--C 1.558 2.768 0 N-CA-C 121.616 3.406 . . . . 0.0 121.616 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -90.02 161.47 15.84 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 119.215 1.508 . . . . 0.0 114.489 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -130.02 141.4 50.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.228 -1.545 . . . . 0.0 110.978 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.19 -98.8 0.18 Allowed Glycine 0 N--CA 1.489 2.186 0 O-C-N 121.732 -0.605 . . . . 0.0 112.964 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.96 -51.76 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 117.275 0.537 . . . . 0.0 111.406 167.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.03 175.97 17.64 Favored Glycine 0 CA--C 1.562 2.986 0 N-CA-C 115.067 0.787 . . . . 0.0 115.067 164.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.06 -179.06 3.97 Favored 'Trans proline' 0 CA--C 1.569 2.249 0 C-N-CA 122.723 2.282 . . . . 0.0 114.569 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -76.97 138.09 39.43 Favored 'General case' 0 CA--C 1.566 1.593 0 O-C-N 120.585 -1.322 . . . . 0.0 113.325 173.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.71 -2.57 34.97 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -65.15 113.44 3.97 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.865 1.666 . . . . 0.0 111.964 164.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.34 54.72 6.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 -168.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.2 -38.15 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 171.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -66.88 107.59 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 120.248 1.385 . . . . 0.0 110.118 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.26 -17.08 59.73 Favored Glycine 0 CA--C 1.551 2.342 0 N-CA-C 118.649 2.22 . . . . 0.0 118.649 -163.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -71.69 142.14 49.85 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.177 2.489 . . . . 0.0 113.107 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -59.19 136.56 57.99 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.82 126.66 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 123.465 0.706 . . . . 0.0 111.134 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 59.05 39.88 22.78 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -166.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.72 3.74 49.63 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 119.353 2.501 . . . . 0.0 119.353 -171.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.79 104.17 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.875 1.838 . . . . 0.0 108.375 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.75 86.24 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.458 0.647 . . . . 0.0 111.704 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.55 -46.93 0.37 Allowed Glycine 0 CA--C 1.545 1.965 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.123 -158.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -86.15 137.83 32.36 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 118.814 1.307 . . . . 0.0 112.184 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.1 85.77 3.59 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.189 0.995 . . . . 0.0 113.191 172.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -77.41 142.99 38.96 Favored 'General case' 0 CA--C 1.567 1.628 0 O-C-N 121.408 -0.808 . . . . 0.0 112.753 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.5 p -70.03 157.63 37.17 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -54.03 -49.27 90.73 Favored Pre-proline 0 CA--C 1.578 2.022 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.24 -28.0 40.56 Favored 'Trans proline' 0 CA--C 1.568 2.192 0 CA-C-N 124.328 2.582 . . . . 0.0 117.154 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -62.67 -47.21 84.68 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 120.379 1.445 . . . . 0.0 114.559 163.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -58.32 -47.05 84.95 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 167.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.59 -17.44 63.54 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 118.916 2.932 . . . . 0.0 118.916 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -58.38 -51.39 70.02 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.64 1.564 . . . . 0.0 114.528 175.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.84 170.65 35.8 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 117.732 1.853 . . . . 0.0 117.732 165.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.86 -143.11 26.23 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 122.088 -0.654 . . . . 0.0 114.629 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -129.89 154.12 47.62 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.669 0.747 . . . . 0.0 111.759 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -76.26 76.75 3.05 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.929 1.347 . . . . 0.0 112.977 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.3 p -74.11 160.05 82.53 Favored Pre-proline 0 CA--C 1.573 1.865 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.662 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.4 -29.04 87.12 Favored 'Trans proline' 0 CA--C 1.569 2.233 0 N-CA-C 117.461 2.062 . . . . 0.0 117.461 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -66.12 -54.7 22.27 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 163.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.97 88.89 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.6 -44.55 93.36 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 164.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -57.73 -42.7 84.37 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -63.43 -55.84 21.01 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.967 1.258 . . . . 0.0 114.226 169.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -60.79 -42.2 97.13 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 71.2 mt -73.87 -16.33 61.12 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.9 m -64.1 -54.62 31.02 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 121.296 1.862 . . . . 0.0 112.788 161.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.98 115.29 3.45 Favored Pre-proline 0 CA--C 1.575 1.922 0 CA-C-N 119.625 1.102 . . . . 0.0 108.805 167.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.32 -45.78 0.32 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 CA-C-N 122.586 1.959 . . . . 0.0 116.753 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -66.11 -33.24 75.32 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.57 95.84 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 165.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.91 -58.14 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-N 118.843 0.747 . . . . 0.0 112.095 171.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.94 98.2 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -73.21 101.32 3.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.877 . . . . 0.0 111.474 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.5 19.96 10.72 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 118.559 2.184 . . . . 0.0 118.559 -164.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -76.35 132.36 39.7 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 119.964 1.882 . . . . 0.0 110.682 156.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.282 64.2 pttt -82.54 26.83 0.54 Allowed 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 170.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.02 101.3 1.37 Allowed 'General case' 0 CA--C 1.567 1.62 0 O-C-N 120.501 -1.375 . . . . 0.0 109.919 159.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.06 73.42 4.62 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.882 1.325 . . . . 0.0 112.166 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -152.42 123.33 7.48 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.094 -166.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.96 -49.63 60.61 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.35 164.42 13.09 Favored Glycine 0 CA--C 1.543 1.824 0 CA-C-O 122.686 1.159 . . . . 0.0 115.557 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.8 mt -101.99 95.16 5.25 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 164.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.33 -34.1 16.77 Favored 'Trans proline' 0 CA--C 1.567 2.154 0 C-N-CA 122.648 2.232 . . . . 0.0 117.343 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -74.64 132.82 42.04 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-O 121.885 0.85 . . . . 0.0 112.913 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.06 -42.97 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.18 -48.27 68.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.05 -43.88 78.3 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -64.5 -52.58 57.14 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 170.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.87 82.85 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -60.1 -48.59 81.08 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 172.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.2 tp -61.2 -45.71 93.45 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 172.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.25 60.6 mt -61.96 -41.09 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 119.79 1.177 . . . . 0.0 112.783 171.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.7 -43.3 80.4 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 164.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -56.71 -48.1 78.47 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 164.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.86 -23.23 61.48 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -64.9 -42.92 94.36 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.326 -1.484 . . . . 0.0 114.684 155.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.53 -56.75 23.54 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.837 1.495 . . . . 0.0 116.837 167.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -82.69 82.38 8.07 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.544 1.172 . . . . 0.0 112.285 165.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 . . . . . 0 C--O 1.259 1.6 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.947 158.626 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.582 ' N ' HD21 ' A' ' 91' ' ' ASN . 16.2 t70 . . . . . 0 CA--C 1.576 1.979 0 CA-C-O 118.135 -0.936 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.68 -28.82 30.51 Favored 'Trans proline' 0 CA--C 1.568 2.211 0 N-CA-C 118.364 2.409 . . . . 0.0 118.364 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.41 -50.32 70.29 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.52 72.08 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 163.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.48 -31.58 66.99 Favored Glycine 0 CA--C 1.55 2.27 0 N-CA-C 118.679 2.231 . . . . 0.0 118.679 165.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.67 -42.51 98.04 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 168.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.11 -40.7 98.38 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 167.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.92 -41.61 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -58.27 -24.8 60.62 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 168.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.19 -29.7 29.91 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 119.495 2.558 . . . . 0.0 119.495 163.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -59.52 -35.81 74.88 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 160.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.79 -33.64 30.73 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 173.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -46.69 -41.75 15.44 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 119.724 3.231 . . . . 0.0 119.724 -173.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.39 -35.95 72.81 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.2 m -91.82 -43.75 9.34 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 169.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -114.04 132.74 55.9 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.318 1.047 . . . . 0.0 111.196 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -117.62 122.68 44.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 170.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.2 mt -47.16 -51.79 17.31 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -92.14 76.78 5.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.083 0.944 . . . . 0.0 111.237 -157.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.89 -21.69 0.96 Allowed Glycine 0 CA--C 1.556 2.614 0 N-CA-C 120.523 2.969 . . . . 0.0 120.523 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -91.42 116.59 28.97 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 118.83 1.315 . . . . 0.0 112.043 -167.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -97.39 121.76 39.66 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.756 0.822 . . . . 0.0 109.972 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.11 -109.88 3.06 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.82 -0.55 . . . . 0.0 113.329 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.19 -47.78 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 117.186 0.493 . . . . 0.0 111.055 167.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.94 170.85 25.41 Favored Glycine 0 CA--C 1.559 2.833 0 N-CA-C 115.444 0.937 . . . . 0.0 115.444 163.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -69.14 169.03 19.05 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 C-N-CA 122.686 2.258 . . . . 0.0 115.111 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -70.07 123.65 22.1 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 120.536 -1.352 . . . . 0.0 112.326 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.4 mt -92.03 11.51 25.04 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 -173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.5 122.67 13.21 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 121.555 1.979 . . . . 0.0 113.267 171.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.85 43.66 94.64 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 118.683 2.233 . . . . 0.0 118.683 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.254 5.2 p -71.65 -23.06 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.1 t -73.82 107.42 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 124.311 1.044 . . . . 0.0 109.565 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.34 -3.82 79.83 Favored Glycine 0 CA--C 1.555 2.535 0 N-CA-C 119.039 2.376 . . . . 0.0 119.039 -162.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -84.83 143.13 29.27 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.802 2.301 . . . . 0.0 112.983 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.2 m -60.74 137.91 58.15 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.9 t -67.06 123.1 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.905 -0.497 . . . . 0.0 110.258 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.266 . . 62.95 50.0 3.34 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -163.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.63 -16.49 28.84 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 119.399 2.519 . . . . 0.0 119.399 -171.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.52 97.67 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 120.048 1.924 . . . . 0.0 109.599 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.21 109.05 5.01 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 123.19 0.596 . . . . 0.0 110.88 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.36 -57.07 0.67 Allowed Glycine 0 N--CA 1.49 2.275 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.018 -157.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -82.42 123.37 29.06 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 117.676 0.738 . . . . 0.0 110.417 167.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.13 124.85 29.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.478 -0.763 . . . . 0.0 110.735 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -94.55 173.53 7.57 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 121.879 0.847 . . . . 0.0 112.36 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.5 t -71.55 154.38 41.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.294 -1.504 . . . . 0.0 113.114 171.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -59.53 -49.66 91.08 Favored Pre-proline 0 CA--C 1.577 1.986 0 CA-C-O 115.959 -1.972 . . . . 0.0 115.239 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.29 -24.39 71.97 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 CA-C-N 124.805 2.752 . . . . 0.0 117.895 166.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.8 tpp -66.86 -49.34 66.01 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.646 1.566 . . . . 0.0 114.158 164.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -59.21 -43.07 92.3 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -12.42 61.47 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 118.862 2.912 . . . . 0.0 118.862 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -65.16 -55.62 17.6 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 120.835 1.652 . . . . 0.0 114.356 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.57 177.63 50.47 Favored Glycine 0 CA--C 1.548 2.104 0 N-CA-C 116.648 1.419 . . . . 0.0 116.648 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.06 -154.18 44.42 Favored Glycine 0 CA--C 1.548 2.147 0 N-CA-C 115.332 0.893 . . . . 0.0 115.332 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -130.7 154.36 48.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.149 0.976 . . . . 0.0 112.261 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -76.64 73.3 3.33 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 123.081 1.42 . . . . 0.0 113.254 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.5 p -70.11 159.6 83.78 Favored Pre-proline 0 CA--C 1.575 1.933 0 C-N-CA 124.516 1.127 . . . . 0.0 112.312 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -57.06 -34.7 98.19 Favored 'Trans proline' 0 CA--C 1.568 2.197 0 N-CA-C 117.794 2.19 . . . . 0.0 117.794 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.82 -45.56 74.35 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 164.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.64 -43.88 85.19 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 170.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.05 -47.37 86.14 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 165.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -55.69 -44.46 77.39 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 121.634 2.016 . . . . 0.0 116.324 169.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -61.41 -55.63 29.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 119.93 1.241 . . . . 0.0 114.111 170.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -60.97 -41.38 96.28 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.1 mt -73.13 -21.66 60.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -63.76 -52.03 62.23 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-N 120.942 1.701 . . . . 0.0 113.352 162.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -150.12 112.61 3.31 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-N 120.146 1.339 . . . . 0.0 109.299 168.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.96 -47.44 0.17 Allowed 'Trans proline' 0 CA--C 1.56 1.819 0 CA-C-N 122.672 1.99 . . . . 0.0 116.933 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.45 -26.53 65.55 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.92 -41.54 86.89 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 161.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.0 t -71.45 -58.86 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.416 1.007 . . . . 0.0 112.629 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.74 100.92 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -74.94 100.69 4.19 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 121.366 0.603 . . . . 0.0 111.685 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.52 18.47 12.94 Favored Glycine 0 CA--C 1.554 2.491 0 N-CA-C 118.58 2.192 . . . . 0.0 118.58 -165.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -71.77 137.46 47.69 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.141 1.971 . . . . 0.0 111.997 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -73.51 6.85 2.71 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 167.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.5 ttt -73.28 94.82 2.05 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 120.415 1.461 . . . . 0.0 111.451 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.62 70.75 5.01 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.754 1.264 . . . . 0.0 113.431 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -130.49 130.45 44.2 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.512 1.125 . . . . 0.0 107.988 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.06 -54.96 22.03 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.98 155.06 6.47 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.0 mt -103.97 98.14 12.84 Favored Pre-proline 0 CA--C 1.573 1.846 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.373 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.03 -33.32 15.78 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 122.572 2.181 . . . . 0.0 117.644 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.03 133.1 36.82 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.102 0.865 . . . . 0.0 112.361 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.1 tt -56.15 -44.58 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 171.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.9 -45.84 71.24 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.16 -47.72 80.49 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 169.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 75.0 mtm-85 -64.73 -50.96 64.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.35 93.11 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.582 HD21 ' N ' ' A' ' 3' ' ' ASP . 10.5 m120 -56.9 -50.17 73.32 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 168.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.0 tp -54.89 -48.67 72.7 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.75 -41.77 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 119.859 1.209 . . . . 0.0 113.411 171.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.21 -43.12 74.18 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 164.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -62.44 -44.68 95.85 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 168.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.2 mt -64.08 -27.86 69.39 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 169.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.22 -44.3 76.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 120.261 1.391 . . . . 0.0 114.657 158.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -53.96 -54.37 31.62 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 117.44 1.736 . . . . 0.0 117.44 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -84.07 81.46 8.79 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 118.539 1.17 . . . . 0.0 111.649 160.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 C--O 1.253 1.249 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 155.149 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.566 ' N ' HD21 ' A' ' 91' ' ' ASN . 15.1 t70 . . . . . 0 CA--C 1.577 1.981 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.84 -28.5 24.79 Favored 'Trans proline' 0 CA--C 1.569 2.25 0 N-CA-C 118.523 2.47 . . . . 0.0 118.523 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.24 -46.83 79.01 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.29 -37.6 78.1 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 159.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.95 -35.5 76.23 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 119.14 2.416 . . . . 0.0 119.14 168.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.12 -42.93 91.74 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 163.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.44 -43.61 96.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.1 -45.01 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 166.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -56.88 -26.61 59.14 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.39 -34.1 6.24 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 161.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -59.2 -35.75 74.15 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 162.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.78 -20.23 43.08 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 171.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -73.86 67.6 1.23 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 123.802 1.763 . . . . 0.0 115.361 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.56 -57.18 0.1 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.365 1.466 . . . . 0.0 108.258 168.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.7 m -71.91 -44.26 63.97 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 166.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -112.42 138.29 49.38 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 119.925 1.238 . . . . 0.0 111.756 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -131.68 123.09 27.05 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.618 0.723 . . . . 0.0 109.774 -171.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.9 mt -72.48 -10.94 60.41 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.9 58.8 1.03 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 120.998 1.726 . . . . 0.0 112.052 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.02 15.6 36.73 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 121.129 3.212 . . . . 0.0 121.129 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -103.73 129.61 51.12 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 119.192 1.496 . . . . 0.0 110.897 -174.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.53 102.51 10.37 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.29 -105.57 3.04 Favored Glycine 0 N--CA 1.49 2.292 0 O-C-N 121.998 -0.439 . . . . 0.0 112.873 -174.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -73.4 -47.06 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.45 167.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.95 167.01 14.22 Favored Glycine 0 CA--C 1.56 2.899 0 CA-C-N 119.315 0.961 . . . . 0.0 114.711 164.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.7 173.03 13.25 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 CA-C-N 120.803 2.302 . . . . 0.0 115.799 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -70.18 122.39 19.38 Favored 'General case' 0 CA--C 1.57 1.713 0 O-C-N 120.561 -1.337 . . . . 0.0 112.43 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.76 7.72 38.22 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -65.07 127.49 31.84 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 120.86 1.664 . . . . 0.0 111.671 164.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.51 24.19 65.94 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 118.26 2.064 . . . . 0.0 118.26 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -79.34 -26.81 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 120.319 2.06 . . . . 0.0 116.259 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.9 t -77.89 105.16 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 120.208 1.367 . . . . 0.0 109.192 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.37 -7.93 64.2 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 118.72 2.248 . . . . 0.0 118.72 -160.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -81.32 142.76 32.77 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 120.987 2.393 . . . . 0.0 113.07 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.3 m -60.12 139.09 57.72 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -67.3 123.23 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.919 -0.488 . . . . 0.0 110.318 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 62.16 49.48 4.4 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -162.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.94 -15.63 30.54 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 119.268 2.467 . . . . 0.0 119.268 -170.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.1 t -83.76 96.67 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 119.965 1.882 . . . . 0.0 109.467 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.35 107.83 3.96 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-O 121.381 0.61 . . . . 0.0 111.006 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.68 -56.1 0.63 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.195 -157.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -83.07 127.12 33.29 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 117.791 0.796 . . . . 0.0 110.777 168.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -81.37 115.72 20.86 Favored 'General case' 0 CA--C 1.565 1.548 0 O-C-N 121.548 -0.72 . . . . 0.0 110.937 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -87.67 168.42 13.02 Favored 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 123.541 0.736 . . . . 0.0 112.529 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 p -73.33 152.58 40.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.106 -1.621 . . . . 0.0 113.056 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -57.57 -42.32 95.07 Favored Pre-proline 0 CA--C 1.574 1.895 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.31 -26.71 41.32 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 CA-C-N 125.017 2.828 . . . . 0.0 117.184 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.9 tpp -63.9 -46.32 85.4 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 120.451 1.478 . . . . 0.0 114.091 162.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.21 -46.63 82.74 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 166.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.81 -14.63 61.56 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 118.87 2.915 . . . . 0.0 118.87 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -62.55 -53.37 55.73 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 120.652 1.569 . . . . 0.0 114.84 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.61 -179.44 50.89 Favored Glycine 0 CA--C 1.547 2.045 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.61 -154.58 48.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -174.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -131.08 155.12 47.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.105 0.955 . . . . 0.0 112.356 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.32 75.15 3.11 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.968 1.366 . . . . 0.0 112.992 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.8 p -72.48 159.38 85.52 Favored Pre-proline 0 CA--C 1.576 1.949 0 C-N-CA 124.428 1.091 . . . . 0.0 112.191 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -57.31 -32.5 93.96 Favored 'Trans proline' 0 CA--C 1.572 2.391 0 N-CA-C 117.636 2.129 . . . . 0.0 117.636 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -64.82 -52.97 53.93 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 164.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.87 -43.73 86.17 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.5 mt -56.93 -50.76 71.61 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 167.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.7 pp0? -64.67 -32.73 74.53 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -61.34 -56.45 20.23 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 162.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -59.74 -41.5 91.06 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.2 mt -74.82 -14.56 60.7 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 171.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -67.54 -65.46 0.68 Allowed 'General case' 0 CA--C 1.57 1.714 0 CA-C-N 120.646 1.567 . . . . 0.0 111.308 156.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -133.06 101.58 13.66 Favored Pre-proline 0 CA--C 1.571 1.766 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.57 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.42 -51.11 0.14 Allowed 'Trans proline' 0 CA--C 1.562 1.917 0 CA-C-N 122.788 2.031 . . . . 0.0 115.693 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.58 -19.18 62.88 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.59 -43.21 56.66 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.692 1.587 . . . . 0.0 114.992 162.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.54 -57.14 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 119.423 1.011 . . . . 0.0 112.748 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.3 t -102.44 102.65 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -72.68 102.71 3.39 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-O 121.26 0.552 . . . . 0.0 111.44 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.58 26.45 9.2 Favored Glycine 0 CA--C 1.553 2.426 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -165.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -72.03 132.27 44.03 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.538 1.669 . . . . 0.0 111.254 160.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -76.03 11.04 1.58 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 166.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -73.52 99.03 2.92 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 120.848 -1.157 . . . . 0.0 111.278 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.4 72.9 6.05 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 122.564 1.174 . . . . 0.0 112.982 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -128.61 135.43 49.32 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 124.484 1.114 . . . . 0.0 108.662 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.46 -58.15 4.34 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.43 149.88 5.18 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-N 118.931 0.787 . . . . 0.0 114.944 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -102.01 99.15 11.52 Favored Pre-proline 0 CA--C 1.572 1.809 0 CA-C-O 117.774 -1.108 . . . . 0.0 109.441 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.43 -35.32 18.27 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 122.657 2.238 . . . . 0.0 117.624 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -72.37 127.42 32.51 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -58.33 -39.95 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 167.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -53.84 -46.59 71.24 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.048 1.869 . . . . 0.0 116.048 169.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.45 -44.43 89.19 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -63.75 -51.27 65.66 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.12 -43.75 91.98 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 170.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.566 HD21 ' N ' ' A' ' 3' ' ' ASP . 8.7 m120 -54.33 -54.2 43.63 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.932 1.242 . . . . 0.0 114.017 168.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.1 tp -55.08 -47.65 74.6 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 170.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.251 61.7 mt -62.98 -41.29 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 117.396 -1.288 . . . . 0.0 113.116 173.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.7 -43.99 69.43 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 163.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -60.75 -47.6 85.59 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 167.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 52.6 mt -63.73 -31.29 72.41 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 171.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.86 -42.66 99.84 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 162.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.58 99.48 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 117.827 1.891 . . . . 0.0 117.827 163.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -83.11 72.5 10.12 Favored 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 118.356 1.078 . . . . 0.0 112.408 172.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.603 175.609 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.452 ' N ' HD21 ' A' ' 91' ' ' ASN . 14.0 t70 . . . . . 0 CA--C 1.576 1.958 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.04 -26.75 25.95 Favored 'Trans proline' 0 CA--C 1.568 2.219 0 N-CA-C 118.38 2.415 . . . . 0.0 118.38 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.82 85.59 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 167.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.85 -39.46 81.36 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 161.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.41 -36.49 77.06 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 119.083 2.393 . . . . 0.0 119.083 168.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -54.39 -47.6 72.51 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 162.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -59.62 -44.18 93.54 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.33 -42.72 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 119.527 1.058 . . . . 0.0 113.831 167.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -55.85 -26.98 49.44 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.93 -34.11 10.94 Favored Glycine 0 N--CA 1.5 2.928 0 N-CA-C 119.818 2.687 . . . . 0.0 119.818 166.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -58.32 -39.64 79.95 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 162.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -78.42 -32.88 48.87 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -45.32 -45.05 12.07 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 -174.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.46 -37.45 70.32 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 m -91.95 -43.31 9.53 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 171.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -112.43 128.04 56.2 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.372 0.987 . . . . 0.0 111.449 -169.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -113.37 130.35 56.31 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.992 0.901 . . . . 0.0 111.265 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.6 mt -74.46 -24.3 59.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.98 56.86 3.63 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 121.117 1.78 . . . . 0.0 113.095 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.39 16.21 34.58 Favored Glycine 0 CA--C 1.558 2.772 0 N-CA-C 120.624 3.009 . . . . 0.0 120.624 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -105.75 133.05 51.11 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.65 1.725 . . . . 0.0 112.395 -171.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.79 122.76 36.6 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.627 169.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.01 -107.37 2.56 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.85 -0.531 . . . . 0.0 112.089 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.51 -50.21 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-N 117.202 0.501 . . . . 0.0 110.987 165.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.04 170.75 21.01 Favored Glycine 0 CA--C 1.56 2.879 0 N-CA-C 115.046 0.778 . . . . 0.0 115.046 163.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.77 176.6 6.56 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 122.627 2.218 . . . . 0.0 116.085 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -71.77 120.18 16.99 Favored 'General case' 0 CA--C 1.566 1.58 0 O-C-N 120.217 -1.552 . . . . 0.0 112.406 173.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.97 -4.68 57.22 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -66.04 115.96 6.64 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-N 119.066 0.848 . . . . 0.0 110.51 160.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.44 39.61 10.8 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 -171.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 p -97.29 -31.84 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.29 109.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 120.871 1.669 . . . . 0.0 108.971 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.69 -14.57 64.63 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 118.778 2.271 . . . . 0.0 118.778 -162.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -75.3 143.11 43.12 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 121.103 2.452 . . . . 0.0 112.965 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.1 m -59.27 142.35 52.13 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.6 t -67.22 122.58 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.83 -0.544 . . . . 0.0 110.348 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 63.47 53.48 2.11 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -162.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.24 -11.28 29.91 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 119.38 2.512 . . . . 0.0 119.38 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.0 t -86.14 95.44 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 120.245 2.023 . . . . 0.0 109.032 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -69.35 118.22 11.97 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.943 0.897 . . . . 0.0 112.199 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.85 -52.56 0.81 Allowed Glycine 0 N--CA 1.492 2.396 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.788 -159.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -79.55 120.93 24.6 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 117.698 0.749 . . . . 0.0 110.918 171.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -76.36 118.29 18.91 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.635 -0.666 . . . . 0.0 110.541 170.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -88.24 169.95 11.43 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.608 0.763 . . . . 0.0 111.217 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.2 p -71.24 157.07 38.76 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 119.832 -1.793 . . . . 0.0 113.43 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -54.74 -50.0 88.29 Favored Pre-proline 0 CA--C 1.578 2.028 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.46 -24.96 48.76 Favored 'Trans proline' 0 CA--C 1.564 1.995 0 CA-C-N 124.349 2.589 . . . . 0.0 117.629 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.2 tpp -65.61 -48.57 71.82 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 120.633 1.56 . . . . 0.0 114.02 163.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -58.97 -44.37 91.52 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 168.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -11.04 60.39 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 118.959 2.948 . . . . 0.0 118.959 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -63.29 -54.2 40.84 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.862 1.664 . . . . 0.0 114.92 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.47 175.45 50.2 Favored Glycine 0 CA--C 1.547 2.062 0 N-CA-C 116.54 1.376 . . . . 0.0 116.54 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.04 -155.75 44.77 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 115.217 0.847 . . . . 0.0 115.217 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -131.85 156.2 46.48 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.891 0.853 . . . . 0.0 112.087 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -76.66 76.17 3.33 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 123.336 1.541 . . . . 0.0 112.831 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.0 p -76.46 160.75 76.76 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.966 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -57.21 -35.39 98.89 Favored 'Trans proline' 0 CA--C 1.571 2.337 0 N-CA-C 117.696 2.152 . . . . 0.0 117.696 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.29 -51.47 67.55 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 164.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.01 94.34 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.6 mt -56.42 -52.05 66.11 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 168.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.293 2.8 pp0? -63.06 -36.56 83.99 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -61.37 -54.46 43.37 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 165.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -57.55 -44.35 85.14 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.3 mt -72.65 -13.34 61.34 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 171.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -64.04 -53.84 43.55 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 120.997 1.726 . . . . 0.0 112.788 161.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.7 103.99 2.33 Favored Pre-proline 0 CA--C 1.577 1.994 0 CA-C-N 119.623 1.101 . . . . 0.0 108.59 173.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.02 -46.51 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 N-CA-C 117.429 2.05 . . . . 0.0 117.429 -168.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.65 -21.28 66.29 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.91 -48.99 56.39 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 161.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.68 -55.71 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 119.521 1.055 . . . . 0.0 113.255 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.23 104.53 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 171.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.15 96.53 2.24 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 121.371 0.605 . . . . 0.0 111.786 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.39 28.29 5.82 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 118.287 2.075 . . . . 0.0 118.287 -167.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -76.25 135.5 39.67 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.526 1.663 . . . . 0.0 111.463 162.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -72.3 7.97 1.53 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 167.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -73.44 99.01 2.87 Favored 'General case' 0 CA--C 1.564 1.512 0 O-C-N 120.63 -1.294 . . . . 0.0 111.395 170.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.41 74.87 4.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 122.737 1.255 . . . . 0.0 113.082 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -138.63 131.18 28.96 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.347 1.059 . . . . 0.0 108.182 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.68 -55.57 10.99 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.27 155.08 6.99 Favored Glycine 0 CA--C 1.545 1.95 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 99.3 mt -103.24 97.68 10.48 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 117.889 -1.053 . . . . 0.0 108.855 170.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.91 -32.95 27.75 Favored 'Trans proline' 0 CA--C 1.568 2.197 0 C-N-CA 122.648 2.232 . . . . 0.0 117.819 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -73.46 118.66 16.68 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 123.941 0.896 . . . . 0.0 113.252 174.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.97 -40.1 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 169.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -53.06 -47.73 68.23 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 170.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -61.41 -41.69 97.54 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 169.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 86.7 mtm-85 -60.12 -50.49 73.47 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.73 -45.58 81.86 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 167.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.452 HD21 ' N ' ' A' ' 3' ' ' ASP . 9.7 m120 -54.55 -52.35 62.33 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 169.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -57.81 -45.7 85.73 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 170.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.258 62.6 mt -63.9 -41.6 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.161 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.46 -43.63 71.84 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 163.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -58.34 -49.94 75.43 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 166.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.1 mt -68.82 -26.64 65.28 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.29 -39.86 84.29 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 158.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.85 -47.52 82.09 Favored Glycine 0 CA--C 1.552 2.402 0 N-CA-C 117.357 1.703 . . . . 0.0 117.357 164.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -77.16 83.81 3.65 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 118.424 1.112 . . . . 0.0 112.344 173.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.188 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 CA--C 1.575 1.934 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.57 -28.25 31.88 Favored 'Trans proline' 0 CA--C 1.566 2.115 0 N-CA-C 118.42 2.431 . . . . 0.0 118.42 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.11 96.86 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 168.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.68 95.13 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 161.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.87 -38.06 72.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 119.146 2.418 . . . . 0.0 119.146 166.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -55.19 -48.8 73.29 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 164.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -59.75 -43.55 94.22 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.57 -38.15 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 167.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.77 -20.61 15.49 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 169.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.78 -38.51 4.41 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 119.636 2.615 . . . . 0.0 119.636 156.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.97 -31.91 73.1 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 166.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -87.91 -33.53 18.47 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -57.91 -32.09 67.4 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 120.505 3.521 . . . . 0.0 120.505 -166.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.02 82.36 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 171.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.2 m -87.41 -44.14 11.57 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -109.22 143.83 38.15 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.339 1.056 . . . . 0.0 112.872 -168.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -118.51 150.28 39.87 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.381 1.086 . . . . 0.0 112.139 -172.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -104.07 1.89 31.46 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -115.52 57.63 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.422 1.464 . . . . 0.0 111.548 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.69 4.87 21.26 Favored Glycine 0 CA--C 1.558 2.771 0 N-CA-C 120.492 2.957 . . . . 0.0 120.492 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -97.7 143.02 28.78 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 118.87 1.335 . . . . 0.0 112.766 -168.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.38 103.97 8.5 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.46 -105.7 3.05 Favored Glycine 0 N--CA 1.49 2.234 0 O-C-N 122.117 -0.365 . . . . 0.0 113.142 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.32 -49.75 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.848 166.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.65 163.49 16.39 Favored Glycine 0 CA--C 1.56 2.864 0 CA-C-N 118.911 0.778 . . . . 0.0 114.851 164.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.72 176.09 8.7 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 CA-C-N 120.845 2.323 . . . . 0.0 115.935 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -70.23 120.2 15.56 Favored 'General case' 0 CA--C 1.568 1.646 0 O-C-N 120.535 -1.353 . . . . 0.0 113.279 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -87.84 -4.01 58.89 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -62.95 111.7 2.27 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.349 1.431 . . . . 0.0 111.729 157.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.66 43.58 7.72 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 -173.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.09 -37.88 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 118.805 1.303 . . . . 0.0 114.491 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.39 107.8 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.898 1.226 . . . . 0.0 110.096 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.81 -19.96 52.26 Favored Glycine 0 CA--C 1.552 2.372 0 N-CA-C 118.503 2.161 . . . . 0.0 118.503 -163.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -73.01 143.63 47.49 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 120.929 2.364 . . . . 0.0 113.415 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.3 m -60.4 140.26 57.28 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.16 124.32 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 123.405 0.682 . . . . 0.0 110.824 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.39 48.72 5.79 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -164.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.05 -8.08 39.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 119.46 2.544 . . . . 0.0 119.46 -169.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.1 t -82.94 103.23 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 120.199 2.0 . . . . 0.0 109.12 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.27 90.33 0.91 Allowed 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.546 0.738 . . . . 0.0 112.081 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.27 -48.84 0.51 Allowed Glycine 0 N--CA 1.486 2.029 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.857 -160.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -81.22 132.16 35.33 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 118.098 0.949 . . . . 0.0 111.572 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -84.48 88.28 7.29 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.435 -0.79 . . . . 0.0 112.017 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -72.85 147.07 45.77 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.2 p -67.74 155.34 39.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -53.82 -49.23 90.45 Favored Pre-proline 0 CA--C 1.578 2.031 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.25 -23.6 38.73 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 CA-C-N 124.125 2.509 . . . . 0.0 117.521 170.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.1 tpp -65.4 -46.65 79.19 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 120.885 1.675 . . . . 0.0 114.147 161.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -57.84 -45.9 85.55 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 168.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.01 -11.96 61.01 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 170.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -60.4 -49.47 77.45 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.045 1.748 . . . . 0.0 114.638 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.88 164.72 36.08 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 163.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.46 -144.69 24.63 Favored Glycine 0 N--CA 1.486 2.015 0 CA-C-N 114.915 -0.642 . . . . 0.0 114.694 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -130.84 154.78 47.69 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.665 0.745 . . . . 0.0 111.493 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -76.12 76.81 2.95 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 123.149 1.452 . . . . 0.0 112.558 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -75.72 159.89 80.28 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.881 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.18 -33.75 91.33 Favored 'Trans proline' 0 CA--C 1.57 2.289 0 N-CA-C 117.66 2.139 . . . . 0.0 117.66 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.31 -50.66 59.27 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 166.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.65 -43.67 85.11 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -57.17 -50.73 71.93 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 165.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.304 1.6 pp0? -61.28 -37.24 82.47 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 175.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.43 -59.02 6.01 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 164.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -58.93 -42.83 90.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.5 mt -69.77 -17.39 63.42 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.5 m -62.71 -55.23 28.6 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.26 1.846 . . . . 0.0 112.869 164.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.23 103.32 2.42 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-N 119.496 1.044 . . . . 0.0 108.525 173.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.02 -46.63 0.37 Allowed 'Trans proline' 0 CA--C 1.558 1.686 0 N-CA-C 117.431 2.05 . . . . 0.0 117.431 -167.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.95 -25.85 68.55 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 169.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 -45.06 70.21 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 163.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.9 t -65.47 -55.3 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.558 1.072 . . . . 0.0 112.782 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.8 104.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -72.99 98.29 2.48 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-O 121.454 0.645 . . . . 0.0 111.316 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.83 23.84 7.61 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 118.657 2.223 . . . . 0.0 118.657 -168.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.4 t -75.41 134.52 40.89 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 119.615 1.708 . . . . 0.0 111.061 160.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -72.92 9.08 1.25 Allowed 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 117.409 2.374 . . . . 0.0 117.409 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -76.25 100.77 5.19 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 120.725 -1.234 . . . . 0.0 111.726 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.64 71.36 4.12 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 122.595 1.188 . . . . 0.0 113.611 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -138.63 128.03 24.49 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.85 -53.48 32.03 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.88 158.79 8.9 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 115.471 0.948 . . . . 0.0 115.471 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.7 mt -100.26 98.56 7.95 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 117.934 -1.031 . . . . 0.0 108.524 166.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.55 -36.39 11.46 Favored 'Trans proline' 0 CA--C 1.565 2.044 0 C-N-CA 122.658 2.239 . . . . 0.0 117.575 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.08 133.53 41.56 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 118.94 0.791 . . . . 0.0 112.527 175.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -57.77 -40.66 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 171.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.57 -43.25 84.37 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.78 -44.72 73.95 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 167.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -66.43 -55.27 16.52 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 173.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.66 98.07 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.64 -47.41 86.36 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.964 1.256 . . . . 0.0 114.11 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.39 -44.0 92.87 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 169.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.0 mt -60.55 -42.87 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 117.539 -1.22 . . . . 0.0 113.101 169.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.67 -44.05 72.97 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 164.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -58.92 -48.22 82.23 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 166.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.9 mt -69.39 -24.47 63.86 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.31 -41.21 92.99 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 156.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.3 -44.96 92.75 Favored Glycine 0 CA--C 1.554 2.5 0 N-CA-C 117.584 1.794 . . . . 0.0 117.584 163.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -79.17 82.36 5.34 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-N 118.623 1.212 . . . . 0.0 111.882 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.43 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.573 1.848 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.71 -23.51 30.93 Favored 'Trans proline' 0 CA--C 1.568 2.203 0 N-CA-C 118.227 2.357 . . . . 0.0 118.227 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.96 -47.36 83.51 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.08 81.56 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 162.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.83 -35.03 66.22 Favored Glycine 0 CA--C 1.552 2.383 0 N-CA-C 119.114 2.405 . . . . 0.0 119.114 164.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.53 -49.77 76.5 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 168.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -59.65 -41.59 90.89 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 169.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.52 -39.16 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 169.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -56.85 -23.03 41.21 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 167.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.05 -35.57 18.99 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 119.585 2.594 . . . . 0.0 119.585 162.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.8 -36.33 76.5 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 162.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -80.27 -32.54 38.22 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 171.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -49.85 -33.8 18.06 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.78 -26.34 23.29 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 118.145 2.646 . . . . 0.0 118.145 167.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.0 m -120.32 -38.77 2.86 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -108.48 147.28 31.9 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.322 1.049 . . . . 0.0 113.169 -169.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -119.74 148.93 42.82 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.937 0.875 . . . . 0.0 112.108 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -105.66 3.94 29.62 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.62 40.23 1.46 Allowed 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 121.095 1.771 . . . . 0.0 114.628 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.36 35.68 91.76 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 117.981 1.952 . . . . 0.0 117.981 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -131.06 142.38 50.29 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 117.905 0.853 . . . . 0.0 111.27 -166.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -91.82 140.66 29.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.032 -1.042 . . . . 0.0 111.505 174.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.91 -115.46 1.89 Allowed Glycine 0 N--CA 1.491 2.341 0 O-C-N 121.518 -0.739 . . . . 0.0 112.108 172.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.18 -47.54 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.817 164.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.39 173.63 27.59 Favored Glycine 0 CA--C 1.562 3.013 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 163.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.42 172.6 12.97 Favored 'Trans proline' 0 CA--C 1.564 1.996 0 C-N-CA 122.845 2.363 . . . . 0.0 115.583 173.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -68.51 125.83 27.73 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 120.425 -1.422 . . . . 0.0 113.754 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -91.57 -0.86 57.64 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -66.46 111.63 3.66 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-N 120.326 1.421 . . . . 0.0 111.234 162.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.99 41.42 7.58 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 116.687 1.435 . . . . 0.0 116.687 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -92.73 -34.31 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.02 106.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 120.428 1.467 . . . . 0.0 109.512 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.48 -12.12 66.51 Favored Glycine 0 CA--C 1.553 2.44 0 N-CA-C 118.731 2.252 . . . . 0.0 118.731 -161.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -78.31 148.45 33.82 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 121.228 2.514 . . . . 0.0 112.84 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.4 m -54.12 141.53 28.56 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.95 120.87 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.758 -0.589 . . . . 0.0 109.974 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.271 . . 66.42 54.66 0.89 Allowed 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -161.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.98 22.13 9.23 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 119.206 2.442 . . . . 0.0 119.206 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.3 t -102.99 109.22 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.323 1.561 . . . . 0.0 107.79 165.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -72.67 88.33 1.28 Allowed 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 123.453 0.701 . . . . 0.0 111.67 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.87 -47.07 0.54 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.075 -159.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -82.23 131.86 35.23 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 118.362 1.081 . . . . 0.0 111.829 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -78.68 105.58 10.07 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.517 0.727 . . . . 0.0 111.848 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -89.56 156.77 18.39 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -63.35 151.8 39.79 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 171.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -59.26 -48.42 96.23 Favored Pre-proline 0 CA--C 1.577 1.997 0 CA-C-O 116.124 -1.893 . . . . 0.0 115.473 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.42 -24.98 63.7 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 CA-C-N 124.477 2.635 . . . . 0.0 117.937 166.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.4 tpp -65.39 -48.61 72.29 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.796 1.634 . . . . 0.0 114.097 164.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -56.27 -47.83 77.8 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 166.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.64 -11.89 60.82 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 118.994 2.961 . . . . 0.0 118.994 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -63.6 -52.63 60.08 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.762 1.619 . . . . 0.0 114.316 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.08 175.26 49.81 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.69 -148.3 36.61 Favored Glycine 0 CA--C 1.547 2.039 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -134.26 155.03 50.91 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.644 0.735 . . . . 0.0 111.639 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -77.1 77.48 3.64 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.91 1.338 . . . . 0.0 112.838 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.0 p -73.84 159.82 83.38 Favored Pre-proline 0 CA--C 1.574 1.885 0 C-N-CA 124.455 1.102 . . . . 0.0 112.344 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -57.59 -34.39 98.02 Favored 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 122.399 2.066 . . . . 0.0 117.459 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.19 -39.84 74.99 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 116.382 1.994 . . . . 0.0 116.382 165.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.96 97.89 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.54 -43.21 93.57 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 166.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -54.27 -44.49 71.92 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -66.51 -55.6 14.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -59.71 -39.87 86.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 67.8 mt -76.37 -15.03 60.05 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 170.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.0 m -66.36 -53.29 37.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 121.323 1.874 . . . . 0.0 112.738 160.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -150.28 113.36 3.29 Favored Pre-proline 0 CA--C 1.575 1.922 0 CA-C-N 119.986 1.266 . . . . 0.0 109.197 168.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.49 -46.26 0.22 Allowed 'Trans proline' 0 CA--C 1.56 1.807 0 CA-C-N 122.597 1.963 . . . . 0.0 116.954 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.75 -28.83 68.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.77 -41.88 86.99 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 162.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.65 -57.76 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.482 1.037 . . . . 0.0 112.655 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -99.87 101.36 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.67 100.13 2.74 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.336 0.589 . . . . 0.0 111.066 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.84 19.39 12.02 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 118.928 2.331 . . . . 0.0 118.928 -167.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.3 t -73.08 136.83 44.98 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.289 2.044 . . . . 0.0 111.937 163.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -76.99 12.81 1.24 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.484 2.402 . . . . 0.0 117.484 169.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -74.12 95.96 2.65 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.665 -1.272 . . . . 0.0 110.972 169.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.92 74.3 4.47 Favored 'General case' 0 CA--C 1.567 1.627 0 CA-C-O 122.802 1.286 . . . . 0.0 113.24 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -142.05 127.36 18.72 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.57 -52.59 43.89 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.11 161.1 10.09 Favored Glycine 0 CA--C 1.545 1.917 0 CA-C-O 122.6 1.111 . . . . 0.0 115.171 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -100.74 99.17 9.57 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 117.851 -1.071 . . . . 0.0 108.646 168.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.79 -34.46 18.28 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 C-N-CA 122.608 2.206 . . . . 0.0 117.432 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.25 129.26 38.44 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.005 0.82 . . . . 0.0 112.85 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 tp -56.79 -45.21 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 169.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.39 -40.35 74.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -59.24 -46.8 87.52 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 120.176 1.353 . . . . 0.0 114.606 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -62.44 -53.75 50.25 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.24 -45.03 95.17 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -61.54 -45.64 93.32 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.9 tp -55.38 -45.0 76.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 166.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 61.3 mt -61.48 -42.62 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 117.46 -1.257 . . . . 0.0 113.219 171.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.3 -44.36 71.89 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 164.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -59.93 -47.85 84.11 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 167.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.04 -25.96 65.63 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -63.59 -42.75 98.24 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 159.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.99 -45.3 96.4 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 117.69 1.836 . . . . 0.0 117.69 165.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -78.33 77.71 4.81 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 118.292 1.046 . . . . 0.0 112.132 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.577 -0.702 . . . . 0.0 109.774 176.701 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.537 ' N ' HD21 ' A' ' 91' ' ' ASN . 13.5 t70 . . . . . 0 CA--C 1.575 1.935 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.66 -29.76 23.83 Favored 'Trans proline' 0 CA--C 1.568 2.221 0 N-CA-C 118.389 2.419 . . . . 0.0 118.389 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.34 -46.19 87.73 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 169.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.35 78.36 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 160.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.89 -34.79 72.72 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 168.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.36 -41.75 94.35 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 163.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -59.99 -44.75 94.31 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 167.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.46 -42.81 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 166.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -54.82 -28.05 46.6 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 169.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.62 -35.44 4.14 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 160.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -60.3 -35.8 76.42 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 163.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -80.12 -18.8 48.89 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -73.47 67.4 1.05 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 123.792 1.758 . . . . 0.0 115.0 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.34 -54.83 0.18 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 125.149 1.379 . . . . 0.0 109.059 167.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 m -83.52 -34.87 25.19 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 171.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -110.5 151.68 27.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 119.549 1.068 . . . . 0.0 112.716 -170.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.67 153.18 41.17 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.363 1.077 . . . . 0.0 110.983 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.9 -25.7 17.19 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.28 57.52 4.02 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 121.49 1.95 . . . . 0.0 113.685 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.65 7.69 12.12 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 121.732 3.453 . . . . 0.0 121.732 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -113.31 146.49 39.32 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.632 1.716 . . . . 0.0 112.925 -169.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.1 138.3 44.6 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.296 1.038 . . . . 0.0 111.102 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.72 -108.08 0.62 Allowed Glycine 0 N--CA 1.489 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 113.206 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.83 -51.35 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 CA-C-N 117.297 0.548 . . . . 0.0 111.088 169.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.13 169.82 17.01 Favored Glycine 0 CA--C 1.562 2.974 0 CA-C-N 118.577 0.626 . . . . 0.0 114.254 161.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.28 175.72 10.58 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 120.878 2.339 . . . . 0.0 115.398 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -68.9 124.68 24.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.647 -1.283 . . . . 0.0 112.615 173.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.85 -5.23 58.7 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.878 2.177 . . . . 0.0 116.878 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -63.65 117.31 6.65 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 119.423 1.011 . . . . 0.0 110.638 157.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.59 40.58 12.44 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 116.633 1.413 . . . . 0.0 116.633 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 p -95.68 -33.28 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.48 107.78 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-N 120.572 1.533 . . . . 0.0 109.57 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.07 -11.76 69.04 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 118.743 2.257 . . . . 0.0 118.743 -162.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -76.06 146.62 39.26 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 121.132 2.466 . . . . 0.0 112.704 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.9 m -53.89 140.94 29.09 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.66 113.37 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.669 -0.644 . . . . 0.0 109.298 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.27 . . 68.05 65.23 0.36 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -157.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.34 -25.52 4.95 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 119.187 2.435 . . . . 0.0 119.187 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.28 98.52 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 120.041 1.921 . . . . 0.0 109.504 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -69.25 107.89 3.43 Favored 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 123.284 0.634 . . . . 0.0 111.21 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.31 -52.79 0.75 Allowed Glycine 0 N--CA 1.49 2.239 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.767 -155.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -79.94 129.15 34.26 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 118.081 0.94 . . . . 0.0 111.749 172.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -76.53 98.76 4.74 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.523 0.729 . . . . 0.0 112.514 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -80.89 158.21 25.38 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.4 t -64.06 151.38 43.19 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 172.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -58.76 -48.03 97.59 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 115.963 -1.97 . . . . 0.0 115.8 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.21 -23.63 66.25 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 CA-C-N 124.724 2.723 . . . . 0.0 117.967 165.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.4 tpp -66.5 -49.14 67.56 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 120.794 1.634 . . . . 0.0 113.806 163.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -57.06 -45.89 82.89 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 168.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.71 -14.47 62.46 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 118.777 2.88 . . . . 0.0 118.777 172.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -65.48 -55.42 17.98 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 120.726 1.603 . . . . 0.0 113.777 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.59 178.32 51.2 Favored Glycine 0 CA--C 1.547 2.042 0 N-CA-C 116.853 1.501 . . . . 0.0 116.853 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.72 -145.4 32.63 Favored Glycine 0 CA--C 1.547 2.062 0 O-C-N 121.961 -0.729 . . . . 0.0 114.627 -174.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -134.74 155.75 50.02 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.891 0.853 . . . . 0.0 111.935 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -76.24 76.65 3.04 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 123.148 1.451 . . . . 0.0 112.791 171.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.4 p -72.78 161.5 79.0 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.565 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -57.11 -36.6 99.24 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 122.293 1.995 . . . . 0.0 116.909 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -61.06 -49.62 76.63 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 165.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.35 -43.51 83.52 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 172.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.09 -44.19 93.09 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 167.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -51.1 -47.71 61.85 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 121.047 1.749 . . . . 0.0 115.598 165.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -61.25 -60.98 2.9 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -61.31 -39.46 90.58 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.0 mt -75.65 -17.08 60.1 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 171.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.1 m -66.23 -51.27 59.23 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 120.838 1.654 . . . . 0.0 113.317 159.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -150.46 113.22 3.24 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 120.045 1.293 . . . . 0.0 109.646 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.92 -48.39 0.23 Allowed 'Trans proline' 0 CA--C 1.561 1.827 0 CA-C-N 122.656 1.984 . . . . 0.0 116.713 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.33 -27.4 64.34 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.69 -40.74 88.63 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 162.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.9 t -71.8 -57.85 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 119.323 0.965 . . . . 0.0 112.514 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.71 100.45 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 172.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -73.25 98.94 2.75 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 121.333 0.587 . . . . 0.0 111.633 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.02 22.82 8.07 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -165.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -74.17 136.65 42.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.733 1.767 . . . . 0.0 111.887 163.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -72.45 3.94 4.32 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.7 ttt -73.15 92.43 1.72 Allowed 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 120.334 1.425 . . . . 0.0 111.789 168.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.78 76.87 9.6 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 122.019 0.914 . . . . 0.0 112.624 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -128.02 129.14 46.22 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.459 0.704 . . . . 0.0 110.102 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.96 106.73 5.79 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 121.874 -0.516 . . . . 0.0 111.233 166.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.42 172.81 9.22 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 119.49 2.556 . . . . 0.0 119.49 -168.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.2 107.86 31.83 Favored Pre-proline 0 CA--C 1.572 1.817 0 CA-C-O 117.682 -1.152 . . . . 0.0 111.219 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.54 -35.84 9.71 Favored 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.691 2.261 . . . . 0.0 117.151 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.71 128.1 34.52 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 123.94 0.896 . . . . 0.0 112.975 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.8 tp -56.36 -45.27 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 170.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.16 -46.04 75.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.12 -45.29 83.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 170.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -64.36 -51.74 61.81 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 171.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.78 92.65 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 171.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.537 HD21 ' N ' ' A' ' 3' ' ' ASP . 8.6 m120 -54.91 -53.55 54.12 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-N 119.813 1.188 . . . . 0.0 114.098 168.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.6 tp -57.42 -47.68 81.12 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 59.4 mt -63.59 -41.97 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.99 1.268 . . . . 0.0 113.083 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.02 68.54 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 163.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.88 -49.48 77.31 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 167.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.7 mt -66.4 -25.76 66.92 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.33 -44.03 97.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 158.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.03 -40.5 97.11 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 118.301 2.081 . . . . 0.0 118.301 167.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -83.2 84.19 7.58 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 118.655 1.228 . . . . 0.0 110.979 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 C--O 1.257 1.456 0 CA-C-O 118.299 -0.858 . . . . 0.0 109.537 176.597 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.559 ' N ' HD21 ' A' ' 91' ' ' ASN . 21.1 t70 . . . . . 0 CA--C 1.574 1.889 0 CA-C-O 118.417 -0.802 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.85 -29.93 34.24 Favored 'Trans proline' 0 CA--C 1.567 2.143 0 N-CA-C 118.549 2.48 . . . . 0.0 118.549 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.27 -42.66 99.15 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.51 93.71 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 161.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.86 -37.06 75.83 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 118.912 2.325 . . . . 0.0 118.912 168.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.85 -37.97 77.69 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 164.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -65.5 -45.09 84.96 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 168.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.0 -40.1 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 166.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -56.5 -18.99 13.29 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.5 -39.23 5.68 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 119.237 2.455 . . . . 0.0 119.237 156.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -65.11 -33.83 76.95 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 166.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -87.32 -35.65 18.3 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -58.38 -27.42 64.22 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 119.896 3.295 . . . . 0.0 119.896 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.87 -31.21 62.59 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 166.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 m -105.87 -39.1 6.13 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 171.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -111.64 137.48 49.45 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.257 1.023 . . . . 0.0 112.901 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.33 147.77 23.45 Favored 'General case' 0 CA--C 1.565 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 113.28 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.9 mt -97.89 17.25 18.61 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 162.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -130.44 60.96 1.61 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.49 -1.381 . . . . 0.0 111.388 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.82 -33.12 0.38 Allowed Glycine 0 CA--C 1.557 2.694 0 N-CA-C 120.483 2.953 . . . . 0.0 120.483 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -76.94 145.56 38.09 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.583 1.153 . . . . 0.0 113.618 -172.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -111.13 115.84 30.09 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -109.44 -113.42 3.58 Favored Glycine 0 N--CA 1.491 2.309 0 O-C-N 121.707 -0.621 . . . . 0.0 113.646 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.12 -48.75 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 122.396 -0.473 . . . . 0.0 111.208 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.67 167.02 17.17 Favored Glycine 0 CA--C 1.561 2.936 0 CA-C-N 118.782 0.719 . . . . 0.0 114.514 159.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -68.98 176.68 5.86 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 CA-C-N 120.889 2.345 . . . . 0.0 115.059 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -68.82 126.75 30.74 Favored 'General case' 0 CA--C 1.57 1.72 0 O-C-N 120.427 -1.42 . . . . 0.0 113.158 175.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.2 -2.57 55.08 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -65.74 108.67 2.18 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.307 1.412 . . . . 0.0 111.711 162.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.02 52.53 4.28 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.82 -37.36 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 171.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.9 t -71.99 109.4 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 120.644 1.566 . . . . 0.0 109.016 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.06 -29.52 12.29 Favored Glycine 0 CA--C 1.551 2.313 0 N-CA-C 117.664 1.825 . . . . 0.0 117.664 -161.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -66.18 144.27 56.75 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 120.933 2.367 . . . . 0.0 113.949 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.4 m -53.38 140.67 26.72 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.12 121.43 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.579 -0.701 . . . . 0.0 110.191 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.267 . . 64.78 44.81 3.56 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -163.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.24 36.68 4.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 117.71 1.844 . . . . 0.0 117.71 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.72 105.27 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.23 96.77 2.31 Favored 'General case' 0 CA--C 1.566 1.596 0 C-N-CA 123.488 0.715 . . . . 0.0 110.697 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 149.06 -52.74 0.53 Allowed Glycine 0 N--CA 1.489 2.173 0 CA-C-O 119.58 -0.567 . . . . 0.0 114.087 -158.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -86.42 134.76 33.67 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.026 0.913 . . . . 0.0 111.955 175.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -76.97 108.62 10.15 Favored 'General case' 0 CA--C 1.568 1.668 0 C-N-CA 123.745 0.818 . . . . 0.0 112.964 171.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -94.49 150.77 19.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.451 -0.781 . . . . 0.0 112.231 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.2 p -69.66 157.21 37.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.622 -1.299 . . . . 0.0 114.323 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -55.79 -48.12 97.28 Favored Pre-proline 0 CA--C 1.576 1.959 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.55 -26.34 34.03 Favored 'Trans proline' 0 CA--C 1.565 2.067 0 CA-C-N 124.969 2.81 . . . . 0.0 117.205 170.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -63.35 -47.74 80.85 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 120.428 1.467 . . . . 0.0 114.189 163.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -59.18 -46.22 88.98 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 168.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.27 -13.79 61.6 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 174.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -61.01 -53.51 56.38 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 120.735 1.607 . . . . 0.0 114.831 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.09 176.59 49.88 Favored Glycine 0 CA--C 1.547 2.043 0 N-CA-C 116.764 1.466 . . . . 0.0 116.764 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.92 -153.17 43.32 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.84 155.9 47.0 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.042 0.925 . . . . 0.0 111.732 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -76.02 75.81 2.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.039 1.4 . . . . 0.0 112.882 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.7 p -73.92 159.93 83.03 Favored Pre-proline 0 CA--C 1.576 1.973 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.098 171.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -57.69 -34.21 97.83 Favored 'Trans proline' 0 CA--C 1.57 2.291 0 N-CA-C 117.777 2.184 . . . . 0.0 117.777 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.67 -47.27 72.99 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 165.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.14 89.58 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 170.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.5 mt -59.49 -45.91 90.32 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 165.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -55.87 -43.91 77.6 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 121.556 1.98 . . . . 0.0 116.307 168.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.69 -57.35 13.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.888 1.222 . . . . 0.0 114.155 169.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -61.82 -40.42 95.2 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.36 -22.82 61.09 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 170.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.2 m -61.85 -52.31 64.66 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.377 1.899 . . . . 0.0 113.445 164.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -151.28 113.17 3.05 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-N 119.91 1.232 . . . . 0.0 108.892 167.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.01 -46.43 0.24 Allowed 'Trans proline' 0 CA--C 1.56 1.81 0 CA-C-N 122.724 2.009 . . . . 0.0 116.798 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.16 -29.12 68.73 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.31 -41.02 90.32 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 162.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.7 t -70.32 -57.94 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 119.45 1.023 . . . . 0.0 112.475 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.37 102.19 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -73.11 99.32 2.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.599 -0.688 . . . . 0.0 111.429 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.84 21.84 9.36 Favored Glycine 0 CA--C 1.553 2.464 0 N-CA-C 118.622 2.209 . . . . 0.0 118.622 -166.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.5 t -74.31 132.27 41.92 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.793 1.797 . . . . 0.0 111.042 159.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -77.03 16.79 0.51 Allowed 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.9 ttt -78.68 101.73 7.67 Favored 'General case' 0 CA--C 1.561 1.377 0 O-C-N 120.847 -1.158 . . . . 0.0 111.059 171.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.12 70.77 3.56 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 122.637 1.208 . . . . 0.0 113.854 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -136.56 128.63 29.58 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 124.517 1.127 . . . . 0.0 108.053 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.38 -53.9 20.81 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.8 158.48 8.53 Favored Glycine 0 CA--C 1.544 1.861 0 N-CA-C 115.928 1.131 . . . . 0.0 115.928 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.5 mt -104.56 96.1 9.71 Favored Pre-proline 0 CA--C 1.575 1.917 0 C-N-CA 124.072 0.949 . . . . 0.0 108.9 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.48 -34.3 20.56 Favored 'Trans proline' 0 CA--C 1.567 2.159 0 C-N-CA 122.652 2.234 . . . . 0.0 117.555 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.88 131.53 38.63 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.835 0.854 . . . . 0.0 111.972 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.9 tt -55.9 -45.11 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 170.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -52.83 -44.29 66.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.7 -44.36 93.71 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 -67.01 -53.91 26.73 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.62 -42.85 93.58 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.559 HD21 ' N ' ' A' ' 3' ' ' ASP . 11.0 m120 -60.05 -48.68 80.71 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 119.816 1.189 . . . . 0.0 113.838 168.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.8 tp -59.34 -44.9 92.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.23 -42.79 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 119.807 1.185 . . . . 0.0 112.88 171.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.67 -43.95 69.27 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 163.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -60.32 -48.77 80.3 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 167.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.8 -25.26 66.37 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.09 -35.36 80.89 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 158.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.79 -46.56 73.79 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 161.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.64 68.72 9.95 Favored 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 118.451 1.125 . . . . 0.0 111.459 172.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.872 -166.227 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 CA--C 1.576 1.955 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.66 -27.82 26.49 Favored 'Trans proline' 0 CA--C 1.568 2.193 0 N-CA-C 118.361 2.408 . . . . 0.0 118.361 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 -48.17 80.24 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 169.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.22 82.06 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 162.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.16 -36.52 68.55 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 119.009 2.364 . . . . 0.0 119.009 167.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -54.86 -47.43 74.2 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 162.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -59.93 -44.1 94.55 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.5 t -58.82 -42.64 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -55.37 -25.97 38.45 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 170.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.04 -34.55 7.71 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 119.75 2.66 . . . . 0.0 119.75 164.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -58.13 -41.85 84.54 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 161.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -75.39 -33.94 61.03 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -47.03 -37.75 9.83 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 119.025 2.972 . . . . 0.0 119.025 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.49 -29.33 58.59 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 170.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.9 m -113.64 -37.13 4.68 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 174.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -112.52 141.43 46.27 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.686 1.194 . . . . 0.0 111.588 -171.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.48 154.73 25.42 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.794 1.283 . . . . 0.0 113.372 171.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.6 mt -94.91 15.35 18.88 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 170.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -119.66 57.21 0.92 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 120.826 1.648 . . . . 0.0 112.776 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.51 -45.83 1.29 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 119.685 2.634 . . . . 0.0 119.685 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -77.57 157.77 30.16 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.32 1.057 . . . . 0.0 113.405 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.96 140.47 34.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.112 -0.992 . . . . 0.0 111.292 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.12 -116.2 3.62 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.802 -0.562 . . . . 0.0 113.045 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -75.88 -49.6 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 122.384 -0.48 . . . . 0.0 110.802 166.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.78 171.41 30.23 Favored Glycine 0 CA--C 1.559 2.832 0 CA-C-N 118.715 0.689 . . . . 0.0 114.796 158.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.41 175.41 7.85 Favored 'Trans proline' 0 CA--C 1.564 2.018 0 CA-C-N 120.845 2.322 . . . . 0.0 115.227 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -65.04 129.55 40.12 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 120.47 -1.394 . . . . 0.0 113.178 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.7 mt -96.51 -0.46 48.88 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -66.11 112.15 3.75 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.468 1.485 . . . . 0.0 111.233 158.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.98 51.45 5.38 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 115.733 1.053 . . . . 0.0 115.733 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -100.64 -35.99 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 170.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 t -72.24 109.87 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 120.503 1.502 . . . . 0.0 109.158 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.32 -17.63 58.25 Favored Glycine 0 CA--C 1.552 2.369 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -161.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -73.57 142.81 46.63 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 121.35 2.575 . . . . 0.0 113.311 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.7 m -59.94 138.65 57.78 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.2 123.92 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.787 -0.571 . . . . 0.0 110.221 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.8 45.51 7.67 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -164.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.43 -4.44 43.55 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 119.636 2.615 . . . . 0.0 119.636 -170.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.9 t -84.75 103.16 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 120.255 2.027 . . . . 0.0 108.994 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.0 94.31 0.63 Allowed 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.8 -46.08 0.82 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 114.934 0.734 . . . . 0.0 114.934 -161.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -76.93 131.8 38.72 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 118.405 1.103 . . . . 0.0 112.274 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -81.39 84.23 6.72 Favored 'General case' 0 CA--C 1.568 1.671 0 O-C-N 121.528 -0.732 . . . . 0.0 111.978 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -71.42 146.15 48.87 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.6 p -67.72 156.8 36.11 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -55.61 -43.94 99.41 Favored Pre-proline 0 CA--C 1.574 1.901 0 CA-C-O 115.162 -2.351 . . . . 0.0 117.316 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.12 -27.63 29.27 Favored 'Trans proline' 0 CA--C 1.565 2.044 0 CA-C-N 124.866 2.774 . . . . 0.0 116.977 168.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.4 tpp -63.33 -47.75 80.89 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.427 1.467 . . . . 0.0 114.019 163.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -57.87 -46.11 85.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 167.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.95 -14.45 61.92 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 118.881 2.919 . . . . 0.0 118.881 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -61.67 -53.7 52.67 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.722 1.601 . . . . 0.0 114.512 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.04 176.16 47.96 Favored Glycine 0 CA--C 1.547 2.059 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.1 -149.83 38.17 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 114.893 0.717 . . . . 0.0 114.893 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -131.91 156.07 46.77 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.818 0.818 . . . . 0.0 111.847 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -75.94 74.25 2.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.237 1.494 . . . . 0.0 112.988 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.0 p -73.75 161.48 78.55 Favored Pre-proline 0 CA--C 1.575 1.937 0 C-N-CA 124.985 1.314 . . . . 0.0 112.371 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -56.87 -35.28 98.28 Favored 'Trans proline' 0 CA--C 1.569 2.247 0 N-CA-C 117.575 2.106 . . . . 0.0 117.575 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -64.82 -49.51 70.33 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 164.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.64 90.48 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 172.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.65 -45.17 95.11 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 165.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -55.88 -44.42 78.11 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.635 2.016 . . . . 0.0 116.238 168.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -61.15 -57.74 11.25 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 120.047 1.294 . . . . 0.0 113.944 169.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -60.27 -41.36 93.11 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.83 -18.9 60.38 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -63.44 -51.4 65.86 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.071 1.76 . . . . 0.0 113.409 161.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -151.95 112.0 2.9 Favored Pre-proline 0 CA--C 1.575 1.94 0 CA-C-N 120.096 1.316 . . . . 0.0 108.993 167.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.51 -47.02 0.19 Allowed 'Trans proline' 0 CA--C 1.559 1.736 0 CA-C-N 122.71 2.004 . . . . 0.0 116.924 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.25 -27.6 67.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.96 -42.84 84.51 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 162.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.11 -57.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 119.546 1.066 . . . . 0.0 112.709 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.26 101.46 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -73.29 94.77 2.05 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-O 121.462 0.649 . . . . 0.0 111.561 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.93 25.93 5.98 Favored Glycine 0 CA--C 1.554 2.499 0 N-CA-C 118.379 2.111 . . . . 0.0 118.379 -166.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -76.08 137.61 40.27 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 119.749 1.774 . . . . 0.0 111.355 160.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -74.32 7.62 2.72 Favored 'General case' 0 CA--C 1.579 2.067 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 167.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -74.6 97.55 3.19 Favored 'General case' 0 CA--C 1.565 1.533 0 O-C-N 120.677 -1.264 . . . . 0.0 111.53 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.22 71.83 5.76 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 122.61 1.195 . . . . 0.0 113.472 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -129.93 133.41 46.82 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.465 1.106 . . . . 0.0 108.479 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.27 -56.09 9.87 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.48 155.2 6.66 Favored Glycine 0 CA--C 1.545 1.933 0 N-CA-C 116.159 1.224 . . . . 0.0 116.159 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.5 mt -105.72 97.88 16.1 Favored Pre-proline 0 CA--C 1.575 1.918 0 C-N-CA 123.962 0.905 . . . . 0.0 109.323 172.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.17 -33.21 15.44 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 122.632 2.221 . . . . 0.0 117.717 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.62 131.37 39.92 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 175.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.8 tt -56.63 -43.88 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -52.71 -47.4 67.34 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -57.19 -47.13 82.01 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -65.01 -51.55 61.03 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.32 83.79 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -56.47 -50.74 70.87 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.5 tp -57.34 -46.4 83.32 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 169.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.8 mt -64.4 -39.82 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-N 119.933 1.242 . . . . 0.0 113.202 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.22 -45.11 75.92 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 163.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -57.37 -50.51 72.76 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.3 mt -67.71 -26.78 66.34 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -62.39 -40.78 97.6 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 158.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.75 88.86 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 163.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -84.28 78.33 9.81 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 123.684 0.794 . . . . 0.0 111.997 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 123.581 0.752 . . . . 0.0 109.508 175.001 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 CA--C 1.58 2.124 0 CA-C-O 117.927 -1.035 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.12 -26.4 18.12 Favored 'Trans proline' 0 CA--C 1.566 2.091 0 N-CA-C 118.501 2.462 . . . . 0.0 118.501 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.08 -47.78 83.15 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 168.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.92 73.01 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 160.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.98 -35.69 70.03 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 168.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.49 -41.85 95.09 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 164.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.4 -44.47 95.67 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 165.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -58.7 -41.06 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -54.85 -19.48 6.61 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.77 -37.59 4.03 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 119.853 2.701 . . . . 0.0 119.853 157.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -65.75 -39.68 91.34 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 164.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.17 -33.9 38.01 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.08 -33.78 67.62 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 119.904 3.298 . . . . 0.0 119.904 -171.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.95 -33.37 66.96 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 171.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.6 m -99.18 -40.88 7.75 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 170.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -109.18 141.62 41.16 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.168 0.987 . . . . 0.0 113.035 -169.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -105.78 153.1 22.36 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.9 0.857 . . . . 0.0 112.77 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.8 mt -106.23 7.62 31.56 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 172.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -115.54 57.61 0.74 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.629 1.559 . . . . 0.0 112.282 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.77 1.93 10.41 Favored Glycine 0 CA--C 1.557 2.712 0 N-CA-C 121.487 3.355 . . . . 0.0 121.487 173.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -124.98 153.2 43.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 119.471 1.636 . . . . 0.0 112.362 -168.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -83.7 143.96 29.7 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.949 -1.095 . . . . 0.0 113.275 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.13 -119.01 2.62 Favored Glycine 0 N--CA 1.491 2.324 0 O-C-N 121.605 -0.685 . . . . 0.0 112.232 170.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.69 -48.08 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 122.178 -0.601 . . . . 0.0 110.938 165.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.36 172.18 30.14 Favored Glycine 0 CA--C 1.561 2.931 0 CA-C-N 118.971 0.805 . . . . 0.0 114.753 157.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -70.51 174.28 10.4 Favored 'Trans proline' 0 CA--C 1.563 1.942 0 CA-C-N 120.853 2.327 . . . . 0.0 115.506 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -66.54 122.59 17.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.499 -1.375 . . . . 0.0 113.36 176.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.22 -5.94 59.3 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -64.81 112.19 3.14 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 120.825 1.648 . . . . 0.0 110.766 159.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.56 36.1 24.05 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 116.981 1.552 . . . . 0.0 116.981 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -80.17 -34.54 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 118.925 1.362 . . . . 0.0 114.252 162.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.8 t -69.45 108.87 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 119.573 1.079 . . . . 0.0 109.966 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.59 -27.38 19.91 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 117.933 1.933 . . . . 0.0 117.933 -164.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -71.27 147.47 48.12 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.482 2.141 . . . . 0.0 113.968 -174.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.3 m -53.26 141.86 22.66 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -68.28 119.83 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.653 . . . . 0.0 109.767 170.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 64.37 55.92 1.35 Allowed 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -159.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.57 -20.1 14.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 119.238 2.455 . . . . 0.0 119.238 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.3 t -83.58 94.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.849 1.825 . . . . 0.0 109.236 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -69.33 113.1 6.35 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 123.315 0.646 . . . . 0.0 111.432 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 131.17 -49.79 0.91 Allowed Glycine 0 N--CA 1.491 2.323 0 CA-C-O 119.731 -0.483 . . . . 0.0 114.069 -155.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -77.48 129.26 35.48 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 118.059 0.93 . . . . 0.0 111.888 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -81.13 89.94 6.02 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.699 -0.625 . . . . 0.0 111.238 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -71.64 154.26 41.52 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.0 p -65.23 153.5 40.84 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.69 -1.256 . . . . 0.0 114.071 171.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.96 -47.45 99.06 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.47 -24.23 56.96 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 CA-C-N 125.115 2.863 . . . . 0.0 117.691 168.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 52.2 tpp -65.57 -48.42 72.44 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 120.65 1.568 . . . . 0.0 113.962 163.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -57.1 -46.29 82.69 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 167.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.67 -13.81 61.44 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -63.95 -54.41 34.95 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 120.805 1.639 . . . . 0.0 114.34 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 175.9 49.85 Favored Glycine 0 CA--C 1.546 2.005 0 N-CA-C 116.698 1.439 . . . . 0.0 116.698 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.78 -150.49 39.67 Favored Glycine 0 CA--C 1.547 2.064 0 O-C-N 121.914 -0.756 . . . . 0.0 114.943 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -133.02 154.11 50.84 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.815 0.817 . . . . 0.0 111.5 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -76.54 77.45 3.23 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.323 1.535 . . . . 0.0 112.552 171.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.0 p -71.75 160.6 82.16 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.208 169.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -58.01 -35.0 99.06 Favored 'Trans proline' 0 CA--C 1.57 2.283 0 N-CA-C 117.118 1.93 . . . . 0.0 117.118 174.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.73 -50.26 74.2 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 164.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.26 87.0 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.18 -43.6 97.78 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -50.91 -47.54 60.81 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 121.046 1.748 . . . . 0.0 115.68 165.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.53 -61.39 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -61.76 -40.11 94.0 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 mt -74.05 -16.87 61.03 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 171.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.4 m -63.9 -54.67 31.12 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 121.241 1.837 . . . . 0.0 112.927 161.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -150.44 112.59 3.23 Favored Pre-proline 0 CA--C 1.576 1.944 0 CA-C-N 119.781 1.173 . . . . 0.0 108.889 168.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.02 -45.95 0.26 Allowed 'Trans proline' 0 CA--C 1.56 1.786 0 CA-C-N 122.622 1.972 . . . . 0.0 116.904 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.18 -25.4 66.13 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.863 2.171 . . . . 0.0 116.863 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.59 78.63 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 161.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.5 t -71.48 -58.62 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-N 119.558 1.072 . . . . 0.0 112.723 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.5 103.62 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 171.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.11 94.15 3.43 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.582 0.706 . . . . 0.0 111.764 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.37 27.39 5.3 Favored Glycine 0 CA--C 1.554 2.489 0 N-CA-C 118.036 1.975 . . . . 0.0 118.036 -165.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.6 t -73.89 132.34 42.4 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.444 1.622 . . . . 0.0 111.187 160.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -73.85 10.41 1.16 Allowed 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 166.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -71.94 97.43 1.85 Allowed 'General case' 0 CA--C 1.564 1.501 0 O-C-N 120.933 -1.104 . . . . 0.0 111.261 166.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 75.48 4.25 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.72 1.248 . . . . 0.0 112.969 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -141.3 128.87 21.41 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.84 -52.7 33.76 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.13 157.06 7.87 Favored Glycine 0 N--CA 1.484 1.879 0 CA-C-O 122.275 0.93 . . . . 0.0 115.231 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.63 96.88 8.08 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.121 -0.942 . . . . 0.0 108.521 168.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.88 -33.63 15.76 Favored 'Trans proline' 0 CA--C 1.568 2.183 0 C-N-CA 122.636 2.224 . . . . 0.0 117.431 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.7 133.33 42.07 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.817 0.847 . . . . 0.0 112.993 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.0 tp -58.27 -42.75 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.12 -53.01 61.37 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -50.98 -41.73 59.72 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -66.91 -54.62 20.29 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.6 -45.6 91.43 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -53.13 -52.83 57.46 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 168.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.1 tp -60.61 -45.8 92.64 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 172.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 62.9 mt -61.55 -41.43 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 120.194 1.361 . . . . 0.0 113.034 172.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.68 -43.94 72.9 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 163.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -60.55 -46.61 89.54 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.58 -24.0 63.62 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 172.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -61.1 -45.48 94.52 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 157.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.9 88.23 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 117.846 1.898 . . . . 0.0 117.846 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -75.56 97.31 3.7 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 118.338 1.069 . . . . 0.0 111.575 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.065 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.628 ' N ' HD21 ' A' ' 91' ' ' ASN . 14.9 t70 . . . . . 0 CA--C 1.578 2.033 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.56 -28.46 26.19 Favored 'Trans proline' 0 CA--C 1.569 2.26 0 N-CA-C 118.522 2.47 . . . . 0.0 118.522 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.73 -42.29 97.92 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 168.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.34 77.87 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 159.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.73 96.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 118.955 2.342 . . . . 0.0 118.955 171.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.73 -38.67 91.38 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.82 97.0 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 164.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.09 -40.42 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 167.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -54.97 -19.81 7.62 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 166.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.72 -36.98 4.96 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 119.718 2.647 . . . . 0.0 119.718 159.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.67 -37.49 86.66 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 164.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -80.28 -34.56 36.84 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -57.52 -32.74 67.35 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -170.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.78 -35.89 71.41 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.2 m -93.69 -42.86 8.93 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 169.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -108.27 142.86 37.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.074 0.95 . . . . 0.0 113.092 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -110.63 150.21 29.31 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.548 1.166 . . . . 0.0 113.013 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -113.7 33.42 5.19 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.239 -0.913 . . . . 0.0 113.263 170.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -137.15 60.68 1.64 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.032 -1.667 . . . . 0.0 111.061 169.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.49 -47.73 1.78 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 119.522 2.569 . . . . 0.0 119.522 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -75.68 151.51 37.7 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.659 1.183 . . . . 0.0 113.109 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -101.9 131.33 48.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.749 . . . . 0.0 110.451 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.64 -114.33 3.7 Favored Glycine 0 N--CA 1.491 2.361 0 O-C-N 121.676 -0.64 . . . . 0.0 113.415 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.08 -47.79 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 122.413 -0.463 . . . . 0.0 110.77 165.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.9 168.72 24.95 Favored Glycine 0 CA--C 1.56 2.894 0 CA-C-N 118.985 0.812 . . . . 0.0 114.966 159.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -70.03 166.36 28.2 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 CA-C-N 120.699 2.249 . . . . 0.0 114.902 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -62.46 123.14 17.51 Favored 'General case' 0 CA--C 1.57 1.735 0 O-C-N 120.776 -1.203 . . . . 0.0 113.226 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.65 6.22 35.78 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -63.23 117.22 6.26 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.971 1.26 . . . . 0.0 110.929 159.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.96 44.35 37.16 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 116.244 1.257 . . . . 0.0 116.244 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 p -87.9 -30.59 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 170.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.79 107.0 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 119.945 1.248 . . . . 0.0 109.653 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.55 -10.28 71.01 Favored Glycine 0 CA--C 1.553 2.438 0 N-CA-C 118.925 2.33 . . . . 0.0 118.925 -163.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -77.0 144.0 38.99 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 121.078 2.439 . . . . 0.0 113.012 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.5 m -52.21 141.03 19.82 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -70.01 112.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.64 -0.663 . . . . 0.0 109.218 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.281 . . 70.0 66.63 0.23 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -154.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.32 -23.22 6.74 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 119.174 2.429 . . . . 0.0 119.174 -172.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.9 t -83.22 98.83 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 119.953 1.877 . . . . 0.0 109.369 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -69.59 104.59 2.41 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.417 0.627 . . . . 0.0 110.988 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.55 -55.12 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 CA-C-O 119.647 -0.53 . . . . 0.0 113.534 -155.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -78.92 129.07 34.1 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 118.037 0.919 . . . . 0.0 111.62 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -78.34 93.5 4.69 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.616 0.767 . . . . 0.0 112.724 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -76.17 161.11 29.09 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.9 t -65.44 152.15 44.62 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.46 -49.46 92.26 Favored Pre-proline 0 CA--C 1.576 1.98 0 CA-C-O 115.991 -1.957 . . . . 0.0 115.513 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.25 -21.75 67.06 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 CA-C-N 124.769 2.739 . . . . 0.0 118.149 166.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.8 tpp -66.94 -51.39 55.77 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.436 1.471 . . . . 0.0 113.344 163.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -57.87 -45.48 86.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 169.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.49 0.55 16.8 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 173.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -63.81 -49.81 71.42 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.69 81.19 1.06 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.27 -160.33 32.5 Favored Glycine 0 N--CA 1.485 1.908 0 CA-C-O 122.361 0.978 . . . . 0.0 115.161 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -125.21 155.1 40.57 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.017 0.913 . . . . 0.0 111.301 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -76.62 74.32 3.32 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 123.122 1.439 . . . . 0.0 113.272 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.0 p -71.44 161.2 79.75 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.67 171.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -58.5 -26.73 79.55 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 N-CA-C 117.528 2.088 . . . . 0.0 117.528 171.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.88 -56.99 10.02 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 161.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.76 94.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.28 -50.43 73.63 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 169.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.68 -35.58 78.38 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.21 -50.96 58.9 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -59.73 -40.57 88.47 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 171.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 70.7 mt -74.77 -16.35 60.72 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 169.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -67.77 -56.77 7.97 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 120.991 1.723 . . . . 0.0 112.293 160.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -145.12 109.55 4.64 Favored Pre-proline 0 CA--C 1.574 1.904 0 CA-C-N 119.503 1.047 . . . . 0.0 108.918 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.63 -41.28 0.82 Allowed 'Trans proline' 0 CA--C 1.561 1.859 0 C-N-CA 122.162 1.908 . . . . 0.0 116.874 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -58.3 -38.73 77.64 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 170.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.26 -42.95 87.76 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 169.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.62 -51.66 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 119.096 0.862 . . . . 0.0 113.31 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.8 101.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -75.07 94.64 2.92 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.322 0.582 . . . . 0.0 111.585 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.66 25.3 6.03 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 118.264 2.066 . . . . 0.0 118.264 -165.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 t -71.68 136.37 47.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.56 1.68 . . . . 0.0 112.046 163.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -73.94 6.96 2.91 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -72.61 100.61 2.82 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 120.72 -1.237 . . . . 0.0 111.507 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.61 75.54 7.49 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.588 1.185 . . . . 0.0 112.815 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -137.98 132.34 32.15 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.207 1.003 . . . . 0.0 108.539 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.65 -55.83 7.84 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.79 153.01 6.24 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 122.222 0.901 . . . . 0.0 115.199 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.8 mt -97.71 104.31 20.65 Favored Pre-proline 0 CA--C 1.574 1.868 0 CA-C-O 117.772 -1.108 . . . . 0.0 109.135 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.44 -36.22 9.36 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.684 2.256 . . . . 0.0 117.769 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.66 134.0 37.17 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 119.227 0.921 . . . . 0.0 112.813 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -58.01 -41.63 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 170.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.98 -47.36 74.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 172.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -56.39 -42.88 78.63 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -64.61 -53.94 39.77 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.89 -43.3 90.94 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.373 2.361 . . . . 0.0 117.373 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.628 HD21 ' N ' ' A' ' 3' ' ' ASP . 11.2 m120 -56.1 -52.17 65.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 169.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.03 -46.13 82.6 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 169.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.7 mt -60.35 -41.63 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 120.096 1.316 . . . . 0.0 113.333 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.69 75.14 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 165.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.39 -44.61 95.51 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 166.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.4 mt -67.21 -26.95 66.86 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 171.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -63.76 -41.36 98.0 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 159.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.61 -48.11 87.84 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 117.421 1.729 . . . . 0.0 117.421 163.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -78.4 84.91 4.53 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 118.015 0.907 . . . . 0.0 112.189 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 . . . . . 0 C--O 1.256 1.414 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.041 174.626 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t70 . . . . . 0 CA--C 1.577 1.988 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.01 -31.92 22.8 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 N-CA-C 117.947 2.249 . . . . 0.0 117.947 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.24 78.76 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 168.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.3 -39.24 74.94 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 159.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.51 -33.86 59.39 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 120.222 2.849 . . . . 0.0 120.222 174.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.25 -36.4 79.88 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 168.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -62.8 -45.37 92.96 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 165.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 t -56.87 -42.6 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 168.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.12 -25.15 44.82 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.27 -35.28 9.36 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 119.79 2.676 . . . . 0.0 119.79 165.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -58.63 -38.17 77.48 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 162.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -77.34 -34.72 55.14 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -46.17 -40.41 11.15 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 119.144 3.016 . . . . 0.0 119.144 -177.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.17 -32.57 64.45 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.7 m -104.92 -38.06 6.76 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 172.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -116.39 142.99 46.13 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.457 1.103 . . . . 0.0 112.421 -167.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -115.84 147.98 40.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.802 0.81 . . . . 0.0 112.387 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.8 mt -102.21 15.11 30.11 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -128.88 65.29 1.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 119.221 -2.175 . . . . 0.0 111.353 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.3 -37.7 0.82 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 119.939 2.736 . . . . 0.0 119.939 170.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -73.9 149.58 41.4 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.532 1.133 . . . . 0.0 113.43 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.71 132.75 49.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.415 -0.803 . . . . 0.0 110.235 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.61 -111.92 3.65 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 121.891 -0.506 . . . . 0.0 113.02 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -78.33 -48.16 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 122.433 -0.451 . . . . 0.0 110.769 164.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.75 170.53 25.38 Favored Glycine 0 CA--C 1.559 2.843 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 161.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -71.53 175.1 9.95 Favored 'Trans proline' 0 CA--C 1.565 2.038 0 CA-C-N 120.617 2.208 . . . . 0.0 115.784 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -66.81 124.95 24.37 Favored 'General case' 0 CA--C 1.568 1.656 0 O-C-N 120.485 -1.384 . . . . 0.0 113.353 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.42 -0.78 57.33 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -66.26 108.21 2.23 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 120.095 1.316 . . . . 0.0 111.483 161.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.91 46.15 5.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -171.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.11 -36.14 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 t -74.58 109.02 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 120.544 1.52 . . . . 0.0 109.202 -172.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.16 -28.58 15.29 Favored Glycine 0 CA--C 1.551 2.295 0 N-CA-C 117.653 1.821 . . . . 0.0 117.653 -160.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -68.09 146.41 53.5 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 120.844 2.322 . . . . 0.0 113.816 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.4 m -53.14 140.59 25.45 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.09 120.78 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.757 -0.59 . . . . 0.0 109.946 171.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . 63.94 51.96 2.19 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -162.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.08 -27.8 9.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 118.693 2.237 . . . . 0.0 118.693 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.2 t -74.95 95.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.329 1.565 . . . . 0.0 109.678 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.96 106.92 8.94 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.468 0.707 . . . . 0.0 110.223 -176.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.2 -50.75 0.82 Allowed Glycine 0 N--CA 1.489 2.232 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.678 -152.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -76.97 130.6 37.71 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 118.224 1.012 . . . . 0.0 111.881 172.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -79.5 80.58 5.86 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -67.73 150.91 48.07 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.5 p -68.97 153.51 43.67 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -53.71 -48.39 93.47 Favored Pre-proline 0 CA--C 1.575 1.912 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.8 -23.56 47.97 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 CA-C-N 124.198 2.535 . . . . 0.0 117.708 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ttm -66.92 -47.11 72.74 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 121.282 1.856 . . . . 0.0 113.849 162.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -57.58 -45.49 85.16 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 168.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.08 -16.65 62.03 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -61.72 -54.53 41.31 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 120.808 1.64 . . . . 0.0 114.404 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 177.39 49.96 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.14 -149.5 39.29 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 114.931 0.733 . . . . 0.0 114.931 -175.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -132.39 154.01 50.22 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.04 0.924 . . . . 0.0 111.562 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -75.92 76.42 2.82 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 123.023 1.392 . . . . 0.0 112.913 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.1 p -73.13 159.32 85.41 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.166 171.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.11 -34.84 98.48 Favored 'Trans proline' 0 CA--C 1.571 2.369 0 N-CA-C 117.585 2.11 . . . . 0.0 117.585 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.6 -50.11 70.69 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 165.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.22 92.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 172.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.7 mt -57.34 -49.87 74.77 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.5 pp0? -64.26 -33.85 76.77 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.71 -55.25 28.51 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 163.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -59.54 -41.65 90.54 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 73.9 mt -73.52 -17.51 61.2 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 170.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.9 m -65.83 -63.32 1.11 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 120.919 1.691 . . . . 0.0 111.662 158.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -134.63 100.42 12.35 Favored Pre-proline 0 CA--C 1.571 1.774 0 CA-C-O 118.397 -0.811 . . . . 0.0 109.834 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.1 -46.58 0.23 Allowed 'Trans proline' 0 CA--C 1.563 1.929 0 CA-C-N 122.504 1.93 . . . . 0.0 115.708 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -61.49 -34.51 75.6 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 169.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.97 -43.26 65.44 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 170.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.24 -54.83 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 119.261 0.937 . . . . 0.0 112.795 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.11 100.59 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -74.94 98.6 3.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.684 -0.635 . . . . 0.0 111.362 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.59 25.24 7.39 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -165.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 t -69.33 135.11 49.93 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.409 1.604 . . . . 0.0 111.307 159.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -72.88 7.92 1.78 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 166.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -77.34 104.64 7.97 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 120.81 -1.181 . . . . 0.0 111.955 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.32 69.85 6.85 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 122.316 1.055 . . . . 0.0 113.492 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -125.81 135.69 52.28 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.222 1.009 . . . . 0.0 108.951 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.33 -57.68 4.01 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.95 150.49 5.49 Favored Glycine 0 N--CA 1.485 1.902 0 CA-C-N 119.069 0.85 . . . . 0.0 115.138 -175.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -101.99 97.13 7.71 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.135 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.26 -32.72 20.07 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 C-N-CA 122.652 2.235 . . . . 0.0 117.812 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -76.94 127.58 32.96 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 119.039 0.836 . . . . 0.0 112.505 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -58.8 -41.0 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 172.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.05 -46.47 71.94 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 170.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.89 -45.92 82.24 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -62.82 -52.53 62.81 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 171.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.08 86.29 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -57.29 -50.4 73.05 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 170.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.5 -48.25 74.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.255 57.7 mt -63.92 -40.92 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 119.765 1.166 . . . . 0.0 113.231 174.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.25 74.12 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 163.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -59.32 -47.82 83.94 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 166.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.3 -27.87 69.33 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.26 -34.42 77.97 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 162.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.91 -47.07 68.16 Favored Glycine 0 CA--C 1.553 2.446 0 N-CA-C 116.989 1.555 . . . . 0.0 116.989 160.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 70.12 9.55 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 118.419 1.11 . . . . 0.0 111.534 172.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.254 1.32 0 O-C-N 121.339 -0.851 . . . . 0.0 111.181 -164.34 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.576 1.961 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.68 -29.4 19.54 Favored 'Trans proline' 0 CA--C 1.567 2.146 0 N-CA-C 118.333 2.397 . . . . 0.0 118.333 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.52 80.72 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 168.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.58 72.97 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 162.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.81 -33.91 84.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 118.126 2.01 . . . . 0.0 118.126 168.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -38.75 86.69 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 115.888 1.811 . . . . 0.0 115.888 167.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.254 21.7 pttm -67.01 -43.52 82.64 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.872 1.669 . . . . 0.0 115.083 166.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.8 t -60.43 -34.58 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 114.384 1.254 . . . . 0.0 114.384 171.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -54.82 -20.23 8.18 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 168.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.99 -37.28 5.44 Favored Glycine 0 CA--C 1.559 2.808 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 157.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.65 -31.44 72.12 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 166.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 m -90.73 -33.95 15.56 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -32.27 62.53 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 120.416 3.487 . . . . 0.0 120.416 -171.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.78 -34.84 71.91 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 170.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.7 m -95.55 -43.23 8.05 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -110.14 126.39 54.01 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.244 1.018 . . . . 0.0 111.752 -168.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -94.81 147.24 23.56 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.807 0.813 . . . . 0.0 111.427 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.5 -28.76 28.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -81.29 61.74 4.92 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.33 1.877 . . . . 0.0 113.805 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.75 10.11 16.88 Favored Glycine 0 CA--C 1.556 2.605 0 N-CA-C 121.94 3.536 . . . . 0.0 121.94 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -128.35 156.77 42.57 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 119.278 1.539 . . . . 0.0 112.557 -170.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.42 148.23 30.64 Favored 'General case' 0 CA--C 1.572 1.826 0 O-C-N 120.885 -1.135 . . . . 0.0 112.559 166.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.21 -100.75 2.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 157.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -79.73 -51.88 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.617 160.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.32 156.0 19.91 Favored Glycine 0 CA--C 1.559 2.84 0 N-CA-C 115.068 0.787 . . . . 0.0 115.068 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.93 151.23 27.45 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 CA-C-N 120.985 2.393 . . . . 0.0 113.601 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -45.51 126.74 6.94 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -167.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.74 -6.58 59.36 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -64.22 117.71 7.55 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 119.609 1.095 . . . . 0.0 110.651 158.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.05 44.61 11.51 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.65 -31.04 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -80.84 100.31 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 120.588 1.54 . . . . 0.0 109.162 -172.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.47 -20.7 29.67 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 117.872 1.909 . . . . 0.0 117.872 -158.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -73.05 146.45 45.85 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 120.743 2.272 . . . . 0.0 113.337 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.8 m -54.27 141.01 31.21 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.3 116.44 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.681 -0.637 . . . . 0.0 109.484 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.286 . . 68.14 61.6 0.4 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -159.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.45 -26.03 6.38 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 119.221 2.449 . . . . 0.0 119.221 -170.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.77 94.59 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 120.078 1.939 . . . . 0.0 109.625 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.43 126.73 30.56 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 123.269 0.628 . . . . 0.0 112.167 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.67 -54.7 0.63 Allowed Glycine 0 N--CA 1.491 2.341 0 CA-C-O 119.925 -0.375 . . . . 0.0 113.567 -157.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -79.23 116.58 19.58 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 117.771 0.786 . . . . 0.0 110.844 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -78.78 98.87 6.45 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.814 0.816 . . . . 0.0 110.817 172.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -65.21 162.71 16.65 Favored 'General case' 0 CA--C 1.574 1.874 0 C-N-CA 123.865 0.866 . . . . 0.0 112.969 172.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 p -68.59 158.66 33.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.243 -1.536 . . . . 0.0 114.216 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -54.25 -49.99 87.24 Favored Pre-proline 0 CA--C 1.578 2.027 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.68 -25.16 46.98 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 CA-C-N 124.241 2.55 . . . . 0.0 117.521 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -65.57 -48.8 71.13 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 120.419 1.463 . . . . 0.0 114.056 163.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -58.84 -43.79 90.78 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 168.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 -15.06 61.88 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 118.909 2.929 . . . . 0.0 118.909 172.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -62.7 -55.42 26.97 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 120.958 1.708 . . . . 0.0 114.364 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.35 178.15 50.82 Favored Glycine 0 CA--C 1.548 2.128 0 N-CA-C 116.879 1.511 . . . . 0.0 116.879 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.46 -148.7 35.94 Favored Glycine 0 N--CA 1.488 2.156 0 O-C-N 121.95 -0.736 . . . . 0.0 114.796 -174.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -133.86 153.11 51.97 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.863 0.839 . . . . 0.0 111.925 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -76.35 78.73 3.1 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.73 1.253 . . . . 0.0 112.782 171.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -73.99 157.45 87.02 Favored Pre-proline 0 CA--C 1.575 1.908 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.438 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -58.96 -29.17 89.8 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 N-CA-C 117.495 2.075 . . . . 0.0 117.495 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.75 -56.53 13.06 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 162.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.99 -38.93 84.03 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.2 mt -56.4 -40.23 74.31 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 167.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -56.81 -41.73 78.27 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 170.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.89 -55.73 20.52 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.239 1.381 . . . . 0.0 113.357 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -59.57 -41.63 90.64 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -71.74 -24.21 61.74 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.1 m -62.68 -52.29 63.88 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.265 1.848 . . . . 0.0 113.364 164.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -150.41 114.5 3.3 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-N 119.82 1.191 . . . . 0.0 108.94 169.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.53 -44.15 0.25 Allowed 'Trans proline' 0 CA--C 1.563 1.927 0 CA-C-N 122.693 1.998 . . . . 0.0 116.22 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.19 -43.01 73.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 117.033 2.234 . . . . 0.0 117.033 169.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.26 92.78 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 170.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.12 -57.51 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 118.876 0.762 . . . . 0.0 112.43 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.72 102.96 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 172.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -74.92 90.28 2.41 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.762 0.791 . . . . 0.0 111.627 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.03 28.76 3.75 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 118.01 1.964 . . . . 0.0 118.01 -166.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 t -76.11 134.95 39.86 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.677 1.738 . . . . 0.0 111.42 163.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -76.75 21.58 0.2 Allowed 'General case' 0 CA--C 1.582 2.176 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 170.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.8 ttt -87.92 102.53 14.8 Favored 'General case' 0 CA--C 1.56 1.358 0 O-C-N 120.776 -1.202 . . . . 0.0 110.813 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.1 69.79 2.7 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -135.98 131.83 35.56 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.434 1.093 . . . . 0.0 108.613 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.07 -55.37 8.39 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.03 155.74 7.52 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 115.769 1.068 . . . . 0.0 115.769 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.8 mt -100.85 98.16 7.97 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 118.167 -0.921 . . . . 0.0 109.076 168.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.02 -34.76 16.28 Favored 'Trans proline' 0 CA--C 1.568 2.182 0 C-N-CA 122.674 2.249 . . . . 0.0 117.272 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.06 129.87 40.08 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.66 0.784 . . . . 0.0 112.982 175.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.1 tt -57.54 -43.08 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 166.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.54 -48.69 68.85 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -54.82 -45.88 74.5 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.7 mtm-85 -66.49 -54.13 27.41 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.27 -44.14 88.27 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -59.4 -52.73 64.37 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 113.728 1.011 . . . . 0.0 113.728 169.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.18 -46.49 85.69 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -61.12 -42.38 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 117.552 -1.213 . . . . 0.0 112.945 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.76 -44.32 73.52 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 164.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -58.42 -50.67 72.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 167.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.09 -24.51 65.95 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 174.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.85 -44.82 96.05 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 158.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.69 -41.8 93.63 Favored Glycine 0 CA--C 1.553 2.427 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 168.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.99 83.27 6.74 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 118.725 1.262 . . . . 0.0 111.0 172.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.414 -0.803 . . . . 0.0 109.753 175.872 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.583 ' N ' HD21 ' A' ' 91' ' ' ASN . 14.9 t70 . . . . . 0 CA--C 1.575 1.938 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.45 -27.8 27.5 Favored 'Trans proline' 0 CA--C 1.569 2.26 0 N-CA-C 118.458 2.445 . . . . 0.0 118.458 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.7 98.73 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 167.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.48 -32.79 74.37 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 159.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.75 -38.43 95.18 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 118.848 2.299 . . . . 0.0 118.848 171.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.01 -38.96 90.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 169.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -61.87 -42.02 98.56 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 164.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.67 -39.13 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 168.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -55.61 -25.29 37.84 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 169.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.9 -29.08 26.2 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 119.809 2.684 . . . . 0.0 119.809 165.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -58.51 -38.4 77.63 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 159.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -82.05 -32.2 30.54 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -45.39 -46.33 13.17 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 119.664 3.209 . . . . 0.0 119.664 -173.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.83 -38.5 70.13 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.8 m -89.84 -43.91 10.31 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -112.36 132.94 54.73 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 119.453 1.024 . . . . 0.0 112.179 -169.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -117.61 132.52 56.5 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.9 0.857 . . . . 0.0 111.105 -173.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.2 mt -80.04 -9.14 59.67 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 117.33 2.345 . . . . 0.0 117.33 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -102.76 58.62 0.78 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.175 1.807 . . . . 0.0 112.011 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.2 24.23 50.47 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 121.124 3.21 . . . . 0.0 121.124 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -106.57 121.99 45.41 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.007 1.404 . . . . 0.0 110.697 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -93.22 103.59 15.84 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.381 0.672 . . . . 0.0 109.454 173.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.0 -107.41 3.21 Favored Glycine 0 N--CA 1.489 2.224 0 O-C-N 122.096 -0.377 . . . . 0.0 112.689 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.19 -49.44 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 118.923 -0.561 . . . . 0.0 111.087 166.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.95 166.77 14.78 Favored Glycine 0 CA--C 1.561 2.93 0 CA-C-N 119.035 0.834 . . . . 0.0 114.924 164.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.78 169.24 20.68 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 120.813 2.307 . . . . 0.0 115.174 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -65.76 124.34 22.17 Favored 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.456 -1.402 . . . . 0.0 113.434 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.2 mt -90.41 6.47 43.14 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -67.41 125.97 27.79 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 121.149 1.795 . . . . 0.0 110.96 159.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.24 53.51 13.67 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 115.619 1.007 . . . . 0.0 115.619 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -107.0 -29.87 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 t -79.36 100.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 120.811 1.642 . . . . 0.0 109.0 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.82 -15.62 48.3 Favored Glycine 0 CA--C 1.552 2.398 0 N-CA-C 118.304 2.082 . . . . 0.0 118.304 -159.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -72.12 141.06 49.16 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 121.339 2.569 . . . . 0.0 113.201 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.8 m -58.18 136.99 57.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -67.12 123.85 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 123.267 0.627 . . . . 0.0 110.72 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 62.76 45.31 5.88 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -165.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.05 12.82 29.08 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 -170.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.5 t -92.74 115.18 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 120.072 1.936 . . . . 0.0 109.09 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.92 120.19 16.13 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.904 -0.497 . . . . 0.0 110.717 166.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.21 17.91 21.02 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 118.209 2.044 . . . . 0.0 118.209 -163.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -139.11 127.45 22.8 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 119.785 1.792 . . . . 0.0 109.118 165.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -80.61 93.39 6.1 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.376 -0.827 . . . . 0.0 112.765 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -76.73 152.14 35.79 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.9 p -70.08 156.7 38.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.766 -1.209 . . . . 0.0 114.061 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.26 -49.6 91.43 Favored Pre-proline 0 CA--C 1.576 1.98 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.01 -24.39 45.42 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 CA-C-N 124.095 2.498 . . . . 0.0 117.468 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.8 tpp -65.89 -46.44 78.34 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.784 1.629 . . . . 0.0 114.253 163.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -57.81 -45.64 85.84 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 166.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.38 -13.5 61.87 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 170.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -60.7 -48.67 80.75 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 120.87 1.668 . . . . 0.0 114.915 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.72 164.69 35.73 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 117.704 1.842 . . . . 0.0 117.704 163.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.8 -144.14 26.16 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 114.756 0.662 . . . . 0.0 114.756 -177.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -129.53 154.02 47.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.781 0.801 . . . . 0.0 111.528 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -75.82 76.65 2.75 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 123.05 1.405 . . . . 0.0 112.782 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.2 p -73.71 159.7 83.81 Favored Pre-proline 0 CA--C 1.574 1.892 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.114 173.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -56.01 -39.2 92.64 Favored 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 122.403 2.069 . . . . 0.0 117.159 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.01 -42.12 94.75 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 166.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.76 98.06 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 170.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -58.86 -49.11 78.97 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 166.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -55.21 -40.31 70.65 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 172.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.17 -57.54 11.13 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 167.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -60.36 -40.96 92.66 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.87 -27.83 66.16 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.8 m -67.99 -60.09 2.77 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 120.61 1.55 . . . . 0.0 113.37 161.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 82.5 m-20 -127.63 97.13 31.17 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-N 120.864 1.666 . . . . 0.0 110.562 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.63 -51.88 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.886 0 CA-C-N 122.514 1.934 . . . . 0.0 115.625 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.5 -21.19 62.78 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 173.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -74.47 -43.46 55.97 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.867 1.667 . . . . 0.0 115.06 163.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.33 -54.7 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.474 1.034 . . . . 0.0 112.695 172.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.85 101.63 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -72.61 98.47 2.34 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 121.701 -0.624 . . . . 0.0 111.383 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.54 24.1 8.01 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 118.457 2.143 . . . . 0.0 118.457 -166.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -76.09 135.34 39.87 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.627 1.713 . . . . 0.0 111.025 159.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -74.89 8.92 2.15 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 117.32 2.341 . . . . 0.0 117.32 167.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -73.42 95.94 2.29 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 120.565 -1.334 . . . . 0.0 111.294 170.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.72 69.65 6.07 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-O 122.497 1.142 . . . . 0.0 113.382 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.28 133.28 55.5 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.349 1.059 . . . . 0.0 108.95 175.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.14 -56.2 14.28 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 115.886 1.809 . . . . 0.0 115.886 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.18 142.76 3.65 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 115.664 1.026 . . . . 0.0 115.664 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.2 mt -95.22 106.73 27.72 Favored Pre-proline 0 CA--C 1.574 1.879 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.084 168.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.97 -40.16 1.45 Allowed 'Trans proline' 0 CA--C 1.569 2.236 0 CA-C-N 123.239 2.192 . . . . 0.0 116.982 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.9 132.9 40.59 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.8 tt -51.36 -47.94 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 168.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -48.95 -50.63 34.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 173.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.18 -41.16 97.23 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -65.84 -52.93 46.34 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 170.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.76 -44.71 86.31 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.583 HD21 ' N ' ' A' ' 3' ' ' ASP . 11.2 m120 -58.53 -51.73 68.65 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 169.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.43 -48.08 72.08 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 168.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 62.1 mt -62.33 -40.72 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.273 172.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.14 -44.68 71.6 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 121.778 2.081 . . . . 0.0 116.567 163.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -60.14 -47.97 83.7 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 166.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.5 mt -65.07 -30.43 71.38 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -61.1 -43.24 99.18 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 161.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.01 -42.48 99.74 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 117.809 1.884 . . . . 0.0 117.809 165.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -80.33 72.05 7.17 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-N 118.526 1.163 . . . . 0.0 112.478 171.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.242 -0.885 . . . . 0.0 109.466 176.293 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.7 t0 . . . . . 0 CA--C 1.575 1.94 0 CA-C-O 118.6 -0.714 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -67.8 -35.54 21.13 Favored 'Trans proline' 0 CA--C 1.563 1.972 0 N-CA-C 119.18 2.723 . . . . 0.0 119.18 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.86 75.74 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.01 82.65 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 164.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.46 -38.12 94.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.281 2.072 . . . . 0.0 118.281 167.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -58.16 -44.57 88.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 164.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -58.24 -47.08 84.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 167.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.75 -40.73 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 169.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -52.87 -24.99 10.25 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.06 -34.51 5.92 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 119.79 2.676 . . . . 0.0 119.79 161.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -58.98 -38.73 79.8 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 163.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -83.2 -31.45 27.07 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -48.17 -34.92 10.75 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.59 -28.63 47.54 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 117.932 2.568 . . . . 0.0 117.932 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.1 m -112.9 -43.97 3.35 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -102.18 152.1 21.43 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.127 0.965 . . . . 0.0 113.503 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -128.2 138.59 52.53 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.793 0.806 . . . . 0.0 111.13 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.5 mt -100.68 41.4 1.18 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.373 -0.829 . . . . 0.0 113.186 168.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -143.53 55.92 1.35 Allowed 'General case' 0 CA--C 1.571 1.768 0 O-C-N 120.79 -1.194 . . . . 0.0 110.802 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.6 -43.62 1.63 Allowed Glycine 0 N--CA 1.497 2.739 0 N-CA-C 119.465 2.546 . . . . 0.0 119.465 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -74.81 136.86 41.6 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -112.25 125.88 54.63 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.78 0.832 . . . . 0.0 109.385 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.4 -101.01 0.6 Allowed Glycine 0 N--CA 1.491 2.336 0 O-C-N 121.748 -0.595 . . . . 0.0 113.966 -172.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.11 -52.98 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 117.396 0.598 . . . . 0.0 110.901 170.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.71 164.5 13.92 Favored Glycine 0 CA--C 1.561 2.909 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.811 161.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.17 170.4 15.95 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 CA-C-N 120.961 2.38 . . . . 0.0 115.116 174.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -71.39 127.19 31.75 Favored 'General case' 0 CA--C 1.568 1.662 0 O-C-N 120.526 -1.359 . . . . 0.0 111.933 173.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -90.33 4.95 49.29 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -61.71 118.97 7.82 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 119.954 1.252 . . . . 0.0 111.511 168.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.65 19.71 65.37 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -175.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.92 -29.05 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-N 121.005 2.403 . . . . 0.0 116.68 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.0 t -78.98 103.42 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 120.068 1.303 . . . . 0.0 109.181 -171.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.96 -19.68 45.93 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 118.25 2.06 . . . . 0.0 118.25 -159.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -75.24 147.02 40.65 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.776 2.288 . . . . 0.0 113.866 -174.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.3 m -55.15 138.63 44.16 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.21 122.03 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.78 -0.575 . . . . 0.0 110.224 172.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.07 49.64 4.42 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -164.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.75 -18.59 24.83 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 119.185 2.434 . . . . 0.0 119.185 -169.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 65.0 t -84.97 100.6 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.686 1.743 . . . . 0.0 109.622 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.35 105.08 2.44 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.534 0.683 . . . . 0.0 110.999 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.65 -56.53 0.53 Allowed Glycine 0 N--CA 1.487 2.098 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.213 -157.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -82.55 129.58 34.95 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 117.894 0.847 . . . . 0.0 111.111 169.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.54 99.96 10.48 Favored 'General case' 0 CA--C 1.567 1.597 0 O-C-N 121.539 -0.726 . . . . 0.0 110.918 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -77.83 158.56 29.43 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.9 p -71.37 156.09 39.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.616 -1.302 . . . . 0.0 113.782 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.85 -48.67 92.89 Favored Pre-proline 0 CA--C 1.576 1.962 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.11 -26.12 43.09 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 CA-C-N 124.322 2.579 . . . . 0.0 117.66 171.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.9 ttm -65.86 -46.79 77.15 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 121.253 1.842 . . . . 0.0 113.97 162.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -56.89 -45.65 82.41 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 167.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.19 -17.14 61.39 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 118.81 2.892 . . . . 0.0 118.81 172.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -61.44 -54.58 41.63 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.853 1.66 . . . . 0.0 114.617 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.09 -179.27 50.38 Favored Glycine 0 CA--C 1.546 2.03 0 N-CA-C 116.709 1.443 . . . . 0.0 116.709 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.34 -151.52 43.63 Favored Glycine 0 N--CA 1.487 2.099 0 O-C-N 121.879 -0.777 . . . . 0.0 114.88 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -132.84 153.41 51.33 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.052 0.929 . . . . 0.0 111.722 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -76.87 74.32 3.48 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 122.832 1.301 . . . . 0.0 113.166 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.7 p -69.7 158.93 85.81 Favored Pre-proline 0 CA--C 1.576 1.969 0 C-N-CA 124.293 1.037 . . . . 0.0 112.382 171.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.55 -33.24 96.2 Favored 'Trans proline' 0 CA--C 1.57 2.292 0 N-CA-C 117.559 2.1 . . . . 0.0 117.559 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.51 -49.5 68.76 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 164.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.11 90.55 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 171.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.3 mt -59.77 -45.83 91.05 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 165.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -56.19 -43.07 78.08 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 121.636 2.016 . . . . 0.0 116.329 168.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -60.81 -56.42 21.43 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 120.068 1.304 . . . . 0.0 114.261 169.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -62.26 -39.98 94.69 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 74.2 mt -71.14 -25.0 62.37 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 169.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.1 m -62.45 -51.86 65.81 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 121.247 1.84 . . . . 0.0 113.504 164.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -150.54 112.63 3.21 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 120.05 1.295 . . . . 0.0 109.147 167.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.22 -46.9 0.21 Allowed 'Trans proline' 0 CA--C 1.559 1.76 0 CA-C-N 122.714 2.005 . . . . 0.0 116.985 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.02 -28.15 67.16 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.91 -40.88 91.9 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 161.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.3 t -71.44 -58.54 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.394 0.997 . . . . 0.0 112.511 175.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.35 101.28 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -74.43 102.54 4.48 Favored 'General case' 0 CA--C 1.566 1.589 0 O-C-N 121.566 -0.709 . . . . 0.0 111.578 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.56 22.16 10.64 Favored Glycine 0 CA--C 1.554 2.507 0 N-CA-C 118.446 2.138 . . . . 0.0 118.446 -164.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -74.79 134.14 41.84 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 119.64 1.72 . . . . 0.0 111.321 161.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -74.21 9.86 1.48 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -72.99 95.88 2.06 Favored 'General case' 0 CA--C 1.565 1.551 0 O-C-N 120.696 -1.253 . . . . 0.0 111.194 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.18 72.63 4.72 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 122.8 1.286 . . . . 0.0 113.383 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -136.32 128.86 30.48 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.94 -54.54 24.96 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.12 156.88 7.58 Favored Glycine 0 CA--C 1.544 1.852 0 N-CA-C 115.664 1.025 . . . . 0.0 115.664 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.1 mt -104.06 96.04 8.9 Favored Pre-proline 0 CA--C 1.574 1.868 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.176 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.08 -34.2 17.39 Favored 'Trans proline' 0 CA--C 1.568 2.193 0 C-N-CA 122.672 2.248 . . . . 0.0 117.198 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -73.04 129.56 38.35 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.76 0.824 . . . . 0.0 112.831 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 tt -57.73 -43.05 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -52.68 -45.27 66.73 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.38 -46.6 88.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 73.5 mtm-85 -64.4 -52.38 58.46 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -47.25 86.75 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -60.12 -46.45 89.59 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 119.732 1.151 . . . . 0.0 113.971 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.9 tp -60.04 -47.73 84.65 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.43 -43.36 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-N 119.918 1.236 . . . . 0.0 112.884 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.1 73.55 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 165.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -57.5 -47.68 81.27 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 165.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.29 -31.6 72.82 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.57 -40.42 91.61 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 159.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.51 -49.56 75.63 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -87.22 77.85 8.94 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 118.814 1.307 . . . . 0.0 112.445 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 . . . . . 0 N--CA 1.487 1.402 0 C-N-CA 123.679 0.792 . . . . 0.0 110.05 172.135 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 CA--C 1.578 2.049 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.25 -32.13 21.32 Favored 'Trans proline' 0 CA--C 1.567 2.13 0 N-CA-C 118.317 2.391 . . . . 0.0 118.317 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.65 -48.7 79.66 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 169.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.7 71.43 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 164.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.41 -33.04 65.09 Favored Glycine 0 CA--C 1.551 2.318 0 N-CA-C 119.145 2.418 . . . . 0.0 119.145 166.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -65.42 -40.85 93.85 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -61.7 -41.14 97.2 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 164.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.92 -37.45 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 169.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -54.95 -18.9 5.61 Favored 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 165.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.12 -38.28 6.17 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 119.81 2.684 . . . . 0.0 119.81 158.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.04 -31.47 72.71 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 164.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -87.58 -34.23 18.62 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -56.79 -34.37 67.58 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 119.981 3.326 . . . . 0.0 119.981 -169.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.22 -35.9 72.36 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.6 m -91.15 -42.87 10.21 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 168.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -110.32 135.14 51.51 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.207 0.912 . . . . 0.0 112.617 -169.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.25 146.15 27.24 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.684 0.754 . . . . 0.0 112.571 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.5 mt -95.19 6.09 49.99 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 166.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.15 -40.4 52.71 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.9 -38.43 1.9 Allowed Glycine 0 N--CA 1.496 2.65 0 CA-C-N 119.3 0.955 . . . . 0.0 115.335 -163.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -73.69 153.71 39.97 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-O 121.979 0.895 . . . . 0.0 112.623 168.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -91.21 145.56 24.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 111.668 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.36 -115.35 4.02 Favored Glycine 0 N--CA 1.492 2.392 0 O-C-N 121.571 -0.706 . . . . 0.0 112.843 175.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -78.52 -48.3 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 122.337 -0.508 . . . . 0.0 110.745 163.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.29 173.89 33.27 Favored Glycine 0 CA--C 1.56 2.896 0 N-CA-C 115.327 0.891 . . . . 0.0 115.327 160.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -69.62 173.18 11.22 Favored 'Trans proline' 0 CA--C 1.565 2.039 0 CA-C-N 120.578 2.189 . . . . 0.0 115.468 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -65.75 126.21 27.71 Favored 'General case' 0 CA--C 1.573 1.828 0 O-C-N 120.468 -1.395 . . . . 0.0 113.399 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.48 1.08 57.45 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -64.97 125.33 24.56 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 121.496 1.953 . . . . 0.0 111.112 158.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.05 47.13 32.51 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 116.787 1.475 . . . . 0.0 116.787 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -99.17 -28.45 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 t -81.05 105.14 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 120.631 1.559 . . . . 0.0 109.173 -171.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.35 -13.33 61.56 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.085 1.994 . . . . 0.0 118.085 -159.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -74.42 146.37 42.95 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.025 2.412 . . . . 0.0 112.745 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 64.9 m -54.62 141.56 31.34 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.64 114.71 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.639 -0.663 . . . . 0.0 109.386 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.276 . . 67.59 62.26 0.43 Allowed 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -158.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.83 -20.99 8.07 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 119.462 2.545 . . . . 0.0 119.462 -170.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.3 t -81.88 101.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 120.23 2.015 . . . . 0.0 109.877 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -70.27 102.04 2.04 Favored 'General case' 0 CA--C 1.566 1.58 0 C-N-CA 123.727 0.811 . . . . 0.0 110.784 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.91 -51.87 0.72 Allowed Glycine 0 N--CA 1.49 2.287 0 CA-C-O 119.783 -0.454 . . . . 0.0 113.782 -155.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -85.74 124.93 32.81 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 117.98 0.89 . . . . 0.0 110.479 168.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -80.62 118.18 21.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.422 -0.799 . . . . 0.0 110.07 167.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -89.81 172.51 8.85 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.829 0.823 . . . . 0.0 112.423 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.5 t -70.55 152.92 43.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.373 -1.455 . . . . 0.0 112.961 171.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.56 -45.55 99.85 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-O 115.274 -2.298 . . . . 0.0 116.525 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.63 -26.84 45.98 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 CA-C-N 124.807 2.753 . . . . 0.0 117.338 166.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.2 tpp -64.2 -47.85 78.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.604 1.547 . . . . 0.0 114.123 164.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -60.55 -43.47 97.18 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 168.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.41 -14.96 62.33 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 118.784 2.883 . . . . 0.0 118.784 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -65.18 -56.21 14.19 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.741 1.609 . . . . 0.0 114.247 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.08 -179.78 52.6 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 116.717 1.447 . . . . 0.0 116.717 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.99 -149.57 37.96 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 121.836 -0.802 . . . . 0.0 114.809 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -133.87 155.25 50.21 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.923 0.868 . . . . 0.0 112.061 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -76.8 78.17 3.41 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.938 1.352 . . . . 0.0 112.962 172.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.7 p -75.47 159.85 80.89 Favored Pre-proline 0 CA--C 1.577 1.983 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.514 173.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -59.09 -28.01 86.62 Favored 'Trans proline' 0 CA--C 1.572 2.388 0 N-CA-C 118.014 2.275 . . . . 0.0 118.014 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.13 -53.49 30.2 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 163.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.38 -43.25 88.39 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.62 -51.14 71.2 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -62.62 -33.07 74.27 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 175.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -63.89 -54.44 34.76 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 164.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -60.63 -42.59 97.2 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.55 -20.48 62.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 170.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -65.42 -63.17 1.16 Allowed 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.802 1.637 . . . . 0.0 111.756 158.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 96.0 m-20 -134.66 102.24 11.51 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.921 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.52 -50.77 0.12 Allowed 'Trans proline' 0 CA--C 1.561 1.865 0 CA-C-N 122.731 2.011 . . . . 0.0 115.947 -175.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -69.87 -20.68 63.39 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 171.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -71.03 -42.4 69.56 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 121.363 1.892 . . . . 0.0 114.92 163.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.18 -56.88 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.492 0.717 . . . . 0.0 112.538 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.63 97.28 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 172.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -73.01 104.95 4.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.385 -0.822 . . . . 0.0 111.909 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.33 17.26 22.67 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 118.554 2.182 . . . . 0.0 118.554 -166.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 t -69.1 136.27 52.0 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.121 1.96 . . . . 0.0 111.841 163.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -73.78 8.61 1.85 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 168.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 ttt -74.35 99.61 3.55 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 120.784 -1.198 . . . . 0.0 111.302 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.16 70.99 6.89 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 122.604 1.192 . . . . 0.0 113.327 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -130.37 134.16 46.95 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.31 1.044 . . . . 0.0 108.69 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.88 -56.47 6.99 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.56 154.18 6.84 Favored Glycine 0 CA--C 1.544 1.89 0 CA-C-O 121.983 0.768 . . . . 0.0 114.668 -177.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.1 mt -98.86 98.15 5.88 Favored Pre-proline 0 CA--C 1.573 1.832 0 CA-C-O 117.851 -1.071 . . . . 0.0 108.87 167.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 -33.63 19.8 Favored 'Trans proline' 0 CA--C 1.568 2.214 0 C-N-CA 122.706 2.271 . . . . 0.0 117.383 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -71.41 126.06 28.64 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.974 0.91 . . . . 0.0 113.335 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -56.37 -43.6 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 168.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -54.08 -45.22 71.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.39 -45.56 88.09 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 169.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -62.68 -54.34 40.86 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 171.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.38 -45.59 87.99 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -59.34 -49.81 76.38 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 171.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.57 -44.9 89.9 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.6 mt -66.71 -34.49 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-N 119.804 1.184 . . . . 0.0 113.688 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.49 79.85 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 121.792 2.087 . . . . 0.0 115.905 159.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.67 -51.47 69.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 170.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.1 mt -66.29 -24.22 66.52 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.14 -45.64 87.6 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 160.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.68 91.41 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 117.882 1.913 . . . . 0.0 117.882 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -79.31 71.59 5.86 Favored 'General case' 0 CA--C 1.573 1.853 0 CA-C-N 118.372 1.086 . . . . 0.0 112.566 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.353 -177.887 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 CA--C 1.576 1.974 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.52 -25.78 29.37 Favored 'Trans proline' 0 CA--C 1.567 2.131 0 N-CA-C 118.424 2.432 . . . . 0.0 118.424 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.82 -49.22 71.48 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.37 77.59 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 162.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.9 -41.49 84.24 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 118.825 2.29 . . . . 0.0 118.825 166.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -56.09 -44.09 78.67 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 164.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.73 -47.03 87.29 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 168.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.0 t -58.6 -36.46 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -54.26 -19.43 5.28 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 168.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.93 -38.46 4.58 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 120.045 2.778 . . . . 0.0 120.045 158.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -66.07 -38.04 87.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 164.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -81.59 -33.44 31.57 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -55.8 -35.06 65.89 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 119.95 3.315 . . . . 0.0 119.95 -171.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.08 -35.27 71.15 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 117.041 2.238 . . . . 0.0 117.041 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 m -96.38 -43.05 7.83 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -103.69 127.77 51.11 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.281 1.032 . . . . 0.0 111.91 -172.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -102.95 135.76 44.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.646 0.736 . . . . 0.0 110.965 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.2 mt -79.14 -23.75 43.78 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.43 61.64 6.94 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 121.502 1.955 . . . . 0.0 112.79 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.91 -30.58 0.4 Allowed Glycine 0 CA--C 1.557 2.674 0 N-CA-C 120.908 3.123 . . . . 0.0 120.908 173.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -79.24 148.18 32.3 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 124.339 1.056 . . . . 0.0 113.534 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -113.84 106.08 14.04 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -171.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.32 -108.9 3.16 Favored Glycine 0 N--CA 1.491 2.338 0 O-C-N 121.824 -0.547 . . . . 0.0 113.625 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.0 t -70.32 -53.34 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 119.222 -0.418 . . . . 0.0 110.666 165.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.39 152.38 18.83 Favored Glycine 0 CA--C 1.56 2.879 0 CA-C-O 119.118 -0.824 . . . . 0.0 114.675 167.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.56 143.57 27.49 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 CA-C-N 121.255 2.528 . . . . 0.0 113.319 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -44.32 122.94 3.22 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -169.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.16 -7.86 59.63 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -65.39 113.53 4.16 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 119.139 0.882 . . . . 0.0 110.767 160.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.03 44.07 8.4 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.35 -33.54 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 174.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.69 106.32 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 120.418 1.463 . . . . 0.0 109.401 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.67 -10.99 66.69 Favored Glycine 0 CA--C 1.553 2.466 0 N-CA-C 118.733 2.253 . . . . 0.0 118.733 -162.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -73.47 145.36 45.75 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 121.23 2.515 . . . . 0.0 112.924 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.0 m -54.39 140.3 34.18 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.71 117.6 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.605 -0.685 . . . . 0.0 109.524 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.264 . . 64.36 57.84 1.15 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -157.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.53 -27.11 5.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 -169.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.8 t -70.47 115.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 119.614 1.707 . . . . 0.0 109.948 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.81 73.9 6.54 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.87 1.319 . . . . 0.0 111.852 176.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.99 39.49 0.02 OUTLIER Glycine 0 CA--C 1.551 2.312 0 CA-C-N 114.421 -1.263 . . . . 0.0 115.23 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -154.12 144.05 21.86 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 118.137 0.969 . . . . 0.0 110.12 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -74.83 90.51 2.38 Favored 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 111.593 170.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -82.82 146.24 29.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.419 -0.801 . . . . 0.0 112.574 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.9 t -68.15 153.64 43.32 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -60.7 -46.85 97.12 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 115.906 -1.997 . . . . 0.0 115.24 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.92 -24.25 67.73 Favored 'Trans proline' 0 CA--C 1.564 1.988 0 CA-C-N 124.902 2.786 . . . . 0.0 117.975 166.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.4 tpp -65.08 -49.44 70.03 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 121.131 1.787 . . . . 0.0 113.818 162.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -59.93 -46.67 88.62 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 171.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -12.66 60.57 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 118.979 2.955 . . . . 0.0 118.979 169.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -68.53 -58.08 4.83 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 120.366 1.439 . . . . 0.0 113.643 175.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.2 -178.59 52.52 Favored Glycine 0 CA--C 1.547 2.08 0 N-CA-C 116.574 1.39 . . . . 0.0 116.574 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.48 -149.39 38.55 Favored Glycine 0 N--CA 1.488 2.143 0 O-C-N 121.818 -0.813 . . . . 0.0 114.905 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -133.67 155.56 49.48 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.972 0.892 . . . . 0.0 111.987 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -76.56 77.99 3.25 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-O 123.111 1.434 . . . . 0.0 112.817 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.9 p -77.19 161.24 73.72 Favored Pre-proline 0 CA--C 1.575 1.938 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.317 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -56.29 -35.82 96.23 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 N-CA-C 117.709 2.157 . . . . 0.0 117.709 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.43 -51.75 64.4 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 166.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.37 94.91 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 172.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.5 mt -57.77 -51.96 67.42 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 167.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.3 2.6 pp0? -62.52 -33.71 75.45 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 176.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -62.88 -55.26 27.66 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 164.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -59.38 -41.33 89.09 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.79 -18.6 62.09 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.7 m -66.18 -64.35 0.88 Allowed 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 120.554 1.525 . . . . 0.0 111.46 159.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 93.3 m-20 -134.72 101.92 11.57 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 118.191 -0.909 . . . . 0.0 109.66 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.66 -51.4 0.11 Allowed 'Trans proline' 0 CA--C 1.561 1.853 0 CA-C-N 122.89 2.068 . . . . 0.0 116.218 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.65 -20.95 64.48 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -73.12 -43.89 61.04 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.771 1.623 . . . . 0.0 114.995 162.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.4 -57.27 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-N 119.426 1.012 . . . . 0.0 112.723 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.76 99.63 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -74.24 94.49 2.49 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.645 0.736 . . . . 0.0 111.945 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.05 20.71 7.01 Favored Glycine 0 CA--C 1.551 2.286 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 -166.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.4 t -72.71 137.62 46.06 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 120.199 2.0 . . . . 0.0 111.549 160.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -73.46 5.52 3.69 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 117.608 2.447 . . . . 0.0 117.608 165.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -70.26 98.21 1.34 Allowed 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 120.334 1.425 . . . . 0.0 112.198 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.06 69.57 5.25 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 122.481 1.134 . . . . 0.0 113.847 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.36 135.9 50.2 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.32 1.048 . . . . 0.0 109.044 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.26 -58.26 3.96 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 176.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.13 154.21 6.9 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-O 122.207 0.893 . . . . 0.0 115.109 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.5 mt -98.63 101.83 12.96 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-O 117.747 -1.121 . . . . 0.0 108.893 168.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.36 -37.38 10.2 Favored 'Trans proline' 0 CA--C 1.565 2.039 0 C-N-CA 122.574 2.183 . . . . 0.0 117.59 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -78.22 135.34 37.58 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 119.414 1.006 . . . . 0.0 112.454 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -58.37 -39.84 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 168.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.09 -44.78 79.34 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -56.46 -45.6 80.79 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -64.42 -54.24 35.83 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.45 90.19 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 117.379 2.362 . . . . 0.0 117.379 173.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -60.29 -47.96 83.79 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.4 tp -58.65 -46.53 86.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 168.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.4 mt -59.29 -41.45 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.914 1.233 . . . . 0.0 113.16 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.16 -44.58 75.32 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 164.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -58.94 -47.29 85.59 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 166.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.05 -22.57 63.06 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.43 -42.87 98.7 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 156.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.22 96.56 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 117.672 1.829 . . . . 0.0 117.672 165.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -77.98 85.1 4.23 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 118.136 0.968 . . . . 0.0 111.581 170.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.419 -0.8 . . . . 0.0 109.22 173.733 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 CA--C 1.576 1.967 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.11 -34.06 23.45 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 C-N-CA 122.573 2.182 . . . . 0.0 117.666 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.41 -44.55 96.95 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.42 77.86 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 165.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.49 -27.23 58.14 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 119.866 2.707 . . . . 0.0 119.866 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -59.66 -39.56 84.84 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 166.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -65.26 -44.06 89.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 168.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.6 t -56.14 -44.71 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 166.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.75 -23.53 18.29 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 170.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.05 -37.79 16.91 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 119.556 2.582 . . . . 0.0 119.556 162.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -60.72 -33.64 73.19 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 164.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -82.94 -30.0 28.69 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 171.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -56.26 -19.63 14.95 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.36 -26.52 19.56 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 159.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.0 m -125.13 -43.61 1.94 Allowed 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -96.47 140.39 31.19 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -126.06 123.11 37.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.758 -0.589 . . . . 0.0 110.301 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.66 -25.56 63.96 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.82 55.57 2.78 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.366 1.894 . . . . 0.0 113.72 -172.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.84 12.95 7.45 Favored Glycine 0 CA--C 1.561 2.941 0 N-CA-C 120.192 2.837 . . . . 0.0 120.192 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.86 137.67 38.93 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 118.936 1.368 . . . . 0.0 112.281 -168.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -127.58 110.37 12.64 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.14 -97.78 0.75 Allowed Glycine 0 N--CA 1.493 2.452 0 O-C-N 121.875 -0.516 . . . . 0.0 113.943 -171.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.71 -49.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.913 166.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.64 160.67 13.35 Favored Glycine 0 CA--C 1.56 2.895 0 CA-C-N 119.195 0.907 . . . . 0.0 114.004 163.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -69.93 174.62 9.39 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 CA-C-N 120.92 2.36 . . . . 0.0 115.369 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -74.48 118.19 17.16 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 120.439 -1.413 . . . . 0.0 112.615 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.0 mt -83.36 -4.92 58.93 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -59.18 117.88 5.25 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 120.033 1.288 . . . . 0.0 111.06 155.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.1 39.99 30.89 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 116.9 1.52 . . . . 0.0 116.9 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.01 -36.93 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.19 1.495 . . . . 0.0 114.512 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.5 t -68.18 108.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 119.966 1.257 . . . . 0.0 110.004 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.35 -19.16 55.56 Favored Glycine 0 CA--C 1.554 2.471 0 N-CA-C 118.535 2.174 . . . . 0.0 118.535 -162.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -73.51 144.14 46.27 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 120.802 2.301 . . . . 0.0 113.086 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.8 m -59.07 144.07 46.58 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.66 117.51 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.616 -0.677 . . . . 0.0 110.351 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.267 . . 65.76 56.77 0.88 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -160.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.69 31.2 5.08 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 -169.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.73 110.73 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 162.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -72.17 97.31 1.93 Allowed 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 123.593 0.757 . . . . 0.0 112.019 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.2 -52.09 0.58 Allowed Glycine 0 N--CA 1.489 2.167 0 CA-C-O 119.304 -0.72 . . . . 0.0 114.507 -159.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -81.57 134.58 35.52 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-N 118.449 1.125 . . . . 0.0 111.955 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -82.87 105.06 13.57 Favored 'General case' 0 CA--C 1.566 1.574 0 O-C-N 121.587 -0.696 . . . . 0.0 111.267 172.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.62 168.89 14.91 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.6 0.714 . . . . 0.0 112.628 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.1 t -70.92 153.01 43.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.305 -1.497 . . . . 0.0 113.319 171.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.15 -49.58 92.26 Favored Pre-proline 0 CA--C 1.577 2.001 0 CA-C-O 116.035 -1.936 . . . . 0.0 115.368 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.95 -21.29 64.02 Favored 'Trans proline' 0 CA--C 1.567 2.169 0 CA-C-N 124.744 2.73 . . . . 0.0 118.001 166.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.5 tpp -67.85 -50.44 56.57 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 120.394 1.452 . . . . 0.0 113.897 162.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -56.68 -44.37 81.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 169.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.86 -8.59 55.28 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 118.967 2.951 . . . . 0.0 118.967 171.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -66.44 -55.03 17.63 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 120.775 1.625 . . . . 0.0 114.637 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.47 174.85 50.33 Favored Glycine 0 CA--C 1.548 2.103 0 N-CA-C 116.451 1.341 . . . . 0.0 116.451 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.4 -158.52 47.55 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 115.321 0.888 . . . . 0.0 115.321 -174.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -128.7 156.61 43.21 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.913 0.863 . . . . 0.0 112.247 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -76.31 76.08 3.09 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.338 1.542 . . . . 0.0 112.898 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.5 p -76.42 160.43 77.54 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.943 172.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -57.25 -35.0 98.83 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.387 2.058 . . . . 0.0 117.416 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.64 -51.53 69.02 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 164.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.54 -44.78 93.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 171.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -59.47 -48.73 80.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -62.53 -36.89 84.03 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -62.29 -55.65 26.14 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 165.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -60.6 -40.38 91.61 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.8 mt -74.74 -12.62 60.45 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 169.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 m -67.04 -55.32 14.85 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 121.247 1.839 . . . . 0.0 112.337 161.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -149.19 114.24 3.61 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 117.919 -1.039 . . . . 0.0 108.503 167.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.04 -45.85 0.43 Allowed 'Trans proline' 0 CA--C 1.562 1.881 0 CA-C-N 122.655 1.984 . . . . 0.0 116.599 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.22 -28.57 67.35 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.63 93.44 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 162.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.7 t -70.56 -57.35 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.501 1.046 . . . . 0.0 112.532 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.9 103.27 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-N 120.083 1.31 . . . . 0.0 107.564 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -72.84 106.54 4.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.744 . . . . 0.0 111.058 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.98 17.68 17.71 Favored Glycine 0 CA--C 1.554 2.497 0 N-CA-C 118.919 2.327 . . . . 0.0 118.919 -169.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.1 t -75.57 135.88 40.55 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.806 1.803 . . . . 0.0 112.764 169.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.279 64.5 pttt -82.24 12.77 4.01 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 168.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.2 mmm -59.77 83.32 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.777 0 C-N-CA 125.195 1.398 . . . . 0.0 112.548 153.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.94 78.95 7.7 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 122.931 1.348 . . . . 0.0 112.47 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -150.77 133.92 16.11 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.509 -171.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.53 -56.05 9.63 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.46 158.68 8.99 Favored Glycine 0 N--CA 1.484 1.863 0 CA-C-O 122.292 0.94 . . . . 0.0 114.934 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.2 mt -99.04 101.66 13.11 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.767 -1.111 . . . . 0.0 108.315 168.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.87 -35.67 9.02 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 C-N-CA 122.697 2.265 . . . . 0.0 117.805 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -78.74 135.41 37.12 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 119.257 0.935 . . . . 0.0 112.503 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.15 -40.61 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 169.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.19 -45.12 75.82 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 170.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -57.18 -47.2 81.81 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 120.791 1.632 . . . . 0.0 115.173 169.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -61.77 -54.14 46.39 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.9 -43.37 86.1 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 171.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -58.5 -50.38 73.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 170.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.92 -45.38 92.77 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.2 -46.21 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 120.039 1.291 . . . . 0.0 113.0 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.84 -44.96 74.41 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 166.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -56.61 -48.54 77.23 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 167.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.7 mt -71.02 -25.14 62.54 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -60.77 -42.88 98.36 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 159.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 -44.35 95.35 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 164.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -81.6 85.3 6.56 Favored 'General case' 0 CA--C 1.572 1.81 0 CA-C-N 118.372 1.086 . . . . 0.0 111.855 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 123.828 0.851 . . . . 0.0 109.689 -174.649 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 CA--C 1.578 2.02 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.48 -29.08 25.79 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 N-CA-C 118.243 2.363 . . . . 0.0 118.243 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.93 86.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 167.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.62 79.79 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 162.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.69 -35.94 69.63 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 118.784 2.274 . . . . 0.0 118.784 165.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.74 -46.53 87.2 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.86 -41.71 98.18 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 167.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.3 t -60.63 -37.25 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 169.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -55.66 -19.57 11.09 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 117.014 2.228 . . . . 0.0 117.014 167.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.1 -37.02 7.48 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 119.699 2.639 . . . . 0.0 119.699 160.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -64.55 -38.1 89.85 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 164.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.64 -34.84 34.66 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -55.66 -35.74 66.31 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 120.299 3.444 . . . . 0.0 120.299 -168.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.34 80.66 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.8 m -89.85 -40.32 12.51 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 169.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -115.31 121.67 43.57 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.472 1.109 . . . . 0.0 110.643 -169.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -105.02 131.12 52.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 111.07 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.2 mt -70.82 -26.11 63.16 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -83.35 54.47 2.82 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.194 1.816 . . . . 0.0 113.396 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.32 9.84 18.81 Favored Glycine 0 CA--C 1.559 2.838 0 N-CA-C 120.593 2.997 . . . . 0.0 120.593 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -101.85 134.09 45.58 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.442 1.621 . . . . 0.0 111.869 -170.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -102.54 104.57 14.99 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.48 -106.45 2.93 Favored Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.966 -0.459 . . . . 0.0 113.386 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.02 -44.33 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.256 166.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.69 166.17 12.51 Favored Glycine 0 CA--C 1.564 3.115 0 CA-C-N 119.505 1.048 . . . . 0.0 115.051 161.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.29 151.79 43.76 Favored 'Trans proline' 0 CA--C 1.562 1.908 0 C-N-CA 122.835 2.357 . . . . 0.0 114.745 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -48.19 121.16 4.07 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.0 -9.32 59.6 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -63.03 111.86 2.36 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 118.921 0.782 . . . . 0.0 110.986 161.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.69 45.42 8.55 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 -170.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 p -100.37 -31.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 170.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.5 t -73.09 106.45 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 120.477 1.49 . . . . 0.0 109.563 -175.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.69 -12.33 66.1 Favored Glycine 0 CA--C 1.553 2.425 0 N-CA-C 118.692 2.237 . . . . 0.0 118.692 -162.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -72.52 140.12 47.98 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 121.018 2.409 . . . . 0.0 113.125 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.3 m -59.89 136.97 58.17 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.7 125.92 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 123.391 0.676 . . . . 0.0 110.797 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.254 . . 60.98 42.42 12.78 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -164.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.87 -3.12 39.7 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 119.751 2.66 . . . . 0.0 119.751 -170.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.6 t -83.53 103.3 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 120.386 2.093 . . . . 0.0 109.541 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.6 104.27 3.27 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.331 0.586 . . . . 0.0 110.482 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.32 -56.43 0.55 Allowed Glycine 0 N--CA 1.489 2.205 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.269 -157.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -87.67 128.24 35.29 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 117.721 0.761 . . . . 0.0 111.278 171.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -81.81 105.12 12.69 Favored 'General case' 0 CA--C 1.566 1.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.599 171.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -78.7 159.13 28.13 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.7 p -76.71 147.13 37.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.032 -1.043 . . . . 0.0 113.067 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -53.79 -44.45 98.05 Favored Pre-proline 0 CA--C 1.576 1.979 0 N-CA-C 117.882 2.549 . . . . 0.0 117.882 -175.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.95 -19.58 58.04 Favored 'Trans proline' 0 CA--C 1.569 2.238 0 CA-C-N 125.069 2.846 . . . . 0.0 117.977 170.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.7 tpp -69.24 -45.28 70.16 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.128 1.331 . . . . 0.0 114.187 162.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -55.6 -44.24 76.8 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 164.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.13 -17.27 64.31 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 118.672 2.841 . . . . 0.0 118.672 169.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -64.4 -52.57 57.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.528 1.513 . . . . 0.0 114.44 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.85 167.33 34.9 Favored Glycine 0 CA--C 1.548 2.139 0 N-CA-C 117.842 1.897 . . . . 0.0 117.842 167.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.07 -145.52 23.39 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -130.52 153.35 48.92 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.801 0.81 . . . . 0.0 111.536 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.42 76.04 3.17 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 123.217 1.484 . . . . 0.0 113.11 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.3 p -75.3 160.52 79.76 Favored Pre-proline 0 CA--C 1.577 1.981 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.547 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -58.74 -27.6 84.07 Favored 'Trans proline' 0 CA--C 1.572 2.381 0 N-CA-C 118.171 2.335 . . . . 0.0 118.171 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.58 -53.27 23.88 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 163.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.1 90.1 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 174.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.2 mt -56.84 -52.42 65.16 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 168.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.253 8.2 pt20 -64.26 -33.85 76.77 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 176.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -60.39 -55.76 29.64 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 119.636 1.107 . . . . 0.0 113.938 163.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -58.3 -41.02 83.55 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.98 -16.75 61.51 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 170.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.5 m -65.2 -54.83 23.57 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 121.1 1.773 . . . . 0.0 112.693 164.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -149.73 112.53 3.4 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.334 167.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.05 -45.19 0.48 Allowed 'Trans proline' 0 CA--C 1.559 1.749 0 CA-C-N 122.565 1.952 . . . . 0.0 116.889 -174.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.03 -29.16 68.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 173.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.17 88.0 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 163.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.1 t -68.94 -56.36 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 119.48 1.036 . . . . 0.0 112.584 173.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.56 101.04 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -69.62 102.67 1.91 Allowed 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 121.307 0.575 . . . . 0.0 111.642 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.15 10.25 32.36 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 119.352 2.501 . . . . 0.0 119.352 -170.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 t -66.47 134.73 53.06 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.48 2.64 . . . . 0.0 112.742 171.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -73.11 9.78 1.13 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -77.08 103.73 7.17 Favored 'General case' 0 CA--C 1.563 1.461 0 O-C-N 120.585 -1.322 . . . . 0.0 111.691 173.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.28 71.48 4.75 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 122.535 1.159 . . . . 0.0 113.624 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -137.44 129.51 29.14 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.303 1.041 . . . . 0.0 108.405 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.01 -54.46 15.08 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.08 157.96 8.3 Favored Glycine 0 CA--C 1.544 1.897 0 CA-C-O 122.525 1.07 . . . . 0.0 115.555 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.22 101.13 15.37 Favored Pre-proline 0 CA--C 1.575 1.912 0 CA-C-O 117.924 -1.036 . . . . 0.0 108.665 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.41 -37.17 7.95 Favored 'Trans proline' 0 CA--C 1.566 2.085 0 C-N-CA 122.689 2.259 . . . . 0.0 117.752 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -76.89 134.2 39.05 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 119.193 0.906 . . . . 0.0 112.888 174.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.8 tt -57.06 -41.25 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 168.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.86 -49.32 49.7 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.81 -45.11 90.69 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 171.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -62.77 -53.73 49.9 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 171.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.71 -46.32 84.54 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 172.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -56.95 -50.98 70.97 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 169.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.3 tp -56.65 -45.63 81.53 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 169.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.0 -42.18 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.237 171.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.93 -43.28 77.25 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 165.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -58.32 -48.01 81.89 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.6 -23.64 63.56 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.866 2.172 . . . . 0.0 116.866 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -61.63 -43.14 99.41 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 156.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.23 -47.2 90.1 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 117.576 1.79 . . . . 0.0 117.576 166.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -76.48 88.82 3.24 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 118.317 1.058 . . . . 0.0 112.119 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.48 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 CA--C 1.578 2.032 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.49 -28.45 26.54 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 N-CA-C 118.428 2.434 . . . . 0.0 118.428 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.36 -47.08 80.65 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 169.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.92 -38.77 79.73 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 161.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.47 -38.46 80.22 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 119.009 2.364 . . . . 0.0 119.009 166.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -55.63 -45.9 77.51 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 163.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.49 -47.75 84.31 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 t -57.83 -39.87 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 168.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -55.07 -20.82 10.58 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 169.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.52 -36.8 24.99 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 119.525 2.57 . . . . 0.0 119.525 160.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -57.87 -41.74 83.09 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 163.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -76.59 -34.18 58.41 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -52.6 -25.95 12.11 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 119.061 2.986 . . . . 0.0 119.061 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.18 -25.89 15.35 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 162.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.5 m -128.55 -34.32 2.02 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -108.0 142.12 38.62 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.547 1.139 . . . . 0.0 112.922 -169.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -103.1 157.16 17.19 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.244 1.021 . . . . 0.0 111.814 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.68 -27.52 13.63 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -84.74 60.3 6.06 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-N 121.542 1.974 . . . . 0.0 113.982 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.6 -40.01 0.39 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 120.166 2.827 . . . . 0.0 120.166 174.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -80.32 154.99 27.44 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 124.879 1.271 . . . . 0.0 112.96 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -96.77 152.21 18.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 111.952 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -122.68 -118.93 2.5 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 121.397 -0.815 . . . . 0.0 112.742 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.7 t -73.82 -48.23 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 122.337 -0.507 . . . . 0.0 111.104 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.11 171.06 26.62 Favored Glycine 0 CA--C 1.562 3.027 0 CA-C-N 118.836 0.744 . . . . 0.0 114.775 156.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.44 175.24 9.7 Favored 'Trans proline' 0 CA--C 1.567 2.137 0 CA-C-N 121.124 2.462 . . . . 0.0 114.799 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -65.08 122.52 17.25 Favored 'General case' 0 CA--C 1.568 1.668 0 O-C-N 120.402 -1.436 . . . . 0.0 113.094 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.32 -3.68 59.04 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 116.631 2.085 . . . . 0.0 116.631 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -63.95 121.11 13.3 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 119.401 1.001 . . . . 0.0 110.792 155.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.77 42.81 16.07 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 116.413 1.325 . . . . 0.0 116.413 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -100.45 -33.69 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.9 t -74.99 105.02 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 120.652 1.569 . . . . 0.0 109.4 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.22 -26.45 22.89 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 117.761 1.864 . . . . 0.0 117.761 -160.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -66.07 142.92 57.63 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 120.978 2.389 . . . . 0.0 113.736 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.0 m -53.68 139.71 31.48 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.39 120.34 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.647 -0.658 . . . . 0.0 109.738 173.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 63.54 49.01 3.21 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -162.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.93 -27.01 13.13 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 118.875 2.31 . . . . 0.0 118.875 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.5 t -73.53 98.43 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.266 1.533 . . . . 0.0 109.966 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.25 105.65 8.48 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.369 0.667 . . . . 0.0 110.168 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.9 -52.43 0.71 Allowed Glycine 0 N--CA 1.489 2.216 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.66 -154.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -79.65 130.23 35.17 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 118.036 0.918 . . . . 0.0 111.647 171.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -81.27 90.5 6.12 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 121.581 -0.699 . . . . 0.0 111.642 177.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.91 157.38 37.95 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 t -66.87 155.02 39.5 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 174.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -59.58 -49.12 93.7 Favored Pre-proline 0 CA--C 1.577 2.003 0 CA-C-O 116.094 -1.908 . . . . 0.0 115.488 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.36 -25.14 64.01 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 CA-C-N 124.71 2.718 . . . . 0.0 117.732 166.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.5 tpp -65.22 -48.38 73.57 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.533 1.515 . . . . 0.0 114.17 164.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -58.78 -45.81 88.97 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 167.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.79 -14.7 62.52 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 118.976 2.954 . . . . 0.0 118.976 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -62.52 -53.15 59.04 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.715 1.598 . . . . 0.0 114.708 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.98 175.72 48.67 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 116.728 1.451 . . . . 0.0 116.728 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.46 -151.76 40.34 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 115.121 0.808 . . . . 0.0 115.121 -176.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -132.34 154.76 49.42 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.001 0.905 . . . . 0.0 111.568 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -76.04 76.16 2.91 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 123.01 1.386 . . . . 0.0 112.877 172.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -72.58 160.17 83.5 Favored Pre-proline 0 CA--C 1.576 1.964 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.386 171.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.27 -32.39 95.82 Favored 'Trans proline' 0 CA--C 1.571 2.366 0 N-CA-C 117.504 2.079 . . . . 0.0 117.504 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -64.06 -52.71 58.05 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 163.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.77 80.55 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 172.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.9 mt -60.9 -45.22 95.5 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 166.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -55.81 -43.56 77.01 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 121.583 1.992 . . . . 0.0 116.207 167.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -61.72 -56.02 24.03 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 120.029 1.286 . . . . 0.0 114.333 169.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.54 -39.87 95.0 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.0 mt -72.2 -22.67 61.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 169.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.5 m -62.48 -52.53 63.13 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.347 1.885 . . . . 0.0 113.365 163.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -151.35 113.11 3.03 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-N 119.902 1.228 . . . . 0.0 109.088 167.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.94 -47.8 0.16 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 CA-C-N 122.752 2.019 . . . . 0.0 116.91 -174.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -67.27 -26.3 66.49 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.77 -42.47 86.06 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 161.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.53 -58.56 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.432 1.014 . . . . 0.0 112.617 175.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.51 99.89 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -74.91 98.85 3.66 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-O 121.477 0.656 . . . . 0.0 111.725 -177.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.08 18.33 10.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 -166.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -69.92 138.37 52.36 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.268 2.034 . . . . 0.0 112.003 163.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -73.95 8.76 1.84 Allowed 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.4 ttt -78.4 99.05 6.23 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.708 -1.245 . . . . 0.0 111.795 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.99 73.33 4.55 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 122.504 1.145 . . . . 0.0 113.702 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -135.99 130.15 33.16 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.229 1.012 . . . . 0.0 108.507 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.11 -54.39 18.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.24 159.93 9.27 Favored Glycine 0 CA--C 1.544 1.862 0 N-CA-C 115.909 1.124 . . . . 0.0 115.909 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.0 mt -102.39 98.96 11.66 Favored Pre-proline 0 CA--C 1.575 1.908 0 C-N-CA 123.903 0.881 . . . . 0.0 108.932 168.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.61 -34.05 15.89 Favored 'Trans proline' 0 CA--C 1.567 2.131 0 C-N-CA 122.592 2.195 . . . . 0.0 117.623 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -76.98 136.0 38.72 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 119.214 0.916 . . . . 0.0 113.064 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 tt -57.12 -43.18 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 167.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -54.57 -46.15 73.64 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.18 -45.97 83.23 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 75.7 mtm-85 -66.49 -52.48 45.57 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 172.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.56 -46.62 86.5 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -57.2 -49.33 76.33 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 169.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.6 tp -59.28 -46.45 88.5 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 170.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.72 -40.47 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-N 120.099 1.318 . . . . 0.0 112.976 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.77 -44.82 74.03 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 163.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -58.55 -47.78 83.09 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 167.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.1 mt -71.94 -23.01 61.39 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.29 -43.24 99.27 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 155.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.7 -41.91 98.84 Favored Glycine 0 CA--C 1.554 2.481 0 N-CA-C 118.056 1.982 . . . . 0.0 118.056 166.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -81.47 83.6 6.93 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 118.527 1.164 . . . . 0.0 111.351 170.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 . . . . . 0 N--CA 1.487 1.396 0 O-C-N 121.472 -0.768 . . . . 0.0 109.58 173.925 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 CA--C 1.572 1.824 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -57.15 -34.64 98.12 Favored 'Trans proline' 0 CA--C 1.566 2.108 0 N-CA-C 119.605 2.887 . . . . 0.0 119.605 172.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.83 76.75 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.31 -42.35 77.48 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 162.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.97 -36.71 91.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 169.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.88 -46.96 78.16 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 163.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -57.62 -46.81 83.64 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 168.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.22 -39.45 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -55.21 -18.46 6.03 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.24 -37.94 6.26 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 119.6 2.6 . . . . 0.0 119.6 158.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.25 -38.72 88.54 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 164.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -79.42 -37.1 37.9 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -56.28 -27.77 56.47 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 120.133 3.382 . . . . 0.0 120.133 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.24 -33.17 67.29 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.812 2.153 . . . . 0.0 116.812 168.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.6 m -103.69 -35.95 8.06 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -112.01 142.5 44.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -167.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -107.9 148.6 29.39 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.997 0.903 . . . . 0.0 113.288 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.97 10.29 39.8 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 171.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -123.72 62.29 1.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 120.388 1.449 . . . . 0.0 110.999 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.12 -15.72 0.71 Allowed Glycine 0 CA--C 1.558 2.768 0 N-CA-C 121.616 3.406 . . . . 0.0 121.616 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -90.02 161.47 15.84 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 119.215 1.508 . . . . 0.0 114.489 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -130.02 141.4 50.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.228 -1.545 . . . . 0.0 110.978 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.19 -98.8 0.18 Allowed Glycine 0 N--CA 1.489 2.186 0 O-C-N 121.732 -0.605 . . . . 0.0 112.964 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.96 -51.76 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 117.275 0.537 . . . . 0.0 111.406 167.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.03 175.97 17.64 Favored Glycine 0 CA--C 1.562 2.986 0 N-CA-C 115.067 0.787 . . . . 0.0 115.067 164.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.06 -179.06 3.97 Favored 'Trans proline' 0 CA--C 1.569 2.249 0 C-N-CA 122.723 2.282 . . . . 0.0 114.569 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -76.97 138.09 39.43 Favored 'General case' 0 CA--C 1.566 1.593 0 O-C-N 120.585 -1.322 . . . . 0.0 113.325 173.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.71 -2.57 34.97 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -65.15 113.44 3.97 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.865 1.666 . . . . 0.0 111.964 164.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.34 54.72 6.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 -168.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.2 -38.15 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 171.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -66.88 107.59 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 120.248 1.385 . . . . 0.0 110.118 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.26 -17.08 59.73 Favored Glycine 0 CA--C 1.551 2.342 0 N-CA-C 118.649 2.22 . . . . 0.0 118.649 -163.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -71.69 142.14 49.85 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.177 2.489 . . . . 0.0 113.107 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -59.19 136.56 57.99 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.82 126.66 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 123.465 0.706 . . . . 0.0 111.134 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 59.05 39.88 22.78 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -166.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.72 3.74 49.63 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 119.353 2.501 . . . . 0.0 119.353 -171.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.79 104.17 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.875 1.838 . . . . 0.0 108.375 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.75 86.24 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.458 0.647 . . . . 0.0 111.704 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.55 -46.93 0.37 Allowed Glycine 0 CA--C 1.545 1.965 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.123 -158.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -86.15 137.83 32.36 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 118.814 1.307 . . . . 0.0 112.184 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.1 85.77 3.59 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.189 0.995 . . . . 0.0 113.191 172.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -77.41 142.99 38.96 Favored 'General case' 0 CA--C 1.567 1.628 0 O-C-N 121.408 -0.808 . . . . 0.0 112.753 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.5 p -70.03 157.63 37.17 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -54.03 -49.27 90.73 Favored Pre-proline 0 CA--C 1.578 2.022 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.24 -28.0 40.56 Favored 'Trans proline' 0 CA--C 1.568 2.192 0 CA-C-N 124.328 2.582 . . . . 0.0 117.154 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -62.67 -47.21 84.68 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 120.379 1.445 . . . . 0.0 114.559 163.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -58.32 -47.05 84.95 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 167.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.59 -17.44 63.54 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 118.916 2.932 . . . . 0.0 118.916 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -58.38 -51.39 70.02 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.64 1.564 . . . . 0.0 114.528 175.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.84 170.65 35.8 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 117.732 1.853 . . . . 0.0 117.732 165.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.86 -143.11 26.23 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 122.088 -0.654 . . . . 0.0 114.629 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -129.89 154.12 47.62 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.669 0.747 . . . . 0.0 111.759 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -76.26 76.75 3.05 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.929 1.347 . . . . 0.0 112.977 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.3 p -74.11 160.05 82.53 Favored Pre-proline 0 CA--C 1.573 1.865 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.662 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.4 -29.04 87.12 Favored 'Trans proline' 0 CA--C 1.569 2.233 0 N-CA-C 117.461 2.062 . . . . 0.0 117.461 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -66.12 -54.7 22.27 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 163.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.97 88.89 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.6 -44.55 93.36 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 164.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -57.73 -42.7 84.37 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -63.43 -55.84 21.01 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.967 1.258 . . . . 0.0 114.226 169.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -60.79 -42.2 97.13 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 71.2 mt -73.87 -16.33 61.12 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.9 m -64.1 -54.62 31.02 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 121.296 1.862 . . . . 0.0 112.788 161.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.98 115.29 3.45 Favored Pre-proline 0 CA--C 1.575 1.922 0 CA-C-N 119.625 1.102 . . . . 0.0 108.805 167.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.32 -45.78 0.32 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 CA-C-N 122.586 1.959 . . . . 0.0 116.753 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -66.11 -33.24 75.32 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.57 95.84 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 165.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.91 -58.14 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-N 118.843 0.747 . . . . 0.0 112.095 171.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.94 98.2 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -73.21 101.32 3.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.877 . . . . 0.0 111.474 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.5 19.96 10.72 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 118.559 2.184 . . . . 0.0 118.559 -164.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -76.35 132.36 39.7 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 119.964 1.882 . . . . 0.0 110.682 156.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.282 64.2 pttt -82.54 26.83 0.54 Allowed 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 170.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.02 101.3 1.37 Allowed 'General case' 0 CA--C 1.567 1.62 0 O-C-N 120.501 -1.375 . . . . 0.0 109.919 159.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.06 73.42 4.62 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.882 1.325 . . . . 0.0 112.166 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -152.42 123.33 7.48 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.094 -166.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.96 -49.63 60.61 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.35 164.42 13.09 Favored Glycine 0 CA--C 1.543 1.824 0 CA-C-O 122.686 1.159 . . . . 0.0 115.557 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.8 mt -101.99 95.16 5.25 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 164.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.33 -34.1 16.77 Favored 'Trans proline' 0 CA--C 1.567 2.154 0 C-N-CA 122.648 2.232 . . . . 0.0 117.343 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -74.64 132.82 42.04 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-O 121.885 0.85 . . . . 0.0 112.913 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.06 -42.97 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.18 -48.27 68.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.05 -43.88 78.3 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -64.5 -52.58 57.14 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 170.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.87 82.85 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -60.1 -48.59 81.08 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 172.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.2 tp -61.2 -45.71 93.45 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 172.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.25 60.6 mt -61.96 -41.09 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 119.79 1.177 . . . . 0.0 112.783 171.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.7 -43.3 80.4 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 164.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -56.71 -48.1 78.47 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 164.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.86 -23.23 61.48 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -64.9 -42.92 94.36 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.326 -1.484 . . . . 0.0 114.684 155.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.53 -56.75 23.54 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.837 1.495 . . . . 0.0 116.837 167.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -82.69 82.38 8.07 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.544 1.172 . . . . 0.0 112.285 165.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 . . . . . 0 C--O 1.259 1.6 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.947 158.626 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtm . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.675 0.274 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.46 73.63 0.96 Allowed 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.037 0.923 . . . . 0.0 112.347 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -101.97 119.67 56.11 Favored Pre-proline 0 CA--C 1.576 1.979 0 C-N-CA 124.095 0.958 . . . . 0.0 111.24 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.68 -28.82 30.51 Favored 'Trans proline' 0 CA--C 1.568 2.211 0 N-CA-C 118.364 2.409 . . . . 0.0 118.364 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.41 -50.32 70.29 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.52 72.08 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 163.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.48 -31.58 66.99 Favored Glycine 0 CA--C 1.55 2.27 0 N-CA-C 118.679 2.231 . . . . 0.0 118.679 165.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.67 -42.51 98.04 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 168.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.11 -40.7 98.38 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 167.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.92 -41.61 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -58.27 -24.8 60.62 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 168.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.19 -29.7 29.91 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 119.495 2.558 . . . . 0.0 119.495 163.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -59.52 -35.81 74.88 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 160.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.79 -33.64 30.73 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 173.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -46.69 -41.75 15.44 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 119.724 3.231 . . . . 0.0 119.724 -173.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.39 -35.95 72.81 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.2 m -91.82 -43.75 9.34 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 169.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -114.04 132.74 55.9 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.318 1.047 . . . . 0.0 111.196 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -117.62 122.68 44.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 170.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.2 mt -47.16 -51.79 17.31 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -92.14 76.78 5.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.083 0.944 . . . . 0.0 111.237 -157.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.89 -21.69 0.96 Allowed Glycine 0 CA--C 1.556 2.614 0 N-CA-C 120.523 2.969 . . . . 0.0 120.523 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -91.42 116.59 28.97 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 118.83 1.315 . . . . 0.0 112.043 -167.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -97.39 121.76 39.66 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.756 0.822 . . . . 0.0 109.972 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.11 -109.88 3.06 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.82 -0.55 . . . . 0.0 113.329 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.19 -47.78 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 117.186 0.493 . . . . 0.0 111.055 167.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.94 170.85 25.41 Favored Glycine 0 CA--C 1.559 2.833 0 N-CA-C 115.444 0.937 . . . . 0.0 115.444 163.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -69.14 169.03 19.05 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 C-N-CA 122.686 2.258 . . . . 0.0 115.111 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -70.07 123.65 22.1 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 120.536 -1.352 . . . . 0.0 112.326 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.4 mt -92.03 11.51 25.04 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 -173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.5 122.67 13.21 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 121.555 1.979 . . . . 0.0 113.267 171.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.85 43.66 94.64 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 118.683 2.233 . . . . 0.0 118.683 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.254 5.2 p -71.65 -23.06 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.1 t -73.82 107.42 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 124.311 1.044 . . . . 0.0 109.565 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.34 -3.82 79.83 Favored Glycine 0 CA--C 1.555 2.535 0 N-CA-C 119.039 2.376 . . . . 0.0 119.039 -162.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -84.83 143.13 29.27 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.802 2.301 . . . . 0.0 112.983 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.2 m -60.74 137.91 58.15 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.9 t -67.06 123.1 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.905 -0.497 . . . . 0.0 110.258 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.266 . . 62.95 50.0 3.34 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -163.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.63 -16.49 28.84 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 119.399 2.519 . . . . 0.0 119.399 -171.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.52 97.67 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 120.048 1.924 . . . . 0.0 109.599 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.21 109.05 5.01 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 123.19 0.596 . . . . 0.0 110.88 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.36 -57.07 0.67 Allowed Glycine 0 N--CA 1.49 2.275 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.018 -157.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -82.42 123.37 29.06 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 117.676 0.738 . . . . 0.0 110.417 167.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.13 124.85 29.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.478 -0.763 . . . . 0.0 110.735 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -94.55 173.53 7.57 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 121.879 0.847 . . . . 0.0 112.36 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.5 t -71.55 154.38 41.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.294 -1.504 . . . . 0.0 113.114 171.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -59.53 -49.66 91.08 Favored Pre-proline 0 CA--C 1.577 1.986 0 CA-C-O 115.959 -1.972 . . . . 0.0 115.239 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.29 -24.39 71.97 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 CA-C-N 124.805 2.752 . . . . 0.0 117.895 166.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.8 tpp -66.86 -49.34 66.01 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.646 1.566 . . . . 0.0 114.158 164.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -59.21 -43.07 92.3 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -12.42 61.47 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 118.862 2.912 . . . . 0.0 118.862 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -65.16 -55.62 17.6 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 120.835 1.652 . . . . 0.0 114.356 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.57 177.63 50.47 Favored Glycine 0 CA--C 1.548 2.104 0 N-CA-C 116.648 1.419 . . . . 0.0 116.648 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.06 -154.18 44.42 Favored Glycine 0 CA--C 1.548 2.147 0 N-CA-C 115.332 0.893 . . . . 0.0 115.332 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -130.7 154.36 48.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.149 0.976 . . . . 0.0 112.261 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -76.64 73.3 3.33 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 123.081 1.42 . . . . 0.0 113.254 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.5 p -70.11 159.6 83.78 Favored Pre-proline 0 CA--C 1.575 1.933 0 C-N-CA 124.516 1.127 . . . . 0.0 112.312 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -57.06 -34.7 98.19 Favored 'Trans proline' 0 CA--C 1.568 2.197 0 N-CA-C 117.794 2.19 . . . . 0.0 117.794 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.82 -45.56 74.35 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 164.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.64 -43.88 85.19 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 170.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.05 -47.37 86.14 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 165.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -55.69 -44.46 77.39 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 121.634 2.016 . . . . 0.0 116.324 169.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -61.41 -55.63 29.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 119.93 1.241 . . . . 0.0 114.111 170.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -60.97 -41.38 96.28 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.1 mt -73.13 -21.66 60.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -63.76 -52.03 62.23 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-N 120.942 1.701 . . . . 0.0 113.352 162.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -150.12 112.61 3.31 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-N 120.146 1.339 . . . . 0.0 109.299 168.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.96 -47.44 0.17 Allowed 'Trans proline' 0 CA--C 1.56 1.819 0 CA-C-N 122.672 1.99 . . . . 0.0 116.933 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.45 -26.53 65.55 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.92 -41.54 86.89 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 161.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.0 t -71.45 -58.86 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.416 1.007 . . . . 0.0 112.629 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.74 100.92 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -74.94 100.69 4.19 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 121.366 0.603 . . . . 0.0 111.685 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.52 18.47 12.94 Favored Glycine 0 CA--C 1.554 2.491 0 N-CA-C 118.58 2.192 . . . . 0.0 118.58 -165.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -71.77 137.46 47.69 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.141 1.971 . . . . 0.0 111.997 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -73.51 6.85 2.71 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 167.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.412 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.5 ttt -73.28 94.82 2.05 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 120.415 1.461 . . . . 0.0 111.451 171.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.62 70.75 5.01 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.754 1.264 . . . . 0.0 113.431 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -130.49 130.45 44.2 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.512 1.125 . . . . 0.0 107.988 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.06 -54.96 22.03 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.98 155.06 6.47 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.0 mt -103.97 98.14 12.84 Favored Pre-proline 0 CA--C 1.573 1.846 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.373 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.03 -33.32 15.78 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 122.572 2.181 . . . . 0.0 117.644 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.03 133.1 36.82 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.102 0.865 . . . . 0.0 112.361 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.1 tt -56.15 -44.58 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 171.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.9 -45.84 71.24 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.16 -47.72 80.49 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 169.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 75.0 mtm-85 -64.73 -50.96 64.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.35 93.11 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -56.9 -50.17 73.32 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 168.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.0 tp -54.89 -48.67 72.7 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.75 -41.77 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 119.859 1.209 . . . . 0.0 113.411 171.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.21 -43.12 74.18 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 164.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -62.44 -44.68 95.85 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 168.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.2 mt -64.08 -27.86 69.39 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 169.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.22 -44.3 76.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 120.261 1.391 . . . . 0.0 114.657 158.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -53.96 -54.37 31.62 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 117.44 1.736 . . . . 0.0 117.44 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -84.07 81.46 8.79 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 118.539 1.17 . . . . 0.0 111.649 160.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 C--O 1.253 1.249 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 155.149 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.618 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.91 70.37 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.104 0.865 . . . . 0.0 113.06 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -102.64 118.55 58.26 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.009 0.924 . . . . 0.0 111.118 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.84 -28.5 24.79 Favored 'Trans proline' 0 CA--C 1.569 2.25 0 N-CA-C 118.523 2.47 . . . . 0.0 118.523 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.24 -46.83 79.01 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.29 -37.6 78.1 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 159.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.95 -35.5 76.23 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 119.14 2.416 . . . . 0.0 119.14 168.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.12 -42.93 91.74 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 163.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.44 -43.61 96.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.1 -45.01 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 166.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -56.88 -26.61 59.14 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.39 -34.1 6.24 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 161.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -59.2 -35.75 74.15 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 162.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.78 -20.23 43.08 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 171.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -73.86 67.6 1.23 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 123.802 1.763 . . . . 0.0 115.361 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.56 -57.18 0.1 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.365 1.466 . . . . 0.0 108.258 168.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.7 m -71.91 -44.26 63.97 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 166.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -112.42 138.29 49.38 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 119.925 1.238 . . . . 0.0 111.756 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -131.68 123.09 27.05 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.618 0.723 . . . . 0.0 109.774 -171.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.9 mt -72.48 -10.94 60.41 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.9 58.8 1.03 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 120.998 1.726 . . . . 0.0 112.052 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.02 15.6 36.73 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 121.129 3.212 . . . . 0.0 121.129 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -103.73 129.61 51.12 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 119.192 1.496 . . . . 0.0 110.897 -174.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.53 102.51 10.37 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.29 -105.57 3.04 Favored Glycine 0 N--CA 1.49 2.292 0 O-C-N 121.998 -0.439 . . . . 0.0 112.873 -174.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.447 ' O ' HMD3 ' A' ' 101' ' ' HEC . 58.3 t -73.4 -47.06 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.45 167.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.95 167.01 14.22 Favored Glycine 0 CA--C 1.56 2.899 0 CA-C-N 119.315 0.961 . . . . 0.0 114.711 164.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.7 173.03 13.25 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 CA-C-N 120.803 2.302 . . . . 0.0 115.799 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -70.18 122.39 19.38 Favored 'General case' 0 CA--C 1.57 1.713 0 O-C-N 120.561 -1.337 . . . . 0.0 112.43 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.76 7.72 38.22 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -65.07 127.49 31.84 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 120.86 1.664 . . . . 0.0 111.671 164.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.51 24.19 65.94 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 118.26 2.064 . . . . 0.0 118.26 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -79.34 -26.81 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 120.319 2.06 . . . . 0.0 116.259 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.9 t -77.89 105.16 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 120.208 1.367 . . . . 0.0 109.192 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.37 -7.93 64.2 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 118.72 2.248 . . . . 0.0 118.72 -160.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -81.32 142.76 32.77 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 120.987 2.393 . . . . 0.0 113.07 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.3 m -60.12 139.09 57.72 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -67.3 123.23 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.919 -0.488 . . . . 0.0 110.318 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 62.16 49.48 4.4 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -162.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.94 -15.63 30.54 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 119.268 2.467 . . . . 0.0 119.268 -170.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.1 t -83.76 96.67 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 119.965 1.882 . . . . 0.0 109.467 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.35 107.83 3.96 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-O 121.381 0.61 . . . . 0.0 111.006 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.68 -56.1 0.63 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.195 -157.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -83.07 127.12 33.29 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 117.791 0.796 . . . . 0.0 110.777 168.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -81.37 115.72 20.86 Favored 'General case' 0 CA--C 1.565 1.548 0 O-C-N 121.548 -0.72 . . . . 0.0 110.937 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -87.67 168.42 13.02 Favored 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 123.541 0.736 . . . . 0.0 112.529 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 p -73.33 152.58 40.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.106 -1.621 . . . . 0.0 113.056 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -57.57 -42.32 95.07 Favored Pre-proline 0 CA--C 1.574 1.895 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.31 -26.71 41.32 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 CA-C-N 125.017 2.828 . . . . 0.0 117.184 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.9 tpp -63.9 -46.32 85.4 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 120.451 1.478 . . . . 0.0 114.091 162.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.21 -46.63 82.74 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 166.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.81 -14.63 61.56 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 118.87 2.915 . . . . 0.0 118.87 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -62.55 -53.37 55.73 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 120.652 1.569 . . . . 0.0 114.84 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.61 -179.44 50.89 Favored Glycine 0 CA--C 1.547 2.045 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.61 -154.58 48.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -174.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -131.08 155.12 47.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.105 0.955 . . . . 0.0 112.356 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.32 75.15 3.11 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.968 1.366 . . . . 0.0 112.992 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.8 p -72.48 159.38 85.52 Favored Pre-proline 0 CA--C 1.576 1.949 0 C-N-CA 124.428 1.091 . . . . 0.0 112.191 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -57.31 -32.5 93.96 Favored 'Trans proline' 0 CA--C 1.572 2.391 0 N-CA-C 117.636 2.129 . . . . 0.0 117.636 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -64.82 -52.97 53.93 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 164.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.87 -43.73 86.17 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.5 mt -56.93 -50.76 71.61 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 167.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.7 pp0? -64.67 -32.73 74.53 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -61.34 -56.45 20.23 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 162.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -59.74 -41.5 91.06 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.2 mt -74.82 -14.56 60.7 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 171.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -67.54 -65.46 0.68 Allowed 'General case' 0 CA--C 1.57 1.714 0 CA-C-N 120.646 1.567 . . . . 0.0 111.308 156.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -133.06 101.58 13.66 Favored Pre-proline 0 CA--C 1.571 1.766 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.57 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.42 -51.11 0.14 Allowed 'Trans proline' 0 CA--C 1.562 1.917 0 CA-C-N 122.788 2.031 . . . . 0.0 115.693 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.58 -19.18 62.88 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.59 -43.21 56.66 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.692 1.587 . . . . 0.0 114.992 162.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.54 -57.14 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 119.423 1.011 . . . . 0.0 112.748 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.3 t -102.44 102.65 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -72.68 102.71 3.39 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-O 121.26 0.552 . . . . 0.0 111.44 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.58 26.45 9.2 Favored Glycine 0 CA--C 1.553 2.426 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -165.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -72.03 132.27 44.03 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.538 1.669 . . . . 0.0 111.254 160.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -76.03 11.04 1.58 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 166.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -73.52 99.03 2.92 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 120.848 -1.157 . . . . 0.0 111.278 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.4 72.9 6.05 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 122.564 1.174 . . . . 0.0 112.982 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -128.61 135.43 49.32 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 124.484 1.114 . . . . 0.0 108.662 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.46 -58.15 4.34 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.43 149.88 5.18 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-N 118.931 0.787 . . . . 0.0 114.944 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -102.01 99.15 11.52 Favored Pre-proline 0 CA--C 1.572 1.809 0 CA-C-O 117.774 -1.108 . . . . 0.0 109.441 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.43 -35.32 18.27 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 122.657 2.238 . . . . 0.0 117.624 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -72.37 127.42 32.51 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -58.33 -39.95 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 167.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -53.84 -46.59 71.24 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.048 1.869 . . . . 0.0 116.048 169.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.45 -44.43 89.19 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -63.75 -51.27 65.66 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.12 -43.75 91.98 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 170.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -54.33 -54.2 43.63 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.932 1.242 . . . . 0.0 114.017 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.1 tp -55.08 -47.65 74.6 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 170.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.251 61.7 mt -62.98 -41.29 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 117.396 -1.288 . . . . 0.0 113.116 173.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.7 -43.99 69.43 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 163.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -60.75 -47.6 85.59 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 167.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 52.6 mt -63.73 -31.29 72.41 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 171.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.86 -42.66 99.84 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 162.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.58 99.48 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 117.827 1.891 . . . . 0.0 117.827 163.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -83.11 72.5 10.12 Favored 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 118.356 1.078 . . . . 0.0 112.408 172.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.603 175.609 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.647 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.6 ttm . . . . . 0 CA--C 1.562 1.417 0 CA-C-O 121.142 0.496 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.279 . . 61.66 29.46 18.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 118.606 2.817 . . . . 0.0 118.606 -174.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -98.9 113.18 64.3 Favored Pre-proline 0 CA--C 1.576 1.958 0 O-C-N 120.883 -1.136 . . . . 0.0 110.355 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.04 -26.75 25.95 Favored 'Trans proline' 0 CA--C 1.568 2.219 0 N-CA-C 118.38 2.415 . . . . 0.0 118.38 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.82 85.59 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 167.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.85 -39.46 81.36 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 161.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.41 -36.49 77.06 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 119.083 2.393 . . . . 0.0 119.083 168.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -54.39 -47.6 72.51 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 162.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -59.62 -44.18 93.54 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.33 -42.72 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 119.527 1.058 . . . . 0.0 113.831 167.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -55.85 -26.98 49.44 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.93 -34.11 10.94 Favored Glycine 0 N--CA 1.5 2.928 0 N-CA-C 119.818 2.687 . . . . 0.0 119.818 166.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -58.32 -39.64 79.95 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 162.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -78.42 -32.88 48.87 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -45.32 -45.05 12.07 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 -174.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.46 -37.45 70.32 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 m -91.95 -43.31 9.53 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 171.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -112.43 128.04 56.2 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.372 0.987 . . . . 0.0 111.449 -169.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -113.37 130.35 56.31 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.992 0.901 . . . . 0.0 111.265 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.6 mt -74.46 -24.3 59.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.98 56.86 3.63 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 121.117 1.78 . . . . 0.0 113.095 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.39 16.21 34.58 Favored Glycine 0 CA--C 1.558 2.772 0 N-CA-C 120.624 3.009 . . . . 0.0 120.624 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -105.75 133.05 51.11 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.65 1.725 . . . . 0.0 112.395 -171.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.79 122.76 36.6 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.627 169.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.01 -107.37 2.56 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.85 -0.531 . . . . 0.0 112.089 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.51 -50.21 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-N 117.202 0.501 . . . . 0.0 110.987 165.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.04 170.75 21.01 Favored Glycine 0 CA--C 1.56 2.879 0 N-CA-C 115.046 0.778 . . . . 0.0 115.046 163.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.77 176.6 6.56 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 122.627 2.218 . . . . 0.0 116.085 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -71.77 120.18 16.99 Favored 'General case' 0 CA--C 1.566 1.58 0 O-C-N 120.217 -1.552 . . . . 0.0 112.406 173.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.97 -4.68 57.22 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -66.04 115.96 6.64 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-N 119.066 0.848 . . . . 0.0 110.51 160.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.44 39.61 10.8 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 -171.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 p -97.29 -31.84 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.29 109.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 120.871 1.669 . . . . 0.0 108.971 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.69 -14.57 64.63 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 118.778 2.271 . . . . 0.0 118.778 -162.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -75.3 143.11 43.12 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 121.103 2.452 . . . . 0.0 112.965 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.1 m -59.27 142.35 52.13 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.6 t -67.22 122.58 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.83 -0.544 . . . . 0.0 110.348 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 63.47 53.48 2.11 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -162.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.24 -11.28 29.91 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 119.38 2.512 . . . . 0.0 119.38 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.0 t -86.14 95.44 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 120.245 2.023 . . . . 0.0 109.032 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -69.35 118.22 11.97 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.943 0.897 . . . . 0.0 112.199 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.85 -52.56 0.81 Allowed Glycine 0 N--CA 1.492 2.396 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.788 -159.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -79.55 120.93 24.6 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 117.698 0.749 . . . . 0.0 110.918 171.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -76.36 118.29 18.91 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.635 -0.666 . . . . 0.0 110.541 170.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -88.24 169.95 11.43 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.608 0.763 . . . . 0.0 111.217 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.2 p -71.24 157.07 38.76 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 119.832 -1.793 . . . . 0.0 113.43 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -54.74 -50.0 88.29 Favored Pre-proline 0 CA--C 1.578 2.028 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.46 -24.96 48.76 Favored 'Trans proline' 0 CA--C 1.564 1.995 0 CA-C-N 124.349 2.589 . . . . 0.0 117.629 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.2 tpp -65.61 -48.57 71.82 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 120.633 1.56 . . . . 0.0 114.02 163.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -58.97 -44.37 91.52 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 168.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -11.04 60.39 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 118.959 2.948 . . . . 0.0 118.959 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -63.29 -54.2 40.84 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.862 1.664 . . . . 0.0 114.92 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.47 175.45 50.2 Favored Glycine 0 CA--C 1.547 2.062 0 N-CA-C 116.54 1.376 . . . . 0.0 116.54 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.04 -155.75 44.77 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 115.217 0.847 . . . . 0.0 115.217 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -131.85 156.2 46.48 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.891 0.853 . . . . 0.0 112.087 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -76.66 76.17 3.33 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 123.336 1.541 . . . . 0.0 112.831 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.0 p -76.46 160.75 76.76 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.966 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -57.21 -35.39 98.89 Favored 'Trans proline' 0 CA--C 1.571 2.337 0 N-CA-C 117.696 2.152 . . . . 0.0 117.696 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.29 -51.47 67.55 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 164.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.01 94.34 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.6 mt -56.42 -52.05 66.11 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 168.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.293 2.8 pp0? -63.06 -36.56 83.99 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -61.37 -54.46 43.37 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 165.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -57.55 -44.35 85.14 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.3 mt -72.65 -13.34 61.34 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 171.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -64.04 -53.84 43.55 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 120.997 1.726 . . . . 0.0 112.788 161.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.7 103.99 2.33 Favored Pre-proline 0 CA--C 1.577 1.994 0 CA-C-N 119.623 1.101 . . . . 0.0 108.59 173.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.02 -46.51 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 N-CA-C 117.429 2.05 . . . . 0.0 117.429 -168.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.65 -21.28 66.29 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.91 -48.99 56.39 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 161.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.68 -55.71 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 119.521 1.055 . . . . 0.0 113.255 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.23 104.53 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 171.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.15 96.53 2.24 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 121.371 0.605 . . . . 0.0 111.786 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.39 28.29 5.82 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 118.287 2.075 . . . . 0.0 118.287 -167.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -76.25 135.5 39.67 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.526 1.663 . . . . 0.0 111.463 162.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -72.3 7.97 1.53 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 167.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -73.44 99.01 2.87 Favored 'General case' 0 CA--C 1.564 1.512 0 O-C-N 120.63 -1.294 . . . . 0.0 111.395 170.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.41 74.87 4.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 122.737 1.255 . . . . 0.0 113.082 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -138.63 131.18 28.96 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.347 1.059 . . . . 0.0 108.182 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.68 -55.57 10.99 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.27 155.08 6.99 Favored Glycine 0 CA--C 1.545 1.95 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 99.3 mt -103.24 97.68 10.48 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 117.889 -1.053 . . . . 0.0 108.855 170.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.91 -32.95 27.75 Favored 'Trans proline' 0 CA--C 1.568 2.197 0 C-N-CA 122.648 2.232 . . . . 0.0 117.819 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -73.46 118.66 16.68 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 123.941 0.896 . . . . 0.0 113.252 174.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.97 -40.1 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 169.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -53.06 -47.73 68.23 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 170.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -61.41 -41.69 97.54 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 169.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 86.7 mtm-85 -60.12 -50.49 73.47 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.73 -45.58 81.86 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 167.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -54.55 -52.35 62.33 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -57.81 -45.7 85.73 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 170.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.258 62.6 mt -63.9 -41.6 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.161 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.46 -43.63 71.84 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 163.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -58.34 -49.94 75.43 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 166.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.1 mt -68.82 -26.64 65.28 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.29 -39.86 84.29 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 158.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.85 -47.52 82.09 Favored Glycine 0 CA--C 1.552 2.402 0 N-CA-C 117.357 1.703 . . . . 0.0 117.357 164.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -77.16 83.81 3.65 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 118.424 1.112 . . . . 0.0 112.344 173.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.188 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.634 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 mmt . . . . . 0 CA--C 1.567 1.623 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.73 70.65 1.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.055 -1.028 . . . . 0.0 112.36 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -105.72 111.36 64.69 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.703 -175.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.57 -28.25 31.88 Favored 'Trans proline' 0 CA--C 1.566 2.115 0 N-CA-C 118.42 2.431 . . . . 0.0 118.42 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.11 96.86 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 168.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.68 95.13 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 161.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.87 -38.06 72.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 119.146 2.418 . . . . 0.0 119.146 166.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -55.19 -48.8 73.29 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 164.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -59.75 -43.55 94.22 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.57 -38.15 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 167.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.77 -20.61 15.49 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 169.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.78 -38.51 4.41 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 119.636 2.615 . . . . 0.0 119.636 156.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.97 -31.91 73.1 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 166.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -87.91 -33.53 18.47 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -57.91 -32.09 67.4 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 120.505 3.521 . . . . 0.0 120.505 -166.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.02 82.36 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 171.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.2 m -87.41 -44.14 11.57 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -109.22 143.83 38.15 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.339 1.056 . . . . 0.0 112.872 -168.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -118.51 150.28 39.87 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.381 1.086 . . . . 0.0 112.139 -172.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -104.07 1.89 31.46 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -115.52 57.63 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.422 1.464 . . . . 0.0 111.548 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.69 4.87 21.26 Favored Glycine 0 CA--C 1.558 2.771 0 N-CA-C 120.492 2.957 . . . . 0.0 120.492 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -97.7 143.02 28.78 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 118.87 1.335 . . . . 0.0 112.766 -168.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.38 103.97 8.5 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.46 -105.7 3.05 Favored Glycine 0 N--CA 1.49 2.234 0 O-C-N 122.117 -0.365 . . . . 0.0 113.142 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.32 -49.75 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.848 166.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.65 163.49 16.39 Favored Glycine 0 CA--C 1.56 2.864 0 CA-C-N 118.911 0.778 . . . . 0.0 114.851 164.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.72 176.09 8.7 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 CA-C-N 120.845 2.323 . . . . 0.0 115.935 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -70.23 120.2 15.56 Favored 'General case' 0 CA--C 1.568 1.646 0 O-C-N 120.535 -1.353 . . . . 0.0 113.279 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -87.84 -4.01 58.89 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -62.95 111.7 2.27 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.349 1.431 . . . . 0.0 111.729 157.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.66 43.58 7.72 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 -173.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.09 -37.88 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 118.805 1.303 . . . . 0.0 114.491 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.39 107.8 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.898 1.226 . . . . 0.0 110.096 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.81 -19.96 52.26 Favored Glycine 0 CA--C 1.552 2.372 0 N-CA-C 118.503 2.161 . . . . 0.0 118.503 -163.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -73.01 143.63 47.49 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 120.929 2.364 . . . . 0.0 113.415 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.3 m -60.4 140.26 57.28 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.16 124.32 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 123.405 0.682 . . . . 0.0 110.824 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.39 48.72 5.79 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -164.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.05 -8.08 39.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 119.46 2.544 . . . . 0.0 119.46 -169.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.1 t -82.94 103.23 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 120.199 2.0 . . . . 0.0 109.12 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.27 90.33 0.91 Allowed 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.546 0.738 . . . . 0.0 112.081 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.27 -48.84 0.51 Allowed Glycine 0 N--CA 1.486 2.029 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.857 -160.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -81.22 132.16 35.33 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 118.098 0.949 . . . . 0.0 111.572 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -84.48 88.28 7.29 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.435 -0.79 . . . . 0.0 112.017 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -72.85 147.07 45.77 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.2 p -67.74 155.34 39.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -53.82 -49.23 90.45 Favored Pre-proline 0 CA--C 1.578 2.031 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.25 -23.6 38.73 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 CA-C-N 124.125 2.509 . . . . 0.0 117.521 170.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.1 tpp -65.4 -46.65 79.19 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 120.885 1.675 . . . . 0.0 114.147 161.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -57.84 -45.9 85.55 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 168.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.01 -11.96 61.01 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 170.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -60.4 -49.47 77.45 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.045 1.748 . . . . 0.0 114.638 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.88 164.72 36.08 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 163.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.46 -144.69 24.63 Favored Glycine 0 N--CA 1.486 2.015 0 CA-C-N 114.915 -0.642 . . . . 0.0 114.694 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -130.84 154.78 47.69 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.665 0.745 . . . . 0.0 111.493 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -76.12 76.81 2.95 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 123.149 1.452 . . . . 0.0 112.558 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -75.72 159.89 80.28 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.881 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.18 -33.75 91.33 Favored 'Trans proline' 0 CA--C 1.57 2.289 0 N-CA-C 117.66 2.139 . . . . 0.0 117.66 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.31 -50.66 59.27 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 166.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.65 -43.67 85.11 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -57.17 -50.73 71.93 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 165.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.304 1.6 pp0? -61.28 -37.24 82.47 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 175.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.43 -59.02 6.01 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 164.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -58.93 -42.83 90.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.5 mt -69.77 -17.39 63.42 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.5 m -62.71 -55.23 28.6 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.26 1.846 . . . . 0.0 112.869 164.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.23 103.32 2.42 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-N 119.496 1.044 . . . . 0.0 108.525 173.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.02 -46.63 0.37 Allowed 'Trans proline' 0 CA--C 1.558 1.686 0 N-CA-C 117.431 2.05 . . . . 0.0 117.431 -167.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.95 -25.85 68.55 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 169.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 -45.06 70.21 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 163.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.9 t -65.47 -55.3 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.558 1.072 . . . . 0.0 112.782 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.8 104.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -72.99 98.29 2.48 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-O 121.454 0.645 . . . . 0.0 111.316 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.83 23.84 7.61 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 118.657 2.223 . . . . 0.0 118.657 -168.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.4 t -75.41 134.52 40.89 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 119.615 1.708 . . . . 0.0 111.061 160.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -72.92 9.08 1.25 Allowed 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 117.409 2.374 . . . . 0.0 117.409 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -76.25 100.77 5.19 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 120.725 -1.234 . . . . 0.0 111.726 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.64 71.36 4.12 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 122.595 1.188 . . . . 0.0 113.611 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -138.63 128.03 24.49 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.85 -53.48 32.03 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.88 158.79 8.9 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 115.471 0.948 . . . . 0.0 115.471 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.7 mt -100.26 98.56 7.95 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 117.934 -1.031 . . . . 0.0 108.524 166.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.55 -36.39 11.46 Favored 'Trans proline' 0 CA--C 1.565 2.044 0 C-N-CA 122.658 2.239 . . . . 0.0 117.575 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.08 133.53 41.56 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 118.94 0.791 . . . . 0.0 112.527 175.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -57.77 -40.66 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 171.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.57 -43.25 84.37 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.78 -44.72 73.95 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 167.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -66.43 -55.27 16.52 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 173.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.66 98.07 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.64 -47.41 86.36 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.964 1.256 . . . . 0.0 114.11 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.5 HD21 HMB1 ' A' ' 101' ' ' HEC . 35.9 tp -59.39 -44.0 92.87 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 169.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.0 mt -60.55 -42.87 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 117.539 -1.22 . . . . 0.0 113.101 169.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.67 -44.05 72.97 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 164.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -58.92 -48.22 82.23 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 166.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.9 mt -69.39 -24.47 63.86 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.31 -41.21 92.99 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 156.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.3 -44.96 92.75 Favored Glycine 0 CA--C 1.554 2.5 0 N-CA-C 117.584 1.794 . . . . 0.0 117.584 163.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -79.17 82.36 5.34 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-N 118.623 1.212 . . . . 0.0 111.882 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.43 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.628 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mmt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.99 56.3 0.9 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -114.53 103.67 54.82 Favored Pre-proline 0 CA--C 1.573 1.848 0 O-C-N 120.865 -1.147 . . . . 0.0 109.807 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.71 -23.51 30.93 Favored 'Trans proline' 0 CA--C 1.568 2.203 0 N-CA-C 118.227 2.357 . . . . 0.0 118.227 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.96 -47.36 83.51 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.08 81.56 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 162.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.83 -35.03 66.22 Favored Glycine 0 CA--C 1.552 2.383 0 N-CA-C 119.114 2.405 . . . . 0.0 119.114 164.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.53 -49.77 76.5 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 168.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -59.65 -41.59 90.89 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 169.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.52 -39.16 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 169.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -56.85 -23.03 41.21 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 167.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.05 -35.57 18.99 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 119.585 2.594 . . . . 0.0 119.585 162.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.8 -36.33 76.5 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 162.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -80.27 -32.54 38.22 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 171.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -49.85 -33.8 18.06 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.78 -26.34 23.29 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 118.145 2.646 . . . . 0.0 118.145 167.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.0 m -120.32 -38.77 2.86 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -108.48 147.28 31.9 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.322 1.049 . . . . 0.0 113.169 -169.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -119.74 148.93 42.82 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.937 0.875 . . . . 0.0 112.108 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -105.66 3.94 29.62 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.62 40.23 1.46 Allowed 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 121.095 1.771 . . . . 0.0 114.628 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.36 35.68 91.76 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 117.981 1.952 . . . . 0.0 117.981 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -131.06 142.38 50.29 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 117.905 0.853 . . . . 0.0 111.27 -166.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -91.82 140.66 29.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.032 -1.042 . . . . 0.0 111.505 174.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.91 -115.46 1.89 Allowed Glycine 0 N--CA 1.491 2.341 0 O-C-N 121.518 -0.739 . . . . 0.0 112.108 172.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.18 -47.54 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.817 164.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.39 173.63 27.59 Favored Glycine 0 CA--C 1.562 3.013 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 163.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.42 172.6 12.97 Favored 'Trans proline' 0 CA--C 1.564 1.996 0 C-N-CA 122.845 2.363 . . . . 0.0 115.583 173.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -68.51 125.83 27.73 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 120.425 -1.422 . . . . 0.0 113.754 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -91.57 -0.86 57.64 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -66.46 111.63 3.66 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-N 120.326 1.421 . . . . 0.0 111.234 162.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.99 41.42 7.58 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 116.687 1.435 . . . . 0.0 116.687 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -92.73 -34.31 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.02 106.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 120.428 1.467 . . . . 0.0 109.512 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.48 -12.12 66.51 Favored Glycine 0 CA--C 1.553 2.44 0 N-CA-C 118.731 2.252 . . . . 0.0 118.731 -161.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -78.31 148.45 33.82 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 121.228 2.514 . . . . 0.0 112.84 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.4 m -54.12 141.53 28.56 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.95 120.87 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.758 -0.589 . . . . 0.0 109.974 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.271 . . 66.42 54.66 0.89 Allowed 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -161.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.98 22.13 9.23 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 119.206 2.442 . . . . 0.0 119.206 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.3 t -102.99 109.22 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.323 1.561 . . . . 0.0 107.79 165.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -72.67 88.33 1.28 Allowed 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 123.453 0.701 . . . . 0.0 111.67 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.87 -47.07 0.54 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.075 -159.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -82.23 131.86 35.23 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 118.362 1.081 . . . . 0.0 111.829 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -78.68 105.58 10.07 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.517 0.727 . . . . 0.0 111.848 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -89.56 156.77 18.39 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -63.35 151.8 39.79 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 171.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -59.26 -48.42 96.23 Favored Pre-proline 0 CA--C 1.577 1.997 0 CA-C-O 116.124 -1.893 . . . . 0.0 115.473 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.42 -24.98 63.7 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 CA-C-N 124.477 2.635 . . . . 0.0 117.937 166.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.4 tpp -65.39 -48.61 72.29 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.796 1.634 . . . . 0.0 114.097 164.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -56.27 -47.83 77.8 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 166.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.64 -11.89 60.82 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 118.994 2.961 . . . . 0.0 118.994 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -63.6 -52.63 60.08 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.762 1.619 . . . . 0.0 114.316 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.08 175.26 49.81 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.69 -148.3 36.61 Favored Glycine 0 CA--C 1.547 2.039 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -134.26 155.03 50.91 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.644 0.735 . . . . 0.0 111.639 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -77.1 77.48 3.64 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.91 1.338 . . . . 0.0 112.838 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.0 p -73.84 159.82 83.38 Favored Pre-proline 0 CA--C 1.574 1.885 0 C-N-CA 124.455 1.102 . . . . 0.0 112.344 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -57.59 -34.39 98.02 Favored 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 122.399 2.066 . . . . 0.0 117.459 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.19 -39.84 74.99 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 116.382 1.994 . . . . 0.0 116.382 165.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.96 97.89 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.54 -43.21 93.57 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 166.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -54.27 -44.49 71.92 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -66.51 -55.6 14.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -59.71 -39.87 86.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 67.8 mt -76.37 -15.03 60.05 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 170.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.0 m -66.36 -53.29 37.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 121.323 1.874 . . . . 0.0 112.738 160.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -150.28 113.36 3.29 Favored Pre-proline 0 CA--C 1.575 1.922 0 CA-C-N 119.986 1.266 . . . . 0.0 109.197 168.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.49 -46.26 0.22 Allowed 'Trans proline' 0 CA--C 1.56 1.807 0 CA-C-N 122.597 1.963 . . . . 0.0 116.954 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.75 -28.83 68.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.77 -41.88 86.99 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 162.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.65 -57.76 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.482 1.037 . . . . 0.0 112.655 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -99.87 101.36 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.67 100.13 2.74 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.336 0.589 . . . . 0.0 111.066 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.84 19.39 12.02 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 118.928 2.331 . . . . 0.0 118.928 -167.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.3 t -73.08 136.83 44.98 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.289 2.044 . . . . 0.0 111.937 163.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -76.99 12.81 1.24 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.484 2.402 . . . . 0.0 117.484 169.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -74.12 95.96 2.65 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.665 -1.272 . . . . 0.0 110.972 169.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.92 74.3 4.47 Favored 'General case' 0 CA--C 1.567 1.627 0 CA-C-O 122.802 1.286 . . . . 0.0 113.24 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -142.05 127.36 18.72 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.57 -52.59 43.89 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.11 161.1 10.09 Favored Glycine 0 CA--C 1.545 1.917 0 CA-C-O 122.6 1.111 . . . . 0.0 115.171 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -100.74 99.17 9.57 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 117.851 -1.071 . . . . 0.0 108.646 168.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.79 -34.46 18.28 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 C-N-CA 122.608 2.206 . . . . 0.0 117.432 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.25 129.26 38.44 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.005 0.82 . . . . 0.0 112.85 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 tp -56.79 -45.21 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 169.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.39 -40.35 74.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -59.24 -46.8 87.52 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 120.176 1.353 . . . . 0.0 114.606 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -62.44 -53.75 50.25 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.24 -45.03 95.17 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -61.54 -45.64 93.32 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.408 HD21 HMB1 ' A' ' 101' ' ' HEC . 46.9 tp -55.38 -45.0 76.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 166.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 61.3 mt -61.48 -42.62 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 117.46 -1.257 . . . . 0.0 113.219 171.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.3 -44.36 71.89 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 164.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -59.93 -47.85 84.11 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 167.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.04 -25.96 65.63 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -63.59 -42.75 98.24 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 159.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.99 -45.3 96.4 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 117.69 1.836 . . . . 0.0 117.69 165.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -78.33 77.71 4.81 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 118.292 1.046 . . . . 0.0 112.132 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.577 -0.702 . . . . 0.0 109.774 176.701 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.619 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 mmt . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.83 70.32 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.373 0.988 . . . . 0.0 113.064 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -104.17 115.8 62.5 Favored Pre-proline 0 CA--C 1.575 1.935 0 C-N-CA 124.009 0.924 . . . . 0.0 110.565 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.66 -29.76 23.83 Favored 'Trans proline' 0 CA--C 1.568 2.221 0 N-CA-C 118.389 2.419 . . . . 0.0 118.389 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.34 -46.19 87.73 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 169.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.35 78.36 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 160.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.89 -34.79 72.72 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 168.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.36 -41.75 94.35 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 163.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -59.99 -44.75 94.31 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 167.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.46 -42.81 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 166.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -54.82 -28.05 46.6 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 169.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.62 -35.44 4.14 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 160.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -60.3 -35.8 76.42 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 163.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -80.12 -18.8 48.89 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -73.47 67.4 1.05 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 123.792 1.758 . . . . 0.0 115.0 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.34 -54.83 0.18 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 125.149 1.379 . . . . 0.0 109.059 167.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 m -83.52 -34.87 25.19 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 171.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -110.5 151.68 27.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 119.549 1.068 . . . . 0.0 112.716 -170.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.67 153.18 41.17 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.363 1.077 . . . . 0.0 110.983 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.9 -25.7 17.19 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.28 57.52 4.02 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 121.49 1.95 . . . . 0.0 113.685 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.65 7.69 12.12 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 121.732 3.453 . . . . 0.0 121.732 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -113.31 146.49 39.32 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.632 1.716 . . . . 0.0 112.925 -169.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.1 138.3 44.6 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.296 1.038 . . . . 0.0 111.102 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.72 -108.08 0.62 Allowed Glycine 0 N--CA 1.489 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 113.206 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.83 -51.35 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 CA-C-N 117.297 0.548 . . . . 0.0 111.088 169.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.13 169.82 17.01 Favored Glycine 0 CA--C 1.562 2.974 0 CA-C-N 118.577 0.626 . . . . 0.0 114.254 161.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.28 175.72 10.58 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 120.878 2.339 . . . . 0.0 115.398 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -68.9 124.68 24.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.647 -1.283 . . . . 0.0 112.615 173.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.85 -5.23 58.7 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.878 2.177 . . . . 0.0 116.878 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -63.65 117.31 6.65 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 119.423 1.011 . . . . 0.0 110.638 157.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.59 40.58 12.44 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 116.633 1.413 . . . . 0.0 116.633 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 p -95.68 -33.28 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.48 107.78 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-N 120.572 1.533 . . . . 0.0 109.57 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.07 -11.76 69.04 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 118.743 2.257 . . . . 0.0 118.743 -162.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -76.06 146.62 39.26 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 121.132 2.466 . . . . 0.0 112.704 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.9 m -53.89 140.94 29.09 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.66 113.37 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.669 -0.644 . . . . 0.0 109.298 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.27 . . 68.05 65.23 0.36 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -157.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.34 -25.52 4.95 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 119.187 2.435 . . . . 0.0 119.187 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.28 98.52 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 120.041 1.921 . . . . 0.0 109.504 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -69.25 107.89 3.43 Favored 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 123.284 0.634 . . . . 0.0 111.21 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.31 -52.79 0.75 Allowed Glycine 0 N--CA 1.49 2.239 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.767 -155.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -79.94 129.15 34.26 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 118.081 0.94 . . . . 0.0 111.749 172.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -76.53 98.76 4.74 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.523 0.729 . . . . 0.0 112.514 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -80.89 158.21 25.38 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.4 t -64.06 151.38 43.19 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 172.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -58.76 -48.03 97.59 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 115.963 -1.97 . . . . 0.0 115.8 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.21 -23.63 66.25 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 CA-C-N 124.724 2.723 . . . . 0.0 117.967 165.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.4 tpp -66.5 -49.14 67.56 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 120.794 1.634 . . . . 0.0 113.806 163.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -57.06 -45.89 82.89 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 168.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.71 -14.47 62.46 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 118.777 2.88 . . . . 0.0 118.777 172.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -65.48 -55.42 17.98 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 120.726 1.603 . . . . 0.0 113.777 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.59 178.32 51.2 Favored Glycine 0 CA--C 1.547 2.042 0 N-CA-C 116.853 1.501 . . . . 0.0 116.853 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.72 -145.4 32.63 Favored Glycine 0 CA--C 1.547 2.062 0 O-C-N 121.961 -0.729 . . . . 0.0 114.627 -174.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -134.74 155.75 50.02 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.891 0.853 . . . . 0.0 111.935 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -76.24 76.65 3.04 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 123.148 1.451 . . . . 0.0 112.791 171.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.4 p -72.78 161.5 79.0 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.565 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -57.11 -36.6 99.24 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 122.293 1.995 . . . . 0.0 116.909 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -61.06 -49.62 76.63 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 165.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.35 -43.51 83.52 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 172.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.09 -44.19 93.09 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 167.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -51.1 -47.71 61.85 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 121.047 1.749 . . . . 0.0 115.598 165.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -61.25 -60.98 2.9 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -61.31 -39.46 90.58 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.0 mt -75.65 -17.08 60.1 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 171.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.1 m -66.23 -51.27 59.23 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 120.838 1.654 . . . . 0.0 113.317 159.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -150.46 113.22 3.24 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 120.045 1.293 . . . . 0.0 109.646 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.92 -48.39 0.23 Allowed 'Trans proline' 0 CA--C 1.561 1.827 0 CA-C-N 122.656 1.984 . . . . 0.0 116.713 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.33 -27.4 64.34 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.69 -40.74 88.63 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 162.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.9 t -71.8 -57.85 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 119.323 0.965 . . . . 0.0 112.514 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.71 100.45 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 172.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -73.25 98.94 2.75 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 121.333 0.587 . . . . 0.0 111.633 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.02 22.82 8.07 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -165.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -74.17 136.65 42.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.733 1.767 . . . . 0.0 111.887 163.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -72.45 3.94 4.32 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.7 ttt -73.15 92.43 1.72 Allowed 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 120.334 1.425 . . . . 0.0 111.789 168.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.78 76.87 9.6 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 122.019 0.914 . . . . 0.0 112.624 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -128.02 129.14 46.22 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.459 0.704 . . . . 0.0 110.102 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.96 106.73 5.79 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 121.874 -0.516 . . . . 0.0 111.233 166.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.42 172.81 9.22 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 119.49 2.556 . . . . 0.0 119.49 -168.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.2 107.86 31.83 Favored Pre-proline 0 CA--C 1.572 1.817 0 CA-C-O 117.682 -1.152 . . . . 0.0 111.219 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.54 -35.84 9.71 Favored 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.691 2.261 . . . . 0.0 117.151 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.71 128.1 34.52 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 123.94 0.896 . . . . 0.0 112.975 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.8 tp -56.36 -45.27 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 170.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.16 -46.04 75.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.12 -45.29 83.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 170.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -64.36 -51.74 61.81 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 171.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.78 92.65 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 171.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -54.91 -53.55 54.12 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-N 119.813 1.188 . . . . 0.0 114.098 168.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.6 tp -57.42 -47.68 81.12 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 59.4 mt -63.59 -41.97 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.99 1.268 . . . . 0.0 113.083 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.02 68.54 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 163.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.88 -49.48 77.31 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 167.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.7 mt -66.4 -25.76 66.92 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.33 -44.03 97.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 158.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.03 -40.5 97.11 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 118.301 2.081 . . . . 0.0 118.301 167.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -83.2 84.19 7.58 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 118.655 1.228 . . . . 0.0 110.979 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 C--O 1.257 1.456 0 CA-C-O 118.299 -0.858 . . . . 0.0 109.537 176.597 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.673 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.44 68.39 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.688 0.756 . . . . 0.0 112.492 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.1 111.82 63.35 Favored Pre-proline 0 CA--C 1.574 1.889 0 O-C-N 121.36 -0.837 . . . . 0.0 110.73 -175.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.85 -29.93 34.24 Favored 'Trans proline' 0 CA--C 1.567 2.143 0 N-CA-C 118.549 2.48 . . . . 0.0 118.549 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.27 -42.66 99.15 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.51 93.71 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 161.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.86 -37.06 75.83 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 118.912 2.325 . . . . 0.0 118.912 168.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.85 -37.97 77.69 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 164.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -65.5 -45.09 84.96 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 168.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.0 -40.1 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 166.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -56.5 -18.99 13.29 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.5 -39.23 5.68 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 119.237 2.455 . . . . 0.0 119.237 156.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -65.11 -33.83 76.95 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 166.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -87.32 -35.65 18.3 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -58.38 -27.42 64.22 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 119.896 3.295 . . . . 0.0 119.896 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.87 -31.21 62.59 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 166.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 m -105.87 -39.1 6.13 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 171.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -111.64 137.48 49.45 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.257 1.023 . . . . 0.0 112.901 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.33 147.77 23.45 Favored 'General case' 0 CA--C 1.565 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 113.28 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.9 mt -97.89 17.25 18.61 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 162.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -130.44 60.96 1.61 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.49 -1.381 . . . . 0.0 111.388 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.82 -33.12 0.38 Allowed Glycine 0 CA--C 1.557 2.694 0 N-CA-C 120.483 2.953 . . . . 0.0 120.483 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -76.94 145.56 38.09 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.583 1.153 . . . . 0.0 113.618 -172.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -111.13 115.84 30.09 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -109.44 -113.42 3.58 Favored Glycine 0 N--CA 1.491 2.309 0 O-C-N 121.707 -0.621 . . . . 0.0 113.646 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.12 -48.75 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 122.396 -0.473 . . . . 0.0 111.208 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.67 167.02 17.17 Favored Glycine 0 CA--C 1.561 2.936 0 CA-C-N 118.782 0.719 . . . . 0.0 114.514 159.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -68.98 176.68 5.86 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 CA-C-N 120.889 2.345 . . . . 0.0 115.059 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -68.82 126.75 30.74 Favored 'General case' 0 CA--C 1.57 1.72 0 O-C-N 120.427 -1.42 . . . . 0.0 113.158 175.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.2 -2.57 55.08 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -65.74 108.67 2.18 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.307 1.412 . . . . 0.0 111.711 162.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.02 52.53 4.28 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.82 -37.36 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 171.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.9 t -71.99 109.4 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 120.644 1.566 . . . . 0.0 109.016 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.06 -29.52 12.29 Favored Glycine 0 CA--C 1.551 2.313 0 N-CA-C 117.664 1.825 . . . . 0.0 117.664 -161.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -66.18 144.27 56.75 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 120.933 2.367 . . . . 0.0 113.949 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.4 m -53.38 140.67 26.72 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.12 121.43 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.579 -0.701 . . . . 0.0 110.191 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.267 . . 64.78 44.81 3.56 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -163.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.24 36.68 4.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 117.71 1.844 . . . . 0.0 117.71 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.72 105.27 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.23 96.77 2.31 Favored 'General case' 0 CA--C 1.566 1.596 0 C-N-CA 123.488 0.715 . . . . 0.0 110.697 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 149.06 -52.74 0.53 Allowed Glycine 0 N--CA 1.489 2.173 0 CA-C-O 119.58 -0.567 . . . . 0.0 114.087 -158.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -86.42 134.76 33.67 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.026 0.913 . . . . 0.0 111.955 175.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -76.97 108.62 10.15 Favored 'General case' 0 CA--C 1.568 1.668 0 C-N-CA 123.745 0.818 . . . . 0.0 112.964 171.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -94.49 150.77 19.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.451 -0.781 . . . . 0.0 112.231 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.2 p -69.66 157.21 37.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.622 -1.299 . . . . 0.0 114.323 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -55.79 -48.12 97.28 Favored Pre-proline 0 CA--C 1.576 1.959 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.55 -26.34 34.03 Favored 'Trans proline' 0 CA--C 1.565 2.067 0 CA-C-N 124.969 2.81 . . . . 0.0 117.205 170.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -63.35 -47.74 80.85 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 120.428 1.467 . . . . 0.0 114.189 163.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -59.18 -46.22 88.98 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 168.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.27 -13.79 61.6 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 174.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -61.01 -53.51 56.38 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 120.735 1.607 . . . . 0.0 114.831 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.09 176.59 49.88 Favored Glycine 0 CA--C 1.547 2.043 0 N-CA-C 116.764 1.466 . . . . 0.0 116.764 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.92 -153.17 43.32 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.84 155.9 47.0 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.042 0.925 . . . . 0.0 111.732 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -76.02 75.81 2.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.039 1.4 . . . . 0.0 112.882 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.7 p -73.92 159.93 83.03 Favored Pre-proline 0 CA--C 1.576 1.973 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.098 171.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -57.69 -34.21 97.83 Favored 'Trans proline' 0 CA--C 1.57 2.291 0 N-CA-C 117.777 2.184 . . . . 0.0 117.777 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.67 -47.27 72.99 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 165.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.14 89.58 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 170.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.5 mt -59.49 -45.91 90.32 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 165.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -55.87 -43.91 77.6 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 121.556 1.98 . . . . 0.0 116.307 168.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.69 -57.35 13.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.888 1.222 . . . . 0.0 114.155 169.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -61.82 -40.42 95.2 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.36 -22.82 61.09 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 170.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.2 m -61.85 -52.31 64.66 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.377 1.899 . . . . 0.0 113.445 164.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -151.28 113.17 3.05 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-N 119.91 1.232 . . . . 0.0 108.892 167.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.01 -46.43 0.24 Allowed 'Trans proline' 0 CA--C 1.56 1.81 0 CA-C-N 122.724 2.009 . . . . 0.0 116.798 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.16 -29.12 68.73 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.31 -41.02 90.32 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 162.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.7 t -70.32 -57.94 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 119.45 1.023 . . . . 0.0 112.475 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.37 102.19 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -73.11 99.32 2.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.599 -0.688 . . . . 0.0 111.429 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.84 21.84 9.36 Favored Glycine 0 CA--C 1.553 2.464 0 N-CA-C 118.622 2.209 . . . . 0.0 118.622 -166.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.5 t -74.31 132.27 41.92 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.793 1.797 . . . . 0.0 111.042 159.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -77.03 16.79 0.51 Allowed 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.403 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 1.9 ttt -78.68 101.73 7.67 Favored 'General case' 0 CA--C 1.561 1.377 0 O-C-N 120.847 -1.158 . . . . 0.0 111.059 171.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.12 70.77 3.56 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 122.637 1.208 . . . . 0.0 113.854 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -136.56 128.63 29.58 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 124.517 1.127 . . . . 0.0 108.053 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.38 -53.9 20.81 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.8 158.48 8.53 Favored Glycine 0 CA--C 1.544 1.861 0 N-CA-C 115.928 1.131 . . . . 0.0 115.928 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.5 mt -104.56 96.1 9.71 Favored Pre-proline 0 CA--C 1.575 1.917 0 C-N-CA 124.072 0.949 . . . . 0.0 108.9 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.48 -34.3 20.56 Favored 'Trans proline' 0 CA--C 1.567 2.159 0 C-N-CA 122.652 2.234 . . . . 0.0 117.555 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.88 131.53 38.63 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.835 0.854 . . . . 0.0 111.972 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.9 tt -55.9 -45.11 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 170.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -52.83 -44.29 66.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.7 -44.36 93.71 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 -67.01 -53.91 26.73 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.62 -42.85 93.58 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.05 -48.68 80.71 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 119.816 1.189 . . . . 0.0 113.838 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.518 HD21 HMB1 ' A' ' 101' ' ' HEC . 46.8 tp -59.34 -44.9 92.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 170.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.23 -42.79 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 119.807 1.185 . . . . 0.0 112.88 171.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.67 -43.95 69.27 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 163.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -60.32 -48.77 80.3 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 167.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.8 -25.26 66.37 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.09 -35.36 80.89 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 158.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.79 -46.56 73.79 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 161.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.64 68.72 9.95 Favored 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 118.451 1.125 . . . . 0.0 111.459 172.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.872 -166.227 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.665 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.009 0.433 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.261 . . 58.68 39.26 24.64 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -174.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -99.21 112.87 64.11 Favored Pre-proline 0 CA--C 1.576 1.955 0 O-C-N 121.012 -1.055 . . . . 0.0 110.675 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.66 -27.82 26.49 Favored 'Trans proline' 0 CA--C 1.568 2.193 0 N-CA-C 118.361 2.408 . . . . 0.0 118.361 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 -48.17 80.24 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 169.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.22 82.06 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 162.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.16 -36.52 68.55 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 119.009 2.364 . . . . 0.0 119.009 167.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -54.86 -47.43 74.2 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 162.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -59.93 -44.1 94.55 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.5 t -58.82 -42.64 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -55.37 -25.97 38.45 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 170.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.04 -34.55 7.71 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 119.75 2.66 . . . . 0.0 119.75 164.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -58.13 -41.85 84.54 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 161.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -75.39 -33.94 61.03 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -47.03 -37.75 9.83 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 119.025 2.972 . . . . 0.0 119.025 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.49 -29.33 58.59 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 170.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.9 m -113.64 -37.13 4.68 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 174.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -112.52 141.43 46.27 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.686 1.194 . . . . 0.0 111.588 -171.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.48 154.73 25.42 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.794 1.283 . . . . 0.0 113.372 171.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.6 mt -94.91 15.35 18.88 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 170.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -119.66 57.21 0.92 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 120.826 1.648 . . . . 0.0 112.776 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.51 -45.83 1.29 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 119.685 2.634 . . . . 0.0 119.685 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -77.57 157.77 30.16 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.32 1.057 . . . . 0.0 113.405 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.96 140.47 34.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.112 -0.992 . . . . 0.0 111.292 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.12 -116.2 3.62 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.802 -0.562 . . . . 0.0 113.045 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -75.88 -49.6 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 122.384 -0.48 . . . . 0.0 110.802 166.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.78 171.41 30.23 Favored Glycine 0 CA--C 1.559 2.832 0 CA-C-N 118.715 0.689 . . . . 0.0 114.796 158.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.41 175.41 7.85 Favored 'Trans proline' 0 CA--C 1.564 2.018 0 CA-C-N 120.845 2.322 . . . . 0.0 115.227 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -65.04 129.55 40.12 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 120.47 -1.394 . . . . 0.0 113.178 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.7 mt -96.51 -0.46 48.88 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -66.11 112.15 3.75 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.468 1.485 . . . . 0.0 111.233 158.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.98 51.45 5.38 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 115.733 1.053 . . . . 0.0 115.733 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -100.64 -35.99 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 170.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 t -72.24 109.87 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 120.503 1.502 . . . . 0.0 109.158 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.32 -17.63 58.25 Favored Glycine 0 CA--C 1.552 2.369 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -161.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -73.57 142.81 46.63 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 121.35 2.575 . . . . 0.0 113.311 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.7 m -59.94 138.65 57.78 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.2 123.92 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.787 -0.571 . . . . 0.0 110.221 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.8 45.51 7.67 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -164.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.43 -4.44 43.55 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 119.636 2.615 . . . . 0.0 119.636 -170.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.9 t -84.75 103.16 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 120.255 2.027 . . . . 0.0 108.994 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.0 94.31 0.63 Allowed 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.8 -46.08 0.82 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 114.934 0.734 . . . . 0.0 114.934 -161.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -76.93 131.8 38.72 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 118.405 1.103 . . . . 0.0 112.274 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -81.39 84.23 6.72 Favored 'General case' 0 CA--C 1.568 1.671 0 O-C-N 121.528 -0.732 . . . . 0.0 111.978 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -71.42 146.15 48.87 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.6 p -67.72 156.8 36.11 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -55.61 -43.94 99.41 Favored Pre-proline 0 CA--C 1.574 1.901 0 CA-C-O 115.162 -2.351 . . . . 0.0 117.316 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.12 -27.63 29.27 Favored 'Trans proline' 0 CA--C 1.565 2.044 0 CA-C-N 124.866 2.774 . . . . 0.0 116.977 168.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.4 tpp -63.33 -47.75 80.89 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.427 1.467 . . . . 0.0 114.019 163.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -57.87 -46.11 85.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 167.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.95 -14.45 61.92 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 118.881 2.919 . . . . 0.0 118.881 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -61.67 -53.7 52.67 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.722 1.601 . . . . 0.0 114.512 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.04 176.16 47.96 Favored Glycine 0 CA--C 1.547 2.059 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.1 -149.83 38.17 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 114.893 0.717 . . . . 0.0 114.893 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -131.91 156.07 46.77 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.818 0.818 . . . . 0.0 111.847 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -75.94 74.25 2.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.237 1.494 . . . . 0.0 112.988 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.0 p -73.75 161.48 78.55 Favored Pre-proline 0 CA--C 1.575 1.937 0 C-N-CA 124.985 1.314 . . . . 0.0 112.371 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -56.87 -35.28 98.28 Favored 'Trans proline' 0 CA--C 1.569 2.247 0 N-CA-C 117.575 2.106 . . . . 0.0 117.575 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -64.82 -49.51 70.33 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 164.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.64 90.48 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 172.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.65 -45.17 95.11 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 165.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -55.88 -44.42 78.11 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.635 2.016 . . . . 0.0 116.238 168.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -61.15 -57.74 11.25 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 120.047 1.294 . . . . 0.0 113.944 169.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -60.27 -41.36 93.11 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.83 -18.9 60.38 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -63.44 -51.4 65.86 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.071 1.76 . . . . 0.0 113.409 161.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -151.95 112.0 2.9 Favored Pre-proline 0 CA--C 1.575 1.94 0 CA-C-N 120.096 1.316 . . . . 0.0 108.993 167.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.51 -47.02 0.19 Allowed 'Trans proline' 0 CA--C 1.559 1.736 0 CA-C-N 122.71 2.004 . . . . 0.0 116.924 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.25 -27.6 67.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.96 -42.84 84.51 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 162.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.11 -57.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 119.546 1.066 . . . . 0.0 112.709 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.26 101.46 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -73.29 94.77 2.05 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-O 121.462 0.649 . . . . 0.0 111.561 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.93 25.93 5.98 Favored Glycine 0 CA--C 1.554 2.499 0 N-CA-C 118.379 2.111 . . . . 0.0 118.379 -166.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -76.08 137.61 40.27 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 119.749 1.774 . . . . 0.0 111.355 160.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -74.32 7.62 2.72 Favored 'General case' 0 CA--C 1.579 2.067 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 167.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -74.6 97.55 3.19 Favored 'General case' 0 CA--C 1.565 1.533 0 O-C-N 120.677 -1.264 . . . . 0.0 111.53 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.22 71.83 5.76 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 122.61 1.195 . . . . 0.0 113.472 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -129.93 133.41 46.82 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.465 1.106 . . . . 0.0 108.479 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.27 -56.09 9.87 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.48 155.2 6.66 Favored Glycine 0 CA--C 1.545 1.933 0 N-CA-C 116.159 1.224 . . . . 0.0 116.159 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.5 mt -105.72 97.88 16.1 Favored Pre-proline 0 CA--C 1.575 1.918 0 C-N-CA 123.962 0.905 . . . . 0.0 109.323 172.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.17 -33.21 15.44 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 122.632 2.221 . . . . 0.0 117.717 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.62 131.37 39.92 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 175.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.8 tt -56.63 -43.88 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -52.71 -47.4 67.34 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -57.19 -47.13 82.01 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -65.01 -51.55 61.03 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.32 83.79 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -56.47 -50.74 70.87 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.5 tp -57.34 -46.4 83.32 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 169.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.8 mt -64.4 -39.82 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-N 119.933 1.242 . . . . 0.0 113.202 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.22 -45.11 75.92 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 163.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -57.37 -50.51 72.76 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.3 mt -67.71 -26.78 66.34 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -62.39 -40.78 97.6 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 158.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.75 88.86 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 163.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -84.28 78.33 9.81 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 123.684 0.794 . . . . 0.0 111.997 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 123.581 0.752 . . . . 0.0 109.508 175.001 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.62 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptp . . . . . 0 CA--C 1.563 1.47 0 CA-C-O 121.675 0.75 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.29 . . 63.88 7.8 3.48 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 119.865 3.283 . . . . 0.0 119.865 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -83.25 117.44 68.61 Favored Pre-proline 0 CA--C 1.58 2.124 0 O-C-N 120.747 -1.221 . . . . 0.0 111.238 172.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.12 -26.4 18.12 Favored 'Trans proline' 0 CA--C 1.566 2.091 0 N-CA-C 118.501 2.462 . . . . 0.0 118.501 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.08 -47.78 83.15 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 168.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.92 73.01 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 160.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.98 -35.69 70.03 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 168.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.49 -41.85 95.09 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 164.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.4 -44.47 95.67 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 165.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -58.7 -41.06 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -54.85 -19.48 6.61 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.77 -37.59 4.03 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 119.853 2.701 . . . . 0.0 119.853 157.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -65.75 -39.68 91.34 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 164.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.17 -33.9 38.01 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.08 -33.78 67.62 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 119.904 3.298 . . . . 0.0 119.904 -171.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.95 -33.37 66.96 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 171.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.6 m -99.18 -40.88 7.75 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 170.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -109.18 141.62 41.16 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.168 0.987 . . . . 0.0 113.035 -169.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -105.78 153.1 22.36 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.9 0.857 . . . . 0.0 112.77 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.8 mt -106.23 7.62 31.56 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 172.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -115.54 57.61 0.74 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.629 1.559 . . . . 0.0 112.282 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.77 1.93 10.41 Favored Glycine 0 CA--C 1.557 2.712 0 N-CA-C 121.487 3.355 . . . . 0.0 121.487 173.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -124.98 153.2 43.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 119.471 1.636 . . . . 0.0 112.362 -168.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -83.7 143.96 29.7 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.949 -1.095 . . . . 0.0 113.275 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.13 -119.01 2.62 Favored Glycine 0 N--CA 1.491 2.324 0 O-C-N 121.605 -0.685 . . . . 0.0 112.232 170.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.69 -48.08 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 122.178 -0.601 . . . . 0.0 110.938 165.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.36 172.18 30.14 Favored Glycine 0 CA--C 1.561 2.931 0 CA-C-N 118.971 0.805 . . . . 0.0 114.753 157.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -70.51 174.28 10.4 Favored 'Trans proline' 0 CA--C 1.563 1.942 0 CA-C-N 120.853 2.327 . . . . 0.0 115.506 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -66.54 122.59 17.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.499 -1.375 . . . . 0.0 113.36 176.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.22 -5.94 59.3 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -64.81 112.19 3.14 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 120.825 1.648 . . . . 0.0 110.766 159.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.56 36.1 24.05 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 116.981 1.552 . . . . 0.0 116.981 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -80.17 -34.54 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 118.925 1.362 . . . . 0.0 114.252 162.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.8 t -69.45 108.87 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 119.573 1.079 . . . . 0.0 109.966 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.59 -27.38 19.91 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 117.933 1.933 . . . . 0.0 117.933 -164.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -71.27 147.47 48.12 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.482 2.141 . . . . 0.0 113.968 -174.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.3 m -53.26 141.86 22.66 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -68.28 119.83 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.653 . . . . 0.0 109.767 170.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 64.37 55.92 1.35 Allowed 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -159.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.57 -20.1 14.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 119.238 2.455 . . . . 0.0 119.238 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.3 t -83.58 94.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.849 1.825 . . . . 0.0 109.236 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -69.33 113.1 6.35 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 123.315 0.646 . . . . 0.0 111.432 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 131.17 -49.79 0.91 Allowed Glycine 0 N--CA 1.491 2.323 0 CA-C-O 119.731 -0.483 . . . . 0.0 114.069 -155.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -77.48 129.26 35.48 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 118.059 0.93 . . . . 0.0 111.888 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -81.13 89.94 6.02 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.699 -0.625 . . . . 0.0 111.238 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -71.64 154.26 41.52 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.0 p -65.23 153.5 40.84 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.69 -1.256 . . . . 0.0 114.071 171.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.96 -47.45 99.06 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.47 -24.23 56.96 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 CA-C-N 125.115 2.863 . . . . 0.0 117.691 168.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 52.2 tpp -65.57 -48.42 72.44 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 120.65 1.568 . . . . 0.0 113.962 163.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -57.1 -46.29 82.69 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 167.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.67 -13.81 61.44 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -63.95 -54.41 34.95 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 120.805 1.639 . . . . 0.0 114.34 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 175.9 49.85 Favored Glycine 0 CA--C 1.546 2.005 0 N-CA-C 116.698 1.439 . . . . 0.0 116.698 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.78 -150.49 39.67 Favored Glycine 0 CA--C 1.547 2.064 0 O-C-N 121.914 -0.756 . . . . 0.0 114.943 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -133.02 154.11 50.84 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.815 0.817 . . . . 0.0 111.5 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -76.54 77.45 3.23 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.323 1.535 . . . . 0.0 112.552 171.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.0 p -71.75 160.6 82.16 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.208 169.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -58.01 -35.0 99.06 Favored 'Trans proline' 0 CA--C 1.57 2.283 0 N-CA-C 117.118 1.93 . . . . 0.0 117.118 174.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.73 -50.26 74.2 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 164.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.26 87.0 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.18 -43.6 97.78 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -50.91 -47.54 60.81 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 121.046 1.748 . . . . 0.0 115.68 165.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.53 -61.39 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -61.76 -40.11 94.0 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 mt -74.05 -16.87 61.03 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 171.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.4 m -63.9 -54.67 31.12 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 121.241 1.837 . . . . 0.0 112.927 161.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -150.44 112.59 3.23 Favored Pre-proline 0 CA--C 1.576 1.944 0 CA-C-N 119.781 1.173 . . . . 0.0 108.889 168.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.02 -45.95 0.26 Allowed 'Trans proline' 0 CA--C 1.56 1.786 0 CA-C-N 122.622 1.972 . . . . 0.0 116.904 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.18 -25.4 66.13 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.863 2.171 . . . . 0.0 116.863 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.59 78.63 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 161.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.5 t -71.48 -58.62 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-N 119.558 1.072 . . . . 0.0 112.723 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.5 103.62 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 171.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.11 94.15 3.43 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.582 0.706 . . . . 0.0 111.764 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.37 27.39 5.3 Favored Glycine 0 CA--C 1.554 2.489 0 N-CA-C 118.036 1.975 . . . . 0.0 118.036 -165.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.6 t -73.89 132.34 42.4 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.444 1.622 . . . . 0.0 111.187 160.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -73.85 10.41 1.16 Allowed 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 166.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -71.94 97.43 1.85 Allowed 'General case' 0 CA--C 1.564 1.501 0 O-C-N 120.933 -1.104 . . . . 0.0 111.261 166.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 75.48 4.25 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.72 1.248 . . . . 0.0 112.969 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -141.3 128.87 21.41 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.84 -52.7 33.76 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.13 157.06 7.87 Favored Glycine 0 N--CA 1.484 1.879 0 CA-C-O 122.275 0.93 . . . . 0.0 115.231 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.63 96.88 8.08 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.121 -0.942 . . . . 0.0 108.521 168.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.88 -33.63 15.76 Favored 'Trans proline' 0 CA--C 1.568 2.183 0 C-N-CA 122.636 2.224 . . . . 0.0 117.431 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.7 133.33 42.07 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.817 0.847 . . . . 0.0 112.993 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.0 tp -58.27 -42.75 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.12 -53.01 61.37 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -50.98 -41.73 59.72 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -66.91 -54.62 20.29 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.6 -45.6 91.43 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -53.13 -52.83 57.46 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 168.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.469 HD21 HMB1 ' A' ' 101' ' ' HEC . 45.1 tp -60.61 -45.8 92.64 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 172.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 62.9 mt -61.55 -41.43 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 120.194 1.361 . . . . 0.0 113.034 172.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.68 -43.94 72.9 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 163.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -60.55 -46.61 89.54 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.58 -24.0 63.62 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 172.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -61.1 -45.48 94.52 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 157.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.9 88.23 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 117.846 1.898 . . . . 0.0 117.846 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -75.56 97.31 3.7 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 118.338 1.069 . . . . 0.0 111.575 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.065 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.615 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 tpp . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.42 73.0 0.82 Allowed 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 121.902 0.858 . . . . 0.0 112.684 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -106.48 119.48 51.63 Favored Pre-proline 0 CA--C 1.578 2.033 0 C-N-CA 123.98 0.912 . . . . 0.0 111.248 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.56 -28.46 26.19 Favored 'Trans proline' 0 CA--C 1.569 2.26 0 N-CA-C 118.522 2.47 . . . . 0.0 118.522 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.73 -42.29 97.92 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 168.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.34 77.87 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 159.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.73 96.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 118.955 2.342 . . . . 0.0 118.955 171.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.73 -38.67 91.38 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.82 97.0 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 164.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.09 -40.42 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 167.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -54.97 -19.81 7.62 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 166.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.72 -36.98 4.96 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 119.718 2.647 . . . . 0.0 119.718 159.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.67 -37.49 86.66 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 164.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -80.28 -34.56 36.84 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -57.52 -32.74 67.35 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -170.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.78 -35.89 71.41 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.2 m -93.69 -42.86 8.93 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 169.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -108.27 142.86 37.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.074 0.95 . . . . 0.0 113.092 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -110.63 150.21 29.31 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.548 1.166 . . . . 0.0 113.013 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -113.7 33.42 5.19 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.239 -0.913 . . . . 0.0 113.263 170.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -137.15 60.68 1.64 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.032 -1.667 . . . . 0.0 111.061 169.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.49 -47.73 1.78 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 119.522 2.569 . . . . 0.0 119.522 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -75.68 151.51 37.7 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.659 1.183 . . . . 0.0 113.109 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -101.9 131.33 48.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.749 . . . . 0.0 110.451 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.64 -114.33 3.7 Favored Glycine 0 N--CA 1.491 2.361 0 O-C-N 121.676 -0.64 . . . . 0.0 113.415 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.08 -47.79 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 122.413 -0.463 . . . . 0.0 110.77 165.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.9 168.72 24.95 Favored Glycine 0 CA--C 1.56 2.894 0 CA-C-N 118.985 0.812 . . . . 0.0 114.966 159.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -70.03 166.36 28.2 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 CA-C-N 120.699 2.249 . . . . 0.0 114.902 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -62.46 123.14 17.51 Favored 'General case' 0 CA--C 1.57 1.735 0 O-C-N 120.776 -1.203 . . . . 0.0 113.226 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.65 6.22 35.78 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -63.23 117.22 6.26 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.971 1.26 . . . . 0.0 110.929 159.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.96 44.35 37.16 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 116.244 1.257 . . . . 0.0 116.244 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 p -87.9 -30.59 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 170.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.79 107.0 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 119.945 1.248 . . . . 0.0 109.653 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.55 -10.28 71.01 Favored Glycine 0 CA--C 1.553 2.438 0 N-CA-C 118.925 2.33 . . . . 0.0 118.925 -163.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -77.0 144.0 38.99 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 121.078 2.439 . . . . 0.0 113.012 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.5 m -52.21 141.03 19.82 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -70.01 112.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.64 -0.663 . . . . 0.0 109.218 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.281 . . 70.0 66.63 0.23 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -154.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.32 -23.22 6.74 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 119.174 2.429 . . . . 0.0 119.174 -172.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.9 t -83.22 98.83 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 119.953 1.877 . . . . 0.0 109.369 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -69.59 104.59 2.41 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.417 0.627 . . . . 0.0 110.988 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.55 -55.12 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 CA-C-O 119.647 -0.53 . . . . 0.0 113.534 -155.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -78.92 129.07 34.1 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 118.037 0.919 . . . . 0.0 111.62 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -78.34 93.5 4.69 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.616 0.767 . . . . 0.0 112.724 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -76.17 161.11 29.09 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.9 t -65.44 152.15 44.62 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.46 -49.46 92.26 Favored Pre-proline 0 CA--C 1.576 1.98 0 CA-C-O 115.991 -1.957 . . . . 0.0 115.513 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.25 -21.75 67.06 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 CA-C-N 124.769 2.739 . . . . 0.0 118.149 166.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.8 tpp -66.94 -51.39 55.77 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.436 1.471 . . . . 0.0 113.344 163.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -57.87 -45.48 86.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 169.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.49 0.55 16.8 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 173.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -63.81 -49.81 71.42 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.69 81.19 1.06 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.27 -160.33 32.5 Favored Glycine 0 N--CA 1.485 1.908 0 CA-C-O 122.361 0.978 . . . . 0.0 115.161 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -125.21 155.1 40.57 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.017 0.913 . . . . 0.0 111.301 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -76.62 74.32 3.32 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 123.122 1.439 . . . . 0.0 113.272 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.0 p -71.44 161.2 79.75 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.67 171.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -58.5 -26.73 79.55 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 N-CA-C 117.528 2.088 . . . . 0.0 117.528 171.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.88 -56.99 10.02 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 161.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.76 94.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.28 -50.43 73.63 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 169.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.68 -35.58 78.38 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.21 -50.96 58.9 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -59.73 -40.57 88.47 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 171.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 70.7 mt -74.77 -16.35 60.72 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 169.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -67.77 -56.77 7.97 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 120.991 1.723 . . . . 0.0 112.293 160.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -145.12 109.55 4.64 Favored Pre-proline 0 CA--C 1.574 1.904 0 CA-C-N 119.503 1.047 . . . . 0.0 108.918 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.63 -41.28 0.82 Allowed 'Trans proline' 0 CA--C 1.561 1.859 0 C-N-CA 122.162 1.908 . . . . 0.0 116.874 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -58.3 -38.73 77.64 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 170.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.26 -42.95 87.76 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 169.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.62 -51.66 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 119.096 0.862 . . . . 0.0 113.31 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.8 101.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -75.07 94.64 2.92 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.322 0.582 . . . . 0.0 111.585 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.66 25.3 6.03 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 118.264 2.066 . . . . 0.0 118.264 -165.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 t -71.68 136.37 47.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.56 1.68 . . . . 0.0 112.046 163.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -73.94 6.96 2.91 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -72.61 100.61 2.82 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 120.72 -1.237 . . . . 0.0 111.507 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.61 75.54 7.49 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.588 1.185 . . . . 0.0 112.815 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -137.98 132.34 32.15 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.207 1.003 . . . . 0.0 108.539 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.65 -55.83 7.84 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.79 153.01 6.24 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 122.222 0.901 . . . . 0.0 115.199 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.8 mt -97.71 104.31 20.65 Favored Pre-proline 0 CA--C 1.574 1.868 0 CA-C-O 117.772 -1.108 . . . . 0.0 109.135 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.44 -36.22 9.36 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.684 2.256 . . . . 0.0 117.769 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.66 134.0 37.17 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 119.227 0.921 . . . . 0.0 112.813 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -58.01 -41.63 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 170.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.98 -47.36 74.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 172.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -56.39 -42.88 78.63 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -64.61 -53.94 39.77 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.89 -43.3 90.94 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.373 2.361 . . . . 0.0 117.373 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -56.1 -52.17 65.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 169.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.499 HD21 HMB1 ' A' ' 101' ' ' HEC . 50.4 tp -57.03 -46.13 82.6 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 169.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.7 mt -60.35 -41.63 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 120.096 1.316 . . . . 0.0 113.333 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.69 75.14 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 165.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.39 -44.61 95.51 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 166.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.4 mt -67.21 -26.95 66.86 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 171.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -63.76 -41.36 98.0 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 159.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.61 -48.11 87.84 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 117.421 1.729 . . . . 0.0 117.421 163.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -78.4 84.91 4.53 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 118.015 0.907 . . . . 0.0 112.189 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 . . . . . 0 C--O 1.256 1.414 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.041 174.626 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.623 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtp . . . . . 0 CA--C 1.561 1.37 0 CA-C-O 121.385 0.612 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.287 . . 63.47 34.35 12.86 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 118.322 2.712 . . . . 0.0 118.322 -177.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.27 111.45 62.45 Favored Pre-proline 0 CA--C 1.577 1.988 0 O-C-N 121.025 -1.047 . . . . 0.0 110.388 176.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.01 -31.92 22.8 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 N-CA-C 117.947 2.249 . . . . 0.0 117.947 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.24 78.76 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 168.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.3 -39.24 74.94 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 159.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.51 -33.86 59.39 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 120.222 2.849 . . . . 0.0 120.222 174.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.25 -36.4 79.88 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 168.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -62.8 -45.37 92.96 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 165.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 t -56.87 -42.6 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 168.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.12 -25.15 44.82 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.27 -35.28 9.36 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 119.79 2.676 . . . . 0.0 119.79 165.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -58.63 -38.17 77.48 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 162.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -77.34 -34.72 55.14 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -46.17 -40.41 11.15 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 119.144 3.016 . . . . 0.0 119.144 -177.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.17 -32.57 64.45 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.7 m -104.92 -38.06 6.76 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 172.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -116.39 142.99 46.13 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.457 1.103 . . . . 0.0 112.421 -167.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -115.84 147.98 40.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.802 0.81 . . . . 0.0 112.387 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.8 mt -102.21 15.11 30.11 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -128.88 65.29 1.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 119.221 -2.175 . . . . 0.0 111.353 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.3 -37.7 0.82 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 119.939 2.736 . . . . 0.0 119.939 170.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -73.9 149.58 41.4 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.532 1.133 . . . . 0.0 113.43 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.71 132.75 49.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.415 -0.803 . . . . 0.0 110.235 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.61 -111.92 3.65 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 121.891 -0.506 . . . . 0.0 113.02 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -78.33 -48.16 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 122.433 -0.451 . . . . 0.0 110.769 164.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.75 170.53 25.38 Favored Glycine 0 CA--C 1.559 2.843 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 161.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -71.53 175.1 9.95 Favored 'Trans proline' 0 CA--C 1.565 2.038 0 CA-C-N 120.617 2.208 . . . . 0.0 115.784 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -66.81 124.95 24.37 Favored 'General case' 0 CA--C 1.568 1.656 0 O-C-N 120.485 -1.384 . . . . 0.0 113.353 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.42 -0.78 57.33 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -66.26 108.21 2.23 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 120.095 1.316 . . . . 0.0 111.483 161.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.91 46.15 5.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -171.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.11 -36.14 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 t -74.58 109.02 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 120.544 1.52 . . . . 0.0 109.202 -172.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.16 -28.58 15.29 Favored Glycine 0 CA--C 1.551 2.295 0 N-CA-C 117.653 1.821 . . . . 0.0 117.653 -160.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -68.09 146.41 53.5 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 120.844 2.322 . . . . 0.0 113.816 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.4 m -53.14 140.59 25.45 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.09 120.78 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.757 -0.59 . . . . 0.0 109.946 171.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . 63.94 51.96 2.19 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -162.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.08 -27.8 9.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 118.693 2.237 . . . . 0.0 118.693 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.2 t -74.95 95.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.329 1.565 . . . . 0.0 109.678 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.96 106.92 8.94 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.468 0.707 . . . . 0.0 110.223 -176.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.2 -50.75 0.82 Allowed Glycine 0 N--CA 1.489 2.232 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.678 -152.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -76.97 130.6 37.71 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 118.224 1.012 . . . . 0.0 111.881 172.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -79.5 80.58 5.86 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -67.73 150.91 48.07 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.5 p -68.97 153.51 43.67 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -53.71 -48.39 93.47 Favored Pre-proline 0 CA--C 1.575 1.912 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.8 -23.56 47.97 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 CA-C-N 124.198 2.535 . . . . 0.0 117.708 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ttm -66.92 -47.11 72.74 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 121.282 1.856 . . . . 0.0 113.849 162.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -57.58 -45.49 85.16 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 168.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.08 -16.65 62.03 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -61.72 -54.53 41.31 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 120.808 1.64 . . . . 0.0 114.404 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 177.39 49.96 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.14 -149.5 39.29 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 114.931 0.733 . . . . 0.0 114.931 -175.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -132.39 154.01 50.22 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.04 0.924 . . . . 0.0 111.562 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -75.92 76.42 2.82 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 123.023 1.392 . . . . 0.0 112.913 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.1 p -73.13 159.32 85.41 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.166 171.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.11 -34.84 98.48 Favored 'Trans proline' 0 CA--C 1.571 2.369 0 N-CA-C 117.585 2.11 . . . . 0.0 117.585 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.6 -50.11 70.69 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 165.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.22 92.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 172.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.7 mt -57.34 -49.87 74.77 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.5 pp0? -64.26 -33.85 76.77 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.71 -55.25 28.51 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 163.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -59.54 -41.65 90.54 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 73.9 mt -73.52 -17.51 61.2 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 170.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.9 m -65.83 -63.32 1.11 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 120.919 1.691 . . . . 0.0 111.662 158.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -134.63 100.42 12.35 Favored Pre-proline 0 CA--C 1.571 1.774 0 CA-C-O 118.397 -0.811 . . . . 0.0 109.834 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.1 -46.58 0.23 Allowed 'Trans proline' 0 CA--C 1.563 1.929 0 CA-C-N 122.504 1.93 . . . . 0.0 115.708 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -61.49 -34.51 75.6 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 169.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.97 -43.26 65.44 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 170.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.24 -54.83 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 119.261 0.937 . . . . 0.0 112.795 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.11 100.59 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -74.94 98.6 3.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.684 -0.635 . . . . 0.0 111.362 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.59 25.24 7.39 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -165.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 t -69.33 135.11 49.93 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.409 1.604 . . . . 0.0 111.307 159.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -72.88 7.92 1.78 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 166.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -77.34 104.64 7.97 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 120.81 -1.181 . . . . 0.0 111.955 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.32 69.85 6.85 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 122.316 1.055 . . . . 0.0 113.492 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -125.81 135.69 52.28 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.222 1.009 . . . . 0.0 108.951 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.33 -57.68 4.01 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.95 150.49 5.49 Favored Glycine 0 N--CA 1.485 1.902 0 CA-C-N 119.069 0.85 . . . . 0.0 115.138 -175.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -101.99 97.13 7.71 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.135 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.26 -32.72 20.07 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 C-N-CA 122.652 2.235 . . . . 0.0 117.812 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -76.94 127.58 32.96 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 119.039 0.836 . . . . 0.0 112.505 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -58.8 -41.0 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 172.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.05 -46.47 71.94 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 170.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.89 -45.92 82.24 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -62.82 -52.53 62.81 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 171.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.08 86.29 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -57.29 -50.4 73.05 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 170.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.5 -48.25 74.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.255 57.7 mt -63.92 -40.92 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 119.765 1.166 . . . . 0.0 113.231 174.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.25 74.12 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 163.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -59.32 -47.82 83.94 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 166.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.3 -27.87 69.33 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.26 -34.42 77.97 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 162.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.91 -47.07 68.16 Favored Glycine 0 CA--C 1.553 2.446 0 N-CA-C 116.989 1.555 . . . . 0.0 116.989 160.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 70.12 9.55 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 118.419 1.11 . . . . 0.0 111.534 172.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.254 1.32 0 O-C-N 121.339 -0.851 . . . . 0.0 111.181 -164.34 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.607 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 CA--C 1.56 1.346 0 CA-C-O 121.183 0.516 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.4 72.95 9.67 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -107.32 108.59 62.01 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.905 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.68 -29.4 19.54 Favored 'Trans proline' 0 CA--C 1.567 2.146 0 N-CA-C 118.333 2.397 . . . . 0.0 118.333 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.52 80.72 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 168.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.58 72.97 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 162.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.81 -33.91 84.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 118.126 2.01 . . . . 0.0 118.126 168.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -38.75 86.69 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 115.888 1.811 . . . . 0.0 115.888 167.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.254 21.7 pttm -67.01 -43.52 82.64 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.872 1.669 . . . . 0.0 115.083 166.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.8 t -60.43 -34.58 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 114.384 1.254 . . . . 0.0 114.384 171.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -54.82 -20.23 8.18 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 168.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.99 -37.28 5.44 Favored Glycine 0 CA--C 1.559 2.808 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 157.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.65 -31.44 72.12 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 166.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 m -90.73 -33.95 15.56 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -32.27 62.53 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 120.416 3.487 . . . . 0.0 120.416 -171.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.78 -34.84 71.91 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 170.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.7 m -95.55 -43.23 8.05 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -110.14 126.39 54.01 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.244 1.018 . . . . 0.0 111.752 -168.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -94.81 147.24 23.56 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.807 0.813 . . . . 0.0 111.427 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.5 -28.76 28.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -81.29 61.74 4.92 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.33 1.877 . . . . 0.0 113.805 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.75 10.11 16.88 Favored Glycine 0 CA--C 1.556 2.605 0 N-CA-C 121.94 3.536 . . . . 0.0 121.94 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -128.35 156.77 42.57 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 119.278 1.539 . . . . 0.0 112.557 -170.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.42 148.23 30.64 Favored 'General case' 0 CA--C 1.572 1.826 0 O-C-N 120.885 -1.135 . . . . 0.0 112.559 166.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.21 -100.75 2.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 157.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -79.73 -51.88 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.617 160.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.32 156.0 19.91 Favored Glycine 0 CA--C 1.559 2.84 0 N-CA-C 115.068 0.787 . . . . 0.0 115.068 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.93 151.23 27.45 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 CA-C-N 120.985 2.393 . . . . 0.0 113.601 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -45.51 126.74 6.94 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -167.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.74 -6.58 59.36 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -64.22 117.71 7.55 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 119.609 1.095 . . . . 0.0 110.651 158.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.05 44.61 11.51 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.65 -31.04 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -80.84 100.31 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 120.588 1.54 . . . . 0.0 109.162 -172.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.47 -20.7 29.67 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 117.872 1.909 . . . . 0.0 117.872 -158.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -73.05 146.45 45.85 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 120.743 2.272 . . . . 0.0 113.337 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.8 m -54.27 141.01 31.21 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.3 116.44 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.681 -0.637 . . . . 0.0 109.484 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.286 . . 68.14 61.6 0.4 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -159.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.45 -26.03 6.38 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 119.221 2.449 . . . . 0.0 119.221 -170.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.77 94.59 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 120.078 1.939 . . . . 0.0 109.625 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.43 126.73 30.56 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 123.269 0.628 . . . . 0.0 112.167 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.67 -54.7 0.63 Allowed Glycine 0 N--CA 1.491 2.341 0 CA-C-O 119.925 -0.375 . . . . 0.0 113.567 -157.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -79.23 116.58 19.58 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 117.771 0.786 . . . . 0.0 110.844 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -78.78 98.87 6.45 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.814 0.816 . . . . 0.0 110.817 172.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -65.21 162.71 16.65 Favored 'General case' 0 CA--C 1.574 1.874 0 C-N-CA 123.865 0.866 . . . . 0.0 112.969 172.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 p -68.59 158.66 33.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.243 -1.536 . . . . 0.0 114.216 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -54.25 -49.99 87.24 Favored Pre-proline 0 CA--C 1.578 2.027 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.68 -25.16 46.98 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 CA-C-N 124.241 2.55 . . . . 0.0 117.521 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -65.57 -48.8 71.13 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 120.419 1.463 . . . . 0.0 114.056 163.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -58.84 -43.79 90.78 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 168.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 -15.06 61.88 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 118.909 2.929 . . . . 0.0 118.909 172.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -62.7 -55.42 26.97 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 120.958 1.708 . . . . 0.0 114.364 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.35 178.15 50.82 Favored Glycine 0 CA--C 1.548 2.128 0 N-CA-C 116.879 1.511 . . . . 0.0 116.879 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.46 -148.7 35.94 Favored Glycine 0 N--CA 1.488 2.156 0 O-C-N 121.95 -0.736 . . . . 0.0 114.796 -174.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -133.86 153.11 51.97 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.863 0.839 . . . . 0.0 111.925 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -76.35 78.73 3.1 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.73 1.253 . . . . 0.0 112.782 171.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -73.99 157.45 87.02 Favored Pre-proline 0 CA--C 1.575 1.908 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.438 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -58.96 -29.17 89.8 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 N-CA-C 117.495 2.075 . . . . 0.0 117.495 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.75 -56.53 13.06 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 162.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.99 -38.93 84.03 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.2 mt -56.4 -40.23 74.31 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 167.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -56.81 -41.73 78.27 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 170.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.89 -55.73 20.52 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.239 1.381 . . . . 0.0 113.357 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -59.57 -41.63 90.64 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -71.74 -24.21 61.74 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.1 m -62.68 -52.29 63.88 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.265 1.848 . . . . 0.0 113.364 164.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -150.41 114.5 3.3 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-N 119.82 1.191 . . . . 0.0 108.94 169.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.53 -44.15 0.25 Allowed 'Trans proline' 0 CA--C 1.563 1.927 0 CA-C-N 122.693 1.998 . . . . 0.0 116.22 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.19 -43.01 73.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 117.033 2.234 . . . . 0.0 117.033 169.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.26 92.78 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 170.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.12 -57.51 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 118.876 0.762 . . . . 0.0 112.43 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.72 102.96 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 172.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -74.92 90.28 2.41 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.762 0.791 . . . . 0.0 111.627 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.03 28.76 3.75 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 118.01 1.964 . . . . 0.0 118.01 -166.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 t -76.11 134.95 39.86 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.677 1.738 . . . . 0.0 111.42 163.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -76.75 21.58 0.2 Allowed 'General case' 0 CA--C 1.582 2.176 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 170.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.409 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 1.8 ttt -87.92 102.53 14.8 Favored 'General case' 0 CA--C 1.56 1.358 0 O-C-N 120.776 -1.202 . . . . 0.0 110.813 173.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.1 69.79 2.7 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -135.98 131.83 35.56 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.434 1.093 . . . . 0.0 108.613 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.07 -55.37 8.39 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.03 155.74 7.52 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 115.769 1.068 . . . . 0.0 115.769 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.8 mt -100.85 98.16 7.97 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 118.167 -0.921 . . . . 0.0 109.076 168.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.02 -34.76 16.28 Favored 'Trans proline' 0 CA--C 1.568 2.182 0 C-N-CA 122.674 2.249 . . . . 0.0 117.272 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.06 129.87 40.08 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.66 0.784 . . . . 0.0 112.982 175.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.1 tt -57.54 -43.08 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 166.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.54 -48.69 68.85 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -54.82 -45.88 74.5 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.7 mtm-85 -66.49 -54.13 27.41 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.27 -44.14 88.27 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -59.4 -52.73 64.37 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 113.728 1.011 . . . . 0.0 113.728 169.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.509 HD21 HMB1 ' A' ' 101' ' ' HEC . 44.9 tp -58.18 -46.49 85.69 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -61.12 -42.38 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 117.552 -1.213 . . . . 0.0 112.945 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.76 -44.32 73.52 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 164.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -58.42 -50.67 72.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 167.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.09 -24.51 65.95 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 174.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.85 -44.82 96.05 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 158.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.69 -41.8 93.63 Favored Glycine 0 CA--C 1.553 2.427 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 168.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.99 83.27 6.74 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 118.725 1.262 . . . . 0.0 111.0 172.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.414 -0.803 . . . . 0.0 109.753 175.872 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.606 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.5 67.64 0.66 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.767 0.794 . . . . 0.0 112.523 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -106.29 115.4 61.02 Favored Pre-proline 0 CA--C 1.575 1.938 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.914 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.45 -27.8 27.5 Favored 'Trans proline' 0 CA--C 1.569 2.26 0 N-CA-C 118.458 2.445 . . . . 0.0 118.458 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.7 98.73 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 167.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.48 -32.79 74.37 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 159.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.75 -38.43 95.18 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 118.848 2.299 . . . . 0.0 118.848 171.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.01 -38.96 90.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 169.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -61.87 -42.02 98.56 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 164.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.67 -39.13 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 168.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -55.61 -25.29 37.84 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 169.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.9 -29.08 26.2 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 119.809 2.684 . . . . 0.0 119.809 165.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -58.51 -38.4 77.63 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 159.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -82.05 -32.2 30.54 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -45.39 -46.33 13.17 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 119.664 3.209 . . . . 0.0 119.664 -173.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.83 -38.5 70.13 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.8 m -89.84 -43.91 10.31 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -112.36 132.94 54.73 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 119.453 1.024 . . . . 0.0 112.179 -169.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -117.61 132.52 56.5 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.9 0.857 . . . . 0.0 111.105 -173.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.2 mt -80.04 -9.14 59.67 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 117.33 2.345 . . . . 0.0 117.33 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -102.76 58.62 0.78 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.175 1.807 . . . . 0.0 112.011 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.2 24.23 50.47 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 121.124 3.21 . . . . 0.0 121.124 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -106.57 121.99 45.41 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.007 1.404 . . . . 0.0 110.697 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -93.22 103.59 15.84 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.381 0.672 . . . . 0.0 109.454 173.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.0 -107.41 3.21 Favored Glycine 0 N--CA 1.489 2.224 0 O-C-N 122.096 -0.377 . . . . 0.0 112.689 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.19 -49.44 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 118.923 -0.561 . . . . 0.0 111.087 166.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.95 166.77 14.78 Favored Glycine 0 CA--C 1.561 2.93 0 CA-C-N 119.035 0.834 . . . . 0.0 114.924 164.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.78 169.24 20.68 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 120.813 2.307 . . . . 0.0 115.174 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -65.76 124.34 22.17 Favored 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.456 -1.402 . . . . 0.0 113.434 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.2 mt -90.41 6.47 43.14 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -67.41 125.97 27.79 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 121.149 1.795 . . . . 0.0 110.96 159.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.24 53.51 13.67 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 115.619 1.007 . . . . 0.0 115.619 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -107.0 -29.87 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 t -79.36 100.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 120.811 1.642 . . . . 0.0 109.0 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.82 -15.62 48.3 Favored Glycine 0 CA--C 1.552 2.398 0 N-CA-C 118.304 2.082 . . . . 0.0 118.304 -159.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -72.12 141.06 49.16 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 121.339 2.569 . . . . 0.0 113.201 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.8 m -58.18 136.99 57.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -67.12 123.85 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 123.267 0.627 . . . . 0.0 110.72 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 62.76 45.31 5.88 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -165.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.05 12.82 29.08 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 -170.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.5 t -92.74 115.18 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 120.072 1.936 . . . . 0.0 109.09 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.92 120.19 16.13 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.904 -0.497 . . . . 0.0 110.717 166.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.21 17.91 21.02 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 118.209 2.044 . . . . 0.0 118.209 -163.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -139.11 127.45 22.8 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 119.785 1.792 . . . . 0.0 109.118 165.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -80.61 93.39 6.1 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.376 -0.827 . . . . 0.0 112.765 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -76.73 152.14 35.79 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.9 p -70.08 156.7 38.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.766 -1.209 . . . . 0.0 114.061 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.26 -49.6 91.43 Favored Pre-proline 0 CA--C 1.576 1.98 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.01 -24.39 45.42 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 CA-C-N 124.095 2.498 . . . . 0.0 117.468 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.8 tpp -65.89 -46.44 78.34 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.784 1.629 . . . . 0.0 114.253 163.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -57.81 -45.64 85.84 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 166.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.38 -13.5 61.87 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 170.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -60.7 -48.67 80.75 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 120.87 1.668 . . . . 0.0 114.915 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.72 164.69 35.73 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 117.704 1.842 . . . . 0.0 117.704 163.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.8 -144.14 26.16 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 114.756 0.662 . . . . 0.0 114.756 -177.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -129.53 154.02 47.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.781 0.801 . . . . 0.0 111.528 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -75.82 76.65 2.75 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 123.05 1.405 . . . . 0.0 112.782 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.2 p -73.71 159.7 83.81 Favored Pre-proline 0 CA--C 1.574 1.892 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.114 173.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -56.01 -39.2 92.64 Favored 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 122.403 2.069 . . . . 0.0 117.159 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.01 -42.12 94.75 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 166.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.76 98.06 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 170.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -58.86 -49.11 78.97 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 166.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -55.21 -40.31 70.65 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 172.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.17 -57.54 11.13 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 167.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -60.36 -40.96 92.66 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.87 -27.83 66.16 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.8 m -67.99 -60.09 2.77 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 120.61 1.55 . . . . 0.0 113.37 161.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 82.5 m-20 -127.63 97.13 31.17 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-N 120.864 1.666 . . . . 0.0 110.562 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.63 -51.88 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.886 0 CA-C-N 122.514 1.934 . . . . 0.0 115.625 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.5 -21.19 62.78 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 173.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -74.47 -43.46 55.97 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.867 1.667 . . . . 0.0 115.06 163.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.33 -54.7 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.474 1.034 . . . . 0.0 112.695 172.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.85 101.63 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -72.61 98.47 2.34 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 121.701 -0.624 . . . . 0.0 111.383 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.54 24.1 8.01 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 118.457 2.143 . . . . 0.0 118.457 -166.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -76.09 135.34 39.87 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.627 1.713 . . . . 0.0 111.025 159.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -74.89 8.92 2.15 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 117.32 2.341 . . . . 0.0 117.32 167.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -73.42 95.94 2.29 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 120.565 -1.334 . . . . 0.0 111.294 170.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.72 69.65 6.07 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-O 122.497 1.142 . . . . 0.0 113.382 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.28 133.28 55.5 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.349 1.059 . . . . 0.0 108.95 175.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.14 -56.2 14.28 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 115.886 1.809 . . . . 0.0 115.886 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.18 142.76 3.65 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 115.664 1.026 . . . . 0.0 115.664 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.2 mt -95.22 106.73 27.72 Favored Pre-proline 0 CA--C 1.574 1.879 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.084 168.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.97 -40.16 1.45 Allowed 'Trans proline' 0 CA--C 1.569 2.236 0 CA-C-N 123.239 2.192 . . . . 0.0 116.982 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.9 132.9 40.59 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.8 tt -51.36 -47.94 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 168.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -48.95 -50.63 34.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 173.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.18 -41.16 97.23 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -65.84 -52.93 46.34 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 170.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.76 -44.71 86.31 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -58.53 -51.73 68.65 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 169.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.43 -48.08 72.08 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 168.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 62.1 mt -62.33 -40.72 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.273 172.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.14 -44.68 71.6 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 121.778 2.081 . . . . 0.0 116.567 163.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -60.14 -47.97 83.7 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 166.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.5 mt -65.07 -30.43 71.38 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -61.1 -43.24 99.18 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 161.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.01 -42.48 99.74 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 117.809 1.884 . . . . 0.0 117.809 165.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -80.33 72.05 7.17 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-N 118.526 1.163 . . . . 0.0 112.478 171.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.242 -0.885 . . . . 0.0 109.466 176.293 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.62 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.57 1.732 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.68 45.43 21.64 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 119.107 3.002 . . . . 0.0 119.107 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -127.88 84.29 63.73 Favored Pre-proline 0 CA--C 1.575 1.94 0 O-C-N 120.934 -1.104 . . . . 0.0 110.91 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -67.8 -35.54 21.13 Favored 'Trans proline' 0 CA--C 1.563 1.972 0 N-CA-C 119.18 2.723 . . . . 0.0 119.18 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.86 75.74 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.01 82.65 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 164.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.46 -38.12 94.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.281 2.072 . . . . 0.0 118.281 167.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -58.16 -44.57 88.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 164.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -58.24 -47.08 84.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 167.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.75 -40.73 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 169.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -52.87 -24.99 10.25 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.06 -34.51 5.92 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 119.79 2.676 . . . . 0.0 119.79 161.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -58.98 -38.73 79.8 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 163.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -83.2 -31.45 27.07 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -48.17 -34.92 10.75 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.59 -28.63 47.54 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 117.932 2.568 . . . . 0.0 117.932 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.1 m -112.9 -43.97 3.35 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -102.18 152.1 21.43 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.127 0.965 . . . . 0.0 113.503 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -128.2 138.59 52.53 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.793 0.806 . . . . 0.0 111.13 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.5 mt -100.68 41.4 1.18 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.373 -0.829 . . . . 0.0 113.186 168.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -143.53 55.92 1.35 Allowed 'General case' 0 CA--C 1.571 1.768 0 O-C-N 120.79 -1.194 . . . . 0.0 110.802 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.6 -43.62 1.63 Allowed Glycine 0 N--CA 1.497 2.739 0 N-CA-C 119.465 2.546 . . . . 0.0 119.465 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -74.81 136.86 41.6 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -112.25 125.88 54.63 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.78 0.832 . . . . 0.0 109.385 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.4 -101.01 0.6 Allowed Glycine 0 N--CA 1.491 2.336 0 O-C-N 121.748 -0.595 . . . . 0.0 113.966 -172.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' O ' HMD3 ' A' ' 101' ' ' HEC . 84.8 t -71.11 -52.98 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 117.396 0.598 . . . . 0.0 110.901 170.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.71 164.5 13.92 Favored Glycine 0 CA--C 1.561 2.909 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.811 161.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.17 170.4 15.95 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 CA-C-N 120.961 2.38 . . . . 0.0 115.116 174.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -71.39 127.19 31.75 Favored 'General case' 0 CA--C 1.568 1.662 0 O-C-N 120.526 -1.359 . . . . 0.0 111.933 173.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -90.33 4.95 49.29 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -61.71 118.97 7.82 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 119.954 1.252 . . . . 0.0 111.511 168.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.65 19.71 65.37 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -175.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.92 -29.05 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-N 121.005 2.403 . . . . 0.0 116.68 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.0 t -78.98 103.42 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 120.068 1.303 . . . . 0.0 109.181 -171.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.96 -19.68 45.93 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 118.25 2.06 . . . . 0.0 118.25 -159.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -75.24 147.02 40.65 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.776 2.288 . . . . 0.0 113.866 -174.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.3 m -55.15 138.63 44.16 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.21 122.03 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.78 -0.575 . . . . 0.0 110.224 172.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.07 49.64 4.42 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -164.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.75 -18.59 24.83 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 119.185 2.434 . . . . 0.0 119.185 -169.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 65.0 t -84.97 100.6 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.686 1.743 . . . . 0.0 109.622 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.35 105.08 2.44 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.534 0.683 . . . . 0.0 110.999 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.65 -56.53 0.53 Allowed Glycine 0 N--CA 1.487 2.098 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.213 -157.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -82.55 129.58 34.95 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 117.894 0.847 . . . . 0.0 111.111 169.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.54 99.96 10.48 Favored 'General case' 0 CA--C 1.567 1.597 0 O-C-N 121.539 -0.726 . . . . 0.0 110.918 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -77.83 158.56 29.43 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.9 p -71.37 156.09 39.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.616 -1.302 . . . . 0.0 113.782 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.85 -48.67 92.89 Favored Pre-proline 0 CA--C 1.576 1.962 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.11 -26.12 43.09 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 CA-C-N 124.322 2.579 . . . . 0.0 117.66 171.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.9 ttm -65.86 -46.79 77.15 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 121.253 1.842 . . . . 0.0 113.97 162.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -56.89 -45.65 82.41 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 167.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.19 -17.14 61.39 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 118.81 2.892 . . . . 0.0 118.81 172.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -61.44 -54.58 41.63 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.853 1.66 . . . . 0.0 114.617 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.09 -179.27 50.38 Favored Glycine 0 CA--C 1.546 2.03 0 N-CA-C 116.709 1.443 . . . . 0.0 116.709 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.34 -151.52 43.63 Favored Glycine 0 N--CA 1.487 2.099 0 O-C-N 121.879 -0.777 . . . . 0.0 114.88 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -132.84 153.41 51.33 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.052 0.929 . . . . 0.0 111.722 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -76.87 74.32 3.48 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 122.832 1.301 . . . . 0.0 113.166 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.7 p -69.7 158.93 85.81 Favored Pre-proline 0 CA--C 1.576 1.969 0 C-N-CA 124.293 1.037 . . . . 0.0 112.382 171.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.55 -33.24 96.2 Favored 'Trans proline' 0 CA--C 1.57 2.292 0 N-CA-C 117.559 2.1 . . . . 0.0 117.559 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.51 -49.5 68.76 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 164.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.11 90.55 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 171.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.3 mt -59.77 -45.83 91.05 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 165.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -56.19 -43.07 78.08 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 121.636 2.016 . . . . 0.0 116.329 168.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -60.81 -56.42 21.43 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 120.068 1.304 . . . . 0.0 114.261 169.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -62.26 -39.98 94.69 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 74.2 mt -71.14 -25.0 62.37 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 169.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.1 m -62.45 -51.86 65.81 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 121.247 1.84 . . . . 0.0 113.504 164.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -150.54 112.63 3.21 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 120.05 1.295 . . . . 0.0 109.147 167.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.22 -46.9 0.21 Allowed 'Trans proline' 0 CA--C 1.559 1.76 0 CA-C-N 122.714 2.005 . . . . 0.0 116.985 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.02 -28.15 67.16 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.91 -40.88 91.9 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 161.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.3 t -71.44 -58.54 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.394 0.997 . . . . 0.0 112.511 175.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.35 101.28 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -74.43 102.54 4.48 Favored 'General case' 0 CA--C 1.566 1.589 0 O-C-N 121.566 -0.709 . . . . 0.0 111.578 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.56 22.16 10.64 Favored Glycine 0 CA--C 1.554 2.507 0 N-CA-C 118.446 2.138 . . . . 0.0 118.446 -164.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -74.79 134.14 41.84 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 119.64 1.72 . . . . 0.0 111.321 161.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -74.21 9.86 1.48 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -72.99 95.88 2.06 Favored 'General case' 0 CA--C 1.565 1.551 0 O-C-N 120.696 -1.253 . . . . 0.0 111.194 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.18 72.63 4.72 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 122.8 1.286 . . . . 0.0 113.383 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -136.32 128.86 30.48 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.94 -54.54 24.96 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.12 156.88 7.58 Favored Glycine 0 CA--C 1.544 1.852 0 N-CA-C 115.664 1.025 . . . . 0.0 115.664 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.1 mt -104.06 96.04 8.9 Favored Pre-proline 0 CA--C 1.574 1.868 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.176 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.08 -34.2 17.39 Favored 'Trans proline' 0 CA--C 1.568 2.193 0 C-N-CA 122.672 2.248 . . . . 0.0 117.198 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -73.04 129.56 38.35 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.76 0.824 . . . . 0.0 112.831 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 tt -57.73 -43.05 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -52.68 -45.27 66.73 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.38 -46.6 88.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 73.5 mtm-85 -64.4 -52.38 58.46 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -47.25 86.75 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -60.12 -46.45 89.59 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 119.732 1.151 . . . . 0.0 113.971 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.476 HD21 HMB1 ' A' ' 101' ' ' HEC . 45.9 tp -60.04 -47.73 84.65 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 171.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.43 -43.36 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-N 119.918 1.236 . . . . 0.0 112.884 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.1 73.55 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 165.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -57.5 -47.68 81.27 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 165.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.29 -31.6 72.82 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.57 -40.42 91.61 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 159.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.51 -49.56 75.63 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -87.22 77.85 8.94 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 118.814 1.307 . . . . 0.0 112.445 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 . . . . . 0 N--CA 1.487 1.402 0 C-N-CA 123.679 0.792 . . . . 0.0 110.05 172.135 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.651 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ttt . . . . . 0 CA--C 1.565 1.528 0 CA-C-O 121.206 0.527 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.3 85.05 2.07 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 121.786 0.803 . . . . 0.0 111.428 -172.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -97.85 118.54 63.83 Favored Pre-proline 0 CA--C 1.578 2.049 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.685 -175.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.25 -32.13 21.32 Favored 'Trans proline' 0 CA--C 1.567 2.13 0 N-CA-C 118.317 2.391 . . . . 0.0 118.317 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.65 -48.7 79.66 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 169.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.7 71.43 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 164.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.41 -33.04 65.09 Favored Glycine 0 CA--C 1.551 2.318 0 N-CA-C 119.145 2.418 . . . . 0.0 119.145 166.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -65.42 -40.85 93.85 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -61.7 -41.14 97.2 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 164.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.92 -37.45 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 169.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -54.95 -18.9 5.61 Favored 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 165.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.12 -38.28 6.17 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 119.81 2.684 . . . . 0.0 119.81 158.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.04 -31.47 72.71 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 164.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -87.58 -34.23 18.62 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -56.79 -34.37 67.58 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 119.981 3.326 . . . . 0.0 119.981 -169.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.22 -35.9 72.36 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.6 m -91.15 -42.87 10.21 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 168.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -110.32 135.14 51.51 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.207 0.912 . . . . 0.0 112.617 -169.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.25 146.15 27.24 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.684 0.754 . . . . 0.0 112.571 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.5 mt -95.19 6.09 49.99 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 166.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.15 -40.4 52.71 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.9 -38.43 1.9 Allowed Glycine 0 N--CA 1.496 2.65 0 CA-C-N 119.3 0.955 . . . . 0.0 115.335 -163.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -73.69 153.71 39.97 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-O 121.979 0.895 . . . . 0.0 112.623 168.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -91.21 145.56 24.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 111.668 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.36 -115.35 4.02 Favored Glycine 0 N--CA 1.492 2.392 0 O-C-N 121.571 -0.706 . . . . 0.0 112.843 175.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -78.52 -48.3 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 122.337 -0.508 . . . . 0.0 110.745 163.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.29 173.89 33.27 Favored Glycine 0 CA--C 1.56 2.896 0 N-CA-C 115.327 0.891 . . . . 0.0 115.327 160.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -69.62 173.18 11.22 Favored 'Trans proline' 0 CA--C 1.565 2.039 0 CA-C-N 120.578 2.189 . . . . 0.0 115.468 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -65.75 126.21 27.71 Favored 'General case' 0 CA--C 1.573 1.828 0 O-C-N 120.468 -1.395 . . . . 0.0 113.399 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.48 1.08 57.45 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -64.97 125.33 24.56 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 121.496 1.953 . . . . 0.0 111.112 158.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.05 47.13 32.51 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 116.787 1.475 . . . . 0.0 116.787 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -99.17 -28.45 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 t -81.05 105.14 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 120.631 1.559 . . . . 0.0 109.173 -171.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.35 -13.33 61.56 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.085 1.994 . . . . 0.0 118.085 -159.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -74.42 146.37 42.95 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.025 2.412 . . . . 0.0 112.745 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 64.9 m -54.62 141.56 31.34 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.64 114.71 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.639 -0.663 . . . . 0.0 109.386 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.276 . . 67.59 62.26 0.43 Allowed 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -158.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.83 -20.99 8.07 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 119.462 2.545 . . . . 0.0 119.462 -170.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.3 t -81.88 101.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 120.23 2.015 . . . . 0.0 109.877 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -70.27 102.04 2.04 Favored 'General case' 0 CA--C 1.566 1.58 0 C-N-CA 123.727 0.811 . . . . 0.0 110.784 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.91 -51.87 0.72 Allowed Glycine 0 N--CA 1.49 2.287 0 CA-C-O 119.783 -0.454 . . . . 0.0 113.782 -155.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -85.74 124.93 32.81 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 117.98 0.89 . . . . 0.0 110.479 168.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -80.62 118.18 21.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.422 -0.799 . . . . 0.0 110.07 167.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -89.81 172.51 8.85 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.829 0.823 . . . . 0.0 112.423 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.5 t -70.55 152.92 43.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.373 -1.455 . . . . 0.0 112.961 171.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.56 -45.55 99.85 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-O 115.274 -2.298 . . . . 0.0 116.525 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.63 -26.84 45.98 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 CA-C-N 124.807 2.753 . . . . 0.0 117.338 166.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.2 tpp -64.2 -47.85 78.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.604 1.547 . . . . 0.0 114.123 164.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -60.55 -43.47 97.18 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 168.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.41 -14.96 62.33 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 118.784 2.883 . . . . 0.0 118.784 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -65.18 -56.21 14.19 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.741 1.609 . . . . 0.0 114.247 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.08 -179.78 52.6 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 116.717 1.447 . . . . 0.0 116.717 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.99 -149.57 37.96 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 121.836 -0.802 . . . . 0.0 114.809 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -133.87 155.25 50.21 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.923 0.868 . . . . 0.0 112.061 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -76.8 78.17 3.41 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.938 1.352 . . . . 0.0 112.962 172.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.7 p -75.47 159.85 80.89 Favored Pre-proline 0 CA--C 1.577 1.983 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.514 173.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -59.09 -28.01 86.62 Favored 'Trans proline' 0 CA--C 1.572 2.388 0 N-CA-C 118.014 2.275 . . . . 0.0 118.014 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.13 -53.49 30.2 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 163.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.38 -43.25 88.39 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.62 -51.14 71.2 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -62.62 -33.07 74.27 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 175.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -63.89 -54.44 34.76 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 164.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -60.63 -42.59 97.2 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.55 -20.48 62.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 170.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -65.42 -63.17 1.16 Allowed 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.802 1.637 . . . . 0.0 111.756 158.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 96.0 m-20 -134.66 102.24 11.51 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.921 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.52 -50.77 0.12 Allowed 'Trans proline' 0 CA--C 1.561 1.865 0 CA-C-N 122.731 2.011 . . . . 0.0 115.947 -175.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -69.87 -20.68 63.39 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 171.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -71.03 -42.4 69.56 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 121.363 1.892 . . . . 0.0 114.92 163.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.18 -56.88 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.492 0.717 . . . . 0.0 112.538 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.63 97.28 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 172.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -73.01 104.95 4.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.385 -0.822 . . . . 0.0 111.909 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.33 17.26 22.67 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 118.554 2.182 . . . . 0.0 118.554 -166.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 t -69.1 136.27 52.0 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.121 1.96 . . . . 0.0 111.841 163.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -73.78 8.61 1.85 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 168.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.433 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.3 ttt -74.35 99.61 3.55 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 120.784 -1.198 . . . . 0.0 111.302 170.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.16 70.99 6.89 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 122.604 1.192 . . . . 0.0 113.327 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -130.37 134.16 46.95 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.31 1.044 . . . . 0.0 108.69 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.88 -56.47 6.99 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.56 154.18 6.84 Favored Glycine 0 CA--C 1.544 1.89 0 CA-C-O 121.983 0.768 . . . . 0.0 114.668 -177.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.1 mt -98.86 98.15 5.88 Favored Pre-proline 0 CA--C 1.573 1.832 0 CA-C-O 117.851 -1.071 . . . . 0.0 108.87 167.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 -33.63 19.8 Favored 'Trans proline' 0 CA--C 1.568 2.214 0 C-N-CA 122.706 2.271 . . . . 0.0 117.383 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -71.41 126.06 28.64 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.974 0.91 . . . . 0.0 113.335 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -56.37 -43.6 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 168.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -54.08 -45.22 71.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.39 -45.56 88.09 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 169.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -62.68 -54.34 40.86 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 171.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.38 -45.59 87.99 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -59.34 -49.81 76.38 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 171.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.499 HD21 HMB1 ' A' ' 101' ' ' HEC . 43.2 tp -58.57 -44.9 89.9 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.6 mt -66.71 -34.49 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-N 119.804 1.184 . . . . 0.0 113.688 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.49 79.85 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 121.792 2.087 . . . . 0.0 115.905 159.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.67 -51.47 69.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 170.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.1 mt -66.29 -24.22 66.52 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.14 -45.64 87.6 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 160.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.68 91.41 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 117.882 1.913 . . . . 0.0 117.882 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -79.31 71.59 5.86 Favored 'General case' 0 CA--C 1.573 1.853 0 CA-C-N 118.372 1.086 . . . . 0.0 112.566 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.353 -177.887 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.617 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.343 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.094 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.53 57.28 5.06 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -97.09 110.67 55.11 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.158 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.52 -25.78 29.37 Favored 'Trans proline' 0 CA--C 1.567 2.131 0 N-CA-C 118.424 2.432 . . . . 0.0 118.424 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.82 -49.22 71.48 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.37 77.59 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 162.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.9 -41.49 84.24 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 118.825 2.29 . . . . 0.0 118.825 166.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -56.09 -44.09 78.67 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 164.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.73 -47.03 87.29 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 168.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.0 t -58.6 -36.46 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -54.26 -19.43 5.28 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 168.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.93 -38.46 4.58 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 120.045 2.778 . . . . 0.0 120.045 158.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -66.07 -38.04 87.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 164.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -81.59 -33.44 31.57 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -55.8 -35.06 65.89 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 119.95 3.315 . . . . 0.0 119.95 -171.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.08 -35.27 71.15 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 117.041 2.238 . . . . 0.0 117.041 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 m -96.38 -43.05 7.83 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -103.69 127.77 51.11 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.281 1.032 . . . . 0.0 111.91 -172.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -102.95 135.76 44.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.646 0.736 . . . . 0.0 110.965 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.2 mt -79.14 -23.75 43.78 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.43 61.64 6.94 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 121.502 1.955 . . . . 0.0 112.79 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.91 -30.58 0.4 Allowed Glycine 0 CA--C 1.557 2.674 0 N-CA-C 120.908 3.123 . . . . 0.0 120.908 173.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -79.24 148.18 32.3 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 124.339 1.056 . . . . 0.0 113.534 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -113.84 106.08 14.04 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -171.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.32 -108.9 3.16 Favored Glycine 0 N--CA 1.491 2.338 0 O-C-N 121.824 -0.547 . . . . 0.0 113.625 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.0 t -70.32 -53.34 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 119.222 -0.418 . . . . 0.0 110.666 165.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.39 152.38 18.83 Favored Glycine 0 CA--C 1.56 2.879 0 CA-C-O 119.118 -0.824 . . . . 0.0 114.675 167.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.56 143.57 27.49 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 CA-C-N 121.255 2.528 . . . . 0.0 113.319 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -44.32 122.94 3.22 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -169.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.16 -7.86 59.63 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -65.39 113.53 4.16 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 119.139 0.882 . . . . 0.0 110.767 160.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.03 44.07 8.4 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.35 -33.54 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 174.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.69 106.32 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 120.418 1.463 . . . . 0.0 109.401 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.67 -10.99 66.69 Favored Glycine 0 CA--C 1.553 2.466 0 N-CA-C 118.733 2.253 . . . . 0.0 118.733 -162.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -73.47 145.36 45.75 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 121.23 2.515 . . . . 0.0 112.924 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.0 m -54.39 140.3 34.18 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.71 117.6 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.605 -0.685 . . . . 0.0 109.524 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.264 . . 64.36 57.84 1.15 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -157.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.53 -27.11 5.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 -169.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.8 t -70.47 115.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 119.614 1.707 . . . . 0.0 109.948 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.81 73.9 6.54 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.87 1.319 . . . . 0.0 111.852 176.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.99 39.49 0.02 OUTLIER Glycine 0 CA--C 1.551 2.312 0 CA-C-N 114.421 -1.263 . . . . 0.0 115.23 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -154.12 144.05 21.86 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 118.137 0.969 . . . . 0.0 110.12 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -74.83 90.51 2.38 Favored 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 111.593 170.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -82.82 146.24 29.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.419 -0.801 . . . . 0.0 112.574 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.9 t -68.15 153.64 43.32 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -60.7 -46.85 97.12 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 115.906 -1.997 . . . . 0.0 115.24 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.92 -24.25 67.73 Favored 'Trans proline' 0 CA--C 1.564 1.988 0 CA-C-N 124.902 2.786 . . . . 0.0 117.975 166.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.4 tpp -65.08 -49.44 70.03 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 121.131 1.787 . . . . 0.0 113.818 162.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -59.93 -46.67 88.62 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 171.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -12.66 60.57 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 118.979 2.955 . . . . 0.0 118.979 169.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -68.53 -58.08 4.83 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 120.366 1.439 . . . . 0.0 113.643 175.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.2 -178.59 52.52 Favored Glycine 0 CA--C 1.547 2.08 0 N-CA-C 116.574 1.39 . . . . 0.0 116.574 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.48 -149.39 38.55 Favored Glycine 0 N--CA 1.488 2.143 0 O-C-N 121.818 -0.813 . . . . 0.0 114.905 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -133.67 155.56 49.48 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.972 0.892 . . . . 0.0 111.987 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -76.56 77.99 3.25 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-O 123.111 1.434 . . . . 0.0 112.817 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.9 p -77.19 161.24 73.72 Favored Pre-proline 0 CA--C 1.575 1.938 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.317 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -56.29 -35.82 96.23 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 N-CA-C 117.709 2.157 . . . . 0.0 117.709 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.43 -51.75 64.4 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 166.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.37 94.91 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 172.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.5 mt -57.77 -51.96 67.42 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 167.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.3 2.6 pp0? -62.52 -33.71 75.45 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 176.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -62.88 -55.26 27.66 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 164.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -59.38 -41.33 89.09 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.79 -18.6 62.09 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.7 m -66.18 -64.35 0.88 Allowed 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 120.554 1.525 . . . . 0.0 111.46 159.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 93.3 m-20 -134.72 101.92 11.57 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 118.191 -0.909 . . . . 0.0 109.66 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.66 -51.4 0.11 Allowed 'Trans proline' 0 CA--C 1.561 1.853 0 CA-C-N 122.89 2.068 . . . . 0.0 116.218 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.65 -20.95 64.48 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -73.12 -43.89 61.04 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.771 1.623 . . . . 0.0 114.995 162.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.4 -57.27 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-N 119.426 1.012 . . . . 0.0 112.723 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.76 99.63 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -74.24 94.49 2.49 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.645 0.736 . . . . 0.0 111.945 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.05 20.71 7.01 Favored Glycine 0 CA--C 1.551 2.286 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 -166.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.4 t -72.71 137.62 46.06 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 120.199 2.0 . . . . 0.0 111.549 160.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -73.46 5.52 3.69 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 117.608 2.447 . . . . 0.0 117.608 165.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.433 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.8 ttt -70.26 98.21 1.34 Allowed 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 120.334 1.425 . . . . 0.0 112.198 172.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.06 69.57 5.25 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 122.481 1.134 . . . . 0.0 113.847 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.36 135.9 50.2 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.32 1.048 . . . . 0.0 109.044 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.26 -58.26 3.96 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 176.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.13 154.21 6.9 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-O 122.207 0.893 . . . . 0.0 115.109 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.5 mt -98.63 101.83 12.96 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-O 117.747 -1.121 . . . . 0.0 108.893 168.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.36 -37.38 10.2 Favored 'Trans proline' 0 CA--C 1.565 2.039 0 C-N-CA 122.574 2.183 . . . . 0.0 117.59 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -78.22 135.34 37.58 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 119.414 1.006 . . . . 0.0 112.454 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -58.37 -39.84 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 168.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.09 -44.78 79.34 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -56.46 -45.6 80.79 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -64.42 -54.24 35.83 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.45 90.19 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 117.379 2.362 . . . . 0.0 117.379 173.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -60.29 -47.96 83.79 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.514 HD21 HMB1 ' A' ' 101' ' ' HEC . 43.4 tp -58.65 -46.53 86.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 168.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.4 mt -59.29 -41.45 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.914 1.233 . . . . 0.0 113.16 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.16 -44.58 75.32 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 164.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -58.94 -47.29 85.59 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 166.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.05 -22.57 63.06 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.43 -42.87 98.7 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 156.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.22 96.56 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 117.672 1.829 . . . . 0.0 117.672 165.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -77.98 85.1 4.23 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 118.136 0.968 . . . . 0.0 111.581 170.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.419 -0.8 . . . . 0.0 109.22 173.733 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.68 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.571 1.779 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.92 77.4 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.283 -0.886 . . . . 0.0 111.785 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -100.41 115.85 64.99 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.329 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.11 -34.06 23.45 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 C-N-CA 122.573 2.182 . . . . 0.0 117.666 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.41 -44.55 96.95 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.42 77.86 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 165.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.49 -27.23 58.14 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 119.866 2.707 . . . . 0.0 119.866 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -59.66 -39.56 84.84 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 166.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -65.26 -44.06 89.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 168.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.6 t -56.14 -44.71 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 166.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.75 -23.53 18.29 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 170.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.05 -37.79 16.91 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 119.556 2.582 . . . . 0.0 119.556 162.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -60.72 -33.64 73.19 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 164.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -82.94 -30.0 28.69 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 171.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -56.26 -19.63 14.95 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.36 -26.52 19.56 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 159.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.0 m -125.13 -43.61 1.94 Allowed 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -96.47 140.39 31.19 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -126.06 123.11 37.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.758 -0.589 . . . . 0.0 110.301 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.66 -25.56 63.96 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.82 55.57 2.78 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.366 1.894 . . . . 0.0 113.72 -172.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.84 12.95 7.45 Favored Glycine 0 CA--C 1.561 2.941 0 N-CA-C 120.192 2.837 . . . . 0.0 120.192 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.86 137.67 38.93 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 118.936 1.368 . . . . 0.0 112.281 -168.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -127.58 110.37 12.64 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.14 -97.78 0.75 Allowed Glycine 0 N--CA 1.493 2.452 0 O-C-N 121.875 -0.516 . . . . 0.0 113.943 -171.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.429 ' O ' HMD3 ' A' ' 101' ' ' HEC . 90.6 t -73.71 -49.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.913 166.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.64 160.67 13.35 Favored Glycine 0 CA--C 1.56 2.895 0 CA-C-N 119.195 0.907 . . . . 0.0 114.004 163.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -69.93 174.62 9.39 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 CA-C-N 120.92 2.36 . . . . 0.0 115.369 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -74.48 118.19 17.16 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 120.439 -1.413 . . . . 0.0 112.615 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.0 mt -83.36 -4.92 58.93 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -59.18 117.88 5.25 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 120.033 1.288 . . . . 0.0 111.06 155.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.1 39.99 30.89 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 116.9 1.52 . . . . 0.0 116.9 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.01 -36.93 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.19 1.495 . . . . 0.0 114.512 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.5 t -68.18 108.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 119.966 1.257 . . . . 0.0 110.004 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.35 -19.16 55.56 Favored Glycine 0 CA--C 1.554 2.471 0 N-CA-C 118.535 2.174 . . . . 0.0 118.535 -162.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -73.51 144.14 46.27 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 120.802 2.301 . . . . 0.0 113.086 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.8 m -59.07 144.07 46.58 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.66 117.51 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.616 -0.677 . . . . 0.0 110.351 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.267 . . 65.76 56.77 0.88 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -160.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.69 31.2 5.08 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 -169.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.73 110.73 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 162.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -72.17 97.31 1.93 Allowed 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 123.593 0.757 . . . . 0.0 112.019 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.2 -52.09 0.58 Allowed Glycine 0 N--CA 1.489 2.167 0 CA-C-O 119.304 -0.72 . . . . 0.0 114.507 -159.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -81.57 134.58 35.52 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-N 118.449 1.125 . . . . 0.0 111.955 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -82.87 105.06 13.57 Favored 'General case' 0 CA--C 1.566 1.574 0 O-C-N 121.587 -0.696 . . . . 0.0 111.267 172.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.62 168.89 14.91 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.6 0.714 . . . . 0.0 112.628 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.1 t -70.92 153.01 43.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.305 -1.497 . . . . 0.0 113.319 171.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.15 -49.58 92.26 Favored Pre-proline 0 CA--C 1.577 2.001 0 CA-C-O 116.035 -1.936 . . . . 0.0 115.368 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.95 -21.29 64.02 Favored 'Trans proline' 0 CA--C 1.567 2.169 0 CA-C-N 124.744 2.73 . . . . 0.0 118.001 166.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.5 tpp -67.85 -50.44 56.57 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 120.394 1.452 . . . . 0.0 113.897 162.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -56.68 -44.37 81.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 169.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.86 -8.59 55.28 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 118.967 2.951 . . . . 0.0 118.967 171.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -66.44 -55.03 17.63 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 120.775 1.625 . . . . 0.0 114.637 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.47 174.85 50.33 Favored Glycine 0 CA--C 1.548 2.103 0 N-CA-C 116.451 1.341 . . . . 0.0 116.451 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.4 -158.52 47.55 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 115.321 0.888 . . . . 0.0 115.321 -174.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -128.7 156.61 43.21 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.913 0.863 . . . . 0.0 112.247 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -76.31 76.08 3.09 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.338 1.542 . . . . 0.0 112.898 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.5 p -76.42 160.43 77.54 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.943 172.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -57.25 -35.0 98.83 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.387 2.058 . . . . 0.0 117.416 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.64 -51.53 69.02 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 164.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.54 -44.78 93.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 171.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -59.47 -48.73 80.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -62.53 -36.89 84.03 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -62.29 -55.65 26.14 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 165.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -60.6 -40.38 91.61 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.8 mt -74.74 -12.62 60.45 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 169.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 m -67.04 -55.32 14.85 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 121.247 1.839 . . . . 0.0 112.337 161.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -149.19 114.24 3.61 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 117.919 -1.039 . . . . 0.0 108.503 167.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.04 -45.85 0.43 Allowed 'Trans proline' 0 CA--C 1.562 1.881 0 CA-C-N 122.655 1.984 . . . . 0.0 116.599 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.22 -28.57 67.35 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.63 93.44 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 162.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.7 t -70.56 -57.35 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.501 1.046 . . . . 0.0 112.532 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.9 103.27 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-N 120.083 1.31 . . . . 0.0 107.564 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -72.84 106.54 4.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.744 . . . . 0.0 111.058 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.98 17.68 17.71 Favored Glycine 0 CA--C 1.554 2.497 0 N-CA-C 118.919 2.327 . . . . 0.0 118.919 -169.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.412 ' HG1' ' CGD' ' A' ' 101' ' ' HEC . 11.1 t -75.57 135.88 40.55 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.806 1.803 . . . . 0.0 112.764 169.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.279 64.5 pttt -82.24 12.77 4.01 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 168.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.472 ' HG2' ' C4D' ' A' ' 101' ' ' HEC . 1.2 mmm -59.77 83.32 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.777 0 C-N-CA 125.195 1.398 . . . . 0.0 112.548 153.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.94 78.95 7.7 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 122.931 1.348 . . . . 0.0 112.47 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -150.77 133.92 16.11 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.509 -171.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.53 -56.05 9.63 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.46 158.68 8.99 Favored Glycine 0 N--CA 1.484 1.863 0 CA-C-O 122.292 0.94 . . . . 0.0 114.934 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.2 mt -99.04 101.66 13.11 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.767 -1.111 . . . . 0.0 108.315 168.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.87 -35.67 9.02 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 C-N-CA 122.697 2.265 . . . . 0.0 117.805 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -78.74 135.41 37.12 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 119.257 0.935 . . . . 0.0 112.503 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.15 -40.61 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 169.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.19 -45.12 75.82 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 170.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -57.18 -47.2 81.81 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 120.791 1.632 . . . . 0.0 115.173 169.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -61.77 -54.14 46.39 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.9 -43.37 86.1 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 171.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -58.5 -50.38 73.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 170.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.454 HD21 HMB1 ' A' ' 101' ' ' HEC . 33.1 tp -59.92 -45.38 92.77 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 169.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.2 -46.21 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 120.039 1.291 . . . . 0.0 113.0 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.84 -44.96 74.41 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 166.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -56.61 -48.54 77.23 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 167.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.7 mt -71.02 -25.14 62.54 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -60.77 -42.88 98.36 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 159.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 -44.35 95.35 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 164.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -81.6 85.3 6.56 Favored 'General case' 0 CA--C 1.572 1.81 0 CA-C-N 118.372 1.086 . . . . 0.0 111.855 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 123.828 0.851 . . . . 0.0 109.689 -174.649 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.656 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 mtt . . . . . 0 CA--C 1.561 1.373 0 CA-C-O 121.15 0.5 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.273 . . 61.51 29.2 18.26 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 119.507 3.151 . . . . 0.0 119.507 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -97.5 113.15 62.98 Favored Pre-proline 0 CA--C 1.578 2.02 0 O-C-N 120.775 -1.203 . . . . 0.0 110.54 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.48 -29.08 25.79 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 N-CA-C 118.243 2.363 . . . . 0.0 118.243 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.93 86.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 167.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.62 79.79 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 162.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.69 -35.94 69.63 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 118.784 2.274 . . . . 0.0 118.784 165.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.74 -46.53 87.2 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.86 -41.71 98.18 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 167.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.3 t -60.63 -37.25 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 169.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -55.66 -19.57 11.09 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 117.014 2.228 . . . . 0.0 117.014 167.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.1 -37.02 7.48 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 119.699 2.639 . . . . 0.0 119.699 160.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -64.55 -38.1 89.85 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 164.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.64 -34.84 34.66 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -55.66 -35.74 66.31 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 120.299 3.444 . . . . 0.0 120.299 -168.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.34 80.66 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.8 m -89.85 -40.32 12.51 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 169.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -115.31 121.67 43.57 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.472 1.109 . . . . 0.0 110.643 -169.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -105.02 131.12 52.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 111.07 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.2 mt -70.82 -26.11 63.16 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -83.35 54.47 2.82 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.194 1.816 . . . . 0.0 113.396 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.32 9.84 18.81 Favored Glycine 0 CA--C 1.559 2.838 0 N-CA-C 120.593 2.997 . . . . 0.0 120.593 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -101.85 134.09 45.58 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.442 1.621 . . . . 0.0 111.869 -170.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -102.54 104.57 14.99 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.48 -106.45 2.93 Favored Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.966 -0.459 . . . . 0.0 113.386 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.02 -44.33 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.256 166.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.69 166.17 12.51 Favored Glycine 0 CA--C 1.564 3.115 0 CA-C-N 119.505 1.048 . . . . 0.0 115.051 161.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.29 151.79 43.76 Favored 'Trans proline' 0 CA--C 1.562 1.908 0 C-N-CA 122.835 2.357 . . . . 0.0 114.745 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -48.19 121.16 4.07 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.412 HD13 HMB3 ' A' ' 101' ' ' HEC . 85.2 mt -82.0 -9.32 59.6 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -63.03 111.86 2.36 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 118.921 0.782 . . . . 0.0 110.986 161.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.69 45.42 8.55 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 -170.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 p -100.37 -31.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 170.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.5 t -73.09 106.45 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 120.477 1.49 . . . . 0.0 109.563 -175.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.69 -12.33 66.1 Favored Glycine 0 CA--C 1.553 2.425 0 N-CA-C 118.692 2.237 . . . . 0.0 118.692 -162.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -72.52 140.12 47.98 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 121.018 2.409 . . . . 0.0 113.125 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.3 m -59.89 136.97 58.17 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.7 125.92 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 123.391 0.676 . . . . 0.0 110.797 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.254 . . 60.98 42.42 12.78 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -164.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.87 -3.12 39.7 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 119.751 2.66 . . . . 0.0 119.751 -170.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.6 t -83.53 103.3 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 120.386 2.093 . . . . 0.0 109.541 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.6 104.27 3.27 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.331 0.586 . . . . 0.0 110.482 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.32 -56.43 0.55 Allowed Glycine 0 N--CA 1.489 2.205 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.269 -157.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -87.67 128.24 35.29 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 117.721 0.761 . . . . 0.0 111.278 171.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -81.81 105.12 12.69 Favored 'General case' 0 CA--C 1.566 1.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.599 171.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -78.7 159.13 28.13 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.7 p -76.71 147.13 37.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.032 -1.043 . . . . 0.0 113.067 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -53.79 -44.45 98.05 Favored Pre-proline 0 CA--C 1.576 1.979 0 N-CA-C 117.882 2.549 . . . . 0.0 117.882 -175.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.95 -19.58 58.04 Favored 'Trans proline' 0 CA--C 1.569 2.238 0 CA-C-N 125.069 2.846 . . . . 0.0 117.977 170.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.7 tpp -69.24 -45.28 70.16 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.128 1.331 . . . . 0.0 114.187 162.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -55.6 -44.24 76.8 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 164.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.13 -17.27 64.31 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 118.672 2.841 . . . . 0.0 118.672 169.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -64.4 -52.57 57.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.528 1.513 . . . . 0.0 114.44 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.85 167.33 34.9 Favored Glycine 0 CA--C 1.548 2.139 0 N-CA-C 117.842 1.897 . . . . 0.0 117.842 167.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.07 -145.52 23.39 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -130.52 153.35 48.92 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.801 0.81 . . . . 0.0 111.536 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.42 76.04 3.17 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 123.217 1.484 . . . . 0.0 113.11 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.3 p -75.3 160.52 79.76 Favored Pre-proline 0 CA--C 1.577 1.981 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.547 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -58.74 -27.6 84.07 Favored 'Trans proline' 0 CA--C 1.572 2.381 0 N-CA-C 118.171 2.335 . . . . 0.0 118.171 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.58 -53.27 23.88 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 163.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.1 90.1 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 174.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.2 mt -56.84 -52.42 65.16 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 168.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.253 8.2 pt20 -64.26 -33.85 76.77 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 176.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -60.39 -55.76 29.64 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 119.636 1.107 . . . . 0.0 113.938 163.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -58.3 -41.02 83.55 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.98 -16.75 61.51 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 170.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.5 m -65.2 -54.83 23.57 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 121.1 1.773 . . . . 0.0 112.693 164.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -149.73 112.53 3.4 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.334 167.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.05 -45.19 0.48 Allowed 'Trans proline' 0 CA--C 1.559 1.749 0 CA-C-N 122.565 1.952 . . . . 0.0 116.889 -174.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.03 -29.16 68.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 173.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.17 88.0 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 163.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.1 t -68.94 -56.36 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 119.48 1.036 . . . . 0.0 112.584 173.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.56 101.04 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -69.62 102.67 1.91 Allowed 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 121.307 0.575 . . . . 0.0 111.642 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.15 10.25 32.36 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 119.352 2.501 . . . . 0.0 119.352 -170.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 t -66.47 134.73 53.06 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.48 2.64 . . . . 0.0 112.742 171.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -73.11 9.78 1.13 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.444 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -77.08 103.73 7.17 Favored 'General case' 0 CA--C 1.563 1.461 0 O-C-N 120.585 -1.322 . . . . 0.0 111.691 173.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.28 71.48 4.75 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 122.535 1.159 . . . . 0.0 113.624 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -137.44 129.51 29.14 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.303 1.041 . . . . 0.0 108.405 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.01 -54.46 15.08 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.08 157.96 8.3 Favored Glycine 0 CA--C 1.544 1.897 0 CA-C-O 122.525 1.07 . . . . 0.0 115.555 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.22 101.13 15.37 Favored Pre-proline 0 CA--C 1.575 1.912 0 CA-C-O 117.924 -1.036 . . . . 0.0 108.665 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.41 -37.17 7.95 Favored 'Trans proline' 0 CA--C 1.566 2.085 0 C-N-CA 122.689 2.259 . . . . 0.0 117.752 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -76.89 134.2 39.05 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 119.193 0.906 . . . . 0.0 112.888 174.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.8 tt -57.06 -41.25 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 168.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.86 -49.32 49.7 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.81 -45.11 90.69 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 171.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -62.77 -53.73 49.9 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 171.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.71 -46.32 84.54 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 172.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -56.95 -50.98 70.97 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 169.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.512 HD21 HMB1 ' A' ' 101' ' ' HEC . 44.3 tp -56.65 -45.63 81.53 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 169.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.0 -42.18 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.237 171.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.93 -43.28 77.25 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 165.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -58.32 -48.01 81.89 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.6 -23.64 63.56 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.866 2.172 . . . . 0.0 116.866 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -61.63 -43.14 99.41 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 156.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.23 -47.2 90.1 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 117.576 1.79 . . . . 0.0 117.576 166.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -76.48 88.82 3.24 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 118.317 1.058 . . . . 0.0 112.119 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.48 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.627 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tmm? . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.68 96.35 3.0 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -98.86 117.29 64.6 Favored Pre-proline 0 CA--C 1.578 2.032 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.005 -171.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.49 -28.45 26.54 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 N-CA-C 118.428 2.434 . . . . 0.0 118.428 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.36 -47.08 80.65 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 169.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.92 -38.77 79.73 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 161.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.47 -38.46 80.22 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 119.009 2.364 . . . . 0.0 119.009 166.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -55.63 -45.9 77.51 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 163.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.49 -47.75 84.31 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 t -57.83 -39.87 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 168.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -55.07 -20.82 10.58 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 169.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.52 -36.8 24.99 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 119.525 2.57 . . . . 0.0 119.525 160.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -57.87 -41.74 83.09 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 163.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -76.59 -34.18 58.41 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -52.6 -25.95 12.11 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 119.061 2.986 . . . . 0.0 119.061 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.18 -25.89 15.35 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 162.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.5 m -128.55 -34.32 2.02 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -108.0 142.12 38.62 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.547 1.139 . . . . 0.0 112.922 -169.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -103.1 157.16 17.19 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.244 1.021 . . . . 0.0 111.814 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.68 -27.52 13.63 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -84.74 60.3 6.06 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-N 121.542 1.974 . . . . 0.0 113.982 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.6 -40.01 0.39 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 120.166 2.827 . . . . 0.0 120.166 174.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -80.32 154.99 27.44 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 124.879 1.271 . . . . 0.0 112.96 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -96.77 152.21 18.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 111.952 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -122.68 -118.93 2.5 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 121.397 -0.815 . . . . 0.0 112.742 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.7 t -73.82 -48.23 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 122.337 -0.507 . . . . 0.0 111.104 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.11 171.06 26.62 Favored Glycine 0 CA--C 1.562 3.027 0 CA-C-N 118.836 0.744 . . . . 0.0 114.775 156.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.44 175.24 9.7 Favored 'Trans proline' 0 CA--C 1.567 2.137 0 CA-C-N 121.124 2.462 . . . . 0.0 114.799 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -65.08 122.52 17.25 Favored 'General case' 0 CA--C 1.568 1.668 0 O-C-N 120.402 -1.436 . . . . 0.0 113.094 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.32 -3.68 59.04 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 116.631 2.085 . . . . 0.0 116.631 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -63.95 121.11 13.3 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 119.401 1.001 . . . . 0.0 110.792 155.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.77 42.81 16.07 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 116.413 1.325 . . . . 0.0 116.413 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -100.45 -33.69 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.9 t -74.99 105.02 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 120.652 1.569 . . . . 0.0 109.4 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.22 -26.45 22.89 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 117.761 1.864 . . . . 0.0 117.761 -160.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -66.07 142.92 57.63 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 120.978 2.389 . . . . 0.0 113.736 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.0 m -53.68 139.71 31.48 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.39 120.34 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.647 -0.658 . . . . 0.0 109.738 173.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 63.54 49.01 3.21 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -162.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.93 -27.01 13.13 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 118.875 2.31 . . . . 0.0 118.875 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.5 t -73.53 98.43 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.266 1.533 . . . . 0.0 109.966 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.25 105.65 8.48 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.369 0.667 . . . . 0.0 110.168 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.9 -52.43 0.71 Allowed Glycine 0 N--CA 1.489 2.216 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.66 -154.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -79.65 130.23 35.17 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 118.036 0.918 . . . . 0.0 111.647 171.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -81.27 90.5 6.12 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 121.581 -0.699 . . . . 0.0 111.642 177.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.91 157.38 37.95 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 t -66.87 155.02 39.5 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 174.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -59.58 -49.12 93.7 Favored Pre-proline 0 CA--C 1.577 2.003 0 CA-C-O 116.094 -1.908 . . . . 0.0 115.488 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.36 -25.14 64.01 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 CA-C-N 124.71 2.718 . . . . 0.0 117.732 166.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.5 tpp -65.22 -48.38 73.57 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.533 1.515 . . . . 0.0 114.17 164.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -58.78 -45.81 88.97 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 167.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.79 -14.7 62.52 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 118.976 2.954 . . . . 0.0 118.976 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -62.52 -53.15 59.04 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.715 1.598 . . . . 0.0 114.708 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.98 175.72 48.67 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 116.728 1.451 . . . . 0.0 116.728 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.46 -151.76 40.34 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 115.121 0.808 . . . . 0.0 115.121 -176.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -132.34 154.76 49.42 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.001 0.905 . . . . 0.0 111.568 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -76.04 76.16 2.91 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 123.01 1.386 . . . . 0.0 112.877 172.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -72.58 160.17 83.5 Favored Pre-proline 0 CA--C 1.576 1.964 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.386 171.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.27 -32.39 95.82 Favored 'Trans proline' 0 CA--C 1.571 2.366 0 N-CA-C 117.504 2.079 . . . . 0.0 117.504 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -64.06 -52.71 58.05 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 163.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.77 80.55 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 172.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.9 mt -60.9 -45.22 95.5 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 166.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -55.81 -43.56 77.01 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 121.583 1.992 . . . . 0.0 116.207 167.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -61.72 -56.02 24.03 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 120.029 1.286 . . . . 0.0 114.333 169.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.54 -39.87 95.0 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.0 mt -72.2 -22.67 61.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 169.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.5 m -62.48 -52.53 63.13 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.347 1.885 . . . . 0.0 113.365 163.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -151.35 113.11 3.03 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-N 119.902 1.228 . . . . 0.0 109.088 167.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.94 -47.8 0.16 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 CA-C-N 122.752 2.019 . . . . 0.0 116.91 -174.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -67.27 -26.3 66.49 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.77 -42.47 86.06 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 161.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.53 -58.56 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.432 1.014 . . . . 0.0 112.617 175.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.51 99.89 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -74.91 98.85 3.66 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-O 121.477 0.656 . . . . 0.0 111.725 -177.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.08 18.33 10.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 -166.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -69.92 138.37 52.36 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.268 2.034 . . . . 0.0 112.003 163.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -73.95 8.76 1.84 Allowed 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.431 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.4 ttt -78.4 99.05 6.23 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.708 -1.245 . . . . 0.0 111.795 174.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.99 73.33 4.55 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 122.504 1.145 . . . . 0.0 113.702 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -135.99 130.15 33.16 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.229 1.012 . . . . 0.0 108.507 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.11 -54.39 18.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.24 159.93 9.27 Favored Glycine 0 CA--C 1.544 1.862 0 N-CA-C 115.909 1.124 . . . . 0.0 115.909 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.0 mt -102.39 98.96 11.66 Favored Pre-proline 0 CA--C 1.575 1.908 0 C-N-CA 123.903 0.881 . . . . 0.0 108.932 168.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.61 -34.05 15.89 Favored 'Trans proline' 0 CA--C 1.567 2.131 0 C-N-CA 122.592 2.195 . . . . 0.0 117.623 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -76.98 136.0 38.72 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 119.214 0.916 . . . . 0.0 113.064 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 tt -57.12 -43.18 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 167.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -54.57 -46.15 73.64 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.18 -45.97 83.23 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 75.7 mtm-85 -66.49 -52.48 45.57 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 172.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.56 -46.62 86.5 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -57.2 -49.33 76.33 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 169.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.524 HD21 HMB1 ' A' ' 101' ' ' HEC . 44.6 tp -59.28 -46.45 88.5 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 170.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.72 -40.47 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-N 120.099 1.318 . . . . 0.0 112.976 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.77 -44.82 74.03 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 163.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -58.55 -47.78 83.09 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 167.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.1 mt -71.94 -23.01 61.39 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.29 -43.24 99.27 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 155.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.7 -41.91 98.84 Favored Glycine 0 CA--C 1.554 2.481 0 N-CA-C 118.056 1.982 . . . . 0.0 118.056 166.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -81.47 83.6 6.93 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 118.527 1.164 . . . . 0.0 111.351 170.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 . . . . . 0 N--CA 1.487 1.396 0 O-C-N 121.472 -0.768 . . . . 0.0 109.58 173.925 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.641 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 119.647 -0.215 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.06 83.33 7.99 Favored 'General case' 0 CA--C 1.564 1.489 0 O-C-N 121.096 -1.003 . . . . 0.0 113.091 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.57 100.05 10.33 Favored Pre-proline 0 CA--C 1.572 1.824 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.67 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -57.15 -34.64 98.12 Favored 'Trans proline' 0 CA--C 1.566 2.108 0 N-CA-C 119.605 2.887 . . . . 0.0 119.605 172.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.83 76.75 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.31 -42.35 77.48 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 162.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.97 -36.71 91.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 169.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.88 -46.96 78.16 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 163.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -57.62 -46.81 83.64 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 168.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.22 -39.45 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -55.21 -18.46 6.03 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.24 -37.94 6.26 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 119.6 2.6 . . . . 0.0 119.6 158.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.25 -38.72 88.54 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 164.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -79.42 -37.1 37.9 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -56.28 -27.77 56.47 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 120.133 3.382 . . . . 0.0 120.133 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.24 -33.17 67.29 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.812 2.153 . . . . 0.0 116.812 168.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.6 m -103.69 -35.95 8.06 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -112.01 142.5 44.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -167.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -107.9 148.6 29.39 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.997 0.903 . . . . 0.0 113.288 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.97 10.29 39.8 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 171.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -123.72 62.29 1.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 120.388 1.449 . . . . 0.0 110.999 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.12 -15.72 0.71 Allowed Glycine 0 CA--C 1.558 2.768 0 N-CA-C 121.616 3.406 . . . . 0.0 121.616 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -90.02 161.47 15.84 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 119.215 1.508 . . . . 0.0 114.489 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -130.02 141.4 50.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.228 -1.545 . . . . 0.0 110.978 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.19 -98.8 0.18 Allowed Glycine 0 N--CA 1.489 2.186 0 O-C-N 121.732 -0.605 . . . . 0.0 112.964 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.96 -51.76 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 117.275 0.537 . . . . 0.0 111.406 167.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.03 175.97 17.64 Favored Glycine 0 CA--C 1.562 2.986 0 N-CA-C 115.067 0.787 . . . . 0.0 115.067 164.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.06 -179.06 3.97 Favored 'Trans proline' 0 CA--C 1.569 2.249 0 C-N-CA 122.723 2.282 . . . . 0.0 114.569 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -76.97 138.09 39.43 Favored 'General case' 0 CA--C 1.566 1.593 0 O-C-N 120.585 -1.322 . . . . 0.0 113.325 173.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.71 -2.57 34.97 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -65.15 113.44 3.97 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.865 1.666 . . . . 0.0 111.964 164.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.34 54.72 6.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 -168.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.2 -38.15 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 171.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -66.88 107.59 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 120.248 1.385 . . . . 0.0 110.118 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.26 -17.08 59.73 Favored Glycine 0 CA--C 1.551 2.342 0 N-CA-C 118.649 2.22 . . . . 0.0 118.649 -163.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -71.69 142.14 49.85 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.177 2.489 . . . . 0.0 113.107 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -59.19 136.56 57.99 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.82 126.66 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 123.465 0.706 . . . . 0.0 111.134 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 59.05 39.88 22.78 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -166.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.72 3.74 49.63 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 119.353 2.501 . . . . 0.0 119.353 -171.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.79 104.17 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.875 1.838 . . . . 0.0 108.375 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.75 86.24 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.458 0.647 . . . . 0.0 111.704 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.55 -46.93 0.37 Allowed Glycine 0 CA--C 1.545 1.965 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.123 -158.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -86.15 137.83 32.36 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 118.814 1.307 . . . . 0.0 112.184 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.1 85.77 3.59 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.189 0.995 . . . . 0.0 113.191 172.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -77.41 142.99 38.96 Favored 'General case' 0 CA--C 1.567 1.628 0 O-C-N 121.408 -0.808 . . . . 0.0 112.753 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.5 p -70.03 157.63 37.17 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -54.03 -49.27 90.73 Favored Pre-proline 0 CA--C 1.578 2.022 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.24 -28.0 40.56 Favored 'Trans proline' 0 CA--C 1.568 2.192 0 CA-C-N 124.328 2.582 . . . . 0.0 117.154 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -62.67 -47.21 84.68 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 120.379 1.445 . . . . 0.0 114.559 163.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -58.32 -47.05 84.95 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 167.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.59 -17.44 63.54 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 118.916 2.932 . . . . 0.0 118.916 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -58.38 -51.39 70.02 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.64 1.564 . . . . 0.0 114.528 175.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.84 170.65 35.8 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 117.732 1.853 . . . . 0.0 117.732 165.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.86 -143.11 26.23 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 122.088 -0.654 . . . . 0.0 114.629 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -129.89 154.12 47.62 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.669 0.747 . . . . 0.0 111.759 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -76.26 76.75 3.05 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.929 1.347 . . . . 0.0 112.977 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.3 p -74.11 160.05 82.53 Favored Pre-proline 0 CA--C 1.573 1.865 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.662 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.4 -29.04 87.12 Favored 'Trans proline' 0 CA--C 1.569 2.233 0 N-CA-C 117.461 2.062 . . . . 0.0 117.461 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -66.12 -54.7 22.27 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 163.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.97 88.89 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.6 -44.55 93.36 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 164.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -57.73 -42.7 84.37 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -63.43 -55.84 21.01 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.967 1.258 . . . . 0.0 114.226 169.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -60.79 -42.2 97.13 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 71.2 mt -73.87 -16.33 61.12 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.9 m -64.1 -54.62 31.02 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 121.296 1.862 . . . . 0.0 112.788 161.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.98 115.29 3.45 Favored Pre-proline 0 CA--C 1.575 1.922 0 CA-C-N 119.625 1.102 . . . . 0.0 108.805 167.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.32 -45.78 0.32 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 CA-C-N 122.586 1.959 . . . . 0.0 116.753 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -66.11 -33.24 75.32 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.57 95.84 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 165.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.91 -58.14 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-N 118.843 0.747 . . . . 0.0 112.095 171.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.94 98.2 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -73.21 101.32 3.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.877 . . . . 0.0 111.474 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.5 19.96 10.72 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 118.559 2.184 . . . . 0.0 118.559 -164.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -76.35 132.36 39.7 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 119.964 1.882 . . . . 0.0 110.682 156.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.282 64.2 pttt -82.54 26.83 0.54 Allowed 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 170.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.02 101.3 1.37 Allowed 'General case' 0 CA--C 1.567 1.62 0 O-C-N 120.501 -1.375 . . . . 0.0 109.919 159.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.06 73.42 4.62 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.882 1.325 . . . . 0.0 112.166 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -152.42 123.33 7.48 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.094 -166.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.96 -49.63 60.61 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.35 164.42 13.09 Favored Glycine 0 CA--C 1.543 1.824 0 CA-C-O 122.686 1.159 . . . . 0.0 115.557 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.8 mt -101.99 95.16 5.25 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 164.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.33 -34.1 16.77 Favored 'Trans proline' 0 CA--C 1.567 2.154 0 C-N-CA 122.648 2.232 . . . . 0.0 117.343 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -74.64 132.82 42.04 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-O 121.885 0.85 . . . . 0.0 112.913 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.06 -42.97 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.18 -48.27 68.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.05 -43.88 78.3 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -64.5 -52.58 57.14 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 170.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.87 82.85 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -60.1 -48.59 81.08 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 172.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.554 HD21 HMB1 ' A' ' 101' ' ' HEC . 43.2 tp -61.2 -45.71 93.45 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 172.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.25 60.6 mt -61.96 -41.09 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 119.79 1.177 . . . . 0.0 112.783 171.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.7 -43.3 80.4 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 164.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -56.71 -48.1 78.47 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 164.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.86 -23.23 61.48 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -64.9 -42.92 94.36 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.326 -1.484 . . . . 0.0 114.684 155.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.53 -56.75 23.54 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.837 1.495 . . . . 0.0 116.837 167.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -82.69 82.38 8.07 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.544 1.172 . . . . 0.0 112.285 165.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 . . . . . 0 C--O 1.259 1.6 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.947 158.626 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.813 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 CA--C 1.576 1.979 0 CA-C-O 118.135 -0.936 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.68 -28.82 30.51 Favored 'Trans proline' 0 CA--C 1.568 2.211 0 N-CA-C 118.364 2.409 . . . . 0.0 118.364 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.41 -50.32 70.29 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.52 72.08 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 163.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.48 -31.58 66.99 Favored Glycine 0 CA--C 1.55 2.27 0 N-CA-C 118.679 2.231 . . . . 0.0 118.679 165.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.67 -42.51 98.04 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 168.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.11 -40.7 98.38 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 167.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.92 -41.61 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -58.27 -24.8 60.62 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 168.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.19 -29.7 29.91 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 119.495 2.558 . . . . 0.0 119.495 163.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -59.52 -35.81 74.88 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 160.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.79 -33.64 30.73 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 173.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -46.69 -41.75 15.44 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 119.724 3.231 . . . . 0.0 119.724 -173.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.39 -35.95 72.81 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.2 m -91.82 -43.75 9.34 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 169.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -114.04 132.74 55.9 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.318 1.047 . . . . 0.0 111.196 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -117.62 122.68 44.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 170.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.2 mt -47.16 -51.79 17.31 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -92.14 76.78 5.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.083 0.944 . . . . 0.0 111.237 -157.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.89 -21.69 0.96 Allowed Glycine 0 CA--C 1.556 2.614 0 N-CA-C 120.523 2.969 . . . . 0.0 120.523 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -91.42 116.59 28.97 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 118.83 1.315 . . . . 0.0 112.043 -167.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -97.39 121.76 39.66 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.756 0.822 . . . . 0.0 109.972 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.11 -109.88 3.06 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.82 -0.55 . . . . 0.0 113.329 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.19 -47.78 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 117.186 0.493 . . . . 0.0 111.055 167.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.94 170.85 25.41 Favored Glycine 0 CA--C 1.559 2.833 0 N-CA-C 115.444 0.937 . . . . 0.0 115.444 163.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -69.14 169.03 19.05 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 C-N-CA 122.686 2.258 . . . . 0.0 115.111 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -70.07 123.65 22.1 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 120.536 -1.352 . . . . 0.0 112.326 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.4 mt -92.03 11.51 25.04 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 -173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.1 p30 -57.5 122.67 13.21 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 121.555 1.979 . . . . 0.0 113.267 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.85 43.66 94.64 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 118.683 2.233 . . . . 0.0 118.683 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.254 5.2 p -71.65 -23.06 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.1 t -73.82 107.42 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 124.311 1.044 . . . . 0.0 109.565 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.34 -3.82 79.83 Favored Glycine 0 CA--C 1.555 2.535 0 N-CA-C 119.039 2.376 . . . . 0.0 119.039 -162.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -84.83 143.13 29.27 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.802 2.301 . . . . 0.0 112.983 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.2 m -60.74 137.91 58.15 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.9 t -67.06 123.1 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.905 -0.497 . . . . 0.0 110.258 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.266 . . 62.95 50.0 3.34 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -163.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.63 -16.49 28.84 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 119.399 2.519 . . . . 0.0 119.399 -171.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.52 97.67 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 120.048 1.924 . . . . 0.0 109.599 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.21 109.05 5.01 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 123.19 0.596 . . . . 0.0 110.88 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.36 -57.07 0.67 Allowed Glycine 0 N--CA 1.49 2.275 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.018 -157.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -82.42 123.37 29.06 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 117.676 0.738 . . . . 0.0 110.417 167.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.13 124.85 29.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.478 -0.763 . . . . 0.0 110.735 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -94.55 173.53 7.57 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 121.879 0.847 . . . . 0.0 112.36 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.5 t -71.55 154.38 41.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.294 -1.504 . . . . 0.0 113.114 171.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -59.53 -49.66 91.08 Favored Pre-proline 0 CA--C 1.577 1.986 0 CA-C-O 115.959 -1.972 . . . . 0.0 115.239 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.29 -24.39 71.97 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 CA-C-N 124.805 2.752 . . . . 0.0 117.895 166.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.8 tpp -66.86 -49.34 66.01 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.646 1.566 . . . . 0.0 114.158 164.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -59.21 -43.07 92.3 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -12.42 61.47 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 118.862 2.912 . . . . 0.0 118.862 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -65.16 -55.62 17.6 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 120.835 1.652 . . . . 0.0 114.356 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.57 177.63 50.47 Favored Glycine 0 CA--C 1.548 2.104 0 N-CA-C 116.648 1.419 . . . . 0.0 116.648 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.06 -154.18 44.42 Favored Glycine 0 CA--C 1.548 2.147 0 N-CA-C 115.332 0.893 . . . . 0.0 115.332 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -130.7 154.36 48.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.149 0.976 . . . . 0.0 112.261 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -76.64 73.3 3.33 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 123.081 1.42 . . . . 0.0 113.254 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.5 p -70.11 159.6 83.78 Favored Pre-proline 0 CA--C 1.575 1.933 0 C-N-CA 124.516 1.127 . . . . 0.0 112.312 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -57.06 -34.7 98.19 Favored 'Trans proline' 0 CA--C 1.568 2.197 0 N-CA-C 117.794 2.19 . . . . 0.0 117.794 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.82 -45.56 74.35 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 164.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.64 -43.88 85.19 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 170.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.05 -47.37 86.14 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 165.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -55.69 -44.46 77.39 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 121.634 2.016 . . . . 0.0 116.324 169.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -61.41 -55.63 29.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 119.93 1.241 . . . . 0.0 114.111 170.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -60.97 -41.38 96.28 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.1 mt -73.13 -21.66 60.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -63.76 -52.03 62.23 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-N 120.942 1.701 . . . . 0.0 113.352 162.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -150.12 112.61 3.31 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-N 120.146 1.339 . . . . 0.0 109.299 168.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.96 -47.44 0.17 Allowed 'Trans proline' 0 CA--C 1.56 1.819 0 CA-C-N 122.672 1.99 . . . . 0.0 116.933 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.45 -26.53 65.55 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.92 -41.54 86.89 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 161.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.0 t -71.45 -58.86 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.416 1.007 . . . . 0.0 112.629 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.74 100.92 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -74.94 100.69 4.19 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 121.366 0.603 . . . . 0.0 111.685 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.52 18.47 12.94 Favored Glycine 0 CA--C 1.554 2.491 0 N-CA-C 118.58 2.192 . . . . 0.0 118.58 -165.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -71.77 137.46 47.69 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.141 1.971 . . . . 0.0 111.997 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -73.51 6.85 2.71 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 167.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.5 ttt -73.28 94.82 2.05 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 120.415 1.461 . . . . 0.0 111.451 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.62 70.75 5.01 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.754 1.264 . . . . 0.0 113.431 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -130.49 130.45 44.2 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.512 1.125 . . . . 0.0 107.988 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.06 -54.96 22.03 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.98 155.06 6.47 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.0 mt -103.97 98.14 12.84 Favored Pre-proline 0 CA--C 1.573 1.846 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.373 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.03 -33.32 15.78 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 122.572 2.181 . . . . 0.0 117.644 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.03 133.1 36.82 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.102 0.865 . . . . 0.0 112.361 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.1 tt -56.15 -44.58 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 171.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.9 -45.84 71.24 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.16 -47.72 80.49 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 169.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 75.0 mtm-85 -64.73 -50.96 64.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.35 93.11 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -56.9 -50.17 73.32 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 168.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.0 tp -54.89 -48.67 72.7 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.75 -41.77 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 119.859 1.209 . . . . 0.0 113.411 171.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.21 -43.12 74.18 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 164.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -62.44 -44.68 95.85 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 168.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.2 mt -64.08 -27.86 69.39 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 169.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.22 -44.3 76.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 120.261 1.391 . . . . 0.0 114.657 158.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -53.96 -54.37 31.62 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 117.44 1.736 . . . . 0.0 117.44 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -84.07 81.46 8.79 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 118.539 1.17 . . . . 0.0 111.649 160.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 C--O 1.253 1.249 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 155.149 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 CA--C 1.577 1.981 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.84 -28.5 24.79 Favored 'Trans proline' 0 CA--C 1.569 2.25 0 N-CA-C 118.523 2.47 . . . . 0.0 118.523 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.24 -46.83 79.01 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.29 -37.6 78.1 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 159.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.95 -35.5 76.23 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 119.14 2.416 . . . . 0.0 119.14 168.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.12 -42.93 91.74 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 163.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.44 -43.61 96.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.1 -45.01 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 166.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -56.88 -26.61 59.14 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.39 -34.1 6.24 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 161.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -59.2 -35.75 74.15 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 162.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.78 -20.23 43.08 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 171.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -73.86 67.6 1.23 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 123.802 1.763 . . . . 0.0 115.361 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.56 -57.18 0.1 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.365 1.466 . . . . 0.0 108.258 168.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.7 m -71.91 -44.26 63.97 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 166.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -112.42 138.29 49.38 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 119.925 1.238 . . . . 0.0 111.756 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -131.68 123.09 27.05 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.618 0.723 . . . . 0.0 109.774 -171.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.9 mt -72.48 -10.94 60.41 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.9 58.8 1.03 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 120.998 1.726 . . . . 0.0 112.052 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.02 15.6 36.73 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 121.129 3.212 . . . . 0.0 121.129 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -103.73 129.61 51.12 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 119.192 1.496 . . . . 0.0 110.897 -174.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.53 102.51 10.37 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.29 -105.57 3.04 Favored Glycine 0 N--CA 1.49 2.292 0 O-C-N 121.998 -0.439 . . . . 0.0 112.873 -174.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.3 t -73.4 -47.06 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.45 167.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.95 167.01 14.22 Favored Glycine 0 CA--C 1.56 2.899 0 CA-C-N 119.315 0.961 . . . . 0.0 114.711 164.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.7 173.03 13.25 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 CA-C-N 120.803 2.302 . . . . 0.0 115.799 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -70.18 122.39 19.38 Favored 'General case' 0 CA--C 1.57 1.713 0 O-C-N 120.561 -1.337 . . . . 0.0 112.43 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.76 7.72 38.22 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -65.07 127.49 31.84 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 120.86 1.664 . . . . 0.0 111.671 164.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.51 24.19 65.94 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 118.26 2.064 . . . . 0.0 118.26 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -79.34 -26.81 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 120.319 2.06 . . . . 0.0 116.259 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.9 t -77.89 105.16 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 120.208 1.367 . . . . 0.0 109.192 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.37 -7.93 64.2 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 118.72 2.248 . . . . 0.0 118.72 -160.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -81.32 142.76 32.77 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 120.987 2.393 . . . . 0.0 113.07 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.3 m -60.12 139.09 57.72 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -67.3 123.23 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.919 -0.488 . . . . 0.0 110.318 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 62.16 49.48 4.4 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -162.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.94 -15.63 30.54 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 119.268 2.467 . . . . 0.0 119.268 -170.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.1 t -83.76 96.67 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 119.965 1.882 . . . . 0.0 109.467 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.35 107.83 3.96 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-O 121.381 0.61 . . . . 0.0 111.006 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.68 -56.1 0.63 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.195 -157.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -83.07 127.12 33.29 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 117.791 0.796 . . . . 0.0 110.777 168.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -81.37 115.72 20.86 Favored 'General case' 0 CA--C 1.565 1.548 0 O-C-N 121.548 -0.72 . . . . 0.0 110.937 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -87.67 168.42 13.02 Favored 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 123.541 0.736 . . . . 0.0 112.529 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 p -73.33 152.58 40.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.106 -1.621 . . . . 0.0 113.056 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -57.57 -42.32 95.07 Favored Pre-proline 0 CA--C 1.574 1.895 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.31 -26.71 41.32 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 CA-C-N 125.017 2.828 . . . . 0.0 117.184 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.9 tpp -63.9 -46.32 85.4 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 120.451 1.478 . . . . 0.0 114.091 162.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.21 -46.63 82.74 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 166.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.81 -14.63 61.56 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 118.87 2.915 . . . . 0.0 118.87 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -62.55 -53.37 55.73 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 120.652 1.569 . . . . 0.0 114.84 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.61 -179.44 50.89 Favored Glycine 0 CA--C 1.547 2.045 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.61 -154.58 48.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -174.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -131.08 155.12 47.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.105 0.955 . . . . 0.0 112.356 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.32 75.15 3.11 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.968 1.366 . . . . 0.0 112.992 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.8 p -72.48 159.38 85.52 Favored Pre-proline 0 CA--C 1.576 1.949 0 C-N-CA 124.428 1.091 . . . . 0.0 112.191 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -57.31 -32.5 93.96 Favored 'Trans proline' 0 CA--C 1.572 2.391 0 N-CA-C 117.636 2.129 . . . . 0.0 117.636 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -64.82 -52.97 53.93 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 164.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.87 -43.73 86.17 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.5 mt -56.93 -50.76 71.61 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 167.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.7 pp0? -64.67 -32.73 74.53 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -61.34 -56.45 20.23 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 162.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -59.74 -41.5 91.06 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.2 mt -74.82 -14.56 60.7 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 171.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -67.54 -65.46 0.68 Allowed 'General case' 0 CA--C 1.57 1.714 0 CA-C-N 120.646 1.567 . . . . 0.0 111.308 156.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -133.06 101.58 13.66 Favored Pre-proline 0 CA--C 1.571 1.766 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.57 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.42 -51.11 0.14 Allowed 'Trans proline' 0 CA--C 1.562 1.917 0 CA-C-N 122.788 2.031 . . . . 0.0 115.693 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.58 -19.18 62.88 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.59 -43.21 56.66 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.692 1.587 . . . . 0.0 114.992 162.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.54 -57.14 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 119.423 1.011 . . . . 0.0 112.748 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.3 t -102.44 102.65 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -72.68 102.71 3.39 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-O 121.26 0.552 . . . . 0.0 111.44 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.58 26.45 9.2 Favored Glycine 0 CA--C 1.553 2.426 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -165.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -72.03 132.27 44.03 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.538 1.669 . . . . 0.0 111.254 160.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -76.03 11.04 1.58 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 166.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -73.52 99.03 2.92 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 120.848 -1.157 . . . . 0.0 111.278 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.4 72.9 6.05 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 122.564 1.174 . . . . 0.0 112.982 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -128.61 135.43 49.32 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 124.484 1.114 . . . . 0.0 108.662 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.46 -58.15 4.34 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.43 149.88 5.18 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-N 118.931 0.787 . . . . 0.0 114.944 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -102.01 99.15 11.52 Favored Pre-proline 0 CA--C 1.572 1.809 0 CA-C-O 117.774 -1.108 . . . . 0.0 109.441 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.43 -35.32 18.27 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 122.657 2.238 . . . . 0.0 117.624 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -72.37 127.42 32.51 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -58.33 -39.95 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 167.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -53.84 -46.59 71.24 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.048 1.869 . . . . 0.0 116.048 169.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.45 -44.43 89.19 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -63.75 -51.27 65.66 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.12 -43.75 91.98 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 170.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -54.33 -54.2 43.63 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.932 1.242 . . . . 0.0 114.017 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.1 tp -55.08 -47.65 74.6 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 170.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.251 61.7 mt -62.98 -41.29 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 117.396 -1.288 . . . . 0.0 113.116 173.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.7 -43.99 69.43 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 163.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -60.75 -47.6 85.59 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 167.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 52.6 mt -63.73 -31.29 72.41 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 171.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.86 -42.66 99.84 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 162.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.58 99.48 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 117.827 1.891 . . . . 0.0 117.827 163.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -83.11 72.5 10.12 Favored 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 118.356 1.078 . . . . 0.0 112.408 172.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.603 175.609 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 CA--C 1.576 1.958 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.04 -26.75 25.95 Favored 'Trans proline' 0 CA--C 1.568 2.219 0 N-CA-C 118.38 2.415 . . . . 0.0 118.38 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.82 85.59 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 167.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.85 -39.46 81.36 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 161.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.41 -36.49 77.06 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 119.083 2.393 . . . . 0.0 119.083 168.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -54.39 -47.6 72.51 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 162.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -59.62 -44.18 93.54 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.33 -42.72 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 119.527 1.058 . . . . 0.0 113.831 167.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -55.85 -26.98 49.44 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.93 -34.11 10.94 Favored Glycine 0 N--CA 1.5 2.928 0 N-CA-C 119.818 2.687 . . . . 0.0 119.818 166.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -58.32 -39.64 79.95 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 162.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -78.42 -32.88 48.87 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -45.32 -45.05 12.07 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 -174.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.46 -37.45 70.32 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 m -91.95 -43.31 9.53 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 171.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -112.43 128.04 56.2 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.372 0.987 . . . . 0.0 111.449 -169.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -113.37 130.35 56.31 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.992 0.901 . . . . 0.0 111.265 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.6 mt -74.46 -24.3 59.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.98 56.86 3.63 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 121.117 1.78 . . . . 0.0 113.095 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.39 16.21 34.58 Favored Glycine 0 CA--C 1.558 2.772 0 N-CA-C 120.624 3.009 . . . . 0.0 120.624 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -105.75 133.05 51.11 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.65 1.725 . . . . 0.0 112.395 -171.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.79 122.76 36.6 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.627 169.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.01 -107.37 2.56 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.85 -0.531 . . . . 0.0 112.089 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.51 -50.21 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-N 117.202 0.501 . . . . 0.0 110.987 165.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.04 170.75 21.01 Favored Glycine 0 CA--C 1.56 2.879 0 N-CA-C 115.046 0.778 . . . . 0.0 115.046 163.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.77 176.6 6.56 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 122.627 2.218 . . . . 0.0 116.085 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -71.77 120.18 16.99 Favored 'General case' 0 CA--C 1.566 1.58 0 O-C-N 120.217 -1.552 . . . . 0.0 112.406 173.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.97 -4.68 57.22 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -66.04 115.96 6.64 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-N 119.066 0.848 . . . . 0.0 110.51 160.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.44 39.61 10.8 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 -171.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 p -97.29 -31.84 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.29 109.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 120.871 1.669 . . . . 0.0 108.971 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.69 -14.57 64.63 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 118.778 2.271 . . . . 0.0 118.778 -162.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -75.3 143.11 43.12 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 121.103 2.452 . . . . 0.0 112.965 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.1 m -59.27 142.35 52.13 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.6 t -67.22 122.58 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.83 -0.544 . . . . 0.0 110.348 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 63.47 53.48 2.11 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -162.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.24 -11.28 29.91 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 119.38 2.512 . . . . 0.0 119.38 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.0 t -86.14 95.44 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 120.245 2.023 . . . . 0.0 109.032 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -69.35 118.22 11.97 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.943 0.897 . . . . 0.0 112.199 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.85 -52.56 0.81 Allowed Glycine 0 N--CA 1.492 2.396 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.788 -159.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -79.55 120.93 24.6 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 117.698 0.749 . . . . 0.0 110.918 171.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -76.36 118.29 18.91 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.635 -0.666 . . . . 0.0 110.541 170.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -88.24 169.95 11.43 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.608 0.763 . . . . 0.0 111.217 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.2 p -71.24 157.07 38.76 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 119.832 -1.793 . . . . 0.0 113.43 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -54.74 -50.0 88.29 Favored Pre-proline 0 CA--C 1.578 2.028 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.46 -24.96 48.76 Favored 'Trans proline' 0 CA--C 1.564 1.995 0 CA-C-N 124.349 2.589 . . . . 0.0 117.629 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.2 tpp -65.61 -48.57 71.82 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 120.633 1.56 . . . . 0.0 114.02 163.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -58.97 -44.37 91.52 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 168.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -11.04 60.39 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 118.959 2.948 . . . . 0.0 118.959 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -63.29 -54.2 40.84 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.862 1.664 . . . . 0.0 114.92 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.47 175.45 50.2 Favored Glycine 0 CA--C 1.547 2.062 0 N-CA-C 116.54 1.376 . . . . 0.0 116.54 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.04 -155.75 44.77 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 115.217 0.847 . . . . 0.0 115.217 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -131.85 156.2 46.48 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.891 0.853 . . . . 0.0 112.087 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -76.66 76.17 3.33 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 123.336 1.541 . . . . 0.0 112.831 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.0 p -76.46 160.75 76.76 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.966 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -57.21 -35.39 98.89 Favored 'Trans proline' 0 CA--C 1.571 2.337 0 N-CA-C 117.696 2.152 . . . . 0.0 117.696 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.29 -51.47 67.55 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 164.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.01 94.34 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.6 mt -56.42 -52.05 66.11 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 168.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.293 2.8 pp0? -63.06 -36.56 83.99 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -61.37 -54.46 43.37 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 165.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -57.55 -44.35 85.14 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.3 mt -72.65 -13.34 61.34 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 171.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -64.04 -53.84 43.55 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 120.997 1.726 . . . . 0.0 112.788 161.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.7 103.99 2.33 Favored Pre-proline 0 CA--C 1.577 1.994 0 CA-C-N 119.623 1.101 . . . . 0.0 108.59 173.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.02 -46.51 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 N-CA-C 117.429 2.05 . . . . 0.0 117.429 -168.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.65 -21.28 66.29 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.91 -48.99 56.39 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 161.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.68 -55.71 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 119.521 1.055 . . . . 0.0 113.255 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.23 104.53 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 171.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.15 96.53 2.24 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 121.371 0.605 . . . . 0.0 111.786 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.39 28.29 5.82 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 118.287 2.075 . . . . 0.0 118.287 -167.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -76.25 135.5 39.67 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.526 1.663 . . . . 0.0 111.463 162.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -72.3 7.97 1.53 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 167.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -73.44 99.01 2.87 Favored 'General case' 0 CA--C 1.564 1.512 0 O-C-N 120.63 -1.294 . . . . 0.0 111.395 170.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.41 74.87 4.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 122.737 1.255 . . . . 0.0 113.082 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -138.63 131.18 28.96 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.347 1.059 . . . . 0.0 108.182 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.68 -55.57 10.99 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.27 155.08 6.99 Favored Glycine 0 CA--C 1.545 1.95 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 99.3 mt -103.24 97.68 10.48 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 117.889 -1.053 . . . . 0.0 108.855 170.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.91 -32.95 27.75 Favored 'Trans proline' 0 CA--C 1.568 2.197 0 C-N-CA 122.648 2.232 . . . . 0.0 117.819 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -73.46 118.66 16.68 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 123.941 0.896 . . . . 0.0 113.252 174.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.97 -40.1 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 169.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -53.06 -47.73 68.23 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 170.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -61.41 -41.69 97.54 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 169.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 86.7 mtm-85 -60.12 -50.49 73.47 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.73 -45.58 81.86 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 167.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -54.55 -52.35 62.33 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -57.81 -45.7 85.73 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 170.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.258 62.6 mt -63.9 -41.6 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.161 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.46 -43.63 71.84 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 163.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -58.34 -49.94 75.43 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 166.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.1 mt -68.82 -26.64 65.28 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.29 -39.86 84.29 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 158.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.85 -47.52 82.09 Favored Glycine 0 CA--C 1.552 2.402 0 N-CA-C 117.357 1.703 . . . . 0.0 117.357 164.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -77.16 83.81 3.65 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 118.424 1.112 . . . . 0.0 112.344 173.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.188 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 CA--C 1.575 1.934 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.57 -28.25 31.88 Favored 'Trans proline' 0 CA--C 1.566 2.115 0 N-CA-C 118.42 2.431 . . . . 0.0 118.42 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.11 96.86 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 168.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.68 95.13 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 161.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.87 -38.06 72.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 119.146 2.418 . . . . 0.0 119.146 166.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -55.19 -48.8 73.29 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 164.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -59.75 -43.55 94.22 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.57 -38.15 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 167.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.77 -20.61 15.49 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 169.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.78 -38.51 4.41 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 119.636 2.615 . . . . 0.0 119.636 156.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.97 -31.91 73.1 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 166.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -87.91 -33.53 18.47 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -57.91 -32.09 67.4 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 120.505 3.521 . . . . 0.0 120.505 -166.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.02 82.36 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 171.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.2 m -87.41 -44.14 11.57 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -109.22 143.83 38.15 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.339 1.056 . . . . 0.0 112.872 -168.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -118.51 150.28 39.87 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.381 1.086 . . . . 0.0 112.139 -172.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -104.07 1.89 31.46 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -115.52 57.63 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.422 1.464 . . . . 0.0 111.548 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.69 4.87 21.26 Favored Glycine 0 CA--C 1.558 2.771 0 N-CA-C 120.492 2.957 . . . . 0.0 120.492 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -97.7 143.02 28.78 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 118.87 1.335 . . . . 0.0 112.766 -168.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.38 103.97 8.5 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.46 -105.7 3.05 Favored Glycine 0 N--CA 1.49 2.234 0 O-C-N 122.117 -0.365 . . . . 0.0 113.142 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.32 -49.75 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.848 166.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.65 163.49 16.39 Favored Glycine 0 CA--C 1.56 2.864 0 CA-C-N 118.911 0.778 . . . . 0.0 114.851 164.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.72 176.09 8.7 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 CA-C-N 120.845 2.323 . . . . 0.0 115.935 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -70.23 120.2 15.56 Favored 'General case' 0 CA--C 1.568 1.646 0 O-C-N 120.535 -1.353 . . . . 0.0 113.279 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -87.84 -4.01 58.89 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -62.95 111.7 2.27 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.349 1.431 . . . . 0.0 111.729 157.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.66 43.58 7.72 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 -173.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.09 -37.88 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 118.805 1.303 . . . . 0.0 114.491 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.39 107.8 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.898 1.226 . . . . 0.0 110.096 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.81 -19.96 52.26 Favored Glycine 0 CA--C 1.552 2.372 0 N-CA-C 118.503 2.161 . . . . 0.0 118.503 -163.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -73.01 143.63 47.49 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 120.929 2.364 . . . . 0.0 113.415 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.3 m -60.4 140.26 57.28 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.16 124.32 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 123.405 0.682 . . . . 0.0 110.824 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.39 48.72 5.79 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -164.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.05 -8.08 39.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 119.46 2.544 . . . . 0.0 119.46 -169.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.1 t -82.94 103.23 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 120.199 2.0 . . . . 0.0 109.12 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.27 90.33 0.91 Allowed 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.546 0.738 . . . . 0.0 112.081 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.27 -48.84 0.51 Allowed Glycine 0 N--CA 1.486 2.029 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.857 -160.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -81.22 132.16 35.33 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 118.098 0.949 . . . . 0.0 111.572 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -84.48 88.28 7.29 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.435 -0.79 . . . . 0.0 112.017 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -72.85 147.07 45.77 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.2 p -67.74 155.34 39.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -53.82 -49.23 90.45 Favored Pre-proline 0 CA--C 1.578 2.031 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.25 -23.6 38.73 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 CA-C-N 124.125 2.509 . . . . 0.0 117.521 170.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.1 tpp -65.4 -46.65 79.19 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 120.885 1.675 . . . . 0.0 114.147 161.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -57.84 -45.9 85.55 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 168.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.01 -11.96 61.01 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 170.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -60.4 -49.47 77.45 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.045 1.748 . . . . 0.0 114.638 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.88 164.72 36.08 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 163.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.46 -144.69 24.63 Favored Glycine 0 N--CA 1.486 2.015 0 CA-C-N 114.915 -0.642 . . . . 0.0 114.694 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -130.84 154.78 47.69 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.665 0.745 . . . . 0.0 111.493 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -76.12 76.81 2.95 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 123.149 1.452 . . . . 0.0 112.558 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -75.72 159.89 80.28 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.881 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.18 -33.75 91.33 Favored 'Trans proline' 0 CA--C 1.57 2.289 0 N-CA-C 117.66 2.139 . . . . 0.0 117.66 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.31 -50.66 59.27 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 166.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.65 -43.67 85.11 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -57.17 -50.73 71.93 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 165.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.304 1.6 pp0? -61.28 -37.24 82.47 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 175.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.43 -59.02 6.01 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 164.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -58.93 -42.83 90.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.5 mt -69.77 -17.39 63.42 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.5 m -62.71 -55.23 28.6 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.26 1.846 . . . . 0.0 112.869 164.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.23 103.32 2.42 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-N 119.496 1.044 . . . . 0.0 108.525 173.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.02 -46.63 0.37 Allowed 'Trans proline' 0 CA--C 1.558 1.686 0 N-CA-C 117.431 2.05 . . . . 0.0 117.431 -167.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.95 -25.85 68.55 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 169.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 -45.06 70.21 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 163.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.9 t -65.47 -55.3 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.558 1.072 . . . . 0.0 112.782 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.8 104.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -72.99 98.29 2.48 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-O 121.454 0.645 . . . . 0.0 111.316 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.83 23.84 7.61 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 118.657 2.223 . . . . 0.0 118.657 -168.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.4 t -75.41 134.52 40.89 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 119.615 1.708 . . . . 0.0 111.061 160.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -72.92 9.08 1.25 Allowed 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 117.409 2.374 . . . . 0.0 117.409 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -76.25 100.77 5.19 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 120.725 -1.234 . . . . 0.0 111.726 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.64 71.36 4.12 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 122.595 1.188 . . . . 0.0 113.611 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -138.63 128.03 24.49 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.85 -53.48 32.03 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.88 158.79 8.9 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 115.471 0.948 . . . . 0.0 115.471 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.7 mt -100.26 98.56 7.95 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 117.934 -1.031 . . . . 0.0 108.524 166.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.55 -36.39 11.46 Favored 'Trans proline' 0 CA--C 1.565 2.044 0 C-N-CA 122.658 2.239 . . . . 0.0 117.575 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.08 133.53 41.56 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 118.94 0.791 . . . . 0.0 112.527 175.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -57.77 -40.66 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 171.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.57 -43.25 84.37 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.78 -44.72 73.95 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 167.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -66.43 -55.27 16.52 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 173.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.66 98.07 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.64 -47.41 86.36 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.964 1.256 . . . . 0.0 114.11 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.39 -44.0 92.87 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 169.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.0 mt -60.55 -42.87 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 117.539 -1.22 . . . . 0.0 113.101 169.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.67 -44.05 72.97 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 164.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -58.92 -48.22 82.23 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 166.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.9 mt -69.39 -24.47 63.86 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.31 -41.21 92.99 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 156.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.3 -44.96 92.75 Favored Glycine 0 CA--C 1.554 2.5 0 N-CA-C 117.584 1.794 . . . . 0.0 117.584 163.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -79.17 82.36 5.34 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-N 118.623 1.212 . . . . 0.0 111.882 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.43 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.573 1.848 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.71 -23.51 30.93 Favored 'Trans proline' 0 CA--C 1.568 2.203 0 N-CA-C 118.227 2.357 . . . . 0.0 118.227 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.96 -47.36 83.51 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.08 81.56 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 162.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.83 -35.03 66.22 Favored Glycine 0 CA--C 1.552 2.383 0 N-CA-C 119.114 2.405 . . . . 0.0 119.114 164.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.53 -49.77 76.5 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 168.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -59.65 -41.59 90.89 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 169.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.52 -39.16 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 169.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -56.85 -23.03 41.21 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 167.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.05 -35.57 18.99 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 119.585 2.594 . . . . 0.0 119.585 162.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.8 -36.33 76.5 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 162.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -80.27 -32.54 38.22 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 171.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -49.85 -33.8 18.06 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.78 -26.34 23.29 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 118.145 2.646 . . . . 0.0 118.145 167.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.0 m -120.32 -38.77 2.86 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -108.48 147.28 31.9 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.322 1.049 . . . . 0.0 113.169 -169.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -119.74 148.93 42.82 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.937 0.875 . . . . 0.0 112.108 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -105.66 3.94 29.62 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.62 40.23 1.46 Allowed 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 121.095 1.771 . . . . 0.0 114.628 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.36 35.68 91.76 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 117.981 1.952 . . . . 0.0 117.981 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -131.06 142.38 50.29 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 117.905 0.853 . . . . 0.0 111.27 -166.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -91.82 140.66 29.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.032 -1.042 . . . . 0.0 111.505 174.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.91 -115.46 1.89 Allowed Glycine 0 N--CA 1.491 2.341 0 O-C-N 121.518 -0.739 . . . . 0.0 112.108 172.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.18 -47.54 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.817 164.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.39 173.63 27.59 Favored Glycine 0 CA--C 1.562 3.013 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 163.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.42 172.6 12.97 Favored 'Trans proline' 0 CA--C 1.564 1.996 0 C-N-CA 122.845 2.363 . . . . 0.0 115.583 173.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -68.51 125.83 27.73 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 120.425 -1.422 . . . . 0.0 113.754 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -91.57 -0.86 57.64 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -66.46 111.63 3.66 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-N 120.326 1.421 . . . . 0.0 111.234 162.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.99 41.42 7.58 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 116.687 1.435 . . . . 0.0 116.687 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -92.73 -34.31 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.02 106.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 120.428 1.467 . . . . 0.0 109.512 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.48 -12.12 66.51 Favored Glycine 0 CA--C 1.553 2.44 0 N-CA-C 118.731 2.252 . . . . 0.0 118.731 -161.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -78.31 148.45 33.82 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 121.228 2.514 . . . . 0.0 112.84 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.4 m -54.12 141.53 28.56 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.95 120.87 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.758 -0.589 . . . . 0.0 109.974 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.271 . . 66.42 54.66 0.89 Allowed 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -161.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.98 22.13 9.23 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 119.206 2.442 . . . . 0.0 119.206 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.3 t -102.99 109.22 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.323 1.561 . . . . 0.0 107.79 165.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -72.67 88.33 1.28 Allowed 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 123.453 0.701 . . . . 0.0 111.67 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.87 -47.07 0.54 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.075 -159.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -82.23 131.86 35.23 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 118.362 1.081 . . . . 0.0 111.829 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -78.68 105.58 10.07 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.517 0.727 . . . . 0.0 111.848 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -89.56 156.77 18.39 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -63.35 151.8 39.79 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 171.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -59.26 -48.42 96.23 Favored Pre-proline 0 CA--C 1.577 1.997 0 CA-C-O 116.124 -1.893 . . . . 0.0 115.473 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.42 -24.98 63.7 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 CA-C-N 124.477 2.635 . . . . 0.0 117.937 166.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.4 tpp -65.39 -48.61 72.29 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.796 1.634 . . . . 0.0 114.097 164.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -56.27 -47.83 77.8 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 166.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.64 -11.89 60.82 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 118.994 2.961 . . . . 0.0 118.994 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -63.6 -52.63 60.08 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.762 1.619 . . . . 0.0 114.316 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.08 175.26 49.81 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.69 -148.3 36.61 Favored Glycine 0 CA--C 1.547 2.039 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -134.26 155.03 50.91 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.644 0.735 . . . . 0.0 111.639 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -77.1 77.48 3.64 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.91 1.338 . . . . 0.0 112.838 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.0 p -73.84 159.82 83.38 Favored Pre-proline 0 CA--C 1.574 1.885 0 C-N-CA 124.455 1.102 . . . . 0.0 112.344 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -57.59 -34.39 98.02 Favored 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 122.399 2.066 . . . . 0.0 117.459 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.19 -39.84 74.99 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 116.382 1.994 . . . . 0.0 116.382 165.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.96 97.89 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.54 -43.21 93.57 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 166.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -54.27 -44.49 71.92 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -66.51 -55.6 14.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -59.71 -39.87 86.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 67.8 mt -76.37 -15.03 60.05 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 170.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.0 m -66.36 -53.29 37.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 121.323 1.874 . . . . 0.0 112.738 160.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -150.28 113.36 3.29 Favored Pre-proline 0 CA--C 1.575 1.922 0 CA-C-N 119.986 1.266 . . . . 0.0 109.197 168.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.49 -46.26 0.22 Allowed 'Trans proline' 0 CA--C 1.56 1.807 0 CA-C-N 122.597 1.963 . . . . 0.0 116.954 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.75 -28.83 68.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.77 -41.88 86.99 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 162.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.65 -57.76 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.482 1.037 . . . . 0.0 112.655 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -99.87 101.36 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.67 100.13 2.74 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.336 0.589 . . . . 0.0 111.066 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.84 19.39 12.02 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 118.928 2.331 . . . . 0.0 118.928 -167.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.3 t -73.08 136.83 44.98 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.289 2.044 . . . . 0.0 111.937 163.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -76.99 12.81 1.24 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.484 2.402 . . . . 0.0 117.484 169.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -74.12 95.96 2.65 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.665 -1.272 . . . . 0.0 110.972 169.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.92 74.3 4.47 Favored 'General case' 0 CA--C 1.567 1.627 0 CA-C-O 122.802 1.286 . . . . 0.0 113.24 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -142.05 127.36 18.72 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.57 -52.59 43.89 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.11 161.1 10.09 Favored Glycine 0 CA--C 1.545 1.917 0 CA-C-O 122.6 1.111 . . . . 0.0 115.171 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -100.74 99.17 9.57 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 117.851 -1.071 . . . . 0.0 108.646 168.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.79 -34.46 18.28 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 C-N-CA 122.608 2.206 . . . . 0.0 117.432 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.25 129.26 38.44 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.005 0.82 . . . . 0.0 112.85 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 tp -56.79 -45.21 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 169.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.39 -40.35 74.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -59.24 -46.8 87.52 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 120.176 1.353 . . . . 0.0 114.606 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -62.44 -53.75 50.25 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.24 -45.03 95.17 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -61.54 -45.64 93.32 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.9 tp -55.38 -45.0 76.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 166.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 61.3 mt -61.48 -42.62 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 117.46 -1.257 . . . . 0.0 113.219 171.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.3 -44.36 71.89 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 164.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -59.93 -47.85 84.11 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 167.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.04 -25.96 65.63 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -63.59 -42.75 98.24 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 159.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.99 -45.3 96.4 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 117.69 1.836 . . . . 0.0 117.69 165.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -78.33 77.71 4.81 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 118.292 1.046 . . . . 0.0 112.132 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.577 -0.702 . . . . 0.0 109.774 176.701 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 CA--C 1.575 1.935 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.66 -29.76 23.83 Favored 'Trans proline' 0 CA--C 1.568 2.221 0 N-CA-C 118.389 2.419 . . . . 0.0 118.389 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.34 -46.19 87.73 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 169.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.35 78.36 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 160.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.89 -34.79 72.72 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 168.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.36 -41.75 94.35 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 163.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -59.99 -44.75 94.31 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 167.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.46 -42.81 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 166.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -54.82 -28.05 46.6 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 169.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.62 -35.44 4.14 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 160.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -60.3 -35.8 76.42 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 163.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -80.12 -18.8 48.89 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -73.47 67.4 1.05 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 123.792 1.758 . . . . 0.0 115.0 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.34 -54.83 0.18 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 125.149 1.379 . . . . 0.0 109.059 167.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 m -83.52 -34.87 25.19 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 171.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -110.5 151.68 27.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 119.549 1.068 . . . . 0.0 112.716 -170.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.67 153.18 41.17 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.363 1.077 . . . . 0.0 110.983 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.9 -25.7 17.19 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.28 57.52 4.02 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 121.49 1.95 . . . . 0.0 113.685 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.65 7.69 12.12 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 121.732 3.453 . . . . 0.0 121.732 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -113.31 146.49 39.32 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.632 1.716 . . . . 0.0 112.925 -169.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.1 138.3 44.6 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.296 1.038 . . . . 0.0 111.102 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.72 -108.08 0.62 Allowed Glycine 0 N--CA 1.489 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 113.206 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.83 -51.35 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 CA-C-N 117.297 0.548 . . . . 0.0 111.088 169.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.13 169.82 17.01 Favored Glycine 0 CA--C 1.562 2.974 0 CA-C-N 118.577 0.626 . . . . 0.0 114.254 161.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.28 175.72 10.58 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 120.878 2.339 . . . . 0.0 115.398 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -68.9 124.68 24.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.647 -1.283 . . . . 0.0 112.615 173.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.85 -5.23 58.7 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.878 2.177 . . . . 0.0 116.878 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -63.65 117.31 6.65 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 119.423 1.011 . . . . 0.0 110.638 157.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.59 40.58 12.44 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 116.633 1.413 . . . . 0.0 116.633 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 p -95.68 -33.28 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.48 107.78 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-N 120.572 1.533 . . . . 0.0 109.57 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.07 -11.76 69.04 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 118.743 2.257 . . . . 0.0 118.743 -162.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -76.06 146.62 39.26 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 121.132 2.466 . . . . 0.0 112.704 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.9 m -53.89 140.94 29.09 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.66 113.37 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.669 -0.644 . . . . 0.0 109.298 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.27 . . 68.05 65.23 0.36 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -157.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.34 -25.52 4.95 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 119.187 2.435 . . . . 0.0 119.187 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.28 98.52 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 120.041 1.921 . . . . 0.0 109.504 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -69.25 107.89 3.43 Favored 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 123.284 0.634 . . . . 0.0 111.21 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.31 -52.79 0.75 Allowed Glycine 0 N--CA 1.49 2.239 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.767 -155.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -79.94 129.15 34.26 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 118.081 0.94 . . . . 0.0 111.749 172.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -76.53 98.76 4.74 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.523 0.729 . . . . 0.0 112.514 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -80.89 158.21 25.38 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.4 t -64.06 151.38 43.19 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 172.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -58.76 -48.03 97.59 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 115.963 -1.97 . . . . 0.0 115.8 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.21 -23.63 66.25 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 CA-C-N 124.724 2.723 . . . . 0.0 117.967 165.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.4 tpp -66.5 -49.14 67.56 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 120.794 1.634 . . . . 0.0 113.806 163.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -57.06 -45.89 82.89 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 168.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.71 -14.47 62.46 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 118.777 2.88 . . . . 0.0 118.777 172.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -65.48 -55.42 17.98 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 120.726 1.603 . . . . 0.0 113.777 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.59 178.32 51.2 Favored Glycine 0 CA--C 1.547 2.042 0 N-CA-C 116.853 1.501 . . . . 0.0 116.853 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.72 -145.4 32.63 Favored Glycine 0 CA--C 1.547 2.062 0 O-C-N 121.961 -0.729 . . . . 0.0 114.627 -174.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -134.74 155.75 50.02 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.891 0.853 . . . . 0.0 111.935 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -76.24 76.65 3.04 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 123.148 1.451 . . . . 0.0 112.791 171.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.4 p -72.78 161.5 79.0 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.565 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -57.11 -36.6 99.24 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 122.293 1.995 . . . . 0.0 116.909 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -61.06 -49.62 76.63 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 165.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.35 -43.51 83.52 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 172.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.09 -44.19 93.09 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 167.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -51.1 -47.71 61.85 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 121.047 1.749 . . . . 0.0 115.598 165.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -61.25 -60.98 2.9 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -61.31 -39.46 90.58 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.0 mt -75.65 -17.08 60.1 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 171.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.1 m -66.23 -51.27 59.23 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 120.838 1.654 . . . . 0.0 113.317 159.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -150.46 113.22 3.24 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 120.045 1.293 . . . . 0.0 109.646 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.92 -48.39 0.23 Allowed 'Trans proline' 0 CA--C 1.561 1.827 0 CA-C-N 122.656 1.984 . . . . 0.0 116.713 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.33 -27.4 64.34 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.69 -40.74 88.63 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 162.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.9 t -71.8 -57.85 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 119.323 0.965 . . . . 0.0 112.514 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.71 100.45 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 172.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -73.25 98.94 2.75 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 121.333 0.587 . . . . 0.0 111.633 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.02 22.82 8.07 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -165.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -74.17 136.65 42.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.733 1.767 . . . . 0.0 111.887 163.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -72.45 3.94 4.32 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.7 ttt -73.15 92.43 1.72 Allowed 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 120.334 1.425 . . . . 0.0 111.789 168.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.78 76.87 9.6 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 122.019 0.914 . . . . 0.0 112.624 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -128.02 129.14 46.22 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.459 0.704 . . . . 0.0 110.102 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.96 106.73 5.79 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 121.874 -0.516 . . . . 0.0 111.233 166.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.42 172.81 9.22 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 119.49 2.556 . . . . 0.0 119.49 -168.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.2 107.86 31.83 Favored Pre-proline 0 CA--C 1.572 1.817 0 CA-C-O 117.682 -1.152 . . . . 0.0 111.219 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.54 -35.84 9.71 Favored 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.691 2.261 . . . . 0.0 117.151 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.71 128.1 34.52 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 123.94 0.896 . . . . 0.0 112.975 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.8 tp -56.36 -45.27 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 170.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.16 -46.04 75.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.12 -45.29 83.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 170.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -64.36 -51.74 61.81 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 171.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.78 92.65 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 171.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -54.91 -53.55 54.12 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-N 119.813 1.188 . . . . 0.0 114.098 168.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.6 tp -57.42 -47.68 81.12 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 59.4 mt -63.59 -41.97 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.99 1.268 . . . . 0.0 113.083 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.02 68.54 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 163.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.88 -49.48 77.31 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 167.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.7 mt -66.4 -25.76 66.92 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.33 -44.03 97.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 158.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.03 -40.5 97.11 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 118.301 2.081 . . . . 0.0 118.301 167.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -83.2 84.19 7.58 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 118.655 1.228 . . . . 0.0 110.979 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 C--O 1.257 1.456 0 CA-C-O 118.299 -0.858 . . . . 0.0 109.537 176.597 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.1 t70 . . . . . 0 CA--C 1.574 1.889 0 CA-C-O 118.417 -0.802 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.85 -29.93 34.24 Favored 'Trans proline' 0 CA--C 1.567 2.143 0 N-CA-C 118.549 2.48 . . . . 0.0 118.549 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.27 -42.66 99.15 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.51 93.71 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 161.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.86 -37.06 75.83 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 118.912 2.325 . . . . 0.0 118.912 168.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.85 -37.97 77.69 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 164.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -65.5 -45.09 84.96 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 168.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.0 -40.1 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 166.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -56.5 -18.99 13.29 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.5 -39.23 5.68 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 119.237 2.455 . . . . 0.0 119.237 156.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -65.11 -33.83 76.95 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 166.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -87.32 -35.65 18.3 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -58.38 -27.42 64.22 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 119.896 3.295 . . . . 0.0 119.896 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.87 -31.21 62.59 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 166.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 m -105.87 -39.1 6.13 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 171.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -111.64 137.48 49.45 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.257 1.023 . . . . 0.0 112.901 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.33 147.77 23.45 Favored 'General case' 0 CA--C 1.565 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 113.28 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.9 mt -97.89 17.25 18.61 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 162.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -130.44 60.96 1.61 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.49 -1.381 . . . . 0.0 111.388 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.82 -33.12 0.38 Allowed Glycine 0 CA--C 1.557 2.694 0 N-CA-C 120.483 2.953 . . . . 0.0 120.483 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -76.94 145.56 38.09 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.583 1.153 . . . . 0.0 113.618 -172.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -111.13 115.84 30.09 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -109.44 -113.42 3.58 Favored Glycine 0 N--CA 1.491 2.309 0 O-C-N 121.707 -0.621 . . . . 0.0 113.646 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.12 -48.75 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 122.396 -0.473 . . . . 0.0 111.208 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.67 167.02 17.17 Favored Glycine 0 CA--C 1.561 2.936 0 CA-C-N 118.782 0.719 . . . . 0.0 114.514 159.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -68.98 176.68 5.86 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 CA-C-N 120.889 2.345 . . . . 0.0 115.059 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -68.82 126.75 30.74 Favored 'General case' 0 CA--C 1.57 1.72 0 O-C-N 120.427 -1.42 . . . . 0.0 113.158 175.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.2 -2.57 55.08 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -65.74 108.67 2.18 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.307 1.412 . . . . 0.0 111.711 162.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.02 52.53 4.28 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.82 -37.36 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 171.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.9 t -71.99 109.4 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 120.644 1.566 . . . . 0.0 109.016 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.06 -29.52 12.29 Favored Glycine 0 CA--C 1.551 2.313 0 N-CA-C 117.664 1.825 . . . . 0.0 117.664 -161.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -66.18 144.27 56.75 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 120.933 2.367 . . . . 0.0 113.949 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.4 m -53.38 140.67 26.72 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.12 121.43 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.579 -0.701 . . . . 0.0 110.191 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.267 . . 64.78 44.81 3.56 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -163.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.24 36.68 4.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 117.71 1.844 . . . . 0.0 117.71 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.72 105.27 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.23 96.77 2.31 Favored 'General case' 0 CA--C 1.566 1.596 0 C-N-CA 123.488 0.715 . . . . 0.0 110.697 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 149.06 -52.74 0.53 Allowed Glycine 0 N--CA 1.489 2.173 0 CA-C-O 119.58 -0.567 . . . . 0.0 114.087 -158.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -86.42 134.76 33.67 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.026 0.913 . . . . 0.0 111.955 175.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -76.97 108.62 10.15 Favored 'General case' 0 CA--C 1.568 1.668 0 C-N-CA 123.745 0.818 . . . . 0.0 112.964 171.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -94.49 150.77 19.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.451 -0.781 . . . . 0.0 112.231 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.2 p -69.66 157.21 37.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.622 -1.299 . . . . 0.0 114.323 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -55.79 -48.12 97.28 Favored Pre-proline 0 CA--C 1.576 1.959 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.55 -26.34 34.03 Favored 'Trans proline' 0 CA--C 1.565 2.067 0 CA-C-N 124.969 2.81 . . . . 0.0 117.205 170.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -63.35 -47.74 80.85 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 120.428 1.467 . . . . 0.0 114.189 163.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -59.18 -46.22 88.98 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 168.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.27 -13.79 61.6 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 174.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -61.01 -53.51 56.38 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 120.735 1.607 . . . . 0.0 114.831 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.09 176.59 49.88 Favored Glycine 0 CA--C 1.547 2.043 0 N-CA-C 116.764 1.466 . . . . 0.0 116.764 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.92 -153.17 43.32 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.84 155.9 47.0 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.042 0.925 . . . . 0.0 111.732 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -76.02 75.81 2.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.039 1.4 . . . . 0.0 112.882 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.7 p -73.92 159.93 83.03 Favored Pre-proline 0 CA--C 1.576 1.973 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.098 171.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -57.69 -34.21 97.83 Favored 'Trans proline' 0 CA--C 1.57 2.291 0 N-CA-C 117.777 2.184 . . . . 0.0 117.777 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.67 -47.27 72.99 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 165.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.14 89.58 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 170.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.5 mt -59.49 -45.91 90.32 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 165.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -55.87 -43.91 77.6 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 121.556 1.98 . . . . 0.0 116.307 168.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.69 -57.35 13.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.888 1.222 . . . . 0.0 114.155 169.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -61.82 -40.42 95.2 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.36 -22.82 61.09 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 170.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.2 m -61.85 -52.31 64.66 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.377 1.899 . . . . 0.0 113.445 164.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -151.28 113.17 3.05 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-N 119.91 1.232 . . . . 0.0 108.892 167.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.01 -46.43 0.24 Allowed 'Trans proline' 0 CA--C 1.56 1.81 0 CA-C-N 122.724 2.009 . . . . 0.0 116.798 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.16 -29.12 68.73 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.31 -41.02 90.32 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 162.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.7 t -70.32 -57.94 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 119.45 1.023 . . . . 0.0 112.475 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.37 102.19 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -73.11 99.32 2.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.599 -0.688 . . . . 0.0 111.429 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.84 21.84 9.36 Favored Glycine 0 CA--C 1.553 2.464 0 N-CA-C 118.622 2.209 . . . . 0.0 118.622 -166.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.5 t -74.31 132.27 41.92 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.793 1.797 . . . . 0.0 111.042 159.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -77.03 16.79 0.51 Allowed 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.9 ttt -78.68 101.73 7.67 Favored 'General case' 0 CA--C 1.561 1.377 0 O-C-N 120.847 -1.158 . . . . 0.0 111.059 171.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.12 70.77 3.56 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 122.637 1.208 . . . . 0.0 113.854 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -136.56 128.63 29.58 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 124.517 1.127 . . . . 0.0 108.053 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.38 -53.9 20.81 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.8 158.48 8.53 Favored Glycine 0 CA--C 1.544 1.861 0 N-CA-C 115.928 1.131 . . . . 0.0 115.928 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.5 mt -104.56 96.1 9.71 Favored Pre-proline 0 CA--C 1.575 1.917 0 C-N-CA 124.072 0.949 . . . . 0.0 108.9 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.48 -34.3 20.56 Favored 'Trans proline' 0 CA--C 1.567 2.159 0 C-N-CA 122.652 2.234 . . . . 0.0 117.555 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.88 131.53 38.63 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.835 0.854 . . . . 0.0 111.972 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.9 tt -55.9 -45.11 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 170.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -52.83 -44.29 66.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.7 -44.36 93.71 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 -67.01 -53.91 26.73 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.62 -42.85 93.58 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.05 -48.68 80.71 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 119.816 1.189 . . . . 0.0 113.838 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.8 tp -59.34 -44.9 92.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.23 -42.79 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 119.807 1.185 . . . . 0.0 112.88 171.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.67 -43.95 69.27 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 163.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -60.32 -48.77 80.3 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 167.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.8 -25.26 66.37 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.09 -35.36 80.89 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 158.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.79 -46.56 73.79 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 161.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.64 68.72 9.95 Favored 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 118.451 1.125 . . . . 0.0 111.459 172.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.872 -166.227 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 CA--C 1.576 1.955 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.66 -27.82 26.49 Favored 'Trans proline' 0 CA--C 1.568 2.193 0 N-CA-C 118.361 2.408 . . . . 0.0 118.361 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 -48.17 80.24 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 169.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.22 82.06 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 162.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.16 -36.52 68.55 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 119.009 2.364 . . . . 0.0 119.009 167.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -54.86 -47.43 74.2 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 162.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -59.93 -44.1 94.55 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.5 t -58.82 -42.64 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -55.37 -25.97 38.45 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 170.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.04 -34.55 7.71 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 119.75 2.66 . . . . 0.0 119.75 164.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -58.13 -41.85 84.54 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 161.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -75.39 -33.94 61.03 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -47.03 -37.75 9.83 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 119.025 2.972 . . . . 0.0 119.025 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.49 -29.33 58.59 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 170.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.9 m -113.64 -37.13 4.68 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 174.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -112.52 141.43 46.27 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.686 1.194 . . . . 0.0 111.588 -171.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.48 154.73 25.42 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.794 1.283 . . . . 0.0 113.372 171.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.6 mt -94.91 15.35 18.88 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 170.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -119.66 57.21 0.92 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 120.826 1.648 . . . . 0.0 112.776 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.51 -45.83 1.29 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 119.685 2.634 . . . . 0.0 119.685 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -77.57 157.77 30.16 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.32 1.057 . . . . 0.0 113.405 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.96 140.47 34.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.112 -0.992 . . . . 0.0 111.292 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.12 -116.2 3.62 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.802 -0.562 . . . . 0.0 113.045 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -75.88 -49.6 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 122.384 -0.48 . . . . 0.0 110.802 166.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.78 171.41 30.23 Favored Glycine 0 CA--C 1.559 2.832 0 CA-C-N 118.715 0.689 . . . . 0.0 114.796 158.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.41 175.41 7.85 Favored 'Trans proline' 0 CA--C 1.564 2.018 0 CA-C-N 120.845 2.322 . . . . 0.0 115.227 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -65.04 129.55 40.12 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 120.47 -1.394 . . . . 0.0 113.178 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.7 mt -96.51 -0.46 48.88 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -66.11 112.15 3.75 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.468 1.485 . . . . 0.0 111.233 158.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.98 51.45 5.38 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 115.733 1.053 . . . . 0.0 115.733 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -100.64 -35.99 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 170.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 t -72.24 109.87 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 120.503 1.502 . . . . 0.0 109.158 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.32 -17.63 58.25 Favored Glycine 0 CA--C 1.552 2.369 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -161.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -73.57 142.81 46.63 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 121.35 2.575 . . . . 0.0 113.311 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.7 m -59.94 138.65 57.78 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.2 123.92 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.787 -0.571 . . . . 0.0 110.221 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.8 45.51 7.67 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -164.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.43 -4.44 43.55 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 119.636 2.615 . . . . 0.0 119.636 -170.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.9 t -84.75 103.16 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 120.255 2.027 . . . . 0.0 108.994 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.0 94.31 0.63 Allowed 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.8 -46.08 0.82 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 114.934 0.734 . . . . 0.0 114.934 -161.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -76.93 131.8 38.72 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 118.405 1.103 . . . . 0.0 112.274 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -81.39 84.23 6.72 Favored 'General case' 0 CA--C 1.568 1.671 0 O-C-N 121.528 -0.732 . . . . 0.0 111.978 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -71.42 146.15 48.87 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.6 p -67.72 156.8 36.11 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -55.61 -43.94 99.41 Favored Pre-proline 0 CA--C 1.574 1.901 0 CA-C-O 115.162 -2.351 . . . . 0.0 117.316 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.12 -27.63 29.27 Favored 'Trans proline' 0 CA--C 1.565 2.044 0 CA-C-N 124.866 2.774 . . . . 0.0 116.977 168.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.4 tpp -63.33 -47.75 80.89 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.427 1.467 . . . . 0.0 114.019 163.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -57.87 -46.11 85.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 167.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.95 -14.45 61.92 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 118.881 2.919 . . . . 0.0 118.881 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -61.67 -53.7 52.67 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.722 1.601 . . . . 0.0 114.512 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.04 176.16 47.96 Favored Glycine 0 CA--C 1.547 2.059 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.1 -149.83 38.17 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 114.893 0.717 . . . . 0.0 114.893 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -131.91 156.07 46.77 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.818 0.818 . . . . 0.0 111.847 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -75.94 74.25 2.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.237 1.494 . . . . 0.0 112.988 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.0 p -73.75 161.48 78.55 Favored Pre-proline 0 CA--C 1.575 1.937 0 C-N-CA 124.985 1.314 . . . . 0.0 112.371 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -56.87 -35.28 98.28 Favored 'Trans proline' 0 CA--C 1.569 2.247 0 N-CA-C 117.575 2.106 . . . . 0.0 117.575 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -64.82 -49.51 70.33 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 164.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.64 90.48 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 172.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.65 -45.17 95.11 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 165.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -55.88 -44.42 78.11 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.635 2.016 . . . . 0.0 116.238 168.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -61.15 -57.74 11.25 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 120.047 1.294 . . . . 0.0 113.944 169.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -60.27 -41.36 93.11 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.83 -18.9 60.38 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -63.44 -51.4 65.86 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.071 1.76 . . . . 0.0 113.409 161.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -151.95 112.0 2.9 Favored Pre-proline 0 CA--C 1.575 1.94 0 CA-C-N 120.096 1.316 . . . . 0.0 108.993 167.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.51 -47.02 0.19 Allowed 'Trans proline' 0 CA--C 1.559 1.736 0 CA-C-N 122.71 2.004 . . . . 0.0 116.924 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.25 -27.6 67.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.96 -42.84 84.51 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 162.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.11 -57.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 119.546 1.066 . . . . 0.0 112.709 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.26 101.46 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -73.29 94.77 2.05 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-O 121.462 0.649 . . . . 0.0 111.561 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.93 25.93 5.98 Favored Glycine 0 CA--C 1.554 2.499 0 N-CA-C 118.379 2.111 . . . . 0.0 118.379 -166.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -76.08 137.61 40.27 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 119.749 1.774 . . . . 0.0 111.355 160.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -74.32 7.62 2.72 Favored 'General case' 0 CA--C 1.579 2.067 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 167.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -74.6 97.55 3.19 Favored 'General case' 0 CA--C 1.565 1.533 0 O-C-N 120.677 -1.264 . . . . 0.0 111.53 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.22 71.83 5.76 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 122.61 1.195 . . . . 0.0 113.472 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -129.93 133.41 46.82 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.465 1.106 . . . . 0.0 108.479 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.27 -56.09 9.87 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.48 155.2 6.66 Favored Glycine 0 CA--C 1.545 1.933 0 N-CA-C 116.159 1.224 . . . . 0.0 116.159 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.5 mt -105.72 97.88 16.1 Favored Pre-proline 0 CA--C 1.575 1.918 0 C-N-CA 123.962 0.905 . . . . 0.0 109.323 172.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.17 -33.21 15.44 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 122.632 2.221 . . . . 0.0 117.717 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.62 131.37 39.92 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 175.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.8 tt -56.63 -43.88 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -52.71 -47.4 67.34 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -57.19 -47.13 82.01 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -65.01 -51.55 61.03 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.32 83.79 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -56.47 -50.74 70.87 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.5 tp -57.34 -46.4 83.32 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 169.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.8 mt -64.4 -39.82 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-N 119.933 1.242 . . . . 0.0 113.202 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.22 -45.11 75.92 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 163.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -57.37 -50.51 72.76 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.3 mt -67.71 -26.78 66.34 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -62.39 -40.78 97.6 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 158.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.75 88.86 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 163.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -84.28 78.33 9.81 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 123.684 0.794 . . . . 0.0 111.997 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 123.581 0.752 . . . . 0.0 109.508 175.001 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 CA--C 1.58 2.124 0 CA-C-O 117.927 -1.035 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.12 -26.4 18.12 Favored 'Trans proline' 0 CA--C 1.566 2.091 0 N-CA-C 118.501 2.462 . . . . 0.0 118.501 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.08 -47.78 83.15 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 168.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.92 73.01 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 160.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.98 -35.69 70.03 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 168.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.49 -41.85 95.09 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 164.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.4 -44.47 95.67 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 165.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -58.7 -41.06 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -54.85 -19.48 6.61 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.77 -37.59 4.03 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 119.853 2.701 . . . . 0.0 119.853 157.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -65.75 -39.68 91.34 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 164.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.17 -33.9 38.01 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.08 -33.78 67.62 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 119.904 3.298 . . . . 0.0 119.904 -171.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.95 -33.37 66.96 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 171.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.6 m -99.18 -40.88 7.75 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 170.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -109.18 141.62 41.16 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.168 0.987 . . . . 0.0 113.035 -169.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -105.78 153.1 22.36 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.9 0.857 . . . . 0.0 112.77 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.8 mt -106.23 7.62 31.56 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 172.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -115.54 57.61 0.74 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.629 1.559 . . . . 0.0 112.282 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.77 1.93 10.41 Favored Glycine 0 CA--C 1.557 2.712 0 N-CA-C 121.487 3.355 . . . . 0.0 121.487 173.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -124.98 153.2 43.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 119.471 1.636 . . . . 0.0 112.362 -168.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -83.7 143.96 29.7 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.949 -1.095 . . . . 0.0 113.275 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.13 -119.01 2.62 Favored Glycine 0 N--CA 1.491 2.324 0 O-C-N 121.605 -0.685 . . . . 0.0 112.232 170.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.69 -48.08 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 122.178 -0.601 . . . . 0.0 110.938 165.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.36 172.18 30.14 Favored Glycine 0 CA--C 1.561 2.931 0 CA-C-N 118.971 0.805 . . . . 0.0 114.753 157.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -70.51 174.28 10.4 Favored 'Trans proline' 0 CA--C 1.563 1.942 0 CA-C-N 120.853 2.327 . . . . 0.0 115.506 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -66.54 122.59 17.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.499 -1.375 . . . . 0.0 113.36 176.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.22 -5.94 59.3 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -64.81 112.19 3.14 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 120.825 1.648 . . . . 0.0 110.766 159.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.56 36.1 24.05 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 116.981 1.552 . . . . 0.0 116.981 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -80.17 -34.54 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 118.925 1.362 . . . . 0.0 114.252 162.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.8 t -69.45 108.87 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 119.573 1.079 . . . . 0.0 109.966 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.59 -27.38 19.91 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 117.933 1.933 . . . . 0.0 117.933 -164.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -71.27 147.47 48.12 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.482 2.141 . . . . 0.0 113.968 -174.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.3 m -53.26 141.86 22.66 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -68.28 119.83 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.653 . . . . 0.0 109.767 170.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 64.37 55.92 1.35 Allowed 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -159.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.57 -20.1 14.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 119.238 2.455 . . . . 0.0 119.238 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.3 t -83.58 94.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.849 1.825 . . . . 0.0 109.236 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -69.33 113.1 6.35 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 123.315 0.646 . . . . 0.0 111.432 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 131.17 -49.79 0.91 Allowed Glycine 0 N--CA 1.491 2.323 0 CA-C-O 119.731 -0.483 . . . . 0.0 114.069 -155.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -77.48 129.26 35.48 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 118.059 0.93 . . . . 0.0 111.888 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -81.13 89.94 6.02 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.699 -0.625 . . . . 0.0 111.238 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -71.64 154.26 41.52 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.0 p -65.23 153.5 40.84 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.69 -1.256 . . . . 0.0 114.071 171.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.96 -47.45 99.06 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.47 -24.23 56.96 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 CA-C-N 125.115 2.863 . . . . 0.0 117.691 168.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 52.2 tpp -65.57 -48.42 72.44 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 120.65 1.568 . . . . 0.0 113.962 163.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -57.1 -46.29 82.69 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 167.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.67 -13.81 61.44 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -63.95 -54.41 34.95 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 120.805 1.639 . . . . 0.0 114.34 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 175.9 49.85 Favored Glycine 0 CA--C 1.546 2.005 0 N-CA-C 116.698 1.439 . . . . 0.0 116.698 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.78 -150.49 39.67 Favored Glycine 0 CA--C 1.547 2.064 0 O-C-N 121.914 -0.756 . . . . 0.0 114.943 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -133.02 154.11 50.84 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.815 0.817 . . . . 0.0 111.5 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -76.54 77.45 3.23 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.323 1.535 . . . . 0.0 112.552 171.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.0 p -71.75 160.6 82.16 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.208 169.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -58.01 -35.0 99.06 Favored 'Trans proline' 0 CA--C 1.57 2.283 0 N-CA-C 117.118 1.93 . . . . 0.0 117.118 174.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.73 -50.26 74.2 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 164.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.26 87.0 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.18 -43.6 97.78 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -50.91 -47.54 60.81 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 121.046 1.748 . . . . 0.0 115.68 165.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.53 -61.39 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -61.76 -40.11 94.0 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 mt -74.05 -16.87 61.03 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 171.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.4 m -63.9 -54.67 31.12 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 121.241 1.837 . . . . 0.0 112.927 161.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -150.44 112.59 3.23 Favored Pre-proline 0 CA--C 1.576 1.944 0 CA-C-N 119.781 1.173 . . . . 0.0 108.889 168.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.02 -45.95 0.26 Allowed 'Trans proline' 0 CA--C 1.56 1.786 0 CA-C-N 122.622 1.972 . . . . 0.0 116.904 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.18 -25.4 66.13 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.863 2.171 . . . . 0.0 116.863 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.59 78.63 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 161.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.5 t -71.48 -58.62 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-N 119.558 1.072 . . . . 0.0 112.723 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.5 103.62 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 171.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.11 94.15 3.43 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.582 0.706 . . . . 0.0 111.764 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.37 27.39 5.3 Favored Glycine 0 CA--C 1.554 2.489 0 N-CA-C 118.036 1.975 . . . . 0.0 118.036 -165.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.6 t -73.89 132.34 42.4 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.444 1.622 . . . . 0.0 111.187 160.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -73.85 10.41 1.16 Allowed 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 166.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -71.94 97.43 1.85 Allowed 'General case' 0 CA--C 1.564 1.501 0 O-C-N 120.933 -1.104 . . . . 0.0 111.261 166.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 75.48 4.25 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.72 1.248 . . . . 0.0 112.969 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -141.3 128.87 21.41 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.84 -52.7 33.76 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.13 157.06 7.87 Favored Glycine 0 N--CA 1.484 1.879 0 CA-C-O 122.275 0.93 . . . . 0.0 115.231 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.63 96.88 8.08 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.121 -0.942 . . . . 0.0 108.521 168.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.88 -33.63 15.76 Favored 'Trans proline' 0 CA--C 1.568 2.183 0 C-N-CA 122.636 2.224 . . . . 0.0 117.431 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.7 133.33 42.07 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.817 0.847 . . . . 0.0 112.993 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.0 tp -58.27 -42.75 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.12 -53.01 61.37 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -50.98 -41.73 59.72 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -66.91 -54.62 20.29 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.6 -45.6 91.43 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -53.13 -52.83 57.46 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 168.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.1 tp -60.61 -45.8 92.64 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 172.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 62.9 mt -61.55 -41.43 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 120.194 1.361 . . . . 0.0 113.034 172.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.68 -43.94 72.9 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 163.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -60.55 -46.61 89.54 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.58 -24.0 63.62 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 172.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -61.1 -45.48 94.52 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 157.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.9 88.23 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 117.846 1.898 . . . . 0.0 117.846 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -75.56 97.31 3.7 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 118.338 1.069 . . . . 0.0 111.575 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.065 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 CA--C 1.578 2.033 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.56 -28.46 26.19 Favored 'Trans proline' 0 CA--C 1.569 2.26 0 N-CA-C 118.522 2.47 . . . . 0.0 118.522 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.73 -42.29 97.92 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 168.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.34 77.87 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 159.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.73 96.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 118.955 2.342 . . . . 0.0 118.955 171.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.73 -38.67 91.38 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.82 97.0 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 164.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.09 -40.42 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 167.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -54.97 -19.81 7.62 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 166.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.72 -36.98 4.96 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 119.718 2.647 . . . . 0.0 119.718 159.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.67 -37.49 86.66 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 164.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -80.28 -34.56 36.84 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -57.52 -32.74 67.35 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -170.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.78 -35.89 71.41 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.2 m -93.69 -42.86 8.93 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 169.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -108.27 142.86 37.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.074 0.95 . . . . 0.0 113.092 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -110.63 150.21 29.31 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.548 1.166 . . . . 0.0 113.013 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -113.7 33.42 5.19 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.239 -0.913 . . . . 0.0 113.263 170.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -137.15 60.68 1.64 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.032 -1.667 . . . . 0.0 111.061 169.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.49 -47.73 1.78 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 119.522 2.569 . . . . 0.0 119.522 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -75.68 151.51 37.7 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.659 1.183 . . . . 0.0 113.109 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -101.9 131.33 48.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.749 . . . . 0.0 110.451 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.64 -114.33 3.7 Favored Glycine 0 N--CA 1.491 2.361 0 O-C-N 121.676 -0.64 . . . . 0.0 113.415 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.08 -47.79 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 122.413 -0.463 . . . . 0.0 110.77 165.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.9 168.72 24.95 Favored Glycine 0 CA--C 1.56 2.894 0 CA-C-N 118.985 0.812 . . . . 0.0 114.966 159.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -70.03 166.36 28.2 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 CA-C-N 120.699 2.249 . . . . 0.0 114.902 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -62.46 123.14 17.51 Favored 'General case' 0 CA--C 1.57 1.735 0 O-C-N 120.776 -1.203 . . . . 0.0 113.226 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.65 6.22 35.78 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -63.23 117.22 6.26 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.971 1.26 . . . . 0.0 110.929 159.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.96 44.35 37.16 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 116.244 1.257 . . . . 0.0 116.244 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 p -87.9 -30.59 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 170.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.79 107.0 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 119.945 1.248 . . . . 0.0 109.653 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.55 -10.28 71.01 Favored Glycine 0 CA--C 1.553 2.438 0 N-CA-C 118.925 2.33 . . . . 0.0 118.925 -163.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -77.0 144.0 38.99 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 121.078 2.439 . . . . 0.0 113.012 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.5 m -52.21 141.03 19.82 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -70.01 112.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.64 -0.663 . . . . 0.0 109.218 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.281 . . 70.0 66.63 0.23 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -154.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.32 -23.22 6.74 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 119.174 2.429 . . . . 0.0 119.174 -172.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.9 t -83.22 98.83 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 119.953 1.877 . . . . 0.0 109.369 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -69.59 104.59 2.41 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.417 0.627 . . . . 0.0 110.988 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.55 -55.12 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 CA-C-O 119.647 -0.53 . . . . 0.0 113.534 -155.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -78.92 129.07 34.1 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 118.037 0.919 . . . . 0.0 111.62 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -78.34 93.5 4.69 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.616 0.767 . . . . 0.0 112.724 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -76.17 161.11 29.09 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.9 t -65.44 152.15 44.62 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.46 -49.46 92.26 Favored Pre-proline 0 CA--C 1.576 1.98 0 CA-C-O 115.991 -1.957 . . . . 0.0 115.513 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.25 -21.75 67.06 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 CA-C-N 124.769 2.739 . . . . 0.0 118.149 166.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.8 tpp -66.94 -51.39 55.77 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.436 1.471 . . . . 0.0 113.344 163.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -57.87 -45.48 86.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 169.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.49 0.55 16.8 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 173.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -63.81 -49.81 71.42 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.69 81.19 1.06 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.27 -160.33 32.5 Favored Glycine 0 N--CA 1.485 1.908 0 CA-C-O 122.361 0.978 . . . . 0.0 115.161 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -125.21 155.1 40.57 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.017 0.913 . . . . 0.0 111.301 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -76.62 74.32 3.32 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 123.122 1.439 . . . . 0.0 113.272 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.0 p -71.44 161.2 79.75 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.67 171.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -58.5 -26.73 79.55 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 N-CA-C 117.528 2.088 . . . . 0.0 117.528 171.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.88 -56.99 10.02 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 161.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.76 94.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.28 -50.43 73.63 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 169.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.68 -35.58 78.38 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.21 -50.96 58.9 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -59.73 -40.57 88.47 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 171.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 70.7 mt -74.77 -16.35 60.72 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 169.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -67.77 -56.77 7.97 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 120.991 1.723 . . . . 0.0 112.293 160.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -145.12 109.55 4.64 Favored Pre-proline 0 CA--C 1.574 1.904 0 CA-C-N 119.503 1.047 . . . . 0.0 108.918 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.63 -41.28 0.82 Allowed 'Trans proline' 0 CA--C 1.561 1.859 0 C-N-CA 122.162 1.908 . . . . 0.0 116.874 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -58.3 -38.73 77.64 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 170.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.26 -42.95 87.76 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 169.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.62 -51.66 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 119.096 0.862 . . . . 0.0 113.31 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.8 101.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -75.07 94.64 2.92 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.322 0.582 . . . . 0.0 111.585 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.66 25.3 6.03 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 118.264 2.066 . . . . 0.0 118.264 -165.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 t -71.68 136.37 47.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.56 1.68 . . . . 0.0 112.046 163.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -73.94 6.96 2.91 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -72.61 100.61 2.82 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 120.72 -1.237 . . . . 0.0 111.507 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.61 75.54 7.49 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.588 1.185 . . . . 0.0 112.815 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -137.98 132.34 32.15 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.207 1.003 . . . . 0.0 108.539 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.65 -55.83 7.84 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.79 153.01 6.24 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 122.222 0.901 . . . . 0.0 115.199 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.8 mt -97.71 104.31 20.65 Favored Pre-proline 0 CA--C 1.574 1.868 0 CA-C-O 117.772 -1.108 . . . . 0.0 109.135 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.44 -36.22 9.36 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.684 2.256 . . . . 0.0 117.769 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.66 134.0 37.17 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 119.227 0.921 . . . . 0.0 112.813 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -58.01 -41.63 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 170.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.98 -47.36 74.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 172.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -56.39 -42.88 78.63 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -64.61 -53.94 39.77 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.89 -43.3 90.94 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.373 2.361 . . . . 0.0 117.373 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -56.1 -52.17 65.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 169.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.03 -46.13 82.6 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 169.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.7 mt -60.35 -41.63 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 120.096 1.316 . . . . 0.0 113.333 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.69 75.14 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 165.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.39 -44.61 95.51 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 166.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.4 mt -67.21 -26.95 66.86 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 171.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -63.76 -41.36 98.0 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 159.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.61 -48.11 87.84 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 117.421 1.729 . . . . 0.0 117.421 163.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -78.4 84.91 4.53 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 118.015 0.907 . . . . 0.0 112.189 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 . . . . . 0 C--O 1.256 1.414 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.041 174.626 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t70 . . . . . 0 CA--C 1.577 1.988 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.01 -31.92 22.8 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 N-CA-C 117.947 2.249 . . . . 0.0 117.947 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.24 78.76 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 168.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.3 -39.24 74.94 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 159.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.51 -33.86 59.39 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 120.222 2.849 . . . . 0.0 120.222 174.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.25 -36.4 79.88 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 168.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -62.8 -45.37 92.96 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 165.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 t -56.87 -42.6 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 168.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.12 -25.15 44.82 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.27 -35.28 9.36 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 119.79 2.676 . . . . 0.0 119.79 165.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -58.63 -38.17 77.48 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 162.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -77.34 -34.72 55.14 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -46.17 -40.41 11.15 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 119.144 3.016 . . . . 0.0 119.144 -177.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.17 -32.57 64.45 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.7 m -104.92 -38.06 6.76 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 172.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -116.39 142.99 46.13 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.457 1.103 . . . . 0.0 112.421 -167.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -115.84 147.98 40.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.802 0.81 . . . . 0.0 112.387 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.8 mt -102.21 15.11 30.11 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -128.88 65.29 1.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 119.221 -2.175 . . . . 0.0 111.353 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.3 -37.7 0.82 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 119.939 2.736 . . . . 0.0 119.939 170.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -73.9 149.58 41.4 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.532 1.133 . . . . 0.0 113.43 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.71 132.75 49.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.415 -0.803 . . . . 0.0 110.235 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.61 -111.92 3.65 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 121.891 -0.506 . . . . 0.0 113.02 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -78.33 -48.16 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 122.433 -0.451 . . . . 0.0 110.769 164.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.75 170.53 25.38 Favored Glycine 0 CA--C 1.559 2.843 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 161.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -71.53 175.1 9.95 Favored 'Trans proline' 0 CA--C 1.565 2.038 0 CA-C-N 120.617 2.208 . . . . 0.0 115.784 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -66.81 124.95 24.37 Favored 'General case' 0 CA--C 1.568 1.656 0 O-C-N 120.485 -1.384 . . . . 0.0 113.353 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.42 -0.78 57.33 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -66.26 108.21 2.23 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 120.095 1.316 . . . . 0.0 111.483 161.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.91 46.15 5.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -171.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.11 -36.14 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 t -74.58 109.02 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 120.544 1.52 . . . . 0.0 109.202 -172.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.16 -28.58 15.29 Favored Glycine 0 CA--C 1.551 2.295 0 N-CA-C 117.653 1.821 . . . . 0.0 117.653 -160.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -68.09 146.41 53.5 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 120.844 2.322 . . . . 0.0 113.816 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.4 m -53.14 140.59 25.45 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.09 120.78 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.757 -0.59 . . . . 0.0 109.946 171.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . 63.94 51.96 2.19 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -162.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.08 -27.8 9.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 118.693 2.237 . . . . 0.0 118.693 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.2 t -74.95 95.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.329 1.565 . . . . 0.0 109.678 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.96 106.92 8.94 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.468 0.707 . . . . 0.0 110.223 -176.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.2 -50.75 0.82 Allowed Glycine 0 N--CA 1.489 2.232 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.678 -152.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -76.97 130.6 37.71 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 118.224 1.012 . . . . 0.0 111.881 172.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -79.5 80.58 5.86 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -67.73 150.91 48.07 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.5 p -68.97 153.51 43.67 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -53.71 -48.39 93.47 Favored Pre-proline 0 CA--C 1.575 1.912 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.8 -23.56 47.97 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 CA-C-N 124.198 2.535 . . . . 0.0 117.708 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ttm -66.92 -47.11 72.74 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 121.282 1.856 . . . . 0.0 113.849 162.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -57.58 -45.49 85.16 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 168.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.08 -16.65 62.03 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -61.72 -54.53 41.31 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 120.808 1.64 . . . . 0.0 114.404 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 177.39 49.96 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.14 -149.5 39.29 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 114.931 0.733 . . . . 0.0 114.931 -175.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -132.39 154.01 50.22 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.04 0.924 . . . . 0.0 111.562 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -75.92 76.42 2.82 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 123.023 1.392 . . . . 0.0 112.913 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.1 p -73.13 159.32 85.41 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.166 171.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.11 -34.84 98.48 Favored 'Trans proline' 0 CA--C 1.571 2.369 0 N-CA-C 117.585 2.11 . . . . 0.0 117.585 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.6 -50.11 70.69 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 165.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.22 92.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 172.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.7 mt -57.34 -49.87 74.77 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.5 pp0? -64.26 -33.85 76.77 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.71 -55.25 28.51 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 163.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -59.54 -41.65 90.54 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 73.9 mt -73.52 -17.51 61.2 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 170.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.9 m -65.83 -63.32 1.11 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 120.919 1.691 . . . . 0.0 111.662 158.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -134.63 100.42 12.35 Favored Pre-proline 0 CA--C 1.571 1.774 0 CA-C-O 118.397 -0.811 . . . . 0.0 109.834 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.1 -46.58 0.23 Allowed 'Trans proline' 0 CA--C 1.563 1.929 0 CA-C-N 122.504 1.93 . . . . 0.0 115.708 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -61.49 -34.51 75.6 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 169.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.97 -43.26 65.44 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 170.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.24 -54.83 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 119.261 0.937 . . . . 0.0 112.795 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.11 100.59 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -74.94 98.6 3.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.684 -0.635 . . . . 0.0 111.362 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.59 25.24 7.39 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -165.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 t -69.33 135.11 49.93 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.409 1.604 . . . . 0.0 111.307 159.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -72.88 7.92 1.78 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 166.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -77.34 104.64 7.97 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 120.81 -1.181 . . . . 0.0 111.955 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.32 69.85 6.85 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 122.316 1.055 . . . . 0.0 113.492 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -125.81 135.69 52.28 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.222 1.009 . . . . 0.0 108.951 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.33 -57.68 4.01 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.95 150.49 5.49 Favored Glycine 0 N--CA 1.485 1.902 0 CA-C-N 119.069 0.85 . . . . 0.0 115.138 -175.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -101.99 97.13 7.71 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.135 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.26 -32.72 20.07 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 C-N-CA 122.652 2.235 . . . . 0.0 117.812 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -76.94 127.58 32.96 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 119.039 0.836 . . . . 0.0 112.505 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -58.8 -41.0 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 172.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.05 -46.47 71.94 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 170.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.89 -45.92 82.24 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -62.82 -52.53 62.81 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 171.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.08 86.29 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -57.29 -50.4 73.05 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 170.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.5 -48.25 74.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.255 57.7 mt -63.92 -40.92 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 119.765 1.166 . . . . 0.0 113.231 174.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.25 74.12 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 163.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -59.32 -47.82 83.94 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 166.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.3 -27.87 69.33 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.26 -34.42 77.97 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 162.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.91 -47.07 68.16 Favored Glycine 0 CA--C 1.553 2.446 0 N-CA-C 116.989 1.555 . . . . 0.0 116.989 160.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 70.12 9.55 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 118.419 1.11 . . . . 0.0 111.534 172.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.254 1.32 0 O-C-N 121.339 -0.851 . . . . 0.0 111.181 -164.34 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.576 1.961 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.68 -29.4 19.54 Favored 'Trans proline' 0 CA--C 1.567 2.146 0 N-CA-C 118.333 2.397 . . . . 0.0 118.333 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.52 80.72 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 168.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.58 72.97 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 162.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.81 -33.91 84.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 118.126 2.01 . . . . 0.0 118.126 168.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -38.75 86.69 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 115.888 1.811 . . . . 0.0 115.888 167.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.254 21.7 pttm -67.01 -43.52 82.64 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.872 1.669 . . . . 0.0 115.083 166.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.8 t -60.43 -34.58 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 114.384 1.254 . . . . 0.0 114.384 171.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -54.82 -20.23 8.18 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 168.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.99 -37.28 5.44 Favored Glycine 0 CA--C 1.559 2.808 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 157.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.65 -31.44 72.12 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 166.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 m -90.73 -33.95 15.56 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -32.27 62.53 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 120.416 3.487 . . . . 0.0 120.416 -171.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.78 -34.84 71.91 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 170.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.7 m -95.55 -43.23 8.05 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -110.14 126.39 54.01 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.244 1.018 . . . . 0.0 111.752 -168.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -94.81 147.24 23.56 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.807 0.813 . . . . 0.0 111.427 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.5 -28.76 28.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -81.29 61.74 4.92 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.33 1.877 . . . . 0.0 113.805 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.75 10.11 16.88 Favored Glycine 0 CA--C 1.556 2.605 0 N-CA-C 121.94 3.536 . . . . 0.0 121.94 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -128.35 156.77 42.57 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 119.278 1.539 . . . . 0.0 112.557 -170.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.42 148.23 30.64 Favored 'General case' 0 CA--C 1.572 1.826 0 O-C-N 120.885 -1.135 . . . . 0.0 112.559 166.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.21 -100.75 2.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 157.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -79.73 -51.88 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.617 160.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.32 156.0 19.91 Favored Glycine 0 CA--C 1.559 2.84 0 N-CA-C 115.068 0.787 . . . . 0.0 115.068 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.93 151.23 27.45 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 CA-C-N 120.985 2.393 . . . . 0.0 113.601 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -45.51 126.74 6.94 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -167.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.74 -6.58 59.36 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -64.22 117.71 7.55 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 119.609 1.095 . . . . 0.0 110.651 158.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.05 44.61 11.51 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.65 -31.04 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -80.84 100.31 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 120.588 1.54 . . . . 0.0 109.162 -172.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.47 -20.7 29.67 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 117.872 1.909 . . . . 0.0 117.872 -158.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -73.05 146.45 45.85 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 120.743 2.272 . . . . 0.0 113.337 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.8 m -54.27 141.01 31.21 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.3 116.44 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.681 -0.637 . . . . 0.0 109.484 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.286 . . 68.14 61.6 0.4 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -159.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.45 -26.03 6.38 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 119.221 2.449 . . . . 0.0 119.221 -170.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.77 94.59 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 120.078 1.939 . . . . 0.0 109.625 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.43 126.73 30.56 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 123.269 0.628 . . . . 0.0 112.167 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.67 -54.7 0.63 Allowed Glycine 0 N--CA 1.491 2.341 0 CA-C-O 119.925 -0.375 . . . . 0.0 113.567 -157.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -79.23 116.58 19.58 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 117.771 0.786 . . . . 0.0 110.844 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -78.78 98.87 6.45 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.814 0.816 . . . . 0.0 110.817 172.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -65.21 162.71 16.65 Favored 'General case' 0 CA--C 1.574 1.874 0 C-N-CA 123.865 0.866 . . . . 0.0 112.969 172.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 p -68.59 158.66 33.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.243 -1.536 . . . . 0.0 114.216 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -54.25 -49.99 87.24 Favored Pre-proline 0 CA--C 1.578 2.027 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.68 -25.16 46.98 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 CA-C-N 124.241 2.55 . . . . 0.0 117.521 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -65.57 -48.8 71.13 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 120.419 1.463 . . . . 0.0 114.056 163.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -58.84 -43.79 90.78 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 168.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 -15.06 61.88 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 118.909 2.929 . . . . 0.0 118.909 172.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -62.7 -55.42 26.97 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 120.958 1.708 . . . . 0.0 114.364 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.35 178.15 50.82 Favored Glycine 0 CA--C 1.548 2.128 0 N-CA-C 116.879 1.511 . . . . 0.0 116.879 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.46 -148.7 35.94 Favored Glycine 0 N--CA 1.488 2.156 0 O-C-N 121.95 -0.736 . . . . 0.0 114.796 -174.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -133.86 153.11 51.97 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.863 0.839 . . . . 0.0 111.925 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -76.35 78.73 3.1 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.73 1.253 . . . . 0.0 112.782 171.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -73.99 157.45 87.02 Favored Pre-proline 0 CA--C 1.575 1.908 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.438 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -58.96 -29.17 89.8 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 N-CA-C 117.495 2.075 . . . . 0.0 117.495 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.75 -56.53 13.06 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 162.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.99 -38.93 84.03 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.2 mt -56.4 -40.23 74.31 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 167.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -56.81 -41.73 78.27 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 170.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.89 -55.73 20.52 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.239 1.381 . . . . 0.0 113.357 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -59.57 -41.63 90.64 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -71.74 -24.21 61.74 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.1 m -62.68 -52.29 63.88 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.265 1.848 . . . . 0.0 113.364 164.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -150.41 114.5 3.3 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-N 119.82 1.191 . . . . 0.0 108.94 169.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.53 -44.15 0.25 Allowed 'Trans proline' 0 CA--C 1.563 1.927 0 CA-C-N 122.693 1.998 . . . . 0.0 116.22 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.19 -43.01 73.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 117.033 2.234 . . . . 0.0 117.033 169.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.26 92.78 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 170.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.12 -57.51 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 118.876 0.762 . . . . 0.0 112.43 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.72 102.96 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 172.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -74.92 90.28 2.41 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.762 0.791 . . . . 0.0 111.627 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.03 28.76 3.75 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 118.01 1.964 . . . . 0.0 118.01 -166.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 t -76.11 134.95 39.86 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.677 1.738 . . . . 0.0 111.42 163.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -76.75 21.58 0.2 Allowed 'General case' 0 CA--C 1.582 2.176 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 170.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.8 ttt -87.92 102.53 14.8 Favored 'General case' 0 CA--C 1.56 1.358 0 O-C-N 120.776 -1.202 . . . . 0.0 110.813 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.1 69.79 2.7 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -135.98 131.83 35.56 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.434 1.093 . . . . 0.0 108.613 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.07 -55.37 8.39 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.03 155.74 7.52 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 115.769 1.068 . . . . 0.0 115.769 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.8 mt -100.85 98.16 7.97 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 118.167 -0.921 . . . . 0.0 109.076 168.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.02 -34.76 16.28 Favored 'Trans proline' 0 CA--C 1.568 2.182 0 C-N-CA 122.674 2.249 . . . . 0.0 117.272 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.06 129.87 40.08 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.66 0.784 . . . . 0.0 112.982 175.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.1 tt -57.54 -43.08 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 166.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.54 -48.69 68.85 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -54.82 -45.88 74.5 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.7 mtm-85 -66.49 -54.13 27.41 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.27 -44.14 88.27 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -59.4 -52.73 64.37 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 113.728 1.011 . . . . 0.0 113.728 169.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.18 -46.49 85.69 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -61.12 -42.38 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 117.552 -1.213 . . . . 0.0 112.945 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.76 -44.32 73.52 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 164.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -58.42 -50.67 72.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 167.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.09 -24.51 65.95 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 174.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.85 -44.82 96.05 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 158.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.69 -41.8 93.63 Favored Glycine 0 CA--C 1.553 2.427 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 168.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.99 83.27 6.74 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 118.725 1.262 . . . . 0.0 111.0 172.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.414 -0.803 . . . . 0.0 109.753 175.872 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 CA--C 1.575 1.938 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.45 -27.8 27.5 Favored 'Trans proline' 0 CA--C 1.569 2.26 0 N-CA-C 118.458 2.445 . . . . 0.0 118.458 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.7 98.73 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 167.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.48 -32.79 74.37 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 159.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.75 -38.43 95.18 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 118.848 2.299 . . . . 0.0 118.848 171.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.01 -38.96 90.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 169.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -61.87 -42.02 98.56 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 164.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.67 -39.13 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 168.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -55.61 -25.29 37.84 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 169.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.9 -29.08 26.2 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 119.809 2.684 . . . . 0.0 119.809 165.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -58.51 -38.4 77.63 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 159.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -82.05 -32.2 30.54 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -45.39 -46.33 13.17 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 119.664 3.209 . . . . 0.0 119.664 -173.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.83 -38.5 70.13 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.8 m -89.84 -43.91 10.31 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -112.36 132.94 54.73 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 119.453 1.024 . . . . 0.0 112.179 -169.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -117.61 132.52 56.5 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.9 0.857 . . . . 0.0 111.105 -173.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.2 mt -80.04 -9.14 59.67 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 117.33 2.345 . . . . 0.0 117.33 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -102.76 58.62 0.78 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.175 1.807 . . . . 0.0 112.011 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.2 24.23 50.47 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 121.124 3.21 . . . . 0.0 121.124 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -106.57 121.99 45.41 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.007 1.404 . . . . 0.0 110.697 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -93.22 103.59 15.84 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.381 0.672 . . . . 0.0 109.454 173.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.0 -107.41 3.21 Favored Glycine 0 N--CA 1.489 2.224 0 O-C-N 122.096 -0.377 . . . . 0.0 112.689 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.19 -49.44 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 118.923 -0.561 . . . . 0.0 111.087 166.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.95 166.77 14.78 Favored Glycine 0 CA--C 1.561 2.93 0 CA-C-N 119.035 0.834 . . . . 0.0 114.924 164.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.78 169.24 20.68 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 120.813 2.307 . . . . 0.0 115.174 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -65.76 124.34 22.17 Favored 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.456 -1.402 . . . . 0.0 113.434 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.2 mt -90.41 6.47 43.14 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -67.41 125.97 27.79 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 121.149 1.795 . . . . 0.0 110.96 159.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.24 53.51 13.67 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 115.619 1.007 . . . . 0.0 115.619 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -107.0 -29.87 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 t -79.36 100.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 120.811 1.642 . . . . 0.0 109.0 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.82 -15.62 48.3 Favored Glycine 0 CA--C 1.552 2.398 0 N-CA-C 118.304 2.082 . . . . 0.0 118.304 -159.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -72.12 141.06 49.16 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 121.339 2.569 . . . . 0.0 113.201 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.8 m -58.18 136.99 57.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -67.12 123.85 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 123.267 0.627 . . . . 0.0 110.72 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 62.76 45.31 5.88 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -165.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.05 12.82 29.08 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 -170.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.5 t -92.74 115.18 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 120.072 1.936 . . . . 0.0 109.09 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.92 120.19 16.13 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.904 -0.497 . . . . 0.0 110.717 166.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.21 17.91 21.02 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 118.209 2.044 . . . . 0.0 118.209 -163.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -139.11 127.45 22.8 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 119.785 1.792 . . . . 0.0 109.118 165.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -80.61 93.39 6.1 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.376 -0.827 . . . . 0.0 112.765 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -76.73 152.14 35.79 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.9 p -70.08 156.7 38.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.766 -1.209 . . . . 0.0 114.061 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.26 -49.6 91.43 Favored Pre-proline 0 CA--C 1.576 1.98 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.01 -24.39 45.42 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 CA-C-N 124.095 2.498 . . . . 0.0 117.468 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.8 tpp -65.89 -46.44 78.34 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.784 1.629 . . . . 0.0 114.253 163.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -57.81 -45.64 85.84 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 166.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.38 -13.5 61.87 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 170.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -60.7 -48.67 80.75 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 120.87 1.668 . . . . 0.0 114.915 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.72 164.69 35.73 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 117.704 1.842 . . . . 0.0 117.704 163.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.8 -144.14 26.16 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 114.756 0.662 . . . . 0.0 114.756 -177.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -129.53 154.02 47.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.781 0.801 . . . . 0.0 111.528 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -75.82 76.65 2.75 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 123.05 1.405 . . . . 0.0 112.782 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.2 p -73.71 159.7 83.81 Favored Pre-proline 0 CA--C 1.574 1.892 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.114 173.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -56.01 -39.2 92.64 Favored 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 122.403 2.069 . . . . 0.0 117.159 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.01 -42.12 94.75 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 166.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.76 98.06 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 170.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -58.86 -49.11 78.97 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 166.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -55.21 -40.31 70.65 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 172.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.17 -57.54 11.13 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 167.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -60.36 -40.96 92.66 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.87 -27.83 66.16 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.8 m -67.99 -60.09 2.77 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 120.61 1.55 . . . . 0.0 113.37 161.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 82.5 m-20 -127.63 97.13 31.17 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-N 120.864 1.666 . . . . 0.0 110.562 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.63 -51.88 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.886 0 CA-C-N 122.514 1.934 . . . . 0.0 115.625 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.5 -21.19 62.78 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 173.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -74.47 -43.46 55.97 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.867 1.667 . . . . 0.0 115.06 163.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.33 -54.7 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.474 1.034 . . . . 0.0 112.695 172.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.85 101.63 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -72.61 98.47 2.34 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 121.701 -0.624 . . . . 0.0 111.383 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.54 24.1 8.01 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 118.457 2.143 . . . . 0.0 118.457 -166.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -76.09 135.34 39.87 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.627 1.713 . . . . 0.0 111.025 159.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -74.89 8.92 2.15 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 117.32 2.341 . . . . 0.0 117.32 167.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -73.42 95.94 2.29 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 120.565 -1.334 . . . . 0.0 111.294 170.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.72 69.65 6.07 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-O 122.497 1.142 . . . . 0.0 113.382 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.28 133.28 55.5 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.349 1.059 . . . . 0.0 108.95 175.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.14 -56.2 14.28 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 115.886 1.809 . . . . 0.0 115.886 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.18 142.76 3.65 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 115.664 1.026 . . . . 0.0 115.664 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.2 mt -95.22 106.73 27.72 Favored Pre-proline 0 CA--C 1.574 1.879 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.084 168.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.97 -40.16 1.45 Allowed 'Trans proline' 0 CA--C 1.569 2.236 0 CA-C-N 123.239 2.192 . . . . 0.0 116.982 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.9 132.9 40.59 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.8 tt -51.36 -47.94 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 168.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -48.95 -50.63 34.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 173.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.18 -41.16 97.23 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -65.84 -52.93 46.34 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 170.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.76 -44.71 86.31 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -58.53 -51.73 68.65 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 169.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.43 -48.08 72.08 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 168.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 62.1 mt -62.33 -40.72 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.273 172.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.14 -44.68 71.6 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 121.778 2.081 . . . . 0.0 116.567 163.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -60.14 -47.97 83.7 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 166.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.5 mt -65.07 -30.43 71.38 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -61.1 -43.24 99.18 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 161.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.01 -42.48 99.74 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 117.809 1.884 . . . . 0.0 117.809 165.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -80.33 72.05 7.17 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-N 118.526 1.163 . . . . 0.0 112.478 171.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.242 -0.885 . . . . 0.0 109.466 176.293 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.7 t0 . . . . . 0 CA--C 1.575 1.94 0 CA-C-O 118.6 -0.714 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -67.8 -35.54 21.13 Favored 'Trans proline' 0 CA--C 1.563 1.972 0 N-CA-C 119.18 2.723 . . . . 0.0 119.18 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.86 75.74 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.01 82.65 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 164.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.46 -38.12 94.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.281 2.072 . . . . 0.0 118.281 167.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -58.16 -44.57 88.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 164.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -58.24 -47.08 84.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 167.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.75 -40.73 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 169.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -52.87 -24.99 10.25 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.06 -34.51 5.92 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 119.79 2.676 . . . . 0.0 119.79 161.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -58.98 -38.73 79.8 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 163.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -83.2 -31.45 27.07 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -48.17 -34.92 10.75 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.59 -28.63 47.54 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 117.932 2.568 . . . . 0.0 117.932 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.1 m -112.9 -43.97 3.35 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -102.18 152.1 21.43 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.127 0.965 . . . . 0.0 113.503 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -128.2 138.59 52.53 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.793 0.806 . . . . 0.0 111.13 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.5 mt -100.68 41.4 1.18 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.373 -0.829 . . . . 0.0 113.186 168.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -143.53 55.92 1.35 Allowed 'General case' 0 CA--C 1.571 1.768 0 O-C-N 120.79 -1.194 . . . . 0.0 110.802 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.6 -43.62 1.63 Allowed Glycine 0 N--CA 1.497 2.739 0 N-CA-C 119.465 2.546 . . . . 0.0 119.465 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -74.81 136.86 41.6 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -112.25 125.88 54.63 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.78 0.832 . . . . 0.0 109.385 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.4 -101.01 0.6 Allowed Glycine 0 N--CA 1.491 2.336 0 O-C-N 121.748 -0.595 . . . . 0.0 113.966 -172.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.11 -52.98 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 117.396 0.598 . . . . 0.0 110.901 170.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.71 164.5 13.92 Favored Glycine 0 CA--C 1.561 2.909 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.811 161.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.17 170.4 15.95 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 CA-C-N 120.961 2.38 . . . . 0.0 115.116 174.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -71.39 127.19 31.75 Favored 'General case' 0 CA--C 1.568 1.662 0 O-C-N 120.526 -1.359 . . . . 0.0 111.933 173.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -90.33 4.95 49.29 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -61.71 118.97 7.82 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 119.954 1.252 . . . . 0.0 111.511 168.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.65 19.71 65.37 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -175.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.92 -29.05 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-N 121.005 2.403 . . . . 0.0 116.68 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.0 t -78.98 103.42 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 120.068 1.303 . . . . 0.0 109.181 -171.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.96 -19.68 45.93 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 118.25 2.06 . . . . 0.0 118.25 -159.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -75.24 147.02 40.65 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.776 2.288 . . . . 0.0 113.866 -174.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.3 m -55.15 138.63 44.16 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.21 122.03 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.78 -0.575 . . . . 0.0 110.224 172.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.07 49.64 4.42 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -164.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.75 -18.59 24.83 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 119.185 2.434 . . . . 0.0 119.185 -169.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 65.0 t -84.97 100.6 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.686 1.743 . . . . 0.0 109.622 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.35 105.08 2.44 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.534 0.683 . . . . 0.0 110.999 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.65 -56.53 0.53 Allowed Glycine 0 N--CA 1.487 2.098 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.213 -157.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -82.55 129.58 34.95 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 117.894 0.847 . . . . 0.0 111.111 169.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.54 99.96 10.48 Favored 'General case' 0 CA--C 1.567 1.597 0 O-C-N 121.539 -0.726 . . . . 0.0 110.918 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -77.83 158.56 29.43 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.9 p -71.37 156.09 39.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.616 -1.302 . . . . 0.0 113.782 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.85 -48.67 92.89 Favored Pre-proline 0 CA--C 1.576 1.962 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.11 -26.12 43.09 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 CA-C-N 124.322 2.579 . . . . 0.0 117.66 171.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.9 ttm -65.86 -46.79 77.15 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 121.253 1.842 . . . . 0.0 113.97 162.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -56.89 -45.65 82.41 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 167.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.19 -17.14 61.39 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 118.81 2.892 . . . . 0.0 118.81 172.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -61.44 -54.58 41.63 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.853 1.66 . . . . 0.0 114.617 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.09 -179.27 50.38 Favored Glycine 0 CA--C 1.546 2.03 0 N-CA-C 116.709 1.443 . . . . 0.0 116.709 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.34 -151.52 43.63 Favored Glycine 0 N--CA 1.487 2.099 0 O-C-N 121.879 -0.777 . . . . 0.0 114.88 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -132.84 153.41 51.33 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.052 0.929 . . . . 0.0 111.722 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -76.87 74.32 3.48 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 122.832 1.301 . . . . 0.0 113.166 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.7 p -69.7 158.93 85.81 Favored Pre-proline 0 CA--C 1.576 1.969 0 C-N-CA 124.293 1.037 . . . . 0.0 112.382 171.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.55 -33.24 96.2 Favored 'Trans proline' 0 CA--C 1.57 2.292 0 N-CA-C 117.559 2.1 . . . . 0.0 117.559 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.51 -49.5 68.76 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 164.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.11 90.55 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 171.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.3 mt -59.77 -45.83 91.05 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 165.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -56.19 -43.07 78.08 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 121.636 2.016 . . . . 0.0 116.329 168.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -60.81 -56.42 21.43 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 120.068 1.304 . . . . 0.0 114.261 169.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -62.26 -39.98 94.69 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 74.2 mt -71.14 -25.0 62.37 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 169.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.1 m -62.45 -51.86 65.81 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 121.247 1.84 . . . . 0.0 113.504 164.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -150.54 112.63 3.21 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 120.05 1.295 . . . . 0.0 109.147 167.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.22 -46.9 0.21 Allowed 'Trans proline' 0 CA--C 1.559 1.76 0 CA-C-N 122.714 2.005 . . . . 0.0 116.985 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.02 -28.15 67.16 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.91 -40.88 91.9 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 161.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.3 t -71.44 -58.54 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.394 0.997 . . . . 0.0 112.511 175.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.35 101.28 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -74.43 102.54 4.48 Favored 'General case' 0 CA--C 1.566 1.589 0 O-C-N 121.566 -0.709 . . . . 0.0 111.578 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.56 22.16 10.64 Favored Glycine 0 CA--C 1.554 2.507 0 N-CA-C 118.446 2.138 . . . . 0.0 118.446 -164.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -74.79 134.14 41.84 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 119.64 1.72 . . . . 0.0 111.321 161.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -74.21 9.86 1.48 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -72.99 95.88 2.06 Favored 'General case' 0 CA--C 1.565 1.551 0 O-C-N 120.696 -1.253 . . . . 0.0 111.194 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.18 72.63 4.72 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 122.8 1.286 . . . . 0.0 113.383 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -136.32 128.86 30.48 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.94 -54.54 24.96 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.12 156.88 7.58 Favored Glycine 0 CA--C 1.544 1.852 0 N-CA-C 115.664 1.025 . . . . 0.0 115.664 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.1 mt -104.06 96.04 8.9 Favored Pre-proline 0 CA--C 1.574 1.868 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.176 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.08 -34.2 17.39 Favored 'Trans proline' 0 CA--C 1.568 2.193 0 C-N-CA 122.672 2.248 . . . . 0.0 117.198 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -73.04 129.56 38.35 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.76 0.824 . . . . 0.0 112.831 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 tt -57.73 -43.05 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -52.68 -45.27 66.73 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.38 -46.6 88.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 73.5 mtm-85 -64.4 -52.38 58.46 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -47.25 86.75 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -60.12 -46.45 89.59 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 119.732 1.151 . . . . 0.0 113.971 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.9 tp -60.04 -47.73 84.65 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.43 -43.36 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-N 119.918 1.236 . . . . 0.0 112.884 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.1 73.55 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 165.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -57.5 -47.68 81.27 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 165.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.29 -31.6 72.82 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.57 -40.42 91.61 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 159.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.51 -49.56 75.63 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -87.22 77.85 8.94 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 118.814 1.307 . . . . 0.0 112.445 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 . . . . . 0 N--CA 1.487 1.402 0 C-N-CA 123.679 0.792 . . . . 0.0 110.05 172.135 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 CA--C 1.578 2.049 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.25 -32.13 21.32 Favored 'Trans proline' 0 CA--C 1.567 2.13 0 N-CA-C 118.317 2.391 . . . . 0.0 118.317 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.65 -48.7 79.66 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 169.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.7 71.43 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 164.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.41 -33.04 65.09 Favored Glycine 0 CA--C 1.551 2.318 0 N-CA-C 119.145 2.418 . . . . 0.0 119.145 166.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -65.42 -40.85 93.85 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -61.7 -41.14 97.2 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 164.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.92 -37.45 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 169.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -54.95 -18.9 5.61 Favored 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 165.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.12 -38.28 6.17 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 119.81 2.684 . . . . 0.0 119.81 158.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.04 -31.47 72.71 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 164.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -87.58 -34.23 18.62 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -56.79 -34.37 67.58 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 119.981 3.326 . . . . 0.0 119.981 -169.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.22 -35.9 72.36 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.6 m -91.15 -42.87 10.21 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 168.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -110.32 135.14 51.51 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.207 0.912 . . . . 0.0 112.617 -169.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.25 146.15 27.24 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.684 0.754 . . . . 0.0 112.571 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.5 mt -95.19 6.09 49.99 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 166.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.15 -40.4 52.71 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.9 -38.43 1.9 Allowed Glycine 0 N--CA 1.496 2.65 0 CA-C-N 119.3 0.955 . . . . 0.0 115.335 -163.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -73.69 153.71 39.97 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-O 121.979 0.895 . . . . 0.0 112.623 168.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -91.21 145.56 24.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 111.668 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.36 -115.35 4.02 Favored Glycine 0 N--CA 1.492 2.392 0 O-C-N 121.571 -0.706 . . . . 0.0 112.843 175.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -78.52 -48.3 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 122.337 -0.508 . . . . 0.0 110.745 163.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.29 173.89 33.27 Favored Glycine 0 CA--C 1.56 2.896 0 N-CA-C 115.327 0.891 . . . . 0.0 115.327 160.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -69.62 173.18 11.22 Favored 'Trans proline' 0 CA--C 1.565 2.039 0 CA-C-N 120.578 2.189 . . . . 0.0 115.468 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -65.75 126.21 27.71 Favored 'General case' 0 CA--C 1.573 1.828 0 O-C-N 120.468 -1.395 . . . . 0.0 113.399 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.48 1.08 57.45 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -64.97 125.33 24.56 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 121.496 1.953 . . . . 0.0 111.112 158.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.05 47.13 32.51 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 116.787 1.475 . . . . 0.0 116.787 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -99.17 -28.45 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 t -81.05 105.14 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 120.631 1.559 . . . . 0.0 109.173 -171.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.35 -13.33 61.56 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.085 1.994 . . . . 0.0 118.085 -159.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -74.42 146.37 42.95 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.025 2.412 . . . . 0.0 112.745 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 64.9 m -54.62 141.56 31.34 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.64 114.71 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.639 -0.663 . . . . 0.0 109.386 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.276 . . 67.59 62.26 0.43 Allowed 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -158.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.83 -20.99 8.07 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 119.462 2.545 . . . . 0.0 119.462 -170.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.3 t -81.88 101.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 120.23 2.015 . . . . 0.0 109.877 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -70.27 102.04 2.04 Favored 'General case' 0 CA--C 1.566 1.58 0 C-N-CA 123.727 0.811 . . . . 0.0 110.784 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.91 -51.87 0.72 Allowed Glycine 0 N--CA 1.49 2.287 0 CA-C-O 119.783 -0.454 . . . . 0.0 113.782 -155.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -85.74 124.93 32.81 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 117.98 0.89 . . . . 0.0 110.479 168.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -80.62 118.18 21.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.422 -0.799 . . . . 0.0 110.07 167.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -89.81 172.51 8.85 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.829 0.823 . . . . 0.0 112.423 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.5 t -70.55 152.92 43.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.373 -1.455 . . . . 0.0 112.961 171.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.56 -45.55 99.85 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-O 115.274 -2.298 . . . . 0.0 116.525 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.63 -26.84 45.98 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 CA-C-N 124.807 2.753 . . . . 0.0 117.338 166.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.2 tpp -64.2 -47.85 78.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.604 1.547 . . . . 0.0 114.123 164.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -60.55 -43.47 97.18 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 168.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.41 -14.96 62.33 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 118.784 2.883 . . . . 0.0 118.784 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -65.18 -56.21 14.19 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.741 1.609 . . . . 0.0 114.247 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.08 -179.78 52.6 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 116.717 1.447 . . . . 0.0 116.717 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.99 -149.57 37.96 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 121.836 -0.802 . . . . 0.0 114.809 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -133.87 155.25 50.21 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.923 0.868 . . . . 0.0 112.061 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -76.8 78.17 3.41 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.938 1.352 . . . . 0.0 112.962 172.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.7 p -75.47 159.85 80.89 Favored Pre-proline 0 CA--C 1.577 1.983 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.514 173.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -59.09 -28.01 86.62 Favored 'Trans proline' 0 CA--C 1.572 2.388 0 N-CA-C 118.014 2.275 . . . . 0.0 118.014 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.13 -53.49 30.2 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 163.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.38 -43.25 88.39 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.62 -51.14 71.2 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -62.62 -33.07 74.27 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 175.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -63.89 -54.44 34.76 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 164.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -60.63 -42.59 97.2 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.55 -20.48 62.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 170.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -65.42 -63.17 1.16 Allowed 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.802 1.637 . . . . 0.0 111.756 158.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 96.0 m-20 -134.66 102.24 11.51 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.921 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.52 -50.77 0.12 Allowed 'Trans proline' 0 CA--C 1.561 1.865 0 CA-C-N 122.731 2.011 . . . . 0.0 115.947 -175.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -69.87 -20.68 63.39 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 171.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -71.03 -42.4 69.56 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 121.363 1.892 . . . . 0.0 114.92 163.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.18 -56.88 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.492 0.717 . . . . 0.0 112.538 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.63 97.28 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 172.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -73.01 104.95 4.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.385 -0.822 . . . . 0.0 111.909 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.33 17.26 22.67 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 118.554 2.182 . . . . 0.0 118.554 -166.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 t -69.1 136.27 52.0 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.121 1.96 . . . . 0.0 111.841 163.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -73.78 8.61 1.85 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 168.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 ttt -74.35 99.61 3.55 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 120.784 -1.198 . . . . 0.0 111.302 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.16 70.99 6.89 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 122.604 1.192 . . . . 0.0 113.327 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -130.37 134.16 46.95 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.31 1.044 . . . . 0.0 108.69 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.88 -56.47 6.99 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.56 154.18 6.84 Favored Glycine 0 CA--C 1.544 1.89 0 CA-C-O 121.983 0.768 . . . . 0.0 114.668 -177.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.1 mt -98.86 98.15 5.88 Favored Pre-proline 0 CA--C 1.573 1.832 0 CA-C-O 117.851 -1.071 . . . . 0.0 108.87 167.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 -33.63 19.8 Favored 'Trans proline' 0 CA--C 1.568 2.214 0 C-N-CA 122.706 2.271 . . . . 0.0 117.383 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -71.41 126.06 28.64 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.974 0.91 . . . . 0.0 113.335 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -56.37 -43.6 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 168.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -54.08 -45.22 71.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.39 -45.56 88.09 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 169.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -62.68 -54.34 40.86 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 171.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.38 -45.59 87.99 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -59.34 -49.81 76.38 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 171.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.57 -44.9 89.9 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.6 mt -66.71 -34.49 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-N 119.804 1.184 . . . . 0.0 113.688 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.49 79.85 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 121.792 2.087 . . . . 0.0 115.905 159.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.67 -51.47 69.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 170.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.1 mt -66.29 -24.22 66.52 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.14 -45.64 87.6 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 160.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.68 91.41 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 117.882 1.913 . . . . 0.0 117.882 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -79.31 71.59 5.86 Favored 'General case' 0 CA--C 1.573 1.853 0 CA-C-N 118.372 1.086 . . . . 0.0 112.566 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.353 -177.887 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 CA--C 1.576 1.974 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.52 -25.78 29.37 Favored 'Trans proline' 0 CA--C 1.567 2.131 0 N-CA-C 118.424 2.432 . . . . 0.0 118.424 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.82 -49.22 71.48 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.37 77.59 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 162.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.9 -41.49 84.24 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 118.825 2.29 . . . . 0.0 118.825 166.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -56.09 -44.09 78.67 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 164.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.73 -47.03 87.29 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 168.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.0 t -58.6 -36.46 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -54.26 -19.43 5.28 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 168.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.93 -38.46 4.58 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 120.045 2.778 . . . . 0.0 120.045 158.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -66.07 -38.04 87.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 164.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -81.59 -33.44 31.57 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -55.8 -35.06 65.89 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 119.95 3.315 . . . . 0.0 119.95 -171.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.08 -35.27 71.15 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 117.041 2.238 . . . . 0.0 117.041 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 m -96.38 -43.05 7.83 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -103.69 127.77 51.11 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.281 1.032 . . . . 0.0 111.91 -172.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -102.95 135.76 44.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.646 0.736 . . . . 0.0 110.965 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.2 mt -79.14 -23.75 43.78 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.43 61.64 6.94 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 121.502 1.955 . . . . 0.0 112.79 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.91 -30.58 0.4 Allowed Glycine 0 CA--C 1.557 2.674 0 N-CA-C 120.908 3.123 . . . . 0.0 120.908 173.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -79.24 148.18 32.3 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 124.339 1.056 . . . . 0.0 113.534 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -113.84 106.08 14.04 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -171.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.32 -108.9 3.16 Favored Glycine 0 N--CA 1.491 2.338 0 O-C-N 121.824 -0.547 . . . . 0.0 113.625 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.0 t -70.32 -53.34 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 119.222 -0.418 . . . . 0.0 110.666 165.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.39 152.38 18.83 Favored Glycine 0 CA--C 1.56 2.879 0 CA-C-O 119.118 -0.824 . . . . 0.0 114.675 167.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.56 143.57 27.49 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 CA-C-N 121.255 2.528 . . . . 0.0 113.319 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -44.32 122.94 3.22 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -169.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.16 -7.86 59.63 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -65.39 113.53 4.16 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 119.139 0.882 . . . . 0.0 110.767 160.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.03 44.07 8.4 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.35 -33.54 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 174.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.69 106.32 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 120.418 1.463 . . . . 0.0 109.401 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.67 -10.99 66.69 Favored Glycine 0 CA--C 1.553 2.466 0 N-CA-C 118.733 2.253 . . . . 0.0 118.733 -162.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -73.47 145.36 45.75 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 121.23 2.515 . . . . 0.0 112.924 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.0 m -54.39 140.3 34.18 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.71 117.6 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.605 -0.685 . . . . 0.0 109.524 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.264 . . 64.36 57.84 1.15 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -157.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.53 -27.11 5.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 -169.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.8 t -70.47 115.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 119.614 1.707 . . . . 0.0 109.948 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.81 73.9 6.54 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.87 1.319 . . . . 0.0 111.852 176.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.99 39.49 0.02 OUTLIER Glycine 0 CA--C 1.551 2.312 0 CA-C-N 114.421 -1.263 . . . . 0.0 115.23 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -154.12 144.05 21.86 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 118.137 0.969 . . . . 0.0 110.12 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -74.83 90.51 2.38 Favored 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 111.593 170.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -82.82 146.24 29.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.419 -0.801 . . . . 0.0 112.574 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.9 t -68.15 153.64 43.32 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -60.7 -46.85 97.12 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 115.906 -1.997 . . . . 0.0 115.24 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.92 -24.25 67.73 Favored 'Trans proline' 0 CA--C 1.564 1.988 0 CA-C-N 124.902 2.786 . . . . 0.0 117.975 166.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.4 tpp -65.08 -49.44 70.03 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 121.131 1.787 . . . . 0.0 113.818 162.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -59.93 -46.67 88.62 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 171.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -12.66 60.57 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 118.979 2.955 . . . . 0.0 118.979 169.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -68.53 -58.08 4.83 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 120.366 1.439 . . . . 0.0 113.643 175.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.2 -178.59 52.52 Favored Glycine 0 CA--C 1.547 2.08 0 N-CA-C 116.574 1.39 . . . . 0.0 116.574 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.48 -149.39 38.55 Favored Glycine 0 N--CA 1.488 2.143 0 O-C-N 121.818 -0.813 . . . . 0.0 114.905 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -133.67 155.56 49.48 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.972 0.892 . . . . 0.0 111.987 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -76.56 77.99 3.25 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-O 123.111 1.434 . . . . 0.0 112.817 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.9 p -77.19 161.24 73.72 Favored Pre-proline 0 CA--C 1.575 1.938 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.317 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -56.29 -35.82 96.23 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 N-CA-C 117.709 2.157 . . . . 0.0 117.709 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.43 -51.75 64.4 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 166.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.37 94.91 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 172.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.5 mt -57.77 -51.96 67.42 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 167.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.3 2.6 pp0? -62.52 -33.71 75.45 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 176.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -62.88 -55.26 27.66 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 164.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -59.38 -41.33 89.09 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.79 -18.6 62.09 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.7 m -66.18 -64.35 0.88 Allowed 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 120.554 1.525 . . . . 0.0 111.46 159.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 93.3 m-20 -134.72 101.92 11.57 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 118.191 -0.909 . . . . 0.0 109.66 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.66 -51.4 0.11 Allowed 'Trans proline' 0 CA--C 1.561 1.853 0 CA-C-N 122.89 2.068 . . . . 0.0 116.218 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.65 -20.95 64.48 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -73.12 -43.89 61.04 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.771 1.623 . . . . 0.0 114.995 162.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.4 -57.27 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-N 119.426 1.012 . . . . 0.0 112.723 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.76 99.63 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -74.24 94.49 2.49 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.645 0.736 . . . . 0.0 111.945 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.05 20.71 7.01 Favored Glycine 0 CA--C 1.551 2.286 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 -166.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.4 t -72.71 137.62 46.06 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 120.199 2.0 . . . . 0.0 111.549 160.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -73.46 5.52 3.69 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 117.608 2.447 . . . . 0.0 117.608 165.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -70.26 98.21 1.34 Allowed 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 120.334 1.425 . . . . 0.0 112.198 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.06 69.57 5.25 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 122.481 1.134 . . . . 0.0 113.847 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.36 135.9 50.2 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.32 1.048 . . . . 0.0 109.044 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.26 -58.26 3.96 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 176.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.13 154.21 6.9 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-O 122.207 0.893 . . . . 0.0 115.109 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.5 mt -98.63 101.83 12.96 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-O 117.747 -1.121 . . . . 0.0 108.893 168.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.36 -37.38 10.2 Favored 'Trans proline' 0 CA--C 1.565 2.039 0 C-N-CA 122.574 2.183 . . . . 0.0 117.59 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -78.22 135.34 37.58 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 119.414 1.006 . . . . 0.0 112.454 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -58.37 -39.84 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 168.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.09 -44.78 79.34 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -56.46 -45.6 80.79 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -64.42 -54.24 35.83 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.45 90.19 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 117.379 2.362 . . . . 0.0 117.379 173.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -60.29 -47.96 83.79 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.4 tp -58.65 -46.53 86.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 168.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.4 mt -59.29 -41.45 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.914 1.233 . . . . 0.0 113.16 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.16 -44.58 75.32 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 164.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -58.94 -47.29 85.59 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 166.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.05 -22.57 63.06 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.43 -42.87 98.7 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 156.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.22 96.56 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 117.672 1.829 . . . . 0.0 117.672 165.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -77.98 85.1 4.23 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 118.136 0.968 . . . . 0.0 111.581 170.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.419 -0.8 . . . . 0.0 109.22 173.733 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 CA--C 1.576 1.967 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.11 -34.06 23.45 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 C-N-CA 122.573 2.182 . . . . 0.0 117.666 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.41 -44.55 96.95 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.42 77.86 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 165.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.49 -27.23 58.14 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 119.866 2.707 . . . . 0.0 119.866 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -59.66 -39.56 84.84 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 166.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -65.26 -44.06 89.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 168.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.6 t -56.14 -44.71 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 166.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.75 -23.53 18.29 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 170.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.05 -37.79 16.91 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 119.556 2.582 . . . . 0.0 119.556 162.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -60.72 -33.64 73.19 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 164.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -82.94 -30.0 28.69 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 171.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -56.26 -19.63 14.95 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.36 -26.52 19.56 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 159.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.0 m -125.13 -43.61 1.94 Allowed 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -96.47 140.39 31.19 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -126.06 123.11 37.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.758 -0.589 . . . . 0.0 110.301 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.66 -25.56 63.96 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.82 55.57 2.78 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.366 1.894 . . . . 0.0 113.72 -172.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.84 12.95 7.45 Favored Glycine 0 CA--C 1.561 2.941 0 N-CA-C 120.192 2.837 . . . . 0.0 120.192 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.86 137.67 38.93 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 118.936 1.368 . . . . 0.0 112.281 -168.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -127.58 110.37 12.64 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.14 -97.78 0.75 Allowed Glycine 0 N--CA 1.493 2.452 0 O-C-N 121.875 -0.516 . . . . 0.0 113.943 -171.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.6 t -73.71 -49.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.913 166.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.64 160.67 13.35 Favored Glycine 0 CA--C 1.56 2.895 0 CA-C-N 119.195 0.907 . . . . 0.0 114.004 163.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -69.93 174.62 9.39 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 CA-C-N 120.92 2.36 . . . . 0.0 115.369 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -74.48 118.19 17.16 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 120.439 -1.413 . . . . 0.0 112.615 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.0 mt -83.36 -4.92 58.93 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -59.18 117.88 5.25 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 120.033 1.288 . . . . 0.0 111.06 155.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.1 39.99 30.89 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 116.9 1.52 . . . . 0.0 116.9 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.01 -36.93 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.19 1.495 . . . . 0.0 114.512 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.5 t -68.18 108.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 119.966 1.257 . . . . 0.0 110.004 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.35 -19.16 55.56 Favored Glycine 0 CA--C 1.554 2.471 0 N-CA-C 118.535 2.174 . . . . 0.0 118.535 -162.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -73.51 144.14 46.27 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 120.802 2.301 . . . . 0.0 113.086 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.8 m -59.07 144.07 46.58 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.66 117.51 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.616 -0.677 . . . . 0.0 110.351 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.267 . . 65.76 56.77 0.88 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -160.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.69 31.2 5.08 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 -169.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.73 110.73 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 162.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -72.17 97.31 1.93 Allowed 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 123.593 0.757 . . . . 0.0 112.019 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.2 -52.09 0.58 Allowed Glycine 0 N--CA 1.489 2.167 0 CA-C-O 119.304 -0.72 . . . . 0.0 114.507 -159.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -81.57 134.58 35.52 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-N 118.449 1.125 . . . . 0.0 111.955 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -82.87 105.06 13.57 Favored 'General case' 0 CA--C 1.566 1.574 0 O-C-N 121.587 -0.696 . . . . 0.0 111.267 172.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.62 168.89 14.91 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.6 0.714 . . . . 0.0 112.628 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.1 t -70.92 153.01 43.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.305 -1.497 . . . . 0.0 113.319 171.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.15 -49.58 92.26 Favored Pre-proline 0 CA--C 1.577 2.001 0 CA-C-O 116.035 -1.936 . . . . 0.0 115.368 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.95 -21.29 64.02 Favored 'Trans proline' 0 CA--C 1.567 2.169 0 CA-C-N 124.744 2.73 . . . . 0.0 118.001 166.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.5 tpp -67.85 -50.44 56.57 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 120.394 1.452 . . . . 0.0 113.897 162.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -56.68 -44.37 81.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 169.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.86 -8.59 55.28 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 118.967 2.951 . . . . 0.0 118.967 171.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -66.44 -55.03 17.63 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 120.775 1.625 . . . . 0.0 114.637 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.47 174.85 50.33 Favored Glycine 0 CA--C 1.548 2.103 0 N-CA-C 116.451 1.341 . . . . 0.0 116.451 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.4 -158.52 47.55 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 115.321 0.888 . . . . 0.0 115.321 -174.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -128.7 156.61 43.21 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.913 0.863 . . . . 0.0 112.247 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -76.31 76.08 3.09 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.338 1.542 . . . . 0.0 112.898 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.5 p -76.42 160.43 77.54 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.943 172.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -57.25 -35.0 98.83 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.387 2.058 . . . . 0.0 117.416 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.64 -51.53 69.02 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 164.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.54 -44.78 93.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 171.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -59.47 -48.73 80.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -62.53 -36.89 84.03 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -62.29 -55.65 26.14 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 165.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -60.6 -40.38 91.61 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.8 mt -74.74 -12.62 60.45 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 169.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 m -67.04 -55.32 14.85 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 121.247 1.839 . . . . 0.0 112.337 161.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -149.19 114.24 3.61 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 117.919 -1.039 . . . . 0.0 108.503 167.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.04 -45.85 0.43 Allowed 'Trans proline' 0 CA--C 1.562 1.881 0 CA-C-N 122.655 1.984 . . . . 0.0 116.599 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.22 -28.57 67.35 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.63 93.44 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 162.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.7 t -70.56 -57.35 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.501 1.046 . . . . 0.0 112.532 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.9 103.27 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-N 120.083 1.31 . . . . 0.0 107.564 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -72.84 106.54 4.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.744 . . . . 0.0 111.058 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.98 17.68 17.71 Favored Glycine 0 CA--C 1.554 2.497 0 N-CA-C 118.919 2.327 . . . . 0.0 118.919 -169.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.1 t -75.57 135.88 40.55 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.806 1.803 . . . . 0.0 112.764 169.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.279 64.5 pttt -82.24 12.77 4.01 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 168.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.2 mmm -59.77 83.32 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.777 0 C-N-CA 125.195 1.398 . . . . 0.0 112.548 153.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.94 78.95 7.7 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 122.931 1.348 . . . . 0.0 112.47 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -150.77 133.92 16.11 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.509 -171.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.53 -56.05 9.63 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.46 158.68 8.99 Favored Glycine 0 N--CA 1.484 1.863 0 CA-C-O 122.292 0.94 . . . . 0.0 114.934 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.2 mt -99.04 101.66 13.11 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.767 -1.111 . . . . 0.0 108.315 168.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.87 -35.67 9.02 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 C-N-CA 122.697 2.265 . . . . 0.0 117.805 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -78.74 135.41 37.12 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 119.257 0.935 . . . . 0.0 112.503 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.15 -40.61 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 169.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.19 -45.12 75.82 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 170.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -57.18 -47.2 81.81 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 120.791 1.632 . . . . 0.0 115.173 169.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -61.77 -54.14 46.39 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.9 -43.37 86.1 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 171.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -58.5 -50.38 73.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 170.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.92 -45.38 92.77 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.2 -46.21 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 120.039 1.291 . . . . 0.0 113.0 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.84 -44.96 74.41 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 166.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -56.61 -48.54 77.23 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 167.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.7 mt -71.02 -25.14 62.54 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -60.77 -42.88 98.36 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 159.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 -44.35 95.35 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 164.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -81.6 85.3 6.56 Favored 'General case' 0 CA--C 1.572 1.81 0 CA-C-N 118.372 1.086 . . . . 0.0 111.855 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 123.828 0.851 . . . . 0.0 109.689 -174.649 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 CA--C 1.578 2.02 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.48 -29.08 25.79 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 N-CA-C 118.243 2.363 . . . . 0.0 118.243 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.93 86.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 167.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.62 79.79 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 162.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.69 -35.94 69.63 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 118.784 2.274 . . . . 0.0 118.784 165.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.74 -46.53 87.2 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.86 -41.71 98.18 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 167.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.3 t -60.63 -37.25 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 169.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -55.66 -19.57 11.09 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 117.014 2.228 . . . . 0.0 117.014 167.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.1 -37.02 7.48 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 119.699 2.639 . . . . 0.0 119.699 160.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -64.55 -38.1 89.85 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 164.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.64 -34.84 34.66 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -55.66 -35.74 66.31 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 120.299 3.444 . . . . 0.0 120.299 -168.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.34 80.66 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.8 m -89.85 -40.32 12.51 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 169.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -115.31 121.67 43.57 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.472 1.109 . . . . 0.0 110.643 -169.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -105.02 131.12 52.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 111.07 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.2 mt -70.82 -26.11 63.16 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -83.35 54.47 2.82 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.194 1.816 . . . . 0.0 113.396 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.32 9.84 18.81 Favored Glycine 0 CA--C 1.559 2.838 0 N-CA-C 120.593 2.997 . . . . 0.0 120.593 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -101.85 134.09 45.58 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.442 1.621 . . . . 0.0 111.869 -170.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -102.54 104.57 14.99 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.48 -106.45 2.93 Favored Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.966 -0.459 . . . . 0.0 113.386 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.02 -44.33 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.256 166.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.69 166.17 12.51 Favored Glycine 0 CA--C 1.564 3.115 0 CA-C-N 119.505 1.048 . . . . 0.0 115.051 161.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.29 151.79 43.76 Favored 'Trans proline' 0 CA--C 1.562 1.908 0 C-N-CA 122.835 2.357 . . . . 0.0 114.745 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -48.19 121.16 4.07 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.0 -9.32 59.6 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -63.03 111.86 2.36 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 118.921 0.782 . . . . 0.0 110.986 161.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.69 45.42 8.55 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 -170.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 p -100.37 -31.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 170.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.5 t -73.09 106.45 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 120.477 1.49 . . . . 0.0 109.563 -175.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.69 -12.33 66.1 Favored Glycine 0 CA--C 1.553 2.425 0 N-CA-C 118.692 2.237 . . . . 0.0 118.692 -162.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -72.52 140.12 47.98 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 121.018 2.409 . . . . 0.0 113.125 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.3 m -59.89 136.97 58.17 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.7 125.92 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 123.391 0.676 . . . . 0.0 110.797 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.254 . . 60.98 42.42 12.78 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -164.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.87 -3.12 39.7 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 119.751 2.66 . . . . 0.0 119.751 -170.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.6 t -83.53 103.3 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 120.386 2.093 . . . . 0.0 109.541 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.6 104.27 3.27 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.331 0.586 . . . . 0.0 110.482 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.32 -56.43 0.55 Allowed Glycine 0 N--CA 1.489 2.205 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.269 -157.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -87.67 128.24 35.29 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 117.721 0.761 . . . . 0.0 111.278 171.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -81.81 105.12 12.69 Favored 'General case' 0 CA--C 1.566 1.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.599 171.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -78.7 159.13 28.13 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.7 p -76.71 147.13 37.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.032 -1.043 . . . . 0.0 113.067 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -53.79 -44.45 98.05 Favored Pre-proline 0 CA--C 1.576 1.979 0 N-CA-C 117.882 2.549 . . . . 0.0 117.882 -175.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.95 -19.58 58.04 Favored 'Trans proline' 0 CA--C 1.569 2.238 0 CA-C-N 125.069 2.846 . . . . 0.0 117.977 170.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.7 tpp -69.24 -45.28 70.16 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.128 1.331 . . . . 0.0 114.187 162.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -55.6 -44.24 76.8 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 164.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.13 -17.27 64.31 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 118.672 2.841 . . . . 0.0 118.672 169.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -64.4 -52.57 57.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.528 1.513 . . . . 0.0 114.44 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.85 167.33 34.9 Favored Glycine 0 CA--C 1.548 2.139 0 N-CA-C 117.842 1.897 . . . . 0.0 117.842 167.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.07 -145.52 23.39 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -130.52 153.35 48.92 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.801 0.81 . . . . 0.0 111.536 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.42 76.04 3.17 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 123.217 1.484 . . . . 0.0 113.11 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.3 p -75.3 160.52 79.76 Favored Pre-proline 0 CA--C 1.577 1.981 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.547 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -58.74 -27.6 84.07 Favored 'Trans proline' 0 CA--C 1.572 2.381 0 N-CA-C 118.171 2.335 . . . . 0.0 118.171 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.58 -53.27 23.88 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 163.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.1 90.1 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 174.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.2 mt -56.84 -52.42 65.16 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 168.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.253 8.2 pt20 -64.26 -33.85 76.77 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 176.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -60.39 -55.76 29.64 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 119.636 1.107 . . . . 0.0 113.938 163.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -58.3 -41.02 83.55 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.98 -16.75 61.51 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 170.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.5 m -65.2 -54.83 23.57 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 121.1 1.773 . . . . 0.0 112.693 164.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -149.73 112.53 3.4 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.334 167.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.05 -45.19 0.48 Allowed 'Trans proline' 0 CA--C 1.559 1.749 0 CA-C-N 122.565 1.952 . . . . 0.0 116.889 -174.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.03 -29.16 68.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 173.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.17 88.0 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 163.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.1 t -68.94 -56.36 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 119.48 1.036 . . . . 0.0 112.584 173.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.56 101.04 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -69.62 102.67 1.91 Allowed 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 121.307 0.575 . . . . 0.0 111.642 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.15 10.25 32.36 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 119.352 2.501 . . . . 0.0 119.352 -170.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 t -66.47 134.73 53.06 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.48 2.64 . . . . 0.0 112.742 171.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -73.11 9.78 1.13 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -77.08 103.73 7.17 Favored 'General case' 0 CA--C 1.563 1.461 0 O-C-N 120.585 -1.322 . . . . 0.0 111.691 173.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.28 71.48 4.75 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 122.535 1.159 . . . . 0.0 113.624 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -137.44 129.51 29.14 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.303 1.041 . . . . 0.0 108.405 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.01 -54.46 15.08 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.08 157.96 8.3 Favored Glycine 0 CA--C 1.544 1.897 0 CA-C-O 122.525 1.07 . . . . 0.0 115.555 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.22 101.13 15.37 Favored Pre-proline 0 CA--C 1.575 1.912 0 CA-C-O 117.924 -1.036 . . . . 0.0 108.665 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.41 -37.17 7.95 Favored 'Trans proline' 0 CA--C 1.566 2.085 0 C-N-CA 122.689 2.259 . . . . 0.0 117.752 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -76.89 134.2 39.05 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 119.193 0.906 . . . . 0.0 112.888 174.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.8 tt -57.06 -41.25 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 168.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.86 -49.32 49.7 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.81 -45.11 90.69 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 171.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -62.77 -53.73 49.9 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 171.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.71 -46.32 84.54 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 172.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -56.95 -50.98 70.97 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 169.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.3 tp -56.65 -45.63 81.53 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 169.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.0 -42.18 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.237 171.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.93 -43.28 77.25 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 165.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -58.32 -48.01 81.89 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.6 -23.64 63.56 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.866 2.172 . . . . 0.0 116.866 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -61.63 -43.14 99.41 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 156.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.23 -47.2 90.1 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 117.576 1.79 . . . . 0.0 117.576 166.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -76.48 88.82 3.24 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 118.317 1.058 . . . . 0.0 112.119 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.48 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 CA--C 1.578 2.032 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.49 -28.45 26.54 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 N-CA-C 118.428 2.434 . . . . 0.0 118.428 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.36 -47.08 80.65 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 169.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.92 -38.77 79.73 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 161.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.47 -38.46 80.22 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 119.009 2.364 . . . . 0.0 119.009 166.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -55.63 -45.9 77.51 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 163.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.49 -47.75 84.31 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 t -57.83 -39.87 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 168.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -55.07 -20.82 10.58 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 169.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.52 -36.8 24.99 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 119.525 2.57 . . . . 0.0 119.525 160.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -57.87 -41.74 83.09 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 163.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -76.59 -34.18 58.41 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -52.6 -25.95 12.11 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 119.061 2.986 . . . . 0.0 119.061 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.18 -25.89 15.35 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 162.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.5 m -128.55 -34.32 2.02 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -108.0 142.12 38.62 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.547 1.139 . . . . 0.0 112.922 -169.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -103.1 157.16 17.19 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.244 1.021 . . . . 0.0 111.814 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.68 -27.52 13.63 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -84.74 60.3 6.06 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-N 121.542 1.974 . . . . 0.0 113.982 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.6 -40.01 0.39 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 120.166 2.827 . . . . 0.0 120.166 174.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -80.32 154.99 27.44 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 124.879 1.271 . . . . 0.0 112.96 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -96.77 152.21 18.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 111.952 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -122.68 -118.93 2.5 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 121.397 -0.815 . . . . 0.0 112.742 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.7 t -73.82 -48.23 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 122.337 -0.507 . . . . 0.0 111.104 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.11 171.06 26.62 Favored Glycine 0 CA--C 1.562 3.027 0 CA-C-N 118.836 0.744 . . . . 0.0 114.775 156.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.44 175.24 9.7 Favored 'Trans proline' 0 CA--C 1.567 2.137 0 CA-C-N 121.124 2.462 . . . . 0.0 114.799 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -65.08 122.52 17.25 Favored 'General case' 0 CA--C 1.568 1.668 0 O-C-N 120.402 -1.436 . . . . 0.0 113.094 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.32 -3.68 59.04 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 116.631 2.085 . . . . 0.0 116.631 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -63.95 121.11 13.3 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 119.401 1.001 . . . . 0.0 110.792 155.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.77 42.81 16.07 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 116.413 1.325 . . . . 0.0 116.413 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -100.45 -33.69 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.9 t -74.99 105.02 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 120.652 1.569 . . . . 0.0 109.4 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.22 -26.45 22.89 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 117.761 1.864 . . . . 0.0 117.761 -160.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -66.07 142.92 57.63 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 120.978 2.389 . . . . 0.0 113.736 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.0 m -53.68 139.71 31.48 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.39 120.34 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.647 -0.658 . . . . 0.0 109.738 173.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 63.54 49.01 3.21 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -162.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.93 -27.01 13.13 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 118.875 2.31 . . . . 0.0 118.875 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.5 t -73.53 98.43 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.266 1.533 . . . . 0.0 109.966 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.25 105.65 8.48 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.369 0.667 . . . . 0.0 110.168 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.9 -52.43 0.71 Allowed Glycine 0 N--CA 1.489 2.216 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.66 -154.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -79.65 130.23 35.17 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 118.036 0.918 . . . . 0.0 111.647 171.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -81.27 90.5 6.12 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 121.581 -0.699 . . . . 0.0 111.642 177.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.91 157.38 37.95 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 t -66.87 155.02 39.5 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 174.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -59.58 -49.12 93.7 Favored Pre-proline 0 CA--C 1.577 2.003 0 CA-C-O 116.094 -1.908 . . . . 0.0 115.488 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.36 -25.14 64.01 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 CA-C-N 124.71 2.718 . . . . 0.0 117.732 166.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.5 tpp -65.22 -48.38 73.57 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.533 1.515 . . . . 0.0 114.17 164.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -58.78 -45.81 88.97 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 167.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.79 -14.7 62.52 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 118.976 2.954 . . . . 0.0 118.976 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -62.52 -53.15 59.04 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.715 1.598 . . . . 0.0 114.708 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.98 175.72 48.67 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 116.728 1.451 . . . . 0.0 116.728 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.46 -151.76 40.34 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 115.121 0.808 . . . . 0.0 115.121 -176.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -132.34 154.76 49.42 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.001 0.905 . . . . 0.0 111.568 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -76.04 76.16 2.91 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 123.01 1.386 . . . . 0.0 112.877 172.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -72.58 160.17 83.5 Favored Pre-proline 0 CA--C 1.576 1.964 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.386 171.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.27 -32.39 95.82 Favored 'Trans proline' 0 CA--C 1.571 2.366 0 N-CA-C 117.504 2.079 . . . . 0.0 117.504 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -64.06 -52.71 58.05 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 163.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.77 80.55 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 172.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.9 mt -60.9 -45.22 95.5 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 166.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -55.81 -43.56 77.01 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 121.583 1.992 . . . . 0.0 116.207 167.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -61.72 -56.02 24.03 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 120.029 1.286 . . . . 0.0 114.333 169.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.54 -39.87 95.0 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.0 mt -72.2 -22.67 61.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 169.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.5 m -62.48 -52.53 63.13 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.347 1.885 . . . . 0.0 113.365 163.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -151.35 113.11 3.03 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-N 119.902 1.228 . . . . 0.0 109.088 167.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.94 -47.8 0.16 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 CA-C-N 122.752 2.019 . . . . 0.0 116.91 -174.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -67.27 -26.3 66.49 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.77 -42.47 86.06 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 161.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.53 -58.56 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.432 1.014 . . . . 0.0 112.617 175.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.51 99.89 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -74.91 98.85 3.66 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-O 121.477 0.656 . . . . 0.0 111.725 -177.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.08 18.33 10.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 -166.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -69.92 138.37 52.36 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.268 2.034 . . . . 0.0 112.003 163.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -73.95 8.76 1.84 Allowed 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.4 ttt -78.4 99.05 6.23 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.708 -1.245 . . . . 0.0 111.795 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.99 73.33 4.55 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 122.504 1.145 . . . . 0.0 113.702 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -135.99 130.15 33.16 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.229 1.012 . . . . 0.0 108.507 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.11 -54.39 18.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.24 159.93 9.27 Favored Glycine 0 CA--C 1.544 1.862 0 N-CA-C 115.909 1.124 . . . . 0.0 115.909 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.0 mt -102.39 98.96 11.66 Favored Pre-proline 0 CA--C 1.575 1.908 0 C-N-CA 123.903 0.881 . . . . 0.0 108.932 168.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.61 -34.05 15.89 Favored 'Trans proline' 0 CA--C 1.567 2.131 0 C-N-CA 122.592 2.195 . . . . 0.0 117.623 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -76.98 136.0 38.72 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 119.214 0.916 . . . . 0.0 113.064 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 tt -57.12 -43.18 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 167.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -54.57 -46.15 73.64 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.18 -45.97 83.23 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 75.7 mtm-85 -66.49 -52.48 45.57 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 172.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.56 -46.62 86.5 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -57.2 -49.33 76.33 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 169.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.6 tp -59.28 -46.45 88.5 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 170.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.72 -40.47 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-N 120.099 1.318 . . . . 0.0 112.976 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.77 -44.82 74.03 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 163.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -58.55 -47.78 83.09 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 167.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.1 mt -71.94 -23.01 61.39 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.29 -43.24 99.27 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 155.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.7 -41.91 98.84 Favored Glycine 0 CA--C 1.554 2.481 0 N-CA-C 118.056 1.982 . . . . 0.0 118.056 166.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -81.47 83.6 6.93 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 118.527 1.164 . . . . 0.0 111.351 170.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 . . . . . 0 N--CA 1.487 1.396 0 O-C-N 121.472 -0.768 . . . . 0.0 109.58 173.925 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 CA--C 1.572 1.824 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -57.15 -34.64 98.12 Favored 'Trans proline' 0 CA--C 1.566 2.108 0 N-CA-C 119.605 2.887 . . . . 0.0 119.605 172.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.83 76.75 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.31 -42.35 77.48 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 162.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.97 -36.71 91.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 169.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.88 -46.96 78.16 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 163.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -57.62 -46.81 83.64 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 168.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.22 -39.45 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -55.21 -18.46 6.03 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.24 -37.94 6.26 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 119.6 2.6 . . . . 0.0 119.6 158.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.25 -38.72 88.54 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 164.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -79.42 -37.1 37.9 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -56.28 -27.77 56.47 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 120.133 3.382 . . . . 0.0 120.133 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.24 -33.17 67.29 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.812 2.153 . . . . 0.0 116.812 168.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.6 m -103.69 -35.95 8.06 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -112.01 142.5 44.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -167.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -107.9 148.6 29.39 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.997 0.903 . . . . 0.0 113.288 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.97 10.29 39.8 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 171.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -123.72 62.29 1.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 120.388 1.449 . . . . 0.0 110.999 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.12 -15.72 0.71 Allowed Glycine 0 CA--C 1.558 2.768 0 N-CA-C 121.616 3.406 . . . . 0.0 121.616 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -90.02 161.47 15.84 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 119.215 1.508 . . . . 0.0 114.489 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -130.02 141.4 50.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.228 -1.545 . . . . 0.0 110.978 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.19 -98.8 0.18 Allowed Glycine 0 N--CA 1.489 2.186 0 O-C-N 121.732 -0.605 . . . . 0.0 112.964 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.96 -51.76 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 117.275 0.537 . . . . 0.0 111.406 167.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.03 175.97 17.64 Favored Glycine 0 CA--C 1.562 2.986 0 N-CA-C 115.067 0.787 . . . . 0.0 115.067 164.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.06 -179.06 3.97 Favored 'Trans proline' 0 CA--C 1.569 2.249 0 C-N-CA 122.723 2.282 . . . . 0.0 114.569 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -76.97 138.09 39.43 Favored 'General case' 0 CA--C 1.566 1.593 0 O-C-N 120.585 -1.322 . . . . 0.0 113.325 173.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.71 -2.57 34.97 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -65.15 113.44 3.97 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.865 1.666 . . . . 0.0 111.964 164.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.34 54.72 6.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 -168.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.2 -38.15 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 171.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -66.88 107.59 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 120.248 1.385 . . . . 0.0 110.118 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.26 -17.08 59.73 Favored Glycine 0 CA--C 1.551 2.342 0 N-CA-C 118.649 2.22 . . . . 0.0 118.649 -163.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -71.69 142.14 49.85 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.177 2.489 . . . . 0.0 113.107 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -59.19 136.56 57.99 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.82 126.66 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 123.465 0.706 . . . . 0.0 111.134 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 59.05 39.88 22.78 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -166.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.72 3.74 49.63 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 119.353 2.501 . . . . 0.0 119.353 -171.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.79 104.17 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.875 1.838 . . . . 0.0 108.375 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.75 86.24 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.458 0.647 . . . . 0.0 111.704 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.55 -46.93 0.37 Allowed Glycine 0 CA--C 1.545 1.965 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.123 -158.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -86.15 137.83 32.36 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 118.814 1.307 . . . . 0.0 112.184 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.1 85.77 3.59 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.189 0.995 . . . . 0.0 113.191 172.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -77.41 142.99 38.96 Favored 'General case' 0 CA--C 1.567 1.628 0 O-C-N 121.408 -0.808 . . . . 0.0 112.753 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.5 p -70.03 157.63 37.17 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -54.03 -49.27 90.73 Favored Pre-proline 0 CA--C 1.578 2.022 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.24 -28.0 40.56 Favored 'Trans proline' 0 CA--C 1.568 2.192 0 CA-C-N 124.328 2.582 . . . . 0.0 117.154 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -62.67 -47.21 84.68 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 120.379 1.445 . . . . 0.0 114.559 163.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -58.32 -47.05 84.95 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 167.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.59 -17.44 63.54 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 118.916 2.932 . . . . 0.0 118.916 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -58.38 -51.39 70.02 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.64 1.564 . . . . 0.0 114.528 175.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.84 170.65 35.8 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 117.732 1.853 . . . . 0.0 117.732 165.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.86 -143.11 26.23 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 122.088 -0.654 . . . . 0.0 114.629 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -129.89 154.12 47.62 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.669 0.747 . . . . 0.0 111.759 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -76.26 76.75 3.05 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.929 1.347 . . . . 0.0 112.977 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.3 p -74.11 160.05 82.53 Favored Pre-proline 0 CA--C 1.573 1.865 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.662 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.4 -29.04 87.12 Favored 'Trans proline' 0 CA--C 1.569 2.233 0 N-CA-C 117.461 2.062 . . . . 0.0 117.461 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -66.12 -54.7 22.27 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 163.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.97 88.89 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.6 -44.55 93.36 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 164.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -57.73 -42.7 84.37 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -63.43 -55.84 21.01 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.967 1.258 . . . . 0.0 114.226 169.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -60.79 -42.2 97.13 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 71.2 mt -73.87 -16.33 61.12 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.9 m -64.1 -54.62 31.02 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 121.296 1.862 . . . . 0.0 112.788 161.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.98 115.29 3.45 Favored Pre-proline 0 CA--C 1.575 1.922 0 CA-C-N 119.625 1.102 . . . . 0.0 108.805 167.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.32 -45.78 0.32 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 CA-C-N 122.586 1.959 . . . . 0.0 116.753 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -66.11 -33.24 75.32 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.57 95.84 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 165.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.91 -58.14 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-N 118.843 0.747 . . . . 0.0 112.095 171.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.94 98.2 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -73.21 101.32 3.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.877 . . . . 0.0 111.474 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.5 19.96 10.72 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 118.559 2.184 . . . . 0.0 118.559 -164.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -76.35 132.36 39.7 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 119.964 1.882 . . . . 0.0 110.682 156.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.282 64.2 pttt -82.54 26.83 0.54 Allowed 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 170.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.02 101.3 1.37 Allowed 'General case' 0 CA--C 1.567 1.62 0 O-C-N 120.501 -1.375 . . . . 0.0 109.919 159.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.06 73.42 4.62 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.882 1.325 . . . . 0.0 112.166 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -152.42 123.33 7.48 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.094 -166.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.96 -49.63 60.61 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.35 164.42 13.09 Favored Glycine 0 CA--C 1.543 1.824 0 CA-C-O 122.686 1.159 . . . . 0.0 115.557 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.8 mt -101.99 95.16 5.25 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 164.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.33 -34.1 16.77 Favored 'Trans proline' 0 CA--C 1.567 2.154 0 C-N-CA 122.648 2.232 . . . . 0.0 117.343 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -74.64 132.82 42.04 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-O 121.885 0.85 . . . . 0.0 112.913 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.06 -42.97 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.18 -48.27 68.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.05 -43.88 78.3 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -64.5 -52.58 57.14 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 170.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.87 82.85 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -60.1 -48.59 81.08 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 172.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.2 tp -61.2 -45.71 93.45 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 172.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.25 60.6 mt -61.96 -41.09 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 119.79 1.177 . . . . 0.0 112.783 171.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.7 -43.3 80.4 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 164.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -56.71 -48.1 78.47 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 164.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.86 -23.23 61.48 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -64.9 -42.92 94.36 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.326 -1.484 . . . . 0.0 114.684 155.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.53 -56.75 23.54 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.837 1.495 . . . . 0.0 116.837 167.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -82.69 82.38 8.07 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.544 1.172 . . . . 0.0 112.285 165.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 . . . . . 0 C--O 1.259 1.6 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.947 158.626 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtm . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.675 0.274 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.46 73.63 0.96 Allowed 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.037 0.923 . . . . 0.0 112.347 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -101.97 119.67 56.11 Favored Pre-proline 0 CA--C 1.576 1.979 0 C-N-CA 124.095 0.958 . . . . 0.0 111.24 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.68 -28.82 30.51 Favored 'Trans proline' 0 CA--C 1.568 2.211 0 N-CA-C 118.364 2.409 . . . . 0.0 118.364 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.41 -50.32 70.29 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.52 72.08 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 163.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.48 -31.58 66.99 Favored Glycine 0 CA--C 1.55 2.27 0 N-CA-C 118.679 2.231 . . . . 0.0 118.679 165.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.67 -42.51 98.04 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 168.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.11 -40.7 98.38 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 167.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.92 -41.61 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -58.27 -24.8 60.62 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 168.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.19 -29.7 29.91 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 119.495 2.558 . . . . 0.0 119.495 163.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -59.52 -35.81 74.88 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 160.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.79 -33.64 30.73 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 173.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -46.69 -41.75 15.44 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 119.724 3.231 . . . . 0.0 119.724 -173.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.39 -35.95 72.81 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.2 m -91.82 -43.75 9.34 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 169.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -114.04 132.74 55.9 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.318 1.047 . . . . 0.0 111.196 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -117.62 122.68 44.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 170.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.2 mt -47.16 -51.79 17.31 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -92.14 76.78 5.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.083 0.944 . . . . 0.0 111.237 -157.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.89 -21.69 0.96 Allowed Glycine 0 CA--C 1.556 2.614 0 N-CA-C 120.523 2.969 . . . . 0.0 120.523 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -91.42 116.59 28.97 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 118.83 1.315 . . . . 0.0 112.043 -167.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -97.39 121.76 39.66 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.756 0.822 . . . . 0.0 109.972 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.11 -109.88 3.06 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.82 -0.55 . . . . 0.0 113.329 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.19 -47.78 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 117.186 0.493 . . . . 0.0 111.055 167.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.94 170.85 25.41 Favored Glycine 0 CA--C 1.559 2.833 0 N-CA-C 115.444 0.937 . . . . 0.0 115.444 163.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -69.14 169.03 19.05 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 C-N-CA 122.686 2.258 . . . . 0.0 115.111 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -70.07 123.65 22.1 Favored 'General case' 0 CA--C 1.57 1.716 0 O-C-N 120.536 -1.352 . . . . 0.0 112.326 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.4 mt -92.03 11.51 25.04 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 -173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.1 p30 -57.5 122.67 13.21 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 121.555 1.979 . . . . 0.0 113.267 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.85 43.66 94.64 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 118.683 2.233 . . . . 0.0 118.683 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.254 5.2 p -71.65 -23.06 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.1 t -73.82 107.42 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 124.311 1.044 . . . . 0.0 109.565 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.34 -3.82 79.83 Favored Glycine 0 CA--C 1.555 2.535 0 N-CA-C 119.039 2.376 . . . . 0.0 119.039 -162.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -84.83 143.13 29.27 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.802 2.301 . . . . 0.0 112.983 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.2 m -60.74 137.91 58.15 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.9 t -67.06 123.1 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.905 -0.497 . . . . 0.0 110.258 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.266 . . 62.95 50.0 3.34 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -163.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.63 -16.49 28.84 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 119.399 2.519 . . . . 0.0 119.399 -171.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.52 97.67 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 120.048 1.924 . . . . 0.0 109.599 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.21 109.05 5.01 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 123.19 0.596 . . . . 0.0 110.88 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.36 -57.07 0.67 Allowed Glycine 0 N--CA 1.49 2.275 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.018 -157.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -82.42 123.37 29.06 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 117.676 0.738 . . . . 0.0 110.417 167.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.13 124.85 29.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.478 -0.763 . . . . 0.0 110.735 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -94.55 173.53 7.57 Favored 'General case' 0 CA--C 1.574 1.877 0 CA-C-O 121.879 0.847 . . . . 0.0 112.36 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.5 t -71.55 154.38 41.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.294 -1.504 . . . . 0.0 113.114 171.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -59.53 -49.66 91.08 Favored Pre-proline 0 CA--C 1.577 1.986 0 CA-C-O 115.959 -1.972 . . . . 0.0 115.239 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.29 -24.39 71.97 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 CA-C-N 124.805 2.752 . . . . 0.0 117.895 166.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.8 tpp -66.86 -49.34 66.01 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.646 1.566 . . . . 0.0 114.158 164.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -59.21 -43.07 92.3 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -12.42 61.47 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 118.862 2.912 . . . . 0.0 118.862 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -65.16 -55.62 17.6 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 120.835 1.652 . . . . 0.0 114.356 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.57 177.63 50.47 Favored Glycine 0 CA--C 1.548 2.104 0 N-CA-C 116.648 1.419 . . . . 0.0 116.648 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.06 -154.18 44.42 Favored Glycine 0 CA--C 1.548 2.147 0 N-CA-C 115.332 0.893 . . . . 0.0 115.332 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -130.7 154.36 48.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.149 0.976 . . . . 0.0 112.261 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -76.64 73.3 3.33 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 123.081 1.42 . . . . 0.0 113.254 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.5 p -70.11 159.6 83.78 Favored Pre-proline 0 CA--C 1.575 1.933 0 C-N-CA 124.516 1.127 . . . . 0.0 112.312 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -57.06 -34.7 98.19 Favored 'Trans proline' 0 CA--C 1.568 2.197 0 N-CA-C 117.794 2.19 . . . . 0.0 117.794 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -67.82 -45.56 74.35 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 164.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.64 -43.88 85.19 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 170.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.05 -47.37 86.14 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 165.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -55.69 -44.46 77.39 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 121.634 2.016 . . . . 0.0 116.324 169.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -61.41 -55.63 29.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 119.93 1.241 . . . . 0.0 114.111 170.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -60.97 -41.38 96.28 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.1 mt -73.13 -21.66 60.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -63.76 -52.03 62.23 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-N 120.942 1.701 . . . . 0.0 113.352 162.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -150.12 112.61 3.31 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-N 120.146 1.339 . . . . 0.0 109.299 168.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.96 -47.44 0.17 Allowed 'Trans proline' 0 CA--C 1.56 1.819 0 CA-C-N 122.672 1.99 . . . . 0.0 116.933 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.45 -26.53 65.55 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.92 -41.54 86.89 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 161.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.0 t -71.45 -58.86 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.416 1.007 . . . . 0.0 112.629 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.74 100.92 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -74.94 100.69 4.19 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 121.366 0.603 . . . . 0.0 111.685 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.52 18.47 12.94 Favored Glycine 0 CA--C 1.554 2.491 0 N-CA-C 118.58 2.192 . . . . 0.0 118.58 -165.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -71.77 137.46 47.69 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.141 1.971 . . . . 0.0 111.997 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -73.51 6.85 2.71 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 167.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.412 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.5 ttt -73.28 94.82 2.05 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 120.415 1.461 . . . . 0.0 111.451 171.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.62 70.75 5.01 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.754 1.264 . . . . 0.0 113.431 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -130.49 130.45 44.2 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.512 1.125 . . . . 0.0 107.988 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.06 -54.96 22.03 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.98 155.06 6.47 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.0 mt -103.97 98.14 12.84 Favored Pre-proline 0 CA--C 1.573 1.846 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.373 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.03 -33.32 15.78 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 122.572 2.181 . . . . 0.0 117.644 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.03 133.1 36.82 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.102 0.865 . . . . 0.0 112.361 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.1 tt -56.15 -44.58 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 171.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.9 -45.84 71.24 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.16 -47.72 80.49 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 169.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 75.0 mtm-85 -64.73 -50.96 64.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.35 93.11 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -56.9 -50.17 73.32 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 168.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.0 tp -54.89 -48.67 72.7 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.75 -41.77 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 119.859 1.209 . . . . 0.0 113.411 171.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.21 -43.12 74.18 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 164.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -62.44 -44.68 95.85 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 168.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.2 mt -64.08 -27.86 69.39 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 169.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.22 -44.3 76.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 120.261 1.391 . . . . 0.0 114.657 158.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -53.96 -54.37 31.62 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 117.44 1.736 . . . . 0.0 117.44 169.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -84.07 81.46 8.79 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 118.539 1.17 . . . . 0.0 111.649 160.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 C--O 1.253 1.249 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 155.149 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.618 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.91 70.37 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.104 0.865 . . . . 0.0 113.06 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -102.64 118.55 58.26 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.009 0.924 . . . . 0.0 111.118 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.84 -28.5 24.79 Favored 'Trans proline' 0 CA--C 1.569 2.25 0 N-CA-C 118.523 2.47 . . . . 0.0 118.523 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.24 -46.83 79.01 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.29 -37.6 78.1 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 159.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.95 -35.5 76.23 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 119.14 2.416 . . . . 0.0 119.14 168.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.12 -42.93 91.74 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 163.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.44 -43.61 96.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.1 -45.01 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 166.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -56.88 -26.61 59.14 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.39 -34.1 6.24 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 119.597 2.599 . . . . 0.0 119.597 161.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -59.2 -35.75 74.15 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 162.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -80.78 -20.23 43.08 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 171.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -73.86 67.6 1.23 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 123.802 1.763 . . . . 0.0 115.361 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.56 -57.18 0.1 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.365 1.466 . . . . 0.0 108.258 168.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.7 m -71.91 -44.26 63.97 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 166.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -112.42 138.29 49.38 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 119.925 1.238 . . . . 0.0 111.756 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -131.68 123.09 27.05 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.618 0.723 . . . . 0.0 109.774 -171.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.9 mt -72.48 -10.94 60.41 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.9 58.8 1.03 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 120.998 1.726 . . . . 0.0 112.052 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.02 15.6 36.73 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 121.129 3.212 . . . . 0.0 121.129 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -103.73 129.61 51.12 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 119.192 1.496 . . . . 0.0 110.897 -174.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.53 102.51 10.37 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.29 -105.57 3.04 Favored Glycine 0 N--CA 1.49 2.292 0 O-C-N 121.998 -0.439 . . . . 0.0 112.873 -174.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.447 ' O ' HMD3 ' A' ' 101' ' ' HEC . 58.3 t -73.4 -47.06 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.45 167.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.95 167.01 14.22 Favored Glycine 0 CA--C 1.56 2.899 0 CA-C-N 119.315 0.961 . . . . 0.0 114.711 164.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.7 173.03 13.25 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 CA-C-N 120.803 2.302 . . . . 0.0 115.799 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -70.18 122.39 19.38 Favored 'General case' 0 CA--C 1.57 1.713 0 O-C-N 120.561 -1.337 . . . . 0.0 112.43 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.76 7.72 38.22 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -65.07 127.49 31.84 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 120.86 1.664 . . . . 0.0 111.671 164.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.51 24.19 65.94 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 118.26 2.064 . . . . 0.0 118.26 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -79.34 -26.81 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 120.319 2.06 . . . . 0.0 116.259 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.9 t -77.89 105.16 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 120.208 1.367 . . . . 0.0 109.192 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.37 -7.93 64.2 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 118.72 2.248 . . . . 0.0 118.72 -160.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -81.32 142.76 32.77 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 120.987 2.393 . . . . 0.0 113.07 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.3 m -60.12 139.09 57.72 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -67.3 123.23 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.919 -0.488 . . . . 0.0 110.318 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 62.16 49.48 4.4 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -162.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.94 -15.63 30.54 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 119.268 2.467 . . . . 0.0 119.268 -170.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.1 t -83.76 96.67 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 119.965 1.882 . . . . 0.0 109.467 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.35 107.83 3.96 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-O 121.381 0.61 . . . . 0.0 111.006 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.68 -56.1 0.63 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.195 -157.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -83.07 127.12 33.29 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 117.791 0.796 . . . . 0.0 110.777 168.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -81.37 115.72 20.86 Favored 'General case' 0 CA--C 1.565 1.548 0 O-C-N 121.548 -0.72 . . . . 0.0 110.937 171.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -87.67 168.42 13.02 Favored 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 123.541 0.736 . . . . 0.0 112.529 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 p -73.33 152.58 40.85 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.106 -1.621 . . . . 0.0 113.056 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -57.57 -42.32 95.07 Favored Pre-proline 0 CA--C 1.574 1.895 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -67.31 -26.71 41.32 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 CA-C-N 125.017 2.828 . . . . 0.0 117.184 168.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.9 tpp -63.9 -46.32 85.4 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 120.451 1.478 . . . . 0.0 114.091 162.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.21 -46.63 82.74 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 166.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.81 -14.63 61.56 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 118.87 2.915 . . . . 0.0 118.87 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -62.55 -53.37 55.73 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 120.652 1.569 . . . . 0.0 114.84 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.61 -179.44 50.89 Favored Glycine 0 CA--C 1.547 2.045 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.61 -154.58 48.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -174.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -131.08 155.12 47.47 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.105 0.955 . . . . 0.0 112.356 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.32 75.15 3.11 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.968 1.366 . . . . 0.0 112.992 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.8 p -72.48 159.38 85.52 Favored Pre-proline 0 CA--C 1.576 1.949 0 C-N-CA 124.428 1.091 . . . . 0.0 112.191 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -57.31 -32.5 93.96 Favored 'Trans proline' 0 CA--C 1.572 2.391 0 N-CA-C 117.636 2.129 . . . . 0.0 117.636 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -64.82 -52.97 53.93 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 164.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.87 -43.73 86.17 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.5 mt -56.93 -50.76 71.61 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 167.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.7 pp0? -64.67 -32.73 74.53 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -61.34 -56.45 20.23 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 162.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -59.74 -41.5 91.06 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.2 mt -74.82 -14.56 60.7 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 171.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -67.54 -65.46 0.68 Allowed 'General case' 0 CA--C 1.57 1.714 0 CA-C-N 120.646 1.567 . . . . 0.0 111.308 156.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -133.06 101.58 13.66 Favored Pre-proline 0 CA--C 1.571 1.766 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.57 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.42 -51.11 0.14 Allowed 'Trans proline' 0 CA--C 1.562 1.917 0 CA-C-N 122.788 2.031 . . . . 0.0 115.693 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.58 -19.18 62.88 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.59 -43.21 56.66 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.692 1.587 . . . . 0.0 114.992 162.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.54 -57.14 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 119.423 1.011 . . . . 0.0 112.748 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.3 t -102.44 102.65 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -72.68 102.71 3.39 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-O 121.26 0.552 . . . . 0.0 111.44 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.58 26.45 9.2 Favored Glycine 0 CA--C 1.553 2.426 0 N-CA-C 118.256 2.062 . . . . 0.0 118.256 -165.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -72.03 132.27 44.03 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.538 1.669 . . . . 0.0 111.254 160.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -76.03 11.04 1.58 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 166.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -73.52 99.03 2.92 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 120.848 -1.157 . . . . 0.0 111.278 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.4 72.9 6.05 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 122.564 1.174 . . . . 0.0 112.982 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -128.61 135.43 49.32 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 124.484 1.114 . . . . 0.0 108.662 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.46 -58.15 4.34 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.43 149.88 5.18 Favored Glycine 0 N--CA 1.486 1.993 0 CA-C-N 118.931 0.787 . . . . 0.0 114.944 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -102.01 99.15 11.52 Favored Pre-proline 0 CA--C 1.572 1.809 0 CA-C-O 117.774 -1.108 . . . . 0.0 109.441 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.43 -35.32 18.27 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 122.657 2.238 . . . . 0.0 117.624 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -72.37 127.42 32.51 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -58.33 -39.95 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 167.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -53.84 -46.59 71.24 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.048 1.869 . . . . 0.0 116.048 169.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.45 -44.43 89.19 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -63.75 -51.27 65.66 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.12 -43.75 91.98 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 170.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -54.33 -54.2 43.63 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.932 1.242 . . . . 0.0 114.017 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.1 tp -55.08 -47.65 74.6 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 170.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.251 61.7 mt -62.98 -41.29 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 117.396 -1.288 . . . . 0.0 113.116 173.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.7 -43.99 69.43 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 163.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -60.75 -47.6 85.59 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 167.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 52.6 mt -63.73 -31.29 72.41 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 171.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.86 -42.66 99.84 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 162.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.58 99.48 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 117.827 1.891 . . . . 0.0 117.827 163.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -83.11 72.5 10.12 Favored 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 118.356 1.078 . . . . 0.0 112.408 172.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.603 175.609 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.647 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.6 ttm . . . . . 0 CA--C 1.562 1.417 0 CA-C-O 121.142 0.496 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.279 . . 61.66 29.46 18.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 118.606 2.817 . . . . 0.0 118.606 -174.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -98.9 113.18 64.3 Favored Pre-proline 0 CA--C 1.576 1.958 0 O-C-N 120.883 -1.136 . . . . 0.0 110.355 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.04 -26.75 25.95 Favored 'Trans proline' 0 CA--C 1.568 2.219 0 N-CA-C 118.38 2.415 . . . . 0.0 118.38 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.82 85.59 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 167.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.85 -39.46 81.36 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 161.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.41 -36.49 77.06 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 119.083 2.393 . . . . 0.0 119.083 168.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -54.39 -47.6 72.51 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 162.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -59.62 -44.18 93.54 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.33 -42.72 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 119.527 1.058 . . . . 0.0 113.831 167.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -55.85 -26.98 49.44 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.93 -34.11 10.94 Favored Glycine 0 N--CA 1.5 2.928 0 N-CA-C 119.818 2.687 . . . . 0.0 119.818 166.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -58.32 -39.64 79.95 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 162.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -78.42 -32.88 48.87 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -45.32 -45.05 12.07 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 -174.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.46 -37.45 70.32 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 m -91.95 -43.31 9.53 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 171.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -112.43 128.04 56.2 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.372 0.987 . . . . 0.0 111.449 -169.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -113.37 130.35 56.31 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.992 0.901 . . . . 0.0 111.265 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.6 mt -74.46 -24.3 59.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.98 56.86 3.63 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 121.117 1.78 . . . . 0.0 113.095 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.39 16.21 34.58 Favored Glycine 0 CA--C 1.558 2.772 0 N-CA-C 120.624 3.009 . . . . 0.0 120.624 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -105.75 133.05 51.11 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.65 1.725 . . . . 0.0 112.395 -171.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.79 122.76 36.6 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.627 169.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.01 -107.37 2.56 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.85 -0.531 . . . . 0.0 112.089 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.51 -50.21 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-N 117.202 0.501 . . . . 0.0 110.987 165.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.04 170.75 21.01 Favored Glycine 0 CA--C 1.56 2.879 0 N-CA-C 115.046 0.778 . . . . 0.0 115.046 163.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.77 176.6 6.56 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 122.627 2.218 . . . . 0.0 116.085 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -71.77 120.18 16.99 Favored 'General case' 0 CA--C 1.566 1.58 0 O-C-N 120.217 -1.552 . . . . 0.0 112.406 173.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.97 -4.68 57.22 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -66.04 115.96 6.64 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-N 119.066 0.848 . . . . 0.0 110.51 160.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.44 39.61 10.8 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 -171.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 p -97.29 -31.84 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.29 109.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 120.871 1.669 . . . . 0.0 108.971 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.69 -14.57 64.63 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 118.778 2.271 . . . . 0.0 118.778 -162.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -75.3 143.11 43.12 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 121.103 2.452 . . . . 0.0 112.965 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.1 m -59.27 142.35 52.13 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.6 t -67.22 122.58 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.83 -0.544 . . . . 0.0 110.348 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 63.47 53.48 2.11 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -162.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.24 -11.28 29.91 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 119.38 2.512 . . . . 0.0 119.38 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.0 t -86.14 95.44 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 120.245 2.023 . . . . 0.0 109.032 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -69.35 118.22 11.97 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 123.943 0.897 . . . . 0.0 112.199 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.85 -52.56 0.81 Allowed Glycine 0 N--CA 1.492 2.396 0 CA-C-O 119.99 -0.339 . . . . 0.0 113.788 -159.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -79.55 120.93 24.6 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 117.698 0.749 . . . . 0.0 110.918 171.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -76.36 118.29 18.91 Favored 'General case' 0 CA--C 1.564 1.504 0 O-C-N 121.635 -0.666 . . . . 0.0 110.541 170.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -88.24 169.95 11.43 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.608 0.763 . . . . 0.0 111.217 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.2 p -71.24 157.07 38.76 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 119.832 -1.793 . . . . 0.0 113.43 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -54.74 -50.0 88.29 Favored Pre-proline 0 CA--C 1.578 2.028 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.46 -24.96 48.76 Favored 'Trans proline' 0 CA--C 1.564 1.995 0 CA-C-N 124.349 2.589 . . . . 0.0 117.629 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.2 tpp -65.61 -48.57 71.82 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 120.633 1.56 . . . . 0.0 114.02 163.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -58.97 -44.37 91.52 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 168.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.16 -11.04 60.39 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 118.959 2.948 . . . . 0.0 118.959 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -63.29 -54.2 40.84 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.862 1.664 . . . . 0.0 114.92 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.47 175.45 50.2 Favored Glycine 0 CA--C 1.547 2.062 0 N-CA-C 116.54 1.376 . . . . 0.0 116.54 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.04 -155.75 44.77 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 115.217 0.847 . . . . 0.0 115.217 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -131.85 156.2 46.48 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.891 0.853 . . . . 0.0 112.087 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -76.66 76.17 3.33 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 123.336 1.541 . . . . 0.0 112.831 174.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.0 p -76.46 160.75 76.76 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.966 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -57.21 -35.39 98.89 Favored 'Trans proline' 0 CA--C 1.571 2.337 0 N-CA-C 117.696 2.152 . . . . 0.0 117.696 178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.29 -51.47 67.55 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 164.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.01 94.34 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.6 mt -56.42 -52.05 66.11 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 168.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.293 2.8 pp0? -63.06 -36.56 83.99 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -61.37 -54.46 43.37 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 165.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -57.55 -44.35 85.14 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.3 mt -72.65 -13.34 61.34 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 171.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -64.04 -53.84 43.55 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 120.997 1.726 . . . . 0.0 112.788 161.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.7 103.99 2.33 Favored Pre-proline 0 CA--C 1.577 1.994 0 CA-C-N 119.623 1.101 . . . . 0.0 108.59 173.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.02 -46.51 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 N-CA-C 117.429 2.05 . . . . 0.0 117.429 -168.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.65 -21.28 66.29 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.91 -48.99 56.39 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 161.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.68 -55.71 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 119.521 1.055 . . . . 0.0 113.255 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.23 104.53 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 171.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.15 96.53 2.24 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-O 121.371 0.605 . . . . 0.0 111.786 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.39 28.29 5.82 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 118.287 2.075 . . . . 0.0 118.287 -167.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -76.25 135.5 39.67 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.526 1.663 . . . . 0.0 111.463 162.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -72.3 7.97 1.53 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 167.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -73.44 99.01 2.87 Favored 'General case' 0 CA--C 1.564 1.512 0 O-C-N 120.63 -1.294 . . . . 0.0 111.395 170.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.41 74.87 4.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 122.737 1.255 . . . . 0.0 113.082 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -138.63 131.18 28.96 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.347 1.059 . . . . 0.0 108.182 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.68 -55.57 10.99 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.27 155.08 6.99 Favored Glycine 0 CA--C 1.545 1.95 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 99.3 mt -103.24 97.68 10.48 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 117.889 -1.053 . . . . 0.0 108.855 170.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.91 -32.95 27.75 Favored 'Trans proline' 0 CA--C 1.568 2.197 0 C-N-CA 122.648 2.232 . . . . 0.0 117.819 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -73.46 118.66 16.68 Favored 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 123.941 0.896 . . . . 0.0 113.252 174.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.97 -40.1 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 169.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -53.06 -47.73 68.23 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 170.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -61.41 -41.69 97.54 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 169.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 86.7 mtm-85 -60.12 -50.49 73.47 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.73 -45.58 81.86 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 167.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -54.55 -52.35 62.33 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 tp -57.81 -45.7 85.73 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 170.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.258 62.6 mt -63.9 -41.6 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 117.477 -1.249 . . . . 0.0 113.161 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.46 -43.63 71.84 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 163.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -58.34 -49.94 75.43 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 166.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.1 mt -68.82 -26.64 65.28 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.29 -39.86 84.29 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 158.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.85 -47.52 82.09 Favored Glycine 0 CA--C 1.552 2.402 0 N-CA-C 117.357 1.703 . . . . 0.0 117.357 164.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -77.16 83.81 3.65 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 118.424 1.112 . . . . 0.0 112.344 173.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.188 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.634 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 mmt . . . . . 0 CA--C 1.567 1.623 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.73 70.65 1.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.055 -1.028 . . . . 0.0 112.36 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -105.72 111.36 64.69 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.703 -175.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.57 -28.25 31.88 Favored 'Trans proline' 0 CA--C 1.566 2.115 0 N-CA-C 118.42 2.431 . . . . 0.0 118.42 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.11 96.86 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 168.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.68 95.13 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 161.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.87 -38.06 72.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 119.146 2.418 . . . . 0.0 119.146 166.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -55.19 -48.8 73.29 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 164.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -59.75 -43.55 94.22 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.57 -38.15 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 167.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.77 -20.61 15.49 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 169.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.78 -38.51 4.41 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 119.636 2.615 . . . . 0.0 119.636 156.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -65.97 -31.91 73.1 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 166.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -87.91 -33.53 18.47 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -57.91 -32.09 67.4 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 120.505 3.521 . . . . 0.0 120.505 -166.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.02 82.36 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 171.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.2 m -87.41 -44.14 11.57 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -109.22 143.83 38.15 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.339 1.056 . . . . 0.0 112.872 -168.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -118.51 150.28 39.87 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.381 1.086 . . . . 0.0 112.139 -172.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -104.07 1.89 31.46 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -115.52 57.63 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.422 1.464 . . . . 0.0 111.548 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.69 4.87 21.26 Favored Glycine 0 CA--C 1.558 2.771 0 N-CA-C 120.492 2.957 . . . . 0.0 120.492 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -97.7 143.02 28.78 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 118.87 1.335 . . . . 0.0 112.766 -168.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.38 103.97 8.5 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.46 -105.7 3.05 Favored Glycine 0 N--CA 1.49 2.234 0 O-C-N 122.117 -0.365 . . . . 0.0 113.142 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.32 -49.75 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.848 166.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.65 163.49 16.39 Favored Glycine 0 CA--C 1.56 2.864 0 CA-C-N 118.911 0.778 . . . . 0.0 114.851 164.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.72 176.09 8.7 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 CA-C-N 120.845 2.323 . . . . 0.0 115.935 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -70.23 120.2 15.56 Favored 'General case' 0 CA--C 1.568 1.646 0 O-C-N 120.535 -1.353 . . . . 0.0 113.279 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -87.84 -4.01 58.89 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -62.95 111.7 2.27 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.349 1.431 . . . . 0.0 111.729 157.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.66 43.58 7.72 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 -173.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -98.09 -37.88 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-N 118.805 1.303 . . . . 0.0 114.491 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.39 107.8 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.898 1.226 . . . . 0.0 110.096 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.81 -19.96 52.26 Favored Glycine 0 CA--C 1.552 2.372 0 N-CA-C 118.503 2.161 . . . . 0.0 118.503 -163.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -73.01 143.63 47.49 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 120.929 2.364 . . . . 0.0 113.415 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.3 m -60.4 140.26 57.28 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.16 124.32 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 123.405 0.682 . . . . 0.0 110.824 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.39 48.72 5.79 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -164.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.05 -8.08 39.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 119.46 2.544 . . . . 0.0 119.46 -169.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.1 t -82.94 103.23 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 120.199 2.0 . . . . 0.0 109.12 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.27 90.33 0.91 Allowed 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.546 0.738 . . . . 0.0 112.081 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.27 -48.84 0.51 Allowed Glycine 0 N--CA 1.486 2.029 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.857 -160.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -81.22 132.16 35.33 Favored 'General case' 0 CA--C 1.571 1.751 0 CA-C-N 118.098 0.949 . . . . 0.0 111.572 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -84.48 88.28 7.29 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.435 -0.79 . . . . 0.0 112.017 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -72.85 147.07 45.77 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.2 p -67.74 155.34 39.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -53.82 -49.23 90.45 Favored Pre-proline 0 CA--C 1.578 2.031 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.25 -23.6 38.73 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 CA-C-N 124.125 2.509 . . . . 0.0 117.521 170.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.1 tpp -65.4 -46.65 79.19 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 120.885 1.675 . . . . 0.0 114.147 161.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -57.84 -45.9 85.55 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 168.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.01 -11.96 61.01 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 170.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -60.4 -49.47 77.45 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.045 1.748 . . . . 0.0 114.638 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.88 164.72 36.08 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 163.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.46 -144.69 24.63 Favored Glycine 0 N--CA 1.486 2.015 0 CA-C-N 114.915 -0.642 . . . . 0.0 114.694 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -130.84 154.78 47.69 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.665 0.745 . . . . 0.0 111.493 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -76.12 76.81 2.95 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 123.149 1.452 . . . . 0.0 112.558 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -75.72 159.89 80.28 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.881 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.18 -33.75 91.33 Favored 'Trans proline' 0 CA--C 1.57 2.289 0 N-CA-C 117.66 2.139 . . . . 0.0 117.66 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.31 -50.66 59.27 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 166.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.65 -43.67 85.11 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -57.17 -50.73 71.93 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 165.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.304 1.6 pp0? -61.28 -37.24 82.47 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 175.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.43 -59.02 6.01 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 164.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -58.93 -42.83 90.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.5 mt -69.77 -17.39 63.42 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.5 m -62.71 -55.23 28.6 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.26 1.846 . . . . 0.0 112.869 164.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.23 103.32 2.42 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-N 119.496 1.044 . . . . 0.0 108.525 173.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.02 -46.63 0.37 Allowed 'Trans proline' 0 CA--C 1.558 1.686 0 N-CA-C 117.431 2.05 . . . . 0.0 117.431 -167.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.95 -25.85 68.55 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 169.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 -45.06 70.21 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 163.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.9 t -65.47 -55.3 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.558 1.072 . . . . 0.0 112.782 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.8 104.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -72.99 98.29 2.48 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-O 121.454 0.645 . . . . 0.0 111.316 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.83 23.84 7.61 Favored Glycine 0 CA--C 1.554 2.505 0 N-CA-C 118.657 2.223 . . . . 0.0 118.657 -168.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.4 t -75.41 134.52 40.89 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 119.615 1.708 . . . . 0.0 111.061 160.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -72.92 9.08 1.25 Allowed 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 117.409 2.374 . . . . 0.0 117.409 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -76.25 100.77 5.19 Favored 'General case' 0 CA--C 1.562 1.408 0 O-C-N 120.725 -1.234 . . . . 0.0 111.726 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.64 71.36 4.12 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 122.595 1.188 . . . . 0.0 113.611 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -138.63 128.03 24.49 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.85 -53.48 32.03 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.88 158.79 8.9 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 115.471 0.948 . . . . 0.0 115.471 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.7 mt -100.26 98.56 7.95 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 117.934 -1.031 . . . . 0.0 108.524 166.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.55 -36.39 11.46 Favored 'Trans proline' 0 CA--C 1.565 2.044 0 C-N-CA 122.658 2.239 . . . . 0.0 117.575 -176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.08 133.53 41.56 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 118.94 0.791 . . . . 0.0 112.527 175.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -57.77 -40.66 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 171.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.57 -43.25 84.37 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.78 -44.72 73.95 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 167.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -66.43 -55.27 16.52 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 173.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.66 98.07 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.64 -47.41 86.36 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.964 1.256 . . . . 0.0 114.11 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.5 HD21 HMB1 ' A' ' 101' ' ' HEC . 35.9 tp -59.39 -44.0 92.87 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 169.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.0 mt -60.55 -42.87 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-O 117.539 -1.22 . . . . 0.0 113.101 169.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.67 -44.05 72.97 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 164.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -58.92 -48.22 82.23 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 166.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.9 mt -69.39 -24.47 63.86 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.31 -41.21 92.99 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 156.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.3 -44.96 92.75 Favored Glycine 0 CA--C 1.554 2.5 0 N-CA-C 117.584 1.794 . . . . 0.0 117.584 163.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -79.17 82.36 5.34 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-N 118.623 1.212 . . . . 0.0 111.882 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.43 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.628 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mmt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.99 56.3 0.9 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -114.53 103.67 54.82 Favored Pre-proline 0 CA--C 1.573 1.848 0 O-C-N 120.865 -1.147 . . . . 0.0 109.807 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.71 -23.51 30.93 Favored 'Trans proline' 0 CA--C 1.568 2.203 0 N-CA-C 118.227 2.357 . . . . 0.0 118.227 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.96 -47.36 83.51 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.08 81.56 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 162.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.83 -35.03 66.22 Favored Glycine 0 CA--C 1.552 2.383 0 N-CA-C 119.114 2.405 . . . . 0.0 119.114 164.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.53 -49.77 76.5 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 168.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -59.65 -41.59 90.89 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 169.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.52 -39.16 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 169.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -56.85 -23.03 41.21 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 167.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.05 -35.57 18.99 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 119.585 2.594 . . . . 0.0 119.585 162.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.8 -36.33 76.5 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 162.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -80.27 -32.54 38.22 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 171.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -49.85 -33.8 18.06 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.78 -26.34 23.29 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 118.145 2.646 . . . . 0.0 118.145 167.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.0 m -120.32 -38.77 2.86 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -108.48 147.28 31.9 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.322 1.049 . . . . 0.0 113.169 -169.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -119.74 148.93 42.82 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.937 0.875 . . . . 0.0 112.108 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -105.66 3.94 29.62 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.62 40.23 1.46 Allowed 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 121.095 1.771 . . . . 0.0 114.628 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.36 35.68 91.76 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 117.981 1.952 . . . . 0.0 117.981 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -131.06 142.38 50.29 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 117.905 0.853 . . . . 0.0 111.27 -166.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -91.82 140.66 29.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.032 -1.042 . . . . 0.0 111.505 174.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.91 -115.46 1.89 Allowed Glycine 0 N--CA 1.491 2.341 0 O-C-N 121.518 -0.739 . . . . 0.0 112.108 172.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.18 -47.54 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.817 164.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.39 173.63 27.59 Favored Glycine 0 CA--C 1.562 3.013 0 N-CA-C 115.78 1.072 . . . . 0.0 115.78 163.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.42 172.6 12.97 Favored 'Trans proline' 0 CA--C 1.564 1.996 0 C-N-CA 122.845 2.363 . . . . 0.0 115.583 173.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -68.51 125.83 27.73 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 120.425 -1.422 . . . . 0.0 113.754 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -91.57 -0.86 57.64 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -66.46 111.63 3.66 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-N 120.326 1.421 . . . . 0.0 111.234 162.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.99 41.42 7.58 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 116.687 1.435 . . . . 0.0 116.687 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -92.73 -34.31 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.02 106.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 120.428 1.467 . . . . 0.0 109.512 -171.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.48 -12.12 66.51 Favored Glycine 0 CA--C 1.553 2.44 0 N-CA-C 118.731 2.252 . . . . 0.0 118.731 -161.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -78.31 148.45 33.82 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 121.228 2.514 . . . . 0.0 112.84 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.4 m -54.12 141.53 28.56 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.95 120.87 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.758 -0.589 . . . . 0.0 109.974 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.271 . . 66.42 54.66 0.89 Allowed 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -161.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -118.98 22.13 9.23 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 119.206 2.442 . . . . 0.0 119.206 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.3 t -102.99 109.22 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.323 1.561 . . . . 0.0 107.79 165.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -72.67 88.33 1.28 Allowed 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 123.453 0.701 . . . . 0.0 111.67 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.87 -47.07 0.54 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.075 -159.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -82.23 131.86 35.23 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 118.362 1.081 . . . . 0.0 111.829 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -78.68 105.58 10.07 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 123.517 0.727 . . . . 0.0 111.848 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -89.56 156.77 18.39 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -63.35 151.8 39.79 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 171.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -59.26 -48.42 96.23 Favored Pre-proline 0 CA--C 1.577 1.997 0 CA-C-O 116.124 -1.893 . . . . 0.0 115.473 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.42 -24.98 63.7 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 CA-C-N 124.477 2.635 . . . . 0.0 117.937 166.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.4 tpp -65.39 -48.61 72.29 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.796 1.634 . . . . 0.0 114.097 164.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -56.27 -47.83 77.8 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 166.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.64 -11.89 60.82 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 118.994 2.961 . . . . 0.0 118.994 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -63.6 -52.63 60.08 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.762 1.619 . . . . 0.0 114.316 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.08 175.26 49.81 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.69 -148.3 36.61 Favored Glycine 0 CA--C 1.547 2.039 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -134.26 155.03 50.91 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.644 0.735 . . . . 0.0 111.639 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -77.1 77.48 3.64 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.91 1.338 . . . . 0.0 112.838 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.0 p -73.84 159.82 83.38 Favored Pre-proline 0 CA--C 1.574 1.885 0 C-N-CA 124.455 1.102 . . . . 0.0 112.344 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -57.59 -34.39 98.02 Favored 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 122.399 2.066 . . . . 0.0 117.459 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.19 -39.84 74.99 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 116.382 1.994 . . . . 0.0 116.382 165.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.96 97.89 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.54 -43.21 93.57 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 166.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -54.27 -44.49 71.92 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 167.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -66.51 -55.6 14.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -59.71 -39.87 86.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 67.8 mt -76.37 -15.03 60.05 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 170.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.0 m -66.36 -53.29 37.83 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 121.323 1.874 . . . . 0.0 112.738 160.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -150.28 113.36 3.29 Favored Pre-proline 0 CA--C 1.575 1.922 0 CA-C-N 119.986 1.266 . . . . 0.0 109.197 168.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.49 -46.26 0.22 Allowed 'Trans proline' 0 CA--C 1.56 1.807 0 CA-C-N 122.597 1.963 . . . . 0.0 116.954 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.75 -28.83 68.72 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.77 -41.88 86.99 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 162.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.65 -57.76 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.482 1.037 . . . . 0.0 112.655 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -99.87 101.36 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.67 100.13 2.74 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.336 0.589 . . . . 0.0 111.066 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.84 19.39 12.02 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 118.928 2.331 . . . . 0.0 118.928 -167.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.3 t -73.08 136.83 44.98 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 120.289 2.044 . . . . 0.0 111.937 163.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -76.99 12.81 1.24 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.484 2.402 . . . . 0.0 117.484 169.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -74.12 95.96 2.65 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.665 -1.272 . . . . 0.0 110.972 169.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.92 74.3 4.47 Favored 'General case' 0 CA--C 1.567 1.627 0 CA-C-O 122.802 1.286 . . . . 0.0 113.24 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -142.05 127.36 18.72 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.57 -52.59 43.89 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.11 161.1 10.09 Favored Glycine 0 CA--C 1.545 1.917 0 CA-C-O 122.6 1.111 . . . . 0.0 115.171 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -100.74 99.17 9.57 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 117.851 -1.071 . . . . 0.0 108.646 168.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.79 -34.46 18.28 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 C-N-CA 122.608 2.206 . . . . 0.0 117.432 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.25 129.26 38.44 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.005 0.82 . . . . 0.0 112.85 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.0 tp -56.79 -45.21 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 169.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.39 -40.35 74.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -59.24 -46.8 87.52 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 120.176 1.353 . . . . 0.0 114.606 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -62.44 -53.75 50.25 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.24 -45.03 95.17 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 117.111 2.263 . . . . 0.0 117.111 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -61.54 -45.64 93.32 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.408 HD21 HMB1 ' A' ' 101' ' ' HEC . 46.9 tp -55.38 -45.0 76.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 166.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 61.3 mt -61.48 -42.62 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 117.46 -1.257 . . . . 0.0 113.219 171.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.3 -44.36 71.89 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 164.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -59.93 -47.85 84.11 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 167.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.04 -25.96 65.63 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -63.59 -42.75 98.24 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 159.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.99 -45.3 96.4 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 117.69 1.836 . . . . 0.0 117.69 165.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -78.33 77.71 4.81 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 118.292 1.046 . . . . 0.0 112.132 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.577 -0.702 . . . . 0.0 109.774 176.701 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.619 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 mmt . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.83 70.32 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.373 0.988 . . . . 0.0 113.064 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -104.17 115.8 62.5 Favored Pre-proline 0 CA--C 1.575 1.935 0 C-N-CA 124.009 0.924 . . . . 0.0 110.565 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.66 -29.76 23.83 Favored 'Trans proline' 0 CA--C 1.568 2.221 0 N-CA-C 118.389 2.419 . . . . 0.0 118.389 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.34 -46.19 87.73 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 169.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.35 78.36 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 160.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.89 -34.79 72.72 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 168.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.36 -41.75 94.35 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 163.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -59.99 -44.75 94.31 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 167.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.46 -42.81 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 166.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -54.82 -28.05 46.6 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 169.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.62 -35.44 4.14 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 160.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -60.3 -35.8 76.42 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 163.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -80.12 -18.8 48.89 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 169.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -73.47 67.4 1.05 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 123.792 1.758 . . . . 0.0 115.0 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.34 -54.83 0.18 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 125.149 1.379 . . . . 0.0 109.059 167.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 m -83.52 -34.87 25.19 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 171.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -110.5 151.68 27.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 119.549 1.068 . . . . 0.0 112.716 -170.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.67 153.18 41.17 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.363 1.077 . . . . 0.0 110.983 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.9 -25.7 17.19 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.28 57.52 4.02 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 121.49 1.95 . . . . 0.0 113.685 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.65 7.69 12.12 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 121.732 3.453 . . . . 0.0 121.732 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -113.31 146.49 39.32 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.632 1.716 . . . . 0.0 112.925 -169.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.1 138.3 44.6 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.296 1.038 . . . . 0.0 111.102 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.72 -108.08 0.62 Allowed Glycine 0 N--CA 1.489 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 113.206 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.83 -51.35 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 CA-C-N 117.297 0.548 . . . . 0.0 111.088 169.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.13 169.82 17.01 Favored Glycine 0 CA--C 1.562 2.974 0 CA-C-N 118.577 0.626 . . . . 0.0 114.254 161.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.28 175.72 10.58 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 120.878 2.339 . . . . 0.0 115.398 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -68.9 124.68 24.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.647 -1.283 . . . . 0.0 112.615 173.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 99.2 mt -87.85 -5.23 58.7 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.878 2.177 . . . . 0.0 116.878 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -63.65 117.31 6.65 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 119.423 1.011 . . . . 0.0 110.638 157.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.59 40.58 12.44 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 116.633 1.413 . . . . 0.0 116.633 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 p -95.68 -33.28 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.48 107.78 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-N 120.572 1.533 . . . . 0.0 109.57 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.07 -11.76 69.04 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 118.743 2.257 . . . . 0.0 118.743 -162.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -76.06 146.62 39.26 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 121.132 2.466 . . . . 0.0 112.704 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.9 m -53.89 140.94 29.09 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.66 113.37 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.669 -0.644 . . . . 0.0 109.298 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.27 . . 68.05 65.23 0.36 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -157.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.34 -25.52 4.95 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 119.187 2.435 . . . . 0.0 119.187 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.28 98.52 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 120.041 1.921 . . . . 0.0 109.504 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -69.25 107.89 3.43 Favored 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 123.284 0.634 . . . . 0.0 111.21 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.31 -52.79 0.75 Allowed Glycine 0 N--CA 1.49 2.239 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.767 -155.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -79.94 129.15 34.26 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 118.081 0.94 . . . . 0.0 111.749 172.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -76.53 98.76 4.74 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.523 0.729 . . . . 0.0 112.514 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -80.89 158.21 25.38 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.4 t -64.06 151.38 43.19 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 172.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -58.76 -48.03 97.59 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 115.963 -1.97 . . . . 0.0 115.8 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.21 -23.63 66.25 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 CA-C-N 124.724 2.723 . . . . 0.0 117.967 165.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.4 tpp -66.5 -49.14 67.56 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 120.794 1.634 . . . . 0.0 113.806 163.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -57.06 -45.89 82.89 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 168.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.71 -14.47 62.46 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 118.777 2.88 . . . . 0.0 118.777 172.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -65.48 -55.42 17.98 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 120.726 1.603 . . . . 0.0 113.777 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.59 178.32 51.2 Favored Glycine 0 CA--C 1.547 2.042 0 N-CA-C 116.853 1.501 . . . . 0.0 116.853 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.72 -145.4 32.63 Favored Glycine 0 CA--C 1.547 2.062 0 O-C-N 121.961 -0.729 . . . . 0.0 114.627 -174.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -134.74 155.75 50.02 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.891 0.853 . . . . 0.0 111.935 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -76.24 76.65 3.04 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 123.148 1.451 . . . . 0.0 112.791 171.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.4 p -72.78 161.5 79.0 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.565 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -57.11 -36.6 99.24 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 122.293 1.995 . . . . 0.0 116.909 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -61.06 -49.62 76.63 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 165.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.35 -43.51 83.52 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 172.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.09 -44.19 93.09 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 167.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -51.1 -47.71 61.85 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 121.047 1.749 . . . . 0.0 115.598 165.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -61.25 -60.98 2.9 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -61.31 -39.46 90.58 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.0 mt -75.65 -17.08 60.1 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 171.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.1 m -66.23 -51.27 59.23 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 120.838 1.654 . . . . 0.0 113.317 159.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -150.46 113.22 3.24 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 120.045 1.293 . . . . 0.0 109.646 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.92 -48.39 0.23 Allowed 'Trans proline' 0 CA--C 1.561 1.827 0 CA-C-N 122.656 1.984 . . . . 0.0 116.713 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.33 -27.4 64.34 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.69 -40.74 88.63 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 162.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.9 t -71.8 -57.85 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 119.323 0.965 . . . . 0.0 112.514 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -101.71 100.45 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 172.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -73.25 98.94 2.75 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 121.333 0.587 . . . . 0.0 111.633 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.02 22.82 8.07 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -165.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -74.17 136.65 42.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.733 1.767 . . . . 0.0 111.887 163.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -72.45 3.94 4.32 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.7 ttt -73.15 92.43 1.72 Allowed 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 120.334 1.425 . . . . 0.0 111.789 168.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.78 76.87 9.6 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 122.019 0.914 . . . . 0.0 112.624 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -128.02 129.14 46.22 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.459 0.704 . . . . 0.0 110.102 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.96 106.73 5.79 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 121.874 -0.516 . . . . 0.0 111.233 166.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.42 172.81 9.22 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 119.49 2.556 . . . . 0.0 119.49 -168.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.2 107.86 31.83 Favored Pre-proline 0 CA--C 1.572 1.817 0 CA-C-O 117.682 -1.152 . . . . 0.0 111.219 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.54 -35.84 9.71 Favored 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.691 2.261 . . . . 0.0 117.151 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.71 128.1 34.52 Favored 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 123.94 0.896 . . . . 0.0 112.975 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.8 tp -56.36 -45.27 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 170.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.16 -46.04 75.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.12 -45.29 83.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 170.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -64.36 -51.74 61.81 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 171.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.78 92.65 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 171.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -54.91 -53.55 54.12 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-N 119.813 1.188 . . . . 0.0 114.098 168.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.6 tp -57.42 -47.68 81.12 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 59.4 mt -63.59 -41.97 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.99 1.268 . . . . 0.0 113.083 173.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.02 68.54 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 163.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.88 -49.48 77.31 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 167.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.7 mt -66.4 -25.76 66.92 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.33 -44.03 97.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 158.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.03 -40.5 97.11 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 118.301 2.081 . . . . 0.0 118.301 167.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -83.2 84.19 7.58 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 118.655 1.228 . . . . 0.0 110.979 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 C--O 1.257 1.456 0 CA-C-O 118.299 -0.858 . . . . 0.0 109.537 176.597 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.673 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.44 68.39 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.688 0.756 . . . . 0.0 112.492 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.1 111.82 63.35 Favored Pre-proline 0 CA--C 1.574 1.889 0 O-C-N 121.36 -0.837 . . . . 0.0 110.73 -175.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.85 -29.93 34.24 Favored 'Trans proline' 0 CA--C 1.567 2.143 0 N-CA-C 118.549 2.48 . . . . 0.0 118.549 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.27 -42.66 99.15 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.51 93.71 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 161.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.86 -37.06 75.83 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 118.912 2.325 . . . . 0.0 118.912 168.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.85 -37.97 77.69 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 164.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -65.5 -45.09 84.96 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 168.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.0 -40.1 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 166.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -56.5 -18.99 13.29 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.5 -39.23 5.68 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 119.237 2.455 . . . . 0.0 119.237 156.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -65.11 -33.83 76.95 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 166.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -87.32 -35.65 18.3 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -58.38 -27.42 64.22 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 119.896 3.295 . . . . 0.0 119.896 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.87 -31.21 62.59 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 166.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 m -105.87 -39.1 6.13 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 171.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -111.64 137.48 49.45 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.257 1.023 . . . . 0.0 112.901 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.33 147.77 23.45 Favored 'General case' 0 CA--C 1.565 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 113.28 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.9 mt -97.89 17.25 18.61 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 162.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -130.44 60.96 1.61 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.49 -1.381 . . . . 0.0 111.388 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.82 -33.12 0.38 Allowed Glycine 0 CA--C 1.557 2.694 0 N-CA-C 120.483 2.953 . . . . 0.0 120.483 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -76.94 145.56 38.09 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.583 1.153 . . . . 0.0 113.618 -172.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -111.13 115.84 30.09 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -109.44 -113.42 3.58 Favored Glycine 0 N--CA 1.491 2.309 0 O-C-N 121.707 -0.621 . . . . 0.0 113.646 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.12 -48.75 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 122.396 -0.473 . . . . 0.0 111.208 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.67 167.02 17.17 Favored Glycine 0 CA--C 1.561 2.936 0 CA-C-N 118.782 0.719 . . . . 0.0 114.514 159.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -68.98 176.68 5.86 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 CA-C-N 120.889 2.345 . . . . 0.0 115.059 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -68.82 126.75 30.74 Favored 'General case' 0 CA--C 1.57 1.72 0 O-C-N 120.427 -1.42 . . . . 0.0 113.158 175.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.2 -2.57 55.08 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -65.74 108.67 2.18 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 120.307 1.412 . . . . 0.0 111.711 162.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.02 52.53 4.28 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.82 -37.36 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 171.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.9 t -71.99 109.4 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 120.644 1.566 . . . . 0.0 109.016 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.06 -29.52 12.29 Favored Glycine 0 CA--C 1.551 2.313 0 N-CA-C 117.664 1.825 . . . . 0.0 117.664 -161.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -66.18 144.27 56.75 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 120.933 2.367 . . . . 0.0 113.949 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.4 m -53.38 140.67 26.72 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.12 121.43 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.579 -0.701 . . . . 0.0 110.191 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.267 . . 64.78 44.81 3.56 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -163.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.24 36.68 4.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 117.71 1.844 . . . . 0.0 117.71 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.72 105.27 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.23 96.77 2.31 Favored 'General case' 0 CA--C 1.566 1.596 0 C-N-CA 123.488 0.715 . . . . 0.0 110.697 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 149.06 -52.74 0.53 Allowed Glycine 0 N--CA 1.489 2.173 0 CA-C-O 119.58 -0.567 . . . . 0.0 114.087 -158.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -86.42 134.76 33.67 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.026 0.913 . . . . 0.0 111.955 175.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -76.97 108.62 10.15 Favored 'General case' 0 CA--C 1.568 1.668 0 C-N-CA 123.745 0.818 . . . . 0.0 112.964 171.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -94.49 150.77 19.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.451 -0.781 . . . . 0.0 112.231 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.2 p -69.66 157.21 37.68 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.622 -1.299 . . . . 0.0 114.323 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -55.79 -48.12 97.28 Favored Pre-proline 0 CA--C 1.576 1.959 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.55 -26.34 34.03 Favored 'Trans proline' 0 CA--C 1.565 2.067 0 CA-C-N 124.969 2.81 . . . . 0.0 117.205 170.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -63.35 -47.74 80.85 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 120.428 1.467 . . . . 0.0 114.189 163.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -59.18 -46.22 88.98 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 168.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.27 -13.79 61.6 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 174.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -61.01 -53.51 56.38 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 120.735 1.607 . . . . 0.0 114.831 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.09 176.59 49.88 Favored Glycine 0 CA--C 1.547 2.043 0 N-CA-C 116.764 1.466 . . . . 0.0 116.764 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.92 -153.17 43.32 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.84 155.9 47.0 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.042 0.925 . . . . 0.0 111.732 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -76.02 75.81 2.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.039 1.4 . . . . 0.0 112.882 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.7 p -73.92 159.93 83.03 Favored Pre-proline 0 CA--C 1.576 1.973 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.098 171.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -57.69 -34.21 97.83 Favored 'Trans proline' 0 CA--C 1.57 2.291 0 N-CA-C 117.777 2.184 . . . . 0.0 117.777 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.67 -47.27 72.99 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 165.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.14 89.58 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 170.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.5 mt -59.49 -45.91 90.32 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 165.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -55.87 -43.91 77.6 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 121.556 1.98 . . . . 0.0 116.307 168.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.69 -57.35 13.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 119.888 1.222 . . . . 0.0 114.155 169.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -61.82 -40.42 95.2 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.36 -22.82 61.09 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 170.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.2 m -61.85 -52.31 64.66 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.377 1.899 . . . . 0.0 113.445 164.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -151.28 113.17 3.05 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-N 119.91 1.232 . . . . 0.0 108.892 167.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.01 -46.43 0.24 Allowed 'Trans proline' 0 CA--C 1.56 1.81 0 CA-C-N 122.724 2.009 . . . . 0.0 116.798 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.16 -29.12 68.73 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.31 -41.02 90.32 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 162.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.7 t -70.32 -57.94 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 119.45 1.023 . . . . 0.0 112.475 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.37 102.19 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -73.11 99.32 2.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.599 -0.688 . . . . 0.0 111.429 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.84 21.84 9.36 Favored Glycine 0 CA--C 1.553 2.464 0 N-CA-C 118.622 2.209 . . . . 0.0 118.622 -166.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.5 t -74.31 132.27 41.92 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.793 1.797 . . . . 0.0 111.042 159.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -77.03 16.79 0.51 Allowed 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.403 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 1.9 ttt -78.68 101.73 7.67 Favored 'General case' 0 CA--C 1.561 1.377 0 O-C-N 120.847 -1.158 . . . . 0.0 111.059 171.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.12 70.77 3.56 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 122.637 1.208 . . . . 0.0 113.854 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -136.56 128.63 29.58 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 124.517 1.127 . . . . 0.0 108.053 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.38 -53.9 20.81 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.8 158.48 8.53 Favored Glycine 0 CA--C 1.544 1.861 0 N-CA-C 115.928 1.131 . . . . 0.0 115.928 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.5 mt -104.56 96.1 9.71 Favored Pre-proline 0 CA--C 1.575 1.917 0 C-N-CA 124.072 0.949 . . . . 0.0 108.9 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.48 -34.3 20.56 Favored 'Trans proline' 0 CA--C 1.567 2.159 0 C-N-CA 122.652 2.234 . . . . 0.0 117.555 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.88 131.53 38.63 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.835 0.854 . . . . 0.0 111.972 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.9 tt -55.9 -45.11 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 170.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -52.83 -44.29 66.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 173.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.7 -44.36 93.71 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 -67.01 -53.91 26.73 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.62 -42.85 93.58 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.05 -48.68 80.71 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 119.816 1.189 . . . . 0.0 113.838 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.518 HD21 HMB1 ' A' ' 101' ' ' HEC . 46.8 tp -59.34 -44.9 92.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 170.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.23 -42.79 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 119.807 1.185 . . . . 0.0 112.88 171.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.67 -43.95 69.27 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 163.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -60.32 -48.77 80.3 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 167.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.8 -25.26 66.37 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.09 -35.36 80.89 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 158.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.79 -46.56 73.79 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 161.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.64 68.72 9.95 Favored 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 118.451 1.125 . . . . 0.0 111.459 172.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.872 -166.227 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.665 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.009 0.433 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.261 . . 58.68 39.26 24.64 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 117.979 2.585 . . . . 0.0 117.979 -174.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -99.21 112.87 64.11 Favored Pre-proline 0 CA--C 1.576 1.955 0 O-C-N 121.012 -1.055 . . . . 0.0 110.675 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.66 -27.82 26.49 Favored 'Trans proline' 0 CA--C 1.568 2.193 0 N-CA-C 118.361 2.408 . . . . 0.0 118.361 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.84 -48.17 80.24 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 169.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.22 82.06 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 162.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.16 -36.52 68.55 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 119.009 2.364 . . . . 0.0 119.009 167.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -54.86 -47.43 74.2 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 162.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -59.93 -44.1 94.55 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.5 t -58.82 -42.64 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -55.37 -25.97 38.45 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 170.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.04 -34.55 7.71 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 119.75 2.66 . . . . 0.0 119.75 164.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -58.13 -41.85 84.54 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 161.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -75.39 -33.94 61.03 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -47.03 -37.75 9.83 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 119.025 2.972 . . . . 0.0 119.025 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.49 -29.33 58.59 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 170.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.9 m -113.64 -37.13 4.68 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 174.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -112.52 141.43 46.27 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.686 1.194 . . . . 0.0 111.588 -171.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.48 154.73 25.42 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.794 1.283 . . . . 0.0 113.372 171.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.6 mt -94.91 15.35 18.88 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 170.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -119.66 57.21 0.92 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 120.826 1.648 . . . . 0.0 112.776 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.51 -45.83 1.29 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 119.685 2.634 . . . . 0.0 119.685 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -77.57 157.77 30.16 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.32 1.057 . . . . 0.0 113.405 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.96 140.47 34.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.112 -0.992 . . . . 0.0 111.292 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.12 -116.2 3.62 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.802 -0.562 . . . . 0.0 113.045 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -75.88 -49.6 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 122.384 -0.48 . . . . 0.0 110.802 166.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.78 171.41 30.23 Favored Glycine 0 CA--C 1.559 2.832 0 CA-C-N 118.715 0.689 . . . . 0.0 114.796 158.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.41 175.41 7.85 Favored 'Trans proline' 0 CA--C 1.564 2.018 0 CA-C-N 120.845 2.322 . . . . 0.0 115.227 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -65.04 129.55 40.12 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 120.47 -1.394 . . . . 0.0 113.178 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.7 mt -96.51 -0.46 48.88 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -66.11 112.15 3.75 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.468 1.485 . . . . 0.0 111.233 158.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.98 51.45 5.38 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 115.733 1.053 . . . . 0.0 115.733 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -100.64 -35.99 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 170.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.8 t -72.24 109.87 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 120.503 1.502 . . . . 0.0 109.158 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.32 -17.63 58.25 Favored Glycine 0 CA--C 1.552 2.369 0 N-CA-C 118.47 2.148 . . . . 0.0 118.47 -161.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -73.57 142.81 46.63 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 121.35 2.575 . . . . 0.0 113.311 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.7 m -59.94 138.65 57.78 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.2 123.92 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.787 -0.571 . . . . 0.0 110.221 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.8 45.51 7.67 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -164.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.43 -4.44 43.55 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 119.636 2.615 . . . . 0.0 119.636 -170.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.9 t -84.75 103.16 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 120.255 2.027 . . . . 0.0 108.994 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.0 94.31 0.63 Allowed 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.8 -46.08 0.82 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 114.934 0.734 . . . . 0.0 114.934 -161.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -76.93 131.8 38.72 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 118.405 1.103 . . . . 0.0 112.274 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -81.39 84.23 6.72 Favored 'General case' 0 CA--C 1.568 1.671 0 O-C-N 121.528 -0.732 . . . . 0.0 111.978 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -71.42 146.15 48.87 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.6 p -67.72 156.8 36.11 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -55.61 -43.94 99.41 Favored Pre-proline 0 CA--C 1.574 1.901 0 CA-C-O 115.162 -2.351 . . . . 0.0 117.316 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.12 -27.63 29.27 Favored 'Trans proline' 0 CA--C 1.565 2.044 0 CA-C-N 124.866 2.774 . . . . 0.0 116.977 168.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.4 tpp -63.33 -47.75 80.89 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.427 1.467 . . . . 0.0 114.019 163.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -57.87 -46.11 85.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 167.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.95 -14.45 61.92 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 118.881 2.919 . . . . 0.0 118.881 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -61.67 -53.7 52.67 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.722 1.601 . . . . 0.0 114.512 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.04 176.16 47.96 Favored Glycine 0 CA--C 1.547 2.059 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.1 -149.83 38.17 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 114.893 0.717 . . . . 0.0 114.893 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -131.91 156.07 46.77 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.818 0.818 . . . . 0.0 111.847 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -75.94 74.25 2.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.237 1.494 . . . . 0.0 112.988 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.0 p -73.75 161.48 78.55 Favored Pre-proline 0 CA--C 1.575 1.937 0 C-N-CA 124.985 1.314 . . . . 0.0 112.371 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -56.87 -35.28 98.28 Favored 'Trans proline' 0 CA--C 1.569 2.247 0 N-CA-C 117.575 2.106 . . . . 0.0 117.575 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -64.82 -49.51 70.33 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 164.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.72 -44.64 90.48 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 172.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.65 -45.17 95.11 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 165.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -55.88 -44.42 78.11 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.635 2.016 . . . . 0.0 116.238 168.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -61.15 -57.74 11.25 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 120.047 1.294 . . . . 0.0 113.944 169.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -60.27 -41.36 93.11 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.83 -18.9 60.38 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.6 m -63.44 -51.4 65.86 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.071 1.76 . . . . 0.0 113.409 161.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -151.95 112.0 2.9 Favored Pre-proline 0 CA--C 1.575 1.94 0 CA-C-N 120.096 1.316 . . . . 0.0 108.993 167.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.51 -47.02 0.19 Allowed 'Trans proline' 0 CA--C 1.559 1.736 0 CA-C-N 122.71 2.004 . . . . 0.0 116.924 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.25 -27.6 67.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.96 -42.84 84.51 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 162.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.11 -57.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 119.546 1.066 . . . . 0.0 112.709 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.26 101.46 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -73.29 94.77 2.05 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-O 121.462 0.649 . . . . 0.0 111.561 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.93 25.93 5.98 Favored Glycine 0 CA--C 1.554 2.499 0 N-CA-C 118.379 2.111 . . . . 0.0 118.379 -166.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -76.08 137.61 40.27 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 119.749 1.774 . . . . 0.0 111.355 160.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -74.32 7.62 2.72 Favored 'General case' 0 CA--C 1.579 2.067 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 167.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -74.6 97.55 3.19 Favored 'General case' 0 CA--C 1.565 1.533 0 O-C-N 120.677 -1.264 . . . . 0.0 111.53 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.22 71.83 5.76 Favored 'General case' 0 CA--C 1.569 1.703 0 CA-C-O 122.61 1.195 . . . . 0.0 113.472 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -129.93 133.41 46.82 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.465 1.106 . . . . 0.0 108.479 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.27 -56.09 9.87 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.48 155.2 6.66 Favored Glycine 0 CA--C 1.545 1.933 0 N-CA-C 116.159 1.224 . . . . 0.0 116.159 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.5 mt -105.72 97.88 16.1 Favored Pre-proline 0 CA--C 1.575 1.918 0 C-N-CA 123.962 0.905 . . . . 0.0 109.323 172.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.17 -33.21 15.44 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 122.632 2.221 . . . . 0.0 117.717 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.62 131.37 39.92 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 175.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.8 tt -56.63 -43.88 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -52.71 -47.4 67.34 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -57.19 -47.13 82.01 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -65.01 -51.55 61.03 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.32 83.79 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -56.47 -50.74 70.87 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.5 tp -57.34 -46.4 83.32 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 169.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.8 mt -64.4 -39.82 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-N 119.933 1.242 . . . . 0.0 113.202 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.22 -45.11 75.92 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 163.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -57.37 -50.51 72.76 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.3 mt -67.71 -26.78 66.34 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -62.39 -40.78 97.6 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 158.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.75 88.86 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 117.142 1.617 . . . . 0.0 117.142 163.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -84.28 78.33 9.81 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 123.684 0.794 . . . . 0.0 111.997 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 123.581 0.752 . . . . 0.0 109.508 175.001 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.62 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptp . . . . . 0 CA--C 1.563 1.47 0 CA-C-O 121.675 0.75 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.29 . . 63.88 7.8 3.48 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 119.865 3.283 . . . . 0.0 119.865 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' H ' HD22 ' A' ' 91' ' ' ASN . 14.9 t70 -83.25 117.44 68.61 Favored Pre-proline 0 CA--C 1.58 2.124 0 O-C-N 120.747 -1.221 . . . . 0.0 111.238 172.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.12 -26.4 18.12 Favored 'Trans proline' 0 CA--C 1.566 2.091 0 N-CA-C 118.501 2.462 . . . . 0.0 118.501 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.08 -47.78 83.15 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 168.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.69 -40.92 73.01 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 160.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.98 -35.69 70.03 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 168.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.49 -41.85 95.09 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 164.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -60.4 -44.47 95.67 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 165.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -58.7 -41.06 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -54.85 -19.48 6.61 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 169.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.77 -37.59 4.03 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 119.853 2.701 . . . . 0.0 119.853 157.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -65.75 -39.68 91.34 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 164.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.17 -33.9 38.01 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.08 -33.78 67.62 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 119.904 3.298 . . . . 0.0 119.904 -171.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.95 -33.37 66.96 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 171.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.6 m -99.18 -40.88 7.75 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 170.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -109.18 141.62 41.16 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.168 0.987 . . . . 0.0 113.035 -169.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -105.78 153.1 22.36 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.9 0.857 . . . . 0.0 112.77 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.8 mt -106.23 7.62 31.56 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 172.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -115.54 57.61 0.74 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.629 1.559 . . . . 0.0 112.282 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.77 1.93 10.41 Favored Glycine 0 CA--C 1.557 2.712 0 N-CA-C 121.487 3.355 . . . . 0.0 121.487 173.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -124.98 153.2 43.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 119.471 1.636 . . . . 0.0 112.362 -168.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -83.7 143.96 29.7 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.949 -1.095 . . . . 0.0 113.275 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.13 -119.01 2.62 Favored Glycine 0 N--CA 1.491 2.324 0 O-C-N 121.605 -0.685 . . . . 0.0 112.232 170.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.69 -48.08 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 122.178 -0.601 . . . . 0.0 110.938 165.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.36 172.18 30.14 Favored Glycine 0 CA--C 1.561 2.931 0 CA-C-N 118.971 0.805 . . . . 0.0 114.753 157.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -70.51 174.28 10.4 Favored 'Trans proline' 0 CA--C 1.563 1.942 0 CA-C-N 120.853 2.327 . . . . 0.0 115.506 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -66.54 122.59 17.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.499 -1.375 . . . . 0.0 113.36 176.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.22 -5.94 59.3 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -64.81 112.19 3.14 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 120.825 1.648 . . . . 0.0 110.766 159.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.56 36.1 24.05 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 116.981 1.552 . . . . 0.0 116.981 -174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -80.17 -34.54 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 118.925 1.362 . . . . 0.0 114.252 162.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.8 t -69.45 108.87 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 119.573 1.079 . . . . 0.0 109.966 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.59 -27.38 19.91 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 117.933 1.933 . . . . 0.0 117.933 -164.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -71.27 147.47 48.12 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.482 2.141 . . . . 0.0 113.968 -174.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 41.3 m -53.26 141.86 22.66 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -68.28 119.83 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.653 . . . . 0.0 109.767 170.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 64.37 55.92 1.35 Allowed 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -159.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.57 -20.1 14.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 119.238 2.455 . . . . 0.0 119.238 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.3 t -83.58 94.36 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.849 1.825 . . . . 0.0 109.236 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -69.33 113.1 6.35 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 123.315 0.646 . . . . 0.0 111.432 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 131.17 -49.79 0.91 Allowed Glycine 0 N--CA 1.491 2.323 0 CA-C-O 119.731 -0.483 . . . . 0.0 114.069 -155.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -77.48 129.26 35.48 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 118.059 0.93 . . . . 0.0 111.888 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -81.13 89.94 6.02 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.699 -0.625 . . . . 0.0 111.238 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -71.64 154.26 41.52 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.0 p -65.23 153.5 40.84 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.69 -1.256 . . . . 0.0 114.071 171.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.96 -47.45 99.06 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.47 -24.23 56.96 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 CA-C-N 125.115 2.863 . . . . 0.0 117.691 168.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 52.2 tpp -65.57 -48.42 72.44 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 120.65 1.568 . . . . 0.0 113.962 163.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -57.1 -46.29 82.69 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 167.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.67 -13.81 61.44 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -63.95 -54.41 34.95 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 120.805 1.639 . . . . 0.0 114.34 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 175.9 49.85 Favored Glycine 0 CA--C 1.546 2.005 0 N-CA-C 116.698 1.439 . . . . 0.0 116.698 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.78 -150.49 39.67 Favored Glycine 0 CA--C 1.547 2.064 0 O-C-N 121.914 -0.756 . . . . 0.0 114.943 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -133.02 154.11 50.84 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.815 0.817 . . . . 0.0 111.5 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -76.54 77.45 3.23 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.323 1.535 . . . . 0.0 112.552 171.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.0 p -71.75 160.6 82.16 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.208 169.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -58.01 -35.0 99.06 Favored 'Trans proline' 0 CA--C 1.57 2.283 0 N-CA-C 117.118 1.93 . . . . 0.0 117.118 174.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.73 -50.26 74.2 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 164.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.26 87.0 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.18 -43.6 97.78 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -50.91 -47.54 60.81 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 121.046 1.748 . . . . 0.0 115.68 165.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.53 -61.39 2.63 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -61.76 -40.11 94.0 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 mt -74.05 -16.87 61.03 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 171.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.4 m -63.9 -54.67 31.12 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 121.241 1.837 . . . . 0.0 112.927 161.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -150.44 112.59 3.23 Favored Pre-proline 0 CA--C 1.576 1.944 0 CA-C-N 119.781 1.173 . . . . 0.0 108.889 168.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.02 -45.95 0.26 Allowed 'Trans proline' 0 CA--C 1.56 1.786 0 CA-C-N 122.622 1.972 . . . . 0.0 116.904 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.18 -25.4 66.13 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.863 2.171 . . . . 0.0 116.863 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.59 78.63 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 161.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.5 t -71.48 -58.62 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-N 119.558 1.072 . . . . 0.0 112.723 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.5 103.62 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 171.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.11 94.15 3.43 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.582 0.706 . . . . 0.0 111.764 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.37 27.39 5.3 Favored Glycine 0 CA--C 1.554 2.489 0 N-CA-C 118.036 1.975 . . . . 0.0 118.036 -165.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.6 t -73.89 132.34 42.4 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.444 1.622 . . . . 0.0 111.187 160.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -73.85 10.41 1.16 Allowed 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 166.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -71.94 97.43 1.85 Allowed 'General case' 0 CA--C 1.564 1.501 0 O-C-N 120.933 -1.104 . . . . 0.0 111.261 166.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 75.48 4.25 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.72 1.248 . . . . 0.0 112.969 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -141.3 128.87 21.41 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.84 -52.7 33.76 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.13 157.06 7.87 Favored Glycine 0 N--CA 1.484 1.879 0 CA-C-O 122.275 0.93 . . . . 0.0 115.231 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.63 96.88 8.08 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.121 -0.942 . . . . 0.0 108.521 168.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.88 -33.63 15.76 Favored 'Trans proline' 0 CA--C 1.568 2.183 0 C-N-CA 122.636 2.224 . . . . 0.0 117.431 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.7 133.33 42.07 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.817 0.847 . . . . 0.0 112.993 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.0 tp -58.27 -42.75 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.12 -53.01 61.37 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -50.98 -41.73 59.72 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -66.91 -54.62 20.29 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.6 -45.6 91.43 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.416 HD22 ' H ' ' A' ' 3' ' ' ASP . 28.1 m120 -53.13 -52.83 57.46 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 168.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.469 HD21 HMB1 ' A' ' 101' ' ' HEC . 45.1 tp -60.61 -45.8 92.64 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 172.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.256 62.9 mt -61.55 -41.43 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 120.194 1.361 . . . . 0.0 113.034 172.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.68 -43.94 72.9 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 163.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -60.55 -46.61 89.54 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.58 -24.0 63.62 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 172.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -61.1 -45.48 94.52 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 157.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.9 88.23 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 117.846 1.898 . . . . 0.0 117.846 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -75.56 97.31 3.7 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 118.338 1.069 . . . . 0.0 111.575 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.065 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.615 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 tpp . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.42 73.0 0.82 Allowed 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 121.902 0.858 . . . . 0.0 112.684 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -106.48 119.48 51.63 Favored Pre-proline 0 CA--C 1.578 2.033 0 C-N-CA 123.98 0.912 . . . . 0.0 111.248 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.56 -28.46 26.19 Favored 'Trans proline' 0 CA--C 1.569 2.26 0 N-CA-C 118.522 2.47 . . . . 0.0 118.522 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.73 -42.29 97.92 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 168.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.34 77.87 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 159.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.73 96.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 118.955 2.342 . . . . 0.0 118.955 171.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.73 -38.67 91.38 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.82 97.0 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 164.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.09 -40.42 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 167.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -54.97 -19.81 7.62 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 166.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.72 -36.98 4.96 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 119.718 2.647 . . . . 0.0 119.718 159.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.67 -37.49 86.66 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 164.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -80.28 -34.56 36.84 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -57.52 -32.74 67.35 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -170.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.78 -35.89 71.41 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.2 m -93.69 -42.86 8.93 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 169.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -108.27 142.86 37.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.074 0.95 . . . . 0.0 113.092 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -110.63 150.21 29.31 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.548 1.166 . . . . 0.0 113.013 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -113.7 33.42 5.19 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.239 -0.913 . . . . 0.0 113.263 170.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -137.15 60.68 1.64 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.032 -1.667 . . . . 0.0 111.061 169.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.49 -47.73 1.78 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 119.522 2.569 . . . . 0.0 119.522 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -75.68 151.51 37.7 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.659 1.183 . . . . 0.0 113.109 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -101.9 131.33 48.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.749 . . . . 0.0 110.451 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.64 -114.33 3.7 Favored Glycine 0 N--CA 1.491 2.361 0 O-C-N 121.676 -0.64 . . . . 0.0 113.415 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.08 -47.79 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 122.413 -0.463 . . . . 0.0 110.77 165.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.9 168.72 24.95 Favored Glycine 0 CA--C 1.56 2.894 0 CA-C-N 118.985 0.812 . . . . 0.0 114.966 159.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -70.03 166.36 28.2 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 CA-C-N 120.699 2.249 . . . . 0.0 114.902 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -62.46 123.14 17.51 Favored 'General case' 0 CA--C 1.57 1.735 0 O-C-N 120.776 -1.203 . . . . 0.0 113.226 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.65 6.22 35.78 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -63.23 117.22 6.26 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 119.971 1.26 . . . . 0.0 110.929 159.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.96 44.35 37.16 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 116.244 1.257 . . . . 0.0 116.244 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 p -87.9 -30.59 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 170.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.79 107.0 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 119.945 1.248 . . . . 0.0 109.653 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.55 -10.28 71.01 Favored Glycine 0 CA--C 1.553 2.438 0 N-CA-C 118.925 2.33 . . . . 0.0 118.925 -163.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -77.0 144.0 38.99 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 121.078 2.439 . . . . 0.0 113.012 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.5 m -52.21 141.03 19.82 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -70.01 112.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.64 -0.663 . . . . 0.0 109.218 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.281 . . 70.0 66.63 0.23 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -154.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.32 -23.22 6.74 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 119.174 2.429 . . . . 0.0 119.174 -172.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.9 t -83.22 98.83 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 119.953 1.877 . . . . 0.0 109.369 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -69.59 104.59 2.41 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.417 0.627 . . . . 0.0 110.988 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.55 -55.12 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 CA-C-O 119.647 -0.53 . . . . 0.0 113.534 -155.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -78.92 129.07 34.1 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 118.037 0.919 . . . . 0.0 111.62 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -78.34 93.5 4.69 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.616 0.767 . . . . 0.0 112.724 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -76.17 161.11 29.09 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.9 t -65.44 152.15 44.62 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.46 -49.46 92.26 Favored Pre-proline 0 CA--C 1.576 1.98 0 CA-C-O 115.991 -1.957 . . . . 0.0 115.513 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.25 -21.75 67.06 Favored 'Trans proline' 0 CA--C 1.565 2.071 0 CA-C-N 124.769 2.739 . . . . 0.0 118.149 166.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.8 tpp -66.94 -51.39 55.77 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 120.436 1.471 . . . . 0.0 113.344 163.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -57.87 -45.48 86.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 169.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.49 0.55 16.8 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 173.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -63.81 -49.81 71.42 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.69 81.19 1.06 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.27 -160.33 32.5 Favored Glycine 0 N--CA 1.485 1.908 0 CA-C-O 122.361 0.978 . . . . 0.0 115.161 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -125.21 155.1 40.57 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.017 0.913 . . . . 0.0 111.301 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -76.62 74.32 3.32 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 123.122 1.439 . . . . 0.0 113.272 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.0 p -71.44 161.2 79.75 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.67 171.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -58.5 -26.73 79.55 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 N-CA-C 117.528 2.088 . . . . 0.0 117.528 171.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.88 -56.99 10.02 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 161.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.76 94.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.28 -50.43 73.63 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 169.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.68 -35.58 78.38 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.21 -50.96 58.9 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -59.73 -40.57 88.47 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 171.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 70.7 mt -74.77 -16.35 60.72 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 169.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -67.77 -56.77 7.97 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 120.991 1.723 . . . . 0.0 112.293 160.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -145.12 109.55 4.64 Favored Pre-proline 0 CA--C 1.574 1.904 0 CA-C-N 119.503 1.047 . . . . 0.0 108.918 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.63 -41.28 0.82 Allowed 'Trans proline' 0 CA--C 1.561 1.859 0 C-N-CA 122.162 1.908 . . . . 0.0 116.874 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -58.3 -38.73 77.64 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 170.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.26 -42.95 87.76 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 169.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.62 -51.66 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 119.096 0.862 . . . . 0.0 113.31 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.8 101.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -75.07 94.64 2.92 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.322 0.582 . . . . 0.0 111.585 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.66 25.3 6.03 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 118.264 2.066 . . . . 0.0 118.264 -165.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 t -71.68 136.37 47.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.56 1.68 . . . . 0.0 112.046 163.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -73.94 6.96 2.91 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -72.61 100.61 2.82 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 120.72 -1.237 . . . . 0.0 111.507 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.61 75.54 7.49 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.588 1.185 . . . . 0.0 112.815 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -137.98 132.34 32.15 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.207 1.003 . . . . 0.0 108.539 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.65 -55.83 7.84 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.79 153.01 6.24 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 122.222 0.901 . . . . 0.0 115.199 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.8 mt -97.71 104.31 20.65 Favored Pre-proline 0 CA--C 1.574 1.868 0 CA-C-O 117.772 -1.108 . . . . 0.0 109.135 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.44 -36.22 9.36 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.684 2.256 . . . . 0.0 117.769 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.66 134.0 37.17 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 119.227 0.921 . . . . 0.0 112.813 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -58.01 -41.63 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 170.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.98 -47.36 74.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 172.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -56.39 -42.88 78.63 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 -64.61 -53.94 39.77 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.89 -43.3 90.94 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.373 2.361 . . . . 0.0 117.373 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -56.1 -52.17 65.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 169.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.499 HD21 HMB1 ' A' ' 101' ' ' HEC . 50.4 tp -57.03 -46.13 82.6 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 169.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.7 mt -60.35 -41.63 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 120.096 1.316 . . . . 0.0 113.333 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.32 -43.69 75.14 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 165.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.39 -44.61 95.51 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 166.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.4 mt -67.21 -26.95 66.86 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 171.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -63.76 -41.36 98.0 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 159.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.61 -48.11 87.84 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 117.421 1.729 . . . . 0.0 117.421 163.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -78.4 84.91 4.53 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 118.015 0.907 . . . . 0.0 112.189 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 . . . . . 0 C--O 1.256 1.414 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.041 174.626 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.623 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtp . . . . . 0 CA--C 1.561 1.37 0 CA-C-O 121.385 0.612 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.287 . . 63.47 34.35 12.86 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 118.322 2.712 . . . . 0.0 118.322 -177.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.27 111.45 62.45 Favored Pre-proline 0 CA--C 1.577 1.988 0 O-C-N 121.025 -1.047 . . . . 0.0 110.388 176.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.01 -31.92 22.8 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 N-CA-C 117.947 2.249 . . . . 0.0 117.947 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.51 -35.24 78.76 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 168.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.3 -39.24 74.94 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 159.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.51 -33.86 59.39 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 120.222 2.849 . . . . 0.0 120.222 174.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.25 -36.4 79.88 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 168.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -62.8 -45.37 92.96 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 165.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 t -56.87 -42.6 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 168.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -56.12 -25.15 44.82 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.27 -35.28 9.36 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 119.79 2.676 . . . . 0.0 119.79 165.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -58.63 -38.17 77.48 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 162.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -77.34 -34.72 55.14 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -46.17 -40.41 11.15 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 119.144 3.016 . . . . 0.0 119.144 -177.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.17 -32.57 64.45 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.7 m -104.92 -38.06 6.76 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 172.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -116.39 142.99 46.13 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.457 1.103 . . . . 0.0 112.421 -167.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -115.84 147.98 40.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.802 0.81 . . . . 0.0 112.387 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.8 mt -102.21 15.11 30.11 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -128.88 65.29 1.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 119.221 -2.175 . . . . 0.0 111.353 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.3 -37.7 0.82 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 119.939 2.736 . . . . 0.0 119.939 170.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -73.9 149.58 41.4 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.532 1.133 . . . . 0.0 113.43 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.71 132.75 49.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.415 -0.803 . . . . 0.0 110.235 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.61 -111.92 3.65 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 121.891 -0.506 . . . . 0.0 113.02 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -78.33 -48.16 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 122.433 -0.451 . . . . 0.0 110.769 164.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.75 170.53 25.38 Favored Glycine 0 CA--C 1.559 2.843 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 161.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -71.53 175.1 9.95 Favored 'Trans proline' 0 CA--C 1.565 2.038 0 CA-C-N 120.617 2.208 . . . . 0.0 115.784 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -66.81 124.95 24.37 Favored 'General case' 0 CA--C 1.568 1.656 0 O-C-N 120.485 -1.384 . . . . 0.0 113.353 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.42 -0.78 57.33 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -66.26 108.21 2.23 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 120.095 1.316 . . . . 0.0 111.483 161.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.91 46.15 5.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -171.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.11 -36.14 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 172.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 t -74.58 109.02 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 120.544 1.52 . . . . 0.0 109.202 -172.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.16 -28.58 15.29 Favored Glycine 0 CA--C 1.551 2.295 0 N-CA-C 117.653 1.821 . . . . 0.0 117.653 -160.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -68.09 146.41 53.5 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 120.844 2.322 . . . . 0.0 113.816 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.4 m -53.14 140.59 25.45 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.09 120.78 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.757 -0.59 . . . . 0.0 109.946 171.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . 63.94 51.96 2.19 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -162.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.08 -27.8 9.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 118.693 2.237 . . . . 0.0 118.693 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.2 t -74.95 95.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.329 1.565 . . . . 0.0 109.678 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.96 106.92 8.94 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.468 0.707 . . . . 0.0 110.223 -176.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.2 -50.75 0.82 Allowed Glycine 0 N--CA 1.489 2.232 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.678 -152.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -76.97 130.6 37.71 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-N 118.224 1.012 . . . . 0.0 111.881 172.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -79.5 80.58 5.86 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -67.73 150.91 48.07 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.5 p -68.97 153.51 43.67 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -53.71 -48.39 93.47 Favored Pre-proline 0 CA--C 1.575 1.912 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.8 -23.56 47.97 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 CA-C-N 124.198 2.535 . . . . 0.0 117.708 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ttm -66.92 -47.11 72.74 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 121.282 1.856 . . . . 0.0 113.849 162.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -57.58 -45.49 85.16 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 168.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.08 -16.65 62.03 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -61.72 -54.53 41.31 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 120.808 1.64 . . . . 0.0 114.404 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 177.39 49.96 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 175.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.14 -149.5 39.29 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 114.931 0.733 . . . . 0.0 114.931 -175.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -132.39 154.01 50.22 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.04 0.924 . . . . 0.0 111.562 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -75.92 76.42 2.82 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 123.023 1.392 . . . . 0.0 112.913 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.1 p -73.13 159.32 85.41 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.166 171.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.11 -34.84 98.48 Favored 'Trans proline' 0 CA--C 1.571 2.369 0 N-CA-C 117.585 2.11 . . . . 0.0 117.585 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.6 -50.11 70.69 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 165.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.22 92.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 172.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.7 mt -57.34 -49.87 74.77 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.5 pp0? -64.26 -33.85 76.77 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.71 -55.25 28.51 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 163.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -59.54 -41.65 90.54 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 73.9 mt -73.52 -17.51 61.2 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 170.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.9 m -65.83 -63.32 1.11 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 120.919 1.691 . . . . 0.0 111.662 158.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -134.63 100.42 12.35 Favored Pre-proline 0 CA--C 1.571 1.774 0 CA-C-O 118.397 -0.811 . . . . 0.0 109.834 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.1 -46.58 0.23 Allowed 'Trans proline' 0 CA--C 1.563 1.929 0 CA-C-N 122.504 1.93 . . . . 0.0 115.708 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -61.49 -34.51 75.6 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 169.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.97 -43.26 65.44 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 170.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.24 -54.83 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 119.261 0.937 . . . . 0.0 112.795 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.11 100.59 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -74.94 98.6 3.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.684 -0.635 . . . . 0.0 111.362 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.59 25.24 7.39 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -165.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 t -69.33 135.11 49.93 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.409 1.604 . . . . 0.0 111.307 159.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -72.88 7.92 1.78 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 166.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -77.34 104.64 7.97 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 120.81 -1.181 . . . . 0.0 111.955 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.32 69.85 6.85 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 122.316 1.055 . . . . 0.0 113.492 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -125.81 135.69 52.28 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.222 1.009 . . . . 0.0 108.951 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.33 -57.68 4.01 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.95 150.49 5.49 Favored Glycine 0 N--CA 1.485 1.902 0 CA-C-N 119.069 0.85 . . . . 0.0 115.138 -175.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -101.99 97.13 7.71 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.135 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.26 -32.72 20.07 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 C-N-CA 122.652 2.235 . . . . 0.0 117.812 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -76.94 127.58 32.96 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 119.039 0.836 . . . . 0.0 112.505 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -58.8 -41.0 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 172.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -54.05 -46.47 71.94 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 170.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.89 -45.92 82.24 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -62.82 -52.53 62.81 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 171.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.15 -46.08 86.29 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -57.29 -50.4 73.05 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 170.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.5 -48.25 74.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.255 57.7 mt -63.92 -40.92 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-N 119.765 1.166 . . . . 0.0 113.231 174.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.25 74.12 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 163.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -59.32 -47.82 83.94 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 166.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.3 -27.87 69.33 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -66.26 -34.42 77.97 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 162.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.91 -47.07 68.16 Favored Glycine 0 CA--C 1.553 2.446 0 N-CA-C 116.989 1.555 . . . . 0.0 116.989 160.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 70.12 9.55 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 118.419 1.11 . . . . 0.0 111.534 172.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 . . . . . 0 C--O 1.254 1.32 0 O-C-N 121.339 -0.851 . . . . 0.0 111.181 -164.34 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.607 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 CA--C 1.56 1.346 0 CA-C-O 121.183 0.516 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.4 72.95 9.67 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -107.32 108.59 62.01 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.905 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.68 -29.4 19.54 Favored 'Trans proline' 0 CA--C 1.567 2.146 0 N-CA-C 118.333 2.397 . . . . 0.0 118.333 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.49 -48.52 80.72 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 168.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.58 72.97 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 162.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.81 -33.91 84.93 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 118.126 2.01 . . . . 0.0 118.126 168.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -38.75 86.69 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 115.888 1.811 . . . . 0.0 115.888 167.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.254 21.7 pttm -67.01 -43.52 82.64 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 120.872 1.669 . . . . 0.0 115.083 166.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.8 t -60.43 -34.58 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 114.384 1.254 . . . . 0.0 114.384 171.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -54.82 -20.23 8.18 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 168.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.99 -37.28 5.44 Favored Glycine 0 CA--C 1.559 2.808 0 N-CA-C 119.747 2.659 . . . . 0.0 119.747 157.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.65 -31.44 72.12 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 166.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 m -90.73 -33.95 15.56 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -32.27 62.53 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 120.416 3.487 . . . . 0.0 120.416 -171.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.78 -34.84 71.91 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 170.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.7 m -95.55 -43.23 8.05 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -110.14 126.39 54.01 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.244 1.018 . . . . 0.0 111.752 -168.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -94.81 147.24 23.56 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.807 0.813 . . . . 0.0 111.427 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.5 -28.76 28.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -81.29 61.74 4.92 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.33 1.877 . . . . 0.0 113.805 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.75 10.11 16.88 Favored Glycine 0 CA--C 1.556 2.605 0 N-CA-C 121.94 3.536 . . . . 0.0 121.94 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -128.35 156.77 42.57 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 119.278 1.539 . . . . 0.0 112.557 -170.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.42 148.23 30.64 Favored 'General case' 0 CA--C 1.572 1.826 0 O-C-N 120.885 -1.135 . . . . 0.0 112.559 166.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.21 -100.75 2.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 157.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.8 t -79.73 -51.88 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.617 160.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.32 156.0 19.91 Favored Glycine 0 CA--C 1.559 2.84 0 N-CA-C 115.068 0.787 . . . . 0.0 115.068 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.93 151.23 27.45 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 CA-C-N 120.985 2.393 . . . . 0.0 113.601 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -45.51 126.74 6.94 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 -167.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.74 -6.58 59.36 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -64.22 117.71 7.55 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 119.609 1.095 . . . . 0.0 110.651 158.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.05 44.61 11.51 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 116.243 1.257 . . . . 0.0 116.243 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.65 -31.04 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -80.84 100.31 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 120.588 1.54 . . . . 0.0 109.162 -172.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.47 -20.7 29.67 Favored Glycine 0 CA--C 1.553 2.46 0 N-CA-C 117.872 1.909 . . . . 0.0 117.872 -158.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -73.05 146.45 45.85 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 120.743 2.272 . . . . 0.0 113.337 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.8 m -54.27 141.01 31.21 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.3 116.44 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.681 -0.637 . . . . 0.0 109.484 170.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.286 . . 68.14 61.6 0.4 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -159.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.45 -26.03 6.38 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 119.221 2.449 . . . . 0.0 119.221 -170.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.77 94.59 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 CA-C-N 120.078 1.939 . . . . 0.0 109.625 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.43 126.73 30.56 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 123.269 0.628 . . . . 0.0 112.167 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.67 -54.7 0.63 Allowed Glycine 0 N--CA 1.491 2.341 0 CA-C-O 119.925 -0.375 . . . . 0.0 113.567 -157.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -79.23 116.58 19.58 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-N 117.771 0.786 . . . . 0.0 110.844 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -78.78 98.87 6.45 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.814 0.816 . . . . 0.0 110.817 172.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -65.21 162.71 16.65 Favored 'General case' 0 CA--C 1.574 1.874 0 C-N-CA 123.865 0.866 . . . . 0.0 112.969 172.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 p -68.59 158.66 33.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.243 -1.536 . . . . 0.0 114.216 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -54.25 -49.99 87.24 Favored Pre-proline 0 CA--C 1.578 2.027 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.68 -25.16 46.98 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 CA-C-N 124.241 2.55 . . . . 0.0 117.521 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -65.57 -48.8 71.13 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 120.419 1.463 . . . . 0.0 114.056 163.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -58.84 -43.79 90.78 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 168.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.32 -15.06 61.88 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 118.909 2.929 . . . . 0.0 118.909 172.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -62.7 -55.42 26.97 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 120.958 1.708 . . . . 0.0 114.364 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.35 178.15 50.82 Favored Glycine 0 CA--C 1.548 2.128 0 N-CA-C 116.879 1.511 . . . . 0.0 116.879 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.46 -148.7 35.94 Favored Glycine 0 N--CA 1.488 2.156 0 O-C-N 121.95 -0.736 . . . . 0.0 114.796 -174.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -133.86 153.11 51.97 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.863 0.839 . . . . 0.0 111.925 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -76.35 78.73 3.1 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.73 1.253 . . . . 0.0 112.782 171.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -73.99 157.45 87.02 Favored Pre-proline 0 CA--C 1.575 1.908 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.438 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -58.96 -29.17 89.8 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 N-CA-C 117.495 2.075 . . . . 0.0 117.495 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.75 -56.53 13.06 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 162.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.99 -38.93 84.03 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.2 mt -56.4 -40.23 74.31 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 167.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -56.81 -41.73 78.27 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 170.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.89 -55.73 20.52 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 120.239 1.381 . . . . 0.0 113.357 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -59.57 -41.63 90.64 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -71.74 -24.21 61.74 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.1 m -62.68 -52.29 63.88 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 121.265 1.848 . . . . 0.0 113.364 164.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -150.41 114.5 3.3 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-N 119.82 1.191 . . . . 0.0 108.94 169.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.53 -44.15 0.25 Allowed 'Trans proline' 0 CA--C 1.563 1.927 0 CA-C-N 122.693 1.998 . . . . 0.0 116.22 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.19 -43.01 73.98 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 117.033 2.234 . . . . 0.0 117.033 169.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.26 92.78 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 170.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.12 -57.51 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 118.876 0.762 . . . . 0.0 112.43 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.72 102.96 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 172.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -74.92 90.28 2.41 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 121.762 0.791 . . . . 0.0 111.627 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.03 28.76 3.75 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 118.01 1.964 . . . . 0.0 118.01 -166.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 t -76.11 134.95 39.86 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.677 1.738 . . . . 0.0 111.42 163.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -76.75 21.58 0.2 Allowed 'General case' 0 CA--C 1.582 2.176 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 170.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.409 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 1.8 ttt -87.92 102.53 14.8 Favored 'General case' 0 CA--C 1.56 1.358 0 O-C-N 120.776 -1.202 . . . . 0.0 110.813 173.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.1 69.79 2.7 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -135.98 131.83 35.56 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.434 1.093 . . . . 0.0 108.613 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.07 -55.37 8.39 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.03 155.74 7.52 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 115.769 1.068 . . . . 0.0 115.769 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.8 mt -100.85 98.16 7.97 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 118.167 -0.921 . . . . 0.0 109.076 168.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.02 -34.76 16.28 Favored 'Trans proline' 0 CA--C 1.568 2.182 0 C-N-CA 122.674 2.249 . . . . 0.0 117.272 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.06 129.87 40.08 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.66 0.784 . . . . 0.0 112.982 175.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.1 tt -57.54 -43.08 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 166.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.54 -48.69 68.85 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -54.82 -45.88 74.5 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.7 mtm-85 -66.49 -54.13 27.41 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.27 -44.14 88.27 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -59.4 -52.73 64.37 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 113.728 1.011 . . . . 0.0 113.728 169.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.509 HD21 HMB1 ' A' ' 101' ' ' HEC . 44.9 tp -58.18 -46.49 85.69 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -61.12 -42.38 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 117.552 -1.213 . . . . 0.0 112.945 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.76 -44.32 73.52 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 164.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -58.42 -50.67 72.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 167.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.09 -24.51 65.95 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 174.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.85 -44.82 96.05 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 158.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.69 -41.8 93.63 Favored Glycine 0 CA--C 1.553 2.427 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 168.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.99 83.27 6.74 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 118.725 1.262 . . . . 0.0 111.0 172.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 N--CA 1.487 1.409 0 O-C-N 121.414 -0.803 . . . . 0.0 109.753 175.872 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.606 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.5 67.64 0.66 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.767 0.794 . . . . 0.0 112.523 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -106.29 115.4 61.02 Favored Pre-proline 0 CA--C 1.575 1.938 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.914 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.45 -27.8 27.5 Favored 'Trans proline' 0 CA--C 1.569 2.26 0 N-CA-C 118.458 2.445 . . . . 0.0 118.458 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.7 98.73 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 167.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.48 -32.79 74.37 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 159.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.75 -38.43 95.18 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 118.848 2.299 . . . . 0.0 118.848 171.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.01 -38.96 90.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 169.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -61.87 -42.02 98.56 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 164.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.67 -39.13 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 168.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -55.61 -25.29 37.84 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 169.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.9 -29.08 26.2 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 119.809 2.684 . . . . 0.0 119.809 165.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -58.51 -38.4 77.63 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 159.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -82.05 -32.2 30.54 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -45.39 -46.33 13.17 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 119.664 3.209 . . . . 0.0 119.664 -173.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.83 -38.5 70.13 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.8 m -89.84 -43.91 10.31 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -112.36 132.94 54.73 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 119.453 1.024 . . . . 0.0 112.179 -169.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -117.61 132.52 56.5 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.9 0.857 . . . . 0.0 111.105 -173.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.2 mt -80.04 -9.14 59.67 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 117.33 2.345 . . . . 0.0 117.33 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -102.76 58.62 0.78 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.175 1.807 . . . . 0.0 112.011 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.2 24.23 50.47 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 121.124 3.21 . . . . 0.0 121.124 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -106.57 121.99 45.41 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.007 1.404 . . . . 0.0 110.697 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -93.22 103.59 15.84 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.381 0.672 . . . . 0.0 109.454 173.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.0 -107.41 3.21 Favored Glycine 0 N--CA 1.489 2.224 0 O-C-N 122.096 -0.377 . . . . 0.0 112.689 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.19 -49.44 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 118.923 -0.561 . . . . 0.0 111.087 166.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.95 166.77 14.78 Favored Glycine 0 CA--C 1.561 2.93 0 CA-C-N 119.035 0.834 . . . . 0.0 114.924 164.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.78 169.24 20.68 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 120.813 2.307 . . . . 0.0 115.174 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -65.76 124.34 22.17 Favored 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.456 -1.402 . . . . 0.0 113.434 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.2 mt -90.41 6.47 43.14 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -67.41 125.97 27.79 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 121.149 1.795 . . . . 0.0 110.96 159.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.24 53.51 13.67 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 115.619 1.007 . . . . 0.0 115.619 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -107.0 -29.87 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 t -79.36 100.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 120.811 1.642 . . . . 0.0 109.0 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.82 -15.62 48.3 Favored Glycine 0 CA--C 1.552 2.398 0 N-CA-C 118.304 2.082 . . . . 0.0 118.304 -159.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -72.12 141.06 49.16 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 121.339 2.569 . . . . 0.0 113.201 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.8 m -58.18 136.99 57.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.0 t -67.12 123.85 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 123.267 0.627 . . . . 0.0 110.72 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.255 . . 62.76 45.31 5.88 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -165.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.05 12.82 29.08 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 -170.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.5 t -92.74 115.18 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 120.072 1.936 . . . . 0.0 109.09 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.92 120.19 16.13 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 121.904 -0.497 . . . . 0.0 110.717 166.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.21 17.91 21.02 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 118.209 2.044 . . . . 0.0 118.209 -163.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -139.11 127.45 22.8 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 119.785 1.792 . . . . 0.0 109.118 165.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -80.61 93.39 6.1 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.376 -0.827 . . . . 0.0 112.765 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -76.73 152.14 35.79 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.9 p -70.08 156.7 38.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.766 -1.209 . . . . 0.0 114.061 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.26 -49.6 91.43 Favored Pre-proline 0 CA--C 1.576 1.98 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.01 -24.39 45.42 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 CA-C-N 124.095 2.498 . . . . 0.0 117.468 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.8 tpp -65.89 -46.44 78.34 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.784 1.629 . . . . 0.0 114.253 163.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -57.81 -45.64 85.84 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 166.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.38 -13.5 61.87 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 170.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -60.7 -48.67 80.75 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 120.87 1.668 . . . . 0.0 114.915 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.72 164.69 35.73 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 117.704 1.842 . . . . 0.0 117.704 163.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.8 -144.14 26.16 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 114.756 0.662 . . . . 0.0 114.756 -177.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -129.53 154.02 47.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.781 0.801 . . . . 0.0 111.528 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -75.82 76.65 2.75 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 123.05 1.405 . . . . 0.0 112.782 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.2 p -73.71 159.7 83.81 Favored Pre-proline 0 CA--C 1.574 1.892 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.114 173.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -56.01 -39.2 92.64 Favored 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 122.403 2.069 . . . . 0.0 117.159 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -65.01 -42.12 94.75 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 166.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.76 98.06 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 170.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -58.86 -49.11 78.97 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 166.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -55.21 -40.31 70.65 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 172.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.17 -57.54 11.13 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 167.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -60.36 -40.96 92.66 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.87 -27.83 66.16 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.8 m -67.99 -60.09 2.77 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 120.61 1.55 . . . . 0.0 113.37 161.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 82.5 m-20 -127.63 97.13 31.17 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-N 120.864 1.666 . . . . 0.0 110.562 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.63 -51.88 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.886 0 CA-C-N 122.514 1.934 . . . . 0.0 115.625 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.5 -21.19 62.78 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 173.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -74.47 -43.46 55.97 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.867 1.667 . . . . 0.0 115.06 163.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.33 -54.7 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.474 1.034 . . . . 0.0 112.695 172.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.85 101.63 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -72.61 98.47 2.34 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 121.701 -0.624 . . . . 0.0 111.383 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.54 24.1 8.01 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 118.457 2.143 . . . . 0.0 118.457 -166.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -76.09 135.34 39.87 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.627 1.713 . . . . 0.0 111.025 159.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -74.89 8.92 2.15 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 117.32 2.341 . . . . 0.0 117.32 167.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -73.42 95.94 2.29 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 120.565 -1.334 . . . . 0.0 111.294 170.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.72 69.65 6.07 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-O 122.497 1.142 . . . . 0.0 113.382 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.28 133.28 55.5 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 124.349 1.059 . . . . 0.0 108.95 175.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.14 -56.2 14.28 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 115.886 1.809 . . . . 0.0 115.886 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.18 142.76 3.65 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 115.664 1.026 . . . . 0.0 115.664 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.2 mt -95.22 106.73 27.72 Favored Pre-proline 0 CA--C 1.574 1.879 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.084 168.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.97 -40.16 1.45 Allowed 'Trans proline' 0 CA--C 1.569 2.236 0 CA-C-N 123.239 2.192 . . . . 0.0 116.982 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.9 132.9 40.59 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.8 tt -51.36 -47.94 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 168.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -48.95 -50.63 34.61 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 173.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.18 -41.16 97.23 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -65.84 -52.93 46.34 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 170.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.76 -44.71 86.31 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -58.53 -51.73 68.65 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 169.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.43 -48.08 72.08 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 168.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 62.1 mt -62.33 -40.72 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.273 172.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.14 -44.68 71.6 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 121.778 2.081 . . . . 0.0 116.567 163.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -60.14 -47.97 83.7 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 166.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.5 mt -65.07 -30.43 71.38 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -61.1 -43.24 99.18 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 161.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.01 -42.48 99.74 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 117.809 1.884 . . . . 0.0 117.809 165.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -80.33 72.05 7.17 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-N 118.526 1.163 . . . . 0.0 112.478 171.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.242 -0.885 . . . . 0.0 109.466 176.293 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.62 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.57 1.732 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.68 45.43 21.64 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 119.107 3.002 . . . . 0.0 119.107 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -127.88 84.29 63.73 Favored Pre-proline 0 CA--C 1.575 1.94 0 O-C-N 120.934 -1.104 . . . . 0.0 110.91 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -67.8 -35.54 21.13 Favored 'Trans proline' 0 CA--C 1.563 1.972 0 N-CA-C 119.18 2.723 . . . . 0.0 119.18 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.86 75.74 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.01 82.65 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 164.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.46 -38.12 94.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.281 2.072 . . . . 0.0 118.281 167.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -58.16 -44.57 88.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 164.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -58.24 -47.08 84.67 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 167.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.75 -40.73 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 169.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -52.87 -24.99 10.25 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.06 -34.51 5.92 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 119.79 2.676 . . . . 0.0 119.79 161.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -58.98 -38.73 79.8 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 163.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -83.2 -31.45 27.07 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -48.17 -34.92 10.75 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.59 -28.63 47.54 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 117.932 2.568 . . . . 0.0 117.932 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.1 m -112.9 -43.97 3.35 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -102.18 152.1 21.43 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.127 0.965 . . . . 0.0 113.503 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -128.2 138.59 52.53 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.793 0.806 . . . . 0.0 111.13 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.5 mt -100.68 41.4 1.18 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.373 -0.829 . . . . 0.0 113.186 168.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -143.53 55.92 1.35 Allowed 'General case' 0 CA--C 1.571 1.768 0 O-C-N 120.79 -1.194 . . . . 0.0 110.802 174.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.6 -43.62 1.63 Allowed Glycine 0 N--CA 1.497 2.739 0 N-CA-C 119.465 2.546 . . . . 0.0 119.465 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -74.81 136.86 41.6 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -112.25 125.88 54.63 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.78 0.832 . . . . 0.0 109.385 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.4 -101.01 0.6 Allowed Glycine 0 N--CA 1.491 2.336 0 O-C-N 121.748 -0.595 . . . . 0.0 113.966 -172.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' O ' HMD3 ' A' ' 101' ' ' HEC . 84.8 t -71.11 -52.98 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 117.396 0.598 . . . . 0.0 110.901 170.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.71 164.5 13.92 Favored Glycine 0 CA--C 1.561 2.909 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.811 161.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.17 170.4 15.95 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 CA-C-N 120.961 2.38 . . . . 0.0 115.116 174.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -71.39 127.19 31.75 Favored 'General case' 0 CA--C 1.568 1.662 0 O-C-N 120.526 -1.359 . . . . 0.0 111.933 173.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -90.33 4.95 49.29 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -61.71 118.97 7.82 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 119.954 1.252 . . . . 0.0 111.511 168.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.65 19.71 65.37 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -175.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.92 -29.05 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-N 121.005 2.403 . . . . 0.0 116.68 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.0 t -78.98 103.42 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 120.068 1.303 . . . . 0.0 109.181 -171.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.96 -19.68 45.93 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 118.25 2.06 . . . . 0.0 118.25 -159.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -75.24 147.02 40.65 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.776 2.288 . . . . 0.0 113.866 -174.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.3 m -55.15 138.63 44.16 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.21 122.03 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.78 -0.575 . . . . 0.0 110.224 172.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.07 49.64 4.42 Favored 'General case' 0 CA--C 1.573 1.849 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -164.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.75 -18.59 24.83 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 119.185 2.434 . . . . 0.0 119.185 -169.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 65.0 t -84.97 100.6 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 119.686 1.743 . . . . 0.0 109.622 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.35 105.08 2.44 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.534 0.683 . . . . 0.0 110.999 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.65 -56.53 0.53 Allowed Glycine 0 N--CA 1.487 2.098 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.213 -157.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -82.55 129.58 34.95 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 117.894 0.847 . . . . 0.0 111.111 169.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.54 99.96 10.48 Favored 'General case' 0 CA--C 1.567 1.597 0 O-C-N 121.539 -0.726 . . . . 0.0 110.918 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -77.83 158.56 29.43 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.9 p -71.37 156.09 39.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.616 -1.302 . . . . 0.0 113.782 173.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -53.85 -48.67 92.89 Favored Pre-proline 0 CA--C 1.576 1.962 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.11 -26.12 43.09 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 CA-C-N 124.322 2.579 . . . . 0.0 117.66 171.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.9 ttm -65.86 -46.79 77.15 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 121.253 1.842 . . . . 0.0 113.97 162.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -56.89 -45.65 82.41 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 167.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.19 -17.14 61.39 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 118.81 2.892 . . . . 0.0 118.81 172.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -61.44 -54.58 41.63 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.853 1.66 . . . . 0.0 114.617 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.09 -179.27 50.38 Favored Glycine 0 CA--C 1.546 2.03 0 N-CA-C 116.709 1.443 . . . . 0.0 116.709 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.34 -151.52 43.63 Favored Glycine 0 N--CA 1.487 2.099 0 O-C-N 121.879 -0.777 . . . . 0.0 114.88 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -132.84 153.41 51.33 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.052 0.929 . . . . 0.0 111.722 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -76.87 74.32 3.48 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 122.832 1.301 . . . . 0.0 113.166 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.7 p -69.7 158.93 85.81 Favored Pre-proline 0 CA--C 1.576 1.969 0 C-N-CA 124.293 1.037 . . . . 0.0 112.382 171.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.55 -33.24 96.2 Favored 'Trans proline' 0 CA--C 1.57 2.292 0 N-CA-C 117.559 2.1 . . . . 0.0 117.559 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.51 -49.5 68.76 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 164.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.11 90.55 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 171.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.3 mt -59.77 -45.83 91.05 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 165.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -56.19 -43.07 78.08 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 121.636 2.016 . . . . 0.0 116.329 168.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -60.81 -56.42 21.43 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 120.068 1.304 . . . . 0.0 114.261 169.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -62.26 -39.98 94.69 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 74.2 mt -71.14 -25.0 62.37 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 169.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.1 m -62.45 -51.86 65.81 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 121.247 1.84 . . . . 0.0 113.504 164.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -150.54 112.63 3.21 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 120.05 1.295 . . . . 0.0 109.147 167.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.22 -46.9 0.21 Allowed 'Trans proline' 0 CA--C 1.559 1.76 0 CA-C-N 122.714 2.005 . . . . 0.0 116.985 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.02 -28.15 67.16 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.91 -40.88 91.9 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 161.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.3 t -71.44 -58.54 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.394 0.997 . . . . 0.0 112.511 175.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.35 101.28 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -74.43 102.54 4.48 Favored 'General case' 0 CA--C 1.566 1.589 0 O-C-N 121.566 -0.709 . . . . 0.0 111.578 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.56 22.16 10.64 Favored Glycine 0 CA--C 1.554 2.507 0 N-CA-C 118.446 2.138 . . . . 0.0 118.446 -164.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -74.79 134.14 41.84 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 119.64 1.72 . . . . 0.0 111.321 161.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -74.21 9.86 1.48 Allowed 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -72.99 95.88 2.06 Favored 'General case' 0 CA--C 1.565 1.551 0 O-C-N 120.696 -1.253 . . . . 0.0 111.194 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.18 72.63 4.72 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-O 122.8 1.286 . . . . 0.0 113.383 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -136.32 128.86 30.48 Favored 'General case' 0 CA--C 1.562 1.407 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.94 -54.54 24.96 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.12 156.88 7.58 Favored Glycine 0 CA--C 1.544 1.852 0 N-CA-C 115.664 1.025 . . . . 0.0 115.664 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.1 mt -104.06 96.04 8.9 Favored Pre-proline 0 CA--C 1.574 1.868 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.176 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.08 -34.2 17.39 Favored 'Trans proline' 0 CA--C 1.568 2.193 0 C-N-CA 122.672 2.248 . . . . 0.0 117.198 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -73.04 129.56 38.35 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 123.76 0.824 . . . . 0.0 112.831 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 tt -57.73 -43.05 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -52.68 -45.27 66.73 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.38 -46.6 88.23 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 73.5 mtm-85 -64.4 -52.38 58.46 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.18 -47.25 86.75 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -60.12 -46.45 89.59 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 119.732 1.151 . . . . 0.0 113.971 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.476 HD21 HMB1 ' A' ' 101' ' ' HEC . 45.9 tp -60.04 -47.73 84.65 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 171.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.43 -43.36 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 CA-C-N 119.918 1.236 . . . . 0.0 112.884 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.1 73.55 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 165.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -57.5 -47.68 81.27 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 165.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.29 -31.6 72.82 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.57 -40.42 91.61 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 159.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.51 -49.56 75.63 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -87.22 77.85 8.94 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 118.814 1.307 . . . . 0.0 112.445 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 . . . . . 0 N--CA 1.487 1.402 0 C-N-CA 123.679 0.792 . . . . 0.0 110.05 172.135 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.651 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ttt . . . . . 0 CA--C 1.565 1.528 0 CA-C-O 121.206 0.527 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.3 85.05 2.07 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 121.786 0.803 . . . . 0.0 111.428 -172.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -97.85 118.54 63.83 Favored Pre-proline 0 CA--C 1.578 2.049 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.685 -175.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.25 -32.13 21.32 Favored 'Trans proline' 0 CA--C 1.567 2.13 0 N-CA-C 118.317 2.391 . . . . 0.0 118.317 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.65 -48.7 79.66 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 169.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.7 71.43 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 164.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.41 -33.04 65.09 Favored Glycine 0 CA--C 1.551 2.318 0 N-CA-C 119.145 2.418 . . . . 0.0 119.145 166.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -65.42 -40.85 93.85 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -61.7 -41.14 97.2 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 164.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.92 -37.45 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 169.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -54.95 -18.9 5.61 Favored 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 165.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.12 -38.28 6.17 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 119.81 2.684 . . . . 0.0 119.81 158.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.04 -31.47 72.71 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 164.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -87.58 -34.23 18.62 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -56.79 -34.37 67.58 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 119.981 3.326 . . . . 0.0 119.981 -169.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.22 -35.9 72.36 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.6 m -91.15 -42.87 10.21 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 168.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -110.32 135.14 51.51 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.207 0.912 . . . . 0.0 112.617 -169.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -100.25 146.15 27.24 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.684 0.754 . . . . 0.0 112.571 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.5 mt -95.19 6.09 49.99 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 166.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -76.15 -40.4 52.71 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.9 -38.43 1.9 Allowed Glycine 0 N--CA 1.496 2.65 0 CA-C-N 119.3 0.955 . . . . 0.0 115.335 -163.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -73.69 153.71 39.97 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-O 121.979 0.895 . . . . 0.0 112.623 168.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -91.21 145.56 24.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 111.668 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -106.36 -115.35 4.02 Favored Glycine 0 N--CA 1.492 2.392 0 O-C-N 121.571 -0.706 . . . . 0.0 112.843 175.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -78.52 -48.3 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 122.337 -0.508 . . . . 0.0 110.745 163.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.29 173.89 33.27 Favored Glycine 0 CA--C 1.56 2.896 0 N-CA-C 115.327 0.891 . . . . 0.0 115.327 160.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -69.62 173.18 11.22 Favored 'Trans proline' 0 CA--C 1.565 2.039 0 CA-C-N 120.578 2.189 . . . . 0.0 115.468 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -65.75 126.21 27.71 Favored 'General case' 0 CA--C 1.573 1.828 0 O-C-N 120.468 -1.395 . . . . 0.0 113.399 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.48 1.08 57.45 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -64.97 125.33 24.56 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 121.496 1.953 . . . . 0.0 111.112 158.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.05 47.13 32.51 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 116.787 1.475 . . . . 0.0 116.787 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -99.17 -28.45 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.5 t -81.05 105.14 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 120.631 1.559 . . . . 0.0 109.173 -171.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.35 -13.33 61.56 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.085 1.994 . . . . 0.0 118.085 -159.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -74.42 146.37 42.95 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.025 2.412 . . . . 0.0 112.745 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 64.9 m -54.62 141.56 31.34 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.64 114.71 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.639 -0.663 . . . . 0.0 109.386 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.276 . . 67.59 62.26 0.43 Allowed 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -158.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.83 -20.99 8.07 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 119.462 2.545 . . . . 0.0 119.462 -170.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.3 t -81.88 101.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 120.23 2.015 . . . . 0.0 109.877 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -70.27 102.04 2.04 Favored 'General case' 0 CA--C 1.566 1.58 0 C-N-CA 123.727 0.811 . . . . 0.0 110.784 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.91 -51.87 0.72 Allowed Glycine 0 N--CA 1.49 2.287 0 CA-C-O 119.783 -0.454 . . . . 0.0 113.782 -155.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -85.74 124.93 32.81 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 117.98 0.89 . . . . 0.0 110.479 168.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -80.62 118.18 21.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.422 -0.799 . . . . 0.0 110.07 167.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -89.81 172.51 8.85 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.829 0.823 . . . . 0.0 112.423 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.5 t -70.55 152.92 43.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.373 -1.455 . . . . 0.0 112.961 171.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.56 -45.55 99.85 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-O 115.274 -2.298 . . . . 0.0 116.525 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.63 -26.84 45.98 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 CA-C-N 124.807 2.753 . . . . 0.0 117.338 166.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.2 tpp -64.2 -47.85 78.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.604 1.547 . . . . 0.0 114.123 164.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -60.55 -43.47 97.18 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 168.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.41 -14.96 62.33 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 118.784 2.883 . . . . 0.0 118.784 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -65.18 -56.21 14.19 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.741 1.609 . . . . 0.0 114.247 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.08 -179.78 52.6 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 116.717 1.447 . . . . 0.0 116.717 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.99 -149.57 37.96 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 121.836 -0.802 . . . . 0.0 114.809 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -133.87 155.25 50.21 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.923 0.868 . . . . 0.0 112.061 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -76.8 78.17 3.41 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.938 1.352 . . . . 0.0 112.962 172.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.7 p -75.47 159.85 80.89 Favored Pre-proline 0 CA--C 1.577 1.983 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.514 173.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -59.09 -28.01 86.62 Favored 'Trans proline' 0 CA--C 1.572 2.388 0 N-CA-C 118.014 2.275 . . . . 0.0 118.014 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.13 -53.49 30.2 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 163.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.38 -43.25 88.39 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.62 -51.14 71.2 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -62.62 -33.07 74.27 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 175.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -63.89 -54.44 34.76 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 164.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -60.63 -42.59 97.2 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.55 -20.48 62.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 170.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -65.42 -63.17 1.16 Allowed 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.802 1.637 . . . . 0.0 111.756 158.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 96.0 m-20 -134.66 102.24 11.51 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.921 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.52 -50.77 0.12 Allowed 'Trans proline' 0 CA--C 1.561 1.865 0 CA-C-N 122.731 2.011 . . . . 0.0 115.947 -175.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -69.87 -20.68 63.39 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 171.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -71.03 -42.4 69.56 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 121.363 1.892 . . . . 0.0 114.92 163.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.18 -56.88 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.492 0.717 . . . . 0.0 112.538 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.0 t -105.63 97.28 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 172.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -73.01 104.95 4.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.385 -0.822 . . . . 0.0 111.909 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.33 17.26 22.67 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 118.554 2.182 . . . . 0.0 118.554 -166.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 t -69.1 136.27 52.0 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.121 1.96 . . . . 0.0 111.841 163.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -73.78 8.61 1.85 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 168.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.433 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.3 ttt -74.35 99.61 3.55 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 120.784 -1.198 . . . . 0.0 111.302 170.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.16 70.99 6.89 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 122.604 1.192 . . . . 0.0 113.327 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -130.37 134.16 46.95 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.31 1.044 . . . . 0.0 108.69 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.88 -56.47 6.99 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.56 154.18 6.84 Favored Glycine 0 CA--C 1.544 1.89 0 CA-C-O 121.983 0.768 . . . . 0.0 114.668 -177.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.1 mt -98.86 98.15 5.88 Favored Pre-proline 0 CA--C 1.573 1.832 0 CA-C-O 117.851 -1.071 . . . . 0.0 108.87 167.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 -33.63 19.8 Favored 'Trans proline' 0 CA--C 1.568 2.214 0 C-N-CA 122.706 2.271 . . . . 0.0 117.383 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -71.41 126.06 28.64 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.974 0.91 . . . . 0.0 113.335 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -56.37 -43.6 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 168.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -54.08 -45.22 71.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -58.39 -45.56 88.09 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 169.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -62.68 -54.34 40.86 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 171.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.38 -45.59 87.99 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -59.34 -49.81 76.38 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 171.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.499 HD21 HMB1 ' A' ' 101' ' ' HEC . 43.2 tp -58.57 -44.9 89.9 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.6 mt -66.71 -34.49 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-N 119.804 1.184 . . . . 0.0 113.688 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.49 79.85 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 121.792 2.087 . . . . 0.0 115.905 159.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -58.67 -51.47 69.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 170.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.1 mt -66.29 -24.22 66.52 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.14 -45.64 87.6 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 160.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.42 -40.68 91.41 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 117.882 1.913 . . . . 0.0 117.882 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -79.31 71.59 5.86 Favored 'General case' 0 CA--C 1.573 1.853 0 CA-C-N 118.372 1.086 . . . . 0.0 112.566 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 118.232 -0.89 . . . . 0.0 109.353 -177.887 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.617 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.343 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.094 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.53 57.28 5.06 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 118.482 2.771 . . . . 0.0 118.482 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -97.09 110.67 55.11 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.158 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.52 -25.78 29.37 Favored 'Trans proline' 0 CA--C 1.567 2.131 0 N-CA-C 118.424 2.432 . . . . 0.0 118.424 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.82 -49.22 71.48 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.37 77.59 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 162.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.9 -41.49 84.24 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 118.825 2.29 . . . . 0.0 118.825 166.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -56.09 -44.09 78.67 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 164.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.73 -47.03 87.29 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 168.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.0 t -58.6 -36.46 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -54.26 -19.43 5.28 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 168.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.93 -38.46 4.58 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 120.045 2.778 . . . . 0.0 120.045 158.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -66.07 -38.04 87.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 164.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -81.59 -33.44 31.57 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -55.8 -35.06 65.89 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 119.95 3.315 . . . . 0.0 119.95 -171.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.08 -35.27 71.15 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 117.041 2.238 . . . . 0.0 117.041 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.2 m -96.38 -43.05 7.83 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -103.69 127.77 51.11 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.281 1.032 . . . . 0.0 111.91 -172.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -102.95 135.76 44.02 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.646 0.736 . . . . 0.0 110.965 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.2 mt -79.14 -23.75 43.78 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.43 61.64 6.94 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 121.502 1.955 . . . . 0.0 112.79 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.91 -30.58 0.4 Allowed Glycine 0 CA--C 1.557 2.674 0 N-CA-C 120.908 3.123 . . . . 0.0 120.908 173.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -79.24 148.18 32.3 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 124.339 1.056 . . . . 0.0 113.534 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -113.84 106.08 14.04 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -171.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.32 -108.9 3.16 Favored Glycine 0 N--CA 1.491 2.338 0 O-C-N 121.824 -0.547 . . . . 0.0 113.625 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.0 t -70.32 -53.34 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 119.222 -0.418 . . . . 0.0 110.666 165.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.39 152.38 18.83 Favored Glycine 0 CA--C 1.56 2.879 0 CA-C-O 119.118 -0.824 . . . . 0.0 114.675 167.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.56 143.57 27.49 Favored 'Trans proline' 0 CA--C 1.561 1.862 0 CA-C-N 121.255 2.528 . . . . 0.0 113.319 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -44.32 122.94 3.22 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -169.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.16 -7.86 59.63 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -65.39 113.53 4.16 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 119.139 0.882 . . . . 0.0 110.767 160.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.03 44.07 8.4 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 116.352 1.301 . . . . 0.0 116.352 -173.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.35 -33.54 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 174.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.69 106.32 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 120.418 1.463 . . . . 0.0 109.401 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.67 -10.99 66.69 Favored Glycine 0 CA--C 1.553 2.466 0 N-CA-C 118.733 2.253 . . . . 0.0 118.733 -162.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -73.47 145.36 45.75 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 121.23 2.515 . . . . 0.0 112.924 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.0 m -54.39 140.3 34.18 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.71 117.6 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.605 -0.685 . . . . 0.0 109.524 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.264 . . 64.36 57.84 1.15 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -157.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.53 -27.11 5.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 -169.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.8 t -70.47 115.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 119.614 1.707 . . . . 0.0 109.948 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.81 73.9 6.54 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.87 1.319 . . . . 0.0 111.852 176.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.99 39.49 0.02 OUTLIER Glycine 0 CA--C 1.551 2.312 0 CA-C-N 114.421 -1.263 . . . . 0.0 115.23 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -154.12 144.05 21.86 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 118.137 0.969 . . . . 0.0 110.12 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -74.83 90.51 2.38 Favored 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.618 -0.676 . . . . 0.0 111.593 170.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -82.82 146.24 29.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.419 -0.801 . . . . 0.0 112.574 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.9 t -68.15 153.64 43.32 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -60.7 -46.85 97.12 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 115.906 -1.997 . . . . 0.0 115.24 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.92 -24.25 67.73 Favored 'Trans proline' 0 CA--C 1.564 1.988 0 CA-C-N 124.902 2.786 . . . . 0.0 117.975 166.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.4 tpp -65.08 -49.44 70.03 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 121.131 1.787 . . . . 0.0 113.818 162.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -59.93 -46.67 88.62 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 171.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -12.66 60.57 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 118.979 2.955 . . . . 0.0 118.979 169.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -68.53 -58.08 4.83 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 120.366 1.439 . . . . 0.0 113.643 175.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.2 -178.59 52.52 Favored Glycine 0 CA--C 1.547 2.08 0 N-CA-C 116.574 1.39 . . . . 0.0 116.574 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.48 -149.39 38.55 Favored Glycine 0 N--CA 1.488 2.143 0 O-C-N 121.818 -0.813 . . . . 0.0 114.905 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -133.67 155.56 49.48 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.972 0.892 . . . . 0.0 111.987 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -76.56 77.99 3.25 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-O 123.111 1.434 . . . . 0.0 112.817 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.9 p -77.19 161.24 73.72 Favored Pre-proline 0 CA--C 1.575 1.938 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.317 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -56.29 -35.82 96.23 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 N-CA-C 117.709 2.157 . . . . 0.0 117.709 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.43 -51.75 64.4 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 166.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.37 94.91 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 172.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.5 mt -57.77 -51.96 67.42 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 167.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.3 2.6 pp0? -62.52 -33.71 75.45 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 176.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -62.88 -55.26 27.66 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 164.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -59.38 -41.33 89.09 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.79 -18.6 62.09 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.7 m -66.18 -64.35 0.88 Allowed 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 120.554 1.525 . . . . 0.0 111.46 159.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 93.3 m-20 -134.72 101.92 11.57 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 118.191 -0.909 . . . . 0.0 109.66 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.66 -51.4 0.11 Allowed 'Trans proline' 0 CA--C 1.561 1.853 0 CA-C-N 122.89 2.068 . . . . 0.0 116.218 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.65 -20.95 64.48 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -73.12 -43.89 61.04 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.771 1.623 . . . . 0.0 114.995 162.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.1 t -68.4 -57.27 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-N 119.426 1.012 . . . . 0.0 112.723 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.76 99.63 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -74.24 94.49 2.49 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.645 0.736 . . . . 0.0 111.945 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.05 20.71 7.01 Favored Glycine 0 CA--C 1.551 2.286 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 -166.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.4 t -72.71 137.62 46.06 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 120.199 2.0 . . . . 0.0 111.549 160.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -73.46 5.52 3.69 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 117.608 2.447 . . . . 0.0 117.608 165.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.433 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.8 ttt -70.26 98.21 1.34 Allowed 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 120.334 1.425 . . . . 0.0 112.198 172.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.06 69.57 5.25 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 122.481 1.134 . . . . 0.0 113.847 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.36 135.9 50.2 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.32 1.048 . . . . 0.0 109.044 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.26 -58.26 3.96 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 176.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.13 154.21 6.9 Favored Glycine 0 CA--C 1.545 1.911 0 CA-C-O 122.207 0.893 . . . . 0.0 115.109 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.5 mt -98.63 101.83 12.96 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-O 117.747 -1.121 . . . . 0.0 108.893 168.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.36 -37.38 10.2 Favored 'Trans proline' 0 CA--C 1.565 2.039 0 C-N-CA 122.574 2.183 . . . . 0.0 117.59 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -78.22 135.34 37.58 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 119.414 1.006 . . . . 0.0 112.454 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -58.37 -39.84 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 168.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.09 -44.78 79.34 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -56.46 -45.6 80.79 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -64.42 -54.24 35.83 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.45 90.19 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 117.379 2.362 . . . . 0.0 117.379 173.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -60.29 -47.96 83.79 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.514 HD21 HMB1 ' A' ' 101' ' ' HEC . 43.4 tp -58.65 -46.53 86.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 168.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.4 mt -59.29 -41.45 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.914 1.233 . . . . 0.0 113.16 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.16 -44.58 75.32 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 164.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -58.94 -47.29 85.59 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 166.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.05 -22.57 63.06 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.43 -42.87 98.7 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 156.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.22 96.56 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 117.672 1.829 . . . . 0.0 117.672 165.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -77.98 85.1 4.23 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 118.136 0.968 . . . . 0.0 111.581 170.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.419 -0.8 . . . . 0.0 109.22 173.733 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.68 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.571 1.779 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.92 77.4 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.283 -0.886 . . . . 0.0 111.785 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -100.41 115.85 64.99 Favored Pre-proline 0 CA--C 1.576 1.967 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.329 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.11 -34.06 23.45 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 C-N-CA 122.573 2.182 . . . . 0.0 117.666 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.41 -44.55 96.95 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.42 77.86 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 165.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.49 -27.23 58.14 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 119.866 2.707 . . . . 0.0 119.866 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -59.66 -39.56 84.84 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 166.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -65.26 -44.06 89.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 168.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.6 t -56.14 -44.71 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 166.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.75 -23.53 18.29 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 170.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.05 -37.79 16.91 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 119.556 2.582 . . . . 0.0 119.556 162.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -60.72 -33.64 73.19 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 164.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -82.94 -30.0 28.69 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 171.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -56.26 -19.63 14.95 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.36 -26.52 19.56 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 159.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.0 m -125.13 -43.61 1.94 Allowed 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -96.47 140.39 31.19 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -126.06 123.11 37.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.758 -0.589 . . . . 0.0 110.301 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.66 -25.56 63.96 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -81.82 55.57 2.78 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.366 1.894 . . . . 0.0 113.72 -172.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.84 12.95 7.45 Favored Glycine 0 CA--C 1.561 2.941 0 N-CA-C 120.192 2.837 . . . . 0.0 120.192 -170.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -100.86 137.67 38.93 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 118.936 1.368 . . . . 0.0 112.281 -168.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -127.58 110.37 12.64 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.14 -97.78 0.75 Allowed Glycine 0 N--CA 1.493 2.452 0 O-C-N 121.875 -0.516 . . . . 0.0 113.943 -171.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.429 ' O ' HMD3 ' A' ' 101' ' ' HEC . 90.6 t -73.71 -49.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.913 166.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.64 160.67 13.35 Favored Glycine 0 CA--C 1.56 2.895 0 CA-C-N 119.195 0.907 . . . . 0.0 114.004 163.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -69.93 174.62 9.39 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 CA-C-N 120.92 2.36 . . . . 0.0 115.369 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -74.48 118.19 17.16 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 120.439 -1.413 . . . . 0.0 112.615 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.0 mt -83.36 -4.92 58.93 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -59.18 117.88 5.25 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 120.033 1.288 . . . . 0.0 111.06 155.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.1 39.99 30.89 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 116.9 1.52 . . . . 0.0 116.9 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.01 -36.93 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.19 1.495 . . . . 0.0 114.512 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.5 t -68.18 108.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 119.966 1.257 . . . . 0.0 110.004 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.35 -19.16 55.56 Favored Glycine 0 CA--C 1.554 2.471 0 N-CA-C 118.535 2.174 . . . . 0.0 118.535 -162.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -73.51 144.14 46.27 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 120.802 2.301 . . . . 0.0 113.086 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 72.8 m -59.07 144.07 46.58 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.66 117.51 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.616 -0.677 . . . . 0.0 110.351 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.267 . . 65.76 56.77 0.88 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -160.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.69 31.2 5.08 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 -169.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -113.73 110.73 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 162.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -72.17 97.31 1.93 Allowed 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 123.593 0.757 . . . . 0.0 112.019 174.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.2 -52.09 0.58 Allowed Glycine 0 N--CA 1.489 2.167 0 CA-C-O 119.304 -0.72 . . . . 0.0 114.507 -159.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -81.57 134.58 35.52 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-N 118.449 1.125 . . . . 0.0 111.955 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -82.87 105.06 13.57 Favored 'General case' 0 CA--C 1.566 1.574 0 O-C-N 121.587 -0.696 . . . . 0.0 111.267 172.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.62 168.89 14.91 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.6 0.714 . . . . 0.0 112.628 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.1 t -70.92 153.01 43.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.305 -1.497 . . . . 0.0 113.319 171.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.15 -49.58 92.26 Favored Pre-proline 0 CA--C 1.577 2.001 0 CA-C-O 116.035 -1.936 . . . . 0.0 115.368 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.95 -21.29 64.02 Favored 'Trans proline' 0 CA--C 1.567 2.169 0 CA-C-N 124.744 2.73 . . . . 0.0 118.001 166.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.5 tpp -67.85 -50.44 56.57 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 120.394 1.452 . . . . 0.0 113.897 162.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -56.68 -44.37 81.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 169.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.86 -8.59 55.28 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 118.967 2.951 . . . . 0.0 118.967 171.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -66.44 -55.03 17.63 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 120.775 1.625 . . . . 0.0 114.637 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.47 174.85 50.33 Favored Glycine 0 CA--C 1.548 2.103 0 N-CA-C 116.451 1.341 . . . . 0.0 116.451 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.4 -158.52 47.55 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 115.321 0.888 . . . . 0.0 115.321 -174.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -128.7 156.61 43.21 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.913 0.863 . . . . 0.0 112.247 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -76.31 76.08 3.09 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 123.338 1.542 . . . . 0.0 112.898 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.5 p -76.42 160.43 77.54 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.943 172.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -57.25 -35.0 98.83 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.387 2.058 . . . . 0.0 117.416 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.64 -51.53 69.02 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 164.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.54 -44.78 93.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 171.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -59.47 -48.73 80.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 170.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -62.53 -36.89 84.03 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -62.29 -55.65 26.14 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 165.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -60.6 -40.38 91.61 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.8 mt -74.74 -12.62 60.45 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 169.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 m -67.04 -55.32 14.85 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 121.247 1.839 . . . . 0.0 112.337 161.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -149.19 114.24 3.61 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 117.919 -1.039 . . . . 0.0 108.503 167.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.04 -45.85 0.43 Allowed 'Trans proline' 0 CA--C 1.562 1.881 0 CA-C-N 122.655 1.984 . . . . 0.0 116.599 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.22 -28.57 67.35 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.63 93.44 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 162.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.7 t -70.56 -57.35 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.501 1.046 . . . . 0.0 112.532 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -105.9 103.27 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-N 120.083 1.31 . . . . 0.0 107.564 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -72.84 106.54 4.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.744 . . . . 0.0 111.058 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.98 17.68 17.71 Favored Glycine 0 CA--C 1.554 2.497 0 N-CA-C 118.919 2.327 . . . . 0.0 118.919 -169.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.412 ' HG1' ' CGD' ' A' ' 101' ' ' HEC . 11.1 t -75.57 135.88 40.55 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 119.806 1.803 . . . . 0.0 112.764 169.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.279 64.5 pttt -82.24 12.77 4.01 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 168.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.472 ' HG2' ' C4D' ' A' ' 101' ' ' HEC . 1.2 mmm -59.77 83.32 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.777 0 C-N-CA 125.195 1.398 . . . . 0.0 112.548 153.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.94 78.95 7.7 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-O 122.931 1.348 . . . . 0.0 112.47 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -150.77 133.92 16.11 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.509 -171.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.53 -56.05 9.63 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 156.46 158.68 8.99 Favored Glycine 0 N--CA 1.484 1.863 0 CA-C-O 122.292 0.94 . . . . 0.0 114.934 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.2 mt -99.04 101.66 13.11 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.767 -1.111 . . . . 0.0 108.315 168.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.87 -35.67 9.02 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 C-N-CA 122.697 2.265 . . . . 0.0 117.805 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -78.74 135.41 37.12 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 119.257 0.935 . . . . 0.0 112.503 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.15 -40.61 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 169.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.19 -45.12 75.82 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 170.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -57.18 -47.2 81.81 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 120.791 1.632 . . . . 0.0 115.173 169.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -61.77 -54.14 46.39 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.9 -43.37 86.1 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 171.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -58.5 -50.38 73.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 170.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.454 HD21 HMB1 ' A' ' 101' ' ' HEC . 33.1 tp -59.92 -45.38 92.77 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 169.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.2 -46.21 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 120.039 1.291 . . . . 0.0 113.0 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.84 -44.96 74.41 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 166.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -56.61 -48.54 77.23 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 167.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.7 mt -71.02 -25.14 62.54 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -60.77 -42.88 98.36 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 159.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 -44.35 95.35 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 117.533 1.773 . . . . 0.0 117.533 164.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -81.6 85.3 6.56 Favored 'General case' 0 CA--C 1.572 1.81 0 CA-C-N 118.372 1.086 . . . . 0.0 111.855 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 123.828 0.851 . . . . 0.0 109.689 -174.649 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.656 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 mtt . . . . . 0 CA--C 1.561 1.373 0 CA-C-O 121.15 0.5 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.273 . . 61.51 29.2 18.26 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 119.507 3.151 . . . . 0.0 119.507 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -97.5 113.15 62.98 Favored Pre-proline 0 CA--C 1.578 2.02 0 O-C-N 120.775 -1.203 . . . . 0.0 110.54 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.48 -29.08 25.79 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 N-CA-C 118.243 2.363 . . . . 0.0 118.243 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.93 86.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 167.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.62 79.79 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 162.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.69 -35.94 69.63 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 118.784 2.274 . . . . 0.0 118.784 165.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.74 -46.53 87.2 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.86 -41.71 98.18 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 167.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.3 t -60.63 -37.25 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 169.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -55.66 -19.57 11.09 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 117.014 2.228 . . . . 0.0 117.014 167.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.1 -37.02 7.48 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 119.699 2.639 . . . . 0.0 119.699 160.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -64.55 -38.1 89.85 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 164.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -80.64 -34.84 34.66 Favored 'General case' 0 CA--C 1.574 1.899 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -55.66 -35.74 66.31 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 120.299 3.444 . . . . 0.0 120.299 -168.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.34 80.66 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.8 m -89.85 -40.32 12.51 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 169.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -115.31 121.67 43.57 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.472 1.109 . . . . 0.0 110.643 -169.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -105.02 131.12 52.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 111.07 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.2 mt -70.82 -26.11 63.16 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -83.35 54.47 2.82 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.194 1.816 . . . . 0.0 113.396 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.32 9.84 18.81 Favored Glycine 0 CA--C 1.559 2.838 0 N-CA-C 120.593 2.997 . . . . 0.0 120.593 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -101.85 134.09 45.58 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.442 1.621 . . . . 0.0 111.869 -170.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -102.54 104.57 14.99 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.48 -106.45 2.93 Favored Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.966 -0.459 . . . . 0.0 113.386 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.02 -44.33 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.256 166.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.69 166.17 12.51 Favored Glycine 0 CA--C 1.564 3.115 0 CA-C-N 119.505 1.048 . . . . 0.0 115.051 161.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.29 151.79 43.76 Favored 'Trans proline' 0 CA--C 1.562 1.908 0 C-N-CA 122.835 2.357 . . . . 0.0 114.745 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -48.19 121.16 4.07 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.412 HD13 HMB3 ' A' ' 101' ' ' HEC . 85.2 mt -82.0 -9.32 59.6 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -63.03 111.86 2.36 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 118.921 0.782 . . . . 0.0 110.986 161.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.69 45.42 8.55 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 -170.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 p -100.37 -31.26 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 170.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.5 t -73.09 106.45 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 120.477 1.49 . . . . 0.0 109.563 -175.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.69 -12.33 66.1 Favored Glycine 0 CA--C 1.553 2.425 0 N-CA-C 118.692 2.237 . . . . 0.0 118.692 -162.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -72.52 140.12 47.98 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 121.018 2.409 . . . . 0.0 113.125 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.3 m -59.89 136.97 58.17 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.7 125.92 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 123.391 0.676 . . . . 0.0 110.797 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.254 . . 60.98 42.42 12.78 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -164.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.87 -3.12 39.7 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 119.751 2.66 . . . . 0.0 119.751 -170.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.6 t -83.53 103.3 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 120.386 2.093 . . . . 0.0 109.541 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.6 104.27 3.27 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.331 0.586 . . . . 0.0 110.482 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.32 -56.43 0.55 Allowed Glycine 0 N--CA 1.489 2.205 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.269 -157.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -87.67 128.24 35.29 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 117.721 0.761 . . . . 0.0 111.278 171.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -81.81 105.12 12.69 Favored 'General case' 0 CA--C 1.566 1.58 0 O-C-N 121.637 -0.664 . . . . 0.0 110.599 171.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -78.7 159.13 28.13 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.7 p -76.71 147.13 37.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.032 -1.043 . . . . 0.0 113.067 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -53.79 -44.45 98.05 Favored Pre-proline 0 CA--C 1.576 1.979 0 N-CA-C 117.882 2.549 . . . . 0.0 117.882 -175.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.95 -19.58 58.04 Favored 'Trans proline' 0 CA--C 1.569 2.238 0 CA-C-N 125.069 2.846 . . . . 0.0 117.977 170.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.7 tpp -69.24 -45.28 70.16 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.128 1.331 . . . . 0.0 114.187 162.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -55.6 -44.24 76.8 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 164.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.13 -17.27 64.31 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 118.672 2.841 . . . . 0.0 118.672 169.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -64.4 -52.57 57.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.528 1.513 . . . . 0.0 114.44 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.85 167.33 34.9 Favored Glycine 0 CA--C 1.548 2.139 0 N-CA-C 117.842 1.897 . . . . 0.0 117.842 167.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.07 -145.52 23.39 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -130.52 153.35 48.92 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.801 0.81 . . . . 0.0 111.536 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.42 76.04 3.17 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 123.217 1.484 . . . . 0.0 113.11 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.3 p -75.3 160.52 79.76 Favored Pre-proline 0 CA--C 1.577 1.981 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.547 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -58.74 -27.6 84.07 Favored 'Trans proline' 0 CA--C 1.572 2.381 0 N-CA-C 118.171 2.335 . . . . 0.0 118.171 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.58 -53.27 23.88 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 163.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.67 -44.1 90.1 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 174.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.2 mt -56.84 -52.42 65.16 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 168.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.253 8.2 pt20 -64.26 -33.85 76.77 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 176.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -60.39 -55.76 29.64 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 119.636 1.107 . . . . 0.0 113.938 163.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -58.3 -41.02 83.55 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.98 -16.75 61.51 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 170.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.5 m -65.2 -54.83 23.57 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 121.1 1.773 . . . . 0.0 112.693 164.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -149.73 112.53 3.4 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.334 167.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.05 -45.19 0.48 Allowed 'Trans proline' 0 CA--C 1.559 1.749 0 CA-C-N 122.565 1.952 . . . . 0.0 116.889 -174.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.03 -29.16 68.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 173.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.17 88.0 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 163.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.1 t -68.94 -56.36 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 119.48 1.036 . . . . 0.0 112.584 173.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.56 101.04 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -69.62 102.67 1.91 Allowed 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 121.307 0.575 . . . . 0.0 111.642 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.15 10.25 32.36 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 119.352 2.501 . . . . 0.0 119.352 -170.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 t -66.47 134.73 53.06 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 121.48 2.64 . . . . 0.0 112.742 171.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -73.11 9.78 1.13 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.444 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -77.08 103.73 7.17 Favored 'General case' 0 CA--C 1.563 1.461 0 O-C-N 120.585 -1.322 . . . . 0.0 111.691 173.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.28 71.48 4.75 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 122.535 1.159 . . . . 0.0 113.624 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -137.44 129.51 29.14 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.303 1.041 . . . . 0.0 108.405 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.01 -54.46 15.08 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 153.08 157.96 8.3 Favored Glycine 0 CA--C 1.544 1.897 0 CA-C-O 122.525 1.07 . . . . 0.0 115.555 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.22 101.13 15.37 Favored Pre-proline 0 CA--C 1.575 1.912 0 CA-C-O 117.924 -1.036 . . . . 0.0 108.665 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.41 -37.17 7.95 Favored 'Trans proline' 0 CA--C 1.566 2.085 0 C-N-CA 122.689 2.259 . . . . 0.0 117.752 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -76.89 134.2 39.05 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 119.193 0.906 . . . . 0.0 112.888 174.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.8 tt -57.06 -41.25 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 168.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.86 -49.32 49.7 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.81 -45.11 90.69 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 171.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -62.77 -53.73 49.9 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 171.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.71 -46.32 84.54 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 172.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -56.95 -50.98 70.97 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 169.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.512 HD21 HMB1 ' A' ' 101' ' ' HEC . 44.3 tp -56.65 -45.63 81.53 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 169.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.0 -42.18 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.237 171.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.93 -43.28 77.25 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 165.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -58.32 -48.01 81.89 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 166.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.8 mt -69.6 -23.64 63.56 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.866 2.172 . . . . 0.0 116.866 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -61.63 -43.14 99.41 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 156.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.23 -47.2 90.1 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 117.576 1.79 . . . . 0.0 117.576 166.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -76.48 88.82 3.24 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 118.317 1.058 . . . . 0.0 112.119 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.48 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.627 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tmm? . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.68 96.35 3.0 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -98.86 117.29 64.6 Favored Pre-proline 0 CA--C 1.578 2.032 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.005 -171.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.49 -28.45 26.54 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 N-CA-C 118.428 2.434 . . . . 0.0 118.428 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.36 -47.08 80.65 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 169.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.92 -38.77 79.73 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 161.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.47 -38.46 80.22 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 119.009 2.364 . . . . 0.0 119.009 166.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -55.63 -45.9 77.51 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 163.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.49 -47.75 84.31 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 t -57.83 -39.87 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 168.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -55.07 -20.82 10.58 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 169.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.52 -36.8 24.99 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 119.525 2.57 . . . . 0.0 119.525 160.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -57.87 -41.74 83.09 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 163.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -76.59 -34.18 58.41 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -52.6 -25.95 12.11 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 119.061 2.986 . . . . 0.0 119.061 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.18 -25.89 15.35 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 162.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.5 m -128.55 -34.32 2.02 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -108.0 142.12 38.62 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.547 1.139 . . . . 0.0 112.922 -169.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -103.1 157.16 17.19 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.244 1.021 . . . . 0.0 111.814 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.68 -27.52 13.63 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -84.74 60.3 6.06 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-N 121.542 1.974 . . . . 0.0 113.982 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.6 -40.01 0.39 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 120.166 2.827 . . . . 0.0 120.166 174.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -80.32 154.99 27.44 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 124.879 1.271 . . . . 0.0 112.96 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -96.77 152.21 18.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 111.952 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -122.68 -118.93 2.5 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 121.397 -0.815 . . . . 0.0 112.742 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.7 t -73.82 -48.23 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 122.337 -0.507 . . . . 0.0 111.104 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.11 171.06 26.62 Favored Glycine 0 CA--C 1.562 3.027 0 CA-C-N 118.836 0.744 . . . . 0.0 114.775 156.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.44 175.24 9.7 Favored 'Trans proline' 0 CA--C 1.567 2.137 0 CA-C-N 121.124 2.462 . . . . 0.0 114.799 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 38.2 p-80 -65.08 122.52 17.25 Favored 'General case' 0 CA--C 1.568 1.668 0 O-C-N 120.402 -1.436 . . . . 0.0 113.094 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.32 -3.68 59.04 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 116.631 2.085 . . . . 0.0 116.631 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -63.95 121.11 13.3 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 119.401 1.001 . . . . 0.0 110.792 155.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.77 42.81 16.07 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 116.413 1.325 . . . . 0.0 116.413 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -100.45 -33.69 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.9 t -74.99 105.02 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 120.652 1.569 . . . . 0.0 109.4 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.22 -26.45 22.89 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 117.761 1.864 . . . . 0.0 117.761 -160.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -66.07 142.92 57.63 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 120.978 2.389 . . . . 0.0 113.736 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.0 m -53.68 139.71 31.48 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.39 120.34 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.647 -0.658 . . . . 0.0 109.738 173.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 63.54 49.01 3.21 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -162.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.93 -27.01 13.13 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 118.875 2.31 . . . . 0.0 118.875 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.5 t -73.53 98.43 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.266 1.533 . . . . 0.0 109.966 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.25 105.65 8.48 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.369 0.667 . . . . 0.0 110.168 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.9 -52.43 0.71 Allowed Glycine 0 N--CA 1.489 2.216 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.66 -154.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -79.65 130.23 35.17 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 118.036 0.918 . . . . 0.0 111.647 171.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -81.27 90.5 6.12 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 121.581 -0.699 . . . . 0.0 111.642 177.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.91 157.38 37.95 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 t -66.87 155.02 39.5 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 174.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -59.58 -49.12 93.7 Favored Pre-proline 0 CA--C 1.577 2.003 0 CA-C-O 116.094 -1.908 . . . . 0.0 115.488 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.36 -25.14 64.01 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 CA-C-N 124.71 2.718 . . . . 0.0 117.732 166.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.5 tpp -65.22 -48.38 73.57 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.533 1.515 . . . . 0.0 114.17 164.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -58.78 -45.81 88.97 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 167.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.79 -14.7 62.52 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 118.976 2.954 . . . . 0.0 118.976 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -62.52 -53.15 59.04 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.715 1.598 . . . . 0.0 114.708 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.98 175.72 48.67 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 116.728 1.451 . . . . 0.0 116.728 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.46 -151.76 40.34 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 115.121 0.808 . . . . 0.0 115.121 -176.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -132.34 154.76 49.42 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.001 0.905 . . . . 0.0 111.568 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -76.04 76.16 2.91 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 123.01 1.386 . . . . 0.0 112.877 172.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -72.58 160.17 83.5 Favored Pre-proline 0 CA--C 1.576 1.964 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.386 171.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.27 -32.39 95.82 Favored 'Trans proline' 0 CA--C 1.571 2.366 0 N-CA-C 117.504 2.079 . . . . 0.0 117.504 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -64.06 -52.71 58.05 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 163.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.77 80.55 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 172.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.9 mt -60.9 -45.22 95.5 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 166.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -55.81 -43.56 77.01 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 121.583 1.992 . . . . 0.0 116.207 167.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -61.72 -56.02 24.03 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 120.029 1.286 . . . . 0.0 114.333 169.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.54 -39.87 95.0 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.0 mt -72.2 -22.67 61.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 169.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.5 m -62.48 -52.53 63.13 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.347 1.885 . . . . 0.0 113.365 163.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -151.35 113.11 3.03 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-N 119.902 1.228 . . . . 0.0 109.088 167.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.94 -47.8 0.16 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 CA-C-N 122.752 2.019 . . . . 0.0 116.91 -174.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -67.27 -26.3 66.49 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.693 2.109 . . . . 0.0 116.693 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.77 -42.47 86.06 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 161.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.53 -58.56 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.432 1.014 . . . . 0.0 112.617 175.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.51 99.89 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -74.91 98.85 3.66 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-O 121.477 0.656 . . . . 0.0 111.725 -177.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.08 18.33 10.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 -166.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -69.92 138.37 52.36 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.268 2.034 . . . . 0.0 112.003 163.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -73.95 8.76 1.84 Allowed 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.431 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.4 ttt -78.4 99.05 6.23 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.708 -1.245 . . . . 0.0 111.795 174.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.99 73.33 4.55 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 122.504 1.145 . . . . 0.0 113.702 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -135.99 130.15 33.16 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.229 1.012 . . . . 0.0 108.507 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.11 -54.39 18.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.24 159.93 9.27 Favored Glycine 0 CA--C 1.544 1.862 0 N-CA-C 115.909 1.124 . . . . 0.0 115.909 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.0 mt -102.39 98.96 11.66 Favored Pre-proline 0 CA--C 1.575 1.908 0 C-N-CA 123.903 0.881 . . . . 0.0 108.932 168.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.61 -34.05 15.89 Favored 'Trans proline' 0 CA--C 1.567 2.131 0 C-N-CA 122.592 2.195 . . . . 0.0 117.623 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -76.98 136.0 38.72 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 119.214 0.916 . . . . 0.0 113.064 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 tt -57.12 -43.18 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 167.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -54.57 -46.15 73.64 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.18 -45.97 83.23 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 75.7 mtm-85 -66.49 -52.48 45.57 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 172.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.56 -46.62 86.5 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -57.2 -49.33 76.33 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 169.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.524 HD21 HMB1 ' A' ' 101' ' ' HEC . 44.6 tp -59.28 -46.45 88.5 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 170.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -61.72 -40.47 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-N 120.099 1.318 . . . . 0.0 112.976 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.77 -44.82 74.03 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 163.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -58.55 -47.78 83.09 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 167.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.1 mt -71.94 -23.01 61.39 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.29 -43.24 99.27 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 155.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.7 -41.91 98.84 Favored Glycine 0 CA--C 1.554 2.481 0 N-CA-C 118.056 1.982 . . . . 0.0 118.056 166.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -81.47 83.6 6.93 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 118.527 1.164 . . . . 0.0 111.351 170.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 . . . . . 0 N--CA 1.487 1.396 0 O-C-N 121.472 -0.768 . . . . 0.0 109.58 173.925 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.641 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 119.647 -0.215 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.06 83.33 7.99 Favored 'General case' 0 CA--C 1.564 1.489 0 O-C-N 121.096 -1.003 . . . . 0.0 113.091 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.57 100.05 10.33 Favored Pre-proline 0 CA--C 1.572 1.824 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.67 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -57.15 -34.64 98.12 Favored 'Trans proline' 0 CA--C 1.566 2.108 0 N-CA-C 119.605 2.887 . . . . 0.0 119.605 172.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.83 76.75 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.31 -42.35 77.48 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 162.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.97 -36.71 91.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 169.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -55.88 -46.96 78.16 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 163.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -57.62 -46.81 83.64 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 168.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.22 -39.45 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -55.21 -18.46 6.03 Favored 'General case' 0 CA--C 1.579 2.092 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.24 -37.94 6.26 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 119.6 2.6 . . . . 0.0 119.6 158.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.25 -38.72 88.54 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 164.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -79.42 -37.1 37.9 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 pptp? -56.28 -27.77 56.47 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 120.133 3.382 . . . . 0.0 120.133 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.24 -33.17 67.29 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.812 2.153 . . . . 0.0 116.812 168.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.6 m -103.69 -35.95 8.06 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -112.01 142.5 44.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -167.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -107.9 148.6 29.39 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.997 0.903 . . . . 0.0 113.288 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.97 10.29 39.8 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 171.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -123.72 62.29 1.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 120.388 1.449 . . . . 0.0 110.999 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.12 -15.72 0.71 Allowed Glycine 0 CA--C 1.558 2.768 0 N-CA-C 121.616 3.406 . . . . 0.0 121.616 172.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -90.02 161.47 15.84 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 119.215 1.508 . . . . 0.0 114.489 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -130.02 141.4 50.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.228 -1.545 . . . . 0.0 110.978 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.19 -98.8 0.18 Allowed Glycine 0 N--CA 1.489 2.186 0 O-C-N 121.732 -0.605 . . . . 0.0 112.964 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.96 -51.76 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 117.275 0.537 . . . . 0.0 111.406 167.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.03 175.97 17.64 Favored Glycine 0 CA--C 1.562 2.986 0 N-CA-C 115.067 0.787 . . . . 0.0 115.067 164.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.06 -179.06 3.97 Favored 'Trans proline' 0 CA--C 1.569 2.249 0 C-N-CA 122.723 2.282 . . . . 0.0 114.569 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -76.97 138.09 39.43 Favored 'General case' 0 CA--C 1.566 1.593 0 O-C-N 120.585 -1.322 . . . . 0.0 113.325 173.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.71 -2.57 34.97 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -65.15 113.44 3.97 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.865 1.666 . . . . 0.0 111.964 164.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.34 54.72 6.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 -168.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.2 -38.15 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 171.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -66.88 107.59 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-N 120.248 1.385 . . . . 0.0 110.118 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.26 -17.08 59.73 Favored Glycine 0 CA--C 1.551 2.342 0 N-CA-C 118.649 2.22 . . . . 0.0 118.649 -163.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -71.69 142.14 49.85 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.177 2.489 . . . . 0.0 113.107 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -59.19 136.56 57.99 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.82 126.66 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 123.465 0.706 . . . . 0.0 111.134 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 59.05 39.88 22.78 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -166.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.72 3.74 49.63 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 119.353 2.501 . . . . 0.0 119.353 -171.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.79 104.17 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 119.875 1.838 . . . . 0.0 108.375 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.75 86.24 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.458 0.647 . . . . 0.0 111.704 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.55 -46.93 0.37 Allowed Glycine 0 CA--C 1.545 1.965 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.123 -158.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -86.15 137.83 32.36 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 118.814 1.307 . . . . 0.0 112.184 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.1 85.77 3.59 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.189 0.995 . . . . 0.0 113.191 172.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -77.41 142.99 38.96 Favored 'General case' 0 CA--C 1.567 1.628 0 O-C-N 121.408 -0.808 . . . . 0.0 112.753 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.5 p -70.03 157.63 37.17 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -54.03 -49.27 90.73 Favored Pre-proline 0 CA--C 1.578 2.022 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.24 -28.0 40.56 Favored 'Trans proline' 0 CA--C 1.568 2.192 0 CA-C-N 124.328 2.582 . . . . 0.0 117.154 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.1 tpp -62.67 -47.21 84.68 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 120.379 1.445 . . . . 0.0 114.559 163.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -58.32 -47.05 84.95 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 167.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.59 -17.44 63.54 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 118.916 2.932 . . . . 0.0 118.916 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -58.38 -51.39 70.02 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.64 1.564 . . . . 0.0 114.528 175.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.84 170.65 35.8 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 117.732 1.853 . . . . 0.0 117.732 165.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.86 -143.11 26.23 Favored Glycine 0 N--CA 1.487 2.061 0 O-C-N 122.088 -0.654 . . . . 0.0 114.629 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -129.89 154.12 47.62 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.669 0.747 . . . . 0.0 111.759 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -76.26 76.75 3.05 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.929 1.347 . . . . 0.0 112.977 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.3 p -74.11 160.05 82.53 Favored Pre-proline 0 CA--C 1.573 1.865 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.662 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -58.4 -29.04 87.12 Favored 'Trans proline' 0 CA--C 1.569 2.233 0 N-CA-C 117.461 2.062 . . . . 0.0 117.461 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -66.12 -54.7 22.27 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 163.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.97 88.89 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.6 -44.55 93.36 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 164.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -57.73 -42.7 84.37 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 169.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -63.43 -55.84 21.01 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 119.967 1.258 . . . . 0.0 114.226 169.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -60.79 -42.2 97.13 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 71.2 mt -73.87 -16.33 61.12 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.9 m -64.1 -54.62 31.02 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 121.296 1.862 . . . . 0.0 112.788 161.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -149.98 115.29 3.45 Favored Pre-proline 0 CA--C 1.575 1.922 0 CA-C-N 119.625 1.102 . . . . 0.0 108.805 167.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.32 -45.78 0.32 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 CA-C-N 122.586 1.959 . . . . 0.0 116.753 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -66.11 -33.24 75.32 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.57 95.84 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 165.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.91 -58.14 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-N 118.843 0.747 . . . . 0.0 112.095 171.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.94 98.2 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -73.21 101.32 3.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.877 . . . . 0.0 111.474 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.5 19.96 10.72 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 118.559 2.184 . . . . 0.0 118.559 -164.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -76.35 132.36 39.7 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 119.964 1.882 . . . . 0.0 110.682 156.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.282 64.2 pttt -82.54 26.83 0.54 Allowed 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 170.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.02 101.3 1.37 Allowed 'General case' 0 CA--C 1.567 1.62 0 O-C-N 120.501 -1.375 . . . . 0.0 109.919 159.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.06 73.42 4.62 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.882 1.325 . . . . 0.0 112.166 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -152.42 123.33 7.48 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 114.799 -1.092 . . . . 0.0 108.094 -166.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.96 -49.63 60.61 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.35 164.42 13.09 Favored Glycine 0 CA--C 1.543 1.824 0 CA-C-O 122.686 1.159 . . . . 0.0 115.557 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.8 mt -101.99 95.16 5.25 Favored Pre-proline 0 CA--C 1.572 1.818 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 164.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.33 -34.1 16.77 Favored 'Trans proline' 0 CA--C 1.567 2.154 0 C-N-CA 122.648 2.232 . . . . 0.0 117.343 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -74.64 132.82 42.04 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-O 121.885 0.85 . . . . 0.0 112.913 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.06 -42.97 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.18 -48.27 68.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.05 -43.88 78.3 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -64.5 -52.58 57.14 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 170.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.87 82.85 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -60.1 -48.59 81.08 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 172.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.554 HD21 HMB1 ' A' ' 101' ' ' HEC . 43.2 tp -61.2 -45.71 93.45 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 172.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.25 60.6 mt -61.96 -41.09 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 119.79 1.177 . . . . 0.0 112.783 171.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.7 -43.3 80.4 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 164.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -56.71 -48.1 78.47 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 164.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.86 -23.23 61.48 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -64.9 -42.92 94.36 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.326 -1.484 . . . . 0.0 114.684 155.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.53 -56.75 23.54 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.837 1.495 . . . . 0.0 116.837 167.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -82.69 82.38 8.07 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.544 1.172 . . . . 0.0 112.285 165.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 . . . . . 0 C--O 1.259 1.6 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.947 158.626 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.813 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_